Citrus Sinensis ID: 018396
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 356 | 2.2.26 [Sep-21-2011] | |||||||
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 0.977 | 0.983 | 0.821 | 1e-166 | |
| O80719 | 365 | Probable receptor-like pr | no | no | 0.980 | 0.956 | 0.75 | 1e-148 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.839 | 0.816 | 0.770 | 1e-131 | |
| B9DFG5 | 408 | PTI1-like tyrosine-protei | no | no | 0.851 | 0.742 | 0.747 | 1e-130 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.839 | 0.828 | 0.760 | 1e-129 | |
| P93749 | 365 | Probable protein kinase A | no | no | 0.960 | 0.936 | 0.636 | 1e-122 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.808 | 0.387 | 0.478 | 3e-73 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.985 | 0.769 | 0.427 | 1e-70 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.797 | 0.401 | 0.469 | 2e-70 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.946 | 0.814 | 0.430 | 5e-68 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 584 bits (1506), Expect = e-166, Method: Compositional matrix adjust.
Identities = 286/348 (82%), Positives = 319/348 (91%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+LSEDKVK
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPRLSEDKVK 300
Query: 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
QCVD +L +YPPKAIAKMAAVAALCVQYEADFRPNM IV+KALQPLL
Sbjct: 301 QCVDARLNTDYPPKAIAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 348
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1353), Expect = e-148, Method: Compositional matrix adjust.
Identities = 270/360 (75%), Positives = 304/360 (84%), Gaps = 11/360 (3%)
Query: 1 MSCFGCC-EEDDIRKASKNG-------PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIA 52
MSCFGCC E+DD+ K + G F P N A + E K V +QPI
Sbjct: 1 MSCFGCCGEDDDMHKTADYGGRHNQAKHFPPGNDARH---HQASETAQKGPPVVKLQPIE 57
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQV 112
VP+I ELKE TD+FG+NSLIGEGSYGRVY+GVL + +AIKKLDS+KQPD EFLAQV
Sbjct: 58 VPIIPFSELKEATDDFGSNSLIGEGSYGRVYYGVLNNDLPSAIKKLDSNKQPDNEFLAQV 117
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
SMVSRLK++N V+L+GY VDG R+L+YE A+ GSLHDILHG+KGVKGA+PGPVLSW QR
Sbjct: 118 SMVSRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQR 177
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
VKIAVGAARGLEYLHEKA P IIHR+IKSSNVLLF+DD+AKI+DFDLSNQAPD AARLHS
Sbjct: 178 VKIAVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHS 237
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292
TRVLGTFGYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDH LPRGQQSLVTWATP
Sbjct: 238 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHRLPRGQQSLVTWATP 297
Query: 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352
KLSEDKVKQCVD +LGG+YPPKA+AK+AAVAALCVQYEADFRPNM IV+KALQPLLN R+
Sbjct: 298 KLSEDKVKQCVDARLGGDYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNARA 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 469 bits (1206), Expect = e-131, Method: Compositional matrix adjust.
Identities = 232/301 (77%), Positives = 267/301 (88%), Gaps = 2/301 (0%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQPDQE 107
PI VP +SVDE+KEKTDNFG+ SLIGEGSYGRVY+ L G+A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
FL QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 233 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 292
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347
TWATP+LSEDKVKQCVD KL GEYPPK++AK+AAVAALCVQYE++FRPNM IV+KALQPL
Sbjct: 293 TWATPRLSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPL 352
Query: 348 L 348
L
Sbjct: 353 L 353
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-130, Method: Compositional matrix adjust.
Identities = 228/305 (74%), Positives = 268/305 (87%), Gaps = 2/305 (0%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--EF 108
I VP +S+DELKEKTDNFG+ SLIGEGSYGR Y+ L+ G+A A+KKLD++ +P+ EF
Sbjct: 96 IDVPALSLDELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEF 155
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L QVS VS+LK++N VEL GY V+G R+LAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 156 LTQVSRVSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLD 215
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
W QRV+IAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AA
Sbjct: 216 WIQRVRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAA 275
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288
RLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVT
Sbjct: 276 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 335
Query: 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
WATP+LSEDKVKQCVD KL GEYPPKA+AK+AAVAALCVQYE++FRPNM IV+KALQPLL
Sbjct: 336 WATPRLSEDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLL 395
Query: 349 NTRSG 353
+ +
Sbjct: 396 RSSTA 400
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 462 bits (1188), Expect = e-129, Method: Compositional matrix adjust.
Identities = 229/301 (76%), Positives = 268/301 (89%), Gaps = 2/301 (0%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQPDQE 107
PI VP +S+DE+KEKT+NFG+ +LIGEGSYGRVY+ L G A A+KKLD + + D E
Sbjct: 50 PIEVPPLSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTE 109
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
FL+QVSMVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 110 FLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 169
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D AKI+DF+LSNQAPD A
Sbjct: 170 DWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNA 229
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 230 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 289
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347
TWATP+LSEDKVKQC+D KL +YPPKA+AK+AAVAALCVQYEA+FRPNM IV+KALQPL
Sbjct: 290 TWATPRLSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 349
Query: 348 L 348
L
Sbjct: 350 L 350
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1125), Expect = e-122, Method: Compositional matrix adjust.
Identities = 233/366 (63%), Positives = 287/366 (78%), Gaps = 24/366 (6%)
Query: 6 CCEEDDIRKAS--KNGPFVPNNPAGNP--GGFYVKE----------APAKEMKTVTVQPI 51
CC D A N P N AGNP GG E APAK V PI
Sbjct: 3 CCGGADEEPAGPPANQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAK------VLPI 56
Query: 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSKQPDQEFL 109
+P +++DEL NFG +LIGEGSYGRV+ G + G A AIKKLD SS++PD +F
Sbjct: 57 EIPSVALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFT 115
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
+Q+S+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LHG+KGV+GA+PGPVL+W
Sbjct: 116 SQLSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNW 175
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
QRVKIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D AAR
Sbjct: 176 NQRVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAAR 235
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
LHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTW
Sbjct: 236 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW 295
Query: 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349
ATP+LSEDKVKQC+D KL ++PPKA+AK+AAVAALCVQYEADFRPNM IV+KALQPLLN
Sbjct: 296 ATPRLSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 355
Query: 350 TR-SGP 354
++ +GP
Sbjct: 356 SKPAGP 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 275 bits (704), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 144/301 (47%), Positives = 199/301 (66%), Gaps = 13/301 (4%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-DQEFL 109
++V ++ EL++ TD F ++GEG +GRVY G + G A+K L Q D+EF+
Sbjct: 332 LSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFI 391
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
A+V M+SRL + N+V+L+G ++G R L YE GS+ LH L W
Sbjct: 392 AEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEG----------TLDW 441
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
R+KIA+GAARGL YLHE + PR+IHR+ K+SNVLL DD K+SDF L+ +A + +
Sbjct: 442 DARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 501
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
+ STRV+GTFGY APEYAMTG + KSDVYS+GVVLLELLTGR+PVD + P G+++LVTW
Sbjct: 502 I-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTW 560
Query: 290 ATPKLS-EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
A P L+ + ++Q VD L G Y +AK+AA+A++CV E RP MG V++AL+ +
Sbjct: 561 ARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIY 620
Query: 349 N 349
N
Sbjct: 621 N 621
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 267 bits (682), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 161/377 (42%), Positives = 219/377 (58%), Gaps = 26/377 (6%)
Query: 1 MSCFGCCEEDDIRKAS-----------KNGPFVPNNPAGNP-GGFYVKEAPAKEMKTVTV 48
M CF C + D K + ++ P V NN +G P GG + K +
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 49 QP------IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSS 101
P IA + EL T NF ++ +GEG +GRVY G L S G+ A+K+LD +
Sbjct: 61 LPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRN 120
Query: 102 K-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG 160
Q ++EFL +V M+S L + N+V L+GY DG R+L YE GSL D LH K
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 180
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A L W R+KIA GAA+GLE+LH+KA P +I+R+ KSSN+LL + K+SDF L+
Sbjct: 181 A-----LDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLA 235
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280
P STRV+GT+GY APEYAMTGQ++ KSDVYSFGVV LEL+TGRK +D +P
Sbjct: 236 KLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMP 295
Query: 281 RGQQSLVTWATPKLSE-DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGI 339
G+Q+LV WA P ++ K + D +L G +P +A+ + AVA++C+Q +A RP +
Sbjct: 296 HGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIAD 355
Query: 340 VLKALQPLLNTRSGPSK 356
V+ AL L N PSK
Sbjct: 356 VVTALSYLANQAYDPSK 372
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 266 bits (679), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 140/298 (46%), Positives = 193/298 (64%), Gaps = 14/298 (4%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-SSKQPDQEFLAQVS 113
+ S +EL + T+ F +L+GEG +G VY G+L GR A+K+L Q D+EF A+V
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
+SR+ + ++V +VG+ + G R+L Y++ S L+ LHG+K V L WA RV
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSV--------LDWATRV 475
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
KIA GAARGL YLHE PRIIHR+IKSSN+LL D+ A++SDF L+ A D + +T
Sbjct: 476 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHI-TT 534
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
RV+GTFGY APEYA +G+++ KSDV+SFGVVLLEL+TGRKPVD + P G +SLV WA P
Sbjct: 535 RVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPL 594
Query: 294 LSE----DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347
+S ++ D KLGG Y + +M A CV++ A RP MG +++A + L
Sbjct: 595 ISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESL 652
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (659), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 155/360 (43%), Positives = 213/360 (59%), Gaps = 23/360 (6%)
Query: 1 MSCFGC--------CEEDDIRKASKNGPFV--PNNPAG--NPGGFYVKEAPAKEMKTVTV 48
M+CF C D +NG NN NP + E K VT
Sbjct: 1 MNCFSCFYFHEKKKVPRDSDNSYRRNGEVTGRDNNKTHPENPKTVNEQNKNNDEDKEVT- 59
Query: 49 QPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK-QPDQ 106
IA S EL T NF LIGEG +GRVY G L ++G A+K+LD + Q ++
Sbjct: 60 NNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNK 119
Query: 107 EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
EF+ +V M+S L ++++V L+GY DG R+L YE+ S+GSL D L P +
Sbjct: 120 EFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHL------LDLTPDQI 173
Query: 167 -LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
L W R++IA+GAA GLEYLH+KA P +I+R++K++N+LL + AK+SDF L+ P
Sbjct: 174 PLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPV 233
Query: 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285
+ S+RV+GT+GY APEY TGQ+++KSDVYSFGVVLLEL+TGR+ +D T P+ +Q+
Sbjct: 234 GDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQN 293
Query: 286 LVTWATPKLSE-DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344
LVTWA P E + + D L G +P KA+ + AVAA+C+Q EA RP M V+ AL
Sbjct: 294 LVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 356 | ||||||
| 225432163 | 360 | PREDICTED: pto-interacting protein 1 [Vi | 0.991 | 0.980 | 0.839 | 1e-168 | |
| 170676254 | 354 | Pto kinase interactor 1 [Capsicum annuum | 0.977 | 0.983 | 0.827 | 1e-165 | |
| 357442089 | 476 | Pto kinase interactor [Medicago truncatu | 0.997 | 0.745 | 0.803 | 1e-164 | |
| 357442087 | 361 | Pto kinase interactor [Medicago truncatu | 0.997 | 0.983 | 0.803 | 1e-164 | |
| 350537875 | 354 | pto-interacting protein 1 [Solanum lycop | 0.977 | 0.983 | 0.821 | 1e-164 | |
| 255548287 | 362 | Serine/threonine-protein kinase PBS1, pu | 0.997 | 0.980 | 0.803 | 1e-162 | |
| 225437716 | 362 | PREDICTED: pto-interacting protein 1 [Vi | 0.997 | 0.980 | 0.806 | 1e-162 | |
| 359811321 | 361 | pto-interacting protein 1-like [Glycine | 0.997 | 0.983 | 0.797 | 1e-161 | |
| 351727493 | 360 | Pti1 kinase-like protein [Glycine max] g | 0.997 | 0.986 | 0.766 | 1e-160 | |
| 351727899 | 360 | Pti1 kinase-like protein [Glycine max] g | 0.997 | 0.986 | 0.758 | 1e-159 |
| >gi|225432163|ref|XP_002267003.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297736804|emb|CBI26005.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1535), Expect = e-168, Method: Compositional matrix adjust.
Identities = 298/355 (83%), Positives = 325/355 (91%), Gaps = 2/355 (0%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPA-GNPGGFYVKEAP-AKEMKTVTVQPIAVPVISV 58
MSCF CCEEDDI KAS GP+V NN A G+ G +++ EA + + +TV V PIAV ISV
Sbjct: 1 MSCFSCCEEDDIHKASDTGPYVANNSAVGHNGNYHMTEASRSNDTQTVDVLPIAVSAISV 60
Query: 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
DELKE TDNFG +LIGEGSYGRVY G+L++G+AAAIKKLDSSKQPDQEFLAQVSMVSRL
Sbjct: 61 DELKEITDNFGQQALIGEGSYGRVYHGLLKTGQAAAIKKLDSSKQPDQEFLAQVSMVSRL 120
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
KNENVVELVGY VDG LRV+AYE+AS GSLHDILHG+KGVKGA+PGPVLSW+QRVKIAVG
Sbjct: 121 KNENVVELVGYSVDGGLRVVAYEYASNGSLHDILHGRKGVKGAQPGPVLSWSQRVKIAVG 180
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
AA+GLEYLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD+AARLHSTRVLGT
Sbjct: 181 AAKGLEYLHEKARPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDSAARLHSTRVLGT 240
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
FGYHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK
Sbjct: 241 FGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 300
Query: 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353
VKQCVDT+LGGEYPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLLN R G
Sbjct: 301 VKQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 355
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|170676254|gb|ACB30366.1| Pto kinase interactor 1 [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 288/348 (82%), Positives = 319/348 (91%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CCE+DD+ +AS NGPF+ +N AGN GG + E+ KE +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCEDDDMNRASDNGPFMAHNSAGNNGGLHATESAQKEPQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSW QRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWVQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+LSEDKVK
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPRLSEDKVK 300
Query: 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
QCVD +L +YPPKAIAKMAAVAALCVQYEADFRPNM IV+KALQPLL
Sbjct: 301 QCVDARLNTDYPPKAIAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 348
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442089|ref|XP_003591322.1| Pto kinase interactor [Medicago truncatula] gi|355480370|gb|AES61573.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1507), Expect = e-164, Method: Compositional matrix adjust.
Identities = 286/356 (80%), Positives = 324/356 (91%), Gaps = 1/356 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEED+ KA+++G P+V NPAGN G ++ + + +TV VQPI VP I D
Sbjct: 116 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 175
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG +SLIGEGSYGRVY+GVL+SG+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 176 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 235
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 236 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 295
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 296 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 355
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 356 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 415
Query: 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355
+QCVDT+LGGEYPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLL R+GP+
Sbjct: 416 RQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARAGPA 471
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442087|ref|XP_003591321.1| Pto kinase interactor [Medicago truncatula] gi|355480369|gb|AES61572.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1507), Expect = e-164, Method: Compositional matrix adjust.
Identities = 286/356 (80%), Positives = 324/356 (91%), Gaps = 1/356 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEED+ KA+++G P+V NPAGN G ++ + + +TV VQPI VP I D
Sbjct: 1 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG +SLIGEGSYGRVY+GVL+SG+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 121 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355
+QCVDT+LGGEYPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLL R+GP+
Sbjct: 301 RQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARAGPA 356
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350537875|ref|NP_001233803.1| pto-interacting protein 1 [Solanum lycopersicum] gi|75319610|sp|Q41328.2|PTI1_SOLLC RecName: Full=Pto-interacting protein 1; Short=Pti1; AltName: Full=Pto kinase interactor 1 gi|3668069|gb|AAC61805.1| Pto kinase interactor 1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 286/348 (82%), Positives = 319/348 (91%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+LSEDKVK
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPRLSEDKVK 300
Query: 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
QCVD +L +YPPKAIAKMAAVAALCVQYEADFRPNM IV+KALQPLL
Sbjct: 301 QCVDARLNTDYPPKAIAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 348
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548287|ref|XP_002515200.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223545680|gb|EEF47184.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1490), Expect = e-162, Method: Compositional matrix adjust.
Identities = 286/356 (80%), Positives = 321/356 (90%), Gaps = 1/356 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEEDD+ KA+ +G P+ + AGN GG++ E + + V +QPI VP ISVD
Sbjct: 1 MSCFGCCEEDDMHKAADSGGPYPVKSSAGNVGGYHASETAPRGAQAVKIQPIEVPSISVD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG NSLIGEGSYGRVY+G+L+SG+AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGINSLIGEGSYGRVYYGILKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY VDG RVLAYE AS GSLHDILHG+KGVKGA+PGPVLSW QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A+GLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355
+QCVDT+L G+YPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLLN R GP+
Sbjct: 301 RQCVDTRLQGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA 356
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225437716|ref|XP_002280340.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297744052|emb|CBI37022.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1488), Expect = e-162, Method: Compositional matrix adjust.
Identities = 287/356 (80%), Positives = 321/356 (90%), Gaps = 1/356 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCE+DDI A ++G PF NPAGN GG+ + K + V VQPIAVP I D
Sbjct: 1 MSCFGCCEDDDIHTAPESGNPFAAKNPAGNDGGYRHTDPAPKGTQAVKVQPIAVPPIPFD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFGT++LIGEGSYGRVY+G+L++G+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEITDNFGTSALIGEGSYGRVYYGLLKNGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N VEL+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGP+LSWAQRVKIAVGA
Sbjct: 121 HDNFVELIGYCVDGGSRILAYEFASNGSLHDILHGRKGVKGAQPGPILSWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGL+YLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLDYLHEKASPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355
+QCVDT+LG +YPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLLN R GPS
Sbjct: 301 RQCVDTRLGQDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPS 356
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359811321|ref|NP_001241285.1| pto-interacting protein 1-like [Glycine max] gi|223452480|gb|ACM89567.1| serine/threonine protein kinase [Glycine max] gi|255639418|gb|ACU20004.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 574 bits (1480), Expect = e-161, Method: Compositional matrix adjust.
Identities = 284/356 (79%), Positives = 319/356 (89%), Gaps = 1/356 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCF CCEEDD+ KA+++G P+V NPAGN G + E + + V QPI VP IS D
Sbjct: 1 MSCFSCCEEDDLHKAAESGGPYVVKNPAGNDGNYLASETAKQGTQPVKPQPIEVPNISAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG ++LIGEGSYGRVY+GVL+S AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDALIGEGSYGRVYYGVLKSELAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY +DG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 121 HENFVQLLGYCIDGSSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355
+QCVDT+LGGEYPPKA+AKMAAVAALCVQYEADFRPNM IV+KALQPLL R GP+
Sbjct: 301 RQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARPGPA 356
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727493|ref|NP_001235115.1| Pti1 kinase-like protein [Glycine max] gi|9651969|gb|AAF91336.1|AF249317_1 Pti1 kinase-like protein [Glycine max] gi|255647015|gb|ACU23976.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 273/356 (76%), Positives = 307/356 (86%), Gaps = 1/356 (0%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
M CFG C+ DD + GPF+ + P GNP ++ + A +T+ VQPIAVP I+VDE
Sbjct: 1 MGCFGFCKGDDSVTVADRGPFMQSTPTGNPS-YHGRHAAVTAPRTINVQPIAVPSITVDE 59
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK TDNFG+ IGEG+YG+VY L++GRA IKKLDSS QP+ EFL+QVS+VSRLK+
Sbjct: 60 LKPLTDNFGSKCFIGEGAYGKVYQATLKNGRAVVIKKLDSSNQPEHEFLSQVSIVSRLKH 119
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVELV Y VDGP R LAYE+A KGSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 120 ENVVELVNYCVDGPFRALAYEYAPKGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 179
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGLEYLHEKAE IIHR IKSSN+LLFDDD+AKI+DFDLSNQAPDAAARLHSTRVLGTFG
Sbjct: 180 RGLEYLHEKAEIHIIHRYIKSSNILLFDDDVAKIADFDLSNQAPDAAARLHSTRVLGTFG 239
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTGQ++SKSDVYSFGV+LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK
Sbjct: 240 YHAPEYAMTGQLTSKSDVYSFGVILLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 299
Query: 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPSK 356
QCVD +L GEYP K++AKMAAVAALCVQYEA+FRPNM I++KALQPLLNTRS SK
Sbjct: 300 QCVDVRLKGEYPSKSVAKMAAVAALCVQYEAEFRPNMSIIVKALQPLLNTRSSHSK 355
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727899|ref|NP_001235129.1| Pti1 kinase-like protein [Glycine max] gi|9651971|gb|AAF91337.1|AF249318_1 Pti1 kinase-like protein [Glycine max] gi|255641915|gb|ACU21226.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1460), Expect = e-159, Method: Compositional matrix adjust.
Identities = 270/356 (75%), Positives = 305/356 (85%), Gaps = 1/356 (0%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
M CFG C+ DD + GPF+ + P GNP ++ + +T+ QPIAVP I+VDE
Sbjct: 1 MGCFGFCKGDDSVTVADRGPFMQSTPTGNPS-YHGRHTAVTAPRTINFQPIAVPSITVDE 59
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK TDNFG+ IGEG+YG+VY L++G A IKKLDSS QP+QEFL+QVS+VSRLK+
Sbjct: 60 LKSLTDNFGSKYFIGEGAYGKVYQATLKNGHAVVIKKLDSSNQPEQEFLSQVSIVSRLKH 119
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVELV Y VDGP R LAYE+A KGSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 120 ENVVELVNYCVDGPFRALAYEYAPKGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 179
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGLEYLHEKAE IIHR IKSSN+LLFDDD+AK++DFDLSNQAPDAAARLHSTRVLGTFG
Sbjct: 180 RGLEYLHEKAEIHIIHRYIKSSNILLFDDDVAKVADFDLSNQAPDAAARLHSTRVLGTFG 239
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTGQ++SKSDVYSFGV+LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK
Sbjct: 240 YHAPEYAMTGQLTSKSDVYSFGVILLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 299
Query: 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPSK 356
QCVD +L GEYP K++AKMAAVAALCVQYEA+FRPNM I++KALQPLLNTRS SK
Sbjct: 300 QCVDVRLKGEYPSKSVAKMAAVAALCVQYEAEFRPNMSIIVKALQPLLNTRSVHSK 355
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 356 | ||||||
| TAIR|locus:2088990 | 364 | AT3G17410 [Arabidopsis thalian | 0.994 | 0.972 | 0.721 | 2.3e-135 | |
| TAIR|locus:2023767 | 363 | AT1G48210 [Arabidopsis thalian | 0.994 | 0.975 | 0.715 | 3.3e-134 | |
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 0.997 | 0.983 | 0.707 | 1e-130 | |
| TAIR|locus:2023752 | 364 | AT1G48220 [Arabidopsis thalian | 0.994 | 0.972 | 0.617 | 1.7e-114 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.971 | 0.848 | 0.622 | 4.6e-112 | |
| TAIR|locus:2054502 | 366 | AT2G30740 [Arabidopsis thalian | 0.839 | 0.816 | 0.717 | 5.9e-112 | |
| TAIR|locus:2009115 | 361 | AT1G06700 [Arabidopsis thalian | 0.876 | 0.864 | 0.690 | 2.6e-111 | |
| TAIR|locus:2064557 | 365 | AT2G41970 [Arabidopsis thalian | 0.985 | 0.961 | 0.585 | 1.9e-106 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.876 | 0.923 | 0.649 | 1.2e-104 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.817 | 0.401 | 0.486 | 9.2e-68 |
| TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1326 (471.8 bits), Expect = 2.3e-135, P = 2.3e-135
Identities = 257/356 (72%), Positives = 288/356 (80%)
Query: 1 MSCFGCCEE-DDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
M CFGCC +D R+ S+ GP +N G GG + + P K + + +QPI+V I D
Sbjct: 1 MGCFGCCGGGEDFRRVSETGPKPVHNTGGYNGGHHQRADPPKNLPVIQMQPISVAAIPAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
EL++ TDN+G+ SLIGEGSYGRV++G+L+SG+AAAIKKLDSSKQPDQEFLAQVSMVSRL+
Sbjct: 61 ELRDITDNYGSKSLIGEGSYGRVFYGILKSGKAAAIKKLDSSKQPDQEFLAQVSMVSRLR 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGA 179
ENVV L+GY VDGPLRVLAYE+A GSLHDILH LSW QRVKIAVGA
Sbjct: 121 QENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA P +IHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTG +S+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQS+VTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSVVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNT-RSGP 354
KQCVD +L GEYPPK LCVQYEADFRPNM IV+KALQPLLN RS P
Sbjct: 301 KQCVDARLNGEYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNPPRSAP 356
|
|
| TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1315 (468.0 bits), Expect = 3.3e-134, P = 3.3e-134
Identities = 254/355 (71%), Positives = 286/355 (80%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCFG C +D R A+ GP +NPAG GG Y + P + +QPI+VP I VDE
Sbjct: 1 MSCFGWCGSEDFRNATDTGPRPAHNPAGYNGGHYQRADPPMNQPVIPMQPISVPAIPVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
L++ TDN+G+ +LIGEGSYGRV++GVL+SG AAAIKKLDSSKQPDQEFL+Q+SMVSRL++
Sbjct: 61 LRDITDNYGSKTLIGEGSYGRVFYGVLKSGGAAAIKKLDSSKQPDQEFLSQISMVSRLRH 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGAA 180
+NV L+GY VDGPLRVLAYE A KGSLHD LH ++W QRVKIAVGAA
Sbjct: 121 DNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVMTWQQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGLEYLHEK P++IHR+IKSSNVLLFDDD+AKI DFDLS+QAPD AARLHSTRVLGTFG
Sbjct: 181 RGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTG +SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK
Sbjct: 241 YHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Query: 301 QCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNT-RSGP 354
QCVD +L GEYPPK LCVQYEA+FRPNM IV+KALQPLLN RS P
Sbjct: 301 QCVDARLLGEYPPKAVGKLAAVAALCVQYEANFRPNMSIVVKALQPLLNPPRSAP 355
|
|
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 252/356 (70%), Positives = 283/356 (79%)
Query: 1 MSCFGCCEEDDIRKASKNGPF-VPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCC EDD+ A+ G + GN G E K ++V VQPI V I D
Sbjct: 1 MSCFGCCREDDLPGANDYGGHNMTKQSGGNDGRRNGSETAQKGAQSVKVQPIEVAAILAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
EL E T++FGTNSLIGEGSY RVY GVL++G+ AAIKKLDS+KQP++EFLAQVSMVSRLK
Sbjct: 61 ELIEATNDFGTNSLIGEGSYARVYHGVLKNGQRAAIKKLDSNKQPNEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGA 179
+ N VEL+GY VDG R+L +E A GSLHDILH LSW QRVKIAVGA
Sbjct: 121 HVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA P +IHR+IKSSNVL+FD+D+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+S+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLSAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355
KQCVD++LGG+YPPK LCVQYEADFRPNM IV+KALQPLLN R+GP+
Sbjct: 301 KQCVDSRLGGDYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNARTGPA 356
|
|
| TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 1.7e-114, P = 1.7e-114
Identities = 220/356 (61%), Positives = 268/356 (75%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCFG C +D+R + GP +N G G + + P V +QPIAVP I VDE
Sbjct: 1 MSCFGWCGSEDVRNPADTGPSQAHNSIGYNGRHHQRADPPMNQPVVNMQPIAVPAIPVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
L++ T+NF + L+G+GSYGRV++GVL+SG+ AAIKKL +KQPDQEFL+QVSMVSRL +
Sbjct: 61 LEDITENFSSEVLVGKGSYGRVFYGVLKSGKEAAIKKLYPTKQPDQEFLSQVSMVSRLHH 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGAA 180
ENVV L+ Y VDGPLRVLAYE A+ G+LHD+LH ++W +RVKIA+GAA
Sbjct: 121 ENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVMTWQRRVKIALGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV-LGTF 239
RGLEYLH+K P++IHR+IK+SN+LLFDDDIAKI DFDL +QAP+ A RLHS R+ LG
Sbjct: 181 RGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMAGRLHSCRMALGAS 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
H PE+AMTG +++KSDVYSFGVVLLELLTGRKPVD TLPRGQQ+LVTWATPKLS+DKV
Sbjct: 241 RSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRTLPRGQQNLVTWATPKLSKDKV 300
Query: 300 KQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNT-RSGP 354
KQCVD +L GEYPPK CV Y+ DFRP+M IV+KALQPLLN+ RS P
Sbjct: 301 KQCVDARLLGEYPPKAVAKLAAVSARCVHYDPDFRPDMSIVVKALQPLLNSSRSSP 356
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1106 (394.4 bits), Expect = 4.6e-112, P = 4.6e-112
Identities = 219/352 (62%), Positives = 260/352 (73%)
Query: 3 CFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQP--IAVPVISVDE 60
C C E+ + P + N G + ++ A +P I VP +S+DE
Sbjct: 48 CCACHVEEPYHSSENEHLRSPKHH--NDFGHHTRKPQAAVKPDALKEPPSIDVPALSLDE 105
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRL 118
LKEKTDNFG+ SLIGEGSYGR Y+ L+ G+A A+KKLD++ +P+ EFL QVS VS+L
Sbjct: 106 LKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRVSKL 165
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVG 178
K++N VEL GY V+G R+LAYE A+ GSLHDILH L W QRV+IAV
Sbjct: 166 KHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRIAVD 225
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AARLHSTRVLGT
Sbjct: 226 AARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRVLGT 285
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
FGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+LSEDK
Sbjct: 286 FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK 345
Query: 299 VKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNT 350
VKQCVD KL GEYPPK LCVQYE++FRPNM IV+KALQPLL +
Sbjct: 346 VKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRS 397
|
|
| TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1105 (394.0 bits), Expect = 5.9e-112, P = 5.9e-112
Identities = 216/301 (71%), Positives = 245/301 (81%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--E 107
PI VP +SVDE+KEKTDNFG+ SLIGEGSYGRVY+ L G+A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXL 167
FL QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 233 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 292
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPL 347
TWATP+LSEDKVKQCVD KL GEYPPK LCVQYE++FRPNM IV+KALQPL
Sbjct: 293 TWATPRLSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPL 352
Query: 348 L 348
L
Sbjct: 353 L 353
|
|
| TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
Identities = 219/317 (69%), Positives = 255/317 (80%)
Query: 36 KEAP-AK-EMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAA 93
K AP AK E+K + PI VP +S+DE+KEKT+NFG+ +LIGEGSYGRVY+ L G A
Sbjct: 35 KPAPVAKHEVKKEAL-PIEVPPLSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAV 93
Query: 94 AIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDI 151
A+KKLD + + D EFL+QVSMVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDI
Sbjct: 94 ALKKLDVAPEAETDTEFLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDI 153
Query: 152 LHXXXXXXXXXXXXXLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211
LH L W RVKIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D
Sbjct: 154 LHGRKGVQGAQPGPTLDWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYK 213
Query: 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271
AKI+DF+LSNQAPD AARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTG
Sbjct: 214 AKIADFNLSNQAPDNAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 273
Query: 272 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEA 331
RKPVDHT+PRGQQSLVTWATP+LSEDKVKQC+D KL +YPPK LCVQYEA
Sbjct: 274 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEA 333
Query: 332 DFRPNMGIVLKALQPLL 348
+FRPNM IV+KALQPLL
Sbjct: 334 EFRPNMSIVVKALQPLL 350
|
|
| TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1053 (375.7 bits), Expect = 1.9e-106, P = 1.9e-106
Identities = 213/364 (58%), Positives = 266/364 (73%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNP--GGFYVKE-----APAKEMKTVTVQPIAV 53
M C G +E+ + N P N AGNP GG E AP + V PI +
Sbjct: 1 MFCCGGADEEPAGPPA-NQYAAPPNKAGNPNFGGGNRGEPRNPNAP-RSGAPAKVLPIEI 58
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSKQPDQEFLAQ 111
P +++DEL NFG +LIGEGSYGRV+ G + G A AIKKLD SS++PD +F +Q
Sbjct: 59 PSVALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQ 117
Query: 112 VSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQ 171
+S+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LH L+W Q
Sbjct: 118 LSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQ 177
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
RVKIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D AARLH
Sbjct: 178 RVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLH 237
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291
STRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTWAT
Sbjct: 238 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT 297
Query: 292 PKLSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQPLLNTR 351
P+LSEDKVKQC+D KL ++PPK LCVQYEADFRPNM IV+KALQPLLN++
Sbjct: 298 PRLSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK 357
Query: 352 -SGP 354
+GP
Sbjct: 358 PAGP 361
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
Identities = 204/314 (64%), Positives = 242/314 (77%)
Query: 37 EAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIK 96
+ P K + PI VP +SVDE+ E+TDNFG NSLIGEGSYGRVY+ L G+A A+K
Sbjct: 16 QKPQDLAKPKEILPIIVPSLSVDEVNEQTDNFGPNSLIGEGSYGRVYYATLNDGKAVALK 75
Query: 97 KLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHX 154
KLD + + + EFL+QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH
Sbjct: 76 KLDLAPEDETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHG 135
Query: 155 XXXXXXXXXXXXLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214
L W RVKIAV AARGLEYLHEK +P++IHR+I+SSN+LLFDD AKI
Sbjct: 136 RKGVQDALPGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKI 195
Query: 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+DF+LSNQ+PD AARL STRVLG+FGY++PEYAMTG+++ KSDVY FGVVLLELLTGRKP
Sbjct: 196 ADFNLSNQSPDNAARLQSTRVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKP 255
Query: 275 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFR 334
VDHT+PRGQQSLVTWATPKLSED V++CVD KL GEY PK LCVQYE++ R
Sbjct: 256 VDHTMPRGQQSLVTWATPKLSEDTVEECVDPKLKGEYSPKSVAKLAAVAALCVQYESNCR 315
Query: 335 PNMGIVLKALQPLL 348
P M V+KALQ LL
Sbjct: 316 PKMSTVVKALQQLL 329
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 9.2e-68, P = 9.2e-68
Identities = 146/300 (48%), Positives = 196/300 (65%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS-KQPDQEF 108
P + +S +ELKE T NF + S++GEG +G+VY G+L G A AIKKL S Q D+EF
Sbjct: 362 PASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEF 421
Query: 109 LAQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXX 166
++ M+SRL + N+V+LVGYY D +L YE GSL LH
Sbjct: 422 QVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCP----- 476
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L W R+KIA+ AARGL YLHE ++P +IHR+ K+SN+LL ++ AK++DF L+ QAP+
Sbjct: 477 LDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEG 536
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
STRV+GTFGY APEYAMTG + KSDVYS+GVVLLELLTGRKPVD + P GQ++L
Sbjct: 537 RGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 596
Query: 287 VTWATPKLSE-DKVKQCVDTKLGGEYPPKXXXXXXXXXXLCVQYEADFRPNMGIVLKALQ 345
VTW P L + D++++ VD++L G+YP + CV EA RP MG V+++L+
Sbjct: 597 VTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLK 656
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O80719 | Y2706_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.75 | 0.9803 | 0.9561 | no | no |
| O49339 | PTI12_ARATH | 2, ., 7, ., 1, 0, ., 2 | 0.7707 | 0.8398 | 0.8169 | no | no |
| Q41328 | PTI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.8218 | 0.9775 | 0.9830 | N/A | no |
| Q8H1G6 | PTI11_ARATH | 2, ., 7, ., 1, 0, ., 2 | 0.7607 | 0.8398 | 0.8282 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00019712001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (360 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 356 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.004 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 9e-49
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 38/283 (13%)
Query: 71 NSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENV 123
+GEG++G VY G L+ A+K L Q EFL + ++ +L + NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V+L+G + + E+ G L L K P LS + + A+ ARG+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR--------KNRPKLSLSDLLSFALQIARGM 115
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYH 242
EYL K IHR++ + N L+ ++ + KISDF LS + D R ++ +
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWM 170
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301
APE G+ +SKSDV+SFGV+L E+ T G +P P +S ++V +
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLE 214
Query: 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344
+ PP ++ + C + + RP +++ L
Sbjct: 215 YLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 3e-48
Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
+GEG +G VY + +G+ AIK + +E L ++ ++ +L + N+V+L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
D L E+ GSL D+L +G LS + ++I + GLEYLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSN- 111
Query: 191 EPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-YAM 248
IIHR++K N+LL D+ K++DF LS + L + GT Y APE
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLG 167
Query: 249 TGQMSSKSDVYSFGVVLLEL 268
G S KSD++S GV+L EL
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 5e-48
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 37/283 (13%)
Query: 71 NSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENV 123
+GEG++G VY G L+ A+K L Q EFL + ++ +L + N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V+L+G + ++ E+ G L D L + LS + + A+ ARG+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-------KELSLSDLLSFALQIARGM 116
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYH 242
EYL K IHR++ + N L+ ++ + KISDF LS + D ++ ++ +
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWM 171
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301
APE G+ +SKSDV+SFGV+L E+ T G +P P +S +V +
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP----------------YPGMSNAEVLE 215
Query: 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344
+ PP ++ + C + + RP +++ L
Sbjct: 216 YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 5e-44
Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 32/282 (11%)
Query: 74 IGEGSYGRVYFGVLRSG----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELV 127
+GEG++G VY G L+ A+K L ++ +FL + ++ +L + NVV L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + L E+ G L D L + V + LS + A+ A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYHAPEY 246
K + +HR++ + N L+ +D + KISDF LS + D R + L + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPES 178
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV-- 303
G +SKSDV+SFGV+L E+ T G P P LS ++V + +
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPY----------------PGLSNEEVLEYLRK 222
Query: 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345
+L P ++ + C Q + + RP +++ L+
Sbjct: 223 GYRL--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 4e-43
Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 41/284 (14%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G VY G L+ + A+K L +S++ +EFL + S++ +L + N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G G + E+ G L D L K G L+ +++A+ A+G+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPE 245
K +HR++ + N L+ ++ + KISDF LS D R L APE
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304
G+ +SKSDV+SFGV+L E+ T G +P P +S ++V + ++
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLELLE 218
Query: 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
P ++ + C Y+ + RP L L
Sbjct: 219 DGYRLPRPENCPDELYELMLQCWAYDPEDRPTF----SELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 4e-42
Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
+G GS+G VY + G+ A+K L + DQ ++ ++ RL + N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ D L E+ G L D L LS + KIA+ RGLEYLH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIALQILRGLEYLHSN 117
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
IIHR++K N+LL ++ + KI+DF L+ + +++ L + +GT Y APE +
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLG 172
Query: 250 GQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
G K DV+S GV+L ELLTG+ P Q L+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 3e-40
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEGS+G+VY ++G+ AIK + K + ++ +LK+ N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ D L E+ G L D+L + LS + LEYLH K
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSALEYLHSK 116
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
I+HR++K N+LL +D K++DF L+ Q +T V GT Y APE +
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPEVLLG 170
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
D++S GV+L ELLTG+ P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IG+G +G VY R+G+ AIK + + +E + + ++ + K+ N+V+ G Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
L + E S GSL D+L L+ +Q + +GLEYLH
Sbjct: 68 KKDELW-IVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKGLEYLHSN- 117
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
IIHR+IK++N+LL D K+ DF LS Q D AR ++GT + APE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVINGK 172
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
K+D++S G+ +EL G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-36
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELVG 128
L+G GS+G VY + + +G A+K ++ S++ + ++ ++S L++ N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 129 YYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVL-SWAQRVKIAVGAARGLEY 185
D L E+ S GSL +L + P PV+ + +++ GL Y
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL----PEPVIRKYTRQI------LEGLAY 116
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH I+HR+IK +N+L+ D + K++DF + + D + V GT + APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +D++S G ++E+ TG+ P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 70/204 (34%), Positives = 116/204 (56%), Gaps = 17/204 (8%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+ IG+G +G V G R G+ A+K L Q FLA+ S+++ L++ N+V+L+G +
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E+ +KGSL D L ++ V++ AQ++ A+ G+EYL EK
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLR-------SRGRAVITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+HR++ + NVL+ +D +AK+SDF L A +A+ S ++ + APE +
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGL---AKEASQGQDSGKL--PVKWTAPEALREKK 175
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
S+KSDV+SFG++L E+ + GR P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLK-NENVVEL 126
+GEGS+G VY R + A+K L + + FL ++ +++ L N+V+L
Sbjct: 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
++ D L E+ GSL D+L L ++ LEYL
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI------LSALEYL 117
Query: 187 HEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTR----VLGTFGY 241
H K IIHR+IK N+LL D + K+ DF L+ PD + +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 242 HAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE + SS SD++S G+ L ELLTG P +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 3e-29
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 42/220 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG+GS+G+VY G+ +K++D S ++E L +V ++ +L + N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP---VLSWAQRVKIAVGAARGLEY 185
+ + + E+A G L + KK K KP P +L W V++ + L+Y
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWF--VQLCLA----LKY 118
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFG 240
LH + +I+HR+IK N+ L + + K+ DF +S L ST V+GT
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSSTVDLAKTVVGTPY 168
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y +PE Y + KSD++S G VL EL T + P
Sbjct: 169 YLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNENVVELVG 128
LIG G++G VY G+ L +G AIK++ K ++ + ++ ++ LK+ N+V+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ E+A GSL I+ K GP + +GL YLHE
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK--------KFGP-FPESLVAVYVYQVLQGLAYLHE 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+ +IHR+IK++N+L D + K++DF ++ + D + S V+GT + APE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIE 172
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
S+ SD++S G ++ELLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 5e-28
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 18/213 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEFLAQVSMVSRLKNEN 122
+ ++G+GS G VY + +G+ A+KK +D ++ ++ L ++ + ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 123 VVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
VV+ G +Y +G + + E+ GSL D+L + P PVL+ IA +
Sbjct: 61 VVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLA-----YIARQILK 110
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL+YLH K IIHR+IK SN+L+ KI+DF +S + + +T V GT Y
Sbjct: 111 GLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-GTVTY 166
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE S +D++S G+ LLE G+ P
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 77/265 (29%), Positives = 136/265 (51%), Gaps = 39/265 (14%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IGEG +G V G +G+ A+K K D + Q FL + +++++L ++N+V L+G +
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
L ++ E SKG+L + L + ++S Q ++ ++ A G+EYL K
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+++HR++ + N+L+ +D +AK+SDF L+ + ++++ + APE +
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKL--PVKWTAPEALKHKK 173
Query: 252 MSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE 310
SSKSDV+S+GV+L E+ + GR P PK+S +VK+CV+ E
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPY----------------PKMSLKEVKECVEKGYRME 217
Query: 311 YPPKAIAKMAAVAALCVQYEADFRP 335
P A + + C + E RP
Sbjct: 218 PPEGCPADVYVLMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 74 IGEGSYGRVYFGVLR--SGR--AAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V GV SG+ A+K L + +EFL + S++++L + +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G G +L E A G L L ++ + + + A +V A G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV------AMGMAYLE 112
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG------Y 241
K +HR++ + NVLL + AKISDF +S A S T +
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGSDYYRATTAGRWPLKW 164
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+APE G+ SSKSDV+S+GV L E + G KP
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 71/247 (28%), Positives = 124/247 (50%), Gaps = 27/247 (10%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVEL 126
F +GEGSYG VY + + +G+ AIK + ++ QE + ++S++ + + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 127 VG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G Y+ + L ++ E+ GS+ DI+ L+ + I +GLEY
Sbjct: 64 YGSYFKNTDLWIVM-EYCGAGSVSDIMKIT--------NKTLTEEEIAAILYQTLKGLEY 114
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH + IHR+IK+ N+LL ++ AK++DF +S Q D A+ ++ V+GT + APE
Sbjct: 115 LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPE 169
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSE-------- 296
++K+D++S G+ +E+ G+ P P R + P LS+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229
Query: 297 -DKVKQC 302
D VK+C
Sbjct: 230 NDFVKKC 236
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 71/278 (25%), Positives = 131/278 (47%), Gaps = 34/278 (12%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG+G++G VY GVL+ A+K S+ PD ++FL + ++ + + N+V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V + E GSL L KK L+ + +++++ AA G+EYL K
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAAGMEYLESK- 112
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
IHR++ + N L+ ++++ KISDF +S + + + APE G
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 251 QMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG 309
+ +S+SDV+S+G++L E + G P P +S + ++ +++ G
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPY----------------PGMSNQQTRERIES--GY 212
Query: 310 EYPPKAI--AKMAAVAALCVQYEADFRPNMGIVLKALQ 345
P + ++ + C Y+ + RP+ + LQ
Sbjct: 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 71/207 (34%), Positives = 112/207 (54%), Gaps = 19/207 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG-Y 129
+G G+ G V + R +G+ A+K +L+ ++ ++ L ++ ++ + + +V G +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
Y +G + + E+ GSL IL K V+G P +L KIAV +GL YLHEK
Sbjct: 69 YNNGDI-SICMEYMDGGSLDKIL---KEVQGRIPERILG-----KIAVAVLKGLTYLHEK 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+IIHR++K SN+L+ K+ DF +S Q ++ A+ T V GT Y APE
Sbjct: 120 H--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFV-GTSSYMAPERIQG 173
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKPVD 276
S KSD++S G+ L+EL TGR P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 71/267 (26%), Positives = 126/267 (47%), Gaps = 32/267 (11%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGY 129
IG+GS+G V+ V ++ R A+K++D SK + +E + + ++++L + ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
++D + E+A G LH +L ++G +P L Q + + GL +LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRG----RP---LPEDQVWRFFIQILLGLAHLHSK 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+I+HR+IKS N+ L D KI D ++ D + ++GT Y +PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCED 175
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG 309
+ KSDV++ GVVL E TG+ P D Q +L+ K+ + V +
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALIL---------KIIRGVFPPVSQ 223
Query: 310 EYPPKAIAKMAAVAALCVQYEADFRPN 336
Y ++A + C+ + RP+
Sbjct: 224 MYSQ----QLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 73/215 (33%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGR---------AAAIKKLDSSKQPD--QEFLAQVSMVSRLKNE 121
+G+GS FGV+R G A+K L S K D +FL + +++ L +E
Sbjct: 2 KLGDGS-----FGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N++ L G + PL + E A GSL D L K G L AV A
Sbjct: 57 NLIRLYGVVLTHPLM-MVTELAPLGSLLDRLR--KDALGHFLISTLC-----DYAVQIAN 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT-FG 240
G+ YL K R IHR++ + N+LL DD KI DF L P L F
Sbjct: 109 GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE T S SDV+ FGV L E+ T G +P
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRA------AAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVE 125
+GEG++G+V+ G A+K L + D ++F + +++ ++EN+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV---LSWAQRVKIAVGAA 180
G +G ++ +E+ G L+ L HG P L+ +Q ++IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST---RVLG 237
G+ YL A +HR++ + N L+ D + KI DF +S +++T RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD-------VYTTDYYRVGG 182
Query: 238 T----FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE M + +++SDV+SFGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 30/276 (10%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L+ S + +F ++ ++ L +EN+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 127 VG--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G G L E+ GSL D L + ++ + + + +G++
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLLFSSQICKGMD 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP--DAAARLHSTRVLGTFGYH 242
YL + R IHR++ + N+L+ +D+ KISDF L+ P + F Y
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
APE T + SS SDV+SFGV L EL T D + + L + V +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT---YGDPSQSPPAEFLRMIG-IAQGQMIVTRL 235
Query: 303 VDTKLGGEY---PPKAIAKMAAVAALCVQYEADFRP 335
++ GE PP ++ + LC + E RP
Sbjct: 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-24
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 67 NFGTNSLIGEGSYGRVY-FGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNEN 122
+F +G+GSYG VY L + A+K++D +E + ++ +++ + + N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQRVKIAVGAAR 181
++ ++DG + E+A G L + K K K P W +I + R
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIW----RIFIQLLR 114
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL+ LHE+ +I+HR++KS+N+LL +D+ KI D +S A+ +GT Y
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGTPHY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE S KSD++S G +L E+ T P
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-24
Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 29/222 (13%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVE 125
+GEG++G+VY G L S + AIK L + +P QEF + ++S L++ N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 126 LVGYYV-DGPLRVLAYEHASKGSLH----------DILHGKKGVKGAKPGPVLSWAQRVK 174
L+G + P +L +E+ + G LH D+ L + +
Sbjct: 73 LLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS---LDCSDFLH 128
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA-RLHST 233
IA+ A G+EYL + +HR++ + N L+ + KISDF LS A R+ S
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+L + PE + G+ +++SD++SFGVVL E+ + G +P
Sbjct: 186 SLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-24
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 36/221 (16%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNE------ 121
LIG+G+YGRVY + + +G A+K+++ + + D Q MV L++E
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDS---RQKDMVKALRSEIETLKD 64
Query: 122 ----NVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKI 175
N+V+ +G+ + E+ GS+ L +G+ + V + ++V
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQV-- 117
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
GL YLH K I+HR++K+ N+L+ D I KISDF +S ++ D + +
Sbjct: 118 ----LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 236 LGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKP 274
G+ + APE + S+K D++S G V+LE+ GR+P
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV 112
++S + +E N IGEG+ G VY R +G+ AIKK+ KQ + + ++
Sbjct: 10 DIVSEGDPRELYKNL---EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEI 66
Query: 113 SMVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
++ K+ N+V+ Y V L V E+ GSL DI+ ++ Q
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDELWV-VMEYMDGGSLTDIITQNF--------VRMNEPQ 117
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
+ +GLEYLH + +IHR+IKS N+LL D K++DF + Q ++ +
Sbjct: 118 IAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S V+GT + APE K D++S G++ +E+ G P
Sbjct: 175 S--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ-EFLAQ-VSMVSRLKNENVVELVGY 129
IG+GS+G VY + R+ + AIK +D + D+ E + Q + +S+ ++ + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEYL 186
++ G + E+ GS D+L KPG + IA GLEYL
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL---------KPGKL----DETYIAFILREVLLGLEYL 114
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
HE+ IHR+IK++N+LL ++ K++DF +S Q ++ ++ +GT + APE
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEV 169
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
K+D++S G+ +EL G P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-23
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L + FL + ++ +L+++ +V+L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L K G G L V +A A G+ Y+
Sbjct: 74 PIYIVT-EYMSKGSLLDFL--KDG-----EGRALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++S+N+L+ D + KI+DF L+ D ++ R F + APE A+ G+
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L EL+T GR P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-23
Identities = 72/265 (27%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 74 PIYIVT-EYMSKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
+HR+++++N+L+ ++ + K++DF L+ D ++ R F + APE A+ G+
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE 310
+ KSDV+SFG++L EL T GR P P + +V V+
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPY----------------PGMVNREVLDQVERGYRMP 223
Query: 311 YPPKAIAKMAAVAALCVQYEADFRP 335
PP+ + + C + E + RP
Sbjct: 224 CPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQ----VSMVSRLKNENVVE 125
L+G GS+G VY G+ L G A+K L Q QE + Q ++++S+L++ N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + + E GSL +L G+ P PV+ R + GLEY
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILL-----GLEY 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH++ +HR+IK +N+L+ + + K++DF ++ Q + S + G+ + APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFK--GSPYWMAPE 171
Query: 246 YAM-TGQMSSKSDVYSFGVVLLELLTGRKP 274
G +D++S G +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 32/212 (15%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-- 131
+G G +G V+ G+ + A+K L ++FLA+ ++ +L++ +++L Y V
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--YAVCT 71
Query: 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ P+ ++ E GSL + L G G L Q + +A A G+ YL +
Sbjct: 72 LEEPIYIVT-ELMKYGSLLEYLQGGAGRA-------LKLPQLIDMAAQVASGMAYLEAQ- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTF--GYHA 243
IHR++ + NVL+ +++I K++DF L AR+ + R F + A
Sbjct: 123 --NYIHRDLAARNVLVGENNICKVADFGL--------ARVIKEDIYEAREGAKFPIKWTA 172
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE A+ + S KSDV+SFG++L E++T GR P
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-22
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G G +G V+ G+ ++ AIK L S Q+F +V + RL++++++ L
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
G + E KGSL L + G VL A + +A A G+ YL E+
Sbjct: 74 GEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM 252
IHR++ + N+L+ +D + K++DF L+ + ++ + + APE A G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 253 SSKSDVYSFGVVLLELLT 270
S+KSDV+SFG++L E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 8e-22
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 24/224 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKKLDSSKQPDQEFL-AQV 112
V+ + + DNF IGEGS G V +GR A+KK+D KQ +E L +V
Sbjct: 11 VVDPGDPRSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67
Query: 113 SMVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDIL-HGKKGVKGAKPGPVLSWA 170
++ ++ N+VE+ Y V L V+ E G+L DI+ H + ++
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVV-MEFLEGGALTDIVTHTR-----------MNEE 115
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q + + + L +LH + +IHR+IKS ++LL D K+SDF Q R
Sbjct: 116 QIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S ++GT + APE ++ D++S G++++E++ G P
Sbjct: 173 KS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 23/227 (10%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
L + T F +IGEG+YG+VY ++G+ AIK +D + ++E + +++ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 120 N-ENVVELVGYYVDGPLRV------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
N N+ G ++ L E GS+ D++ G + +++
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--- 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
I RGL YLHE ++IHR+IK N+LL + K+ DF +S Q R ++
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 233 TRVLGTFGYHAPE-----YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+GT + APE ++SDV+S G+ +EL G+ P
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L+++ +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E KGSL D L K+G G L Q V +A A G+ Y+
Sbjct: 74 PIYIVT-EFMGKGSLLDFL--KEG-----DGKYLKLPQLVDMAAQIADGMAYIERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++++N+L+ D+ + KI+DF L+ D ++ R F + APE A+ G+
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L EL+T GR P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L + FL + ++ +L+++ +V+L +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ SKGSL D L +G K L Q V +A A G+ YL +
Sbjct: 74 EPIYIVT-EYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESR--- 122
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTF--GYHAPE 245
IHR++ + N+L+ ++ + KI+DF L ARL ++ R F + APE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGL--------ARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A G+ + KSDV+SFG++L E++T GR P
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 35/275 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD- 132
+G G +G V+ G R AIK + + +F+ + ++ +L + N+V+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ + G L + L +KG G +L V +EYL
Sbjct: 72 RPIFIV-TEYMANGCLLNYLRERKGKLGT--EWLLDMCSDV------CEAMEYLESNG-- 120
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT---FGYHAPEYAMT 249
IHR++ + N L+ +D++ K+SDF L+ D T GT + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTSSQGTKFPVKWAPPEVFDY 175
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG 309
+ SSKSDV+SFGV++ E+ + K +P + S +V + V
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGK-----MP----------YERFSNSEVVESVSAGYRL 220
Query: 310 EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344
P A ++ + C + + RP +L L
Sbjct: 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 85/278 (30%), Positives = 125/278 (44%), Gaps = 32/278 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-QPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
IG G+ VY + L + AIK++D K Q + L + V +S+ + NVV+ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V G L + S GSL DI +K + P L A + +GLEYLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR--VLGTFGYHAPEYAM 248
+ IHR+IK+ N+LL +D KI+DF +S D R R +GT + APE M
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VM 178
Query: 249 TGQM--SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--ATPKLSEDKVKQCVD 304
K+D++SFG+ +EL TG P P + ++T P L +
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY-SKYPPMKVLMLTLQNDPPSLETGADYK--- 234
Query: 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
K K+ KM +LC+Q + RP +LK
Sbjct: 235 -KYS-----KSFRKM---ISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 71/229 (31%), Positives = 111/229 (48%), Gaps = 24/229 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNEN 122
+ S +GEG+ G V L+ +G A+K + + PD ++ L ++ + K+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 123 VVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV--KIAVG 178
+V+ G ++D + A E+ GSL D ++ K +G + G ++V KIA
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------EKVLGKIAES 113
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+GL YLH + +IIHR+IK SN+LL K+ DF +S + ++ A T GT
Sbjct: 114 VLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFT-GT 166
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
Y APE S SDV+S G+ LLE+ R P P G+ L
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-21
Identities = 75/212 (35%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + +L++ N +E G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS DIL K KP Q V+IA GA +GL Y
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHK-----KP------LQEVEIAAICHGALQGLAY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH IHR+IK+ N+LL + K++DF A+ + +GT + APE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFG------SASLVSPANSFVGTPYWMAPE 181
Query: 246 --YAM-TGQMSSKSDVYSFGVVLLELLTGRKP 274
AM GQ K DV+S G+ +E L RKP
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-21
Identities = 76/242 (31%), Positives = 127/242 (52%), Gaps = 33/242 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG+G +G V G R G A+K K D++ Q FLA+ S++++L++ N+V+L+G V
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 132 D--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ G L ++ E+ +KGSL D L ++ VL +K ++ +EYL
Sbjct: 70 EEKGGLYIVT-EYMAKGSLVDYLR-------SRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+HR++ + NVL+ +D++AK+SDF L+ + A+ T L + APE
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKL-PVKWTAPEALRE 173
Query: 250 GQMSSKSDVYSFGVVLLELLT------GRKPVDHTLPR---GQQSLVTWATPKLSEDKVK 300
+ S+KSDV+SFG++L E+ + R P+ +PR G + P + D +K
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233
Query: 301 QC 302
QC
Sbjct: 234 QC 235
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 73/234 (31%), Positives = 113/234 (48%), Gaps = 24/234 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVY-FGVLRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++ ++ L + TD + IG+G+YG+VY + G AA+K LD D+E A+ +
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN 70
Query: 114 MVSRLKNE-NVVELVG------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
++ L N NVV+ G V G L L E + GS+ +++ G G
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQR 124
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L A I GA GL++LH RIIHR++K +N+LL + K+ DF +S Q
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--T 179
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQM-----SSKSDVYSFGVVLLELLTGRKPV 275
+ RL +GT + APE Q ++ DV+S G+ +EL G P+
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 33/276 (11%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
L+G+G++G V+ G L+ A+K K D ++ +FL++ ++ + + N+V+L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L KK L Q VK A+ AA G+ YL K
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLVKFALDAAAGMAYLESK- 112
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--FGYHAPEYAM 248
IHR++ + N L+ ++++ KISDF +S Q D ++S+ L + APE
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG---IYSSSGLKQIPIKWTAPEALN 167
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308
G+ SS+SDV+S+G++L E SL P ++ + ++ V+
Sbjct: 168 YGRYSSESDVWSYGILLWETF---------------SLGVCPYPGMTNQQAREQVEKGYR 212
Query: 309 GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344
P K + V C Y+ + RP + K L
Sbjct: 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG G++G+VY V L +G A+K++ D+ + +E ++ ++ LK+ N+V+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
V + E+ S G+L ++L G +L + GL YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH---------GRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAAARLHSTRVLGTFGYHAPE 245
I+HR+IK +N+ L + + K+ DF L N + S GT Y APE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPE 173
Query: 246 YAMTGQMSSK---SDVYSFGVVLLELLTGRKP 274
G+ +D++S G V+LE+ TG++P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 79/319 (24%), Positives = 137/319 (42%), Gaps = 45/319 (14%)
Query: 40 AKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKKL 98
+K K++T+ I + LKE ++I G G Y G +++G +K++
Sbjct: 677 SKVSKSITINDI------LSSLKE-------ENVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 99 DSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV 158
+ +A + +L++ N+V+L+G L +E+ +L ++L
Sbjct: 724 NDVNSIPSSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776
Query: 159 KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218
LSW +R KIA+G A+ L +LH + P ++ N+ +++ D
Sbjct: 777 --------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR 825
Query: 219 LSNQAP---DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
LS D + S Y APE T ++ KSD+Y FG++L+ELLTG+ P
Sbjct: 826 LSLPGLLCTDTKCFISS-------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878
Query: 276 DHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADF 333
D S+V WA S+ + +D + G+ I ++ +A C +
Sbjct: 879 DAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTA 937
Query: 334 RPNMGIVLKALQPLLNTRS 352
RP VLK L+ + S
Sbjct: 938 RPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-20
Identities = 73/294 (24%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 73 LIGEGSYGRVYFG----VLRSGRA---AAIKKLD--SSKQPDQEFLAQVSMVSRLKNENV 123
+G G++G VY G +L G A+K L ++ Q +EFL + ++S + N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK-PGPVLSWAQRVKIAVGAARG 182
V+L+G + + + E G D+L + + + P+L+ + + I + A+G
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFDL------SNQAPDAAARLH 231
YL + IHR++ + N L+ + + KI DF L S+ L
Sbjct: 119 CVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291
R + APE + G+ +++SDV+SFGV++ E+LT GQQ
Sbjct: 176 PVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILT----------LGQQPY----- 214
Query: 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345
P L+ +V Q V + P K+ + C + RP + + LQ
Sbjct: 215 PALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 45/290 (15%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G+ R A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV----LSWAQRVKIAVGAAR 181
L+G + R + E + G L K ++ +P P L+ + A A+
Sbjct: 74 LIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
G +YL E IHR+I + N LL +AKI+DF ++ A+ R +
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297
+ PE + G +SK+DV+SFGV+L E+ + G P P +
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY----------------PGRTNQ 228
Query: 298 KVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345
+V + V GG + P + + C Q+ + RPN +L+ +Q
Sbjct: 229 EVMEFV--TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 5e-20
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG G+YG VY + +G AIK + D E + Q +SM+ ++ N+V G Y+
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E+ GSL DI GP LS Q + +GL YLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ-------VTRGP-LSELQIAYVCRETLKGLAYLHET-- 120
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA---M 248
IHR+IK +N+LL +D K++DF +S Q A+ S +GT + APE A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVER 177
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
G K D+++ G+ +EL + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 32/263 (12%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AI++++ +QP +E +
Sbjct: 12 IVSVGDPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 114 MVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R KN N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 118
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 173
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWA 290
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 291 TPKLS---------EDKVKQCVD 304
TP+L D + +C+D
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLD 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-20
Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 29/275 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRA-AAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG G++G V+ G LR+ A+K + PD +FL + ++ + + N+V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L + GP L + +++ AA G+EYL K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE--------GPRLKVKELIQMVENAAAGMEYLESK- 113
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
IHR++ + N L+ + ++ KISDF +S + D + APE G
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 251 QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE 310
+ SS+SDV+SFG++L E SL LS + ++ ++ +
Sbjct: 172 RYSSESDVWSFGILLWEAF---------------SLGAVPYANLSNQQTREAIEQGVRLP 216
Query: 311 YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345
P + + C +Y+ RP+ V + LQ
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 8e-20
Identities = 69/246 (28%), Positives = 121/246 (49%), Gaps = 23/246 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AIK+++ +QP +E +
Sbjct: 11 IVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 114 MVSR-LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R K+ N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWA 290
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231
Query: 291 TPKLSE 296
TP+L
Sbjct: 232 TPELQN 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 65/236 (27%), Positives = 117/236 (49%), Gaps = 29/236 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKN---ENVVEL 126
LIG G+YG VY G + +GR A+K LD+ + +V+++S+L+ N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGL 183
G Y+ GP + E+A GS+ ++ K GP+ A++ I+V L
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPI---AEKY-ISVIIREVLVAL 114
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
+Y+H+ +IHR+IK++N+L+ + K+ DF ++ A + +GT + A
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVGTPYWMA 169
Query: 244 PEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPV-DHTLPRGQQSLVTWATPKLSED 297
PE G+ +K+D++S G+ + E+ TG P D R + P+L ++
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN 225
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 1e-19
Identities = 69/244 (28%), Positives = 121/244 (49%), Gaps = 23/244 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AIK+++ +QP +E +
Sbjct: 11 IVSVGDPKKKYTRF---EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 114 MVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R KN N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + L++LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWA 290
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231
Query: 291 TPKL 294
TP+L
Sbjct: 232 TPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 1e-19
Identities = 68/244 (27%), Positives = 124/244 (50%), Gaps = 23/244 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLA-QV 112
++S+ + K+K + IG+G+ G V+ + + +G+ AIK+++ KQP +E + ++
Sbjct: 11 IVSIGDPKKKYTRY---EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
++ LKN N+V + ++ G + E+ + GSL D++ + AQ
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----------TETCMDEAQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS NVLL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWA 290
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231
Query: 291 TPKL 294
TP+L
Sbjct: 232 TPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-19
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L ++S+ Q+F + +++ L+++++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGK-----KGVKGAKPGPVLSWAQRVKIAVGA 179
G +G ++ +E+ G L+ L HG G + PG L+ Q + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQMLAIASQI 131
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+ YL A +HR++ + N L+ + KI DF +S R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE + + +++SD++SFGVVL E+ T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 31/286 (10%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D+S ++F + +++ L++E++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV--LSWAQRVKIAVGAARG 182
G V+G ++ +E+ G L+ L HG V A+ L+ +Q + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ YL A +HR++ + N L+ ++ + KI DF +S + +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301
PE M + +++SDV+S GVVL E+ T G++P W +LS ++V +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------WY--QLSNNEVIE 233
Query: 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347
C+ + P ++ + C Q E R N+ + LQ L
Sbjct: 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY GV G AIK L ++S + ++E L + +++ + + +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + L + G L D + K G++ +L+W ++ A+G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY--LLNWCVQI------AKGMSYL 125
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
EK R++HR++ + NVL+ KI+DF L+ H+ + A E
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ + KSDV+S+GV + EL+T G KP +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G AIK L + FLA+ +++ +L++ +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ GSL D L +G+K L+ + + +A A G+ ++ K
Sbjct: 74 PIYIIT-EYMENGSLVDFLKTPEGIK-------LTINKLIDMAAQIAEGMAFIERK---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++++N+L+ + KI+DF L+ D ++ R F + APE G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L E++T GR P
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-19
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE 121
E+TD + L G G YG VY GV + A+K L +EFL + +++ +K+
Sbjct: 4 ERTDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+G P + E + G+L D L ++ + VL + +A +
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISS 115
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+EYL +K IHR++ + N L+ ++ + K++DF LS H+ +
Sbjct: 116 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKW 171
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + S KSDV++FGV+L E+ T
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKL----DSSKQPDQEFLAQVSM 114
E + + D G ++G+G+YG VY L + AIK++ QP E ++++
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIAL 58
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
S LK+ N+V+ +G + + E GSL +L K G ++ + +++
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI- 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHST 233
GL+YLH+ +I+HR+IK NVL+ + KISDF S + A +
Sbjct: 118 -----LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTE 167
Query: 234 RVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKP 274
GT Y APE G + +D++S G ++E+ TG+ P
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-19
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G VY G+ R+ AIK +D + D+ + +++++S+ + + G Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ G + E+ GS D+L KPGP L I +GL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSE- 120
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
R IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
K+D++S G+ +EL G P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-19
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G V+ G+ R+ + AIK +D + D+ + +++++S+ + V + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E+ GS D+L +PGP L Q I +GL+YLH +
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSEK 121
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+ IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 251 QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE 310
SK+D++S G+ +EL G P P L+ P E G
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE------------GN 224
Query: 311 YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
Y + C+ E FRP +LK
Sbjct: 225 YS----KPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-19
Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 23/216 (10%)
Query: 73 LIGEGSYGRV----YFGVLRSGR--AAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENV 123
+GEG++G+V G+ A+K L D++++ + ++++ M+ + K++N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 124 VELVGYYV-DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKPGPVLSWAQRVKI 175
+ L+G +GPL V+ E+A+ G+L D L + P L+ V
Sbjct: 79 INLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A ARG+E+L K + IHR++ + NVL+ +D + KI+DF L+ +T
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 236 LGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLT 270
+ APE A+ ++ + +SDV+SFGV+L E+ T
Sbjct: 195 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-19
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 30/217 (13%)
Query: 71 NSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVV 124
+IG G +G V G L+ G+ AIK L + Q +FL + S++ + + N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 125 ELVGYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
L G P+ ++ E+ GSL L G + Q V + G A G+
Sbjct: 69 RLEGVVTKSRPVMIIT-EYMENGSLDKFLRENDGK--------FTVGQLVGMLRGIASGM 119
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGT 238
+YL +E +HR++ + N+L+ + + K+SDF LS + D+ A ++T+ + T
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPIRWT 175
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+SFG+V+ E+++ G +P
Sbjct: 176 ----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE-FLAQVSMVSRLKNENVVELV-GYY 130
+G+G++G+VY + +G AA K + + + E F+ ++ ++S K+ N+V L Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ L +L E G+L I+ ++ + L+ Q + L +LH
Sbjct: 73 YENKLWIL-IEFCDGGALDSIM-----LELERG---LTEPQIRYVCRQMLEALNFLHSH- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
++IHR++K+ N+LL D K++DF +S + + + +GT + APE
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE 178
Query: 251 QMSS-----KSDVYSFGVVLLELLTGRKP 274
K+D++S G+ L+EL P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 74 IGEGSYGRVYFGVLRS------GRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G+ + AIK + ++S + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKK-GVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+G G ++ E +KG L L ++ + + + +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQ---APDAAARLHSTRVLG 237
YL K + +HR++ + N ++ +D KI DF D+ L R
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR--- 186
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE G ++KSDV+SFGVVL E+ T
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFL-AQVSMVSRLKNENVVELVGYYV 131
IGEGS G V ++S G+ A+KK+D KQ +E L +V ++ ++ENVVE+ Y+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E G+L DI+ + ++ Q + + + L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG- 136
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+IHR+IKS ++LL D K+SDF Q R S ++GT + APE
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLP 192
Query: 252 MSSKSDVYSFGVVLLELLTGRKP 274
+ D++S G++++E++ G P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GE ++G++Y G L + AIK L P Q EF + S+++ L + N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL-----HGKKGVKGAKPGPV---LSWAQRVKIAVG 178
+G + +E+ ++G LH+ L H G + G V L + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A G+EYL + +H+++ + N+L+ + KISD LS + A + L
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE M G+ SS SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-18
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G R AIK + +++F+ + ++ +L + +V+L G +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L +E G L D L ++G S + + + G+ YL
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT---FGYHAPEYAMTG 250
+IHR++ + N L+ ++ + K+SDF ++ D T GT + +PE
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD----QYTSSTGTKFPVKWSSPEVFSFS 176
Query: 251 QMSSKSDVYSFGVVLLELLT-GRKPVDH 277
+ SSKSDV+SFGV++ E+ + G+ P ++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL-AQV 112
V+S + +E D+F IGEGS G V + +G+ A+KK+D KQ +E L +V
Sbjct: 14 VVSPGDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV 70
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
++ +ENVV++ Y+ G + E G+L DI+ + ++ Q
Sbjct: 71 VIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQI 120
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ + R L YLH + +IHR+IKS ++LL D K+SDF Q + S
Sbjct: 121 ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++GT + APE ++ D++S G++++E++ G P
Sbjct: 178 --LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-18
Identities = 61/215 (28%), Positives = 118/215 (54%), Gaps = 17/215 (7%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLA---QVSMVSRLKNEN 122
+ IGEGS+G++Y +S IK++D +K P +E A +V +++++K+ N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V + + + E+ G L ++ ++GV ++ +LSW V+I++G
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSWF--VQISLG---- 113
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+++H++ +I+HR+IKS N+ L + +AK+ DF ++ Q D+ ++ +GT Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYY 168
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+PE ++K+D++S G VL EL T + P +
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
IGEG+YG+VY ++G A+KK+ + F + ++ ++ +L++ N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 129 YYVDGPLRVLAYEHASKGSL--------HDI--LHGKKGVKGAKPGPVLSWAQRVKIAVG 178
KGS+ HD+ L VK + +Q
Sbjct: 66 IVTSKG----------KGSIYMVFEYMDHDLTGLLDSPEVK-------FTESQIKCYMKQ 108
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
GL+YLH I+HR+IK SN+L+ +D + K++DF L+ + ++ RV+ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 239 FGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
Y PE + + + D++S G +L EL G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 68/209 (32%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNENVVEL--- 126
IGEG+YG VY SG A+KK+ + D L +++++ L++ N+VEL
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 127 -VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
VG ++D V+ Y SL D + P P S +Q + + RGL+Y
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLLDNM----------PTP-FSESQVKCLMLQLLRGLQY 123
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LHE IIHR++K SN+LL D KI+DF L+ A T + T Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPE 178
Query: 246 --YAMTGQMSSKSDVYSFGVVLLELLTGR 272
T ++ D+++ G +L ELL +
Sbjct: 179 LLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 4e-18
Identities = 72/213 (33%), Positives = 107/213 (50%), Gaps = 32/213 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + R+K+ N +E G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAITHGALQGLAY 140
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH +IHR+IK+ N+LL + K++DF ++ A A + +GT + APE
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPE 191
Query: 246 YAMT---GQMSSKSDVYSFGVVLLELLTGRKPV 275
+ GQ K DV+S G+ +EL + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-18
Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 33/212 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF + A+KK+ S KQ + Q+ + +V + +LK+ N +E G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAITHGALQGLAY 136
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH +IHR+IK+ N+LL + K++DF ++++ A + +GT + APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPE 187
Query: 246 YAMT---GQMSSKSDVYSFGVVLLELLTGRKP 274
+ GQ K DV+S G+ +E L RKP
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 36/227 (15%)
Query: 74 IGEGSYGRVY----------------FGVLRSGR----AAAIKKLDSSKQPDQEFLAQVS 113
+GEG +G V+ F V R GR A I + D++K +FL +V
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNV-RKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL----------HGKKGVKGAKP 163
++SRLK+ N++ L+G VD + E+ G L+ L +G V A
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQ 222
P +S++ + +A+ A G++YL + +HR++ + N L+ ++ KI+DF +S N
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269
R+ VL + A E + G+ ++ SDV++FGV L E+L
Sbjct: 189 YAGDYYRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-18
Identities = 75/246 (30%), Positives = 124/246 (50%), Gaps = 28/246 (11%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVL--RSGRAAAIKKLDSSKQPDQE 107
P++ I D + +D + IG+G+YG+V F VL ++G AA+K LD D+E
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKV-FKVLNKKNGSKAAVKILDPIHDIDEE 60
Query: 108 FLAQVSMVSRLKNE-NVVELVGYY-----VDGPLRVLAYEHASKGSLHDILHG--KKGVK 159
A+ +++ L + NVV+ G Y +G L E + GS+ D++ G K+G +
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120
Query: 160 GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
+P ++++ I A GL++LH + IHR++K +N+LL + K+ DF +
Sbjct: 121 MEEP--IIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV 170
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPEY-AMTGQMSS----KSDVYSFGVVLLELLTGRKP 274
S Q + RL +GT + APE A Q+ S + DV+S G+ +EL G P
Sbjct: 171 SAQL--TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
Query: 275 VDHTLP 280
+ P
Sbjct: 229 LADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-18
Identities = 72/213 (33%), Positives = 106/213 (49%), Gaps = 35/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + +L++ N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAVTHGALQGLAY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF-DLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH +IHR++K+ N+LL + + K+ DF S AP + +GT + AP
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAP 180
Query: 245 EYAMT---GQMSSKSDVYSFGVVLLELLTGRKP 274
E + GQ K DV+S G+ +E L RKP
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 8e-18
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 73 LIGEGSYGRVYF----GVLRSGRAA--AIKKLDSSKQPD--QEFLAQVSMVSRLKNENVV 124
+G G +G V+ G+ G +K L +K + EF ++ M +L ++NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILH-GKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
L+G + + E+ G L L K + KP P LS Q+V + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP-LSTKQKVALCTQIALGM 130
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
++L + R +HR++ + N L+ K+S LS + L + A
Sbjct: 131 DHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLRWLA 186
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT 270
PE S+KSDV+SFGV++ E+ T
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-18
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G V+ G+ R+ + AIK +D + D+ + +++++S+ + V + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ G + E+ GS D+L + GP + Q + +GL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------RAGPFDEF-QIATMLKEILKGLDYLHSEK 121
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+ IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQS 176
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
SK+D++S G+ +EL G P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 62/221 (28%), Positives = 116/221 (52%), Gaps = 33/221 (14%)
Query: 74 IGEGSYGRVY----FGVLRSGR----AAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V +G+ +S A+K L +++ + + ++++ ++ + K++N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP------------VLSW 169
++ L+G +GPL V+ E+A+KG+L + L ++ PGP LS+
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARR-----PPGPDYTFDITKVPEEQLSF 133
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
V A ARG+EYL + R IHR++ + NVL+ +D++ KI+DF L+ D
Sbjct: 134 KDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
++ + APE + +SDV+SFG+++ E+ T
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-17
Identities = 74/235 (31%), Positives = 113/235 (48%), Gaps = 23/235 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG G+YG VY + +G AAIK + D + Q + M+ K+ N+V G Y+
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E GSL DI H GP LS +Q ++ +GL YLH K +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIAYVSRETLQGLYYLHSKGK 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-- 249
+HR+IK +N+LL D+ K++DF +S Q A+ S +GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVER 182
Query: 250 -GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVK 300
G + D+++ G+ +EL + P+ P L+T + PKL +DK+K
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL-KDKMK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-D 132
+G G +G V+ G + A+K L Q FL + +++ L+++ +V L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ +KGSL D L +G K P + + + A G+ Y+ K
Sbjct: 74 EPIYIIT-EYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK--- 122
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTG 250
IHR+++++NVL+ + + KI+DF L+ D ++ R F + APE G
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFG 179
Query: 251 QMSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L E++T G+ P
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYF----GVLRSGRA----AAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V G+ + A+K L D++ + + ++++ M+ + K++N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVKGA-----KPGPVLSWAQRVK 174
++ L+G DGPL VL E+ASKG+L + L ++ G+ + P L++ V
Sbjct: 80 IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+ + +T
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE + +SDV+SFGV+L E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 37/271 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRA---AAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV + + AIK K ++ K E + + ++ +L N +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ +L E AS G L+ L GKK ++ + V++ + G++YL
Sbjct: 63 V-CEAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEG 113
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEY 246
K +HR++ + NVLL + AKISDF LS +A A + R G + ++APE
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLS-KALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305
+ SS+SDV+S+G+ + E + G+KP K+ +V ++
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYK----------------KMKGPEVMSFIEQ 213
Query: 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPN 336
+ P + +M A+ C Y+ + RPN
Sbjct: 214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPN 244
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-17
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
+GEG+YG VY ++G A+KK LD+ ++ P L ++S++ LK+ N+V+L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP-STALREISLLKELKHPNIVKLLD 65
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L +E+ L L + G P + S ++ RGL Y H
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMYQL------LRGLAYCHS 116
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------TRVLGTFGYH 242
RI+HR++K N+L+ D + K++DF L AR T + T Y
Sbjct: 117 H---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLRTYTHEVVTLWYR 165
Query: 243 APEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
APE + + S + D++S G + E++TG+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 74 IGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG+GS+G V V R G+ K++D ++E +++V+++ LK+ N+V
Sbjct: 8 IGKGSFGTVR-KVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 129 YYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+D + L Y E+ G L ++ K + + W +I L
Sbjct: 67 RIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-W----RILTQLLLALYE 120
Query: 186 LH--EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
H ++HR++K +N+ L ++ K+ DF L+ ++ + +GT Y +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMS 178
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE KSD++S G ++ EL P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYF-GVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG++G V+ +G A+KK+ + + L ++ + ++ VV+L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ G VL E+ L ++L +P L AQ +G+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR-----DEERP---LPEAQVKSYMRMLLKGVAYMHAN 118
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
I+HR++K +N+L+ D + KI+DF L+ + RL+S +V T Y APE
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174
Query: 250 GQMSSKS-DVYSFGVVLLELLTGR 272
+ D+++ G + ELL G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 29/219 (13%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKL---------DSSKQPDQEFLA-QVSMVSRLKN 120
+LIG GS+G VY G+ SG A+K++ K+ + LA +++++ L++
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP-VLSWAQRVKIAVGA 179
EN+V+ +G +D + E+ GS+ +L+ GA V ++ +++
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQI------ 115
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP----DAAARLHSTRV 235
+GL YLH + IIHR+IK +N+L+ + KISDF +S + +
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
G+ + APE + K+D++S G +++E+LTG+ P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-17
Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 73 LIGEGSYGRVYFGVLR-SGR---AAAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G V+ G+L+ GR A AIK L +++ Q+FL++ S++ + + N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ G+L L G S Q V + G A G++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYL 123
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG-----Y 241
++ +HR++ + N+L+ + K+SDF LS D ++T + G +
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRW 176
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+SFG+V+ E+++ G +P
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 65/216 (30%), Positives = 115/216 (53%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYF----GVLR------SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V G+ + + A + K D++++ + ++++ M+ + K++N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVK-----GAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L ++ G++ P LS+ V
Sbjct: 86 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+ +T
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE + +SDV+SFGV+L E+ T
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 57/252 (22%), Positives = 113/252 (44%), Gaps = 30/252 (11%)
Query: 95 IKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG 154
+ +L ++ D L ++ ++S L++ N++ +++D ++ E+A+ G+L+D +
Sbjct: 35 LTRLSEKERRDA--LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR 92
Query: 155 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214
+KG + + + Y+H+ I+HR+IK+ N+ L + K+
Sbjct: 93 QKGQ-------LFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142
Query: 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
DF +S + V+GT Y +PE + + KSD+++ G VL ELLT ++
Sbjct: 143 GDFGISKILGSE--YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200
Query: 275 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFR 334
D T P +LV K+ Q T + Y +++ ++ +Q + + R
Sbjct: 201 FDATNP---LNLVV---------KIVQGNYTPVVSVYS----SELISLVHSLLQQDPEKR 244
Query: 335 PNMGIVLKALQP 346
P VL
Sbjct: 245 PTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-17
Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 33/275 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ +L +E +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ S G L + L ++ K +P +L + V G+ YL K +
Sbjct: 72 RPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDV------CEGMAYLESK---Q 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR++ + N L+ D K+SDF LS D +++ V F + PE + +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSK 177
Query: 252 MSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE 310
SSKSDV++FGV++ E+ + G+ P + + + + + V L
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYE----------------RFNNSETVEKVSQGLRLY 221
Query: 311 YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345
P A K+ A+ C +A+ RP +L +++
Sbjct: 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 61/192 (31%), Positives = 93/192 (48%), Gaps = 21/192 (10%)
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+Y DG + + EH GSL +L KK G P +L KI++ RGL YL E
Sbjct: 68 FYSDGEISICM-EHMDGGSLDQVL--KKA--GRIPENILG-----KISIAVLRGLTYLRE 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
K + I+HR++K SN+L+ K+ DF +S Q D+ A +GT Y +PE
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQ 171
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308
+ +SD++S G+ L+E+ GR P+ P + L +SE + K+ G
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIP---PPDAKELEAMFGRPVSEGEAKESHRPVSG 228
Query: 309 GEYPPKAIAKMA 320
+PP + MA
Sbjct: 229 --HPPDSPRPMA 238
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 7e-17
Identities = 76/313 (24%), Positives = 136/313 (43%), Gaps = 51/313 (16%)
Query: 67 NFGTNSLIGEGSYGRVY--FGVLRSGRAA----AIKKLDSSKQPDQ--EFLAQVSMVSRL 118
N +GEG +G+V GRA A+K L + + + L++ +++ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 119 KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR----- 172
+ +V++L G DGPL +L E+A GSL L + V P + S R
Sbjct: 61 NHPHVIKLYGACSQDGPL-LLIVEYAKYGSLRSFLRESRKVG---PSYLGSDGNRNSSYL 116
Query: 173 -------------VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
+ A +RG++YL AE +++HR++ + NVL+ + KISDF L
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL 173
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 278
S + + + ++ + A E +++SDV+SFGV+L E++T G P
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--- 230
Query: 279 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 338
P ++ +++ + T E P +M + C + E D RP
Sbjct: 231 -------------PGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277
Query: 339 IVLKALQPLLNTR 351
+ K L+ ++
Sbjct: 278 DISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-17
Identities = 63/244 (25%), Positives = 117/244 (47%), Gaps = 25/244 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ A+K + + FLA+ +++ L+++ +V+L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E +KGSL D L +G K +P P L + + A G+ ++ ++
Sbjct: 74 PIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++++N+L+ + KI+DF L+ D ++ R F + APE G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQSLVTWATPKLSEDKVKQC 302
+ KSDV+SFG++L+E++T GR P V L RG + P+ + + +C
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 239
Query: 303 VDTK 306
+
Sbjct: 240 WKNR 243
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-17
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKL-------DSSKQPDQEFLAQVSMVSRLKNENVVE 125
++G+G+YG VY G+ G+ A+K++ ++++ ++ +V ++ LK+ N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G +D + E GS+ IL+ G P PV K G+ Y
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC-----KYTKQILDGVAY 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL----GTFGY 241
LH ++HR+IK +NV+L + I K+ DF + + + +L GT +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE KSD++S G + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 71/259 (27%), Positives = 128/259 (49%), Gaps = 42/259 (16%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V +++ AAIK L +S+ ++F ++ ++ +L + N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRVKIAVG 178
+G + +A E+A G+L D L K V P L+ Q ++ A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A G++YL EK + IHR++ + NVL+ ++ +KI+DF LS ++ + +G
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGR 179
Query: 239 FG--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQSLV 287
+ A E ++KSDV+SFGV+L E+++ G P + LP+G +
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 236
Query: 288 TWATPKLSEDKV----KQC 302
P+ +D+V +QC
Sbjct: 237 -MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 39/276 (14%)
Query: 74 IGEGSYGRV---YFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V + + +S + A+K L ++ E L + +++ +L N +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + +L E A G L+ L K V + +V + G++YL
Sbjct: 63 GI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKN---ITELVHQVSM------GMKYLE 112
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPE 245
E +HR++ + NVLL AKISDF LS +A A + + G + ++APE
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALGADENYYKAKTHGKWPVKWYAPE 168
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304
+ SSKSDV+SFGV++ E + G+KP +G + ++V Q ++
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY-----KGMKG-----------NEVTQMIE 212
Query: 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 340
+ E P + +M + LC Y D RP +V
Sbjct: 213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 71/289 (24%), Positives = 127/289 (43%), Gaps = 34/289 (11%)
Query: 74 IGEGSYGRVYFG------VLRSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D + ++F + +++ L++E++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV-----LSWAQRVKIAVGA 179
G DG ++ +E+ G L+ L HG + P L +Q + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+ YL A +HR++ + N L+ + + KI DF +S +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 298
+ PE M + +++SDV+SFGV+L E+ T G++P W +LS +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------WF--QLSNTE 233
Query: 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347
V +C+ E P ++ + C Q E R N+ + K L L
Sbjct: 234 VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 1e-16
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 74 IGEGSYGRVYFGV--LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+GS+G+V V +G+ A+K L ++ + L + +++SR+ + +V+L
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 128 GYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----- 181
Y ++ L E+A G L L + + + AR
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLS-----------------KEGRFSEERARFYAAE 101
Query: 182 ---GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LEYLH II+R++K N+LL D K++DF L+ + +R ++ GT
Sbjct: 102 IVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
Y APE + D +S GV+L E+LTG+ P
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG G++G V + + SG A+K++ S+ ++ + L + +V +++ + +V +
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKF 68
Query: 130 YVDGPLRVLAYE----------HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
Y L E S + ++ K P +L KIAV
Sbjct: 69 Y-----GALFREGDCWICMELMDISLDKFYKYVYEVL--KSVIPEEILG-----KIAVAT 116
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ L YL K E +IIHR++K SN+LL + K+ DF +S Q D+ A+ TR G
Sbjct: 117 VKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCR 171
Query: 240 GYHAPEYAMTGQMSS---KSDVYSFGVVLLELLTGRKP 274
Y APE +SDV+S G+ L E+ TG+ P
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 71/287 (24%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLK 119
NF IG+G + VY + L GR A+KK+ + Q+ L ++ ++ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSL-HDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ NV++ + +++ + E A G L I H KK K P + W V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTI-WKYFVQLC-- 116
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LE++H K RI+HR+IK +NV + + K+ D L HS ++GT
Sbjct: 117 --SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
Y +PE + KSD++S G +L E+ + P + ++ K K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLCK----K 219
Query: 299 VKQCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVL 341
+++C +YPP ++ + + C+ + + RP++ VL
Sbjct: 220 IEKC-------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 69/286 (24%), Positives = 126/286 (44%), Gaps = 37/286 (12%)
Query: 73 LIGEGSYGRVYFGVLR-SGRA---AAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G V G L+ G+ AIK L S +++ ++FL++ S++ + + N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E G+L L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYL 122
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG---TFGYHA 243
+E +HR++ + N+L+ + + K+SDF LS D + T LG + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
PE + +S SDV+S+G+V+ E+++ G +P W +S V
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------W---DMSNQDVINA 223
Query: 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
++ P + + C Q + + RP G ++ L ++
Sbjct: 224 IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LEYLH K IIHR+IK N+LL + I+DF+++ + +T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGY 165
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE S D +S GV E L G++P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKK---LDSSKQPDQEFLAQVSMVSRLKN 120
+ ++ T S +G G+ G V KK + + ++ L ++ ++ ++
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V G +++ + E GSL I KKG G P +L KIAV
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKG--GPIPVEILG-----KIAVAVV 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
GL YL+ RI+HR+IK SN+L+ K+ DF +S + ++ A T V GT
Sbjct: 114 EGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTST 167
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y +PE G+ + KSDV+S G+ ++EL G+ P
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 26/287 (9%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + +Q + +++++ L +EN+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 127 VGYYVDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G + + L E+ GSL D L P L+ AQ + A G+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLFAQQICEGMA 121
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--RLHSTRVLGTFGYH 242
YLH + IHR++ + NVLL +D + KI DF L+ P+ R+ F Y
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY- 177
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
A E + S SDV+SFGV L ELLT + P+ + ++ +++ ++ +
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQMTVVRLIEL 236
Query: 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349
++ + P ++ + C + EA FRP ++ L+ + +
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL-AQVSMVSRLKNENVVELVGYYV 131
IGEGS G V + SGR A+K +D KQ +E L +V ++ +++NVVE+ Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E G+L DI+ + L+ Q + + L YLH +
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG- 137
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+IHR+IKS ++LL D K+SDF Q + S ++GT + APE
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTP 193
Query: 252 MSSKSDVYSFGVVLLELLTGRKP 274
++ D++S G++++E++ G P
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 4e-16
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVV 124
+GEG+Y VY +GR AIKK+ ++ + L ++ ++ LK+ N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+ + L +E L ++ K V P + S+ RGLE
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIKSYMLM------TLRGLE 116
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YLH I+HR++K +N+L+ D + K++DF L+ ++ + +V+ T Y AP
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV-TRWYRAP 171
Query: 245 EYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
E + D++S G + ELL R P
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 71/235 (30%), Positives = 111/235 (47%), Gaps = 23/235 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
+G G+YG VY L +G AA+K + D + Q + MV K+ N+V G Y+
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E+ GSL DI H GP LS Q + +GL YLH K +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--- 248
+HR+IK +N+LL D+ K++DF ++ + A+ S +GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEK 182
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVK 300
G + D+++ G+ +EL + P+ P L++ + PKL +DK K
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL-KDKTK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 55/167 (32%), Positives = 83/167 (49%), Gaps = 28/167 (16%)
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
P +L KIAV + LEYLH K +IHR++K SNVL+ + K+ DF +S
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY 153
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSS-----KSDVYSFGVVLLELLTGRKPVD- 276
D+ A+ T G Y APE + +++ KSDV+S G+ ++EL TGR P D
Sbjct: 154 LVDSVAK---TIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
Query: 277 -HTLPRGQQSLVTWATPKLSEDK--------VKQCV--DTKLGGEYP 312
T + + +V +P+L +K V +C+ + K YP
Sbjct: 210 WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 6e-16
Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 27/229 (11%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
L++ F L+G G+YG+VY G +++G+ AAIK +D + ++E +++M+ +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 120 N-ENVVELVGYYV-------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ N+ G ++ D L L E GS+ D++ KG L
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKG-------NTLKEEW 112
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
I RGL +LH+ ++IHR+IK NVLL ++ K+ DF +S Q R +
Sbjct: 113 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 169
Query: 232 STRVLGTFGYHAPEYAMTGQMSS-----KSDVYSFGVVLLELLTGRKPV 275
+ +GT + APE + KSD++S G+ +E+ G P+
Sbjct: 170 T--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-16
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKL-----DSSKQPD--QEFLAQVSMVSRLKNENVV 124
+G G++ Y +++G A+K++ SS+Q + + ++ +++RL + +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 125 ELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
++G D + E + GS+ +L K G A + RGL
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLS--------KYGA-FKEAVIINYTEQLLRGL 116
Query: 184 EYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHST--------- 233
YLHE +IIHR++K +N+L+ +I+DF AAARL +
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFG-------AAARLAAKGTGAGEFQG 166
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++LGT + APE Q DV+S G V++E+ T + P
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-16
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 71 NSLIGEGSYGRVYFGVLRSGR----AAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVV 124
IGEG +G VY GV S A A+K K +S ++FL + ++ + + ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+L+G + P+ ++ E A G L L K L A + + + L
Sbjct: 71 KLIGVITENPVWIV-MELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALA 121
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL K R +HR+I + NVL+ D K+ DF LS + + + +++ + AP
Sbjct: 122 YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKWMAP 177
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
E + +S SDV+ FGV + E+L G KP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 74 IGEGSYGRVYF----GVLR---------SGRA--AAIKKL--DSSKQPDQEFLAQVSMVS 116
+GEG +G V+ G+ G+ A+K L D +K +FL ++ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 117 RLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK---GVKGAKPGPVLSWAQR 172
RLKN N++ L+G V D PL + E+ G L+ L ++ A P +S A
Sbjct: 73 RLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLH 231
+ +AV A G++YL A +HR++ + N L+ + KI+DF +S N R+
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
VL + A E + G+ ++ SDV++FGV L E+ T
Sbjct: 189 GRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-D 132
+G G +G V+ G R+ AIK ++ +++F+ + ++ +L + +V+L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
PL ++ E G L + L ++G +LS Q V G+EYL +
Sbjct: 72 KPLYIVT-EFMENGCLLNYLRQRQGKLS--KDMLLSMCQDV------CEGMEYLERNS-- 120
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG------YHAPEY 246
IHR++ + N L+ + K+SDF ++ D + G + PE
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-------DEYTSSSGAKFPVKWSPPEV 172
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ SSKSDV+SFGV++ E+ T G+ P
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKN 120
K D+F S +G G+ G V + +KL + + + ++ ++ +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS 62
Query: 121 ENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+V G +Y DG + + EH GSL +L K + P +L K+++
Sbjct: 63 PYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAV 112
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
RGL YL EK + I+HR++K SN+L+ K+ DF +S Q D+ A +GT
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTR 166
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
Y +PE S +SD++S G+ L+EL GR P+
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 74 IGEGSYGRVY----FGVL--RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
IG+G++GRV+ G+L A+K L ++S +F + ++++ + N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILH-------------GKKGVKGAKPGPVLSWAQR 172
L+G G L +E+ + G L++ L K LS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ IA A G+ YL +E + +HR++ + N L+ ++ + KI+DF LS A S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE + +++SDV+++GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRLKNE-NVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRVKIAVG 178
+G LA E+A G+L D L K V P LS Q + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS ++ + +G
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 172
Query: 239 FG--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ A E ++ SDV+S+GV+L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 72/291 (24%), Positives = 128/291 (43%), Gaps = 61/291 (20%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEGS+G+ + G+ IK+++ SK +E +V+++S +K+ N+V+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ + + ++ G L+ ++ ++GV + +L W ++ +A L+++H++
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED-QILDWFVQICLA------LKHVHDR 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-----GTFGYHAP 244
+I+HR+IKS N+ L D K+ DF + A L+ST L GT Y +P
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNSTVELARTCIGTPYYLSP 170
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304
E ++KSD+++ G VL E+ T + H G +K V
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT----LKHAFEAGN---------------MKNLVL 211
Query: 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355
+ G YPP + Y D R + + K N R PS
Sbjct: 212 KIIRGSYPP-----------VSSHYSYDLRNLVSQLFKR-----NPRDRPS 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 62/234 (26%), Positives = 113/234 (48%), Gaps = 27/234 (11%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSM 114
I + L++ F ++G G+YG+VY G +++G+ AAIK +D ++ ++E +++M
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 115 VSRLKNE-NVVELVGYYV-------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
+ + + N+ G ++ D L L E GS+ D++ KG +
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKE---- 120
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
W + + RGL +LH ++IHR+IK NVLL ++ K+ DF +S Q
Sbjct: 121 -DWIAYICREI--LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQ-----MSSKSDVYSFGVVLLELLTGRKPV 275
R ++ +GT + APE + +SD++S G+ +E+ G P+
Sbjct: 175 VGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQP-DQEFLAQVSMVSRLKNENVVE 125
+GE +G+VY G L +A AIK L D ++ P +EF + M SRL++ N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 126 LVGYYV-DGPLRVLAYEHASKGSLHDIL-----HGKKG-------VKGAKPGPVLSWAQR 172
L+G + PL ++ + + S LH+ L H G VK L A
Sbjct: 73 LLGVVTKEQPLSMI-FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST-----LEPADF 126
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V I A G+E+L + ++H+++ + NVL+FD KISD L + A
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
L + +PE M G+ S SD++S+GVVL E+ + G +P
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 59/216 (27%), Positives = 110/216 (50%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYFGVL--------RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V + A+K L D++++ + ++++ M+ + K++N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L ++ P +++ V
Sbjct: 83 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
ARG+EYL A + IHR++ + NVL+ ++++ KI+DF L+ + +T
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE + +SDV+SFGV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK 119
K D+F S +G G+ G V F V SG A K + +P + + ++ ++
Sbjct: 3 KDDDFEKISELGAGN-GGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 120 NENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ +V G +Y DG + + EH GSL +L KK G P +L K+++
Sbjct: 62 SPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVL--KKA--GRIPEQILG-----KVSIA 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ A +GT
Sbjct: 112 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGT 165
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
Y +PE S +SD++S G+ L+E+ GR P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 58/213 (27%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGA 179
+G LA E+A G+L D L + ++ LS Q + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS ++ + +G
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 185
Query: 240 G--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ A E ++ SDV+S+GV+L E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 66 DNFGTNSLIGEGSYGRVY-FGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNE 121
+ + ++GEG+YG V +G AIKK + + + L +V ++ +L++E
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 122 NVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV--LSWAQRVKIAVG 178
N+V L + G L L +E+ + +L ++L G G P V W Q ++
Sbjct: 61 NIVNLKEAFRRKGRL-YLVFEYVER-TLLELLEASPG--GLPPDAVRSYIW-QLLQ---- 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+ Y H IIHR+IK N+L+ + + K+ DF + A T + T
Sbjct: 112 ---AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPASPLTDYVAT 164
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + K DV++ G ++ ELL G
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 27/281 (9%)
Query: 74 IGEGSYGRVYFGVLR---SGRA---AAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G R G A A+K ++ S + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG-PVLSWAQRVKIAVGAARGLE 184
L+G G ++ E + G L L + PG P + + +++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL+ K + +HR++ + N ++ D KI DF ++ + + L + AP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304
E G ++ SD++SFGVVL E+ SL LS ++V + V
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 235
Query: 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345
+ P ++ + +C Q+ RP ++ L+
Sbjct: 236 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG-Y 129
+G G+ G VY L + R A+K LD + + ++ ++++ ++ + + ++ G +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+V+ + + E GSL V P VL +IAV +GL YL
Sbjct: 69 FVENRISICT-EFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL 114
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+I+HR++K SN+L+ K+ DF +S Q ++ A+ + +GT Y APE
Sbjct: 115 ---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPERISG 167
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
Q SDV+S G+ +EL GR P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG VY +G AIKK+ + + + L ++ ++ L + N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ L +E D+ +K + G L + +GL + H
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKL---IKDRQRG--LPESLIKSYLYQLLQGLAFCHSH 117
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLH--STRVLGTFGYHAPEY 246
I+HR++K N+L+ + + K++DF L+ H TR Y APE
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 247 AMT-GQMSSKSDVYSFGVVLLELLTGR 272
+ S+ D++S G + ELL+ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 74 IGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G+ + AIK ++ + + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL-SWAQRVKIAVGAARGLE 184
L+G G ++ E ++G L L + P S + +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL+ + +HR++ + N ++ +D KI DF ++ + + L + +P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT 270
E G ++ SDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 47/224 (20%)
Query: 74 IGEGSYGRVYFGVL---RSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVEL 126
IG G+YGRVY + G+ AIKK K+ +++++ LK+ENVV L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 127 VGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW---AQRVKIAVGAAR 181
V ++ V L +++A HD+ ++ + A+RV I +
Sbjct: 68 VEVFLEHADKSVYLLFDYAE----HDLWQ------------IIKFHRQAKRVSIPPSMVK 111
Query: 182 --------GLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSN--QAPDAA 227
G+ YLH ++HR++K +N+L+ + + KI D L+ AP
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LK 167
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLT 270
V+ T Y APE + + +K+ D+++ G + ELLT
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 73 LIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+IG G +G V G L+ G+ AIK L + Q +FL++ S++ + + N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ GSL L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYL 122
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHA 243
++ +HR++ + N+L+ + + K+SDF LS P+AA ++ + A
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTA 177
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE + +S SDV+S+G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 67/285 (23%), Positives = 125/285 (43%), Gaps = 36/285 (12%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNE 121
NF IG G + VY L + A+KK+ + D Q+ + ++ ++ +L +
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
NV++ + +++ + E A G L ++ K K P + W K V
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-W----KYFVQLCS 117
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+E++H + R++HR+IK +NV + + K+ D L HS ++GT Y
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301
+PE + KSD++S G +L E+ + P + +L + K++Q
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSLC------QKIEQ 222
Query: 302 CVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVLK 342
C +YPP K+ + ++C+ + D RP++G V +
Sbjct: 223 C-------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 57/241 (23%), Positives = 88/241 (36%), Gaps = 66/241 (27%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPD--QE-----FLAQVSMVSRL 118
+IGEGS+ V + + + AIK LD K E L + +L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 119 -----KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW--AQ 171
EN+ Y+V E+A G L + G+ + A+
Sbjct: 68 YYTFQDEENL-----YFV--------LEYAPNGELLQYIR----KYGSLDEKCTRFYAAE 110
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--------- 222
+ LEYLH K IIHR++K N+LL D KI+DF +
Sbjct: 111 ILLA-------LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 223 ---------APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273
+ R +GT Y +PE SD+++ G ++ ++LTG+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
Query: 274 P 274
P
Sbjct: 221 P 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 66 DNFGTNSLIGEGSYGRVY----FGVLRSGRA--AAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N +G G++G+V +G+ +S A+K L + + ++++ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 118 LKN-ENVVELVGY-YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
L N EN+V L+G + GP+ V+ E+ G L + L K+ L+ +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRES-------FLTLEDLLSF 146
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAA 228
+ A+G+ +L K IHR++ + NVLL I KI DF L SN A
Sbjct: 147 SYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
RL + APE + +SDV+S+G++L E+ +
Sbjct: 204 RL-------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-14
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 39/224 (17%)
Query: 73 LIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
L+ EG++GR+++G+L +K + Q L + ++ L ++N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 126 LVGYYVDGPLR-VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
++ ++ + Y + + G+L L + + P LS Q V +A+ A G+
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACGMS 131
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-- 242
YLH++ +IH++I + N ++ ++ KI+D LS R L YH
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALS-------------RDLFPMDYHCL 175
Query: 243 -----------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E + + SS SDV+SFGV+L EL+T G+ P
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-14
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 73 LIGEGSYGRVYFGV-LRSGRA----AAIKKLD--SSKQPDQEFLAQVSMVSRLKNENVVE 125
L+G G +G V+ G+ + G + AIK + S +Q QE + + L + +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G G L + + GSL D + + P +L+W ++ A+G+ Y
Sbjct: 74 LLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNWCVQI------AKGMYY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E R++HRN+ + N+LL D I +I+DF +++ + + + A E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ G+ + +SDV+S+GV + E+++ G +P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY + +GR A+K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+E +V+ G D + E+ GS+ D L G + R K
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--------KAYGALTETVTR-KYTRQI 113
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR----- 234
G+EYLH I+HR+IK +N+L K+ DF A+ RL +
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF-------GASKRLQTICSSGTG 163
Query: 235 ---VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V GT + +PE K+DV+S G ++E+LT + P
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 72 SLIGEGSYGRVY-FGVLRSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVVELV 127
IG G+ G+VY ++G A+K++ +K+ ++ L + +V + + +V+
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
GY++ + E S + D L K ++G P +L K+ V + L YL
Sbjct: 81 GYFITDSDVFICMELMS--TCLDKL--LKRIQGPIPEDILG-----KMTVAIVKALHYLK 131
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY- 246
EK +IHR++K SN+LL K+ DF +S + D+ A+ TR G Y APE
Sbjct: 132 EKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERI 186
Query: 247 ---AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++DV+S G+ L+EL TG+ P
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKN 120
D + + I EG+YG VY ++G A+KKL K+ + F L +++++ +L++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQH 63
Query: 121 ENVVEL----VGYYVDGPLRVLAY-EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
N+V + VG +D V+ Y EH K + P ++ +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMET-----------MKQP-FLQSEVKCL 111
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+ G+ +LH+ I+HR++K+SN+LL + I KI DF L+ + T++
Sbjct: 112 MLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQL 166
Query: 236 LGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPV 275
+ T Y APE + + S+ D++S G + ELLT +KP+
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 72 SLIGEGSYGRV---YFGVLR--SGRAAAIKKLD-SSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+G++G V + L+ +G A+KKL S+ + ++F ++ ++ L+++N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 126 L--VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V Y L E+ GSL D L + + +L +A ++ +G+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRK--LLLYASQI------CKGM 121
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG---TFG 240
EYL K R +HR++ + N+L+ ++ KI DF L+ P + R G F
Sbjct: 122 EYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFW 177
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
Y APE + S SDV+SFGVVL EL T
Sbjct: 178 Y-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 74 IGEGSYGRVYFGVLRS--GRAAAIKK----LDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G+YG VY VL G A+K+ LD SK + + ++ ++ + + +V+
Sbjct: 9 LGKGNYGSVY-KVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFY 65
Query: 128 G-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++++G + + E+ GSL D L+ P VL +I +GL++L
Sbjct: 66 GAFFIEGAV-YMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFL 118
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
K E IIHR++K +NVL+ + K+ DF +S + A+ + +G Y APE
Sbjct: 119 --KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPER 172
Query: 247 AMTGQMSS------KSDVYSFGVVLLELLTGRKP 274
+G + +SDV+S G+ +LE+ GR P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 74 IGEGSYGRVY--------------FGVLRSGRA---AAIKKL--DSSKQPDQEFLAQVSM 114
+GEG +G V+ F + SG A+K L D++K +FL ++ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 172
+SRLK+ N++ L+ + + E+ G L+ L H + +S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLH 231
+ +A A G++YL + +HR++ + N L+ + KI+DF +S N R+
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
VL + + E + G+ ++ SDV++FGV L E+LT
Sbjct: 190 GRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKL-----DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
I +G++G VY R +G AIK L + Q + M+ + ++ V +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQRVKIAVGAARGLEYL 186
+ L E+ + G ++ G + WA+ + G+E L
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIK--------TLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
H++ IIHR+IK N+L+ K++DF LS L + + +GT Y APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPET 164
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ SD +S G V+ E L G P
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKK----LDSSKQPDQEFLAQVSMVSRLKN---ENV 123
+ IGEG+YG VY L +GR A+KK L P L +++++ +L++ N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLREIALLKQLESFEHPNI 63
Query: 124 VEL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L G D L++ L +EH + L L K KPG L +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-----KCPKPG--LPPETIKDLMRQ 115
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----T 233
RG+++LH RI+HR++K N+L+ D KI+DF L AR++S T
Sbjct: 116 LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL--------ARIYSFEMALT 164
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V+ T Y APE + ++ D++S G + EL R+P
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 46/220 (20%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
+G+G +G V ++ +G+ A KKLD ++ +Q L + ++ ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-- 58
Query: 129 YYVDGPLRVLAYEHASKGSLHDIL--------------HGKKGVKGAKPGPVLSWAQRVK 174
AY +K L ++ G+ P A+ +
Sbjct: 59 ----------AYAFETKDDLCLVMTLMNGGDLKYHIYNVGE---------PGFPEARAIF 99
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A GLE+LH++ RI++R++K NVLL D +ISD L A +
Sbjct: 100 YAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKG 153
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY APE D ++ G L E++ GR P
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
I +G+YGRV+ +S G AIK + + K + L + ++S+ ++ VV+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 129 YYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA--VGAARGLEY 185
Y G + L E+ G L +L G+ A R+ IA V A LEY
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDE---DVA-RIYIAEIVLA---LEY 108
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS------NQAPDAAARLHSTRVLGTF 239
LH IIHR++K N+L+ + K++DF LS Q R++GT
Sbjct: 109 LHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + GQ SK+ D +S G +L E L G P
Sbjct: 166 DYIAPE-VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 24/204 (11%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVG-YY 130
+G+G++G+VY + +G AA K +++ + + ++++ ++ +++ + +V+L+G +Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 131 VDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
DG L ++ E G++ I L +G L+ Q I L+YLH
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRG---------LTEPQIQVICRQMLEALQYLHSM 129
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+IIHR++K+ NVLL D K++DF +S + R S +GT + APE M
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMC 184
Query: 250 GQMSS-----KSDVYSFGVVLLEL 268
M K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAA----AIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125
++G G++G VY G+ + G AIK L+ + P + EF+ + +++ + + ++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G + P L + G L D +H K G++ +L+W ++ A+G+ Y
Sbjct: 74 LLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQL--LLNWCVQI------AKGMMY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E+ R++HR++ + NVL+ + KI+DF L+ ++ + A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE--DKVKQC 302
+ + +SDV+S+GV + EL+T G KP D + T P L E +++ Q
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------GIPTREIPDLLEKGERLPQ- 232
Query: 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 335
PP + V C +AD RP
Sbjct: 233 ---------PPICTIDVYMVMVKCWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNENVVEL 126
++G G +G + G L + AI L + Q FLA+ + + + N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G G ++ E+ S G+L L +G L Q + + G A G++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--------LVAGQLMGMLPGLASGMKYL 123
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLGTFGYHAPE 245
+E +H+ + + VL+ D + KIS F + D + +++T + APE
Sbjct: 124 ---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE--DKSEAIYTTMSGKSPVLWAAPE 178
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
SS SDV+SFG+V+ E+++ G +P
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 50/222 (22%)
Query: 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLD--SSKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG+G +G VY G L A+K L+ + + ++FL + ++ + NV+ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 127 VGYYVD---GPLRVLAYEHASKGSLHDILHG--KKGVKGAKPGPVLSWAQRVKIAVG--- 178
+G + PL VL Y + HG + ++ P VK +G
Sbjct: 62 LGICLPSEGSPLVVLPY----------MKHGDLRNFIRSETHNPT------VKDLIGFGL 105
Query: 179 -AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD---------AAA 228
A+G+EYL A + +HR++ + N +L + K++DF L+ D A
Sbjct: 106 QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+L + A E T + ++KSDV+SFGV+L EL+T
Sbjct: 163 KL-------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 71/242 (29%), Positives = 110/242 (45%), Gaps = 40/242 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-------SSKQPDQEFLAQVSMVSRLKNENVVE 125
IG G++G V+ R G+ A+KK+ S K+ +E + M+ K++NV+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRE----LKMLCFFKHDNVLS 63
Query: 126 LVGYYVDGPLRVLAYEHA------SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV-G 178
+ + P + +E + LH I+ P P LS + VK+ +
Sbjct: 64 ALD--ILQPPHIDPFEEIYVVTELMQSDLHKII--------VSPQP-LS-SDHVKVFLYQ 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVLG 237
RGL+YLH I+HR+IK N+L+ + + KI DF L+ + PD H T+ +
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVV 166
Query: 238 TFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--WATPKL 294
T Y APE M + +S D++S G + ELL R P Q L+T TP L
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226
Query: 295 SE 296
Sbjct: 227 EA 228
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK-LDSSKQPDQEFLA--QVSMVSRL 118
EK +N G L+GEGSYG V + +G+ AIKK L+S + +A ++ M+ +L
Sbjct: 1 EKYENLG---LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAV 177
++EN+V L+ + L +E L D+ G+ RV K
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLD----------ESRVRKYLF 107
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
RG+E+ H IIHR+IK N+L+ + K+ DF + AA T +
Sbjct: 108 QILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVA 162
Query: 238 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTG 271
T Y APE + ++ D+++ G ++ E+LTG
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
+G+GSYG V R+ G+ IKKL+ +S++ + + ++S+LK+ N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 130 YV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ DG L ++ G L+ L +KG +L Q V+ V A L+YLH
Sbjct: 68 WEGEDGLLYIVM-GFCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLH 119
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAAARLHSTRVLGTFGYHA 243
EK I+HR++K+ NV L +I K+ D L NQ D A+ L +GT Y +
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTL-----IGTPYYMS 170
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT 270
PE + KSDV++ G + E+ T
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
+GEG++G VY +++GR A+KK+ + D F L ++ ++ +LK+ NVV L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLID 74
Query: 129 YYVDGPLRVLAYEHASKGSLHDIL----HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
V+ P + +GS++ + H G+ P L+ +Q + G+
Sbjct: 75 MAVERPDK----SKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLEGIN 129
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL---------SNQAPDAAARLHSTRV 235
YLHE I+HR+IK++N+L+ + I KI+DF L + + T +
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 236 LGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
+ T Y PE + + ++ D++ G V E+ T R
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-12
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY +GR A+K++ S + +E A ++ ++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+E +V+ G D R L+ EH GS+ D L K L+ K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---------KSYGALTENVTRKYTR 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS----- 232
G+ YLH I+HR+IK +N+L K+ DF A+ RL +
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-------ASKRLQTICLSG 163
Query: 233 ---TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V GT + +PE K+D++S G ++E+LT + P
Sbjct: 164 TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 25/200 (12%)
Query: 89 SGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLKNENVVELVGYYVDGPLRVLA-YEHA 143
+G AIK L + ++ F + ++ +RL + N+V L+ P + A +E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203
+L ++L A G L + ++ + L H + I+HR++K N
Sbjct: 62 PGRTLREVL--------AADGA-LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQN 109
Query: 204 VLLFDDDI---AKISDFDLSNQAPDA--AARLHSTR---VLGTFGYHAPEYAMTGQMSSK 255
+++ + AK+ DF + P A TR VLGT Y APE ++
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 256 SDVYSFGVVLLELLTGRKPV 275
SD+Y++G++ LE LTG++ V
Sbjct: 170 SDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 29/212 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV-G 128
++GEGS+GR + S + A+K +L S ++ + +++++K+ N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ DG L ++ E+ G L + ++G K +L W ++ + V +++HE
Sbjct: 67 FEADGHLYIVM-EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGV------QHIHE 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV------LGTFGYH 242
K R++HR+IKS N+ L + K+ DF +ARL ++ +GT Y
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDF--------GSARLLTSPGAYACTYVGTPYYV 167
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE ++KSD++S G +L EL T + P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 46/233 (19%)
Query: 71 NSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-----DQEFLAQVSM---------- 114
+ +GEG+YG+V +G+ AIKK+ + D++ + +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGK-KGVKGAKPGPVLSWAQRV 173
++ +K+EN++ LV YV+G L + DI+ K V K L+ +Q
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINL---------VMDIMASDLKKVVDRKI--RLTESQVK 122
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF-------------DLS 220
I + GL LH+ +HR++ +N+ + I KI+DF LS
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
+++V+ T Y APE M + D++S G + ELLTG+
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVEL---- 126
+GEG+Y VY G R +G A+K LD+ + + ++S++ LK+EN+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 127 --------VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V Y+D L+ H +G+L P V S+ ++
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGAL-------------DPNTVKSFTYQL----- 109
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+G+ + HE R++HR++K N+L+ K++DF L+ +A S V+ T
Sbjct: 110 -LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA-RAFGIPVNTFSNEVV-T 163
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y AP+ + + S S D++S G ++ E++TGR
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 44/222 (19%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVE 125
IG G+YG V V R+GR AIKK+ S D A+ + ++ L++EN++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 126 LVGYYVDGPLRVLAYEHASKGS------------LHDILHGKKGVKGAKPGPVLSWAQRV 173
L L +L + LH ++ + L+ +
Sbjct: 64 L--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ---------PLT-DDHI 105
Query: 174 K-IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLH 231
+ RGL+YLH +IHR++K SN+L+ + KI DF L+ PD +
Sbjct: 106 QYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T + T Y APE ++ +K+ D++S G + ELLT +
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 57/210 (27%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG VY G ++G+ A+KK L+S ++ P + ++S++ L++ N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ L +E S L L + V S+ ++ +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------LQGILFCHS 119
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+ R++HR++K N+L+ + + K++DF L+ +A R+++ V+ T Y APE +
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 249 TGQM-SSKSDVYSFGVVLLELLTGRKPVDH 277
S+ D++S G + E+ T +KP+ H
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNE 121
NF IG G + VY L G A+KK+ + + + ++ ++ +L +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
NV++ +++ + E A G L ++ K K P + W K V
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-W----KYFVQLCS 117
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LE++H + R++HR+IK +NV + + K+ D L HS ++GT Y
Sbjct: 118 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE + KSD++S G +L E+ + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 42/235 (17%)
Query: 74 IGEGSYGRVYF-----------------GVLRSGRAAAIKKL--DSSKQPDQEFLAQVSM 114
+GEG +G V+ + A+K L D+S ++FL +V +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 172
+SRL + N+ L+G P + E+ G L+ L H + A LS++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ +A A G+ YL +HR++ + N L+ + KI+DF +S + + +
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDYY 186
Query: 233 TRVLGTFGYHAP--------EYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDH 277
RV G AP E + G+ ++KSDV++FGV L E+LT +P +H
Sbjct: 187 -RVQG----RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 49/209 (23%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQ--VSMVSRLKNENVVELVG 128
++G G++G V+ ++ + I K +Q D+ AQ ++ L + N++E
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+++ ++ E+A G+L + + K+ +L + ++ +A L ++H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQILLA------LHHVHT 119
Query: 189 KAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
K I+HR++K+ N+LL + KI DF +S + + V+GT Y +PE
Sbjct: 120 K---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELC 173
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+ KSD+++ G VL EL + ++ +
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGR----AAAIKKLDSSKQP--DQEFLAQVSMVS 116
K F ++G G++G VY G+ + G AIK+L + P ++E L + +++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
+ N +V L+G + ++++ + G L D + K G++ +L+W
Sbjct: 65 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNWC------ 115
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
V A+G+ YL E+ R++HR++ + NVL+ KI+DF L+ H+
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ A E + + +SDV+S+GV + EL+T G KP D
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIK------KLDSSKQPD-QEFLAQVSMVSRLKNENVVE 125
++GEG +G V G L + +K KLD + +EFL++ + + + NV++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 126 LVGYYVDG--------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L+G + P+ +L + G LH L + + P+ +K V
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPF--MKHGDLHSFLLYSRLGGLPEKLPL---QTLLKFMV 120
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRV 235
A G+EYL + IHR++ + N +L +D ++DF LS + + D + ++
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ A E +SKSDV++FGV + E+ T G+ P
Sbjct: 178 --PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 22/159 (13%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+H +IHR+IKS+N+LL + + K+ DF S + GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305
S K+D++S GV+L ELLT ++P D E+ +++ +
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD------------------GEN-MEEVMHK 256
Query: 306 KLGGEY---PPKAIAKMAAVAALCVQYEADFRPNMGIVL 341
L G Y PP +M + + + RP+ +L
Sbjct: 257 TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK-LDSSKQPDQEFLA--QVSMVSRLKNENVVELVGY 129
IGEGSYG V+ R +G+ AIKK ++S P + +A ++ M+ +LK+ N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ L +E+ L+++ +GV KI + + + H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH---------LIKKIIWQTLQAVNFCHKH 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------TRVLGTFGYHA 243
IHR++K N+L+ K+ DF AR+ + T + T Y A
Sbjct: 120 ---NCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGDDYTDYVATRWYRA 168
Query: 244 PEYAMTG--QMSSKSDVYSFGVVLLELLTG 271
PE + G Q DV++ G V ELLTG
Sbjct: 169 PEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 53/212 (25%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 73 LIGEGSYGRVYFGV-------LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
++G G++G VY G+ ++ A + + ++S + ++E L + +++ + + V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G + ++ L + G L D + K G++ +L+W ++ A+G+ Y
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQD--LLNWCVQI------AKGMSY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E R++HR++ + NVL+ + KI+DF L+ H+ + A E
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ + + +SDV+S+GV + EL+T G KP D
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + + ++ ++ L +EN+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 127 VGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G + L E GSL + L K K Q++K AV +G++
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--------QQLKYAVQICKGMD 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHSTRVLGTFGYH 242
YL + + +HR++ + NVL+ + KI DF L+ + + F Y
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY- 179
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + + SDV+SFGV L ELLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNE 121
+ F ++GEG+YG V + + AIKK S++ ++ L ++ M+ LK E
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+VEL + L +E+ K L + ++ G P V S+ ++ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQL------IK 111
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+ + H+ I+HR+IK N+L+ +D+ K+ DF + + + + T + T Y
Sbjct: 112 AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
+PE + D++S G +L EL G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 53/203 (26%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELV-GYY 130
+G+G++G+VY + +G AA K +D+ + + ++++ ++ +++ + N+V+L+ +Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ L +L E + G++ ++ ++ +P L+ Q + L YLHE
Sbjct: 73 YENNLWILI-EFCAGGAVDAVM-----LELERP---LTEPQIRVVCKQTLEALNYLHEN- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+IIHR++K+ N+L D K++DF +S + R S +GT + APE M
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178
Query: 251 QMSS-----KSDVYSFGVVLLEL 268
K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A L++LH II+R++K N+LL ++ K++DF LS ++ D + +S GT
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + +D +SFGV++ E+LTG P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 67/292 (22%), Positives = 118/292 (40%), Gaps = 57/292 (19%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAI-----------KKLDSSKQPDQEFLAQVSMVSRLKNEN 122
+G+G++ +Y GVLR I K L S + F S++S+L +++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L G V ++ E+ G L LH +K L W ++ +A A
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKN------NVSLHW--KLDVAKQLASA 113
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDI-------AKISDFDLSNQAPDAAARLHSTRV 235
L YL +K +++H N+ N+L+ + K+SD + R+
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPW 170
Query: 236 LGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP 292
+ APE GQ ++ +D +SFG LLE+ + G +P+ +T
Sbjct: 171 I------APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL--------------STL 210
Query: 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344
SE + + P A++A + C Y+ RP+ +L+ L
Sbjct: 211 SSSEKERFY----QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY + +GR A K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+E +V+ G D + L E+ GS+ D L K L+ + K
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---------KAYGALTESVTRKYTR 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-VL 236
G+ YLH I+HR+IK +N+L K+ DF S + R V
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT + +PE K+DV+S G ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 33/89 (37%), Positives = 51/89 (57%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E +++HR++KS+N+ L I K+ DF S Q D+ + ++ GT Y APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ S K+D++S GV+L ELLT +P
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
S +G G+YG+V +GR AIKKL +P Q + ++ ++ + +ENV+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLS---RPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 125 ELVGYYV-DGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
L+ + L V H L++I+ +K LS +
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK----------LSDDHIQFLVYQI 127
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D T + T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATR 179
Query: 240 GYHAPEYAMTGQMS-SKS-DVYSFGVVLLELLTGR 272
Y APE M M +++ D++S G ++ ELLTG+
Sbjct: 180 WYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 15/161 (9%)
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L + ++ + + +V+ + V G + + H L+ L + L
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH-YSSDLYTYLTKRSRP--------LP 155
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
Q + I GL YLH + RIIHR++K+ N+ + D D I D + Q P A
Sbjct: 156 IDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAP 211
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269
+ GT +APE + +SK+D++S G+VL E+L
Sbjct: 212 AFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 48/241 (19%), Positives = 101/241 (41%), Gaps = 45/241 (18%)
Query: 111 QVSMVSRLKNENVVELVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
++ + R+ + N++++ G+ +D P L E+ ++G L ++L +K
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--------- 118
Query: 167 LSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
LS+ ++ +A+ +GL L++ +P ++N+ S + L+ ++ KI L
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSS 175
Query: 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSS----KSDVYSFGVVLLELLTGRKPVDHTLPR 281
V Y + + M + S K D+YS GVVL E+ TG+ P ++
Sbjct: 176 PP----FKNV-NFMVYFSYK--MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN---- 224
Query: 282 GQQSLVTWATPKLSEDKVKQCVDTKLGGEY-PPKAIAKMAAVAALCVQYEADFRPNMGIV 340
L+ ++ + K P ++ + C +++ RPN+ +
Sbjct: 225 ------------LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
Query: 341 L 341
L
Sbjct: 273 L 273
|
Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 55/277 (19%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMV 115
E + + S +G G+YG V ++G A+KKL +P Q + ++ ++
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLL 70
Query: 116 SRLKNENVVELVGYYVDGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
+K+ENV+ L+ + P R V H L++I+ +K L+
Sbjct: 71 KHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LT 118
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ RGL+Y+H IIHR++K SN+ + +D KI DF L+ D
Sbjct: 119 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 175
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
+TR Y APE + +++ D++S G ++ ELLTGR TL G +
Sbjct: 176 GYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-----TLFPGTDHI- 224
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAA 324
D++K + +L G + + K+++ +A
Sbjct: 225 ---------DQLKLIL--RLVGTPGAELLKKISSESA 250
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVG 128
IG G +G+V G G + A +K+L +S PD++ FL +V L + NV++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
++ +L E G L + L +G+ + QR +A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQR--MACEVASGLLWLHQ 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYHAPEYA 247
IH ++ N L D KI D+ L+ Q P+ + + APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELV 174
Query: 248 -------MTGQMSSKSDVYSFGVVLLELLT 270
+ + KS+++S GV + EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH+ E RI+HR++ +N++L +DD I+DF L+ Q + T V+GT Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE K+DV++FG +L ++ T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 65/233 (27%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 67 NFGTNSLIGEGSYGRVYF----GVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN 122
NF ++G G+YG+V+ G +G+ A+K L + + A+ + R
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER----Q 56
Query: 123 VVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ-----RVKIA 176
V+E V P V L Y + LH IL V G + L + V++
Sbjct: 57 VLEAVR---RCPFLVTLHYAFQTDTKLHLIL---DYVNGGELFTHLYQREHFTESEVRVY 110
Query: 177 VGA-ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTR 234
+ L++LH+ II+R+IK N+LL + ++DF LS + + R +S
Sbjct: 111 IAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-- 165
Query: 235 VLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285
GT Y APE G D +S GV+ ELLTG P + QS
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 50/224 (22%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVG 128
S IGEG+YG V +G AIKK+ + Q L ++ ++ R K+EN++ ++
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 129 YYVDGPLRVLAYEHASKGSLHDI----------LHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+R ++E S +D+ L+ K +K LS
Sbjct: 71 I-----IRPPSFE-----SFNDVYIVQELMETDLY--KLIKTQH----LSNDHIQYFLYQ 114
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------ 232
RGL+Y+H ++HR++K SN+LL + KI DF L AR+
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL--------ARIADPEHDHT 163
Query: 233 ---TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T + T Y APE + + +K+ D++S G +L E+L+ R
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 35/228 (15%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKN 120
D F IGEG+YG+VY + +G A+KK LD+ K+ P + ++ ++ +L +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILRQLNH 65
Query: 121 ENVVELVGYYVDGPLRV----------LAYEHASKGSLHDILHG--KKGVKGAKPGPVLS 168
N+V L D + L +E+ HD L G + G+ + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HD-LMGLLESGLVHFSEDHIKS 120
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ +++ GL Y H+K +HR+IK SN+LL + K++DF L+ +
Sbjct: 121 FMKQL------LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
R ++ +V+ T Y PE + + + DV+S G +L EL T +KP+
Sbjct: 172 RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K I++R++K N+LL D KI+DF + + A+ + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + ++ D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELV 127
++G+G +G V +R +G+ A KKL+ + + + L + ++ ++ + VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 128 GYY--VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
Y D VL + H G+ G + + V A GLE
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRA---------VFYAAEICCGLED 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH++ RI++R++K N+LL D +ISD L+ P+ + RV GT GY APE
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGYMAPE 171
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + D ++ G +L E++ G+ P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 62/252 (24%), Positives = 96/252 (38%), Gaps = 58/252 (23%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKL--DSSKQP--DQEFLAQVSMVSRLKNENVV--- 124
LIG+G G VY R A+KK+ D S+ P + FL + + + L + +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 125 ------ELVGY---YVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+ V Y Y++G L+ L K SL L K V
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS----------- 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--------FDDDIAKI----SDFDLSNQ 222
I +EY+H K ++HR++K N+LL D A + L
Sbjct: 118 IFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 223 APDAAARLHST----RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-------- 270
+ S +++GT Y APE + S +D+Y+ GV+L ++LT
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234
Query: 271 -GRK-PVDHTLP 280
GRK +
Sbjct: 235 KGRKISYRDVIL 246
|
Length = 932 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 46/217 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKNENVVELVGYY 130
+GEGSY VY G+ R +G+ A+K + + F A + S++ LK+ N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIA 176
LHDI+H K+ + PG + + R+
Sbjct: 67 ----------------LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FM 109
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y+H + I+HR++K N+L+ K++DF L+ +A ++ +S+ V+
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV 165
Query: 237 GTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + SS D++ G + +E+L G+
Sbjct: 166 -TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 17/98 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPD----AAARLHS 232
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD ARL
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE +++SDV+SFGV+L E+ +
Sbjct: 238 -----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKN 120
K D++ +GEGSY VY G + +G+ A+K + ++ F A + S++ LK+
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62
Query: 121 ENVVEL--VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N+V L + + + V Y H D K G P V + ++
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMD-----KHPGGLHPENVKLFLFQL----- 112
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
RGL Y+H++ I+HR++K N+L+ D K++DF L+ +A + +S V+ T
Sbjct: 113 -LRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-T 166
Query: 239 FGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTG 271
Y P+ + + + S+ D++ G + +E++ G
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE+LH++ RII+R++K NVLL +D +ISD L+ + D ++ + GT G+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGF 163
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + D ++ GV L E++ R P
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-------PDQEFLAQV--SMVSRLKNENVV 124
+G+GS+G VY +++ +A A ++L K+ P++ A ++S+L + +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ +++ + E+ L L K G LS Q + + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVCEWFIQLLLGVH 120
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLGTFGY 241
Y+H++ RI+HR++K+ N+ L +++ KI DF +S + D A T GT Y
Sbjct: 121 YMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLA-----TTFTGTPYY 171
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLEL 268
+PE SKSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 10/99 (10%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVL 236
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD R S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARL- 238
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE +++SDV+SFGV+L E+ + G P
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKL----DSSKQPDQEFLAQVSMVSRLKNE 121
NF IGEG+YG VY +G A+KK+ ++ P + ++S++ L +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+ L +E LH L KK + + + +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSG-IPLPLIKSYLFQLLQ 111
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL + H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TLWY 166
Query: 242 HAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 272
APE + + S+ D++S G + E++T R
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 61/231 (26%)
Query: 74 IGEGSYGRVY---------FGVLRSGRA---------------AAIKKLDSSKQPDQEFL 109
IG G+YG VY F L+S R A +K+L++ P+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
V SR E V LV +VD LR + K P P L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRT----YLDKV----------------PPPGLPA 107
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
+ RGL++LH I+HR++K N+L+ K++DF L AR
Sbjct: 108 ETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL--------AR 156
Query: 230 LHS-----TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
++S T V+ T Y APE + ++ D++S G + E+ RKP+
Sbjct: 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 40/230 (17%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG G+ G VY + R +GR A+K + + + ++ ++ ++ + + NVV+ +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 131 -VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+G ++VL E GSL +G + +A G+ YLH +
Sbjct: 142 DHNGEIQVL-LEFMDGGSL----------EGTH---IADEQFLADVARQILSGIAYLHRR 187
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHAPEY 246
I+HR+IK SN+L+ KI+DF +S Q D +GT Y +PE
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-----NSSVGTIAYMSPER 239
Query: 247 AMTGQMSSK-----SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291
T D++S GV +LE GR P G+Q WA+
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP----FGVGRQG--DWAS 283
|
Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIKKL----DSSKQPDQEFLAQVSMVSRLK-NENVVELV 127
IGEG++ V ++G+ AIK + S +Q + L ++ + RL + N++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 128 GYYVDGPLRVLAYE-HASKGSLHDILHGKKGVKGAKPGP---VLSWA-QRVKIAVGAARG 182
D LA +L++++ G+K +P P V S+ Q +K
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQLLK-------S 112
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L+++H I HR+IK N+L+ DDI K++DF ++ T + T Y
Sbjct: 113 LDHMHRNG---IFHRDIKPENILI-KDDILKLADF---GSCRGIYSKPPYTEYISTRWYR 165
Query: 243 APEYAMT-GQMSSKSDVYSFGVVLLELLT 270
APE +T G K D+++ G V E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRA---AAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELV 127
+GEG +G V G L + A+K + ++ ++FL++ + + NV+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 128 GYYVDG------PLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQR-VKIAVGA 179
G + P V+ G LH +L+ + G P Q VK
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-----DCPQYLPTQMLVKFMTDI 121
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+EYL K IHR++ + N +L ++ ++DF LS + +
Sbjct: 122 ASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ A E ++KSDV+SFGV + E+ T G+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-- 124
NF ++G G+YG+V+ SG DS K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-------DSGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 125 --ELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR-----VKIA 176
+++ + P V L Y + LH IL + G + LS +R V+I
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL---DYINGGELFTHLSQRERFKEQEVQIY 110
Query: 177 VGA-ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTR 234
G LE+LH+ II+R+IK N+LL + ++DF LS + D R +S
Sbjct: 111 SGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-- 165
Query: 235 VLGTFGYHAPEYAMTGQMSSKS--DVYSFGVVLLELLTGRKP 274
GT Y AP+ G D +S GV++ ELLTG P
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A GL++LHE+ II+R++K NVLL + KI+DF + + ++
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156
Query: 236 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVD 276
GT Y APE ++ Q + D ++ GV+L E+L G+ P +
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 46/217 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y V+ G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGA-------------KPGPVLSWAQRVKIAV 177
+LHDI+H ++ + G ++S VKI +
Sbjct: 67 ----------------TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMS-MHNVKIFM 109
Query: 178 -GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y H++ +I+HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 110 FQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV 165
Query: 237 GTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + + + S+ D++ G +L E+ TGR
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K II+R++K NV+L D KI+DF + + R ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 62/232 (26%)
Query: 74 IGEGSYGRVY----------FGVLRSGRA---------------AAIKKLDSSKQPDQEF 108
IGEG+YG+V+ F L+ R A ++ L++ + P+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L V VSR E + LV +VD L + P P +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--------------------VPEPGVP 108
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ RGL++LH R++HR++K N+L+ K++DF L A
Sbjct: 109 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------A 157
Query: 229 RLHS-----TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
R++S T V+ T Y APE + ++ D++S G + E+ RKP+
Sbjct: 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
+G G+YG V + R+G AIKKL Q + + ++ ++ +K+ENV+ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 130 YV-DGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV-GAA 180
+ D L V+ + G L + H K R++ V
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKL--MKHEKLS------------EDRIQFLVYQML 128
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL+Y+H IIHR++K N+ + +D KI DF L+ Q TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR---KPVDH 277
Y APE + +++ D++S G ++ E+LTG+ K DH
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 13/101 (12%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-----NQAPDAAARLHSTRV 235
GL+Y+H ++HR++K N+L+ D KI DF L+ N +A T
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG---FMTEY 169
Query: 236 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
+ T Y APE ++ Q +K+ DV+S G +L ELL GRKPV
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 39/218 (17%)
Query: 73 LIGEGSYGRVYFGVLR--SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G VY G + +G+ A+K LD KQ + L + M+S + + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 127 V--GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
V Y P ++ + + G LH L HG V S A+ A
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----------VFSEAEMRFYAAEIIL 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 238 TFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
T GY APE G S +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG VY +G A+KK L++ + P + ++S++ L + N+V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV--KIAVGAARGLEYL 186
L +E D+ KK + + P+ + +G+ Y
Sbjct: 66 VVHSENKLYLVFEFLD----LDL---KKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T Y APE
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVV-TLWYRAPEI 170
Query: 247 AMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
+ Q S+ D++S G + E++ R+P
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 73 LIGEGSYGRVYFGVLR--SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G VY G + +G+ A+K LD KQ + L + M+S + + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 127 V--GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
V Y P ++ + + G LH L HG V S + A
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-----------VFSEKEMRFYATEIIL 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 238 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
T GY APE G S +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 74 IGEGSYGRV-YFGVLRSGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G+G +G V V +G+ A KKLD K+ E +A L + ++E V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA-------LLEKEILEKV--- 50
Query: 131 VDGPLRV-LAYEHASKGSL---HDILHGKK--------GVKGAKPGPVLSWAQRVKIAVG 178
+ P V LAY SK L +++G G +G + V+ ++ ++
Sbjct: 51 -NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI----- 104
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
G+ +LH I++R++K NVLL D ++SD L+ + D T+ GT
Sbjct: 105 -TCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGT 157
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GY APE S D ++ G + E++ GR P
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 39/114 (34%), Positives = 60/114 (52%), Gaps = 19/114 (16%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVLGTF 239
RGL+Y+H ++HR++K SN+L+ ++ KI DF L+ Q P T + T
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP------QMTGYVSTR 169
Query: 240 GYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPV----DHTLPRGQQSLVT 288
Y APE +T Q + D++S G + E+L G KP+ DH Q S++T
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHV---NQFSIIT 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 37/94 (39%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH+K II+R++K NVLL D KI+DF + + + + ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + GQ ++S D +SFGV+L E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-----KQPDQEFLAQVSMVSR 117
K +F +G GS+GRV + +G AIK L KQ Q + S++
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV-QHVAQEKSILME 74
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS-WAQRVKIA 176
L + +V ++ + D E G L H +K G P V + + +A
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKA--GRFPNDVAKFYHAELVLA 130
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
EYLH K II+R++K N+LL + K++DF + + PD L
Sbjct: 131 ------FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----C 176
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y APE + D ++ GV+L E + G P
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNEN 122
F ++G+G +G V +R +G+ A K+L+ + + + L + ++ ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 123 VVELVGYY--VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
VV L Y D VL + H G G + + L +A +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER---ALFYAAEILC----- 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
GLE LH + ++R++K N+LL D +ISD L+ + P+ RV GT G
Sbjct: 114 -GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVG 166
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + D + G ++ E++ G+ P
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGR--AAAIKKLDSSK-----QPDQEFLAQV 112
+ K K ++F +G GS+GRV ++ AIK+ + SK Q D F ++
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SER 82
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW--A 170
+++ + + V L G + D L E G L K P V + A
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF----PNDVGCFYAA 138
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q V I EYL I++R++K N+LL D K++DF A++
Sbjct: 139 QIVLI-------FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKV 180
Query: 231 HSTR---VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
TR + GT Y APE + +D ++ G+ + E+L G P
Sbjct: 181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 74 IGEGSYGRVYF-GVLRSGRAAAIKKLDSS-----KQPDQEFLAQVSMVSRLKNENVVELV 127
+G G +GRV V R A+K + Q + F + ++ + +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKLY 59
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ D + E+ G L IL + G + R IA EYLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDR--------GLFDEYTARFYIA-CVVLAFEYLH 110
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
+ II+R++K N+LL + K+ DF + + + + GT Y APE
Sbjct: 111 NRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWT--FCGTPEYVAPEII 164
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ D +S G++L ELLTGR P
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL--SNQAPDAAARLHSTRVLG 237
A GL +LH K II+R++K NV+L + KI+DF + N R G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCG 163
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
T Y APE D ++FGV+L E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 56/267 (20%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLA-----QVSMVSRLKNENVVEL 126
+G G+YG V + R+G AIKKL Q E A +++++ +++ENV+ L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 127 VGYYVDGPL--------RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ + V+ Y L I+ G LS + +
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIM-----------GHPLSEDKVQYLVYQ 125
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
GL+Y+H IIHR++K N+ + +D KI DF L+ A DA T + T
Sbjct: 126 MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA-DA----EMTGYVVT 177
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297
Y APE + +++ D++S G ++ E+LTG+ TL +G+ L D
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL----------D 222
Query: 298 KVKQCVDTKLGGEYPPKAIAKMAAVAA 324
++ Q + K+ G P+ + K+ AA
Sbjct: 223 QLTQIL--KVTGVPGPEFVQKLEDKAA 247
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H IIHR++K SNV + +D +I DF L+ QA D +TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE LH + RI++R++K N+LL D +ISD L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + D + G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----- 121
NF ++G G+YG+V+ +G D+ K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGH-------DTGKLYAMKVLQKAALVQKAKTVEHTRT 53
Query: 122 --NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLS-WAQR----- 172
NV+E V P V L Y ++ LH IL G G + + QR
Sbjct: 54 ERNVLEHVR---QSPFLVTLHYAFQTEAKLHLILDYVSG------GEMFTHLYQRDNFSE 104
Query: 173 --VKIAVGAA-RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAA 228
V+ G LE+LH+ I++R+IK N+LL + ++DF LS + +
Sbjct: 105 DEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
R +S GT Y APE K+ D +S G+++ ELLTG P R QS V
Sbjct: 162 RTYS--FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
Query: 288 T 288
+
Sbjct: 220 S 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 46/217 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y V+ G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAV 177
+LHDI+H K + K K G ++S VKI +
Sbjct: 68 ----------------TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS-MHNVKIFL 110
Query: 178 -GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y H + +++HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 111 YQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV 166
Query: 237 GTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + + + S++ D++ G + E+ +GR
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKN 120
F ++G+G +G V L+ S + A+K L + S +EFL + + + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 121 ENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
NV++L+G + P+ ++ G LH L + G +P L V+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLVR 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A G+EYL K IHR++ + N +L ++ ++DF LS +
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ A E ++ SDV++FGV + E++T G+ P
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 18/103 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPD----AAARLHS 232
A+G+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD ARL
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE + +SDV+SFGV+L E+ + G P
Sbjct: 244 -----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H ++HR++K SN+LL + KI DF L+ + + T + T
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRW 173
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
Y APE + + + DV+S G + ELL GRKP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 54/221 (24%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKNENVVELVGYY 130
+GEGSY VY G + +G+ A+K++ + F A + S++ LK+ N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR-----------------V 173
+LHDI+H KK + V + V
Sbjct: 67 ----------------TLHDIIHTKKTLT-----LVFEYLDTDLKQYMDDCGGGLSMHNV 105
Query: 174 KIAV-GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
++ + RGL Y H++ R++HR++K N+L+ + K++DF L+ +A ++ +S
Sbjct: 106 RLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPSKTYS 161
Query: 233 TRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y P+ + + + S+ D++ G + E+ TGR
Sbjct: 162 NEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 59/245 (24%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+G GS G V+ V + A+KK+ + Q + L ++ ++ RL ++N+V++ Y V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--YEV 70
Query: 132 DGPL-RVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIAVGAARGLEY 185
GP L + S L+ + ++ + + GP+ R+ RGL+Y
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA-KISDFDLSN-QAPDAAARLHSTRVLGTFGYHA 243
+H ++HR++K +NV + +D+ KI DF L+ P + + + + L T Y +
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 244 PEYAMTGQMSSKS-DVYSFGVVLLELLTGRK--PVDHTLPRGQQSLVTWATPKLSEDKVK 300
P ++ +K+ D+++ G + E+LTG+ H L Q L+ + P + E+
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILESVPVVREEDRN 244
Query: 301 QCVDT 305
+ ++
Sbjct: 245 ELLNV 249
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y VY G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAV 177
+LHDI+H +K + K K G ++
Sbjct: 68 ----------------TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF 111
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
RGL Y H + +++HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV- 166
Query: 238 TFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + + S++ D++ G + E+ TGR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 165 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
P LS+ V + A G+E+L K +HR++ + NVL+ + + KI DF L+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ + + APE ++ SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 60/241 (24%), Positives = 98/241 (40%), Gaps = 56/241 (23%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLD-SSKQPDQEF---LAQVSMVSRLKNENVVELV 127
L+G+G GRV+ L+ +G+ A+K LD + L + +++ L + + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS------WAQRVKIAVGAAR 181
+ L ++ G L +L +PG LS +A V +A
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGKCLSEEVARFYAAEVLLA----- 115
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-----------------P 224
LEYLH I++R++K N+LL + +SDFDLS Q+
Sbjct: 116 -LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 225 DAAARLHSTRV----------LGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRK 273
+ T +GT Y APE ++G S D ++ G++L E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 274 P 274
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 20/217 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVG 128
IG G +G+V G + SG A +K+L S ++ FL + L++ N+++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ +L E G L L + + P P QR +A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT--LQR--MACEIALGLLHLHK 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA- 247
IH ++ N LL D KI D+ LS+ + ++ + APE
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 248 ------MTGQMSSKSDVYSFGVVLLELLT-GRKPVDH 277
+ + +S+V+S GV + EL G +P H
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE L + RI++R++K N+LL D +ISD L+ Q P+ RV GT GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV--RGRV-GTVGY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + D + G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 47/218 (21%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEF-----LAQVSMVSRLK-NENVVEL 126
+G+G++G VY + G AIKK+ K+ + L +V + +L + N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ + +E+ +G+L+ ++ +KG + + S ++ +GL ++
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQI------LQGLAHI 115
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHS----TRVLGTFGY 241
H+ HR++K N+L+ ++ KI+DF L AR + S T + T Y
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGL--------AREIRSRPPYTDYVSTRWY 164
Query: 242 HAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
APE Y SS D+++ G ++ EL T R
Sbjct: 165 RAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEF-LAQVSMVSRLKNENVVELVGY 129
IGEG+YG V+ R + A+K+ LD + L ++ ++ LK++N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 130 YVDGPLRVLAYEHASKG--SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
L +E+ + D +G P V S+ ++ +GL + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGD-----IDPEIVKSFMFQL------LKGLAFCH 116
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
++HR++K N+L+ + K++DF L+ +A R +S V+ T Y P+
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPDVL 171
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
++ S S D++S G + EL +P+
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 40/223 (17%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEF----LAQVSMVSRLKNENVVEL 126
IG+G++G V+ + + + A+KK +++ K+ F L ++ ++ LK+ENVV L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNL 76
Query: 127 VGYYVDGPLRVLAYEHASKGSL--------HDI--LHGKKGVKGAKPGPVLSWAQRVKIA 176
+ + KGS HD+ L K VK + ++ K+
Sbjct: 77 IEICRTKATP----YNRYKGSFYLVFEFCEHDLAGLLSNKNVK-------FTLSEIKKVM 125
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHST 233
GL Y+H +I+HR++K++N+L+ D I K++DF L+ + + ++ ++
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 234 RVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPV 275
RV+ T Y PE + D++ G ++ E+ T R P+
Sbjct: 183 RVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE 121
K+ D FG N E + V G +K+ D+++ V M+ +
Sbjct: 148 KKDLDIFGINP-ADESTRSYVILSFENKGDYMDMKQADTTQY--------VPMLEIKEAS 198
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
++ D P +Y+ ++ + ++L G +G +LS+ +V AR
Sbjct: 199 KYSDIQRSNYDRPA---SYKGSNDSEVKNLL-SDDGSEGLTTLDLLSFTYQV------AR 248
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+E+L A +HR++ + NVLL I KI DF L+ + + +
Sbjct: 249 GMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE ++ SDV+S+G++L E+ +
Sbjct: 306 MAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLG 237
RGL+Y+H +IHR++K SN+L+ +D +I DF ++ +P T +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY-FMTEYVA 173
Query: 238 TFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPV 275
T Y APE ++ + ++ D++S G + E+L GR+ +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 18/139 (12%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LE+LH++ II+R++K N+LL K++DF L ++ H+ GT Y
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYM 167
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTG---------RKPVDHTLPRGQQSLVTWATPK 293
APE M D +S G ++ ++LTG +K +D L +G+ +L + TP+
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-KGKLNLPPYLTPE 226
Query: 294 ---LSEDKVKQCVDTKLGG 309
L + +K+ ++LG
Sbjct: 227 ARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRL----- 118
+F ++G+GS+G+V + + AIK K D Q D + +MV +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD---VECTMVEKRVLALQ 57
Query: 119 -KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
K + +L + E+ + G L + H ++ K +P V A+ I+V
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAE---ISV 112
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL- 236
G L +LH + II+R++K NV+L + KI+DF + + +TR
Sbjct: 113 G----LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---TTRTFC 162
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
GT Y APE D +++GV+L E+L G+ P D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 42/284 (14%)
Query: 74 IGEGSYGRVYFGVLRS----GRA----AAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVV 124
+G+G++ +++ G+ R G +K LD S + + F SM+S+L ++++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G V G ++ E+ GSL L K + SW ++++A A L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SW--KLEVAKQLAWALH 114
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD--FDLSNQAPDAAARLHSTRVLGTFGYH 242
+L +K + H N+ + NVLL ++ K + F + + L +L +
Sbjct: 115 FLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171
Query: 243 APEYAMTGQ-MSSKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
PE Q +S +D +SFG L E+ +G KP+ Q+ L + ED+
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKL------QFYEDRH- 222
Query: 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344
+ P ++A + C+ YE DFRP+ +++ L
Sbjct: 223 ---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G G++G VY +GR A+K++ S++ +E A ++ ++ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
++ +V+ G D + L+ E+ GS+ D L GA V R +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQIL-- 116
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-VL 236
+G+ YLH I+HR+IK +N+L K+ DF S + + V
Sbjct: 117 ---QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT + +PE K+DV+S ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 41/201 (20%), Positives = 76/201 (37%), Gaps = 20/201 (9%)
Query: 77 GSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
GS G V+ + +K + K P +E + ++ + + ++ L+ Y
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGRE----IDILKTISHRAIINLIHAYRWK 158
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ D+ V + P L Q + I L YLH +
Sbjct: 159 STVCMVMPKYK----CDLF---TYVDRSGP---LPLEQAITIQRRLLEALAYLHGRG--- 205
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
IIHR++K+ N+ L + + A + DF + + GT ++PE
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
+K+D++S G+VL E+
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 41/120 (34%), Positives = 54/120 (45%), Gaps = 13/120 (10%)
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD----FDLSNQAPDAAARL 230
I GA RGL YLH+ IHRNIK+S++L+ D + +S + L A
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 231 H----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
ST VL + G + KSD+YS G+ EL TGR P + R Q L
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPF-QDMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAARLHS 232
A+G+++L K IHR++ + NVLL D +AKI DF L SN ARL
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL-- 276
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE + +SDV+S+G++L E+ + G+ P
Sbjct: 277 -----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE D + GVV+ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH +E +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE D + GVV+ E++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 8e-07
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + G+ A+K+++ + +++++ LK+ NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 67
Query: 131 VDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPG--PVLSWAQRVK-IAVGAARGLEY 185
+ R L +++A HD+ H K + +K PV VK + G+ Y
Sbjct: 68 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDD-------DIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LH ++HR++K +N+L+ + IA + L N A L V+ T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVT 178
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 277
F Y APE + + +K+ D+++ G + ELLT +P+ H
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 5/95 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LHE+ II+R++K NVLL D K++D+ + + ++ GT Y
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE + D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFL---AQVSMVSRLKNENVVE 125
+LIG+ + + + + A+KK++ ++ ++ +L++ N++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V ++ + + GS D+L H +G+ P L+ A +K L
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL------PELAIAFILK---DVLNAL 114
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--------NQAPDAAARLHSTRV 235
+Y+H K IHR++K+S++LL D +S S Q S +
Sbjct: 115 DYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 236 LGTFGYHAPEY---AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L + +PE + G + KSD+YS G+ EL G P
Sbjct: 172 L---PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH +I++R++K N++L D KI+DF L + AA + + GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEY 161
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE D + GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 11/107 (10%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHSTRVLGTF 239
R L+Y+H + HR++K N+L D KI DF L+ A D + T + T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 240 GYHAPEY--AMTGQMSSKSDVYSFGVVLLELLTGR-----KPVDHTL 279
Y APE + + + D++S G + E+LTG+ K V H L
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + G+ A+K+++ + +++++ LK+ NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVF 67
Query: 131 VDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ R L +++A H I+ + K K L + + G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWH-IIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 189 KAEPRIIHRNIKSSNVLLFDD-------DIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
++HR++K +N+L+ + IA + L N A L V+ TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTFWY 181
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 277
APE + + +K+ D+++ G + ELLT +P+ H
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 24/215 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRA-AAIKKLD-----SSKQPDQEFLAQVSMVSRLK 119
D+ +G G++GRV+ R A+K + KQ +Q + ++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVS 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ ++ L D + E+ G L L L +A + A
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN---STGLFYASEIVCA--- 113
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
LEYLH K I++R++K N+LL + K++DF + + D L GT
Sbjct: 114 ---LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTP 162
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + D ++ G+++ E+L G P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 23/229 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS----KQPDQEFLA 110
V + +L+ K +++ +IG G++G V +S + KL S K+ D F
Sbjct: 32 VRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 111 QVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
+ + N VV+L + D + E+ G L +++ + W
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--------KW 143
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
A+ V A L+ +H +IHR++K N+LL K++DF + D
Sbjct: 144 AKFYTAEVVLA--LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGM 197
Query: 230 LHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y +PE + G + D +S GV L E+L G P
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + ++ GT Y
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD-----SSKQPDQEFLAQVSMVSRLK 119
D+F +G GS+GRV + SG+ A+K L KQ + L + ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIR 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILH--GKKGVKGAKPGPVLSWAQRVKIAV 177
+ +V L G + D L E+ G L L G+ A+ +A +V +A
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVLA- 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
LEYLH I++R++K N+LL D KI+DF + + L G
Sbjct: 114 -----LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL-----CG 160
Query: 238 TFGYHAPEYAMTGQMSSK-----SDVYSFGVVLLELLTGRKP 274
T Y APE + SK D ++ G+++ E+L G P
Sbjct: 161 TPEYLAPEI-----ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 8/98 (8%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV---DH 277
APE D + GVV+ E++ GR P DH
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 42/233 (18%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAA-AIKKLDSS-----KQPDQEFLAQVSMVSRLK 119
++F T LI G+YG VY + R A+KK++ Q Q F + +++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV----LSWAQRVKI 175
N VV + + + E+ G +L K PV + +A+ V
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL------KNIGALPVDMARMYFAETV-- 111
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--------------N 221
LEYLH I+HR++K N+L+ K++DF LS +
Sbjct: 112 -----LALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
D +V GT Y APE + D ++ G++L E L G P
Sbjct: 164 IEKD-TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL+YLHE +I++R++K N+LL + KI+DF L + R ST GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT-ST-FCGTPEF 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + D + GV++ E+L G P
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
IG+GS+G+V ++ G+ A+K L K+ + +A+ +++ LKN LVG
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVL--LKNVKHPFLVG 60
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK---------IAVGA 179
L Y + L+ +L G G + QR + A
Sbjct: 61 ---------LHYSFQTADKLYFVLDYVNG------GELFFHLQRERSFPEPRARFYAAEI 105
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A L YLH II+R++K N+LL ++DF L + ++ GT
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTP 160
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE D + G VL E+L G P
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-----FLAQVS---MVS 116
D + IGEG+YG+VY +G+ A+KK D+E L ++S M+S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM--DEEGIPPTALREISLLQMLS 58
Query: 117 R-------LKNENVVELVGYYVDGPLRVLAYEH-ASKGSLHDILHGKKGVKGAKPGPVLS 168
L E+V E G P L +E+ S +G+ + + S
Sbjct: 59 ESIYIVRLLDVEHVEEKNG----KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAA 227
+ ++ G+ + H+ ++HR++K N+L+ + KI+D L +A
Sbjct: 115 FMYQLLK------GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIP 164
Query: 228 ARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTG 271
+ ++ ++ T Y APE + S+ D++S G + E+
Sbjct: 165 VKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 237
+ L+Y+H +IHR++K SN+LL D K++DF L+ ++ + T +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 238 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T Y APE + +K D++S G +L E+L G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A A GL +LH K II+R++K NV+L + KI+DF + + + + +
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTF 161
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
GT Y APE D ++FGV+L E+L G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L +LHE+ II+R++K NVLL + K++D+ + + ST GT Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTST-FCGTPNYI 163
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE D ++ GV++ E++ GR P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 51/221 (23%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
IGEG+YG VY R + A+KK+ +Q D+ + ++S++ +++ N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRL-- 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV------------KGAKPGPVLSWAQR-VKI 175
D++H +K + K P + R +K
Sbjct: 67 --------------------QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT 106
Query: 176 AV-GAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHS 232
+ RG+ Y H R++HR++K N LL D + K++DF L+ +A R +
Sbjct: 107 YLYQILRGIAYCHSH---RVLHRDLKPQN-LLIDRRTNALKLADFGLA-RAFGIPVRTFT 161
Query: 233 TRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y APE + + S+ D++S G + E++ +
Sbjct: 162 HEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTACTNFMMTPYVVTRYY 188
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271
APE + D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAARLHS 232
A+G+ +L K IHR++ + N+LL I KI DF L SN ARL
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE + +SDV+S+G++L E+ + G P
Sbjct: 279 -----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--- 239
L +LH+K II+R++K NVLL + K++DF + + + + + TF
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG------IFNGKTTSTFCGT 159
Query: 240 -GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE D ++ GV+L E+L G P +
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
R ++YLHE RIIHR+IK+ N+ + + DF + D A + GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
+APE D++S G+VL E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 183
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
APE + D++S G ++ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 23/226 (10%)
Query: 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS----KQPDQEFLAQVS 113
+ +L+ K +++ +IG G++G V +S R KL S K+ D F +
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 114 MVSRLKNEN-VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ N VV+L + D + E+ G L +++ P WA+
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPE---KWARF 146
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V A L+ +H IHR++K N+LL K++DF + + +
Sbjct: 147 YTAEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRC 200
Query: 233 TRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKP 274
+GT Y +PE + G + D +S GV L E+L G P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIK---KLDSSKQPDQEF 108
+ +L+ K ++F +IG G++G V ++R S + A+K K + K+ D F
Sbjct: 32 AEKITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAF 89
Query: 109 L-AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL------HDILHGKKGVKGA 161
+ +++ +E +V+L + D + E+ G L +DI
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------- 141
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
WA+ V A L+ +H IHR++K N+LL K++DF
Sbjct: 142 ------KWARFYTAEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKP 274
+ DA + +GT Y +PE + G + D +S GV L E+L G P
Sbjct: 191 KM-DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LE+LH+ I++R++K N+LL + DF LS + + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 243 APEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + + +K D +S GV++ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 49/197 (24%), Positives = 80/197 (40%), Gaps = 26/197 (13%)
Query: 109 LAQVSMVSRLKNE-------NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA 161
L + S SR + N+V L Y V L +HA G L + +
Sbjct: 26 LRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP-- 83
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
V WA + +A L+ LH + I+ R++ +N+LL D +++ F +
Sbjct: 84 -EECVKRWAAEMVVA------LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWS 133
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281
+ D+ + Y APE + + D +S G +L ELLTG K + P
Sbjct: 134 EVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPS 187
Query: 282 GQQSLVTWATPK-LSED 297
G + T P+ +SE+
Sbjct: 188 GINTHTTLNIPEWVSEE 204
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQ--EFLAQVSMVSRLKNENVVELVG 128
+G+G YG+V+ + +G A+K++ S + ++ L + +++ K+E +V+L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS------WAQRVKIAVGAARG 182
+ D LA E+ G +L+ VLS + + AV A
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDA--- 116
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LHE IHR++K N L+ K++DF LS +S V+G+ Y
Sbjct: 117 ---LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYM 165
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE D +S G +L E L G P
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 23/220 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV----SMVSRLKN 120
+F SL+G G +G V + +G A+K + S QE ++ ++S +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ +L + D L E+ G L +L+ + AQ A
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE------DMAQ-----FYLA 109
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+ +H + +HR+IK NVL+ K++DF S A ++S +GT
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPD 168
Query: 241 YHAPEYAMTGQMSSKS------DVYSFGVVLLELLTGRKP 274
Y APE T K D +S GV+ E++ GR P
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 38/143 (26%), Positives = 55/143 (38%), Gaps = 46/143 (32%)
Query: 195 IHRNIKSSNVLLFDDDIAKISDF--------------------------DLSNQAPDA-- 226
IHR+IK N+L+ D K++DF D SN+ D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 227 -------------AARLH----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269
AAR H + ++GT Y APE + + D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 270 TGRKPVDHTLP-RGQQSLVTWAT 291
G+ P P Q ++ W T
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQT 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 191
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
APE + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 31/119 (26%), Positives = 46/119 (38%), Gaps = 30/119 (25%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL------------ 230
L+ +H+ IHR+IK N+L+ D K++DF L + A R
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 231 ---------------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y APE + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 184
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLE------LLTGRKPVDH 277
APE + D++S G ++ E L GR +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L +LH +I+R++K N+LL + K++DF + + + +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYI 163
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + D ++ GV++ E++ G+ P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 35/151 (23%), Positives = 53/151 (35%), Gaps = 45/151 (29%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF------------------------- 217
+E +H+ IHR+IK N+L+ D K++DF
Sbjct: 114 IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 218 --------DLSNQAPDAAARLH---STRVL-----GTFGYHAPEYAMTGQMSSKSDVYSF 261
++ R R L GT Y APE + + D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 262 GVVLLELLTGRKPVDHTLPRG-QQSLVTWAT 291
GV+L E+L G+ P P Q ++ W T
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 36/216 (16%)
Query: 73 LIGEGSYGRVYFGVL-RSGRAAAIKKLDS----SKQPDQEFLAQVSMVSRLKNENVVELV 127
+IG+GS+G+V G+ A+K L +++ + +A+ +++ LKN LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVL--LKNVKHPFLV 59
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK---------IAVG 178
G L Y + L+ +L G G + QR + A
Sbjct: 60 G---------LHYSFQTTEKLYFVLDFVNG------GELFFHLQRERSFPEPRARFYAAE 104
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A L YLH I++R++K N+LL ++DF L + + +T GT
Sbjct: 105 IASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGT 159
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + D + G VL E+L G P
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+H + +HR+IK NVLL + +++DF + + S+ +GT Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPE 173
Query: 246 Y--AM---TGQMSSKSDVYSFGVVLLELLTGRKP 274
AM G+ + D +S GV + E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 47/221 (21%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVG 128
IG G +G+V + + A +K+L ++ + EFL Q L++ N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
V+ +L +E+ G L L ++ + +L ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMHK 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDL--SNQAPD---------AAARLHSTRVLG 237
+H ++ N L D K+ D+ + S D R + ++G
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL-TGRKPVDH 277
F +T + + S+V++ GV L EL +P H
Sbjct: 175 EF----HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 58/247 (23%), Positives = 104/247 (42%), Gaps = 46/247 (18%)
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG-VKGAKPGPV 166
F S++S++ + ++ + G V G ++ E G L L +KG V
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVP------- 115
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA-------KISDFDL 219
++W ++ +A A L YL +K ++H N+ + N+LL +A K+SD +
Sbjct: 116 VAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV 170
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLEL-LTGRKPVDH 277
S A R+ + APE G +S+ +D +SFG LLE+ G P+
Sbjct: 171 SFTALSREERVERIPWI------APECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224
Query: 278 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 337
P ++ + E K + P + ++A + + C+ YE RP+
Sbjct: 225 RTPSEKE--------RFYEKKHR----------LPEPSCKELATLISQCLTYEPTQRPSF 266
Query: 338 GIVLKAL 344
+L+ L
Sbjct: 267 RTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 39/216 (18%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV--ELVGYYV 131
IG+GS+G+V ++K D+ + + + + +VSR + + + V V
Sbjct: 1 IGKGSFGKV----------MQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV 50
Query: 132 DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAVGAAR-------- 181
+ P V L + S L+ +L G G + QR + + AR
Sbjct: 51 NCPFIVPLKFSFQSPEKLYLVLAFING------GELFHHLQREGRFDLSRARFYTAELLC 104
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLS--NQAPDAAARLHSTRVLGT 238
LE LH+ +I+R++K N+LL + IA + DF L N D + GT
Sbjct: 105 ALENLHKF---NVIYRDLKPENILLDYQGHIA-LCDFGLCKLNMKDDDK----TNTFCGT 156
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + D ++ GV+L E+LTG P
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 30/115 (26%), Positives = 53/115 (46%), Gaps = 18/115 (15%)
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
K P+L + + + A +EY+H+K ++IHR+IK N+ L D + DF
Sbjct: 261 KDRPLLKQTRAIMKQLLCA--VEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFG--- 312
Query: 222 QAPDAAARLHSTRV------LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
A R +GT ++PE +D++S G++LL++L+
Sbjct: 313 ----TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 59/258 (22%), Positives = 100/258 (38%), Gaps = 58/258 (22%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV 124
D+F + +IG G++G V + +G A+K L + ++E +A + R + + +V
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILV 56
Query: 125 ELVGYYV--------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
E G +V D L E G + +L K + ++ +A
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA---ETVLA 113
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------------DLS 220
+ A L + IHR+IK N+LL K+SDF +L+
Sbjct: 114 IDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 221 NQAPD--AAARLHSTR---------------VLGTFGYHAPEYAMTGQMSSKSDVYSFGV 263
+ P + ++S R +GT Y APE M + D +S GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 264 VLLELLTGRKPVDHTLPR 281
++ E+L G P P+
Sbjct: 225 IMYEMLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY--AM-- 248
+HR+IK NVLL + +++DF S A + S +GT Y +PE AM
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 249 -TGQMSSKSDVYSFGVVLLELLTGRKP 274
G+ + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 41/164 (25%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ----------------VSMVS 116
I G++G+VY G + + + A+K + + ++ + Q V +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
L++ N V LV Y+ G G + +LH + G + VK
Sbjct: 72 SLQSANNVYLVMEYLIG------------GDVKSLLH----IYGYFDEEM-----AVKYI 110
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A L+YLH IIHR++K N+L+ ++ K++DF LS
Sbjct: 111 SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 356 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.09 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.98 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.85 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.73 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.61 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.59 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.57 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.37 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.33 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.26 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.25 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.04 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.99 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.99 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.98 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.89 | |
| PLN02236 | 344 | choline kinase | 97.78 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.68 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.49 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.44 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.42 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.42 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.37 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.36 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.34 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.28 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.16 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.12 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.12 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.05 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.97 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 96.85 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.83 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.5 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.47 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.44 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.37 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.93 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=401.59 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=219.5
Q ss_pred CCCCCCceeeccCceEEEEEEE-CCCCEEEEEEcCC----CCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDS----SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
.+|...++||+|||+.||.+++ .+|+.||+|++.+ .....+.+.+|+++.+.|+|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 5899999999987 4555678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|+|..++|.++++.++ ++++.+++.+++||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|
T Consensus 98 ELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccccee
Confidence 9999999999998554 3999999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........+. .+.+|||.|+|||++....++..+||||+||++|-||.|++||+... -.+.+.
T Consensus 166 t~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~---------------vkety~ 228 (592)
T KOG0575|consen 166 TQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT---------------VKETYN 228 (592)
T ss_pred eeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---------------HHHHHH
Confidence 9988664443 67899999999999999999999999999999999999999997441 123334
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+....+ ..|...+.+..+||.++|+.||.+|||+++|+.
T Consensus 229 ~Ik~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 229 KIKLNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHhcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 4444443 345577889999999999999999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=374.47 Aligned_cols=250 Identities=27% Similarity=0.397 Sum_probs=215.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC--CCchHHHHHHHHHHHhccCCceeeeeeEEecCC-eeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e 141 (356)
.+.+..+.||+|..|+||++.++ +++.+|+|++... ....+++.+|+++++..+||+||.+++.|.... ..+|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 46778899999999999999988 8999999999543 333678999999999999999999999999888 5999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||++|+|.+++..... +++.....++.++++||.|||+ ++ ||||||||.||||+..|.|||||||.+
T Consensus 159 YMDgGSLd~~~k~~g~---------i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGR---------IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred hcCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccccc
Confidence 9999999999987542 8999999999999999999996 66 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
..+-... ..+++||..|||||.+.+..|+.++||||||++++|+++|+.||-...+ .....-++.
T Consensus 227 ~~lvnS~----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-----------~~~~~~~Ll 291 (364)
T KOG0581|consen 227 GILVNSI----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-----------PYLDIFELL 291 (364)
T ss_pred HHhhhhh----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-----------CCCCHHHHH
Confidence 8876552 2677899999999999999999999999999999999999999964311 122233344
Q ss_pred HhhcccCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+-.......|.. ++++++.++..||++||.+|||+.++++
T Consensus 292 ~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 292 CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 44444444455555 8999999999999999999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-55 Score=378.73 Aligned_cols=249 Identities=23% Similarity=0.377 Sum_probs=210.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--------hHHHHHHHHHHHhccCCceeeeeeEEecCC
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--------DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 134 (356)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+.... .....+|+++|++|+|||||++.++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5567889999999999999999976 8999999999754221 234579999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC---Cc
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DI 211 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~ 211 (356)
..||||||++||+|.+++-.++. +.+..-..+++|++.|+.|||++| |+||||||+|||+..+ -.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceE
Confidence 99999999999999999988765 777778899999999999999999 9999999999999876 68
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCC---CccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 288 (356)
+||+|||+|+..+..... .+.||||.|.|||++.+..+ ..++|+|||||+||-+++|.+||....
T Consensus 318 lKItDFGlAK~~g~~sfm---~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~--------- 385 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEGSFM---KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY--------- 385 (475)
T ss_pred EEecccchhhccccceeh---hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc---------
Confidence 999999999988754433 78899999999999987543 447899999999999999999997542
Q ss_pred cccccCChhhHhHhhcc-cC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 289 WATPKLSEDKVKQCVDT-KL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 289 ~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+.+.+.. ++ ........+++..+||.+||..||++|||+.|+|+
T Consensus 386 ------~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 386 ------TDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ------CCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 12222333332 22 22334577899999999999999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=378.49 Aligned_cols=289 Identities=52% Similarity=0.872 Sum_probs=255.8
Q ss_pred cccccCHHHHHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEE
Q 018396 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYY 130 (356)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~ 130 (356)
....++..++...+++|.....||+|+||.||+|...++..||||++...... ..+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56678999999999999999999999999999999998899999988776554 56799999999999999999999999
Q ss_pred ecCC-eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 131 VDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 131 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
.+.+ ...||+||+++|+|.+.+...... +++|..+++|+.++|+||+|||....++|+|||||+.|||+|++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 9998 599999999999999999876532 38999999999999999999999988889999999999999999
Q ss_pred CceeEecccccCCCcc-cccccccccc-ccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 210 DIAKISDFDLSNQAPD-AAARLHSTRV-LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
...||+|||+|..... .... ... .||.+|+|||++..+..+.++||||||++|.||++|+.+.+...+.....+.
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CCEEccCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999999966554 2211 122 7999999999999999999999999999999999999998876656666688
Q ss_pred ecccccCChhhHhHhhcccCC-CCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 288 TWATPKLSEDKVKQCVDTKLG-GEYPP-KAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.|....+....+.+++|+.+. ..++. .....+..+...|++.+|.+||++.++++.|+.+...
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 888777877789999999987 66664 5777899999999999999999999999999776644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=365.97 Aligned_cols=242 Identities=24% Similarity=0.300 Sum_probs=209.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|+++++||+|+||+||.++.+ +++.+|+|++.+... ..+...+|..+|..++||+||+++..|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3478999999999999999999976 899999999976432 34678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
|++|+.||.|...|++... +++..+..++..|+.||.|||++| ||||||||+|||++.+|+++|+|||
T Consensus 103 Vld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred EEeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 9999999999999997764 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+++........ +.+++||+.|||||++.+..|+.++|+||||+++|+|++|.+||...+ ...
T Consensus 171 L~k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~----------------~~~ 232 (357)
T KOG0598|consen 171 LCKEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED----------------VKK 232 (357)
T ss_pred cchhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc----------------HHH
Confidence 99865443322 356899999999999999999999999999999999999999997542 122
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 335 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 335 (356)
+.+.+........+.-.+.+.++++++.|..||++|.
T Consensus 233 ~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 233 MYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 2333332222344445778999999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=381.04 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=233.7
Q ss_pred CCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
.+.+++.||+|.||.||+|.++....||+|.+.......+.|.+|+++|++|+|+|||++++++..+..++|||||++.|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34556789999999999999997779999999888777889999999999999999999999999988999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
+|.++|..... ..+...+.+.++.||++|++||++++ +|||||...||||+++..+||+|||+|+...+.
T Consensus 287 sLl~yLr~~~~-------~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 287 SLLDYLRTREG-------GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred cHHHHhhhcCC-------CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999987332 23889999999999999999999999 999999999999999999999999999965554
Q ss_pred cccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
.... .....-...|.|||.+....++.+||||||||+||||+| |+.||. .++..++.+.++.
T Consensus 357 ~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~----------------~msn~ev~~~le~ 419 (468)
T KOG0197|consen 357 EYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP----------------GMSNEEVLELLER 419 (468)
T ss_pred ceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC----------------CCCHHHHHHHHhc
Confidence 4432 222234668999999999999999999999999999999 999994 6788899999999
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
+.+...|..||++++++|..||..+|++|||++.+...|+++.....+
T Consensus 420 GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~ 467 (468)
T KOG0197|consen 420 GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG 467 (468)
T ss_pred cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence 999999999999999999999999999999999999999998876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=367.84 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=205.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
...+|++.+.||+|+||+||+|+++ ++..||||.+.+... ..+.+..|+.+|+.++|||||.+++.+.+++.+|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4578999999999999999999987 789999999987642 245678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC------Ccee
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD------DIAK 213 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~------~~vk 213 (356)
||||.||+|.+|+..... +++..+..++.||+.||++||+++ ||||||||+||||+.. -.+|
T Consensus 88 MEyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEE
Confidence 999999999999998763 899999999999999999999999 9999999999999864 4689
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|+|||+|+.+...... .+.+|+|.|||||++....|+.++|+||+|+++|+|++|+.||...++..
T Consensus 156 IADFGfAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e----------- 221 (429)
T KOG0595|consen 156 IADFGFARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE----------- 221 (429)
T ss_pred ecccchhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH-----------
Confidence 9999999998765443 67899999999999999999999999999999999999999997554322
Q ss_pred CChhhHhHhhcc--cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 018396 294 LSEDKVKQCVDT--KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 340 (356)
Q Consensus 294 ~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~el 340 (356)
+...+.. ......+...+..+.+|+...++.+|.+|-++.+-
T Consensus 222 -----L~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 222 -----LLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred -----HHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 1111111 11223334445556677777777777777666553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-54 Score=357.72 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=216.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeee-EEecCC-eeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVG-YYVDGP-LRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~-~~~~~~-~~~l 138 (356)
..+|++++.||.|.||+||++... +|..+|.|.+.-...+ .+.+..|+.+|++|+|||||++++ .+.++. .++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 356889999999999999999966 8999999999754333 567899999999999999999998 444444 4899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC--CeeecCCCCCcEEEccCCceeEec
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP--RIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~--~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
|||+|.+|+|.+.++..+... ..+++..+|+++.|++.||..+|++ .+ .|+||||||.||+++.+|.|||+|
T Consensus 98 vmE~c~~GDLsqmIk~~K~qk-----r~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQK-----RLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred HHHhhcccCHHHHHHHHHhcc-----ccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeecc
Confidence 999999999999998776543 2389999999999999999999994 22 399999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||+++.+...... ....+|||.||+||.+...+|+.++||||+||++|||+.-++||.+. .-
T Consensus 172 fGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----------------n~ 233 (375)
T KOG0591|consen 172 FGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----------------NL 233 (375)
T ss_pred chhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----------------cH
Confidence 9999988765433 36788999999999999999999999999999999999999999755 22
Q ss_pred hhHhHhhcccCCCCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 297 DKVKQCVDTKLGGEYP-PKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
-++...+..+-....| .-++.++..||..|+..||+.||+.-.++..+..
T Consensus 234 ~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 234 LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3344455554444455 5778999999999999999999997666655544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=370.52 Aligned_cols=260 Identities=32% Similarity=0.502 Sum_probs=220.6
Q ss_pred CCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCC-eeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e~ 142 (356)
...+...||.|+||+||+|.++....||||++...... .+.|.+|+.+|.+++|||||++++++.+.. .+.+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34445569999999999999995445999999865443 348999999999999999999999999887 79999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-ceeEecccccC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~ 221 (356)
+++|+|.+++..... ..+++..++.++.+|++|+.|||++++ ||||||||+|||++.++ ++||+|||+++
T Consensus 122 ~~~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccce
Confidence 999999999987411 239999999999999999999999973 89999999999999998 99999999997
Q ss_pred CCccccccccccccccCcCccCccccc--CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
...... .......||+.|||||++. ...|+.++||||||+++|||+||..||....+ ....
T Consensus 193 ~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---------------~~~~ 255 (362)
T KOG0192|consen 193 EKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---------------VQVA 255 (362)
T ss_pred eecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---------------HHHH
Confidence 655432 1123467999999999999 66999999999999999999999999975532 2233
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
..+.....+...+..++..+..||..||..||..||++.+++..|+.+.+...
T Consensus 256 ~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 256 SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 44445666777777899999999999999999999999999999999876543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=363.48 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=216.8
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCe
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 135 (356)
.....+|..++.||+|+|++|++|+.+ +++.||||++.+.. ...+.+..|-.+|.+| .||.|++++..|.|...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445679999999999999999999976 89999999997642 2234567888899999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
+|+|+||+++|+|.++|.+... +++..++.++.+|+.||+|||++| ||||||||+|||++.+|+++|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEe
Confidence 9999999999999999998864 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccc---------ccc--cccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018396 216 DFDLSNQAPDAAAR---------LHS--TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (356)
Q Consensus 216 Dfg~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (356)
|||.|+.+...... ... ..++||-.|.+||++.....+..+|+|+||||+|+|+.|.+||....+.
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--- 293 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--- 293 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---
Confidence 99999877553322 112 5589999999999999999999999999999999999999999755321
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
-..+.+++-.+ +++...++.+.+||.+.|..||.+|+|+++|-+
T Consensus 294 ------------liFqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 294 ------------LIFQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ------------HHHHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11233333222 566777789999999999999999999998876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=344.70 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=213.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
+.|+.+..+|+|+||+||+|+++ +|+.||||++..+..+ .+-.++|+++|++|+|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888999999999999999988 8999999998765443 2345899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
||+. ++.+-++..... ++...+..+++|++.|+.|+|+++ ++||||||+||||+.+|.+||||||+|+
T Consensus 82 ~~dh-TvL~eLe~~p~G--------~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG--------VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred ecch-HHHHHHHhccCC--------CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence 9998 666666666543 889999999999999999999999 9999999999999999999999999999
Q ss_pred CCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
.+...... .+..+.|.+|.|||.+.| .+|+..+||||+||++.||++|.+-|-+..+.++...+...-..+.++. +
T Consensus 150 ~L~~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh-q 226 (396)
T KOG0593|consen 150 TLSAPGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH-Q 226 (396)
T ss_pred hhcCCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH-H
Confidence 87632222 256678999999999988 7899999999999999999999999988776655544433222222221 1
Q ss_pred Hhhcc-c-C---C----------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDT-K-L---G----------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~-~-~---~----------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.++.. . + . ....++.+.-+.+|+.+||+.||.+|++.++++.
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111 0 0 0 0112345567899999999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=335.77 Aligned_cols=237 Identities=24% Similarity=0.338 Sum_probs=210.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||.|+||+|.+++.+ +|..+|+|++.+...- .+...+|..+|+.+.||+++++++.+.+.+.+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 4578999999999999999999987 7999999999865432 3556789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||.+||.|..++..... +++..+..++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||
T Consensus 122 vmeyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEeccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999988664 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
.|+...... -+.||||.|+|||.+....|+.++|+|||||++|||+.|.+||....+ ...
T Consensus 190 FAK~v~~rT-----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------------~~i 249 (355)
T KOG0616|consen 190 FAKRVSGRT-----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------------IQI 249 (355)
T ss_pred ceEEecCcE-----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------------HHH
Confidence 998876542 567999999999999999999999999999999999999999975532 233
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFR 334 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 334 (356)
...++...+ .+|...+.++++|+.+.|+.|-.+|
T Consensus 250 Y~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 344444444 6777888999999999999999999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=345.57 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=209.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCC--eeEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLAY 140 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~ 140 (356)
..+|...+.||+|+||.||++.+. +|+..|||.+...... .+.+.+|+.+|++++|||||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 456888999999999999999977 5999999998765322 356889999999999999999999755444 699999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeEecccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~ 219 (356)
||+++|+|.+++..... . +++..+..+.+||+.||.|||++| ||||||||+|||++. ++.+||+|||+
T Consensus 96 Ey~~~GsL~~~~~~~g~-~-------l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-K-------LPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eccCCCcHHHHHHHcCC-C-------CCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence 99999999999998763 2 899999999999999999999999 999999999999999 79999999999
Q ss_pred cCCCcc-ccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 220 SNQAPD-AAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 220 a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
+..... ...........||+.|||||++..+ ....++|||||||++.||+||.+||.... ....
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--------------~~~~ 230 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--------------EEAE 230 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--------------chHH
Confidence 887663 1111123457899999999999963 33459999999999999999999996420 1112
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.+..+........+|...+.+..+++.+|+..+|++|||+.++|+.-
T Consensus 231 ~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 231 ALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 22222222233467778889999999999999999999999999854
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=326.17 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=215.5
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.+|...+.||+|.||.||+|++. +|+.||||++...+.. .....+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888999999999999999965 8999999999876444 4567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|++. +|...+..... .++..++..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+|+
T Consensus 82 fm~t-dLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred eccc-cHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchh
Confidence 9987 99999987653 4889999999999999999999999 9999999999999999999999999999
Q ss_pred CCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec--------ccc
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------ATP 292 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~--------~~~ 292 (356)
.+....... ...+.|.+|.|||.+.| ..|+..+||||.|||+.||+.|.+-|.+.++.++...+-. .++
T Consensus 150 ~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 150 FFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred ccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 987665543 33378999999999987 5799999999999999999999998887766544322211 111
Q ss_pred cCCh----hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 293 KLSE----DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 293 ~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.++. .++......... ...+.++.++.+|+.+||.+||.+|+|++|+++.
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111 111111111121 2445667788999999999999999999999873
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=353.75 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=209.9
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----C--CchHHHHHHHHHHHhcc-CCceeeeeeEEecCC
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----K--QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGP 134 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~--~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~ 134 (356)
...+.|.+.+.||+|+||+|+.|.+. +++.||+|++... . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45678999999999999999999876 8899999987654 1 22456778999999998 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-Ccee
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAK 213 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vk 213 (356)
..++||||+.||+|.+++..... +.+..+..++.|++.|++|||++| |+||||||+|||++.+ +.+|
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~---------l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGR---------LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCC---------CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence 99999999999999999988432 888999999999999999999999 9999999999999999 9999
Q ss_pred EecccccCCCc-cccccccccccccCcCccCcccccCCC-C-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 214 ISDFDLSNQAP-DAAARLHSTRVLGTFGYHAPEYAMTGQ-M-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 214 l~Dfg~a~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
|+|||++.... ... .....+||+.|+|||++.+.. | +.++||||+||+||.|++|..||+.....
T Consensus 162 l~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--------- 229 (370)
T KOG0583|consen 162 LSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--------- 229 (370)
T ss_pred EeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---------
Confidence 99999998874 222 236779999999999999977 8 47899999999999999999999753211
Q ss_pred cccCChhhHhHhhcccCCCCCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHH
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKA-IAKMAAVAALCVQYEADFRPNMGIVL 341 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~Rps~~ell 341 (356)
.....+....+ .+|... +.++..|+.+||..||.+|+|+.+++
T Consensus 230 ------~l~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 230 ------NLYRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ------HHHHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11111222212 344555 88999999999999999999999999
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=359.71 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=214.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.+-|++++.||.|+.|.|-+|++. +|+.+|||++.+... ....+.+|+.+|+.+.|||++.+|+++.+...+|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 356999999999999999999976 899999999976522 245689999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
.||++||.|.+++-.... +++.++..+++||+.|+.|||..+ |+||||||+|+|++..+.+||+|||+
T Consensus 91 lEyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred EEecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccce
Confidence 999999999999987654 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
|..-..... ..+.||+|.|.+||+++|.+| +.++||||+|||||.||+|+.||+++ .
T Consensus 159 AsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------------------N 216 (786)
T KOG0588|consen 159 ASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------------------N 216 (786)
T ss_pred eecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------------------c
Confidence 876444332 266799999999999999998 77899999999999999999999743 2
Q ss_pred HhHhhcccCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 299 VKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 299 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
+..++..-.++ +.|.+.+.++++||.+||..||.+|.|++||++.
T Consensus 217 ir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 217 IRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 23333322222 4567889999999999999999999999999983
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=350.41 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=206.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++++.||+|+||.||+|+-+ +|..+|+|++.++... .+.++.|-.+|...++|.||+++..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3568999999999999999999977 8999999999876543 3567888899999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||++||++..+|..... +++..+..++.+++.|++.||+.| +|||||||+|+|||..|++||+|||
T Consensus 219 iMEylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred EEEecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccc
Confidence 9999999999999987663 999999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcc----------------------ccccc----c-------------------ccccccCcCccCcccccCCCCC
Q 018396 219 LSNQAPD----------------------AAARL----H-------------------STRVLGTFGYHAPEYAMTGQMS 253 (356)
Q Consensus 219 ~a~~~~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~ 253 (356)
|+.-+.. ..... . ....+|||.|+|||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 9842211 00000 0 0125799999999999999999
Q ss_pred ccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCC--HHHHHHHHHHHHHhhccCC
Q 018396 254 SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEA 331 (356)
Q Consensus 254 ~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P 331 (356)
..+|+||||||+||||.|.+||...++. +....++.-+.....| ...+.+..+||.+||. ||
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~---------------~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQ---------------ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH
Confidence 9999999999999999999999877543 3333333333222222 2345899999999999 99
Q ss_pred CCCCC---HHHHH
Q 018396 332 DFRPN---MGIVL 341 (356)
Q Consensus 332 ~~Rps---~~ell 341 (356)
++|.- ++||-
T Consensus 431 ~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 431 ENRLGSKGAEEIK 443 (550)
T ss_pred HHhcCcccHHHHh
Confidence 99975 44443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-49 Score=354.38 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=216.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
...|.....||+|+.|.||.|... +++.||||.+...... .+-+.+|+.+|+..+|+|||++++.|..++.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 346888889999999999999966 7889999999877665 45678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
++||+|.+.+.... +++.++..+.+.++.||+|||.+| |+|||||.+|||++.+|.+||+|||++.+
T Consensus 352 m~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred cCCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeec
Confidence 99999999998876 899999999999999999999999 99999999999999999999999999987
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
+..... .....+|||.|||||++....|+++.||||||++++||+-|.+||-...+.. .+.-+
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr---------------AlyLI 481 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---------------ALYLI 481 (550)
T ss_pred cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH---------------HHHHH
Confidence 765432 2367789999999999999999999999999999999999999996443221 11112
Q ss_pred h-cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 V-DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. ........+...+..+++|+.+||+.|+++|+++.|||+
T Consensus 482 a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 482 ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1 222334556778899999999999999999999999998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=321.03 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=218.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++++.||+|.||.||+|+.+ ++-.||+|++.++.. ...++.+|+++-..|+||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578999999999999999999976 788999999976532 35678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
++||...|+|+..+....... +++...+.+..|++.||.|+|.++ |+||||||+|+|++..|.+||+|||
T Consensus 100 ilEya~~gel~k~L~~~~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKR-------FDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred EEEecCCchHHHHHHhccccc-------ccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCC
Confidence 999999999999998665433 888899999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
.+...+.. . ....+||..|.+||++.+..++..+|+|++|++.||++.|.+||.... ..+.
T Consensus 170 wsV~~p~~-k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---------------~~et 230 (281)
T KOG0580|consen 170 WSVHAPSN-K---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---------------HSET 230 (281)
T ss_pred ceeecCCC-C---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---------------hHHH
Confidence 99877632 2 267899999999999999999999999999999999999999997442 2333
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
...+....+ .+|..++.++.++|.+|+.++|.+|.+..|++..
T Consensus 231 YkrI~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 231 YKRIRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 444443333 4567788899999999999999999999998864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=353.23 Aligned_cols=265 Identities=22% Similarity=0.362 Sum_probs=216.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHH--HHHHHHHHhcc-CCceeeeeeEEecCC-eeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEF--LAQVSMVSRLK-NENVVELVGYYVDGP-LRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~--~~e~~~l~~l~-hp~iv~~~~~~~~~~-~~~l 138 (356)
..++|.+.+.||.|.||.||+|+.+ +++.||||.+++.-...++. ++|+..|++|+ ||||+++.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4568999999999999999999976 89999999998765554443 68999999998 999999999999888 9999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
|||||+. +|++++..+.. .+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....|||+|||
T Consensus 88 VfE~Md~-NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred eHHhhhh-hHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccc
Confidence 9999987 99999998743 4999999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCccccc-CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh-
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE- 296 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 296 (356)
+|+........ +..+.|.+|.|||++. ..-|+.+.||||+|||++|+.+-++.|-+..+.++...+...-.....
T Consensus 156 LARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 156 LAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD 232 (538)
T ss_pred cccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence 99988765443 5677899999999876 567899999999999999999999999877665543333211111111
Q ss_pred -----hhHhHhhcccCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 297 -----DKVKQCVDTKLGG-------EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 297 -----~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..+...+.-.+.. ...+.++.++.++|.+|+..||.+|||+.++++.
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1122222211111 1123478899999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=340.59 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=212.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|++..+||.|..++||+|++. .++.||||++..+... ...+.+|+..++.++||||++++..|..++.+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 4578999999999999999999976 7899999999866544 467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
.||.+|++.+++....... +++..+..+++++++||.|||.+| .||||||+.||||+++|.|||+|||.+
T Consensus 104 pfMa~GS~ldIik~~~~~G-------l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG-------LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred hhhcCCcHHHHHHHHcccc-------ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceee
Confidence 9999999999998765322 899999999999999999999999 999999999999999999999999987
Q ss_pred CCCcccccc-ccc-cccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 221 NQAPDAAAR-LHS-TRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 221 ~~~~~~~~~-~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
..+.+...+ ... ...+||++|||||++.. ..|+.++||||||++..||.+|+.||....+.+.........+. .
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp-~- 251 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP-T- 251 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC-C-
Confidence 655443222 112 56789999999999764 57999999999999999999999999876543211110000000 0
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. ...+..+....++..++.++..||++||.+|||++++++
T Consensus 252 --~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 --LL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred --cc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 001111222344568999999999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=368.64 Aligned_cols=268 Identities=26% Similarity=0.439 Sum_probs=233.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
..+.+..+.||+|+||+||+|+.. ....||||.++..... .++|++|++++..|+|||||+++|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345666789999999999999842 3568999999865544 57899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCC-C----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAK-P----GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~-~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
++|+||+..|||.+||.......... . .++++..+.+.||.|||.|+.||-++. +|||||...|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999997665432211 1 334899999999999999999999998 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 290 (356)
|||+|||+++..-..++........-..+|||||.+..++++.+|||||+||+|||+++ |+.||.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~-------------- 707 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY-------------- 707 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc--------------
Confidence 99999999998877666544434445789999999999999999999999999999998 999996
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.++.+++.+.+..+.....|.+||.+++.||..||+.+|.+||+++||-.+|+......
T Consensus 708 --glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 708 --GLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --ccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 44667788888777778999999999999999999999999999999999999876543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=340.36 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=212.5
Q ss_pred hCCCCCCceeeccCceEEEEEEE-CCCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..+|++.+.||+|.||.|-+|+. .+|+.||||.|.++... .-.+++|+++|..|+||||++++++|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999995 58999999999876543 23578999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||..+|.|++|+..+.. +++.++..+++||+.|+.|||+++ ++|||||.+|||+|.++++||+|||+
T Consensus 132 MEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred EEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccch
Confidence 999999999999998775 999999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+-.+...... ..++|+|.|.+||.+.|.+| ++.+|.||||++||.|..|..||++.+.. .-
T Consensus 200 SNly~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---------------~l 261 (668)
T KOG0611|consen 200 SNLYADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---------------RL 261 (668)
T ss_pred hhhhccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---------------HH
Confidence 8777655433 77899999999999999998 78899999999999999999999866321 11
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
+.++-...++ .+..+....-||.+||..||++|.|+.+|....
T Consensus 262 vrQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 262 VRQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2222222121 123344677899999999999999999998754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=348.64 Aligned_cols=268 Identities=22% Similarity=0.376 Sum_probs=210.5
Q ss_pred hCCCCCCceeeccCceEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEecC-C
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG-P 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~-~ 134 (356)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... ...+.+|+.+++.+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999974 13568999998754322 35688999999999 899999999988754 4
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCC-----------------------------------------------------C
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKG-----------------------------------------------------A 161 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~-----------------------------------------------------~ 161 (356)
.++++|||+++|+|.+++........ .
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68999999999999999975432100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCc
Q 018396 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241 (356)
Q Consensus 162 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 241 (356)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++................+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 00124788899999999999999999999 999999999999999999999999999765432222222334467889
Q ss_pred cCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHH
Q 018396 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMA 320 (356)
Q Consensus 242 ~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 320 (356)
+|||++.+..++.++|||||||++|+|++ |..||..... ...+...+........+..+++.+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---------------NEEFCQRLKDGTRMRAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc---------------cHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 99999999999999999999999999997 9999964321 1111222222222233455677899
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 321 AVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 321 ~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
+++.+||+.||.+|||+.++++.|+.++..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=346.47 Aligned_cols=266 Identities=23% Similarity=0.295 Sum_probs=211.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC--CeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~ 137 (356)
..+.|+....||+|.||.||+|++. +|+.||+|++..+... ..-..+|+.+|++|+||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3456888999999999999999966 8999999999776533 23457999999999999999999988765 7899
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
||+|||++ +|.-++....- .+++.++..++.||+.||+|||++| |+|||||..|||||++|.+||+||
T Consensus 195 lVFeYMdh-DL~GLl~~p~v--------kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDF 262 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGV--------KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADF 262 (560)
T ss_pred EEEecccc-hhhhhhcCCCc--------ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccc
Confidence 99999998 99999876532 2899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|+|+.+....... .+..+.|++|.|||++.| ..|+.++|+||.||||.||+.|++.|.+.++..+...+.......+.
T Consensus 263 GLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 263 GLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE 341 (560)
T ss_pred cceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence 9999765543321 355678999999999987 57999999999999999999999999987765443333222222222
Q ss_pred hhHhHhhcc-----cCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDT-----KLGG-------EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~-----~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+.+...-.+ +... +.....+....+|+..+|..||.+|.|+.+.|.
T Consensus 342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 211100000 0000 112234667889999999999999999999876
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=353.52 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=209.0
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeeeEEecCCe
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 135 (356)
....++|.+.++||+|.||+|++|..+ +++.+|||++++... +.+..+.|.+++... +||.+++++..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445689999999999999999999987 789999999987533 345677888887777 59999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
+|+||||+.||++..+.+... +++..+..++..++.||+|||++| |||||||.+|||+|.+|++||+
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~----------F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDV----------FSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred EEEEEEecCCCcEEEEEeccc----------ccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEec
Confidence 999999999999555544333 999999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||+++....... .+.+++|||.|+|||++.+..|+.++|+|||||+||||+.|..||.+++
T Consensus 511 DFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd---------------- 572 (694)
T KOG0694|consen 511 DFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD---------------- 572 (694)
T ss_pred ccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC----------------
Confidence 9999987653222 3478999999999999999999999999999999999999999997553
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 337 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 337 (356)
.+++.+.|... ...+|..++.+..++|.++|.++|++|..+
T Consensus 573 Eee~FdsI~~d-~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 573 EEEVFDSIVND-EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHhcC-CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 23333333211 125788889999999999999999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=347.69 Aligned_cols=243 Identities=28% Similarity=0.385 Sum_probs=213.4
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+..... ..+++|+++++.|+|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999987 88999999998766554 457899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.| +|..++..... ++++.+..++.+++.||.|||+.+ |+|||+||.|||++..|.+|++|||+|+
T Consensus 82 ~a~g-~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred hhhh-hHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhh
Confidence 9988 99999987764 999999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... ..+...|||.|||||++.+..|+..+|+|||||++|||++|++||... .+.+
T Consensus 149 ~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------------------si~~ 207 (808)
T KOG0597|consen 149 AMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------------------SITQ 207 (808)
T ss_pred hcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------------------HHHH
Confidence 7665332 346678999999999999999999999999999999999999999532 2222
Q ss_pred hhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 CVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
++..-. .-..|...+..+.+++...|.+||.+|.|..+++.
T Consensus 208 Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 208 LVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 222211 12456688889999999999999999999999886
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=338.52 Aligned_cols=258 Identities=28% Similarity=0.371 Sum_probs=210.2
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---------------hHHHHHHHHHHHhccCCce
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---------------DQEFLAQVSMVSRLKNENV 123 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------------~~~~~~e~~~l~~l~hp~i 123 (356)
+-....++|++.+.||+|.||.|-+|+.. +++.||||++.+.... .+...+|+.+|++|+||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 44456789999999999999999999977 8999999999753221 2578899999999999999
Q ss_pred eeeeeEEec--CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 124 VELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 124 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
|+++++..+ .+.+|||+|||..|.+...=... +.+.+.+++.++++++.||+|||.+| |+||||||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKP 238 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKP 238 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccch
Confidence 999999875 56899999999988764432211 12899999999999999999999999 99999999
Q ss_pred CcEEEccCCceeEecccccCCCccccc---cccccccccCcCccCcccccCCC----CCccchhhhHHHHHHHHHcCCCC
Q 018396 202 SNVLLFDDDIAKISDFDLSNQAPDAAA---RLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKP 274 (356)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~p 274 (356)
.|+||+++|+|||+|||.+..+..... ........|||.|+|||...++. .+.+.||||+||+||.|+.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 999999999999999999886622111 00113367999999999887632 36788999999999999999999
Q ss_pred CCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 275 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 275 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
|.+.. ..+-...++...+.-...++..+.+.+||.++|.+||+.|.+..+|....
T Consensus 319 F~~~~---------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 319 FFDDF---------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred cccch---------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 97542 23445556666665555566788999999999999999999999987654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=342.18 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=213.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
..|.....||+|.||.||+|.+. +++.||+|++..+... .+++.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999966 8999999999876544 46788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
|.||++.+.+..... +.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.|||+|||++.+
T Consensus 93 ~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred hcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeee
Confidence 999999999987652 477888889999999999999999 99999999999999999999999999988
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
........ ..++|||.|||||++.+..|+.++||||||++.+||++|.+|+....+.... -+
T Consensus 161 l~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------fl 222 (467)
T KOG0201|consen 161 LTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FL 222 (467)
T ss_pred eechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------Ee
Confidence 76654432 6789999999999999999999999999999999999999999766542211 11
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+-..........+++.+++|+..||++||+.||||.++++
T Consensus 223 Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 223 IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1111122233467788999999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=344.11 Aligned_cols=269 Identities=28% Similarity=0.421 Sum_probs=218.8
Q ss_pred cCHHHHHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec
Q 018396 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD 132 (356)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 132 (356)
.+..+|....+.+.+...||+|.||+||+|.+- ..||||++...... .+.|++|+..+++-+|.||+-+.|++..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344666667778888999999999999999986 34999999876554 3678999999999999999999999987
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
... .||+.+|+|-+|+.+++..+.. +...+.+.|+.||++|+.|||.++ |||||||..|||+.+++.|
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etk--------fdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETK--------FDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhh--------hhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcE
Confidence 776 9999999999999999877632 889999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccC---CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 289 (356)
||+|||++................|...|||||+++. .+|++.+||||||+++|||++|..||... ..++ -+...
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq-IifmV 605 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ-IIFMV 605 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh-eEEEe
Confidence 9999999876554433222344567889999999974 46899999999999999999999999732 2111 11111
Q ss_pred ccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
....... .......+++.++.+|+..||.+++++||++.+|+..|+.++.+
T Consensus 606 GrG~l~p----------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 GRGYLMP----------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cccccCc----------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1110000 01123457788999999999999999999999999999988874
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=328.28 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=214.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..+.|++.+.||+|.-|+||+++.+ ++..+|+|++.+.... ..+...|-+||+.++||.++.+|..++.+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3467888999999999999999987 6799999999875433 2455678899999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
+||||+||+|..+.+.+... .+++..+..++..++.||+|||-.| ||+|||||+||||.++|+|-|+||.
T Consensus 155 ~meyCpGGdL~~LrqkQp~~-------~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGK-------RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred EEecCCCccHHHHHhhCCCC-------ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecc
Confidence 99999999999999887754 4999999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcc---------------------------------ccc---------------------cccccccccCcCccCc
Q 018396 219 LSNQAPD---------------------------------AAA---------------------RLHSTRVLGTFGYHAP 244 (356)
Q Consensus 219 ~a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aP 244 (356)
++..... ... ...+..++||-+|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8743211 000 0113356799999999
Q ss_pred ccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHH
Q 018396 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAA 324 (356)
Q Consensus 245 E~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 324 (356)
|++.|..++.++|+|+||+++|||+.|..||.+.. ..+.+.+++...+.-.-.+..+..+++||+
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~---------------~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN---------------NKETLRNIVGQPLKFPEEPEVSSAAKDLIR 369 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC---------------chhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence 99999999999999999999999999999998663 234455565555443334477789999999
Q ss_pred HhhccCCCCCCC----HHHHHH
Q 018396 325 LCVQYEADFRPN----MGIVLK 342 (356)
Q Consensus 325 ~cl~~~P~~Rps----~~ell~ 342 (356)
+.|.+||.+|.. +.||-+
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHhccChhhhhccccchHHhhc
Confidence 999999999998 777654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=340.43 Aligned_cols=251 Identities=22% Similarity=0.364 Sum_probs=220.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCe-eEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL-RVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~lv 139 (356)
.++|+.++++|+|+||.+++++++ ++..+++|.+...... .....+|+.++++++|||||.+.+.|.+++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367999999999999999999987 7889999999765543 3456889999999999999999999998888 9999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|+||+||+|.+.|...+.. .++++.+..++.|++.|++|||++. |+|||||+.|||++.++.|+|+|||+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred EeecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhh
Confidence 9999999999999887732 2899999999999999999999888 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
|+........ .....||+.|+.||.+.+.+|+.++|||||||++|||++-+++|...+ ...+
T Consensus 153 aK~l~~~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~----------------m~~L 214 (426)
T KOG0589|consen 153 AKILNPEDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN----------------MSEL 214 (426)
T ss_pred hhhcCCchhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc----------------hHHH
Confidence 9998776522 266789999999999999999999999999999999999999997552 1222
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..-+........+..++.+++.+|..||+.+|..||++.++|..
T Consensus 215 i~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33333344556788889999999999999999999999999985
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=328.78 Aligned_cols=244 Identities=20% Similarity=0.347 Sum_probs=202.7
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCch----HHHHHHHHHHHhccCCceeeeeeEEec----CCeeEEEEEec
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAYEHA 143 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~e~~ 143 (356)
..||+|+++.||+|... |+.||||.+....... +.+.+|+.++++++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 57999999999999985 8899999997654433 456799999999999999999999876 45789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
++|+|.+++..... +++...+.++.+++.||.|||+. + ++||||||+||++++++.+||+|||++..
T Consensus 105 ~~g~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 105 TRGYLREVLDKEKD---------LSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCcHHHHHhhCCC---------CChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 99999999976532 78899999999999999999985 7 88999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
..... ....|+..|+|||++.+ ..++.++|||||||++|+|++|..||..... .+...
T Consensus 173 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---------------~~~~~ 232 (283)
T PHA02988 173 LSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---------------KEIYD 232 (283)
T ss_pred hcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---------------HHHHH
Confidence 54322 23457899999999876 6889999999999999999999999974421 11112
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
.++........+..++..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus 233 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 222222333444567889999999999999999999999999998864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=342.92 Aligned_cols=265 Identities=21% Similarity=0.341 Sum_probs=210.5
Q ss_pred hCCCCCCceeeccCceEEEEEEE------CCCCEEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeeeEEecCCe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 135 (356)
.++|++.+.||+|+||.||+|.. .++..||||++..... ..+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999973 2466899999875432 235688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCC-------------------------------------------------------
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKG------------------------------------------------------- 160 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~------------------------------------------------------- 160 (356)
.++||||+++|+|.+++........
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975431100
Q ss_pred -----------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccccc
Q 018396 161 -----------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (356)
Q Consensus 161 -----------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (356)
......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 001124788899999999999999999999 999999999999999999999999998765443222
Q ss_pred ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCC
Q 018396 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (356)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (356)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||..... .......+.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---------------~~~~~~~~~~~~~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---------------DSKFYKMIKEGYR 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---------------hHHHHHHHHhCcc
Confidence 11222345678999999999999999999999999999998 8999864321 1122233333333
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 309 GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
...+...+.++.+||.+||+.||++|||+.+|++.|++.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 333344567899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=334.99 Aligned_cols=244 Identities=22% Similarity=0.285 Sum_probs=204.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999987 78999999986432 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++..... +++..+..++.|++.||+|||++| ++||||||+|||++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 81 EYVPGGELFSYLRNSGR---------FSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred eCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcc
Confidence 99999999999976542 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....
T Consensus 149 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---------------~~~~~ 208 (291)
T cd05612 149 KKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---------------FGIYE 208 (291)
T ss_pred hhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHH
Confidence 7654321 335689999999999998999999999999999999999999964421 11111
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLKA 343 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~ 343 (356)
.+.... ...+...+..+.+||.+||+.||.+||+ ++++++.
T Consensus 209 ~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 209 KILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 222211 2344455778999999999999999995 8888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=321.11 Aligned_cols=265 Identities=23% Similarity=0.280 Sum_probs=211.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEe--cCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~ 137 (356)
..+.|+.+..|++|+||.||+|+++ +++.||+|+++.+... .---++|+.+|.+++|||||.+..+.+ +-+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4567999999999999999999987 8999999999876533 234589999999999999999999876 446799
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+|||||+. +|..++...+. .+...++..++.|++.|++|||.+. |+|||||++|+|++..|.+||+||
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred eeHHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence 99999998 99999987762 3889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc---
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK--- 293 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 293 (356)
|+|+.++...... +..+-|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+....++...+......
T Consensus 222 GLAR~ygsp~k~~--T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 222 GLAREYGSPLKPY--TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred chhhhhcCCcccC--cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence 9999988764432 56678999999999887 56899999999999999999999999877665433222111111
Q ss_pred --CChhhHhHhh---------cccCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 --LSEDKVKQCV---------DTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 --~~~~~~~~~~---------~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
|..-.....+ -..++..+... .++.-++|++.+|.+||.+|.|+++.|+
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1110000000 01111112111 4577899999999999999999999886
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=308.53 Aligned_cols=267 Identities=24% Similarity=0.329 Sum_probs=215.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeeeEEecCC-----ee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LR 136 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~ 136 (356)
..++|++.+.||+|||+.||++..- +++.||+|++.... .+.+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4578999999999999999999954 78999999998766 44677899999999999999999998876443 48
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
|+++.|+..|+|.+.++...... ..+++.+++.++.++++||++||+..+ ++.||||||.|||+.+.+.++|.|
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg-----~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKG-----NFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcC-----CccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEe
Confidence 99999999999999998766433 238999999999999999999999964 599999999999999999999999
Q ss_pred ccccCCCcccccccc-------ccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 217 FDLSNQAPDAAARLH-------STRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 217 fg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
||.++...-...... ......|..|.|||.+. +...++++|||||||+||.|+.|..||+.....+..--
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 999887654322211 12234688999999885 45578999999999999999999999976544322211
Q ss_pred eecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 287 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
......+++ -.-...+++.+.++|++||+.||.+||++.+++..++.+++
T Consensus 253 LAv~n~q~s-------------~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li~ 302 (302)
T KOG2345|consen 253 LAVQNAQIS-------------IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLIA 302 (302)
T ss_pred Eeeeccccc-------------cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhcC
Confidence 111111111 11122378899999999999999999999999999998763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=329.76 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=203.9
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.|+..+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++|+||+++++++.+.+..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999975 799999999865322 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++|+|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+|||+++++.++|+|||++.
T Consensus 81 ~~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 9999999988864332 12789999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..
T Consensus 151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------------~~~~~~~ 215 (285)
T cd05631 151 QIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV------------KREEVDR 215 (285)
T ss_pred EcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch------------hHHHHHH
Confidence 6543221 134568999999999999999999999999999999999999997543210 0111111
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 342 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~ 342 (356)
.+. .....++...+.++.+|+.+||+.||.+||+ ++++++
T Consensus 216 ~~~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 216 RVK-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred Hhh-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111 1122345566788999999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=342.06 Aligned_cols=268 Identities=24% Similarity=0.387 Sum_probs=211.9
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEecC
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 133 (356)
-..++|++.+.||+|+||.||+|... ++..||+|.+...... ...+.+|+.+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34468999999999999999999843 3457999999764333 34678999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCC-------------------------------------------------------
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGV------------------------------------------------------- 158 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------- 158 (356)
+..++||||+++|+|.+++......
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999998653210
Q ss_pred ------CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccc
Q 018396 159 ------KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232 (356)
Q Consensus 159 ------~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 232 (356)
........+++..++.++.||+.||.|||+++ ++||||||+|||+++++.++|+|||++............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 00011234788899999999999999999999 999999999999999999999999998765433221112
Q ss_pred cccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCC
Q 018396 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEY 311 (356)
Q Consensus 233 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (356)
....++..|+|||++.+..++.++|||||||++|+|++ |..||..... .......+........
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~---------------~~~~~~~~~~~~~~~~ 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV---------------NSKFYKMVKRGYQMSR 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc---------------cHHHHHHHHcccCccC
Confidence 23345678999999998899999999999999999997 9999964321 1122222333333333
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 312 PPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 312 ~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
+...+.++.++|.+||+.||.+|||+.++++.|++++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 3445678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=326.40 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=214.2
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CC-----CEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SG-----RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
++|++.+.||+|+||.||+|... .+ ..|++|.+...... ...+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 57899999999999999999864 22 57999998754332 356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAK-------PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
+++||+++++|.+++.......... ....+++..++.++.|++.||.|||+++ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 9999999999999997653321110 1134788999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceec
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 289 (356)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~---------- 231 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS---------- 231 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC----------
Confidence 999999999876543322222234456889999999988899999999999999999998 999996442
Q ss_pred ccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
..++...+........+..++.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 232 ------~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 232 ------NQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ------HHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2233333434444455667889999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=330.17 Aligned_cols=266 Identities=23% Similarity=0.346 Sum_probs=206.1
Q ss_pred hCCCCCCceeeccCceEEEEEEECC-----------------CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~ 125 (356)
.++|++.+.||+|+||.||+|.+++ +..||+|.+...... ...+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4679999999999999999998532 336999998764332 356889999999999999999
Q ss_pred eeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 018396 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG----------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 195 (356)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~iv 195 (356)
+++++.+.+..+++|||+.+++|.+++........ ......+++..++.++.||+.||.|||+.+ ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999965432111 111234788899999999999999999999 99
Q ss_pred ecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc--CCC
Q 018396 196 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRK 273 (356)
Q Consensus 196 H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~ 273 (356)
||||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999876543322222233456789999999998899999999999999999986 567
Q ss_pred CCCCCCCCCCccceecccccCChhhHhHhhc---ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 274 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVD---TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 274 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
||........ ......... .......+..++..+.+||.+||+.+|.+|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQV------------IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHH------------HHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7764321100 000001100 01111223456678999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=338.70 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=204.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467999999999999999999987 78999999986432 2235678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+.+++|.+++..... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGR---------FPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred EcCCCCChHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999976542 788899999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||....+. ...
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------------~~~ 224 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---------------RIY 224 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---------------HHH
Confidence 87654322 3356899999999999999999999999999999999999999643211 111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~ 342 (356)
..+.... ...+..++..+.+||.+||+.||.+||+ +++++.
T Consensus 225 ~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 225 EKILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1122211 2334446678999999999999999997 677774
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=363.32 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=225.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC--CCC----EEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR--SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
...+..+.||+|+||.||.|... .+. .||||.+..... ...+|.+|..+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 45666788999999999999965 343 489999976533 3568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
|++|||+||+|..||.+.+..... ...+...+.+.++.+||+|+.||+++. +|||||...|+||+....|||+||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 999999999999999987554433 234889999999999999999999998 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|+|+...+.+.........-...|||||.+..+.++.++|||||||++||+++ |..||... ..
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~----------------~n 910 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR----------------SN 910 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc----------------ch
Confidence 99996655544432232233568999999999999999999999999999999 99999533 44
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.++...+...-+.+.|..|++.++++|..||+.+|++||++..|++.+.++++..
T Consensus 911 ~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 911 FEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 4455533333388999999999999999999999999999999999999988654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.13 Aligned_cols=240 Identities=21% Similarity=0.287 Sum_probs=199.4
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
+.||+|+||.||+|..+ +|+.||+|++.... .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 78999999987532 22345778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 81 ELFFHLSRERV---------FSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 99999976542 889999999999999999999999 999999999999999999999999998753322
Q ss_pred cccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhccc
Q 018396 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK 306 (356)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (356)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+...
T Consensus 149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----------------~~~~~~~~~~ 210 (323)
T cd05571 149 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------EKLFELILME 210 (323)
T ss_pred CC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----------------HHHHHHHHcC
Confidence 11 12445799999999999999999999999999999999999999964321 1111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 307 LGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
....+...+.++.++|.+||+.||++|| ++.++++
T Consensus 211 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 211 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1234556678899999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=321.48 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=211.9
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++.+.+.+..++++||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46799999999999999999998878889999987665556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++...... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~~~L~~~l~~~~~~-------~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 85 KGSLLDFLKSDEGG-------KVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecC
Confidence 99999999754321 2788899999999999999999998 9999999999999999999999999987664
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----------------~~~~~~~ 217 (261)
T cd05072 155 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----------------SDVMSAL 217 (261)
T ss_pred CCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----------------HHHHHHH
Confidence 43221 1122345678999999988889999999999999999998 9999964321 1122222
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
...........++.++.+++.+||..+|++|||++++.+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 22222223334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=321.18 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=208.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
++|++.+.||+|+||.||+|.++ .+..||+|.+...... ...+.+|+.+++.++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56889999999999999999853 3568999998765332 35688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||.
T Consensus 85 ~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred EEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcc
Confidence 999999999999976431 2889999999999999999999999 99999999999999999999999998
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+......... ......++..|+|||.+.+..++.++|||||||++|++++ |..||.... ...
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~----------------~~~ 216 (266)
T cd05064 154 LQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS----------------GQD 216 (266)
T ss_pred cccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC----------------HHH
Confidence 7654322111 1122335678999999999999999999999999999875 999996442 122
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
....+........+..++..+.+++.+||+.+|.+|||+.+|++.|..+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 217 VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 2233333333345566788899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=321.39 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=213.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
..+|++.+.||+|+||.||+|..+ +++.||+|.+.........+.+|+++++.++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 346888899999999999999976 6889999998766555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++...... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++...
T Consensus 85 ~~~~L~~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 85 TYGNLLDYLRECNRQ-------EVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred CCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 999999999764321 2788999999999999999999999 999999999999999999999999998766
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.... .......
T Consensus 155 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~----------------~~~~~~~ 217 (263)
T cd05052 155 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVYEL 217 (263)
T ss_pred ccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----------------HHHHHHH
Confidence 543221 1122234668999999998999999999999999999998 999986432 1222233
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
+........+..++.++.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 218 LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 333333445556678899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=328.59 Aligned_cols=264 Identities=20% Similarity=0.320 Sum_probs=202.2
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.++|++.+.||.|+||.||+|..+ +++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467999999999999999999977 789999999865432 24567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+ +|.+++..... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 84 YLDS-DLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CCCc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 9986 99998865432 2788899999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc-------
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK------- 293 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 293 (356)
........ .....+++.|+|||++.+ ..++.++||||+||++|+|++|++||..................
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 152 AKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred eccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 54332211 133467999999998875 56899999999999999999999999765332111000000000
Q ss_pred --CChhhHhHhhcccCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 --LSEDKVKQCVDTKLGGE----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 --~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...........+..... .....+.++.+||.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00011111111111000 01123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=331.22 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=207.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999987 7889999998764332 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|.+++..... +++..+..++.|++.||.|||+++ +|+||||||+|||++.++.++|+|||++.
T Consensus 84 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 84 HMDGGSLDQVLKEAKR---------IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred cCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 9999999999976542 788999999999999999999863 29999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee------------c
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------------W 289 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~------------~ 289 (356)
...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||............. .
T Consensus 153 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 153 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred cccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 654322 134568999999999999999999999999999999999999996432210000000 0
Q ss_pred ------------------ccccCChhhHhHhhcc-cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 290 ------------------ATPKLSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 290 ------------------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.............+.. .........++.++.+||.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000011111111 11111122457789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=319.22 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=213.2
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|++|.||+|...+++.||+|.+.......+.+.+|+.++++++||||+++++++...+..+++|||+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 46799999999999999999998777889999998766566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++..... ..+++..+..++.|++.||.+||+++ ++|+||||+||++++++.++|+|||++....
T Consensus 85 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 85 YGSLLEYLQGGAG-------RALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred CCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999976542 23889999999999999999999999 9999999999999999999999999987765
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... .......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.... .......+
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----------------~~~~~~~~ 217 (261)
T cd05068 155 EDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT----------------NAEVLQQV 217 (261)
T ss_pred CCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC----------------HHHHHHHH
Confidence 32211 1111223457999999998899999999999999999999 999996432 12222233
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
........+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 218 DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 33333334455678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=327.37 Aligned_cols=264 Identities=21% Similarity=0.277 Sum_probs=202.2
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|++.+.||+|+||.||+|+++ +++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999987 788999999865432 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.++.+..+..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 81 YVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 999876665543221 2888999999999999999999999 9999999999999999999999999988
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ ......|++.|+|||++.+..++.++|||||||++|+|++|++||......+...................
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 149 NLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred cccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 76432221 12345689999999999998899999999999999999999999975432211000000000001000000
Q ss_pred hhc---------ccC------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 CVD---------TKL------GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~~~---------~~~------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
... +.. ........+.++.+||.+||+.||++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 000 00111235678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=333.49 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=198.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|+..+.||+|+||.||+|.+. +++.||||++...... ...+.+|+++++.++|+||+++++++.+.+.+++||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 3467888999999999999999976 7899999998654332 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+++|.+.. ...+..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 152 e~~~~~~L~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 152 EFMDGGSLEGTH-------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred ecCCCCcccccc-------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccc
Confidence 999999986532 1566778899999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC-----CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
......... .....||..|+|||++.. ...+.++|||||||++|+|++|+.||...... .
T Consensus 216 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-------------~ 280 (353)
T PLN00034 216 RILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-------------D 280 (353)
T ss_pred eeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-------------c
Confidence 765432211 134568999999998743 23456899999999999999999999632110 0
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.......+........+..++.++.+||.+||+.||++|||+.|+++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 281 WASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111111112223445667889999999999999999999999984
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=317.53 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=207.0
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
++|++.+.||+|+||.||++..+++..+|+|.+.........+.+|+.+++.++||||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46888899999999999999988778899999876666667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 84 GCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999875432 2788999999999999999999999 99999999999999999999999999876543
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||..... ......+.
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----------------~~~~~~i~ 215 (256)
T cd05114 153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----------------YEVVEMIS 215 (256)
T ss_pred Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----------------HHHHHHHH
Confidence 2221 1122335668999999988889999999999999999999 9999964421 11111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.......+...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 216 RGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111122333456789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=333.83 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=204.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999987 68999999986532 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV---------LSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred eCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 99999999999975432 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............. ...
T Consensus 149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~---------~~~ 214 (333)
T cd05600 149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWK 214 (333)
T ss_pred ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH---------hcc
Confidence 76543 1244578999999999999999999999999999999999999997543211000000 000
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..+............+.++.++|.+||+.+|.+||++.++++.
T Consensus 215 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000000000112457789999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=320.79 Aligned_cols=272 Identities=24% Similarity=0.299 Sum_probs=217.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCC---CCCchHHHHHHHHHHHhccCCceeeeeeEEec-----CC
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKNENVVELVGYYVD-----GP 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 134 (356)
....|...+.||.|++|.|+.|..+ +|+.||||++.. .....++..+|+++|+.++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456666889999999999999977 899999999973 23346778999999999999999999998865 45
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.+|+|+|+++ .+|.+.++.+.. ++...+..+++|+++||.|+|+.+ |+||||||.|++++.+..+||
T Consensus 100 DvYiV~elMe-tDL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEe
Confidence 6899999995 499999987753 889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCccccc-CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||+|+...........+..+.|.+|.|||.+. ...|+.+.||||+|||+.||++|++-|-+.+...+..++......
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 9999999875432222235667899999999775 578999999999999999999999999877665555544444444
Q ss_pred CChhhHhHhh--------ccc-CCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 018396 294 LSEDKVKQCV--------DTK-LGGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 294 ~~~~~~~~~~--------~~~-~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~ 348 (356)
.+.+.+..+. ... .... ..++..+...+|+.+||..||.+|+|++|.|+ .|..+.
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 4443333332 111 1111 11355678999999999999999999999987 344443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=347.88 Aligned_cols=260 Identities=21% Similarity=0.294 Sum_probs=213.0
Q ss_pred hCCCCCCceeeccCceEEEEEEECC-CCEEEEEEcCCCCC-chHHHHHHHHHHHhcc-CCceeeeeeE-Eec------CC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLK-NENVVELVGY-YVD------GP 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~-hp~iv~~~~~-~~~------~~ 134 (356)
..++++.+.|.+|||+.||+|.... |..||+|++-.... .-+.+.+|+.+|+.|+ |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 3467888999999999999999774 49999998865533 3467899999999996 9999999993 221 23
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
+++|+||||.||.|-+++..+.... |++.++++|+.++++|+.+||... ++|+|||||-+||||..+|+.||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-------lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-------LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-------CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence 5789999999999999998765433 899999999999999999999995 45999999999999999999999
Q ss_pred ecccccCCCcccccccc-------ccccccCcCccCcccc---cCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018396 215 SDFDLSNQAPDAAARLH-------STRVLGTFGYHAPEYA---MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (356)
||||.|+.......... .-...-|+.|+|||++ .+...++++|||+|||+||-|++..+||+..-.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---- 263 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---- 263 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----
Confidence 99999875433221110 0112358999999987 477889999999999999999999999975421
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
..++...+.-...+.++..+.+||..||+.||.+||++-+++..+.+|.+..
T Consensus 264 ---------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ---------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 2344444444555789999999999999999999999999999999988765
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=335.60 Aligned_cols=270 Identities=22% Similarity=0.350 Sum_probs=214.4
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhcc-CCceeeeeeEEec
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVD 132 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hp~iv~~~~~~~~ 132 (356)
....++|++++.||+|+||.||+|... .+..||||++...... .+.+.+|+++++++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 334678999999999999999999853 2347999999754332 356889999999996 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCC----------------------------------------------------
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKG---------------------------------------------------- 160 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~---------------------------------------------------- 160 (356)
....++||||+++|+|.+++........
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999875421000
Q ss_pred -----------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEE
Q 018396 161 -----------------------------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (356)
Q Consensus 161 -----------------------------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (356)
......+++..++.++.|++.||.|||+++ ++|+||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 001124778889999999999999999999 999999999999
Q ss_pred EccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~ 284 (356)
+++++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~----- 344 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI----- 344 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc-----
Confidence 99999999999999876543322222233456788999999999899999999999999999997 999986431
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
........+........+..++.++.+++.+||+.+|++|||+.+|.+.|++++.
T Consensus 345 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 345 ----------VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ----------hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1112222222333334455677889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=321.19 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=214.9
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
..+|++.+.||.|+||.||+|...++..+++|.+..... ....+.+|+.+++.++||||+++++++.+....+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 457999999999999999999988889999999976654 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++...... .+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+...
T Consensus 85 ~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 85 EKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred ccCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 999999999765422 2789999999999999999999999 999999999999999999999999998776
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .......
T Consensus 155 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----------------~~~~~~~ 216 (261)
T cd05148 155 KEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----------------NHEVYDQ 216 (261)
T ss_pred CCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----------------HHHHHHH
Confidence 5432221 23345678999999988889999999999999999998 899996432 1222222
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
+........+..++..+.++|.+||+.+|.+|||+.++++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 217 ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 333333444566778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=317.75 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=211.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
++|++.+.||+|+||.||+|.++ +...||+|.+...... ...+.+|+.+++.++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 57999999999999999999975 2457999998754333 35688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred EEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccch
Confidence 999999999999976432 2889999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+................++..|+|||.+.+..++.++||||||+++|+|++ |..||... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~----------------~~~~ 216 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM----------------SNQD 216 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC----------------CHHH
Confidence 987753222222223345678999999998899999999999999999998 99998533 2222
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
....+........+..++..+.+++.+||+.+|++||++.++++.|++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 217 VIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 23333322222334556778999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=330.26 Aligned_cols=238 Identities=20% Similarity=0.252 Sum_probs=196.1
Q ss_pred eeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
||+|+||.||+|... +++.||+|++... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999987 7889999998643 22235677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (356)
.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 81 FHHLQREGR---------FDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence 999976432 889999999999999999999999 99999999999999999999999999875432221
Q ss_pred cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCC
Q 018396 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (356)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (356)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+... .
T Consensus 149 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---------------~~~~~~~~~~--~ 209 (312)
T cd05585 149 --KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---------------NEMYRKILQE--P 209 (312)
T ss_pred --ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---------------HHHHHHHHcC--C
Confidence 12445789999999999999999999999999999999999999964321 1111122221 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 018396 309 GEYPPKAIAKMAAVAALCVQYEADFRPN---MGIVLK 342 (356)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~ell~ 342 (356)
...+...+.++.++|.+||+.||.+||+ +.+++.
T Consensus 210 ~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 2344566788999999999999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=326.93 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=209.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCC----EEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
..+|++.+.||+|+||.||+|.+. ++. .||+|.+..... ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 357999999999999999999864 343 489999865432 246788999999999999999999998765 577
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
++++|+++|+|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+||
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccc
Confidence 89999999999999986532 2788899999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++................++..|+|||++.+..++.++||||||+++|+|++ |..||.... .
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~----------------~ 217 (316)
T cd05108 154 GLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------------A 217 (316)
T ss_pred cccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----------------H
Confidence 99987654332211222334678999999999999999999999999999997 999996431 2
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
......+........+..++..+.+++.+||+.+|.+|||+.+++..|.++....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 218 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 2233333333333334456678999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=336.44 Aligned_cols=239 Identities=29% Similarity=0.458 Sum_probs=208.1
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHHH
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 150 (356)
+.-||.|+.|.||+|+.+ ++.||||++..- -..+++.|++|+||||+.|.++|.....++||||||..|-|++
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 567999999999999988 688999987532 2346889999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccc
Q 018396 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230 (356)
Q Consensus 151 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 230 (356)
+|..... +.......+..+|+.|++|||.+. |||||||.-||||..+..|||+|||.++...+...
T Consensus 202 VLka~~~---------itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST-- 267 (904)
T KOG4721|consen 202 VLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST-- 267 (904)
T ss_pred HHhccCc---------cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh--
Confidence 9987653 788889999999999999999998 99999999999999999999999999987766532
Q ss_pred cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCC
Q 018396 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE 310 (356)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (356)
...++||..|||||++.+.+.++++|||||||+|||||||..||...+. .-+ +..+-...+...
T Consensus 268 -kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAI-----------IwGVGsNsL~Lp 331 (904)
T KOG4721|consen 268 -KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAI-----------IWGVGSNSLHLP 331 (904)
T ss_pred -hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----hee-----------EEeccCCccccc
Confidence 2567899999999999999999999999999999999999999964421 111 122223445667
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 311 YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.|..|++.+.-||++||+..|.+||++.+++..|+=
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 888999999999999999999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=321.89 Aligned_cols=263 Identities=24% Similarity=0.414 Sum_probs=212.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|.+.+.||+|+||.||+|... +++.||+|.+...... .+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 456888999999999999999864 2578999998765443 46789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
+++|||+++++|.+++........ ......+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 999999999999999976532110 112234788999999999999999999999 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 290 (356)
++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~----------- 229 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS----------- 229 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-----------
Confidence 99999999875433222111233345788999999999999999999999999999998 999985432
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.......+........+..++..+.+++.+||+.||.+|||+.|+++.|++
T Consensus 230 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 230 -----NEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 122223333333333344567889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.67 Aligned_cols=252 Identities=20% Similarity=0.246 Sum_probs=205.4
Q ss_pred CCCCCceeeccCceEEEEEEEC-C-CCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
.|.+.+.||+|+||.||+|... + ++.||+|.+...... ...+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4899999999999999999865 4 678899977554333 345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++|+|.+++...... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 148 ~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 148 SGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred CCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999988643211 123788999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ...+...+
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----------------~~~~~~~~ 283 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----------------QREIMQQV 283 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----------------HHHHHHHH
Confidence 54322222345679999999999999999999999999999999999999996431 11111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........+..++.++.++|.+||+.+|.+||++.+++.
T Consensus 284 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 284 LYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111122334456778999999999999999999999875
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=310.18 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=209.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..+.|++...||+|.|+.|+++.+. +|+.+|+|++... ....+++.+|+.+-+.|+||||+++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3567888999999999999999976 8999999998643 33467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC---CceeEec
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISD 216 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~D 216 (356)
+|++.|++|..-|-.+. .+++..+-..++||+.+|.|+|.++ |||||+||+|+++.+. .-+||+|
T Consensus 89 Fe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred EecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecc
Confidence 99999999976665543 2788999999999999999999999 9999999999999754 3599999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||+|....+.... ....|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+ .
T Consensus 157 FGvAi~l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~----------------~ 217 (355)
T KOG0033|consen 157 FGLAIEVNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----------------Q 217 (355)
T ss_pred cceEEEeCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc----------------H
Confidence 9999988744332 56789999999999999999999999999999999999999996531 2
Q ss_pred hhHhH-hhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQ-CVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~-~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+.+ ++...+ .+..-+.++++.++|+++||..||.+|.|+.|.|.
T Consensus 218 ~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 218 HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 22222 222222 23344567789999999999999999999999875
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=307.15 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=213.0
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---------hHHHHHHHHHHHhc-cCCceeeeee
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRL-KNENVVELVG 128 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l-~hp~iv~~~~ 128 (356)
.-......|+-.+.||.|..++|.++..+ +|+.+|+|++...... .+.-++|+.+|+++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 34456678889999999999999999876 8899999988542211 13446789999998 7999999999
Q ss_pred EEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc
Q 018396 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (356)
Q Consensus 129 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (356)
+|+....+++|+|.++.|.|.|++..... +++.....+++|++.|+.|||.++ ||||||||+|||+++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~Vt---------lSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILldd 158 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKVT---------LSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDD 158 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhhee---------ecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecc
Confidence 99999999999999999999999988764 899999999999999999999999 999999999999999
Q ss_pred CCceeEecccccCCCccccccccccccccCcCccCccccc------CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCC
Q 018396 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (356)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (356)
+.+++|+|||+|+++...... +..+|||+|+|||.+. ...|+..+|+|++|||+|.|+.|.+||.+..
T Consensus 159 n~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--- 232 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--- 232 (411)
T ss_pred ccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---
Confidence 999999999999999877654 7789999999999885 3468889999999999999999999996431
Q ss_pred CccceecccccCChhhHhHhhccc--CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 283 QQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
++ -.+..+.... +.++.-.+.+....+||.+||+.||.+|.|++|+|+
T Consensus 233 ----------Qm--lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 233 ----------QM--LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ----------HH--HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11 1112222222 233444577889999999999999999999999997
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=325.86 Aligned_cols=248 Identities=20% Similarity=0.343 Sum_probs=219.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
+.+-|.+.+.||+|.|+.|-+|++- +|+.||||++.+.+.+ ...+..|++-|+..+|||||++|++......+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4456899999999999999999976 8999999999876654 46789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc-cCCceeEeccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFD 218 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg 218 (356)
+|.-.+|+|++||-+.... +.+..+.+++.||+.|+.|||+.. +|||||||+|+.+. .-|-|||+|||
T Consensus 96 LELGD~GDl~DyImKHe~G--------l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEG--------LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred EEecCCchHHHHHHhhhcc--------ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecc
Confidence 9999999999999776543 899999999999999999999998 99999999999876 46899999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCC-ccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++-.+...... ...+|++.|-|||.+.|..|+ +++||||||||||.|.+|++||+... ..+
T Consensus 165 FSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN---------------DSE 226 (864)
T KOG4717|consen 165 FSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN---------------DSE 226 (864)
T ss_pred ccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc---------------chh
Confidence 99887765544 677999999999999999995 67899999999999999999997542 334
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+..+++.++ ..|..++.++++||..||..||.+|.|.++|..
T Consensus 227 TLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 227 TLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4555666666 678889999999999999999999999999875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=329.24 Aligned_cols=240 Identities=21% Similarity=0.291 Sum_probs=198.1
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
+.||+|+||.||++... +|..||+|++.... .....+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999976 78999999986532 22345678999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
+|.+++..... +++..++.++.||+.||.|||++| ++||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 81 ELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 99998876542 889999999999999999999999 999999999999999999999999998754322
Q ss_pred cccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhccc
Q 018396 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK 306 (356)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (356)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 149 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---------------~~~~~~~~~~ 211 (323)
T cd05595 149 GAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------------RLFELILMEE 211 (323)
T ss_pred CCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhcCC
Confidence 111 13456899999999999999999999999999999999999999643211 1111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 307 LGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
...+..+++++.++|.+||+.||.+|| ++.++++
T Consensus 212 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 133445677899999999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=313.07 Aligned_cols=271 Identities=21% Similarity=0.277 Sum_probs=208.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCc-eeeeeeEEecCC------
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNEN-VVELVGYYVDGP------ 134 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~------ 134 (356)
..|+..+.||+|+||+||+|+.+ +|+.||+|++..... ......+|+.+|+.|+|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45667778999999999999977 899999999976544 3456789999999999999 999999999877
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.+++|+||++. +|..++....... ..++...+..+++||+.||+|||+++ |+||||||+||||+++|.+||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEee
Confidence 89999999987 9999998766321 12666889999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc--
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-- 291 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 291 (356)
+|||+|+......... ...++|.+|.|||++.+. .|+...||||+|||+.||+++++-|.+..+..+...+-...
T Consensus 162 aDFGlAra~~ip~~~y--t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 162 ADFGLARAFSIPMRTY--TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred eccchHHHhcCCcccc--cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 9999998766443332 556789999999999986 78999999999999999999999998775532211111000
Q ss_pred ---ccCChhhHhHhhcccCCC-----CC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHh
Q 018396 292 ---PKLSEDKVKQCVDTKLGG-----EY---PPKAIAKMAAVAALCVQYEADFRPNMGIVLKA--LQPL 347 (356)
Q Consensus 292 ---~~~~~~~~~~~~~~~~~~-----~~---~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~--L~~l 347 (356)
..|.......-.+..+.. .. .+.......+++.+||+.+|.+|.|++..++. +..+
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 011110000000000000 00 11112478899999999999999999999985 5443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=332.51 Aligned_cols=246 Identities=21% Similarity=0.292 Sum_probs=204.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-C-CCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
..++|++.+.||+|+||.||+|.++ + +..||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4567999999999999999999865 3 368999988542 222456788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+.+|+|.+++..... +++..+..++.|++.||.|||++| ++||||||+|||++.++.++|+||
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKR---------FPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecC
Confidence 99999999999999976542 889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+. .
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------------~ 235 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---------------L 235 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---------------H
Confidence 998765432 13457899999999999988999999999999999999999999644211 1
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 343 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~ 343 (356)
....+.... ...+...+..+.++|.+||+.+|.+|+ +++++++.
T Consensus 236 ~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 236 IYQKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111111111 123445567889999999999999995 88888763
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=328.93 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=199.1
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 78999999986532 22356788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 81 ELFFHLSRERV---------FSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 99998875432 889999999999999999999999 999999999999999999999999998754322
Q ss_pred cccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhccc
Q 018396 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK 306 (356)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (356)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+..
T Consensus 149 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----------------~~~~~~~~~- 209 (328)
T cd05593 149 AAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------EKLFELILM- 209 (328)
T ss_pred ccc--cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----------------HHHHHHhcc-
Confidence 111 2345799999999999999999999999999999999999999964321 111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018396 307 LGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 343 (356)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~ 343 (356)
.....+...+.++.++|.+||+.||.+|+ ++.++++.
T Consensus 210 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 210 EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11133445677899999999999999997 89998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=315.03 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=210.1
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||+|.+.++..||+|.+.......+.+.+|+.+++.++||||+++++++. ....+++|||+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3569999999999999999999876667999999876655677899999999999999999999875 456799999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.+....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 84 KGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 9999999975432 12788999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
...... .....++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+
T Consensus 154 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----------------~~~~~~~ 216 (262)
T cd05071 154 DNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQV 216 (262)
T ss_pred cccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----------------HHHHHHH
Confidence 332211 122345678999999988889999999999999999999 8889864321 1122222
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
........+..++..+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 222222344567788999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=323.11 Aligned_cols=265 Identities=21% Similarity=0.297 Sum_probs=199.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|++.+.||+|+||.||+|..+ +++.||+|++...... ...+.+|+.+++.++||||+++++++.+....++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3478999999999999999999987 7899999998754322 345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+. ++|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 83 e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 83 EYVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred ECCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcc
Confidence 9996 488888865432 2788899999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc-cceecccccCChhh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWATPKLSEDK 298 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 298 (356)
......... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ..............
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 151 RAKSVPSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred eeccCCCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 654332211 134568999999998875 45788999999999999999999999754221100 00000000000000
Q ss_pred H------hHhhcccCCCCCC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 V------KQCVDTKLGGEYP---------PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~------~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. ............+ ...+..+.+|+.+||+.||.+|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 0000000000000 012356889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=327.04 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=204.5
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999987 7889999988764332 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|+.+++|.+++..... +++..+..++.|++.||.|||+. + ++|+||||+|||+++++.+||+|||++
T Consensus 84 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 84 HMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred cCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 9999999999976432 78889999999999999999975 6 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce-----------e-
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-----------T- 288 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~-----------~- 288 (356)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||............ .
T Consensus 152 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred hhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 7653321 13456899999999999888999999999999999999999999754321100000 0
Q ss_pred -------------c---ccccCChhhHhHhhcccCCCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 289 -------------W---ATPKLSEDKVKQCVDTKLGGEY-PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 289 -------------~---~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+ ..+..........+........ ....+.++.+||.+||+.||++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0 0000000011111111111111 1124567999999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=315.50 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=207.6
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
++|++.+.||+|+||.||+|.+.++..+|+|.+.........+.+|+.++++++||||+++++++.+.+..+++|||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46888999999999999999987667799999886665567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||.||+++.++.+||+|||++.....
T Consensus 84 ~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 84 GCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999976432 2789999999999999999999999 99999999999999999999999999876543
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+.
T Consensus 153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----------------~~~~~~~~ 215 (256)
T cd05113 153 DEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----------------SETVEKVS 215 (256)
T ss_pred Ccee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----------------HHHHHHHh
Confidence 3211 1122235678999999988889999999999999999998 9999964321 11222222
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
.......+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 216 QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 22222233345678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=318.63 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=213.5
Q ss_pred CCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
+|++.+.||+|+||.||+|... ....+++|.+...... ...+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788999999999999999853 2357889988654432 3568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCc
Q 018396 139 AYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~N 203 (356)
++||+.+++|.+++....... .......+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999987543211 1112234889999999999999999999999 9999999999
Q ss_pred EEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCC
Q 018396 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (356)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (356)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 9999999999999999876533222111223345678999999988889999999999999999998 999996432
Q ss_pred CccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
...+...+........+..++.++.+++..||+.+|.+||++.++++.|++++.+
T Consensus 235 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 -------------PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -------------HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 2233344444334444556678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=313.08 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=201.6
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
+.||+|+||.||+|... +++.+|+|.+...... ...+.+|+++++.++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999976 7899999987643322 35688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (356)
.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 81 LTFLRTEGP--------RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred HHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc
Confidence 999965321 2789999999999999999999999 99999999999999999999999999876443211
Q ss_pred cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccC
Q 018396 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL 307 (356)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (356)
.........+..|+|||.+.+..++.++||||||+++|+|++ |..||... ........+....
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~----------------~~~~~~~~~~~~~ 213 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL----------------SNQQTREAIEQGV 213 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc----------------CHHHHHHHHHcCC
Confidence 111111123457999999998889999999999999999997 88998533 1222333333333
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 308 GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
....+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33455566788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=314.15 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=208.0
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
.+|++.+.||+|+||.||+|.++++..+|+|.+.........+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 45889999999999999999988777899999876555566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999975432 2789999999999999999999999 99999999999999999999999999876543
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+ ......+.
T Consensus 153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~~~~~~ 215 (256)
T cd05059 153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----------------SEVVESVS 215 (256)
T ss_pred cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----------------HHHHHHHH
Confidence 2211 1111223457999999998899999999999999999999 8999964321 11122222
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.......+..++..+.+++.+||..+|++|||+.++++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2223334445678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=334.17 Aligned_cols=267 Identities=30% Similarity=0.452 Sum_probs=225.0
Q ss_pred HHHHHHHhCCCCCCceeeccCceEEEEEEEC--CC---CEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeee
Q 018396 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLR--SG---RAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVG 128 (356)
Q Consensus 58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~---~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~ 128 (356)
...|....++-.+.+.||+|+||.||+|..+ ++ ..||||....+. ....++.+|+++++.++|||||+++|
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3345556677777899999999999999965 22 238999887522 22467899999999999999999999
Q ss_pred EEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc
Q 018396 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (356)
Q Consensus 129 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (356)
+......+++|||+|.||+|.++|..... .++..+...++.+.+.||+|||+++ ++||||..+|+|++.
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSK 297 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecC
Confidence 99999999999999999999999998764 2889999999999999999999999 999999999999999
Q ss_pred CCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccce
Q 018396 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 287 (356)
++.+||+|||++.....-.. ......-...|+|||.+....|+.++|||||||++||+++ |..||.+.
T Consensus 298 ~~~vKISDFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--------- 366 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--------- 366 (474)
T ss_pred CCeEEeCccccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC---------
Confidence 99999999999876541111 1112234678999999999999999999999999999998 89999644
Q ss_pred ecccccCChhhHhHhh-cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 288 TWATPKLSEDKVKQCV-DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
....+...+ ....+...+...+.++..++.+||..+|++|||+.++.+.|+.+.....+
T Consensus 367 -------~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 367 -------KNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -------CHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 333445544 67788888889999999999999999999999999999999998866544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=328.00 Aligned_cols=268 Identities=22% Similarity=0.369 Sum_probs=210.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEec-CC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD-GP 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~-~~ 134 (356)
.++|++.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.+++++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457999999999999999999732 3578999998754322 34577899999999 89999999998764 56
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCC----------------------------------------------------CC
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKG----------------------------------------------------AK 162 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~----------------------------------------------------~~ 162 (356)
.+++++||+++++|.+++........ ..
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 78899999999999999865322100 00
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCcc
Q 018396 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242 (356)
Q Consensus 163 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 242 (356)
....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0124789999999999999999999999 9999999999999999999999999998764333222223345677899
Q ss_pred CcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHH
Q 018396 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAA 321 (356)
Q Consensus 243 aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 321 (356)
|||++.+..++.++|||||||++|+|++ |..||...... +.....+........+...+.++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---------------EEFCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---------------HHHHHHHhccCCCCCCccCCHHHHH
Confidence 9999999999999999999999999997 99999643211 1112222222222334455678999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 322 VAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 322 li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
++.+||+.+|++||++.++++.|++++..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=319.30 Aligned_cols=267 Identities=24% Similarity=0.390 Sum_probs=211.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|.+.+.||+|+||.||++... ++..+|+|.+..... ....+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467899999999999999999842 345689998865432 2456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 138 LAYEHASKGSLHDILHGKKGVKG----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
+++||+++++|.+++........ ......+++..++.++.|++.||+|||++| ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999975432111 111123899999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------------ 228 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------------ 228 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------
Confidence 999999876543222111223345778999999998899999999999999999998 9999864421
Q ss_pred cCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
......+........+..++.++.+|+.+||+.+|.+|||++++++.|+++...
T Consensus 229 ----~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 229 ----NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ----HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111122222211122334566899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=343.58 Aligned_cols=257 Identities=22% Similarity=0.308 Sum_probs=207.7
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCC----
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP---- 134 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~---- 134 (356)
...++|++.+.||+|+||+||+|... +++.||||++...... ...+.+|+..+..++|+||+++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34579999999999999999999976 7999999998764333 345778999999999999999988765332
Q ss_pred ----eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 135 ----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 135 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
.+++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG 180 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence 368999999999999999754321 123889999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----------- 249 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----------- 249 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----------
Confidence 999999999876543322222345679999999999999999999999999999999999999996432
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
...+...+........+..+++++.+++.+||+.+|.+||++.+++..
T Consensus 250 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 250 -----MEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111122222222223455677889999999999999999999999863
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=314.13 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=211.4
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||+|..++++.||+|.+.........+.+|+.+++.++|+||+++++++. .+..++++||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4679999999999999999999888899999999877666778999999999999999999999874 457899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++...... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 84 NGSLVDFLKTPEGI-------KLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999998654322 2788999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||..... ......+
T Consensus 154 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----------------~~~~~~~ 216 (260)
T cd05067 154 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----------------PEVIQNL 216 (260)
T ss_pred CCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----------------HHHHHHH
Confidence 32211 1123345678999999998889999999999999999998 9999964421 1222222
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
........+...+.++.+++.+||+.+|++|||+++++..|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 217 ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 23333344445667899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=314.21 Aligned_cols=259 Identities=21% Similarity=0.337 Sum_probs=210.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|+.. +++.||||.+..... ....+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999976 789999998754222 2346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++....... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQK-----RLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCcHHHHHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence 9999999999886432211 23788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
......... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--------------~~~~~~ 217 (267)
T cd08228 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--------------NLFSLC 217 (267)
T ss_pred eeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--------------cHHHHH
Confidence 765443221 1234688899999999888899999999999999999999999854311 111122
Q ss_pred Hhhccc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 301 QCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 301 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
..+... ........++..+.++|.+||+.+|.+|||+.++++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 218 QKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 222221 112223456678999999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=325.96 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=215.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~ 137 (356)
....|++.+.||.|.||.||+++.+ +|+.+|+|.+.+... ..+.+.+|+++|+++. |||||.+.++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567999999999999999999988 699999999976544 2367899999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC----Ccee
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD----DIAK 213 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~----~~vk 213 (356)
+|||++.||.|.+.+... . +++..+..++.|++.++.|||+.| ++||||||+|+|+... +.++
T Consensus 113 lvmEL~~GGeLfd~i~~~-~---------~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-H---------YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred EEEEecCCchHHHHHHHc-c---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEE
Confidence 999999999999999876 1 899999999999999999999999 9999999999999743 4799
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
++|||++........ ....+||+.|+|||++....|+..+||||+|+++|.|++|.+||......
T Consensus 180 ~~DFGla~~~~~~~~---~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~------------ 244 (382)
T KOG0032|consen 180 LIDFGLAKFIKPGER---LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF------------ 244 (382)
T ss_pred EeeCCCceEccCCce---EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh------------
Confidence 999999998876222 36778999999999999999999999999999999999999999765322
Q ss_pred CChhhHhHhhccc--CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 294 LSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 294 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.....+.... +..+.-..++..+.++|..++..||.+|+|+.++|+.
T Consensus 245 ---~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 245 ---EIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---HHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1122232222 3345556778899999999999999999999999984
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=313.92 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=213.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
..++|++.+.||+|+||.||+|..+++..+|+|.+.......+.+.+|+.+++.++|+||+++++++.+....+++|||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 35689999999999999999999887788999999876666778999999999999999999999999989999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 84 ~~~~L~~~i~~~~~~-------~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 84 SKGSLLDFLKSGEGK-------KLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CCCCHHHHHhccccC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceec
Confidence 999999999765422 2889999999999999999999999 999999999999999999999999998766
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.... .......
T Consensus 154 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----------------~~~~~~~ 216 (261)
T cd05034 154 EDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT----------------NREVLEQ 216 (261)
T ss_pred cchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----------------HHHHHHH
Confidence 532211 1122234678999999998889999999999999999998 999995432 1112222
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
+........+...+.++.+++.+||+.+|.+||+++++.+.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 217 VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 22222233344457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=312.98 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=210.0
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||+|...++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4579999999999999999999887888999999876666678999999999999999999999875 456889999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 84 KGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 9999999975432 12789999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||.... .......+
T Consensus 154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----------------~~~~~~~~ 216 (260)
T cd05070 154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----------------NREVLEQV 216 (260)
T ss_pred Ccccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----------------HHHHHHHH
Confidence 32211 1122235668999999988889999999999999999999 899996432 11222223
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
........+...+..+.+++.+||..+|.+|||+.++.+.|++
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 3333334455667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=333.94 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=206.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999987 79999999986532 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++.... .+++..++.++.||+.||.|||++| ++||||||+|||++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCC
Confidence 9999999999998653 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccc---------------------------ccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCC
Q 018396 221 NQAPDAA---------------------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (356)
Q Consensus 221 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 273 (356)
....... .........||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 7654432 0011234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccceecccccCChhhHhHhhc--ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 018396 274 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVD--TKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-MGIVLKA 343 (356)
Q Consensus 274 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ell~~ 343 (356)
||...... .....+.. ..........+++++.++|.+||. +|.+||+ ++++++.
T Consensus 229 Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 229 PFYSDTLQ---------------ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCHH---------------HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99754311 11112222 111111112257789999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=326.37 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=197.6
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHH---HhccCCceeeeeeEEecCCeeEEE
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMV---SRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l---~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.++ +.++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999976 78999999986432 2234566666654 566899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|..++.... +++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||+
T Consensus 81 ~E~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 81 MEYAAGGDLMMHIHTDV----------FSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EcCCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccC
Confidence 99999999998886532 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+........ ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...
T Consensus 148 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---------------~~~ 210 (324)
T cd05589 148 CKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---------------EVF 210 (324)
T ss_pred CccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---------------HHH
Confidence 865432211 124467899999999999999999999999999999999999999644211 111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
..+.... ...+...+..+.++|.+||+.||.+|| ++.++++
T Consensus 211 ~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 211 DSIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1121111 134445677899999999999999999 5677665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=321.21 Aligned_cols=269 Identities=26% Similarity=0.387 Sum_probs=215.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC--------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeeeEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 133 (356)
.++|.+.+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999853 235799999875432 235678899999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (356)
+..+++|||+.+++|.+++....... .......+++..++.++.|++.||+|||++| ++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997653211 0112234889999999999999999999999 9999999999999
Q ss_pred ccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 018396 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 285 (356)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~ 285 (356)
+.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence 9999999999999876543222111122234578999999998889999999999999999998 888985331
Q ss_pred ceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 286 LVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
...+...+........+..++.++.+++.+||..+|.+|||+.++++.|+++++..+
T Consensus 248 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 248 ----------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ----------HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 223333333333334555667899999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=319.55 Aligned_cols=268 Identities=24% Similarity=0.382 Sum_probs=215.1
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEec
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~ 132 (356)
....++|++.+.||+|+||.||++... ....+|+|.+...... ...+.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 334567999999999999999999864 2367999998754332 34578899999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEE
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (356)
++..+++|||+++++|.+++....... .......+++..++.++.|++.||.|||+++ ++|+||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 999999999999999999997643211 0112345889999999999999999999999 999999999999
Q ss_pred EccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~ 284 (356)
+++++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~------ 238 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI------ 238 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC------
Confidence 99999999999999887654322211222335678999999988899999999999999999997 99998533
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
........+........+..++..+.+|+.+||+.+|.+|||+.++++.|+.++
T Consensus 239 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 ----------PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----------CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 122233333333333445566778999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=332.88 Aligned_cols=249 Identities=21% Similarity=0.230 Sum_probs=198.8
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.|++.+.||+|+||+||+|... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999976 78999999996532 123467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++|+|.+++..... +++..+..++.||+.||.|||+.| |+||||||+|||++.+++++|+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 82 YIPGGDMMSLLIRMEV---------FPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred cCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 9999999999976542 788899999999999999999999 9999999999999999999999999975
Q ss_pred CCccccc---------------------------------------------cccccccccCcCccCcccccCCCCCccc
Q 018396 222 QAPDAAA---------------------------------------------RLHSTRVLGTFGYHAPEYAMTGQMSSKS 256 (356)
Q Consensus 222 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 256 (356)
....... ........||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 4311000 0001235699999999999998999999
Q ss_pred hhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhccc--CCCCCCHHHHHHHHHHHHHh--hccCCC
Q 018396 257 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALC--VQYEAD 332 (356)
Q Consensus 257 DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~c--l~~~P~ 332 (356)
|||||||++|+|++|..||....+. .....++... ........++.++.+||.+| +..++.
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPT---------------ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHH---------------HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCccccc
Confidence 9999999999999999999654221 1111122111 11111224567888999884 455666
Q ss_pred CCCCHHHHHH
Q 018396 333 FRPNMGIVLK 342 (356)
Q Consensus 333 ~Rps~~ell~ 342 (356)
.||++.+++.
T Consensus 295 ~R~~~~~~l~ 304 (381)
T cd05626 295 GRNGADDIKA 304 (381)
T ss_pred CCCCHHHHhc
Confidence 6999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=330.29 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=198.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||+||+|... +++.||+|++.+.. .....+.+|+.+++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999976 78999999986532 12346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++|+|.+++..... +++..+..++.|++.||.|||++| |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT---------LTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred cCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCc
Confidence 99999999999976532 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc---------------------------------ccccccccCcCccCcccccCCCCCccchhhhHHHHHHH
Q 018396 221 NQAPDAAAR---------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 267 (356)
Q Consensus 221 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~ 267 (356)
......... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 754321100 00123579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCH--HHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 018396 268 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP--KAIAKMAAVAALCVQ--YEADFRPNMGIVLKA 343 (356)
Q Consensus 268 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~--~~P~~Rps~~ell~~ 343 (356)
|++|..||....+. +....+.........+. ..++++.++|.+++. .++..||++++|++.
T Consensus 229 ll~G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 229 MLIGYPPFCSETPQ---------------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHhCCCCCCCCCHH---------------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99999999754221 11112221111111121 245678888887654 233356899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=317.28 Aligned_cols=263 Identities=23% Similarity=0.388 Sum_probs=207.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
..++|++.+.||+|+||.||+|... ++..||+|.+..... ...++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999853 356799998865332 23467899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.++||||+++++|.+++......... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999999764321111 11123678889999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------------- 227 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------------- 227 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------------
Confidence 99999876543322211122345778999999998889999999999999999999 7889864321
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
......+........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 228 ---EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1222222111112334456678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=316.62 Aligned_cols=263 Identities=26% Similarity=0.377 Sum_probs=210.0
Q ss_pred hCCCCCCceeeccCceEEEEEEE-----CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|++.+.||+|+||.||+|.. .++..+++|.+...... ...+.+|+.+++.++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 35788999999999999999984 24678999998754332 246788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 138 LAYEHASKGSLHDILHGKKGVK--------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~--------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
++|||+.+++|.+++....... .......+++..+..++.|++.||.|||+++ ++|+||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 9999999999999996432110 0011124788899999999999999999999 9999999999999999
Q ss_pred CceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCcccee
Q 018396 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 288 (356)
+.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--------- 231 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--------- 231 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---------
Confidence 9999999999876543322222233445778999999988889999999999999999998 999985431
Q ss_pred cccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.....+.+........+..++..+.+++.+||+.+|.+||++.+|++.|..
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 -------NQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 222233333333233445567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.24 Aligned_cols=267 Identities=24% Similarity=0.379 Sum_probs=213.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|.+.+.||+|+||.||+|... ++..+++|.+...... .+.+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 356888999999999999999842 3456889988654332 356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 138 LAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
+||||+++++|.+++....... .......+++..++.++.||+.||.|||+++ ++|+||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 9999999999999997643210 0111223789999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceec
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 289 (356)
.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------- 231 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------- 231 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------
Confidence 999999999876544332222233456788999999999999999999999999999998 9999864321
Q ss_pred ccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
......+........+..++..+.+++.+||+.+|.+|||+.++++.|+++...
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 232 -------TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -------HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 122222222222233445567899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=333.23 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=201.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999987 78999999996532 22345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~~g~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT---------FTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred CCCCCcHHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccc
Confidence 99999999999976432 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc------------------------------------ccccccccCcCccCcccccCCCCCccchhhhHHHH
Q 018396 221 NQAPDAAAR------------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 264 (356)
Q Consensus 221 ~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 264 (356)
......... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 654221100 00012468999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCC--HHHHHHHHHHHHHhhccCCCCCCC---HHH
Q 018396 265 LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADFRPN---MGI 339 (356)
Q Consensus 265 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps---~~e 339 (356)
+|+|++|..||....+. .....+.........+ ...++++.++|.+|+. +|.+|++ +.+
T Consensus 229 l~el~~G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQ---------------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred HHHhhcCCCCCCCCCHH---------------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 99999999999754321 1111111111111111 1346788999999996 9999998 888
Q ss_pred HHH
Q 018396 340 VLK 342 (356)
Q Consensus 340 ll~ 342 (356)
+++
T Consensus 293 ll~ 295 (364)
T cd05599 293 IKS 295 (364)
T ss_pred Hhc
Confidence 876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=316.68 Aligned_cols=269 Identities=22% Similarity=0.301 Sum_probs=209.4
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecC---C--eeEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG---P--LRVLAY 140 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---~--~~~lv~ 140 (356)
.|+-.+++|.|+||.||.|... +++.||||+.-.+... --+|+.+|+.++|||||++.-+|... + ...+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 5777889999999999999966 6899999998665543 33699999999999999999887632 2 346899
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-CceeEecccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDL 219 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Dfg~ 219 (356)
||++. +|.+++......+ ..++...+.-+..||++||.|||+.| |+||||||.|+|+|.+ |.+||||||.
T Consensus 102 eymP~-tL~~~~r~~~~~~-----~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRAN-----QRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HhchH-HHHHHHHHHhhcC-----CCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCc
Confidence 99987 9999998642221 12777888999999999999999999 9999999999999976 9999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
|+........ .....|..|.|||.+.| ..|+.+.||||.||++.||+-|++-|.+.+..++...+...-...+.++
T Consensus 173 AK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 173 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred ceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9988766544 45568999999999987 5789999999999999999999999988766544433332222233222
Q ss_pred HhHhhc-------ccCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhcc
Q 018396 299 VKQCVD-------TKLG-----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLNT 350 (356)
Q Consensus 299 ~~~~~~-------~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~~~ 350 (356)
+...-- +.+. .-.....++++.+|+.++|+++|.+|.++.|++. .++++...
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 221110 0110 0123455788999999999999999999999996 56666543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.16 Aligned_cols=268 Identities=25% Similarity=0.378 Sum_probs=209.4
Q ss_pred CCCCceeeccCceEEEEEEE-----CCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEec--CCeeEE
Q 018396 68 FGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVL 138 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 138 (356)
|.+.+.||+|+||+||++.. .++..||+|.+..... ....+.+|+++++.++||||+++++++.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988653 2578899999876433 34567899999999999999999998765 346889
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
+|||+++++|.+++.... +++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||
T Consensus 86 v~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred EecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecc
Confidence 999999999999997643 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccccc-ccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......- ..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~ 231 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVV 231 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchh
Confidence 9876644322111 122235667999999988889999999999999999999999986543211 11111111112222
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
.+....+.......+..++.++.+++.+||+.+|.+|||++++++.|+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 2333333333334455667899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=329.17 Aligned_cols=270 Identities=23% Similarity=0.330 Sum_probs=200.4
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecC-----CeeE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG-----PLRV 137 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 137 (356)
+|++.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999976 78999999986432 2234678999999999999999999987643 3479
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+. ++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD---------LTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred EEEecCC-CCHHHHHHhccc---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence 9999996 589999875432 889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccc-cccccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 218 DLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 218 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...................
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 227 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99876432211 111234568999999999876 678999999999999999999999996543211100000000000
Q ss_pred Chh--------hHhHhh---cccCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhc
Q 018396 295 SED--------KVKQCV---DTKLGGEY---PPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLN 349 (356)
Q Consensus 295 ~~~--------~~~~~~---~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~~ 349 (356)
... .....+ ........ .+..+..+.+++.+||+.||++|||++++++ .+..+..
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000 000011 11000000 1123567899999999999999999999997 3444433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=324.99 Aligned_cols=240 Identities=23% Similarity=0.319 Sum_probs=197.4
Q ss_pred ceeeccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 72 SLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999852 57899999986421 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+++|.+++..... +.+..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 82 LSGGELFMHLEREGI---------FMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCCchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 999999999976542 778889999999999999999999 99999999999999999999999999865
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---------------~~~~~~~ 212 (323)
T cd05584 150 SIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---------------KKTIDKI 212 (323)
T ss_pred cccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---------------HHHHHHH
Confidence 432221 12345689999999999988899999999999999999999999964421 1111222
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
.... ...+...+..+.++|.+||+.+|++|| +++++++
T Consensus 213 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 213 LKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 2211 234445677899999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=333.32 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=198.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|... +++.||||++.+.. ...+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999976 78999999986432 12356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++|+|.+++..... +++..+..++.|++.||+|||++| |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 81 EFLPGGDLMTMLIKYDT---------FSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred eCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999976432 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc---------------------------------------------ccccccccCcCccCcccccCCCCCcc
Q 018396 221 NQAPDAAAR---------------------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSK 255 (356)
Q Consensus 221 ~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 255 (356)
+........ .......||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 633210000 00012468999999999999999999
Q ss_pred chhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCC--HHHHHHHHHHHHHhhccCCCC
Q 018396 256 SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADF 333 (356)
Q Consensus 256 ~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~ 333 (356)
+|||||||++|+|++|..||...... +....+.........+ ...+.++.+||.+||. +|.+
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSH---------------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHH---------------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence 99999999999999999999654321 1111111111111111 1346788999999997 6776
Q ss_pred C---CCHHHHHHH
Q 018396 334 R---PNMGIVLKA 343 (356)
Q Consensus 334 R---ps~~ell~~ 343 (356)
| +|+.+++..
T Consensus 293 r~~r~~~~~~l~h 305 (377)
T cd05629 293 RLGRGGAHEIKSH 305 (377)
T ss_pred cCCCCCHHHHhcC
Confidence 5 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=317.43 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=204.6
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
+|++.+.||+|+||.||++... +++.||+|++..... ....+.+|+.+++.++||||+++++.+.+++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999999976 789999999865322 12456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred ccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999988865332 12889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... .....|++.|+|||++.+..++.++||||+||++|+|++|..||...... .....+..
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~------------~~~~~~~~ 215 (285)
T cd05605 151 EIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK------------VKREEVER 215 (285)
T ss_pred ecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh------------hHHHHHHH
Confidence 6543221 13346899999999999888999999999999999999999999753211 00111111
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 343 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~ 343 (356)
.+.. ....++..++..+.+||.+||+.||.+|| ++.++++.
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 216 RVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred Hhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1211 12234556778899999999999999999 88888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=324.60 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=199.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCC-ceeeeeeEEecCCeeEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNE-NVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~ 140 (356)
+|++.+.||+|+||.||+|... +++.||+|++... ....+.+..|..++..+.|+ +|+.+++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999977 6889999998653 22345677889999999764 6888999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred cCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 99999999999976542 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .....
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---------------~~~~~ 211 (324)
T cd05587 149 KENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---------------DELFQ 211 (324)
T ss_pred eecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---------------HHHHH
Confidence 65322211 12345689999999999999999999999999999999999999964421 11111
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~ 342 (356)
.+... ....+...+.++.+++.+||..||.+|++. +++++
T Consensus 212 ~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 212 SIMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 12111 123444567789999999999999999986 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=330.83 Aligned_cols=252 Identities=19% Similarity=0.276 Sum_probs=203.5
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
...++|++.+.||+|+||.||+|... +++.+|+|++.+.. .....+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999987 78899999986421 22345778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+++|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 120 lv~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred EEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEec
Confidence 9999999999999997543 788899999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCC----CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------------- 252 (370)
T cd05621 187 GTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------------- 252 (370)
T ss_pred ccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------------
Confidence 99876543221 1123557999999999987543 78899999999999999999999964421
Q ss_pred CChhhHhHhhcccCCCCCC--HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018396 294 LSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADF--RPNMGIVLKA 343 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~ 343 (356)
......+.........+ ...+..+.+++.+||..++.+ |+|+.++++.
T Consensus 253 --~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 253 --VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11222333322222222 245778899999999865544 8899999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=326.42 Aligned_cols=250 Identities=21% Similarity=0.284 Sum_probs=200.3
Q ss_pred CCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCee
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 136 (356)
+|++.+.||+|+||.||+++.. +++.||+|++.+.. ...+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5888999999999999999852 58899999986421 2234577899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN---------FSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence 999999999999999976432 889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++......... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------------~ 215 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN------------T 215 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC------------C
Confidence 9998765332221 12345789999999999875 47889999999999999999999996432111 1
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
...+...+. ......+...+..+.+++.+||+.||.+|| +++++++
T Consensus 216 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 216 QSEVSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111111111 111233445677899999999999999999 6778775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=318.18 Aligned_cols=271 Identities=23% Similarity=0.379 Sum_probs=216.6
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC--------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeeeEEe
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYV 131 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~ 131 (356)
...++|++.+.||+|+||.||+|+.. ++..||+|.+..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567899999999999999999741 245799998865322 235688999999999 8999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcE
Q 018396 132 DGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (356)
Q Consensus 132 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (356)
.....+++|||+.+++|.+++........ ..+...+++..+..++.|++.||.|||++| ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999976532110 012234788999999999999999999999 99999999999
Q ss_pred EEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCC
Q 018396 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQ 283 (356)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~ 283 (356)
++++++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----- 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----- 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----
Confidence 999999999999999876654332222233345678999999998889999999999999999998 88888533
Q ss_pred ccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 284 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
+...+...+........+..++..+.+++.+||+.+|.+|||+.++++.|+++++...
T Consensus 244 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 244 -----------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred -----------CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 1222333333333334455677889999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=332.32 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=204.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999977 78999999986421 223457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++|+|.+++.... +++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 121 v~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred EEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecc
Confidence 999999999999987543 778889999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCC----CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG----QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 188 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------------- 252 (370)
T cd05596 188 TCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------------- 252 (370)
T ss_pred ceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------------
Confidence 9876543221 112345799999999998653 378899999999999999999999965421
Q ss_pred ChhhHhHhhcccCCCCCCH--HHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018396 295 SEDKVKQCVDTKLGGEYPP--KAIAKMAAVAALCVQYEADF--RPNMGIVLKA 343 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~P~~--Rps~~ell~~ 343 (356)
......+.........+. .++.++.+||.+||+.+|.+ |+|+.++++.
T Consensus 253 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 -VGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -HHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111222222221112222 45778999999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=309.86 Aligned_cols=259 Identities=22% Similarity=0.366 Sum_probs=212.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++|+|++++++++.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999987 89999999886422 12457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++...... ...+++..++.++.+++.||.|||+.| ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred ecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence 999999999998754321 123788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .....+.
T Consensus 154 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------------~~~~~~~ 217 (267)
T cd08224 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--------------MNLYSLC 217 (267)
T ss_pred eeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC--------------ccHHHHH
Confidence 765432211 133467889999999998889999999999999999999999995432 1111112
Q ss_pred HhhcccCCCCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 301 QCVDTKLGGEYPP-KAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 301 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
..+........+. .++..+.++|.+||..+|.+|||+.+|++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 218 KKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 2222222222333 56778999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=317.17 Aligned_cols=249 Identities=31% Similarity=0.512 Sum_probs=199.7
Q ss_pred CCceeeccCceEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 70 TNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+.+.||.|.||.||+|.+. .+..|+||.+...... .+.+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999965 3678999999654333 47889999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++|+|.+++..... ..+++..++.++.||+.||.|||+++ ++|+||+++||++++++.+||+|||++..
T Consensus 83 ~~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp -TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred ccccccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999988722 12899999999999999999999998 99999999999999999999999999877
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
..................|+|||.+.+..++.++||||||+++|||++ |..||... ....+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~----------------~~~~~~~ 216 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY----------------DNEEIIE 216 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS----------------CHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------ccccccc
Confidence 632222222233456778999999998889999999999999999999 78998533 3333333
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.+........+..++..+.++|..||..+|.+|||++++++.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 217 KLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3344444455666788899999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=312.06 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=206.3
Q ss_pred CCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCe-----
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----- 135 (356)
|.+.+.||+|+||.||+|... .+..||+|.+...... ...+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 577899999999999999864 2478999998754332 3467899999999999999999998866554
Q ss_pred -eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 136 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.++++||+++++|.+++........ ...+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGL---PEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCC---cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEE
Confidence 7999999999999999865432111 123889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-------------- 220 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-------------- 220 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--------------
Confidence 99999876543322211122334678999999988889999999999999999999 889986432
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
.......+........+..++..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 221 --NHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred --HHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 11222222222233445567788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=309.91 Aligned_cols=253 Identities=27% Similarity=0.452 Sum_probs=207.6
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
++|++...||+|++|.||+|....+..+|+|.+.......+.+.+|+.+++.++|||++++++++. ....+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 568899999999999999999886678999998766555677899999999999999999998875 4568899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 85 ~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 85 GSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999975432 12788999999999999999999999 99999999999999999999999999876543
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+ ......+.
T Consensus 155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------------~~~~~~~~ 217 (260)
T cd05069 155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----------------REVLEQVE 217 (260)
T ss_pred Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHH
Confidence 2211 1122345678999999988889999999999999999999 9999964321 11122222
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.......+...+..+.+++.+||..+|.+||+++++++.|++
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 222233445667889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=326.98 Aligned_cols=241 Identities=21% Similarity=0.297 Sum_probs=197.6
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
+.||+|+||.||++... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 78999999986532 22345678999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
+|.+++..... +++..+..++.||+.||.|||+ .| |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 81 ELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred cHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 99998876432 8899999999999999999997 68 99999999999999999999999999865432
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+..
T Consensus 149 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----------------~~~~~~i~~ 210 (325)
T cd05594 149 DGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------EKLFELILM 210 (325)
T ss_pred CCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----------------HHHHHHHhc
Confidence 2111 1345699999999999999999999999999999999999999964321 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 343 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~ 343 (356)
. ....+...+.++.+++.+||+.||.+|+ ++.++++.
T Consensus 211 ~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 211 E-EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C-CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 1123445667899999999999999997 89998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=318.06 Aligned_cols=261 Identities=23% Similarity=0.371 Sum_probs=211.0
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEecC
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 133 (356)
...++|++.+.||+|+||.||+|... ++..+|+|.+...... .+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34467999999999999999999741 3558999988754332 35688999999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
+..+++|||+.+++|.+++...... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEE
Confidence 9999999999999999999754321 2789999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
|+|||++................++..|+|||++.+..++.++||||+||++|+|++ |..||.....
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~------------ 249 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV------------ 249 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc------------
Confidence 999999876543322111223346788999999999899999999999999999998 9999864321
Q ss_pred cCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
.+.....+........+...+.++.+++.+||+.+|++|||+.++++.|++++
T Consensus 250 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 250 ---DSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred ---hHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 12222333333222333445678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=320.34 Aligned_cols=263 Identities=20% Similarity=0.298 Sum_probs=196.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC--CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhc---cCCceeeeeeEEe-----c
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL---KNENVVELVGYYV-----D 132 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~hp~iv~~~~~~~-----~ 132 (356)
++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999974 4688999988653322 34566787777766 6999999999875 3
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
....++++||+.+ +|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence 4568999999974 999998754321 2789999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
+|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.................
T Consensus 150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~ 226 (290)
T cd07862 150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226 (290)
T ss_pred EEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 999999987654332 12445689999999999988999999999999999999999999976533211000000000
Q ss_pred cCChhhHhH-------hhcccCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 293 KLSEDKVKQ-------CVDTKLG---GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 293 ~~~~~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......... ....... ....+..+..+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000 0000000 0011234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=312.62 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=201.7
Q ss_pred CCCCceeeccCceEEEEEEEC-CCC--EEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecC------Ce
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------PL 135 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~~ 135 (356)
|.+.+.||+|+||.||+|... ++. .+|+|.+..... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456789999999999999976 333 689998865432 245678899999999999999999976432 35
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++++||+.+|+|.+++....... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.++|+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGD---CPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccC---CcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEEC
Confidence 689999999999999885432211 1123789999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------------- 220 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------------- 220 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------------
Confidence 9999887644322111223345778999999999999999999999999999999 8899864321
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
......+........+..++..+.++|.+||+.+|++|||+.++++.|+.++
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 221 --SEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred --HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1111222222112233456678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=316.83 Aligned_cols=262 Identities=26% Similarity=0.351 Sum_probs=210.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.+|++.+.||+|+||.||+|... .+..||+|.+...... .+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45788889999999999999853 2578999999754432 356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 138 LAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
+++||+.+++|.+++....... .......+++..++.++.|++.||.|||++| ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999986432110 0111234788899999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceec
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 289 (356)
.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---------- 231 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---------- 231 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----------
Confidence 999999999876544332222233446789999999988889999999999999999998 888886432
Q ss_pred ccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.......+........+..++..+.+++..||+.+|.+||++.+|++.|+.
T Consensus 232 ------~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 232 ------NQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 122333333333334556678889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.97 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=210.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||.||+|..+ ++..||+|.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467899999999999999999864 2468999998654332 34678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
+++|||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999764422111 11223788899999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------------- 226 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--------------- 226 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---------------
Confidence 9999876544322212233456789999999988889999999999999999998 999995432
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
.......+........+..++..+.++|.+||+.+|.+|||+.++++.|+
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 227 -NEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 12222233332233445556788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=312.86 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=205.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCC----EEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
++|++.+.||+|+||.||+|.+. +++ .+++|.+..... ...++..|+.+++.++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57889999999999999999975 444 477787754322 2345677888899999999999999875 456788
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
++||+++|+|.+++..... .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||
T Consensus 86 i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCc
Confidence 9999999999999975432 2889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++................++..|+|||++.+..++.++||||||+++|+|++ |..||....+ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----------------~ 218 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----------------H 218 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----------------H
Confidence 9876543322222234456778999999998899999999999999999998 9999964421 1
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.....+........+..++..+..++.+||..+|.+|||+.++++.|..+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 219 EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 222233322222223345567899999999999999999999999999877644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=323.50 Aligned_cols=235 Identities=22% Similarity=0.317 Sum_probs=193.1
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|..+ +++.||+|++.... ...+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999987 78999999986432 2234567788888776 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~~~---------l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 81 GDLMFHIQKSRR---------FDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred chHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 999999876542 889999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+...+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----------------~~~~~~i~~ 210 (320)
T cd05590 149 NGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----------------DDLFEAILN 210 (320)
T ss_pred CCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----------------HHHHHHHhc
Confidence 211 12345789999999999999999999999999999999999999964421 111222211
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 337 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 337 (356)
. ....+...+.++.+++.+||+.||.+||++
T Consensus 211 ~-~~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 211 D-EVVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred C-CCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 112344567789999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=333.08 Aligned_cols=250 Identities=22% Similarity=0.241 Sum_probs=200.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999976 78999999986432 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||+|
T Consensus 81 E~~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 81 DYIPGGDMMSLLIRLGI---------FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred eCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 99999999999976542 788889999999999999999999 999999999999999999999999997
Q ss_pred CCCcccc-----------------------------------------ccccccccccCcCccCcccccCCCCCccchhh
Q 018396 221 NQAPDAA-----------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY 259 (356)
Q Consensus 221 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 259 (356)
..+.... .........||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 5321000 00001234699999999999999999999999
Q ss_pred hHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhc--ccCCCCCCHHHHHHHHHHHHHhhccCCCCCC--
Q 018396 260 SFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD--TKLGGEYPPKAIAKMAAVAALCVQYEADFRP-- 335 (356)
Q Consensus 260 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-- 335 (356)
||||++|+|++|+.||....+.. ....+.. ...........+.++.++|.+|+ .+|.+|+
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAE---------------TQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHH---------------HHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99999999999999997553211 1111111 01111112245667888898876 5999999
Q ss_pred -CHHHHHHH
Q 018396 336 -NMGIVLKA 343 (356)
Q Consensus 336 -s~~ell~~ 343 (356)
|+.++++.
T Consensus 293 ~t~~ell~h 301 (376)
T cd05598 293 NGADEIKAH 301 (376)
T ss_pred CCHHHHhCC
Confidence 88988863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=323.77 Aligned_cols=249 Identities=21% Similarity=0.277 Sum_probs=197.3
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|..+ +++.||+|++..... ....+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999977 789999999975322 234577899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... +++..++.++.|++.||.|||++| ++||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 81 GDLMFHMQRQRK---------LPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 999998865432 899999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ....+...+.+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~ 219 (329)
T cd05588 149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD-------QNTEDYLFQVILE 219 (329)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc-------ccchHHHHHHHHc
Confidence 111 1234578999999999999999999999999999999999999996432111000 0001111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPN------MGIVLK 342 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps------~~ell~ 342 (356)
. ....+..++.++.++|.+||+.||.+|+| ++++++
T Consensus 220 ~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 220 K-QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C-CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1 12344456778999999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=313.11 Aligned_cols=259 Identities=23% Similarity=0.394 Sum_probs=209.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCC----EEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|++.+.||+|+||+||+|.+. ++. .||+|++...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467899999999999999999864 444 4899988654332 4567889999999999999999999875 4577
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
++++|+++|+|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCC
Confidence 89999999999999976432 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.... .
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----------------~ 217 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----------------A 217 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----------------H
Confidence 99876643322211122234678999999998899999999999999999998 999986432 1
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
......+........+..++..+.+++.+||+.||++||++.++++.|..+....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 218 REIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 2233333333333344556778999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.81 Aligned_cols=260 Identities=18% Similarity=0.251 Sum_probs=199.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
...+|++.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++||||+++++++......++++|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3467999999999999999999976 789999997542 3477899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+. ++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 165 ~~-~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 165 YK-TDLYCYLAAKRN---------IAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred CC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 96 589888865432 788999999999999999999999 99999999999999999999999999865
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcc-----ceec--------
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-----LVTW-------- 289 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~-----~~~~-------- 289 (356)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... +...
T Consensus 232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 232 PVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred ccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 4322111 1234579999999999999999999999999999999999998875432211000 0000
Q ss_pred -ccccCChhhHhHhh----ccc--CCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 -ATPKLSEDKVKQCV----DTK--LGGEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 -~~~~~~~~~~~~~~----~~~--~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.........+.... ... ..... ....+.++.+||.+||+.||.+|||++|+++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000011110 000 00001 1134668999999999999999999999996
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=327.75 Aligned_cols=271 Identities=25% Similarity=0.408 Sum_probs=215.1
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhcc-CCceeeeeeEEe
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYV 131 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hp~iv~~~~~~~ 131 (356)
+....++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3444567889999999999999999853 3468999999764333 346889999999997 999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhcCCCCC----------------------------------------------------
Q 018396 132 DGPLRVLAYEHASKGSLHDILHGKKGVK---------------------------------------------------- 159 (356)
Q Consensus 132 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------------------------------------------- 159 (356)
.....++|+||+.+|+|.+++.......
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999997643210
Q ss_pred -------------------------------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCC
Q 018396 160 -------------------------------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (356)
Q Consensus 160 -------------------------------------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~ 202 (356)
.......+++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 0012234778889999999999999999998 999999999
Q ss_pred cEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCC
Q 018396 203 NVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (356)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (356)
|||+++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~-- 346 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP-- 346 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC--
Confidence 99999999999999999876433221111223456788999999998889999999999999999998 889985431
Q ss_pred CCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 282 GQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
..+.....+....+...+..++.++.+++.+||..+|.+||++++|++.|++++.
T Consensus 347 -------------~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~~ 401 (401)
T cd05107 347 -------------MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLLT 401 (401)
T ss_pred -------------chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhC
Confidence 1122223333333334455567899999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=323.12 Aligned_cols=240 Identities=19% Similarity=0.284 Sum_probs=195.9
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|+.+ +++.||+|++.... .....+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999977 68899999987532 2234567788888866 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|..++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 81 GDLMFQIQRSRK---------FDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999876542 788999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+...
T Consensus 149 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---------------~~~~~i~~~ 211 (321)
T cd05591 149 NGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---------------DLFESILHD 211 (321)
T ss_pred CCcc--ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---------------HHHHHHHcC
Confidence 2211 23456899999999999999999999999999999999999999754211 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRP-------NMGIVLK 342 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-------s~~ell~ 342 (356)
. ...+...+.++.+++.+||+.||.+|| +++++++
T Consensus 212 ~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 212 D--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1 123334567899999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=308.45 Aligned_cols=251 Identities=31% Similarity=0.496 Sum_probs=211.7
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||.|+||.||+|... ++.||+|.+.......+.+.+|+.+++.++|+||+++++++.+.+..+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 467999999999999999999876 7889999997765556678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 84 KGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999765421 2889999999999999999999999 9999999999999999999999999987763
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
... .....+..|+|||++.+..++.++||||||+++|+|++ |..||... ....+...+
T Consensus 154 ~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----------------~~~~~~~~~ 212 (256)
T cd05039 154 QGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----------------PLKDVVPHV 212 (256)
T ss_pred ccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC----------------CHHHHHHHH
Confidence 321 12234667999999988889999999999999999997 99998533 222233333
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
........+..+++.+.++|.+||..+|.+|||+.++++.|+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 213 EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 33333344455678899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=328.67 Aligned_cols=249 Identities=20% Similarity=0.246 Sum_probs=202.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|..+ +++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999977 789999999875422 2356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred CCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCC
Confidence 99999999999976532 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCccccc------CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
......... ......||+.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------------- 215 (330)
T cd05601 150 ARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------------- 215 (330)
T ss_pred eECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------------
Confidence 765433221 123346899999999986 456788999999999999999999999654221
Q ss_pred ChhhHhHhhcccCCCCC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 295 SEDKVKQCVDTKLGGEY--PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.....+......... ....+..+.+|+.+||+ +|.+|||++++++
T Consensus 216 --~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 216 --KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111222211111111 22456789999999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=317.35 Aligned_cols=266 Identities=26% Similarity=0.388 Sum_probs=209.2
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCC--EEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 138 (356)
.++|++.+.||+|+||.||+|.++ ++. .+++|.+..... ....+.+|+.++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 468999999999999999999975 454 457777654322 235678899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 139 AYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
++||+++++|.+++........ ......+++..++.++.|++.||+|||++| ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999976542111 011234889999999999999999999999 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 290 (356)
++|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------- 229 (303)
T cd05088 163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------- 229 (303)
T ss_pred EEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh----------
Confidence 99999999864322111 122234667999999988889999999999999999998 9999964321
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
......+........+..++..+.+++.+||+.+|.+||++.++++.|.+++....
T Consensus 230 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 230 ------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ------HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11122222222223334456789999999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=313.87 Aligned_cols=243 Identities=21% Similarity=0.304 Sum_probs=194.1
Q ss_pred eeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
||+|+||.||++..+ +|+.||+|.+..... ....+..|+++++.++||||+++++++.++...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999976 799999999864321 233456799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (356)
.+++...... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 81 KYHIYNVGER-------GLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred HHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence 9888654321 2788999999999999999999999 99999999999999999999999999876543221
Q ss_pred cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH-hhcccC
Q 018396 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ-CVDTKL 307 (356)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 307 (356)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. .+....
T Consensus 151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~------------~~~~~~~~~~~~~~~ 215 (277)
T cd05607 151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK------------VAKEELKRRTLEDEV 215 (277)
T ss_pred ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch------------hhHHHHHHHhhcccc
Confidence 13346899999999999888999999999999999999999999643211 01111111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 308 GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. .....++.++.+++.+||+.||++||+++|+++
T Consensus 216 ~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 216 K-FEHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred c-cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 1 111245678999999999999999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=322.65 Aligned_cols=240 Identities=22% Similarity=0.293 Sum_probs=196.9
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
+|++.+.||+|+||.||+|... +++.||+|++.+... ....+..|..++..+ +|++|+++++.+.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999977 688999999875321 223456677777777 5799999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCc
Confidence 99999999999876542 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .....
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---------------~~~~~ 211 (323)
T cd05616 149 KENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------------DELFQ 211 (323)
T ss_pred eecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---------------HHHHH
Confidence 75432221 12455789999999999999999999999999999999999999964421 11112
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 337 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 337 (356)
.+.... ..++...+.++.+++.+||+.+|.+|++.
T Consensus 212 ~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 212 SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 222211 23445567889999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=320.43 Aligned_cols=240 Identities=22% Similarity=0.306 Sum_probs=193.8
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHh-ccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|... +++.||+|++.... ...+.+..|..++.. ++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 78899999986532 223345566666665 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQSSGR---------FDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 999999876432 888999999999999999999999 99999999999999999999999999875433
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----------------~~~~~~i~~ 210 (316)
T cd05592 149 GEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----------------DELFDSILN 210 (316)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHc
Confidence 221 12455789999999999999999999999999999999999999964421 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVLK 342 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell~ 342 (356)
.....+..++.++.+++.+||+.+|.+||++. ++++
T Consensus 211 -~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 211 -DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12234455677889999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=315.11 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=209.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCC--EEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 139 (356)
++|++.+.||+|+||.||+|..+ ++. .+++|.+..... ..+.+.+|+.++.++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 67999999999999999999875 333 478888764322 235688999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 140 YEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
+||+++++|.+++........ ......+++..++.++.|++.||+|||+++ ++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999976432110 011134889999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 291 (356)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~------------ 223 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT------------ 223 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------------
Confidence 9999999864322111 111223557999999988889999999999999999997 999996432
Q ss_pred ccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.......+........+..++..+.+|+.+||+.+|.+|||+.++++.|..+++..
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 224 ----CAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 12222223333333444556788999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.70 Aligned_cols=245 Identities=22% Similarity=0.325 Sum_probs=197.2
Q ss_pred eeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
||+|+||+||++..+ +++.||+|.+...... .+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 7899999998653222 24567899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (356)
.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 81 RYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred HHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 9887543211 123889999999999999999999999 99999999999999999999999999876543322
Q ss_pred cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh-HhhcccC
Q 018396 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK-QCVDTKL 307 (356)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 307 (356)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... .....
T Consensus 153 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~------------~~~~~~~~~~~~-- 216 (280)
T cd05608 153 K--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV------------ENKELKQRILND-- 216 (280)
T ss_pred c--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch------------hHHHHHHhhccc--
Confidence 1 234568999999999999999999999999999999999999996442110 001111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 308 GGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
....+..++..+.+++.+||+.||++|| +++++++
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 217 SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1233455678899999999999999999 6777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=312.73 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=208.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|.+.+.||+|++|.||+|.+. .+..|++|.+...... ...+.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467899999999999999999965 3567899988654332 35688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC---cee
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAK 213 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vk 213 (356)
+++|||+++++|.+++........ ....+++..++.++.||+.||+|||+++ ++|+||||+||+++.++ .++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 999999999999999976543211 1124889999999999999999999999 99999999999998765 699
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
|+|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~------------ 227 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------------ 227 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------
Confidence 999999886633222111122233568999999998899999999999999999997 9999964321
Q ss_pred cCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
......+........+..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 228 ----~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 228 ----QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2223333333333445566788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=308.74 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=206.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
++|.+.+.||+|++|.||.|... +++.+|+|.+...... ...+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999976 7899999988643221 2457889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
++||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 82 v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA---------LTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred EEEECCCCcHHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999976532 788899999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccccc-ccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++........... .....++..|+|||++.+..++.++||||||+++|+|++|+.||..... ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------------~~ 214 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---------------MA 214 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---------------HH
Confidence 9876543221110 1234578899999999998899999999999999999999999964311 11
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..............+..++..+.++|.+||..+|.+|||+.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 215 AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1222222223334555677889999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=320.31 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=194.6
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHh-ccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|+.. +++.||+|++.... ........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999977 68899999986532 223456677777776 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 81 GDLMFHIQSCHK---------FDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 999999976432 788999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----------------~~~~~~i~~ 210 (316)
T cd05619 149 GDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----------------EELFQSIRM 210 (316)
T ss_pred CCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHh
Confidence 111 12345689999999999999999999999999999999999999964321 111221211
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVLK 342 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell~ 342 (356)
. ....+...+.++.+++.+||+.+|.+||++. ++++
T Consensus 211 ~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 211 D-NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred C-CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1 1123445667899999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=331.05 Aligned_cols=248 Identities=21% Similarity=0.229 Sum_probs=198.2
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999976 789999999875322 23467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIRMGI---------FPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 9999999999976432 788899999999999999999999 9999999999999999999999999975
Q ss_pred CCccccc---------------------------------------------cccccccccCcCccCcccccCCCCCccc
Q 018396 222 QAPDAAA---------------------------------------------RLHSTRVLGTFGYHAPEYAMTGQMSSKS 256 (356)
Q Consensus 222 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 256 (356)
....... ........||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 3211000 0001234689999999999999999999
Q ss_pred hhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhccc--CCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 018396 257 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADFR 334 (356)
Q Consensus 257 DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~R 334 (356)
|||||||++|+|++|+.||....+. .....++... .........++++.++|.+++ .+|.+|
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPL---------------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHH---------------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence 9999999999999999999654221 1111222111 111122345678888888876 599999
Q ss_pred CC---HHHHHH
Q 018396 335 PN---MGIVLK 342 (356)
Q Consensus 335 ps---~~ell~ 342 (356)
++ +.+++.
T Consensus 294 ~~~~~~~ei~~ 304 (382)
T cd05625 294 LGKNGADEIKA 304 (382)
T ss_pred CCCCCHHHHhc
Confidence 97 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=322.25 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=194.2
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|..+ +++.||+|++.+... ....+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999977 788999999875421 234567788888776 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|..++..... +++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 81 GDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 999998865432 889999999999999999999999 99999999999999999999999999875332
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......+...+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------~~~~~~~~~~~i~~ 219 (329)
T cd05618 149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLFQVILE 219 (329)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc-------ccccHHHHHHHHhc
Confidence 211 123457899999999999999999999999999999999999999643211100 00111111121111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 337 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 337 (356)
.....+...+..+.++|.+||+.||.+||++
T Consensus 220 -~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 -KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1223455667789999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=311.64 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=213.3
Q ss_pred hCCCCCCceeeccCceEEEEEEECC-----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEec-CCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD-GPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~ 136 (356)
.++|++.+.||+|+||.||+|.+.. +..|++|.+...... .+.+.+|+.+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4679999999999999999999764 688999988654322 4567889999999999999999998765 5778
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
+++++|+.+++|.+++........ .....+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEA-NNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred EEEEEcCCCCcHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 999999999999999976543211 11234889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||+++...............++..|+|||++.+..++.++||||||+++|++++ |..||....+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------------- 225 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------------- 225 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---------------
Confidence 999976543322211223345778999999998889999999999999999999 9999964421
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
..+...+........+..+++++.+++.+||+.+|++|||+.++++.|..+...
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 226 -FEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 122222222222233345677899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=337.10 Aligned_cols=270 Identities=20% Similarity=0.276 Sum_probs=198.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecC--------C
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG--------P 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--------~ 134 (356)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 3467999999999999999999976 78999999886433 2345799999999999999998876432 2
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-cee
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAK 213 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vk 213 (356)
.+++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCcee
Confidence 46789999986 787777543211 123889999999999999999999999 99999999999999665 799
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
|+|||+|......... ....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...............
T Consensus 212 L~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 212 LCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred eeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999865433221 34568999999998876 4689999999999999999999999976543211100000000
Q ss_pred cCChhhHhHh------------hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 018396 293 KLSEDKVKQC------------VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 293 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~ 348 (356)
....+.+... ....+...++...+.++.+||.+||++||.+|||+.++++ .++.+.
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0011100000 0000001122334678999999999999999999999996 455543
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=316.60 Aligned_cols=268 Identities=24% Similarity=0.384 Sum_probs=212.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEec
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~ 132 (356)
..++|.+.+.||+|+||.||+|... ....+|+|.+...... ...+.+|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467889999999999999999742 2457999988754332 34678899999999 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEE
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (356)
.+..++++||+++++|.+++....... .......+++..+..++.|++.||.|||++| ++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999999997653211 0111234889999999999999999999999 999999999999
Q ss_pred EccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~ 284 (356)
+++++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~----- 241 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP----- 241 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-----
Confidence 99999999999999976643322111122234567999999998889999999999999999999 889985432
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.......+........+..++.++.+++.+||+.+|.+|||+.++++.|+++...
T Consensus 242 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 242 -----------VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -----------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 2222333333333344556677899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.75 Aligned_cols=267 Identities=25% Similarity=0.404 Sum_probs=238.5
Q ss_pred HHHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
++|.....+.....+||-|.||.||.|.|+ -.-.||||.++.+....++|+.|+.+|+.++|||+|+++++|.....+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 566666667777889999999999999988 5678999999988888899999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
||+|||..|+|.+||.+..... ++....+.++.||..|++||..++ +|||||...|.||.++..||++||
T Consensus 340 IiTEfM~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred EEEecccCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeecc
Confidence 9999999999999998876533 566677889999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|+++......++.+ ....-...|.|||.+....++.++|||+|||+|||+.| |-.||- -+..
T Consensus 410 GLsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP----------------Gidl 472 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP----------------GIDL 472 (1157)
T ss_pred chhhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC----------------CccH
Confidence 99988766554322 22223568999999999999999999999999999998 888983 5567
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
..+..+++.+++++.|..|++.++.||..||+.+|.+||++.|+-+.|+.+....+
T Consensus 473 SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 473 SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 78899999999999999999999999999999999999999999999999887654
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=307.98 Aligned_cols=250 Identities=29% Similarity=0.455 Sum_probs=206.0
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEe-cCCeeEEEEEec
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVLAYEHA 143 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~ 143 (356)
.++|++.+.||+|+||.||++... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. .++..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 457999999999999999999876 7789999886543 3457889999999999999999999754 566789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++..... ..+++..++.++.|++.||+|||++| ++|+||||+||++++++.++|+|||++...
T Consensus 83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 83 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceec
Confidence 99999999976542 12788999999999999999999999 999999999999999999999999998654
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
.... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.... .......
T Consensus 153 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----------------~~~~~~~ 211 (256)
T cd05082 153 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----------------LKDVVPR 211 (256)
T ss_pred cccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----------------HHHHHHH
Confidence 3321 22334668999999998889999999999999999997 999985331 1222222
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
+........+..++..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 333333344456678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=313.58 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=209.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
..++|++.+.||+|+||.||+|..+ .+..||+|.+...... ...+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568999999999999999999753 2458999988654432 3457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKG-AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.+++|||+.+|+|.+++........ ....+...+..+..++.|++.||.|||+++ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999976432111 111233677888999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-------------- 226 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------------- 226 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------------
Confidence 99999876543222211222345678999999998889999999999999999998 788986432
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
.+.....+........+..++..+.+++.+||+.+|.+|||+.++++.|++.+.
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 227 --NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred --HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 122222222111122334456789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=320.08 Aligned_cols=239 Identities=23% Similarity=0.316 Sum_probs=194.2
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|..+ +++.||+|.+.... .....+..|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999987 78999999986532 2234566777777754 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... +++..+..++.|++.||+|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 81 GDLMFHIQDKGR---------FDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 999999876432 788999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~----------------~~~~~~~~~ 210 (316)
T cd05620 149 GDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----------------DELFESIRV 210 (316)
T ss_pred CCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHh
Confidence 111 12445789999999999999999999999999999999999999964321 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVL 341 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell 341 (356)
. ....+...+.++.++|.+||+.||.+||++. +++
T Consensus 211 ~-~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 211 D-TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C-CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 1233444667899999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=308.96 Aligned_cols=255 Identities=22% Similarity=0.408 Sum_probs=210.1
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||++...++..+++|.+.........+.+|+.+++.++|+||+++.+.+.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 46899999999999999999997777789999987665556778899999999999999999999887 77899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 84 KGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CCcHHHHHHhCCcc-------ccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999764321 2788889999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... ......++..|+|||++.+..++.++|+||||+++|++++ |..||.... .......+
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----------------~~~~~~~~ 216 (260)
T cd05073 154 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----------------NPEVIRAL 216 (260)
T ss_pred CCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC----------------HHHHHHHH
Confidence 32221 1122345678999999998889999999999999999998 999996432 12222222
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
........+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 217 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 33333334445667899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=308.11 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=205.8
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
+|++.+.||.|+||.||++.+. +++.+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+++..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5888999999999999999977 78999999885432 23466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++...... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++...
T Consensus 81 ~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 81 DGGDLMQKIKLQRGK-------LFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred CCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceee
Confidence 999999998754321 2788999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
...... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ......+
T Consensus 151 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----------------~~~~~~~ 212 (255)
T cd08219 151 TSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----------------KNLILKV 212 (255)
T ss_pred cccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----------------HHHHHHH
Confidence 432211 2345688999999999988899999999999999999999999964321 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
........+..++..+.++|.+||+.||.+|||+.+++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 213 CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1222223445567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=312.69 Aligned_cols=262 Identities=23% Similarity=0.372 Sum_probs=208.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|...+.||+|+||.||++... ++..+++|.+...... .+.+.+|+++++.++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888999999999999999742 3568899988654332 457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCC------CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 138 LAYEHASKGSLHDILHGKKGV------KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
+++||+++++|.+++...... ........+++..++.++.|++.||+|||+++ ++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 999999999999999764321 01111234789999999999999999999999 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 290 (356)
++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |.+||....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----------- 229 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS----------- 229 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-----------
Confidence 99999999875433222111123345778999999999999999999999999999998 999985332
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
.......+........+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 230 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 230 -----NTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11122222222222334456778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=320.18 Aligned_cols=240 Identities=21% Similarity=0.299 Sum_probs=196.9
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|..+ +++.||+|++.+.. .....+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999977 68899999987532 2234567888888887 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... +++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 81 GDLMFHIQRSGR---------FDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 999999876532 889999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......|++.|+|||++.+..++.++|||||||++|+|++|..||..... ......+..
T Consensus 149 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----------------~~~~~~i~~ 210 (318)
T cd05570 149 GGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----------------DELFQSILE 210 (318)
T ss_pred CCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----------------HHHHHHHHc
Confidence 211 12345689999999999999999999999999999999999999964321 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 342 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~ 342 (356)
. ....+...+..+.+||.+||+.||.+|||+ .++++
T Consensus 211 ~-~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 211 D-EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred C-CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1 113344567789999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=310.30 Aligned_cols=259 Identities=19% Similarity=0.324 Sum_probs=209.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||.|+||.||+|... +++.++||.+..... ....+.+|+.+++.++||||+++++++.+++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57889999999999999999975 889999998865322 2356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++...... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence 999999999998743211 123789999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
......... .....++..|+|||++.+..++.++|+||||+++|+|++|..||...... .....
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------~~~~~ 217 (267)
T cd08229 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--------------LYSLC 217 (267)
T ss_pred hccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--------------HHHHh
Confidence 765433221 13346889999999999888999999999999999999999999643211 01111
Q ss_pred Hhhcc-cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 301 QCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 301 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
..+.. ......+..++..+.+++.+||+.+|.+|||+.+|++.++++-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 218 KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111 1111122356778999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=306.02 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=206.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|++.+.||+|++|.||+|..+ +++.|++|.+.... .....+.+|+++++.++||||+++++++.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999976 78999999986432 2346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 81 AENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred CCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccccee
Confidence 999999999976432 13889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
....... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ......
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~ 212 (256)
T cd08529 151 LSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----------------GALILK 212 (256)
T ss_pred ccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 5543221 2344688999999999988899999999999999999999999964421 111111
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
+........+..++..+.+++.+||+.+|++||++.++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 213 IIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 12222223444567889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.18 Aligned_cols=255 Identities=18% Similarity=0.243 Sum_probs=203.4
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCC
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 134 (356)
++....++|++.+.||+|+||.||+|.++ +++.+|+|++.... .....+.+|+.+++.++||||+++++.+.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445689999999999999999999987 78999999986422 22345678999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..++||||+++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999997543 788889999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCC----CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 184 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------- 252 (371)
T cd05622 184 ADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---------- 252 (371)
T ss_pred EeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----------
Confidence 999998765432211 123457999999999987543 78899999999999999999999975421
Q ss_pred cccCChhhHhHhhcccCCCC--CCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018396 291 TPKLSEDKVKQCVDTKLGGE--YPPKAIAKMAAVAALCVQYEADF--RPNMGIVLKA 343 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~ 343 (356)
......+........ .....+..+.++|.+||..++.+ |++++++++.
T Consensus 253 -----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 253 -----VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -----HHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111222222111111 22346778999999999844433 7799988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=306.57 Aligned_cols=245 Identities=29% Similarity=0.453 Sum_probs=200.5
Q ss_pred eeeccCceEEEEEEEC---CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
.||+|+||.||+|.++ ++..+|+|++...... .+.+.+|+.+++.++||||+++++++. .+..+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999743 5789999998654332 356888999999999999999999875 45678999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
+|.+++..... +++..+..++.|++.||+|||+++ ++|+||||.||+++.++.++|+|||++......
T Consensus 81 ~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKNKH---------VTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999975432 789999999999999999999999 999999999999999999999999998765443
Q ss_pred cccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 227 AARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 227 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.... .......+.
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----------------~~~~~~~i~ 212 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK----------------GNEVTQMIE 212 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----------------HHHHHHHHH
Confidence 2211 1122234678999999988889999999999999999998 999996432 222333344
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.......+..++.++.++|.+||+.||++||++.+|.+.|+.
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 433344556678899999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=313.40 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=202.9
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.|+..+.||+|+||.||++... +++.||+|.+...... ...+.+|+.++++++|++++.+++.+.+.+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4778899999999999999977 7899999998654322 2356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~g~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 81 LMNGGDLKFHIYHMGEA-------GFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeecccee
Confidence 99999999998654321 2888999999999999999999999 9999999999999999999999999986
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... .....|+..|+|||++.+..++.++||||+|+++|+|++|..||...... ...+....
T Consensus 151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~------------~~~~~~~~ 215 (285)
T cd05630 151 HVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK------------IKREEVER 215 (285)
T ss_pred ecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc------------chHHHHHh
Confidence 5433221 12346899999999999989999999999999999999999999754211 01111111
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 342 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~ 342 (356)
... ......+..++.++.+|+.+||+.||.+||| ++++++
T Consensus 216 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 216 LVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111 1112234456678999999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=305.69 Aligned_cols=248 Identities=27% Similarity=0.414 Sum_probs=202.1
Q ss_pred ceeeccCceEEEEEEEC-C---CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|.+. . +..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999854 2 37899999876654 3567889999999999999999999875 5568999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... +++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKRRE---------IPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 999999976542 889999999999999999999999 99999999999999999999999999876643
Q ss_pred cccccc-ccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 226 AAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 226 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ...+...+
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~----------------~~~~~~~~ 211 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK----------------GAEVIAML 211 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC----------------HHHHHHHH
Confidence 322110 111223467999999998899999999999999999998 999996432 12222333
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
........+..++..+.++|.+||+.+|.+|||+.++++.|+++-
T Consensus 212 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 212 ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 333333445566778999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=306.02 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=209.9
Q ss_pred ceeeccCceEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|... . +..+++|.+...... .+.+.+|+++++.++|+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999976 3 889999999765544 46788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..............+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987632111111123899999999999999999999999 99999999999999999999999999987665
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ...+...+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----------------~~~~~~~~~ 221 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----------------NEEVLEYLR 221 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----------------HHHHHHHHH
Confidence 432222344567889999999988889999999999999999999 699996542 122223333
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
.......+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 23334555666889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=323.95 Aligned_cols=237 Identities=22% Similarity=0.310 Sum_probs=195.1
Q ss_pred ceeeccCceEEEEEEE----CCCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 72 SLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
+.||+|+||.||++.. .+++.||+|++..... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 2688999999875322 23456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||++++++.++|+|||++....
T Consensus 82 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 82 GGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 999999996543 2889999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+..
T Consensus 150 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---------------~~~~~~i~~ 212 (318)
T cd05582 150 DHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---------------KETMTMILK 212 (318)
T ss_pred CCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---------------HHHHHHHHc
Confidence 33211 2345789999999999988899999999999999999999999964321 111111211
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGI 339 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e 339 (356)
.. ...+...+..+.++|.+||+.||.+||++.+
T Consensus 213 ~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 AK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 2344556778999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=321.84 Aligned_cols=238 Identities=20% Similarity=0.268 Sum_probs=191.6
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHH-HHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQV-SMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|++. +++.||+|++.... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999987 67899999986532 1123344444 357888999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... +.+..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 81 GELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 999999976432 778888999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+...
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------~~~~~~i~~~ 211 (325)
T cd05602 149 HNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---------------AEMYDNILNK 211 (325)
T ss_pred CCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---------------HHHHHHHHhC
Confidence 221 12455799999999999999999999999999999999999999964321 1111222221
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIV 340 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~el 340 (356)
. ...+...+..+.+++.+||+.+|.+||++.+.
T Consensus 212 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 212 P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred C--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 1 12334567789999999999999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=320.59 Aligned_cols=236 Identities=22% Similarity=0.312 Sum_probs=191.0
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHH-HHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||+||+|... +++.||+|++.... .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999987 79999999986432 12234445544 56789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 81 GELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 999999876432 788999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+...
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---------------~~~~~~i~~~ 211 (323)
T cd05575 149 HSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---------------AEMYDNILNK 211 (323)
T ss_pred CCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---------------HHHHHHHHcC
Confidence 221 12445689999999999999999999999999999999999999964321 1111122221
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 338 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 338 (356)
.. ..+...+..+.++|.+||+.||.+||++.
T Consensus 212 ~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 212 PL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 22334577899999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=310.61 Aligned_cols=271 Identities=23% Similarity=0.319 Sum_probs=205.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-----CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEec--CCeeE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRV 137 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 137 (356)
.+|++.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57889999999999999999742 5789999998754432 4568899999999999999999997653 45689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+++||+++++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||++++++.++|+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence 99999999999999975432 2789999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..|+......-..............
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence 9988664332211 111122345699999999888999999999999999999988776433211000000000000111
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
..+.+.+........+..++.++.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 122223333322233445677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=304.91 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=200.7
Q ss_pred eeeccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018396 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 147 (356)
.||+|+||.||+|.+. .+..||+|++...... .+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 3557999998754332 356889999999999999999999875 457899999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccc
Q 018396 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (356)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (356)
|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 81 LNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred HHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 9999875432 2889999999999999999999999 9999999999999999999999999987554322
Q ss_pred cccc-ccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 228 ARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 228 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
.... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.... .......+..
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----------------~~~~~~~~~~ 213 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK----------------GPEVMSFIEQ 213 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC----------------HHHHHHHHHC
Confidence 2111 111223578999999988889999999999999999996 999996432 2233344444
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
......+..+++++.++|.+||+.+|++||++.+|++.|+.+
T Consensus 214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 444455666788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=333.22 Aligned_cols=269 Identities=17% Similarity=0.251 Sum_probs=196.9
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC------CceeeeeeEEecC
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN------ENVVELVGYYVDG 133 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------p~iv~~~~~~~~~ 133 (356)
+....++|++.+.||+|+||+||+|.+. +++.||||++............|+.+++.++| .+++++++++...
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3344678999999999999999999976 68899999996544444456678888777755 4588899888754
Q ss_pred -CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCC-
Q 018396 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDD- 210 (356)
Q Consensus 134 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~- 210 (356)
..+++||+++ +++|.+++.... .+++..+..++.||+.||.|||+ .| ||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDT 270 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCc
Confidence 5788999888 668998887543 28899999999999999999998 48 99999999999998765
Q ss_pred ---------------ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCC
Q 018396 211 ---------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275 (356)
Q Consensus 211 ---------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf 275 (356)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4999999987543321 24567999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccceecccccCCh--------hhHhHhhccc--CCC-------------CC--CHHHHHHHHHHHHHhhccC
Q 018396 276 DHTLPRGQQSLVTWATPKLSE--------DKVKQCVDTK--LGG-------------EY--PPKAIAKMAAVAALCVQYE 330 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~--~~~-------------~~--~~~~~~~l~~li~~cl~~~ 330 (356)
...........+......+.. .....+.... +.. .. .......+.+||.+||++|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 765432111110000000000 0000000000 000 00 0011356789999999999
Q ss_pred CCCCCCHHHHHH--HHHHh
Q 018396 331 ADFRPNMGIVLK--ALQPL 347 (356)
Q Consensus 331 P~~Rps~~ell~--~L~~l 347 (356)
|.+|||++|+++ .|.+.
T Consensus 426 P~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 426 RQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hhhCCCHHHHhcCcccccc
Confidence 999999999997 45443
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=323.39 Aligned_cols=262 Identities=22% Similarity=0.251 Sum_probs=198.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCC-----
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----- 134 (356)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999976 789999999865422 2456788999999999999999999886443
Q ss_pred -eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 135 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
..+++|||+.+ +|.+.+... +++..+..++.|++.||.|||++| |+||||||+|||++.++.+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence 57999999976 677766421 778889999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus 164 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 240 (359)
T cd07876 164 ILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240 (359)
T ss_pred EecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999876433221 23456899999999999999999999999999999999999999765321110000000000
Q ss_pred CCh-------hhHhHhhccc--CC----------------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 294 LSE-------DKVKQCVDTK--LG----------------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 294 ~~~-------~~~~~~~~~~--~~----------------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
... .......... .. .......+..+.+||.+||+.||++|||+.|++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0000000000 00 01111235678999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.32 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=206.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
++|++.+.||+|+||.||+|... + +..+|+|.+...... .+.+.+|+.+++.++||||+++++++.+++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999864 2 337999998754332 35688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|.+++..... .+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCc
Confidence 999999999999976432 2788999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChh
Q 018396 220 SNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 220 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
+.......... ......++..|+|||++.+..++.++|+||||+++|++++ |..||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---------------- 216 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---------------- 216 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----------------
Confidence 87664432111 1111223568999999998889999999999999999886 99999644211
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
.....+........+..++..+.+++.+||+.+|.+||++.++++.|++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 217 DVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 111112222222333456778999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=318.37 Aligned_cols=240 Identities=21% Similarity=0.294 Sum_probs=196.9
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 140 (356)
+|+..+.||+|+||.||+|..+ +++.||+|++.... ...+.+..|..++..+. |++|+++++.+.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999977 78999999986532 22345677888888885 577888999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++|+|.+++..... +++..++.++.|++.||.|||++| ++||||||+|||++.++.++|+|||++
T Consensus 81 Ey~~~g~L~~~i~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK---------FKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccc
Confidence 99999999999876432 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---------------~~~~~ 211 (323)
T cd05615 149 KEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---------------DELFQ 211 (323)
T ss_pred cccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---------------HHHHH
Confidence 75432221 12345689999999999999999999999999999999999999964421 11122
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 337 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 337 (356)
.+.... ..++...+.++.+++.+||+.+|.+|++.
T Consensus 212 ~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 212 SIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 222211 23455567789999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=311.49 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=208.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||.||+|... ++..||+|.+...... ...+.+|+.+++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999853 4678999998754332 35688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCC-------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCc
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKG-------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~-------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~N 203 (356)
++++||+++++|.+++........ ......+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999975432110 011234788999999999999999999999 9999999999
Q ss_pred EEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCC
Q 018396 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (356)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (356)
|++++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--- 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--- 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 9999999999999999875433221111122334667999999998899999999999999999997 888885331
Q ss_pred CccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.......+........+..++.++.++|.+||+.+|.+|||+.|+++.|++
T Consensus 238 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 -------------HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 112222222222222344567789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=317.44 Aligned_cols=270 Identities=24% Similarity=0.380 Sum_probs=214.5
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEE
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYY 130 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~ 130 (356)
.....+|.+.+.||+|+||.||+|... .+..||+|.+...... .+.+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 334467999999999999999999852 1236899988754322 35788999999999 899999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCc
Q 018396 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (356)
Q Consensus 131 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~N 203 (356)
...+..++++||+++++|.+++........ ..+...+.+..+..++.|++.||.|||++| ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 999999999999999999999976432110 112334788999999999999999999999 9999999999
Q ss_pred EEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCC
Q 018396 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (356)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (356)
|+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---- 240 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---- 240 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC----
Confidence 9999999999999999876543322211222334567999999999999999999999999999998 88998543
Q ss_pred CccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
........+........+..++.++.+++.+||+.+|.+|||+.++++.|++++..
T Consensus 241 ------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 241 ------------PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ------------CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 12223333333333344556677899999999999999999999999999998843
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=325.79 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=198.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|..+ +++.||+|++... ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999977 7899999998642 222356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++|+|.+++..... +++..+..++.|++.||.|||++| |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT---------LSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred eCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCC
Confidence 99999999999976532 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc---------------------------------ccccccccCcCccCcccccCCCCCccchhhhHHHHHHH
Q 018396 221 NQAPDAAAR---------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 267 (356)
Q Consensus 221 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~ 267 (356)
......... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 654321100 00123469999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCH--HHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 018396 268 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP--KAIAKMAAVAALCVQYEADFRPN---MGIVLK 342 (356)
Q Consensus 268 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~P~~Rps---~~ell~ 342 (356)
|++|..||....+. .....+.........+. ..+.++.++|.+++ .+|.+|++ +.++++
T Consensus 229 l~tG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 229 MLIGYPPFCSETPQ---------------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred cccCCCCCCCCCHH---------------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 99999999754321 11111221111111121 24568889999877 49999985 566655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.76 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=206.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
...+|++.+.||+|+||.||+|... +++.+++|.+...... .+.+.+|+.+++.++|||++++++.+..+...++|+|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 4468999999999999999999976 7899999998764433 4668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|.+++.... +++.++..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.
T Consensus 98 ~~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 98 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred ccCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999986543 788899999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ .....+++.|+|||.+.+..++.++|||||||++|+|++|..||....+... ...
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---------------~~~ 227 (296)
T cd06654 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---------------LYL 227 (296)
T ss_pred hccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---------------HHH
Confidence 65432211 1334688999999999988889999999999999999999999965432110 000
Q ss_pred h-hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 C-VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. .........+...+..+.++|.+||..+|++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 0111111223456678999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=309.65 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=202.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecC------Ce
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDG------PL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~------~~ 135 (356)
..+.|++.+.||+|+||.||+|... +++.||+|.+.........+.+|+.+++++ +|+||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 3467888999999999999999976 789999999977666667788999999998 799999999998753 46
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++++||+.+++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEc
Confidence 89999999999999999864322 2789999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
|||++........ ......|++.|+|||++. +..++.++|||||||++|+|++|..||....+..
T Consensus 154 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------- 223 (272)
T cd06637 154 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------- 223 (272)
T ss_pred cCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--------
Confidence 9999876543221 124456899999999986 3457889999999999999999999996432111
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.................++.++.+|+.+||..+|.+|||+.++++
T Consensus 224 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 -------ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -------HHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111111111111222345668999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=306.87 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=207.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCC---EEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
++|+..+.||+|+||.||+|..+ ++. .+++|.+...... .+.+.+|+++++.++|||++++.+++.+.+..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46888899999999999999975 333 7999998754322 45688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 85 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 85 TEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence 999999999999975432 2788999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccccc-ccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChh
Q 018396 220 SNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 220 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
+........... ......+..|+|||++.+..++.++|||||||++|+|++ |..||.... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~----------------~~ 217 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS----------------NH 217 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC----------------HH
Confidence 876543221111 111223457999999998889999999999999999997 999995432 12
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
.....+........+..++..+.+++.+||+.+|.+||++.++++.|++++
T Consensus 218 ~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 218 EVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 222222222222334456678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=308.96 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=206.2
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CC---CEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.+|++.+.||+|+||.||+|..+ ++ ..||+|.+...... ...+..|+.+++.++||||+++++++.++...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46888999999999999999965 33 36999998754322 45788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
+||+.+++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred EecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcc
Confidence 999999999999976432 2789999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccc-cccc--cCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCC
Q 018396 220 SNQAPDAAARLHS-TRVL--GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 220 a~~~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
+............ .... .+..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------------- 217 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------------- 217 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---------------
Confidence 8765432211100 1111 2457999999998899999999999999999886 9999964321
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
......+........+..++..+.+++.+||+.+|.+||++.+++..|+.++
T Consensus 218 -~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 218 -QDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred -HHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 1222222222223334556778999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=326.45 Aligned_cols=262 Identities=24% Similarity=0.315 Sum_probs=199.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCC-----eeE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 137 (356)
+|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5888999999999999999976 799999999865322 2356789999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+|+||+.+ +|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred EEeecccc-CHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccc
Confidence 99999974 8888876543 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++......... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....+......+.........
T Consensus 148 g~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 148 GLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred cceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 998765432211 11334578999999998874 4789999999999999999999999765432211111000000001
Q ss_pred hhH-------hHhh-cccCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKV-------KQCV-DTKLGG-------EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~-------~~~~-~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+.+ ...+ ...... ......++++.+||.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 110 0011 000000 111233678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=302.47 Aligned_cols=247 Identities=27% Similarity=0.473 Sum_probs=203.1
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHH
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 149 (356)
+.||.|+||.||+|...+++.|++|.+...... ...+.+|++++++++|+||+++++++.+....++++||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999776899999988765433 457889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccccc
Q 018396 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (356)
Q Consensus 150 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (356)
+++..... .+++..+..++.+++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 99965432 2788899999999999999999999 999999999999999999999999998765432221
Q ss_pred ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCC
Q 018396 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (356)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (356)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ......+.....
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----------------~~~~~~~~~~~~ 213 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----------------QQTRERIESGYR 213 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----------------HHHHHHHhcCCC
Confidence 11122234567999999988889999999999999999998 8889864421 222223333223
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 309 GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
...+...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3344556778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=317.91 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=194.9
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++.++ +||||+.+++.+.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 788999999975422 234577888988888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... +++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 81 GDLMFHMQRQRK---------LPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 999998875432 899999999999999999999999 99999999999999999999999999875322
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .........+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~---------~~~~~~~~~~~~ 217 (327)
T cd05617 149 PGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM---------NTEDYLFQVILE 217 (327)
T ss_pred CCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc---------ccHHHHHHHHHh
Confidence 111 123457999999999999999999999999999999999999999643221110 011111222111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 338 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 338 (356)
.....+...+..+.+++.+||+.||.+|+++.
T Consensus 218 -~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 218 -KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11234455667889999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=304.24 Aligned_cols=251 Identities=24% Similarity=0.447 Sum_probs=206.3
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
.+|++.+.||.|+||.||+|.+.++..+|+|.+.........+.+|++++++++|||++++++++......++++||+.+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46888899999999999999987778999999987666667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... .+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 84 GCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999875432 2788999999999999999999999 99999999999999999999999999875543
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+.
T Consensus 153 ~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----------------~~~~~~~~ 215 (256)
T cd05112 153 DQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----------------SEVVETIN 215 (256)
T ss_pred Cccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----------------HHHHHHHh
Confidence 2211 1122234678999999998889999999999999999998 9999964321 11111121
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.......+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 216 AGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1111122233467899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.10 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=202.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457999999999999999999976 788999999875433 245678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 88 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 99999999986543 2789999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
....... .....+++.|+|||.+. ...++.++|+||+||++|+|++|..||....+....... ........
T Consensus 156 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~-- 229 (267)
T cd06646 156 ITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSNFQPP-- 229 (267)
T ss_pred ecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCCCCCC--
Confidence 5432211 13346889999999885 345788999999999999999999999644322111000 00000000
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
........+..+.++|.+||+.+|++|||++++++.|
T Consensus 230 --------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 --------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --------CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0011123456899999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=309.92 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=201.8
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.|+..+.||+|+||+||+|... +++.+|+|.+...... ...+.+|+++++.++|+||+.+.+.+.+++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999976 7899999998654321 2456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+++|.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 81 IMNGGDLKFHIYNMGNP-------GFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred eccCccHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcce
Confidence 99999999888654321 2899999999999999999999999 9999999999999999999999999886
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ....+..
T Consensus 151 ~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~------------~~~~~~~ 215 (285)
T cd05632 151 KIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV------------KREEVDR 215 (285)
T ss_pred ecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH------------HHHHHHH
Confidence 5433221 133468999999999998899999999999999999999999996432110 0011111
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLKA 343 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~ 343 (356)
.+.. ....++...+..+.+|+..||+.||.+||+ +.+++..
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 216 RVLE-TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred hhhc-cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1111 112334456678899999999999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=316.89 Aligned_cols=269 Identities=20% Similarity=0.332 Sum_probs=203.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.++|++.+.||+|+||.||+|+.+ +++.||+|.+..... ....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 467999999999999999999977 788999999865432 23467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+ +|.+++..... .+++..+..++.|++.||.|||++| |+||||||+||+++.++.++|+|||++.
T Consensus 85 ~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 85 YLDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 9986 88888865432 2788899999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc--------c
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT--------P 292 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------~ 292 (356)
........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+......... +
T Consensus 153 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 64332221 133457899999998865 467899999999999999999999997554321110000000 0
Q ss_pred cCChh-hHhHhhcccCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHh
Q 018396 293 KLSED-KVKQCVDTKLGG----EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPL 347 (356)
Q Consensus 293 ~~~~~-~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l 347 (356)
.+... .....-...... ......+.++.+||.+||+.||.+|||+.|+++ .++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 00000 000000000000 011235678899999999999999999999988 44443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=309.00 Aligned_cols=271 Identities=21% Similarity=0.346 Sum_probs=208.0
Q ss_pred CCCCCCceeeccCceEEEEEEE-----CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecC--Cee
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 136 (356)
+.|.+.+.||+|+||.||+|.. .++..||+|.+...... ...+.+|+.+++.++|||++++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999974 25789999998654322 35688999999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
+++|||+++++|.+++..... .+++..++.++.|++.||+|||++| ++||||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECC
Confidence 999999999999999965431 2789999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++......... .......++..|+|||++.+..++.++||||||+++|+|+++..|+......... ..........
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHGQMT 231 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hccccccccc
Confidence 9998866433221 1112345677899999998888999999999999999999987765332111000 0000001111
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
.......+........+..++..+.+|+.+||+.+|.+|||+.++++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 11122222222233334456788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.46 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=200.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|++.++||+|+||.||+|.+. +++.||+|.+...... ...+.+|+.++++++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46888999999999999999975 7899999998654322 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|..+.. +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 81 MDGGSLDVYRK-------------IPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CCCCChHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 99999965521 678889999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
..... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||......... .........
T Consensus 145 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~~~~~~~ 211 (279)
T cd06619 145 LVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---------LMPLQLLQC 211 (279)
T ss_pred ccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---------cchHHHHHH
Confidence 54322 23457899999999999889999999999999999999999999653221110 001111111
Q ss_pred hcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 303 VDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 303 ~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
+.... ........+.++.++|.+||+.+|.+||+++++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 212 IVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111 111122355678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=306.71 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=209.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCC----EEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
..+|++.+.||+|+||.||+|..+ +++ .+|+|.+...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 357889999999999999999965 333 5899988765432 3568899999999999999999999887 7889
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+++||+++|+|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+||
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~df 153 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDF 153 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCC
Confidence 99999999999999976532 2789999999999999999999998 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++................++..|+|||.+....++.++|+||||+++|++++ |..||.... .
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----------------~ 217 (279)
T cd05057 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP----------------A 217 (279)
T ss_pred cccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC----------------H
Confidence 99887653322211122223568999999988889999999999999999998 999996432 2
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
..+...+........+..++..+.+++.+||..+|.+|||+.++++.|+++.+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 218 VEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 223333333333333444567889999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=311.71 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=195.2
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhc---cCCceeeeeeEEec-----CC
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL---KNENVVELVGYYVD-----GP 134 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~hp~iv~~~~~~~~-----~~ 134 (356)
+|++.+.||+|+||.||+|..+ +++.||+|.+...... ...+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999987 7899999998753222 23566777777665 79999999998764 34
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..++++||+.+ +|.+++...... .+++..+..++.|++.||.|||++| ++||||||+||++++++.++|
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPP-------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 57999999985 899988754321 2789999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc-eeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-VTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~ 293 (356)
+|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|.+||......+.... ..... .
T Consensus 150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~ 225 (288)
T cd07863 150 ADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-L 225 (288)
T ss_pred CccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-C
Confidence 99999876543221 1334679999999999998999999999999999999999999965432211000 00000 0
Q ss_pred CChhhHhHhh---cccC-------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 LSEDKVKQCV---DTKL-------GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 ~~~~~~~~~~---~~~~-------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.......... .... .....+.++..+.++|.+||+.||++|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 0000 00111235667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=304.73 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=201.4
Q ss_pred ceeeccCceEEEEEEEC-CCC--EEEEEEcCCCC--CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|..+ ++. .+++|.+.... ...+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999976 444 46888876432 2245788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 146 GSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
++|.+++........ ......+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999976542111 011234789999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++........ ......+..|+|||++.+..++.++||||||+++|+|++ |..||..... .
T Consensus 158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----------------~ 218 (270)
T cd05047 158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----------------A 218 (270)
T ss_pred Cccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH----------------H
Confidence 9754322111 112223567999999988889999999999999999997 9999964321 1
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
.....+......+.+..++.++.+++.+||+.+|.+|||+.+++..|.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 219 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 1222222222223344556789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.92 Aligned_cols=269 Identities=23% Similarity=0.365 Sum_probs=208.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEec-C
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD-G 133 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~-~ 133 (356)
..++|++.+.||+|+||.||+|.. .+++.||||++...... ...+.+|+.++.++ +||||+++++++.. +
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346899999999999999999973 25788999999754322 34678899999999 68999999998764 4
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCC-----------------------------------------------------
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKG----------------------------------------------------- 160 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~----------------------------------------------------- 160 (356)
...+++|||+++|+|.+++........
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 567899999999999999975421000
Q ss_pred -----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccccccccccc
Q 018396 161 -----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235 (356)
Q Consensus 161 -----~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 235 (356)
......+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 000123678889999999999999999999 999999999999999999999999998765332221112233
Q ss_pred ccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHH
Q 018396 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK 314 (356)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (356)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .......+........+..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---------------DEEFCRRLKEGTRMRAPDY 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc---------------cHHHHHHHhccCCCCCCCC
Confidence 45678999999998899999999999999999997 9999854311 0111122222222233334
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 315 AIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 315 ~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.++++.+++..||+.+|.+|||+.+|++.|+.++..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 456899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=300.88 Aligned_cols=246 Identities=28% Similarity=0.452 Sum_probs=201.4
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHH
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 149 (356)
++||+|+||.||+|...++..+|+|.+...... ...+.+|+++++.++||||+++++++...+..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999878889999998754332 346789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccccc
Q 018396 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (356)
Q Consensus 150 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (356)
+++..... .+.+..++.++.|++.+|.|||++| ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 81 SFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence 99865432 2788999999999999999999999 999999999999999999999999998654332211
Q ss_pred ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCC
Q 018396 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (356)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (356)
......++..|+|||++.+..++.++||||||+++|++++ |..||..... ......+.....
T Consensus 150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----------------~~~~~~~~~~~~ 212 (250)
T cd05085 150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----------------QQAREQVEKGYR 212 (250)
T ss_pred -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----------------HHHHHHHHcCCC
Confidence 1112234667999999988889999999999999999998 9999964321 122222233333
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 309 GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
...+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3444556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=310.41 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=207.1
Q ss_pred hCCCCCCceeeccCceEEEEEEECC-----------------CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~ 125 (356)
.++|++.+.||+|+||.||+|.... +..||+|.+...... .+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999988541 245899998755432 457889999999999999999
Q ss_pred eeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCc
Q 018396 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA--KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (356)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~N 203 (356)
+++++..++..++++|++.+++|.+++......... .....+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 999999999999999999999999999765421111 11224889999999999999999999999 9999999999
Q ss_pred EEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc--CCCCCCCCCCC
Q 018396 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLPR 281 (356)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~pf~~~~~~ 281 (356)
|++++++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876544332222234456788999999988889999999999999999998 77788543211
Q ss_pred CCccceecccccCChhhHhHhh------cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 282 GQQSLVTWATPKLSEDKVKQCV------DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
..+.... ........+..++.++.+++.+||+.+|.+|||+.+|++.|.
T Consensus 241 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---------------QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---------------HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 0011110 011111223345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=322.23 Aligned_cols=262 Identities=21% Similarity=0.242 Sum_probs=199.7
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC-----
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----- 133 (356)
...++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45679999999999999999999976 7899999998754322 35677899999999999999999988643
Q ss_pred -CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 134 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
...+++|||+.+ +|.+.+... +++..+..++.|++.||.|||++| |+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 357999999976 777776532 788889999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce-ecc-
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TWA- 290 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~- 290 (356)
||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ...
T Consensus 159 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 159 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred EEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999976543321 13456899999999999999999999999999999999999999754321100000 000
Q ss_pred ------cccCChhhHhHhhccc----------------C--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 291 ------TPKLSEDKVKQCVDTK----------------L--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 291 ------~~~~~~~~~~~~~~~~----------------~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..... ..+...++.. . ........+..+.+||.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 236 TPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCCHHHHHhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 0000111000 0 001112235678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=310.49 Aligned_cols=267 Identities=23% Similarity=0.334 Sum_probs=204.8
Q ss_pred hCCCCCCceeeccCceEEEEEEECC---------------CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRS---------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELV 127 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~ 127 (356)
.++|++.+.||+|+||.||+|.... ...||+|.+...... ...+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3689999999999999999987542 235899998754322 35688999999999999999999
Q ss_pred eEEecCCeeEEEEEecCCCCHHHHHhcCCCCC---CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcE
Q 018396 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (356)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (356)
+++...+..++||||+.+++|.+++....... .......+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999996543211 1111223788899999999999999999999 99999999999
Q ss_pred EEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc--CCCCCCCCCCCC
Q 018396 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLPRG 282 (356)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~pf~~~~~~~ 282 (356)
++++++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999876543322212233345778999999998889999999999999999988 667875432110
Q ss_pred CccceecccccCChhhHhHhh---cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 283 QQSLVTWATPKLSEDKVKQCV---DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.. ....... ........+...+..+.+|+.+||+.+|.+|||+.+|++.|.+
T Consensus 241 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VI------------ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HH------------HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 00 0000000 0111112233456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=317.52 Aligned_cols=236 Identities=21% Similarity=0.284 Sum_probs=190.4
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHH-HHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
++||+|+||.||+|+.. +++.||+|++.+.. .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999987 78999999986432 12234455544 57889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+.+..... +.+..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 81 GELFFHLQRERC---------FLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 999988865432 788899999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+...
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------~~~~~~i~~~ 211 (321)
T cd05603 149 PEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---------------SQMYDNILHK 211 (321)
T ss_pred CCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---------------HHHHHHHhcC
Confidence 221 12445689999999999998999999999999999999999999964321 0111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 338 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 338 (356)
....+...+..+.+++.+||+.+|.+||++.
T Consensus 212 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 --PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1233445667899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.91 Aligned_cols=269 Identities=20% Similarity=0.259 Sum_probs=209.4
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999977 7899999998754222 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 141 EHASKGSLHDILHGKKGVKGA--KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||++|++|.+++......... ......++..++.++.||+.||+|||++| |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999999753221111 01123567788999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccc----------------cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCC
Q 018396 219 LSNQAPDAAA----------------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (356)
Q Consensus 219 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (356)
++........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9876521100 001123569999999999999999999999999999999999999996532111
Q ss_pred CccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhccC
Q 018396 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQPLLNTR 351 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ell~~L~~l~~~~ 351 (356)
.. ....+............++.+.+++.+||+.||.+|| +++++++.|+..+...
T Consensus 239 i~--------------~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 IS--------------YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hh--------------hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00 0000000000011124567789999999999999995 6788888888877643
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=310.97 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=203.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|++++++++||||+++++.+.+++..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999976 7888999988754332 35678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
+++++|.+++..... +++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 81 MDGGSLDQVLKKAGR---------IPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcc
Confidence 999999999976532 7889999999999999999998 47 9999999999999999999999999986
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC------
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS------ 295 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------ 295 (356)
...... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||....................
T Consensus 149 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 149 QLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 553321 1345689999999999888899999999999999999999999964432111110000000000
Q ss_pred -----------hhhHhHhhcc---cCCCCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 296 -----------EDKVKQCVDT---KLGGEYP-PKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 296 -----------~~~~~~~~~~---~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
........+. ......+ ..++.++.+++.+||+.+|.+|||+.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000010100 0011111 1256789999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=309.45 Aligned_cols=269 Identities=20% Similarity=0.310 Sum_probs=205.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-----------------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeee
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-----------------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVEL 126 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~ 126 (356)
++|++.+.||+|+||.||++... ++..+|+|++..... ....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56999999999999999998632 234689999875432 23578899999999999999999
Q ss_pred eeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcE
Q 018396 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG--AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (356)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (356)
++++.+.+..+++|||+.+++|.+++........ ......+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999976542211 112234788899999999999999999999 99999999999
Q ss_pred EEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc--CCCCCCCCCCCC
Q 018396 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLPRG 282 (356)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~pf~~~~~~~ 282 (356)
+++.++.++|+|||++................++..|+|||...+..++.++|||||||++|+|++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999876543222111122334678999999888889999999999999999998 778886442211
Q ss_pred CccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.. . .................+..++..+.+|+.+||+.||.+|||+.+|++.|++
T Consensus 242 ~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VI---E------NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---H------HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0 0000000000011112234456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=319.41 Aligned_cols=237 Identities=22% Similarity=0.299 Sum_probs=191.1
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHH-HHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|... +|+.+|+|++.... .....+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999976 78999999986532 22234455554 57789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|..++..... +++..+..++.||+.||.|||++| ++||||||+|||+++++.++|+|||++.....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 81 GELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 999998875432 889999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+...
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---------------~~~~~~~~~ 211 (325)
T cd05604 149 QSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---------------EMYDNILHK 211 (325)
T ss_pred CCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---------------HHHHHHHcC
Confidence 211 124457899999999999999999999999999999999999999644211 111122221
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGI 339 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e 339 (356)
.. ...+..+..+.+++.+||+.+|.+||++.+
T Consensus 212 ~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 212 PL--VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 11 222345677899999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=309.87 Aligned_cols=263 Identities=26% Similarity=0.384 Sum_probs=206.1
Q ss_pred CHHHHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEe---
Q 018396 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV--- 131 (356)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~--- 131 (356)
..+.+....++|++.+.||+|+||.||+|... +++.+|+|++.........+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34556667889999999999999999999976 788999998876544456788999999999 6999999999874
Q ss_pred --cCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 132 --DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 132 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
.+...+++|||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~ 160 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTE 160 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCC
Confidence 456789999999999999988643211 123788999999999999999999999 9999999999999999
Q ss_pred CceeEecccccCCCccccccccccccccCcCccCcccccC-----CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018396 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (356)
+.++|+|||++........ ......|++.|+|||++.. ..++.++||||+||++|+|++|..||....+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~- 237 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA- 237 (286)
T ss_pred CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-
Confidence 9999999999876543221 1233468999999998753 4578899999999999999999999965432110
Q ss_pred cceecccccCChhhHhHhhccc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 285 SLVTWATPKLSEDKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
+....... .....+..++..+.++|.+||+.+|++|||+.++++.+
T Consensus 238 --------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 --------------LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --------------HhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000000 00011223456799999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=308.35 Aligned_cols=259 Identities=26% Similarity=0.395 Sum_probs=205.9
Q ss_pred CHHHHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEec--
Q 018396 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD-- 132 (356)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~-- 132 (356)
+..++....+.|++.+.||.|+||.||+|.+. +++.+|+|++.........+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 33444456678999999999999999999976 789999999876655556788899999998 79999999999853
Q ss_pred ----CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc
Q 018396 133 ----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (356)
Q Consensus 133 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (356)
....+++|||+.+++|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~ 156 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE 156 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 46789999999999999999765432 2778889999999999999999999 999999999999999
Q ss_pred CCceeEecccccCCCccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCC
Q 018396 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (356)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~ 283 (356)
++.++|+|||++........ ......|++.|+|||++. +..++.++|||||||++|+|++|..||....+..
T Consensus 157 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~- 233 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR- 233 (282)
T ss_pred CCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-
Confidence 99999999999876543221 123456899999999886 3467889999999999999999999996442211
Q ss_pred ccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 284 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.................++..+.++|.+||+.||.+|||+.++++
T Consensus 234 --------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 --------------ALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --------------hhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111111111111222346678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=334.22 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=229.2
Q ss_pred CCCCCceeeccCceEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
...+.++||.|.||.|++|+.+ . ...||||.++....+ ..+|+.|+.||-+++||||+.+.++........||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567889999999999999976 2 357999999876544 467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|||++|+|..||..+..+ +...+...+++.|+.|+.||.+.+ +|||||...||||+.+...|++|||++
T Consensus 710 EyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred hhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence 999999999999988753 888999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhh
Q 018396 221 NQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 221 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+.+.+..... .+..-.-...|.|||.+...+++.++||||+|+++||.++ |..||. .++..+
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW----------------dmSNQd 842 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW----------------DMSNQD 842 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc----------------ccchHH
Confidence 9876654221 1111112568999999999999999999999999999887 999995 567788
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
+...++.+++...|.+|+..|.+||..||++|-.+||.+.+|+..|++++...
T Consensus 843 VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 843 VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 89999999999999999999999999999999999999999999999988654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=318.48 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=207.6
Q ss_pred HHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 138 (356)
.+...|++++.||+||.+.||++...+.+.||+|.+.....+ ...|.+|+..|.+| .|.+|+++++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345679999999999999999999887888998877544333 46789999999999 58999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||-+. +|..+|...... .....+..+..|++.++.++|+.| |||.||||.|+|+- .|.+||+|||
T Consensus 438 vmE~Gd~-DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 438 VMECGDI-DLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred Eeecccc-cHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeec
Confidence 9999765 999999877643 333478889999999999999999 99999999999985 5789999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCC-----------CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-----------MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
.|...............+||+.||+||.+.... .+.++||||||||||+|+.|++||+...
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------- 576 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------- 576 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--------
Confidence 999887766666667789999999999885332 4578999999999999999999997541
Q ss_pred ecccccCChhhHhHhhcccCCCCCCHHHH-HHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAI-AKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....++..+.++.-..+++.--. .++.++|+.||..||.+|||+.++|+
T Consensus 577 ------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 ------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12234555555544333332111 23999999999999999999999987
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=324.36 Aligned_cols=198 Identities=26% Similarity=0.348 Sum_probs=176.6
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-C-----CceeeeeeEEecCCeeEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-N-----ENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-----p~iv~~~~~~~~~~~~~lv 139 (356)
+|++.+.||+|+||.|.+|.+. +++.||||+++....-..+...|+.+|..|+ | -|+|+++++|...++++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 5788999999999999999976 8999999999887776777788999999997 4 3899999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC--ceeEecc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDF 217 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~--~vkl~Df 217 (356)
+|.+.. +|+++++.+.-.. ++...++.++.||+.+|.+||+.+ |||+||||+||||.+.+ .|||+||
T Consensus 267 fELL~~-NLYellK~n~f~G-------lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRG-------LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 999966 9999999876433 899999999999999999999999 99999999999998644 7999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCC
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (356)
|+|+....... ...-+..|.|||++.|.+|+.+.||||||||+.||++|.+.|-+.++
T Consensus 336 GSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 336 GSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 99988765432 44568899999999999999999999999999999999988877644
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=303.55 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=207.5
Q ss_pred hCCCCCCceeeccCceEEEEEEECC----CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
.++|.+.+.||+|+||.||+|...+ ...|++|....... ..+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568889999999999999998642 34689998865442 24578899999999999999999998875 45789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
+|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 84 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCc
Confidence 9999999999999976431 2789999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .
T Consensus 153 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----------------~ 215 (270)
T cd05056 153 LSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----------------N 215 (270)
T ss_pred eeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH----------------H
Confidence 987654432111 122234568999999988889999999999999999986 9999964421 1
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.....+........+..++..+.++|.+||..+|.+|||+.++++.|+++.+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 216 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 111112222222344566778999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=320.45 Aligned_cols=262 Identities=19% Similarity=0.235 Sum_probs=197.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
...|.+.+.||+|+||.||+|.+. +++.||||.... ..+.+|++++++++|+||+++++++..++..+++|+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 457999999999999999999987 688999996432 34678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
. ++|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.++|+|||+++..
T Consensus 243 ~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 243 R-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred C-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 6 589888865432 2899999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCC-CCCCccc-------eeccc---c
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL-PRGQQSL-------VTWAT---P 292 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~-~~~~~~~-------~~~~~---~ 292 (356)
.............||+.|+|||++.+..++.++|||||||++|||++|..|+.... ....... +.... .
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43322212234569999999999999999999999999999999999876553221 1100000 00000 0
Q ss_pred cCC---hhhHhHhhc----ccCCCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 293 KLS---EDKVKQCVD----TKLGGEYP-------PKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 293 ~~~---~~~~~~~~~----~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.+. ...+..... ........ ...+..+.+||.+||+.||.+|||+.|+|+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000000000 00000000 1234578899999999999999999999873
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=320.10 Aligned_cols=262 Identities=21% Similarity=0.238 Sum_probs=198.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecC------
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------ 133 (356)
..++|++.+.||+|+||.||+|... +++.||||++..... ....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999976 789999999875422 245678899999999999999999987543
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
...++||||+.+ +|.+++... +++..+..++.|++.||.|||++| |+||||||+|||++.++.+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence 357999999976 787777532 778889999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus 167 L~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 167 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred EEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999976543221 23456899999999999999999999999999999999999999754321110000000000
Q ss_pred CChh-------hHhHhhccc------------------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 294 LSED-------KVKQCVDTK------------------LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 294 ~~~~-------~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
...+ .+....... ............+.+||.+||+.||.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000000000 0001111234578999999999999999999999883
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=320.92 Aligned_cols=262 Identities=18% Similarity=0.276 Sum_probs=200.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..+|++.+.||+|+||.||+|... .+..|++|.+... ....+|+.+++.++||||+++++++......+++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999753 4678999988653 235689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
++. ++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 167 ~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 167 KYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred hcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 996 48988884432 2899999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcc-cee---------ccc
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVT---------WAT 291 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~-~~~---------~~~ 291 (356)
...............||+.|+|||++.+..++.++|||||||++|+|++|..||.......... +.. ...
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 6654433322345679999999999999999999999999999999999999997653321000 000 000
Q ss_pred ccCChhhHhH---hhcccCCCCC--C-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 292 PKLSEDKVKQ---CVDTKLGGEY--P-----PKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 292 ~~~~~~~~~~---~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
+......+.. ......+..+ + ...+.++.++|.+||..||++|||+.+++..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0000111111 0 1234578899999999999999999999873
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=305.58 Aligned_cols=270 Identities=25% Similarity=0.383 Sum_probs=212.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEec--CCee
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 136 (356)
++|++.+.||+|+||.||+|... ++..+|+|.+...... .+.+.+|+++++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46888899999999999999853 4789999999866553 5678999999999999999999999877 6678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++++||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999999976542 2889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+............. ......
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~ 231 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMI 231 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-cccccc
Confidence 99988765322211 1112334567999999988889999999999999999999999986542211100000 001111
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
...+...+........+..++.++.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2223333333333344456678899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=309.07 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=206.6
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCC----EEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|+..+.||+|+||.||+|.+. ++. .+|+|.+...... ...+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457889999999999999999865 444 5788988654332 23678899999999999999999998754 467
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
++++|+++|+|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+||
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Df 153 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDF 153 (303)
T ss_pred eeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccc
Confidence 89999999999999876432 2788899999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++................++..|+|||++.+..++.++||||||+++|+|++ |..||.... .
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----------------~ 217 (303)
T cd05110 154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----------------T 217 (303)
T ss_pred cccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----------------H
Confidence 99986643322222223345778999999998999999999999999999997 999996431 1
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
......+........+..++..+.+++..||..+|++||++.++++.|.++.+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 218 REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 222233332222233344566889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=312.08 Aligned_cols=272 Identities=21% Similarity=0.304 Sum_probs=204.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|++.+.||.|+||.||+|..+ +++.||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4578999999999999999999976 788999999865432 2346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 84 e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 84 EYLDK-DLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred ecccc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcch
Confidence 99975 89998875432 2788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
......... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||........................
T Consensus 152 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 152 RAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229 (301)
T ss_pred hccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence 754332211 123456889999998875 45788999999999999999999999755321110000000000000000
Q ss_pred hHhhc---------ccCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhc
Q 018396 300 KQCVD---------TKLGG----EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLN 349 (356)
Q Consensus 300 ~~~~~---------~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~~ 349 (356)
..... +.... .....++..+.+||.+||+.||.+|||++++++ .+..+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 00000 00000 011234567899999999999999999999997 4444443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=301.56 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=203.5
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----------hHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----------DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
+|.+.+.||.|++|.||+|... +++.+|+|.+...... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999976 6889999988653221 1457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++++||+++++|.+++..... +++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA---------FEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEec
Confidence 9999999999999999976532 788899999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccc----ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 216 DFDLSNQAPDAAAR----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 216 Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
|||++......... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------- 217 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----------- 217 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----------
Confidence 99998766532111 011234578899999999988899999999999999999999999964321
Q ss_pred ccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+..... ......+...+..+.++|.+||+.+|.+||++.++++
T Consensus 218 ----~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 218 ----LQAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----HHHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111111111 2223444566788999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=301.01 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=206.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
++|++.+.||.|+||.||+|... +++.+++|.+..... .+.+.+|+++++.++||||+++++.+.+....++++||+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 67999999999999999999987 588999999876533 5788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 82 ~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 82 AGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred CCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 9999999965432 3889999999999999999999999 9999999999999999999999999988765
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh-
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV- 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 303 (356)
.... ......++..|+|||++.+..++.++||||||+++|+|++|+.||....+.... ....
T Consensus 151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---------------~~~~~ 213 (256)
T cd06612 151 DTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---------------FMIPN 213 (256)
T ss_pred cCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---------------hhhcc
Confidence 4321 123445788999999999889999999999999999999999999754322110 0000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........+..++..+.++|.+||+.+|.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 214 KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000111223455678999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=300.07 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=202.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEec-CCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 141 (356)
+|++.+.||.|++|.||++..+ +++.+|+|.+..... ..+.+.+|++++++++|+|++++++.+.. ....++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999976 688999999865432 23467889999999999999999988764 446899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|.+++..... ..+++.+++.++.+++.||.+||++| ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred ccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence 9999999999976432 13789999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||..... .....
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----------------~~~~~ 212 (257)
T cd08223 151 VLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----------------NSLVY 212 (257)
T ss_pred EecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----------------HHHHH
Confidence 6543221 12345688999999999999999999999999999999999999964311 11111
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+........+...+..+.+++.+||+.+|++|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 213 RIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11112222344567788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=308.58 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=206.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
...+|++.+.||.|+||.||+|... +++.||+|.+...... .+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 4578999999999999999999975 7999999998754333 4567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|.+++.... +++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.
T Consensus 97 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 97 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred ccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccce
Confidence 999999999986543 788899999999999999999999 9999999999999999999999999986
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+........
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~------------- 228 (297)
T cd06656 164 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------- 228 (297)
T ss_pred EccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-------------
Confidence 54332211 133468899999999998889999999999999999999999996543221110000
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.........+...+..+.+++.+||+.+|.+||++.++++
T Consensus 229 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 229 -TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000011223455677899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=301.96 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=202.8
Q ss_pred CCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc-------hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
+|++.+.||.|+||.||+|...+++.+|+|.+...... ...+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 58899999999999999999888899999988654321 24578899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
+||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 81 MEFVPGGSISSILNRFGP---------LPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred EecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence 999999999999975432 788999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccc----cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 220 SNQAPDAAA----RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 220 a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
+........ ........++..|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------------- 215 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------------- 215 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-------------
Confidence 875432111 111133468899999999998889999999999999999999999996432110
Q ss_pred hhhHhHhhcc-cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........ ......+..++.++.++|.+||+.+|.+||++.+++.
T Consensus 216 --~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 216 --AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --HHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111111 1112334456778999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.55 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=205.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
...+|++.+.||.|++|.||+|... +++.|++|.+...... .+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 3457999999999999999999975 7899999988654332 4567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+++|.+++.... +++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 97 ~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 97 YLAGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred ecCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccch
Confidence 999999999987543 789999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ .....++..|+|||.+.+..++.++|||||||++|+|++|..||....+. .....
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---------------~~~~~ 226 (296)
T cd06655 164 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---------------RALYL 226 (296)
T ss_pred hccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHH
Confidence 65433221 13346889999999999888999999999999999999999999654221 11111
Q ss_pred hhc-ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 CVD-TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
... .......+..++..+.++|.+||..+|.+|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111 11111234456678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=312.68 Aligned_cols=204 Identities=23% Similarity=0.376 Sum_probs=164.5
Q ss_pred CceeeccCceEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEec--CCeeEEEEEecCC
Q 018396 71 NSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAYEHASK 145 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~ 145 (356)
.+.||+|+||+||+|..+ +++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...++++||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999964 568899999875433 3457889999999999999999998854 4568899999865
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE----ccCCceeEecccccC
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSN 221 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~Dfg~a~ 221 (356)
+|.+++..............+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 89888865432222222234889999999999999999999999 9999999999999 456789999999997
Q ss_pred CCcccccc-ccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCC
Q 018396 222 QAPDAAAR-LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (356)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (356)
........ .......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 65432211 11234568999999999877 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=303.87 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=202.2
Q ss_pred ceeeccCceEEEEEEECC-------CCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 72 SLIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+.||+|+||.||+|...+ +..+++|.+.... .....+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2579999886543 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-----ceeEecc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDF 217 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-----~vkl~Df 217 (356)
+++++|.+++........ ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+||
T Consensus 81 ~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 81 MEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred cCCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCc
Confidence 999999999975432110 1223788999999999999999999999 99999999999999887 8999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~----------------~ 219 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN----------------N 219 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC----------------H
Confidence 99876543322211223345788999999999899999999999999999998 999996332 1
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
......+........+...+..+.++|.+||+.+|.+||++.+|++.|.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 220 QEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1222222222223444566788999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=314.42 Aligned_cols=259 Identities=21% Similarity=0.292 Sum_probs=193.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++..+...++|+|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3467999999999999999999987 6789999975433 235689999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+ +|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 139 ~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 139 YSS-DLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred cCC-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccc
Confidence 965 88888865432 2889999999999999999999999 99999999999999999999999999875
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCC-CCCCCCCCCccce-------e------
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSLV-------T------ 288 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p-f~~~~~~~~~~~~-------~------ 288 (356)
...... .....||+.|+|||++.+..++.++|||||||++|+|+++..| |............ .
T Consensus 207 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~ 283 (357)
T PHA03209 207 PVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283 (357)
T ss_pred cccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 432221 1345689999999999999999999999999999999985544 4432111000000 0
Q ss_pred ccccc----CChhhHhHhhcccCC--CCC-------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 289 WATPK----LSEDKVKQCVDTKLG--GEY-------PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 289 ~~~~~----~~~~~~~~~~~~~~~--~~~-------~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..... .........+..... ... ....+..+.+||.+||+.||.+|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00000 000000111110000 000 0123456778999999999999999999986
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=314.22 Aligned_cols=251 Identities=19% Similarity=0.226 Sum_probs=197.4
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||++... +++.||+|++.+. ....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999976 7899999998642 122345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+++|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 81 e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred ecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCce
Confidence 99999999999975321 2888999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC-----CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------------- 214 (331)
T cd05597 150 LRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------------- 214 (331)
T ss_pred eecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--------------
Confidence 665432211 1123468999999999863 45788999999999999999999999644211
Q ss_pred hhhHhHhhcccCCC---CCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018396 296 EDKVKQCVDTKLGG---EYPPKAIAKMAAVAALCVQYEADF--RPNMGIVLKA 343 (356)
Q Consensus 296 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~ 343 (356)
+....+....... ......+..+.++|.+||..++.+ |++++++++.
T Consensus 215 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 215 -ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111111111111 111235678899999988654433 7899988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=303.63 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=204.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|++.+.||.|++|.||+|... +++.+|+|.+..... ....+.+|+.+++.++|+||+++++++.++...++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46889999999999999999976 789999999875432 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+++|.+++.... +++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 81 CGGGSCLDLLKPGK----------LDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence 99999999997652 889999999999999999999999 99999999999999999999999999877
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||....+. .....
T Consensus 148 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----------------~~~~~ 209 (274)
T cd06609 148 LTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----------------RVLFL 209 (274)
T ss_pred eccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----------------HHHHH
Confidence 654321 123456788999999999888999999999999999999999999654311 11111
Q ss_pred hcccCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+........+.. ++.++.+++.+||..+|++|||++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 210 IPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred hhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111122222 6678999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=303.30 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=207.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
++|++.+.||.|+||.||+|+.+ +.+.+++|.+...... .+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999964 3467999988654433 357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+++++|.+++..............+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999986653322222234899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--------------- 225 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--------------- 225 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---------------
Confidence 998654322211 1233356778999999988888999999999999999998 88898543211
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
..+............+..++..+.+++.+||+.+|.+|||+.+++..|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 226 EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111111112223445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.97 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=205.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
..|+..+.||.|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++||||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778889999999999999976 688999999875432 245688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++.... +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 84 LGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence 99999999987533 788889999999999999999998 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......++..|+|||++.+..++.++|+||||+++|+|++|..||....+.. ....
T Consensus 151 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----------------~~~~ 212 (277)
T cd06640 151 LTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----------------VLFL 212 (277)
T ss_pred ccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----------------Hhhh
Confidence 543221 1233467889999999988889999999999999999999999996443211 1111
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
+........+..++..+.+++.+||+.+|.+||++.++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122234455678889999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=306.81 Aligned_cols=249 Identities=27% Similarity=0.457 Sum_probs=199.2
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHH---HHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~---~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
|++.+.||+|+||+||++... +++.+|+|++......... ..+|+.++++++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999988 6778999999876554332 345999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
.+++|.+++.... .+++..++.++.|++.||.+||+++ ++|+||||+||++++++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccccc---------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999998333 2899999999999999999999999 999999999999999999999999998653
Q ss_pred ccccccccccccccCcCccCccccc-CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
.... .......++..|+|||++. +..++.++||||||+++|+|++|..||....... ........
T Consensus 149 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~------------~~~~~~~~ 214 (260)
T PF00069_consen 149 SENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD------------QLEIIEKI 214 (260)
T ss_dssp TSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH------------HHHHHHHH
T ss_pred cccc--cccccccccccccccccccccccccccccccccccccccccccccccccccchh------------hhhhhhhc
Confidence 1111 1224556899999999998 8889999999999999999999999997441000 00011111
Q ss_pred hcccCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....... .........+.+++.+||+.||++|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 215 LKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100000 000111378999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=300.87 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=204.2
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||++.. +++.+|+|.+.... ..+.+.+|+.+++.++|||++++++++... ..+++|||+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 35699999999999999999875 47889999986543 346788999999999999999999998754 4789999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++...... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999999764321 2788999999999999999999999 9999999999999999999999999986543
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.... .......+
T Consensus 152 ~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----------------~~~~~~~~ 210 (254)
T cd05083 152 MGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS----------------LKEVKECV 210 (254)
T ss_pred ccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC----------------HHHHHHHH
Confidence 221 22234568999999988889999999999999999997 999996432 12223333
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
........+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 211 EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 3333444455667889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.60 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=205.5
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||.|+||.||+|... +++.+++|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367999999999999999999976 688999999875433 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..
T Consensus 82 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 82 CGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred CCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchh
Confidence 999999999876521 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCC---CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||....+.. ..
T Consensus 151 ~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---------------~~ 213 (262)
T cd06613 151 LTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---------------AL 213 (262)
T ss_pred hhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---------------HH
Confidence 5442211 1345678899999998776 78899999999999999999999996542211 11
Q ss_pred hHhhcc---cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDT---KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... ..........+.++.+++.+||+.+|.+|||+++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 214 FLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111111 0111223456778999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=303.37 Aligned_cols=249 Identities=27% Similarity=0.367 Sum_probs=200.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++||||+++++.+.+.+..++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888999999999999999976 7899999998754332 34577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++..... +++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++..
T Consensus 88 ~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 88 CGGGSLQDIYHVTGP---------LSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 999999999875432 889999999999999999999999 99999999999999999999999999865
Q ss_pred CccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
...... ......|+..|+|||++. ...++.++|+|||||++|+|++|..||....+... .
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---------------~ 218 (267)
T cd06645 156 ITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---------------L 218 (267)
T ss_pred ccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---------------H
Confidence 543211 123456899999999874 45688899999999999999999999864422110 0
Q ss_pred hHhhcccCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKLGG---EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.......... .....++..+.++|.+||+.+|++|||++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 219 FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000000000 001124567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=317.02 Aligned_cols=239 Identities=20% Similarity=0.214 Sum_probs=187.8
Q ss_pred eeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc---cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL---KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
||+|+||+||+|+.. +++.||+|++..... .......|..++..+ +||||+++++.+.+....++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999977 789999999864321 122344566666655 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 81 GELFWHLQKEGR---------FSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred ChHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 999999875442 889999999999999999999999 99999999999999999999999999875433
Q ss_pred ccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+..
T Consensus 149 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---------------~~~~~~i~~ 211 (330)
T cd05586 149 DNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---------------QQMYRNIAF 211 (330)
T ss_pred CCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---------------HHHHHHHHc
Confidence 2221 2445799999999998764 479999999999999999999999964321 111111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRP----NMGIVLK 342 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp----s~~ell~ 342 (356)
.... ......+.++.+++.+||+.||.+|| ++.++++
T Consensus 212 ~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 212 GKVR-FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCC-CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1111 11123467889999999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=303.15 Aligned_cols=248 Identities=28% Similarity=0.417 Sum_probs=211.6
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
|.++..||+|+||.||+|.++ +|..+|||.+..+. +.+++..|+.++++++.|++|++|+.|-....+|+|||||.-|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 566779999999999999987 89999999997643 4678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
++.+.+..+.. ++.+.++..+++..+.||+|||... -+|||||..|||++.+|+.||+|||.|-++.+.
T Consensus 114 SiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 114 SISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred cHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 99999987653 4999999999999999999999997 899999999999999999999999999887664
Q ss_pred cccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhccc
Q 018396 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK 306 (356)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (356)
... .....|||.|||||++..-.|+..+||||||++..||..|++||..--+...-..+ -..+.
T Consensus 183 MAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------PT~PP 246 (502)
T KOG0574|consen 183 MAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------PTKPP 246 (502)
T ss_pred HHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------cCCCC
Confidence 332 36678999999999999999999999999999999999999999754332110000 00111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 307 LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
-.-..|...+.++.++++.||-+.|++|-|+.++++.
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1223456677899999999999999999999998863
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=318.52 Aligned_cols=261 Identities=24% Similarity=0.323 Sum_probs=196.9
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC-----
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----- 133 (356)
...++|++.+.||.|+||.||+|... +++.||+|++...... ...+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999976 7889999998754322 34577899999999999999999887543
Q ss_pred -CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 134 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
...+++++++ +++|.+++.... +++..+..++.|++.||.|||+++ |+||||||+||++++++.+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence 4568999988 679998886433 889999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce-ecc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TWA 290 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~ 290 (356)
||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ...
T Consensus 158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07878 158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232 (343)
T ss_pred EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 99999998765432 134568999999999877 56899999999999999999999999654221100000 000
Q ss_pred -------cccCChhhHhHhhccc--CCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 291 -------TPKLSEDKVKQCVDTK--LGG----EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 291 -------~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+........+... ... ......++.+.+|+.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000110000 000 000122346789999999999999999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.86 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=219.2
Q ss_pred CCCCCceeeccCceEEEEEEEC---CCC--EEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR---SGR--AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.....+.||.|-||.||.|.+. .|+ .||||.-+.+.. ..+.|+.|..+|+.++||||++++|++.+. ..|||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 3444668999999999999953 233 577888766433 357899999999999999999999999754 68999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
||.++-|.|..|++.++.. ++......++.||+.||.|||+.. +|||||...|||+.+...|||+|||+
T Consensus 469 mEL~~~GELr~yLq~nk~s--------L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDS--------LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred EecccchhHHHHHHhcccc--------chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 9999999999999988753 888999999999999999999998 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++...+......+ ...-...|||||.+.-..++.++|||-|||.+||++. |..||.+. ...+
T Consensus 538 SR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv----------------kNsD 600 (974)
T KOG4257|consen 538 SRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV----------------KNSD 600 (974)
T ss_pred hhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc----------------cccc
Confidence 9998887665433 2223568999999999999999999999999999997 99999755 3344
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
+...++.+-+...|++|++.++.|+.+||.++|.+||.+.+|...|.+++.
T Consensus 601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 455667777888999999999999999999999999999999999998875
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.28 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=201.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.+.|++.+.||.|+||.||+|... ++..+++|.+...... .+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999977 6899999998754332 45678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|..++..... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 91 CPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999988765332 2789999999999999999999999 99999999999999999999999998765
Q ss_pred CccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
...... ......+++.|+|||++. ...++.++|||||||++|+|++|..||....+. .
T Consensus 160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---------------~ 222 (292)
T cd06644 160 NVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---------------R 222 (292)
T ss_pred cccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---------------H
Confidence 433211 123446788999999885 345688999999999999999999999644211 1
Q ss_pred hHhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.......... ....+..++.++.++|.+||+.+|++||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 223 VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111111110 11223455668899999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.79 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=195.8
Q ss_pred ceeeccCceEEEEEEEC----CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEe-cCCeeEEEEEecC
Q 018396 72 SLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVLAYEHAS 144 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~ 144 (356)
+.||+|+||.||+|... ....+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 245799998854322 2456788999999999999999999765 4566889999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++..... ...+..+..++.|++.||.|||+.+ ++|+||||+|||+++++.++|+|||++....
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999975432 1567788899999999999999999 9999999999999999999999999987553
Q ss_pred ccccc--ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 225 DAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 225 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
..... .......++..|+|||.+.+..++.++||||||+++|+|++ |.+||.... ......
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----------------~~~~~~ 213 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----------------SFDITV 213 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----------------HHHHHH
Confidence 32111 01123345778999999988889999999999999999999 456664321 111122
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
.+........+..++..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 214 YLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 222222222333456789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=313.75 Aligned_cols=251 Identities=19% Similarity=0.242 Sum_probs=198.2
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||++..+ +++.||+|++.+.. .....+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999977 78899999986421 12345778899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+|+|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred eCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccce
Confidence 99999999999976431 2788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC-----CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------------- 214 (331)
T cd05624 150 LKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------------- 214 (331)
T ss_pred eeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------------
Confidence 765432211 1233568999999999875 46788999999999999999999999644211
Q ss_pred hhhHhHhhcccCCCCCC---HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYP---PKAIAKMAAVAALCVQYEADF--RPNMGIVLKA 343 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~ 343 (356)
+....+.........+ ...+.++.+++.+||...+.+ |++++++++.
T Consensus 215 -~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 215 -ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111121111111111 234678999999999866544 4678887753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.16 Aligned_cols=248 Identities=29% Similarity=0.390 Sum_probs=200.5
Q ss_pred ceeeccCceEEEEEEEC--CC--CEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR--SG--RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|++|.||+|.+. ++ ..||+|.+..... ..+.+.+|+.++++++||||+++++++.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 46899999999999964 23 3689999977655 24678899999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999986542 12889999999999999999999999 99999999999999999999999999887644
Q ss_pred ccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 226 AAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 226 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...... +......
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---------------~~~~~~~ 214 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---------------QILKKID 214 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---------------HHHHHHH
Confidence 22211 1123456788999999998899999999999999999998 99999643211 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
........+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred hcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111222233455678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=297.87 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=206.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|+..+.||.|+||.||.+... +++.+++|.+.... .....+.+|+.++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999966 78999999886543 2245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++..... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 81 ANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred cCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 999999999976532 23789999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||..... .+....+
T Consensus 151 ~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---------------~~~~~~~ 213 (256)
T cd08221 151 LGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---------------LNLVVKI 213 (256)
T ss_pred cccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---------------HHHHHHH
Confidence 544332 12345689999999999888899999999999999999999999964321 1112222
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.. ......+..++.++.+++.+||+.+|.+||++.++++.+
T Consensus 214 ~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 214 VQ-GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred Hc-CCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 21 111223345677899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=312.20 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=218.4
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.+...+.+.||+|-||.|.++....+..||||+++..... ..+|.+|+++|.+|+||||+.++++|..++.+++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 3457778899999999999999887899999999876544 46899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
++.|+|.+|+....... +.-.....++.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++.
T Consensus 617 mEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 99999999998875322 344556779999999999999998 99999999999999999999999999998
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc--CCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
+...+........+-...|||+|.+..++++.++|+|+||+++||+++ ...||... +++.+.
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l----------------t~e~vv 750 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL----------------TDEQVV 750 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh----------------hHHHHH
Confidence 776666555555666789999999999999999999999999999876 88899643 333333
Q ss_pred HhhcccC-------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 301 QCVDTKL-------GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 301 ~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
+.....+ -...|.-|+.+++++|..||+.+-.+|||++++...|.+.
T Consensus 751 en~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 751 ENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 3222211 1245678899999999999999999999999999998765
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=305.40 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=203.3
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|++.+.||+|+||.||+|.+. ++..||+|.+...... ...+.+|+.++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999987 8899999988654222 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
+++++|.+++..... ...+++..+..++.|++.||.|||++ + ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 81 MDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred cCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999999876421 11388999999999999999999974 7 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCC------CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
...... .....+++.|+|||++.+. .++.++|+|||||++|+|++|..||....... .
T Consensus 152 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------------~ 215 (286)
T cd06622 152 NLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN------------I 215 (286)
T ss_pred cccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh------------H
Confidence 653321 1334578899999988654 34789999999999999999999996431100 0
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+..+. .......+..++.++.++|.+||+.+|.+||++.+++.
T Consensus 216 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 216 FAQLSAIV-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHh-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 01111111 12223455567889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=312.58 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=198.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||++..+ +++.+|+|++.+.. .....+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999977 68899999986421 12344778899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+|+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 81 ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred eccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchh
Confidence 99999999999976432 2788899999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
........ .......||+.|+|||++. ...++.++|||||||++|+|++|+.||......
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------------- 214 (332)
T cd05623 150 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------------- 214 (332)
T ss_pred eecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--------------
Confidence 65433211 1123456999999999886 346788999999999999999999999644211
Q ss_pred hhhHhHhhcccCCCCC---CHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEY---PPKAIAKMAAVAALCVQYEADF--RPNMGIVLKA 343 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~ 343 (356)
.....+......... ...++.++.+|+.+|+..++.+ |+++.++++.
T Consensus 215 -~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 215 -ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111222221111111 2345778999999998665444 6899998875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=338.24 Aligned_cols=256 Identities=20% Similarity=0.306 Sum_probs=200.4
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEec--CCee
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 136 (356)
...++|++.+.||.|+||.||+|.+. ++..+|+|++..... ....+..|+.+++.|+|||||++++++.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 45678999999999999999999987 788999999875432 24568899999999999999999998854 4578
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC----CCeeecCCCCCcEEEcc----
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE----PRIIHRNIKSSNVLLFD---- 208 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~----~~ivH~Dlkp~Nill~~---- 208 (356)
||||||+++++|.++|....... ..+++..++.++.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~-----g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMF-----GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 99999999999999997542211 138999999999999999999998531 23999999999999964
Q ss_pred -------------CCceeEecccccCCCccccccccccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCC
Q 018396 209 -------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRK 273 (356)
Q Consensus 209 -------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~ 273 (356)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 23589999999876543322 134568999999999864 458899999999999999999999
Q ss_pred CCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 274 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 274 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
||..... ...+...+..... ......+.++.+||..||+.+|.+||++.+++.
T Consensus 242 PF~~~~~---------------~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANN---------------FSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCc---------------HHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9964321 1111111111111 111234678999999999999999999999985
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.93 Aligned_cols=248 Identities=22% Similarity=0.356 Sum_probs=200.1
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
|++.+.||.|+||.||+|... ++..+++|.+..... ..+.+.+|+++++.++|||++++++++..+...++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 678889999999999999977 678899998865432 245678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|..++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 87 ~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 87 GAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 999998764321 2889999999999999999999999 99999999999999999999999999866533
Q ss_pred ccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
... ......+++.|+|||++. +..++.++||||+||++|+|++|..||....+. ....
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---------------~~~~ 218 (282)
T cd06643 156 TIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---------------RVLL 218 (282)
T ss_pred ccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---------------HHHH
Confidence 221 123456899999999884 345778999999999999999999999644211 1111
Q ss_pred Hhhcc-cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 301 QCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 301 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..... ......+..++.++.++|.+||+.+|.+|||+.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 219 KIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 11112334566789999999999999999999998863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=304.44 Aligned_cols=245 Identities=26% Similarity=0.398 Sum_probs=202.1
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
.|+..+.||+|+||.||+|.+. +++.||+|.+...... .+.+.+|+.+++.++||||+++++.+..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666778999999999999976 6889999998754322 356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++.... +.+..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 85 ~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 85 GGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred CCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccc
Confidence 9999999986532 788999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... ......++..|+|||++.+..++.++|+||||+++|+|++|..||....+.. ....+
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----------------~~~~~ 213 (277)
T cd06642 152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----------------VLFLI 213 (277)
T ss_pred cCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----------------HHhhh
Confidence 43221 1233457889999999998889999999999999999999999986442211 01111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...........++..+.++|.+||+.+|.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111112233345678999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=304.77 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=199.4
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|++.+.||+|++|.||+|... ++..||+|++...... ...+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888999999999999999976 7899999998654322 35678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+. ++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 81 LS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred CC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceee
Confidence 98 589888865432 123889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcc----------ceeccc
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS----------LVTWAT 291 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~ 291 (356)
....... .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||.......... ...|..
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 151 FGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred cCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 5432211 1233568899999988754 57889999999999999999999997543211000 000000
Q ss_pred ccCChhhHhHhhcc---cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 292 PKLSEDKVKQCVDT---KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 292 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. ........... .........++.++.++|.+||+.||.+|||+.++++
T Consensus 229 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 229 VT-SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ch-hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 00000000000 0000112235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=296.90 Aligned_cols=250 Identities=29% Similarity=0.457 Sum_probs=206.2
Q ss_pred CCCCceeeccCceEEEEEEEC-CC----CEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SG----RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
+++.+.||.|+||.||++... .+ ..+|+|.+..... ....+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999999976 33 8899999976554 3567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++....... +++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 81 e~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKE-------LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred eccCCCCHHHHHHhhhhcc-------CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCc
Confidence 9999999999997654211 789999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhH
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
........... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||... .....
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----------------~~~~~ 213 (258)
T smart00219 151 RDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----------------SNEEV 213 (258)
T ss_pred eeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----------------CHHHH
Confidence 77654422211 12236789999999988889999999999999999998 88888642 12222
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
...+........+..++.++.+++.+||+.+|++|||+.++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 214 LEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 223333333344445778899999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.72 Aligned_cols=261 Identities=28% Similarity=0.402 Sum_probs=205.7
Q ss_pred CHHHHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecC-
Q 018396 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDG- 133 (356)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~- 133 (356)
....+....++|++.+.||+|+||.||+|... +++.+|+|.+.........+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 33455556789999999999999999999976 788999999876555556788899999999 899999999998743
Q ss_pred ----CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 134 ----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 134 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
...++|+||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~ 164 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTE 164 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCC
Confidence 4689999999999999998643211 123789999999999999999999999 9999999999999999
Q ss_pred CceeEecccccCCCccccccccccccccCcCccCcccccCC-----CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018396 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (356)
+.++|+|||++......... .....|+..|+|||++... .++.++|||||||++|+|++|+.||....+.
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--- 239 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--- 239 (291)
T ss_pred CCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---
Confidence 99999999998765432221 1334678899999987643 3688999999999999999999999644211
Q ss_pred cceecccccCChhhHhHhhcc-cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 285 SLVTWATPKLSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+...... ......+...+..+.++|.+||+.+|++||++.++++
T Consensus 240 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 ------------KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ------------HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111 0011123345567999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=317.69 Aligned_cols=244 Identities=29% Similarity=0.393 Sum_probs=203.5
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.|.-++.||.|+||.||.|++. +.+.||||+..-+.+ ..++++.|+..|++++|||++.+.+.|......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3666788999999999999976 889999999864332 25789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
||-| +-.|++...+. ++-+.++..|..+.+.||.|||+.+ .||||||..|||+++.|.|||+|||.|.
T Consensus 107 YClG-SAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred HHhc-cHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchh
Confidence 9976 77888776552 3888999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
..... ..++|||.|||||++. .+.|+-++||||||++..||.-.++|+...+. -..
T Consensus 175 i~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---------------MSA 233 (948)
T KOG0577|consen 175 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------MSA 233 (948)
T ss_pred hcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---------------HHH
Confidence 66544 5678999999999986 46899999999999999999999999854321 111
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
+..+-...-.--..++.++.+++|+..||++-|.+|||.+++++.
T Consensus 234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 222222111112245667889999999999999999999999873
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.31 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=203.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCC------e
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP------L 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~------~ 135 (356)
..++|++.+.||.|++|.||+|..+ +++.+++|++.......+.+.+|+.+++++ +|+||+++++++.+.. .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4578999999999999999999986 688999999987666667789999999999 7999999999987544 4
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.+++|||+++++|.+++....... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKG-----KRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence 899999999999999987543111 23889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccC-----CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
|||++......... .....|+..|+|||++.. ..++.++||||||+++|+|++|+.||....+.
T Consensus 156 d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------- 224 (275)
T cd06608 156 DFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------- 224 (275)
T ss_pred CCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---------
Confidence 99998655432211 234568899999998753 34678899999999999999999999643211
Q ss_pred cccCChhhHhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 291 TPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........... ....+..++.++.++|.+||..||++|||+.++++
T Consensus 225 ------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 225 ------RALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ------HHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111111111 11223346778999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=303.56 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=203.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||.|+||.||++... ++..+|+|.+...... .+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356999999999999999999976 7899999998654332 35688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 84 CDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred cCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999876432 2889999999999999999999999 99999999999999999999999998766
Q ss_pred CccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
....... .....+++.|+|||++. +..++.++|+||||+++|+|++|..||...... .
T Consensus 153 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---------------~ 215 (280)
T cd06611 153 NKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---------------R 215 (280)
T ss_pred hcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---------------H
Confidence 5432221 23456899999999875 345678999999999999999999999654211 1
Q ss_pred hHhHhhccc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 298 KVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 298 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
......... .....+..++.++.++|.+||+.+|.+||++.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 216 VLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111111110 1112234566789999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=299.75 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=192.5
Q ss_pred ceeeccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
+.||+|+||.||+|... ++..+|+|.+...... ...+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999854 3567999988765432 346888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
+|.+++....... ....++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 81 DLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred cHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999997643211 112567788889999999999999999 999999999999999999999999998754433
Q ss_pred cccccccccccCcCccCcccccCC-------CCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhh
Q 018396 227 AARLHSTRVLGTFGYHAPEYAMTG-------QMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
..........++..|+|||++.+. .++.++||||||+++|+|++ |..||....+...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--------------- 218 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--------------- 218 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---------------
Confidence 222222344578889999988642 35789999999999999996 9999964322110
Q ss_pred HhHhh-cccC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 299 VKQCV-DTKL---GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 299 ~~~~~-~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
....+ .... ........+..+.+++..|| .+|++|||+++|++.|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 219 LTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000 0000 01111234567889999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=296.97 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=199.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC------chHHHHHHHHHHHhccCCceeeeeeEEec--CCee
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 136 (356)
.+|+..+.||+|+||.||+|... ++..|++|.+..... ....+.+|+.+++.++||||+++++.+.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47999999999999999999976 789999998864321 12457889999999999999999998865 4678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++++||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA---------LTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence 899999999999999975432 788899999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++......... .......++..|+|||.+.+..++.++||||+||++|+|++|+.||.....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------------- 214 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------------- 214 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---------------
Confidence 9998754321111 111234578899999999988899999999999999999999999964321
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
................+...+..+.+++ +||..+|++||+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 215 MAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1112222222223344556667788888 677789999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=307.63 Aligned_cols=263 Identities=17% Similarity=0.251 Sum_probs=195.2
Q ss_pred CCceeecc--CceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 70 TNSLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 70 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
+.++||+| +|++||++..+ +|+.||+|.+...... ...+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999976 8999999999764332 345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++++||+.+...
T Consensus 82 ~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 999999999654321 2788999999999999999999999 999999999999999999999999865433
Q ss_pred cccccc-----ccccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcc-cee------c
Q 018396 224 PDAAAR-----LHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVT------W 289 (356)
Q Consensus 224 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~-~~~------~ 289 (356)
...... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 231 (327)
T ss_pred ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccc
Confidence 211110 01122346778999999876 468999999999999999999999997532210000 000 0
Q ss_pred ccccCChhhHh----------------------HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 ATPKLSEDKVK----------------------QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 ~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.......+... ..............+++.+.+|+.+||+.||.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000000000 000000011122345678999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.00 Aligned_cols=251 Identities=27% Similarity=0.341 Sum_probs=197.4
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHH-HHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|++.+.||+|+||.||+|.++ +|+.||+|.+..... ....+..|+.. ++.++||||+++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999987 799999999876433 23455566665 666799999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|++ ++|.+++....... ..+++..++.++.|++.||.|||++ + ++|+||||+||+++.++.+||+|||++
T Consensus 81 ~~~-~~l~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKG-----LTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred hhc-ccHHHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 997 48988886543211 2389999999999999999999997 7 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC----CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
........ .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||..... ..
T Consensus 152 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------------~~ 214 (283)
T cd06617 152 GYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--------------PF 214 (283)
T ss_pred cccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--------------CH
Confidence 76543211 133457889999998865 4568899999999999999999999953211 11
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+.+...............++.++.++|.+||..+|.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 215 QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1222222211111112245678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=295.74 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=200.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHHhccCCceeeeeeEEecC--Cee
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 136 (356)
.+|++.+.||+|+||.||.|... +++.||+|.+...... .+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999976 6899999988543211 24678899999999999999999988763 568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++++||+++++|.+++..... +++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA---------LTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECc
Confidence 899999999999999875432 778889999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++......... .......++..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------------- 214 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA--------------- 214 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---------------
Confidence 9998765322111 011334588899999999888899999999999999999999999964311
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
................+...+..+.+++.+||. +|.+||+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 215 MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111222222222334566677889999999995 9999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=307.43 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=210.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..+.|+.-++||+||||.||.++.+ +|+.+|.|.+.+. .......++|-.+|.+++.+.||.+-..|+..+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467889999999999999999977 8999999988653 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
|+..|.||+|.-.|..... +.+++..++.++.+|+.||++||+.+ ||+|||||+|||+|+.|+|+|+|+|
T Consensus 263 VLtlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred EEEeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccc
Confidence 9999999999988866553 34999999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+|..+...... ...+||.+|||||++.+..|+...|+|||||++|+|+.|+.||...-. +...++
T Consensus 333 LAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke------------Kvk~eE 397 (591)
T KOG0986|consen 333 LAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE------------KVKREE 397 (591)
T ss_pred eEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh------------hhhHHH
Confidence 99988765433 455899999999999999999999999999999999999999964321 222223
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 338 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 338 (356)
+...+.. -..+++...++++.++....|.+||.+|....
T Consensus 398 vdrr~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 398 VDRRTLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHhc-chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 3222211 12367788899999999999999999997543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.85 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=206.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.++|++.+.||+|+||+||++... +++.||+|++..... ....+.+|+++++.++||||+++++++......++|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 467889999999999999999976 688999998865432 24678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|+++++|.+++.... .+++..+..++.+++.+|.|||+ .+ ++|+||+|+||++++++.++|+|||++
T Consensus 84 ~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 84 FMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred cCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcc
Confidence 999999999987643 27899999999999999999997 47 999999999999999999999999997
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh--
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK-- 298 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 298 (356)
....... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||......... ......
T Consensus 152 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~--------~~~~~~~~ 219 (284)
T cd06620 152 GELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG--------QDDPMGIL 219 (284)
T ss_pred cchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh--------hhhhhHHH
Confidence 6543221 13456899999999998888999999999999999999999999755332110 001111
Q ss_pred --HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 299 --VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 299 --~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
....+...........++.++.+|+.+||+.||.+|||+.|+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 220 DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111111111111123667899999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=296.37 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=204.9
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|++.+.||+|+||.||.+... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999976 78999999986432 2245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+++|.+++...... .+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 81 CEGGDLYKKINAQRGV-------LFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred CCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 9999999999764321 2788999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
....... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..... .+.+..+
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---------------~~~~~~~ 213 (256)
T cd08218 151 LNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---------------KNLVLKI 213 (256)
T ss_pred cCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---------------HHHHHHH
Confidence 5443221 1234578899999999888899999999999999999999999953311 1111122
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+ .......+...+.++.++|.+||+.+|.+||++.++++
T Consensus 214 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 214 I-RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred h-cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 12222344566778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=296.70 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=206.3
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec--CCeeEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAY 140 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 140 (356)
+|++.+.||.|+||.||+|.+. +++.+|+|.+...... .+.+.+|+.+++.++||||+++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5888999999999999999976 7889999998654332 3567889999999999999999997763 45689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----hCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-----EKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-----~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
||+++++|.+++...... ...+++..++.++.|++.||.||| +.+ ++|+||+|+||++++++.++|+
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred hhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEe
Confidence 999999999999764321 123889999999999999999999 777 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||++......... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 153 d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---------------- 214 (265)
T cd08217 153 DFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---------------- 214 (265)
T ss_pred cccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----------------
Confidence 99998876543321 134468999999999998889999999999999999999999996442
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+...+........+...+..+.+++.+||+.+|.+|||+.+|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 215 QLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 12223333333334455667789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=297.89 Aligned_cols=241 Identities=21% Similarity=0.286 Sum_probs=205.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|+.+++||+|.||+|.+++.+ +++.+|+|+++++-.- ...-+.|-++|+..+||.+..+...|...+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4578999999999999999999977 8999999999865322 2345678889999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||..||.|.-.+...+. +++..+..+-..|+.||.|||+++ ||+||||.+|+|+|.+|++||+|||
T Consensus 246 VMeyanGGeLf~HLsrer~---------FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV---------FSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EEEEccCceEeeehhhhhc---------ccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecc
Confidence 9999999999988877653 888999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+++.--.... ....++|||.|+|||++....|+.++|+|.+||++|||++|+.||...+. +.
T Consensus 314 LCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----------------~k 375 (516)
T KOG0690|consen 314 LCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----------------EK 375 (516)
T ss_pred cchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----------------hH
Confidence 9876432222 23778999999999999999999999999999999999999999964432 23
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 335 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 335 (356)
+.+++.-. ...+|...+++...|+...|.+||.+|.
T Consensus 376 LFeLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 376 LFELILME-DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHhh-hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 33333211 1256777888999999999999999996
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=297.45 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=200.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..+.+.....||+|+||.||+|... ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++..++..++++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3445555678999999999999966 688899998875543 34578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeEeccccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a 220 (356)
|+++++|.+++...... ...++..+..++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||++
T Consensus 86 ~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 86 QVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred cCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999754211 00277888899999999999999999 999999999999976 679999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCC--CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
........ ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||....... ..
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--------------~~ 220 (268)
T cd06624 157 KRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--------------AA 220 (268)
T ss_pred eecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--------------hh
Confidence 76533221 11334578999999998654 37889999999999999999999996432110 00
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.............+..+++++.+++.+||+.+|.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 221 MFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11111111223445567788999999999999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=318.81 Aligned_cols=243 Identities=27% Similarity=0.388 Sum_probs=207.6
Q ss_pred eeeccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHHH
Q 018396 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 150 (356)
+||+|.||+||.|++. +....|||.+.... ...+-+..|+.+.++|+|.|||+++|.+..++.+-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999987 67789999997543 335668899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeEecccccCCCcccc
Q 018396 151 ILHGKKGVKGAKPGPVL--SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAA 227 (356)
Q Consensus 151 ~l~~~~~~~~~~~~~~~--~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~ 227 (356)
++...=+ ++ .+.+.-.+..||++||.|||++. |||||||-+|+||+. .|.+||.|||.++.+....
T Consensus 662 LLrskWG--------PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 662 LLRSKWG--------PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred HHHhccC--------CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence 9975432 13 56778889999999999999998 999999999999974 6899999999988765432
Q ss_pred ccccccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 228 ARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
..+..+.||.-|||||++-. ..|+.++|||||||++.||.||++||-... -....+..+-.-
T Consensus 731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg--------------spqAAMFkVGmy 794 (1226)
T KOG4279|consen 731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG--------------SPQAAMFKVGMY 794 (1226)
T ss_pred --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC--------------ChhHhhhhhcce
Confidence 23467889999999999975 468999999999999999999999996442 122334444455
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+.+..+|.+.+.+.+++|.+|+.++|.+||+++++|+
T Consensus 795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6677899999999999999999999999999999987
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=305.23 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=204.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|++|.||+|... +++.||+|.+...... ...+.+|+++++.++||||+++++.+.++...+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46889999999999999999977 6899999999765432 346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred EecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchh
Confidence 99999999999975432 13889999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc---------------------------ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCC
Q 018396 221 NQAPDAAAR---------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (356)
Q Consensus 221 ~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 273 (356)
......... .......|+..|+|||++.+..++.++||||||+++|+|++|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence 654322110 01123467889999999998889999999999999999999999
Q ss_pred CCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 018396 274 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN----MGIVLK 342 (356)
Q Consensus 274 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps----~~ell~ 342 (356)
||..... ......+.............+..+.+++.+||..+|++||| +++++.
T Consensus 231 pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 231 PFKGSNR---------------DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCch---------------HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9964422 11122222222211222225788999999999999999999 777777
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=287.99 Aligned_cols=251 Identities=18% Similarity=0.238 Sum_probs=203.8
Q ss_pred HhCCCCCC-ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEec----CCee
Q 018396 64 KTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD----GPLR 136 (356)
Q Consensus 64 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~----~~~~ 136 (356)
.+++|.+. ++||-|-.|.|..+.++ +|+.+|+|++... ...++|+++.=.. .|||||.++++|.+ ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 56778875 57999999999999987 8999999998644 3466788764444 79999999999874 4567
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCcee
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (356)
.+|||.++||.|...++.+... .+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +-.+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred EeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceE
Confidence 8999999999999999987753 3999999999999999999999999 999999999999975 44799
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|+|||+|+....... ....+-||.|.|||++....|+..+|+||+||++|-|++|.+||..... ..
T Consensus 205 LtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----------~a 270 (400)
T KOG0604|consen 205 LTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----------LA 270 (400)
T ss_pred ecccccccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----------cc
Confidence 999999987654322 2456789999999999999999999999999999999999999965432 12
Q ss_pred CChhhHhHhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 LSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 ~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
++...-..+....+ ..+--..+++...++|+++|..+|.+|.|+++++.
T Consensus 271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 33332233322222 22233567889999999999999999999999876
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=298.82 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=191.1
Q ss_pred ceeeccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
+.||+|+||.||+|... ....+++|.+...... ...+.+|+.+++.++||||+++++.+.+....+++|||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36899999999999743 3457888887644322 346788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
+|.+++........ ....+..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 81 DLKNYLRSNRGMVA----QMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred cHHHHHHhcccccc----ccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccc
Confidence 99999976542211 12467788899999999999999999 999999999999999999999999998654332
Q ss_pred cccccccccccCcCccCcccccC-------CCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhh
Q 018396 227 AARLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
..........++..|+|||++.. ..++.++|||||||++|+|++ |..||....+. +.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---------------~~ 218 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---------------QV 218 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---------------HH
Confidence 22211233345778999998743 356789999999999999999 78888643211 11
Q ss_pred HhHhhccc---C-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 299 VKQCVDTK---L-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 299 ~~~~~~~~---~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
....+... . ....+..++..+.+++..|| .||.+|||+++|++.|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 219 LKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111110 0 11223345677888999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=296.48 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=205.5
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
+|+..+.||+|++|.||++... +++.+|+|++..... ..+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4888999999999999999975 789999999865331 13567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-ceeEecc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDF 217 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Df 217 (356)
++||+++++|.+++.... .+++..++.++.|++.||.|||++| ++|+||+|+||+++.++ .++|+||
T Consensus 81 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred EEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence 999999999999997543 2788999999999999999999999 99999999999998776 5999999
Q ss_pred cccCCCccccccc--cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 218 DLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 218 g~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|.+.......... ......++..|+|||++.+..++.++|+||||+++|+|++|..||........
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------------ 216 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH------------ 216 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch------------
Confidence 9987664432111 11334678899999999888899999999999999999999999964321110
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
................+...+.++.+++.+||+.+|.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 217 LALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01111222222234556677889999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=295.22 Aligned_cols=247 Identities=19% Similarity=0.317 Sum_probs=203.3
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|+..+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.+++.++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999976 789999999865432 245688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-CceeEecccccC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Dfg~a~ 221 (356)
+++++|.+++..... ..+++..+..++.+++.+|.|||+++ ++|+||+|+||+++++ +.++|+|||++.
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 81 APGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred CCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 999999999976432 23788999999999999999999999 9999999999999865 468999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---------------~~~~~ 212 (256)
T cd08220 151 ILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---------------ALVLK 212 (256)
T ss_pred ecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---------------HHHHH
Confidence 6654322 13356889999999999888999999999999999999999999644211 11111
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. .......+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 213 ~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 213 IM-SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HH-hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 11122334456778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=297.49 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=200.8
Q ss_pred CCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCC------
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 134 (356)
|++.+.||+|+||.||+|... ++..||||++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999853 4688999998764322 356788999999999999999999886532
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..+++++|+.+++|.+++........ ...+++..++.++.|++.||+|||+++ ++|+||||+||++++++.++|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEE---PFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEE
Confidence 24788999999999988754321111 113788899999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||++................+++.|++||.+.+..++.++|||||||++|+|++ |.+||.....
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~------------- 221 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------------- 221 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-------------
Confidence 99999886543322211223345678999999998889999999999999999999 8899864421
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
......+........+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 222 ---SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111111111122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=297.06 Aligned_cols=247 Identities=27% Similarity=0.410 Sum_probs=203.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+-|+..+.||.|+||.||+|... +++.+|+|.+..... ....+.+|+..+++++||||+++++++.++...++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34778889999999999999976 789999998865432 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++.... +++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 84 LGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence 99999999986532 789999999999999999999999 99999999999999999999999999866
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......++..|+|||.+.+...+.++|+|||||++|+|++|..||..... ......
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----------------~~~~~~ 212 (277)
T cd06641 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----------------MKVLFL 212 (277)
T ss_pred cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----------------HHHHHH
Confidence 543221 12334678899999999888889999999999999999999999964321 111111
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
+........+..++.++.+++.+||+.+|.+||++.++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11122223344567789999999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.47 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=200.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
+.|.....||+|+||.||++... ++..||||.+..... ..+.+.+|+.+++.++|+||+++++.+..++..+++|||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34455567999999999999976 789999999865432 2456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++.... +++..++.++.||+.||.|||+++ ++|+||||+||++++++.++|+|||++...
T Consensus 102 ~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 102 EGGALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred CCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 9999999986432 788999999999999999999999 999999999999999999999999998654
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
...... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||....+. ..+ ..+
T Consensus 169 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---------------~~~-~~~ 230 (292)
T cd06658 169 SKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---------------QAM-RRI 230 (292)
T ss_pred cccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHH-HHH
Confidence 332211 13346889999999998888999999999999999999999999643211 001 111
Q ss_pred cccCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 304 DTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 304 ~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
...... ......+..+.+++.+||..+|.+|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111 1122346678999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=305.59 Aligned_cols=202 Identities=22% Similarity=0.377 Sum_probs=163.1
Q ss_pred ceeeccCceEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEe--cCCeeEEEEEecCCC
Q 018396 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKG 146 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~~~~ 146 (356)
..||+|+||.||+|..+ ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 58999999999999965 457899998865432 345788999999999999999999885 45678999999876
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE----ccCCceeEecccccCC
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSNQ 222 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~Dfg~a~~ 222 (356)
+|.+++..............+++..++.++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 88888764432221222234888999999999999999999999 9999999999999 4567999999999976
Q ss_pred Ccccccc-ccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCC
Q 018396 223 APDAAAR-LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (356)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (356)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 5433221 11234568999999999876 45799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=295.23 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=203.6
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC------chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
+|+..+.||+|++|.||+|... +++.|++|.+..... ..+.+.+|+.+++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4788899999999999999987 789999998865331 235688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcc
Confidence 99999999999997543 2788899999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCC-CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+....... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||..... ...
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---------------~~~ 210 (258)
T cd06632 149 AKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---------------VAA 210 (258)
T ss_pred ceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---------------HHH
Confidence 87654332 123456889999999987766 89999999999999999999999965421 111
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.............+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 211 VFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11111111222344556788999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=297.41 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=200.1
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-----------hHHHHHHHHHHHhccCCceeeeeeEEecCC
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-----------DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 134 (356)
+|.+.+.||.|+||.||+|... +++.+|+|.+...... .+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999976 7899999988542111 135678999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..++|+||+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEE
Confidence 9999999999999999997653 2788899999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCC--CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
+|||++................++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------- 218 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------- 218 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----------
Confidence 9999987654322211123446789999999987654 789999999999999999999999533210
Q ss_pred cCChhhHhHhhcccC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 293 KLSEDKVKQCVDTKL----GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
........... .......++.++.+++.+||..+|.+|||+.++++.
T Consensus 219 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 219 ----AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111111111 111223456789999999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=311.23 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=212.9
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
.....|.+.+.||+|.|+.|.+|++. ++..||||.+.+.... .+.+.+|+++|+.|+|||||+++.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 35578999999999999999999977 8999999999876554 2457899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+.+|.+.+++..... ..+..+..++.|++.|++|||+++ |||||||++||||+.+..+||+|||
T Consensus 133 V~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred EEEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccc
Confidence 9999999999999988764 566889999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++..+..... ...++|++.|.|||++.+..| ++.+|+||+|+++|-|+.|.+||++..-...
T Consensus 201 fS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------- 263 (596)
T KOG0586|consen 201 FSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------- 263 (596)
T ss_pred cceeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc--------------
Confidence 9988875443 377899999999999999887 7899999999999999999999986532111
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
-..++..++ .++.-.+-++.++|+++|-.+|.+|++.+++.+
T Consensus 264 -r~rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 264 -RPRVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -cchheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111222222 233445668899999999999999999999876
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=300.87 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=203.5
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||++.+. +++.+|+|.+.... ...+.+.+|++++++++||||+++++++.++...+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999976 78999999986532 22456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++..... +++..+..++.|++.||.|||+.| ++|+||+|.||++++++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 81 EYVPGGELFSHLRKSGR---------FPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred ecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999976532 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... .....
T Consensus 149 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------------~~~~~ 208 (290)
T cd05580 149 KRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---------------IQIYE 208 (290)
T ss_pred cccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHH
Confidence 776543 1344689999999999888889999999999999999999999964421 11111
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
..... ....+...+..+.+++.+||..+|.+|+ ++++++.
T Consensus 209 ~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 209 KILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 12211 1233445577899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.09 Aligned_cols=262 Identities=19% Similarity=0.255 Sum_probs=197.1
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|++.+.||+|+||.||+|.+. +|+.+|+|.+...... ...+.+|++++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888899999999999999987 7899999998654222 34678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+ +|.+++..... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 81 CDQ-DLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 975 88888764321 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCC-CccceecccccCChh---
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG-QQSLVTWATPKLSED--- 297 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~--- 297 (356)
....... .....+++.|+|||++.+. .++.++|||||||++|+|++|..||....... ...............
T Consensus 149 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 149 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred cCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 5432211 1234578899999998764 46899999999999999999988864322110 000000000000000
Q ss_pred hHhHhhcccCC---------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLG---------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+.... ....+..+.++.++|.+||+.||.+|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000 0112345678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.79 Aligned_cols=238 Identities=24% Similarity=0.407 Sum_probs=187.7
Q ss_pred ceeeccCceEEEEEEECC-------------CCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 72 SLIGEGSYGRVYFGVLRS-------------GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
+.||+|+||.||+|...+ ...+++|.+...... ...+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998531 235889987654333 346788899999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc------
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI------ 211 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~------ 211 (356)
++|||+.+++|..++..... .+++..++.++.||+.||+|||+++ ++||||||+|||++.++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~ 149 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGP 149 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCc
Confidence 99999999999988865331 2788999999999999999999999 999999999999987664
Q ss_pred -eeEecccccCCCccccccccccccccCcCccCccccc-CCCCCccchhhhHHHHHHHHH-cCCCCCCCCCCCCCcccee
Q 018396 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELL-TGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~-~g~~pf~~~~~~~~~~~~~ 288 (356)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......
T Consensus 150 ~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------- 216 (262)
T cd05077 150 FIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------- 216 (262)
T ss_pred eeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------
Confidence 899999988654322 2345788899999887 467899999999999999998 588888543211
Q ss_pred cccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
........... .....+.++.+||.+||+.||.+||++.+|++.|
T Consensus 217 ---------~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 ---------EKERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---------HHHHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11111111111 1112346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=298.87 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=200.2
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|++.+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|+.+++.++|||++++++++......++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46899999999999999999987 689999998864332 23457899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|..++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 81 YCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred ccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence 999988888765433 2889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec-cccc------
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-ATPK------ 293 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~------ 293 (356)
........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............. ....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 149 ILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred ecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 76543221 133457889999999876 5578999999999999999999999975532211000000 0000
Q ss_pred -CChhhHhH-hhcccCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 -LSEDKVKQ-CVDTKLGGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 -~~~~~~~~-~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........ ...+..... .....+..+.+|+.+||+.+|++|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000 000000000 01133578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=318.03 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=206.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
+-|++...||.|+||.||+|.++ ++-..|.|+|.... ...++++-|+++|..++||+||++++.|...+.+||++|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45788889999999999999988 56677788887543 33578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
.||.+...+-.-. .++.+.++..+.+|++.||.|||+++ |+|||||..|||++-+|.|+|+|||.+...
T Consensus 112 ~GGAVDaimlEL~--------r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--------RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred CCchHhHHHHHhc--------cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 9999998886544 24999999999999999999999998 999999999999999999999999997655
Q ss_pred ccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
..... ....+.|||.|||||+++ ..+|+.++||||||++|.+|..+.+|.....+. .-
T Consensus 181 ~~t~q--kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---------------RV 243 (1187)
T KOG0579|consen 181 KSTRQ--KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---------------RV 243 (1187)
T ss_pred hhHHh--hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---------------HH
Confidence 43222 236789999999999874 568999999999999999999999998654321 11
Q ss_pred HhHhhc-ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVD-TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+..+-. ..-....|...+..+.+++..||.+||..||++.++++
T Consensus 244 llKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 244 LLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111111 11122345667788999999999999999999999986
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=301.79 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=201.5
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||++.++ +++.|++|.+..... ....+.+|+.+++.++||||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999987 688999999875432 2346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 81 e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 81 EYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred ecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCc
Confidence 9999999999997653 2788999999999999999999999 999999999999999999999999987
Q ss_pred CCCcccc-------------ccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 221 NQAPDAA-------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 221 ~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
....... .........++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------ 222 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ 222 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 6321100 000112345788999999998888999999999999999999999999643211
Q ss_pred ecccccCChhhHhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 288 TWATPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
........... .......++.++.++|.+||+.+|.+||++.++++.|+.
T Consensus 223 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 ---------ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---------HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111111111 011112456789999999999999999997666665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.99 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=208.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|++.+.||.|++|.||+|... +++.|++|++..... ....+.+|+..+..++|+|++++++++......++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46889999999999999999987 699999999876543 356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
+++++|.+++.... .+++..++.++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 81 MDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999999997652 28899999999999999999999 98 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .......
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-------------~~~~~~~ 213 (264)
T cd06623 149 VLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-------------SFFELMQ 213 (264)
T ss_pred ecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-------------CHHHHHH
Confidence 66443222 12446788999999999888999999999999999999999999655320 1111111
Q ss_pred hhcccCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 302 CVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 302 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.+........+.. ++..+.++|.+||..+|.+|||+.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 AICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1112222233334 67889999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.73 Aligned_cols=253 Identities=30% Similarity=0.387 Sum_probs=205.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|++.+.||.|+||.||+|... ++..+++|++..... ....+.+|++.++.++|+|++++++.+..++..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999976 788999999865433 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++..... ...+++..+..++.|++.||.|||+.| ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 81 LSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred cCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 999999999976432 012789999999999999999999999 99999999999999999999999999876
Q ss_pred Cccccccc--cccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 223 APDAAARL--HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 223 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
........ ......|+..|+|||++... .++.++|+||||+++|+|++|+.||....... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---------------~~ 216 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---------------VL 216 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---------------hH
Confidence 55432221 12344688999999998876 78999999999999999999999997543211 00
Q ss_pred hHhhcc---cCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDT---KLGGE-YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~---~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... ..... ....++..+.+++.+||+.||++|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 217 MLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111110 01001 11355678999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=295.94 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=205.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|+..+.||.|++|.||+|.++ +++.+++|.+..... ....+.+|+++++.++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888899999999999999987 789999999876533 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 81 MDGGSLDKILKEVQ--------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred cCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccch
Confidence 99999999997653 128889999999999999999999 88 9999999999999999999999999986
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... ....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ........
T Consensus 150 ~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----------~~~~~~~~ 215 (265)
T cd06605 150 QLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD----------GIFELLQY 215 (265)
T ss_pred hhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc----------cHHHHHHH
Confidence 6543221 225688899999999999999999999999999999999999964421000 00111111
Q ss_pred hhcccCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 CVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.... .....+.. ++.++.++|.+||..+|.+|||+.+++.
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 216 IVNE-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HhcC-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111 11222333 6778999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=299.68 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=205.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||++... ++..|++|.+..... ..+.+.+|+.+++.++|||++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 3478999999999999999999975 788999999865332 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 97 ~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 97 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred cCCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCccee
Confidence 999999999997543 788899999999999999999999 9999999999999999999999999886
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ .....+++.|+|||.+.+..++.++|+||||+++|++++|..||.............
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------------- 228 (293)
T cd06647 164 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------- 228 (293)
T ss_pred cccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-------------
Confidence 65433221 233468889999999988889999999999999999999999996543221100000
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.........+...+..+.++|.+||+.+|++||++.+++..
T Consensus 229 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 229 -TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111233456679999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=297.51 Aligned_cols=246 Identities=25% Similarity=0.318 Sum_probs=205.1
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
+|++.+.||.|+||.||+|... ++..||+|.+.... ...+.+.+|++++++++||||+++++.+.++...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999977 79999999997543 224678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 999999999997652 2889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....+..
T Consensus 149 ~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------------~~~~~~~ 212 (258)
T cd05578 149 KVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-------------IRDQIRA 212 (258)
T ss_pred ccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-------------HHHHHHH
Confidence 7654321 13456788999999999888999999999999999999999999755321 1111222
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM--GIVL 341 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~--~ell 341 (356)
.... .....+...+..+.++|.+||+.||.+||++ +|++
T Consensus 213 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 213 KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2221 2234455667899999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.97 Aligned_cols=239 Identities=26% Similarity=0.454 Sum_probs=190.3
Q ss_pred ceeeccCceEEEEEEEC-C-------CCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 72 SLIGEGSYGRVYFGVLR-S-------GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+.||.|+||.||+|..+ . ...+++|.+...... .+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999864 2 234888887654322 45678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc--------eeE
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--------AKI 214 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--------vkl 214 (356)
+++|+|.+++..... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++. +++
T Consensus 81 ~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 81 VKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred CCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEe
Confidence 999999999976542 2788899999999999999999999 999999999999987764 699
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCC-CCCCCCCCCCCccceecccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGR-KPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~ 292 (356)
+|||++...... ....++..|+|||++.+ ..++.++||||||+++|+|++|. .||....+
T Consensus 150 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------------ 211 (258)
T cd05078 150 SDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------------ 211 (258)
T ss_pred cccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------------
Confidence 999987654332 23457889999999886 45799999999999999999984 66643211
Q ss_pred cCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
......... ....+...+.++.++|.+||+.+|++|||++++++.|+
T Consensus 212 ----~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 212 ----QKKLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----HHHHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111111 12333344567999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=300.49 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=201.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|++.+.||+|+||.||+|.++ +++.|++|.+..... ..+.+.+|+++++.++|+||+++++++.+++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999987 688999998865322 24678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.++.+..+..... .+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 81 YVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 999876766554432 2789999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec-----------
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW----------- 289 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~----------- 289 (356)
........ ......++..|+|||++.+. .++.++||||||+++|+|++|..||..............
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 149 ALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred ccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 76544321 11335678899999999887 789999999999999999999999975432110000000
Q ss_pred ---ccccCChhhHhHhhcc-cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 ---ATPKLSEDKVKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 ---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
................ .....++..++.++.++|.+||..+|++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000000000 0000122334788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=301.95 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=200.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
..|+....||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..++++||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 34555668999999999999976 789999999865332 3456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++.... +++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 101 ~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 101 QGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred CCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 9999999886533 789999999999999999999999 999999999999999999999999998654
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+. ..+..+.
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---------------~~~~~~~ 230 (297)
T cd06659 168 SKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---------------QAMKRLR 230 (297)
T ss_pred ccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHh
Confidence 43221 123456899999999999888999999999999999999999999643211 1111110
Q ss_pred ccc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 304 DTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 304 ~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
... .........+..+.++|.+||+.+|.+||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 231 DSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 0011122345678999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.66 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=200.8
Q ss_pred CCCCCceeeccCceEEEEEEEC--CCCEEEEEEcCCCCC-----------chHHHHHHHHHHHh-ccCCceeeeeeEEec
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQ-----------PDQEFLAQVSMVSR-LKNENVVELVGYYVD 132 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~ 132 (356)
+|++.+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4888899999999999999976 378899998753211 12346678887765 799999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCCc
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
++..++++||+++++|.+++....... ..+++..++.++.|++.+|.|||+ .+ ++|+||+|+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKK-----QRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCc
Confidence 999999999999999999886432111 238889999999999999999996 66 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
++|+|||++....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 153 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---------- 219 (269)
T cd08528 153 VTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---------- 219 (269)
T ss_pred EEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----------
Confidence 9999999987655432 123456889999999999888999999999999999999999999643210
Q ss_pred ccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
.....+............++..+.++|.+||+.||.+||++.|+.+.+.
T Consensus 220 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 -----SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111111111112245678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.36 Aligned_cols=238 Identities=25% Similarity=0.441 Sum_probs=190.8
Q ss_pred ceeeccCceEEEEEEECC-C----------CEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 72 SLIGEGSYGRVYFGVLRS-G----------RAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
+.||+|+||.||+|.... + ..+++|.+.........+.+|+.+++.++||||+++++++.. ...++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 468999999999999763 3 257888776554436778899999999999999999999888 7789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-------cee
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-------IAK 213 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-------~vk 213 (356)
||+.+++|.+++..... .+++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .++
T Consensus 80 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred EcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence 99999999999986542 2788999999999999999999999 99999999999999887 799
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCC--CCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 290 (356)
|+|||++...... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||........
T Consensus 149 l~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~------- 215 (259)
T cd05037 149 LSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------- 215 (259)
T ss_pred eCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------
Confidence 9999998765431 233467789999998876 78999999999999999999 5778765421110
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
........ ..+......+.++|.+||..+|.+|||+.++++.|+
T Consensus 216 ---------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 216 ---------ERFYQDQH--RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---------HHHHhcCC--CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000 001111267899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=313.84 Aligned_cols=242 Identities=23% Similarity=0.351 Sum_probs=197.7
Q ss_pred CCceeeccCceEEEEEEEC-CCCEEEEEEc---CC--CCCchHHHHHHHHHHHhccCCceeeeeeEEecCCe--eEEEEE
Q 018396 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKL---DS--SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL--RVLAYE 141 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~---~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~--~~lv~e 141 (356)
...+||+|+|-+||+|.+. +|-.||--.+ .. .....+++..|+++|+.|+||||+++++++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4568999999999999976 6777774333 22 23334789999999999999999999999987665 778999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeEeccccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a 220 (356)
.+..|+|..|+.+.+. .....+..|++||++||.|||++. |+|+|||||-+||||+. -|.|||+|+|+|
T Consensus 124 L~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred cccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHH
Confidence 9999999999998875 788899999999999999999996 45999999999999985 489999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ ....|||.|||||+.. ..|+..+||||||+.+.||+|+..||..-.. ...+.
T Consensus 194 tl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---------------~AQIY 253 (632)
T KOG0584|consen 194 TLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---------------PAQIY 253 (632)
T ss_pred HHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---------------HHHHH
Confidence 87765433 4578999999999877 8999999999999999999999999975532 22233
Q ss_pred HhhcccCCCCCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPKA-IAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+-.+........+ .++++++|.+||.. ..+|||+.|+|.
T Consensus 254 KKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 254 KKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 333333222211111 36899999999998 999999999997
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=299.40 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=198.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
+.++|++.+.||+|++|.||+|..+ +++.||+|.+...... ...+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 3478999999999999999999987 7899999998654322 345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+ +|.+++..... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 83 e~~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 83 EYLDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred ecCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccc
Confidence 99985 99998875432 2788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCC-ccceecccccCChhh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSLVTWATPKLSEDK 298 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 298 (356)
......... .....++..|+|||++.+ ..++.++||||+|+++|+|++|..||........ ...............
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 151 RAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred cccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 654322111 122346889999998875 4578999999999999999999999965431100 000000000000000
Q ss_pred HhHhhc--------------ccCCCCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVD--------------TKLGGEYP-PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~--------------~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... .......+ ......+.+++.+||+.+|.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 00000000 011257889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=291.59 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=202.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|.+.+.||+|+||.||+|... +++.|++|.+..... ....+.+|+.+++.++|+||+++++.+.+.+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999976 789999999876544 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 81 CSGGTLEELLEHGRI---------LDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CCCCcHHHHHhhcCC---------CChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence 999999999976432 778889999999999999999999 99999999999999999999999999877
Q ss_pred Ccccccccc--ccccccCcCccCcccccCCC---CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 223 APDAAARLH--STRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 223 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
......... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||...... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---------------~ 213 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---------------F 213 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---------------H
Confidence 654322111 12345788999999998766 889999999999999999999999643211 0
Q ss_pred hHhHhhcccCCCCCCH--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPP--KAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.....+........+. .++..+.+++.+||+.+|.+|||+.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 214 QIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011111111112222 33678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=293.44 Aligned_cols=249 Identities=19% Similarity=0.296 Sum_probs=188.7
Q ss_pred eeeccCceEEEEEEECC---CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018396 73 LIGEGSYGRVYFGVLRS---GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 147 (356)
.||+|+||.||++...+ ...+++|.+..... ..+.+.+|+.+++.++||||+++++.+.+....+++|||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 69999999999997542 34566777665432 24678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccc
Q 018396 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (356)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (356)
|.+++....... .......++.++.||+.||+|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 82 L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 82 LKSYLSQEQWHR-----RNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred HHHHHHhhhccc-----ccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch
Confidence 999997643211 12567778899999999999999999 9999999999999999999999999976432222
Q ss_pred ccccccccccCcCccCcccccC-------CCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhH
Q 018396 228 ARLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
.........++..|+|||++.. ..++.++||||||+++|+|++ |..||....+. +.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---------------~~~ 218 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---------------EVL 218 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---------------HHH
Confidence 1112234567889999998753 245778999999999999997 67788543211 111
Q ss_pred hHhhcc----cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 300 KQCVDT----KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 300 ~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
...+.. ..........++.+.+++..|| .+|.+||++++|++.|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 219 NHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111 0112222335667888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.60 Aligned_cols=237 Identities=27% Similarity=0.443 Sum_probs=186.6
Q ss_pred eeeccCceEEEEEEEC-------------------------CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeee
Q 018396 73 LIGEGSYGRVYFGVLR-------------------------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVEL 126 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~-------------------------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~ 126 (356)
.||+|+||.||+|... ....|++|++...... ...+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999742 1235888988654332 3467888999999999999999
Q ss_pred eeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE
Q 018396 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (356)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (356)
++++.+....++||||+++++|..++..... .+++..+..++.|++.||+|||+++ ++||||||+||++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill 150 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL 150 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence 9999999999999999999999999865332 2788999999999999999999999 9999999999999
Q ss_pred ccCC-------ceeEecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHH-cCCCCCCC
Q 018396 207 FDDD-------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELL-TGRKPVDH 277 (356)
Q Consensus 207 ~~~~-------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~-~g~~pf~~ 277 (356)
+..+ .++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|+|+ +|..||..
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred eccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 7644 4899999987544322 22346788999998875 56899999999999999995 69999964
Q ss_pred CCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 278 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
..+. .......... ..+......+.++|.+||+.+|.+|||+.++++.|
T Consensus 225 ~~~~----------------~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 225 RTPS----------------EKERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred cChH----------------HHHHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 4221 1111111111 11122335789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=293.87 Aligned_cols=245 Identities=24% Similarity=0.382 Sum_probs=199.6
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhcc---CCceeeeeeEEecCCeeEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~ 140 (356)
.|+..+.||.|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++ |||++++++++.++...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4788899999999999999975 789999999865422 2456788999999986 999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++.... +++..++.++.|++.||.|||+.| ++|+||+|+||++++++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 82 EYAEGGSVRTLMKAGP----------IAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred ecCCCCcHHHHHHccC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCce
Confidence 9999999999986542 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
......... .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------------- 212 (277)
T cd06917 149 ALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------------- 212 (277)
T ss_pred eecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--------------
Confidence 766543321 234468899999998865 456889999999999999999999997543211100
Q ss_pred hHhhcccCCCCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKLGGEYPP-KAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+........+. ..+.++.+++.+||+.||.+||++.+++.
T Consensus 213 --~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 213 --LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 000000011111 25568999999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.27 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=201.0
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|++.+.||.|+||.||+|... +++.|++|++..... ....+.+|+.++++++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999976 789999999875432 245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+ +++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~-~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 81 M-PSDLSEVLRDEE--------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred c-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 9 999999987543 12889999999999999999999999 99999999999999999999999999877
Q ss_pred CccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh----
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED---- 297 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 297 (356)
....... ......++..|+|||++.+. .++.++||||+|+++|+|++|.+||....+.................
T Consensus 149 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 149 FSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred ccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 6543221 11334688999999998754 46899999999999999999988886543211000000000000000
Q ss_pred -----hHhHhhcccCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 -----KVKQCVDTKLG----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 -----~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........... .....+.+..+.+++.+||+.+|++|||+++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0011234578999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=291.63 Aligned_cols=241 Identities=21% Similarity=0.295 Sum_probs=200.6
Q ss_pred eeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
||.|++|.||+|... +++.+++|++..... ..+.+.+|+.+++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 689999999865432 245688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (356)
.+++..... ++...+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 81 WTILRDRGL---------FDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred HHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc
Confidence 999976542 788999999999999999999999 99999999999999999999999999877654321
Q ss_pred cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCC
Q 018396 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (356)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (356)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...............
T Consensus 149 ---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------~~~~~~~~~~~~~~~ 212 (262)
T cd05572 149 ---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-------------DPMEIYNDILKGNGK 212 (262)
T ss_pred ---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-------------CHHHHHHHHhccCCC
Confidence 1334678999999999888899999999999999999999999975531 011112222222233
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 018396 309 GEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 342 (356)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~ 342 (356)
...+...+.++.++|.+||+.+|.+||+ ++|+++
T Consensus 213 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 213 LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3455555789999999999999999999 778776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=294.36 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=207.9
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
...+.|+..+.||+|++|.||+|.+. ++..+++|++.......+.+.+|+++++.++|+|++++++.+......++++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 35567999999999999999999987 78999999997655445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++.
T Consensus 96 ~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 96 YMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred ccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhh
Confidence 999999999998754 12889999999999999999999999 9999999999999999999999999876
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ .....++..|+|||++.+..++.++|+||||+++|+|++|..||....+. .....
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---------------~~~~~ 227 (286)
T cd06614 165 QLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---------------RALFL 227 (286)
T ss_pred hhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHH
Confidence 55432211 13345788999999998888999999999999999999999999643211 11111
Q ss_pred hhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 CVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... ....+..++..+.++|.+||+.+|.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111111 11122336678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=288.21 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=209.2
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecC--CeeEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAY 140 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 140 (356)
+|...+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.++++++||||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999987 789999999876542 356788999999999999999999999988 8999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+++|.+++.... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999998654 2899999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
................++..|+|||.+.+..++.++||||||+++|+|++|..||..... ......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------------~~~~~~ 214 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--------------PMAALY 214 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------------hHHHHH
Confidence 776554321112345688999999999888899999999999999999999999975531 111112
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...........+...+..+.++|.+||+.+|.+||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 222222333455566789999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=293.44 Aligned_cols=241 Identities=23% Similarity=0.316 Sum_probs=190.9
Q ss_pred eeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHH---hccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVS---RLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~---~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.||+|+||.||++... +++.+|+|.+...... ...+.+|..+++ ..+||||+.+++++...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999976 7899999988654321 223344444433 3479999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999987543 2899999999999999999999999 9999999999999999999999999986554
Q ss_pred cccccccccccccCcCccCccccc-CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
... .....|++.|+|||.+. +..++.++||||+||++|+|++|..||....... .......
T Consensus 149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------------~~~~~~~- 210 (279)
T cd05633 149 KKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEIDRM- 210 (279)
T ss_pred ccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-------------HHHHHHH-
Confidence 322 12346899999999886 4568999999999999999999999996542211 0111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 343 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~ 343 (356)
........+..++.++.++|.+||+.||.+|| |++++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 211 TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11122244556778999999999999999999 69998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=296.06 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=199.6
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
+|++.+.||+|++|.||+|... +++.|++|.+...... ...+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999976 7899999999754332 34567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+ +++|.+++..... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred Eccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEcccee
Confidence 9999 8899999976431 2889999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh-
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED- 297 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 297 (356)
+......... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||....+.................
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 149 ARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226 (298)
T ss_pred eeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence 8776543221 123346788999998865 457899999999999999999988886543211000000000000000
Q ss_pred -----hHhHhhcccCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 -----KVKQCVDTKLGG-----EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 -----~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
............ ......+..+.++|.+||+.+|.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000 111234678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=293.99 Aligned_cols=254 Identities=28% Similarity=0.337 Sum_probs=201.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEec--CCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 140 (356)
++|+..+.||.|++|.||++... +++.+|+|.+..... ....+.+|+++++.++||||+++++++.+ ....+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999986 789999999875433 34668899999999999999999998864 44789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++....... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRG-----GRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EecCCCCHHHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccc
Confidence 9999999999876432211 23788899999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+..
T Consensus 153 ~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----------~~~~~~~ 217 (287)
T cd06621 153 GELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-----------LGPIELL 217 (287)
T ss_pred cccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-----------CChHHHH
Confidence 65543221 23457889999999998899999999999999999999999997542210 0001111
Q ss_pred Hhhcc----cCCCCCC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDT----KLGGEYP--PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~----~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+.. ....... ...++.+.++|.+||+.+|.+|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 218 SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111 0111111 234678999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=293.56 Aligned_cols=243 Identities=24% Similarity=0.337 Sum_probs=196.0
Q ss_pred eeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
||+|+||+||+|..+ +++.+|+|.+..... ....+.+|+++++.++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999976 789999999865321 234567899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (356)
.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 150 (277)
T cd05577 81 KYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK 150 (277)
T ss_pred HHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc
Confidence 999976542 12889999999999999999999999 99999999999999999999999999876543211
Q ss_pred cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCC
Q 018396 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (356)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (356)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ....+...+. ...
T Consensus 151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------~~~~~~~~~~-~~~ 214 (277)
T cd05577 151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV------------EKEELKRRTL-EMA 214 (277)
T ss_pred ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc------------cHHHHHhccc-ccc
Confidence 133457889999999988889999999999999999999999996542210 1111111111 112
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 309 GEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
...+...++.+.++|.+||+.+|.+|| ++.+++.
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 234445678899999999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=291.25 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=203.0
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|++.+.||.|+||.||++..+ ++..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+....++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999977 68899999986542 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-ceeEecccccC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~ 221 (356)
+++++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 81 CDGGDLMKRINRQRGV-------LFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred CCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccch
Confidence 9999999999764321 2789999999999999999999999 99999999999999886 46999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ......
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------------~~~~~~ 213 (257)
T cd08225 151 QLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---------------HQLVLK 213 (257)
T ss_pred hccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---------------HHHHHH
Confidence 66443221 1234588999999999888899999999999999999999999964321 111111
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..... ........+..+.+++.+||+.+|.+|||+.++++.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 214 ICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred Hhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111 112333456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.80 Aligned_cols=263 Identities=20% Similarity=0.290 Sum_probs=198.0
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|+..+.||.|++|.||+|+.. +++.||||.+...... ...+.+|++++++++||||+++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999976 7899999998654322 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+. ++|.+++...... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 81 LH-QDLKKFMDASPLS-------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred cc-cCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 96 5899988754322 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCC-CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc-cceecccccCC-----
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWATPKLS----- 295 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~----- 295 (356)
....... .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||......... ...........
T Consensus 150 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 150 FGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred cccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 5432211 12334688999999887644 588999999999999999999999654321100 00000000000
Q ss_pred hhhH---hHhhcccCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKV---KQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.... ......... .......+.++.++|.+||+.||.+|||+++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 000000000 0011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=300.24 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=199.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|++.+.||+|+||.||+|..+ +++.||+|.+...... .+.+.+|+++++.++||||+++++++.++...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999987 6899999988654322 3567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|.++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 81 FVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred cCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 999988888765432 2789999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ .....++..|+|||++.+ ..++.++||||||+++|+|++|.+||...................... ..
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 225 (286)
T cd07846 149 TLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR-HQ 225 (286)
T ss_pred eccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh-hH
Confidence 65433221 133457889999998875 446889999999999999999999996443210000000000000000 00
Q ss_pred Hh------hcccCCC---------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QC------VDTKLGG---------EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~------~~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. ....... ...+..+..+.+++.+||+.+|.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 0000000 011245678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=310.38 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=214.7
Q ss_pred CCCCceeeccCceEEEEEEEC--CCC--EEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR--SGR--AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..+.++||+|.||.|++|.|. +|+ .||||.+...... ..+|++|+.+|-+|+|||++++|++..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 445678999999999999976 343 6899999765443 5789999999999999999999999887 77889999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
.++.|+|.+.|.+... ..+.......++.||+.|+.||..++ +|||||...|+++.....|||+|||+++
T Consensus 191 LaplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hcccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence 9999999999987322 23788889999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhH
Q 018396 222 QAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 222 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
.++..+... ......-...|+|||.+....++.++|||++||++|||++ |..||-+. ....+
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~----------------~g~qI 324 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC----------------RGIQI 324 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC----------------CHHHH
Confidence 876654332 1222233567999999999999999999999999999998 99999644 44566
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
.+.+|.+-+...+..|++++++++..||..+|++|||+..|.+.+-
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 7778888888999999999999999999999999999999975443
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=318.71 Aligned_cols=271 Identities=18% Similarity=0.254 Sum_probs=190.7
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC--CCCEEEEE------------------EcCCCCCchHHHHHHHHHHHhccCCc
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIK------------------KLDSSKQPDQEFLAQVSMVSRLKNEN 122 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~e~~~l~~l~hp~ 122 (356)
...++|++.+.||+|+||+||+|..+ .+..+++| .+.........+.+|+.+++.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34678999999999999999998754 22222222 11111222345789999999999999
Q ss_pred eeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCC
Q 018396 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (356)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~ 202 (356)
|+++++++.+.+..|++++++.+ +|.+++....... ........+..++.||+.||.|||+++ |+||||||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~----~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~ 296 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLE 296 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccc----cccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 99999999999999999999865 7888775443211 011345678889999999999999999 999999999
Q ss_pred cEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCC-CCCCCCCC
Q 018396 203 NVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK-PVDHTLPR 281 (356)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~-pf~~~~~~ 281 (356)
|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|.. ||......
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 999999999999999999776543221 1234579999999999999999999999999999999999775 44322111
Q ss_pred CCccceec------ccccCC--hhhHhHhhcccCCC----CCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 282 GQQSLVTW------ATPKLS--EDKVKQCVDTKLGG----EYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 282 ~~~~~~~~------~~~~~~--~~~~~~~~~~~~~~----~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+... ....+. ...+...+...... ..+ ...+..+.++|.+||+.||.+|||+.|++.
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 000000 01111111111000 000 012346778899999999999999999986
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=330.10 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=215.0
Q ss_pred CHHHHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEe
Q 018396 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYV 131 (356)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 131 (356)
...++....++|+++++||+|+||.|.+++.+ +++.||+|++.+. .....-|..|-.+|..-+.+=|+++...|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 44567777899999999999999999999987 8999999999762 333466888999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 132 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
+..++|+||||++||+|..++..... +++.-+..++..|+.||.-||+.| +|||||||+|||+|..|+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~~---------~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFDR---------LPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcCC---------ChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCc
Confidence 99999999999999999999988762 899999999999999999999999 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCccccc----C-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM----T-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
+||+|||.+-..... ....+...+|||.|++||++. + +.|+..+|+||+||++|||+.|..||....-
T Consensus 214 ikLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------ 286 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------ 286 (1317)
T ss_pred EeeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------
Confidence 999999988766532 334456778999999999985 3 5689999999999999999999999964421
Q ss_pred eecccccCChhhHhHhhcccCCCCCC--HHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 018396 287 VTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADFRPN---MGIVLK 342 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps---~~ell~ 342 (356)
-+.+..+++-.-...+| ..++.++.+||.+.+. +|+.|.. ++++-.
T Consensus 287 ---------veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 287 ---------VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ---------HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 12233333332223444 5678999999999995 7888887 777654
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=292.76 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=200.0
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.|...+.||.|++|.||++... +++.+++|.+...... .+.+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999976 7889999988644322 4567899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++.... +++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.+....
T Consensus 100 ~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 100 GGALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 999999987632 788999999999999999999999 9999999999999999999999999876543
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....+. ........
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---------------~~~~~~~~ 229 (285)
T cd06648 167 KEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---------------QAMKRIRD 229 (285)
T ss_pred cCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---------------HHHHHHHh
Confidence 3221 113346889999999998888999999999999999999999999643211 11111111
Q ss_pred cc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 305 TK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 305 ~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. .....+..++..+.++|.+||+.+|.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 230 NLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 10 011112235678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=288.33 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=202.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC------CchHHHHHHHHHHHhccCCceeeeeeEEecC--Cee
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 136 (356)
.+|++.+.||+|+||.||+|.+. ++..||+|.+.... .....+.+|++++++++|+||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999976 78999999875321 1234678899999999999999999998754 568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++++||+++++|.+++..... +++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA---------LTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECc
Confidence 899999999999999875432 788889999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++......... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||.... .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---------------~ 214 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE---------------A 214 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC---------------H
Confidence 9998765321110 11123468899999999998889999999999999999999999996431 1
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
................+...++.+.+++.+||+ +|..|||+.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 215 MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 122233333333345667788899999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.03 Aligned_cols=245 Identities=29% Similarity=0.388 Sum_probs=197.5
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..|...+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++||||+++.+++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56889999999999999999976 7899999988643221 246789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 95 e~~~g-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 95 EYCLG-SASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred HhhCC-CHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcc
Confidence 99975 77777754321 2789999999999999999999999 999999999999999999999999988
Q ss_pred CCCccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
...... ....+++.|+|||++. ...++.++||||||+++|+|++|..||...... .
T Consensus 163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---------------~ 221 (307)
T cd06607 163 SLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------------S 221 (307)
T ss_pred eecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---------------H
Confidence 654322 2345788999999874 356788999999999999999999999643211 0
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..............+..++..+.++|.+||+.+|.+||++.+++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 222 ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111111111112233466789999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.65 Aligned_cols=246 Identities=29% Similarity=0.457 Sum_probs=204.9
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
+|+..+.||+|++|.||++... +++.+++|++..... ....+.+|+++++.++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999987 789999999976554 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++.... ..+++..++.++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||.+....
T Consensus 81 ~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 81 GGSLKDLLKSTN--------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred CCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 999999997753 12899999999999999999999998 9999999999999999999999999987765
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 150 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~ 211 (253)
T cd05122 150 DTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---------------KALFKIAT 211 (253)
T ss_pred cccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---------------HHHHHHHh
Confidence 4432 23456889999999998888999999999999999999999999644210 11111111
Q ss_pred ccCCCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 305 TKLGGE--YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 305 ~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..... .+..++..+.++|.+||+.||.+|||+.++++
T Consensus 212 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 212 -NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 11223678999999999999999999999885
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=295.12 Aligned_cols=264 Identities=20% Similarity=0.257 Sum_probs=195.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++|+||+++.+++.++...++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999976 7899999998654322 3467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+. ++|.+++..... .+.+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 84 YMH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred ccc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence 996 578777754321 2677888899999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH-
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV- 299 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 299 (356)
........ .....+++.|+|||++.+. .++.++||||||+++|+|++|..||.............+.......+..
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 152 AKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred ccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 54332211 1334578999999998764 5788999999999999999999999754321000000000000000000
Q ss_pred ---------hHhhcccC-CCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 ---------KQCVDTKL-GGEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ---------~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........ .... ....+..+.+++.+|++.||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0000 0012457889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=304.39 Aligned_cols=262 Identities=19% Similarity=0.218 Sum_probs=199.3
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecC-----
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----- 133 (356)
...++|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35678999999999999999999976 799999999865322 234677899999999999999999987643
Q ss_pred -CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 134 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
...++|+||+.+ +|.+.+... ++...+..++.|++.||.|||++| ++|+||||+||+++.++.+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence 357999999975 888887532 678889999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
+|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++|+.||.................
T Consensus 158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999876544321 1334578999999999999999999999999999999999999965432110000000000
Q ss_pred c----------------------CChhhHhHhhcc----cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 293 K----------------------LSEDKVKQCVDT----KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 293 ~----------------------~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. ............ ......+...+..+.++|.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000000000000 0001112244677899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=327.42 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=190.3
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecC------
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------ 133 (356)
.-..+|+..++||+||||.||+++++ +|+.||||+|.... .....+.+|+..|.+|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34568999999999999999999999 99999999998764 3345688999999999999999987433210
Q ss_pred --------------------------------------------------------------------------------
Q 018396 134 -------------------------------------------------------------------------------- 133 (356)
Q Consensus 134 -------------------------------------------------------------------------------- 133 (356)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 018396 134 ---------------------------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180 (356)
Q Consensus 134 ---------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~ 180 (356)
..+||-||||+..+|.+++..+... -.....|.++++|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREIL 707 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHHH
Confidence 1157778888887777777665421 13677899999999
Q ss_pred HHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc----c------------ccccccccccccCcCccCc
Q 018396 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP----D------------AAARLHSTRVLGTFGYHAP 244 (356)
Q Consensus 181 ~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~----~------------~~~~~~~~~~~gt~~y~aP 244 (356)
.||.|+|++| ||||||||.|||+++++.|||+|||+|+... . .......+..+||..|+||
T Consensus 708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999999 9999999999999999999999999998721 0 0111124567899999999
Q ss_pred ccccCC---CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh-HhHhhcccCCCC--CCHHHHHH
Q 018396 245 EYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK-VKQCVDTKLGGE--YPPKAIAK 318 (356)
Q Consensus 245 E~~~~~---~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~ 318 (356)
|++.+. .|+.++|+||||++++||+. ||..... ... +..+.+..+..+ +..+.-+.
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME---------------Ra~iL~~LR~g~iP~~~~f~~~~~~~ 846 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME---------------RASILTNLRKGSIPEPADFFDPEHPE 846 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH---------------HHHHHHhcccCCCCCCcccccccchH
Confidence 998764 49999999999999999986 4643311 111 111111111111 12223345
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHH
Q 018396 319 MAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 319 l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
-..+|.+++++||.+||||.|+|.
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhh
Confidence 678999999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=298.99 Aligned_cols=265 Identities=26% Similarity=0.311 Sum_probs=198.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC--CeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~ 137 (356)
..++|++.+.||.|+||.||+|..+ +|+.||+|.+...... ...+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3568999999999999999999976 7999999998643322 23467899999999999999999998754 5689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+|+||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||||+||++++++.++|+||
T Consensus 85 lv~e~~~~-~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP--------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred EEEecCCC-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 99999975 8988887543 12889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|.+||....+................
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 998776543211 122345788999999875 55789999999999999999999999755332111000000000000
Q ss_pred hhHhHh--------hc-ccCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQC--------VD-TKLGG----EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~--------~~-~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... .. ..... ......+..+.++|.+||+.||++|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 00 00000 001123677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.29 Aligned_cols=250 Identities=29% Similarity=0.390 Sum_probs=201.2
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.|...+.||+|+||.||+|... ++..+|+|.+...... ...+.+|+++++.++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4778889999999999999976 7899999998653222 2467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+ +|.+++..... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 106 ~~~g-~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 106 YCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred CCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCcc
Confidence 9975 78777754321 2889999999999999999999999 9999999999999999999999999876
Q ss_pred CCccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
..... ....+++.|+|||++. ...++.++|||||||++|+|++|..||..... ...
T Consensus 174 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---------------~~~ 232 (317)
T cd06635 174 IASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------MSA 232 (317)
T ss_pred ccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---------------HHH
Confidence 54332 3346888999999874 45688999999999999999999999864311 111
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
...+............++..+.+++.+||+.+|.+||++.++++.+..+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 222222222222233566789999999999999999999999986654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.34 Aligned_cols=271 Identities=23% Similarity=0.303 Sum_probs=201.2
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecC-----Cee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDG-----PLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~ 136 (356)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999976 78999999986432 2245678899999999999999999887644 357
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++++||+.+ +|.+++.... +++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~d 149 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICD 149 (336)
T ss_pred EEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECc
Confidence 999999975 8888886543 889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccc-cccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
||++.......... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...................
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~ 229 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99987654322111 1123468899999998754 568899999999999999999999996432111000000000000
Q ss_pred ChhhHhHhhccc---------CCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhhc
Q 018396 295 SEDKVKQCVDTK---------LGGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA--LQPLLN 349 (356)
Q Consensus 295 ~~~~~~~~~~~~---------~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~--L~~l~~ 349 (356)
..+....+.... .... ..+..+.++.++|.+||+.+|++|||+.++++. |.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 111111111100 0000 012345679999999999999999999999985 555543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=310.34 Aligned_cols=274 Identities=23% Similarity=0.368 Sum_probs=210.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC--CCchHHHHHHHHHHHhccCCceeeeeeEEecC------Cee
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PLR 136 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~~~ 136 (356)
..|+..+.||+|+||.||+++++ +|+.||||.+... ....+...+|+++|++|+|+|||+++++-++. +..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 45778889999999999999977 8999999999763 33456788999999999999999999986543 356
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc--cCC--ce
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDD--IA 212 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~--~v 212 (356)
.++||||.||+|...++...+.. .+++.+.+.++..+..||.|||++| ||||||||.||++- .+| ..
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~------GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAY------GLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred eEEEeecCCCcHHHHhcCccccc------CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEE
Confidence 79999999999999998776543 3899999999999999999999999 99999999999985 334 57
Q ss_pred eEecccccCCCccccccccccccccCcCccCccccc-CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
||+|||.|+...+.... ....||..|++||++. .+.|+..+|.|||||++|+++||..||......+...-..|..
T Consensus 164 KLtDfG~Arel~d~s~~---~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~ 240 (732)
T KOG4250|consen 164 KLTDFGAARELDDNSLF---TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI 240 (732)
T ss_pred eeecccccccCCCCCee---eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh
Confidence 99999999998876643 7788999999999998 4889999999999999999999999997654432211111111
Q ss_pred ccCChhhH--------hHhhcccC----CCCCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHhhccC
Q 018396 292 PKLSEDKV--------KQCVDTKL----GGEYPPKAIAKMAAVAALCVQYEADFRP--NMGIVLKALQPLLNTR 351 (356)
Q Consensus 292 ~~~~~~~~--------~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rp--s~~ell~~L~~l~~~~ 351 (356)
-.-...-+ ..-+.-.. .....+.....+-..+..+|..+|++|. .+.+.-..++++++..
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 00000000 00000000 1112233344566778889999999999 8888888888887643
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=295.84 Aligned_cols=267 Identities=19% Similarity=0.247 Sum_probs=196.5
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc-CCceeeeeeEEecCCe-----
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGPL----- 135 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~----- 135 (356)
++|++.+.||+|+||.||+|.+. +++.||+|.+...... ...+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999976 7899999988654322 356788999999995 6999999999887665
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeE
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKI 214 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl 214 (356)
.+++|||+++ +|.+++...... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.++|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEE
Confidence 8999999986 899988654321 1123789999999999999999999999 999999999999998 889999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....+.............
T Consensus 153 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 153 ADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred eecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998765332211 122356889999998865 45789999999999999999999999654321100000000000
Q ss_pred CChhhHhHhhc-------ccCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 LSEDKVKQCVD-------TKLG----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 ~~~~~~~~~~~-------~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........... .... ....+..+.++.++|.+||+.||.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000 0000 0011235677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=288.02 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=207.2
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|++.+.||.|++|.||++... +++.+++|.+..... ....+.+|+.+++.++|+||+++.+++.+....++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888899999999999999876 788999999875432 234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++...... ...+++..++.++.|++.||.|||+.| ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 81 APFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred cCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999998763211 123889999999999999999999999 99999999999999999999999999877
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
..... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......
T Consensus 153 ~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----------------~~~~~~ 212 (256)
T cd08530 153 LKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----------------QDLRYK 212 (256)
T ss_pred hccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 65431 1334578899999999998899999999999999999999999964421 122222
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+........+...+.++.+++.+||+.+|.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 213 VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 3333333445567788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.46 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=200.2
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC--CeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 138 (356)
.++|++.+.||.|+||.||+|..+ +++.+++|.+...... ...+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 457999999999999999999987 7889999998754322 23467899999999999999999998877 89999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
++||+.+ +|.+++..... .+++..++.++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||
T Consensus 84 v~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred EehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 9999985 99999876432 2889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++......... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......................
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 152 LAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred ceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 98766543211 1234578899999988764 46889999999999999999999997543211000000000000000
Q ss_pred --------------hHhHhhcccCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 --------------KVKQCVDTKLGGEYPPK-AIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 --------------~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.........+....+.. .+..+.++|.+||+.+|++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000111112222 4677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=334.58 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=211.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
.-+|.....||.|.||.||.|.+. +|+..|+|.+...... -..+.+|+.++..|+|||+|+++++-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 346888899999999999999976 8999999988644332 356789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|||++|+|.+++...+. .++.....+..|++.|+.|||+.| ||||||||.||+++.+|.+|++|||.|
T Consensus 1314 EyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccce
Confidence 99999999999988764 566777788999999999999999 999999999999999999999999999
Q ss_pred CCCcccccc--ccccccccCcCccCcccccCC---CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 221 NQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 221 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
......... .......||+.|||||++.+. ....++|||||||++.||+||+.||...+..
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------------- 1447 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------------- 1447 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------------
Confidence 876543211 112456799999999999764 4677899999999999999999999755321
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
=.+.-.+..+-..++|...+.+-+++|..||..||.+|.++.||++.
T Consensus 1448 -~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 -WAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -hHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11222334444557788899999999999999999999999988774
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=291.91 Aligned_cols=274 Identities=28% Similarity=0.405 Sum_probs=220.1
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHh--ccCCceeeeeeEEecCC----eeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDGP----LRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hp~iv~~~~~~~~~~----~~~l 138 (356)
........++|+|.||.||+|... ++.||||++.... .+.+.+|-++.+. ++|+||++++++-..+. .++|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 344556678999999999999987 5899999997543 3567777777554 58999999999877655 8999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC------CCCeeecCCCCCcEEEccCCce
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA------EPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~------~~~ivH~Dlkp~Nill~~~~~v 212 (356)
|++|.+.|+|.+||..+. ++|....+++..+++||+|||+.- .++|+|||||..||||.+|++.
T Consensus 286 Vt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred EeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 999999999999999876 999999999999999999999753 4469999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCC-CC-----ccchhhhHHHHHHHHHcCCCCCC-CCCCCCCcc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MS-----SKSDVYSFGVVLLELLTGRKPVD-HTLPRGQQS 285 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~~l~~g~~pf~-~~~~~~~~~ 285 (356)
.|+|||+|..+............+||.+|||||++.+.- .. .+.||||+|.+||||+++..-+. +..+.-+..
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 999999998876544433334578999999999997642 22 35899999999999999776554 444444555
Q ss_pred ceecccccCChhhHhHhhcccC-CCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 286 LVTWATPKLSEDKVKQCVDTKL-GGEYPP-----KAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
+........+.++++..+-... +..++. .....+.+.+..||..||+-|.|+.=+.+++.++....
T Consensus 436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 6656667777788888765443 434433 22457889999999999999999999999998877544
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.20 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=207.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|++.+.||.|+||.||++.+. ++..+++|++..... ....+.+|+++++.++|||++++.+.+..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888899999999999999976 789999999976533 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++..... ....+++..+..++.+++.||.|||+.| ++|+||+|+||++++++.++|+|||.+..
T Consensus 81 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 81 ADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred cCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence 999999999986531 1123899999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ..+...
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----------------~~~~~~ 214 (258)
T cd08215 153 LSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL----------------LELALK 214 (258)
T ss_pred cccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH----------------HHHHHH
Confidence 654331 12345688999999999888899999999999999999999999964421 111222
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.........+..++..+.+++.+||..+|.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 215 ILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2222223344456778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=301.59 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=204.9
Q ss_pred CCCC--CceeeccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 67 NFGT--NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 67 ~~~~--~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
-|.+ .++||+|.||+||-|.++ +|+.||||+|.+. .+....+++|+.+|+.+.||.||.+...|+..++.++||
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 3444 478999999999999976 8999999999764 333577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC---CceeEecc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISDF 217 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~Df 217 (356)
|.+.| +..+.|-..... .+++.....+..||+.||.|||.++ |||+||||+|||+.+. ..+|||||
T Consensus 643 EKl~G-DMLEMILSsEkg-------RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 643 EKLHG-DMLEMILSSEKG-------RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hhhcc-hHHHHHHHhhcc-------cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccc
Confidence 99976 766666544432 2888899999999999999999999 9999999999999764 47999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|.|+..+....+ +..+|||.|+|||++.++.|+..-|+||.|||+|--++|..||..+.+..+
T Consensus 712 GfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-------------- 774 (888)
T KOG4236|consen 712 GFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-------------- 774 (888)
T ss_pred cceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--------------
Confidence 999998877655 778999999999999999999999999999999999999999976532110
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+ +.-.-.+....-.+.+.+..+||+..|+..-.+|.|....+.
T Consensus 775 QI-QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 775 QI-QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred Hh-hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 00 000111222334567788999999999999999999887654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=290.98 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=200.2
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
+|++.+.||.|++|.||+|++. ++..||+|.+...... ...+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999987 7899999998754332 456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
.+ +|.+++...... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~-~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 81 DK-DLKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred Cc-cHHHHHHhcCCC------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 86 899888654321 23889999999999999999999999 999999999999999999999999998654
Q ss_pred ccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... .....++..|++||++.+ ..++.++||||||+++|+|++|..||...........................
T Consensus 151 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07836 151 GIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228 (284)
T ss_pred cCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence 332111 123456889999998866 45688999999999999999999999765432110000000000000000000
Q ss_pred hc-ccCC-----------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VD-TKLG-----------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~-~~~~-----------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. ..+. ....+..+..+.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0000 0112234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=285.71 Aligned_cols=249 Identities=21% Similarity=0.245 Sum_probs=197.0
Q ss_pred HHHHHHhCCCCCCcee--eccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCC
Q 018396 59 DELKEKTDNFGTNSLI--GEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (356)
Q Consensus 59 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~ 134 (356)
.+.....++|++.+.+ |.|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++.+...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3445556788887776 99999999999976 788999999865432211 22222222 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-cee
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAK 213 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vk 213 (356)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEE
Confidence 9999999999999999997653 2899999999999999999999999 99999999999999998 999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|+|||++...... ....++..|+|||++.+..++.++||||+|+++|+|++|..||.......
T Consensus 151 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~----------- 213 (267)
T PHA03390 151 LCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE----------- 213 (267)
T ss_pred EecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-----------
Confidence 9999998765432 23458899999999998899999999999999999999999997432211
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-MGIVLK 342 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ell~ 342 (356)
.....+..... .....+...+..+.++|.+||+.+|.+||+ ++++++
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 214 LDLESLLKRQQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhHHHHHHhhc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11111222211 111333467788999999999999999996 588874
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=283.82 Aligned_cols=246 Identities=28% Similarity=0.452 Sum_probs=205.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+|++.+.||+|++|.||++... +++.|++|.+..... ....+.+|++++++++|||++++++++.++...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5888999999999999999976 688999999976553 345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++.... .+++..++.++.|++.+|.+||++| ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 81 AENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence 99999999997653 2889999999999999999999999 99999999999999999999999999877
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
....... .....++..|+|||.+.+..++.++||||+|+++|+|++|..||..... .......
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---------------~~~~~~~ 211 (254)
T cd06627 149 LNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---------------MAALFRI 211 (254)
T ss_pred cCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---------------HHHHHHH
Confidence 6543321 1334678899999999888889999999999999999999999964321 0111111
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. .......+...+..+.+++.+||..+|++|||+.+++.
T Consensus 212 ~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 V-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred h-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 12222344456778999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=293.72 Aligned_cols=250 Identities=28% Similarity=0.373 Sum_probs=195.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|+..+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999976 789999999875432 2456788999999996 9999999999999999999999
Q ss_pred ecCCCCHHHHHh---cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 142 HASKGSLHDILH---GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 142 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
|+.. +|.++.. .... ..+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+||
T Consensus 84 ~~~~-~l~~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLK-------SVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred cccC-CHHHHHHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeec
Confidence 9875 5555432 2111 1288999999999999999999975 7 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCC---CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
|++......... ....|+..|+|||++.+. .++.++|||||||++|+|++|+.||......
T Consensus 153 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------- 216 (288)
T cd06616 153 GISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV------------- 216 (288)
T ss_pred chhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-------------
Confidence 998755432211 233578899999998766 6899999999999999999999999643210
Q ss_pred ChhhHhHhhc---ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 295 SEDKVKQCVD---TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 295 ~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
...+..... ..+....+..++.++.+||.+||+.+|.+|||++++++.
T Consensus 217 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 217 -FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111111 111112223467789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.99 Aligned_cols=269 Identities=23% Similarity=0.307 Sum_probs=202.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeeeEEecC-----Ce
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~ 135 (356)
.++|.+.+.||+|+||.||+|... +++.||||.+... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999976 7899999998653 22234677899999999999999999987644 34
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++++||+. ++|.+++..... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQT---------LSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 799999996 589998875432 889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc----
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA---- 290 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---- 290 (356)
|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 151 DFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred cCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999876644321 1133457889999998865 46889999999999999999999999654211000000000
Q ss_pred ----cccCChhhHhHhhccc---CC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhh
Q 018396 291 ----TPKLSEDKVKQCVDTK---LG---GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA--LQPLL 348 (356)
Q Consensus 291 ----~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~--L~~l~ 348 (356)
............+... .. ......++.++.++|.+||+.+|++|||++++++. |..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000001111111000 00 01122456789999999999999999999999985 66554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=288.76 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=194.0
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhcc-CCceeeeeeEEecC--CeeEEEEE
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDG--PLRVLAYE 141 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~--~~~~lv~e 141 (356)
|++.+.||+|+||.||+|... +++.||+|.+...... .....+|+.+++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999976 7899999998754322 234457888888885 99999999999987 88999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+ +|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++.
T Consensus 81 ~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 81 LMDM-NLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cCCc-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccc
Confidence 9975 88888865431 2889999999999999999999999 999999999999999 999999999987
Q ss_pred CCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ ....++..|+|||++.+ ..++.++|||||||++|+|++|..||....+.+............. ..+.
T Consensus 148 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 223 (282)
T cd07831 148 GIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD-AEVL 223 (282)
T ss_pred ccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCC-HHHH
Confidence 66433221 23457889999997654 5578899999999999999999999965432110000000000000 0000
Q ss_pred Hhhccc--CCC-----------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTK--LGG-----------EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~--~~~-----------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... ... ......+.++.++|.+||+++|++|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 000 011245789999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.14 Aligned_cols=265 Identities=26% Similarity=0.445 Sum_probs=206.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
....|...+.||+|+||.||+|... ++..||+|.+...... ...|++.+++++|||||++++++.+.+..++||||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 3456778889999999999999975 7899999998654332 23568899999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++|+|.+++.. ++|..+..++.|++.||+|||....++++||||||+||+++.++..++. ||....
T Consensus 765 ~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 765 IEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999999952 7889999999999999999995533349999999999999998887775 655433
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
.... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......|.............
T Consensus 832 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 832 LCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred cccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhhe
Confidence 2211 2236789999999999999999999999999999999999999543221 11222222222222222333
Q ss_pred hcccCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 303 VDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 303 ~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
+++.... ..+.....++.+++.+||+.+|++|||+.++++.|+++....
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 3333322 334566678899999999999999999999999999987644
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=292.66 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=197.9
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
|++.+.||.|++|.||+|... +|..||+|++...... ...+.+|+.+++.++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678889999999999999976 7999999998754322 356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
. ++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 81 D-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred C-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 6 599999876542 12889999999999999999999998 999999999999999999999999998765
Q ss_pred ccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh------
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE------ 296 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 296 (356)
...... .....++..|+|||++.+. .++.++||||||+++|+|++|..||.....................
T Consensus 150 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 150 GVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred CCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence 332211 1223468899999988764 5688999999999999999999999654321100000000000000
Q ss_pred ---hhHhHhhcc---cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 ---DKVKQCVDT---KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ---~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......... ..........+..+.++|.+||+.+|.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0000112234568899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=290.64 Aligned_cols=242 Identities=26% Similarity=0.403 Sum_probs=197.3
Q ss_pred CCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018396 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 147 (356)
....||+|+||.||++..+ +++.||+|.+..... ....+.+|+.+++.++|+|++++++.+..++..+++|||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3467999999999999976 789999998864332 34568889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccc
Q 018396 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (356)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (356)
|.+++.... +++..+..++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 104 L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 104 LTDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred HHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 999886533 788999999999999999999999 9999999999999999999999999876554322
Q ss_pred ccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccC
Q 018396 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL 307 (356)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (356)
. ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... .....+....
T Consensus 171 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----------------~~~~~~~~~~ 232 (292)
T cd06657 171 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----------------KAMKMIRDNL 232 (292)
T ss_pred c--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhhC
Confidence 1 123356889999999998888899999999999999999999999643211 1111111111
Q ss_pred C--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 308 G--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 308 ~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. .......+..+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 233 PPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1 0112345667899999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.83 Aligned_cols=268 Identities=23% Similarity=0.325 Sum_probs=197.9
Q ss_pred CCCCCceeeccCceEEEEEEEC---CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecC--CeeE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~ 137 (356)
+|++.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999975 47899999987632 2235678899999999999999999999988 8899
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc----CCcee
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----DDIAK 213 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----~~~vk 213 (356)
+|+||+++ +|.+++........ ..+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKR----VSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCC----cCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEE
Confidence 99999976 77777754332111 23888999999999999999999999 999999999999999 89999
Q ss_pred EecccccCCCccccc-cccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 214 ISDFDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
|+|||++........ ........++..|+|||++.+ ..++.++||||||+++|+|++|+.||................
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 232 (316)
T cd07842 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232 (316)
T ss_pred ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence 999999886544322 111234567889999998876 457899999999999999999999997554322000000000
Q ss_pred ---------ccCCh---------hhHhHhhcccCCCCCC-----------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 292 ---------PKLSE---------DKVKQCVDTKLGGEYP-----------PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 292 ---------~~~~~---------~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..... .......+.......+ ...+..+.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000000000000111 023457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=286.98 Aligned_cols=240 Identities=24% Similarity=0.337 Sum_probs=189.9
Q ss_pred eeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHH---HHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVS---MVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~---~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.||+|+||.||+|... +++.||+|.+...... ...+..|.. .++...||+|+.+++++.+.+..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999976 7899999998654322 122334433 3445579999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
|++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999886543 2899999999999999999999999 9999999999999999999999999987554
Q ss_pred cccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
... .....|+..|+|||++.+. .++.++||||+|+++|+|++|+.||........ .......
T Consensus 149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-------------~~~~~~~ 211 (278)
T cd05606 149 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------------HEIDRMT 211 (278)
T ss_pred ccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-------------HHHHHHh
Confidence 322 1334689999999998754 689999999999999999999999965422111 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
.......+...+.++.+++.+||..+|.+|| ++.++++
T Consensus 212 -~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 212 -LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1112233444577899999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=290.76 Aligned_cols=259 Identities=17% Similarity=0.192 Sum_probs=185.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-C---CCEEEEEEcCCCCCch--H----------HHHHHHHHHHhccCCceeeeee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQPD--Q----------EFLAQVSMVSRLKNENVVELVG 128 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~--~----------~~~~e~~~l~~l~hp~iv~~~~ 128 (356)
.++|.+.+.||+|+||.||+|... + +..+|+|+........ + ....++..+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 368999999999999999999976 3 4567777644322211 1 1122334456678999999998
Q ss_pred EEecCC----eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcE
Q 018396 129 YYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (356)
Q Consensus 129 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (356)
.+.... ..+++++++.. ++.+.+..... .++..+..++.|++.||.|||+++ ++||||||+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni 157 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI 157 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 765433 34677777644 67776654321 567788999999999999999999 99999999999
Q ss_pred EEccCCceeEecccccCCCcccccc-----ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCC
Q 018396 205 LLFDDDIAKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (356)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (356)
|++.++.++|+|||+|......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999998765422111 11123468999999999999999999999999999999999999997552
Q ss_pred CCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 280 PRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
..... .. ....+....+..... ....++..+.+++..||+.+|++||+++++++.|+
T Consensus 238 ~~~~~--~~----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 238 HNGNL--IH----AAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred cchHH--HH----HhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11100 00 000000111111111 12334678999999999999999999999998763
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=289.97 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=205.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 139 (356)
++|.+.+.||+|+||.||+|... ++..|++|++.... .....+.+|+.++++++ ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999976 79999999987532 22356788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
||++.+++|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcc
Confidence 99999999999997654 2899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccc------------------ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCC
Q 018396 220 SNQAPDAAAR------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (356)
Q Consensus 220 a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (356)
+......... .......++..|+|||++.+..++.++|+||||++++++++|..||.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~- 227 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE- 227 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-
Confidence 8765443211 112344578899999999888899999999999999999999999974421
Q ss_pred CCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 018396 282 GQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM----GIVLK 342 (356)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~----~ell~ 342 (356)
........ ......+...+..+.+++.+||+.+|.+|||+ +++++
T Consensus 228 --------------~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 --------------YLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --------------HHHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 01111111 12223445557789999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=288.34 Aligned_cols=263 Identities=19% Similarity=0.258 Sum_probs=196.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|++.+.||.|++|.||+|..+ +++.||+|.+...... ...+.+|+++++.++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999977 7899999998654322 3567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeEeccccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a 220 (356)
|+++ +|.+++...... .+++..++.++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++
T Consensus 82 ~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred cccc-cHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence 9965 888887654321 2578888899999999999999999 999999999999985 567999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec--cc---ccC
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--AT---PKL 294 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~---~~~ 294 (356)
......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+....... .. ..+
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 151 RAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred cccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 765432211 123457889999998876 4578999999999999999999999975432110000000 00 000
Q ss_pred C----hhhHhHhhcccCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 295 S----EDKVKQCVDTKLGG----EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 295 ~----~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. ........ ..... ......+.++.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAF-PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhc-ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000000 00000 011234567899999999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=300.31 Aligned_cols=265 Identities=22% Similarity=0.346 Sum_probs=199.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEe----cCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYV----DGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~----~~~~~ 136 (356)
.++|++.+.||.|+||.||+|..+ +++.||+|++..... ....+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999976 799999999875422 2456778999999999999999998875 34568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++|+||+. ++|.+++..... +++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP---------LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence 99999996 589998865432 889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccc--cccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc---
Q 018396 217 FDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA--- 290 (356)
Q Consensus 217 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~--- 290 (356)
||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...............
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~ 230 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence 99987654322111 1123468899999998865 46899999999999999999999999654321110000000
Q ss_pred -----cccCChhhHhHhhcc-cCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 291 -----TPKLSEDKVKQCVDT-KLGGEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 291 -----~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
............... ...... ....+.++.++|.+||+.+|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000011111111111 001111 1234678999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.15 Aligned_cols=268 Identities=20% Similarity=0.299 Sum_probs=196.2
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCC----
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP---- 134 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~---- 134 (356)
...++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 45568999999999999999999977 7899999988643222 335678999999999999999999887544
Q ss_pred ----eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 135 ----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 135 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
..++++||+.+ +|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDG 156 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCC
Confidence 45999999975 88888865431 2889999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCcccccc--ccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 211 IAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
.++|+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||....+.......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999998765432211 111234578899999988764 4688999999999999999999999765432111100
Q ss_pred ecccccCChhhH-----hHhhc-ccCCCCC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 288 TWATPKLSEDKV-----KQCVD-TKLGGEY---------PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 288 ~~~~~~~~~~~~-----~~~~~-~~~~~~~---------~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.........+.. ....+ ....... +...+..+.++|.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000000 00000 0000000 0012346789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=298.51 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=199.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhc-cCCceeeeeeEEec--CCee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL-KNENVVELVGYYVD--GPLR 136 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 136 (356)
..++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.. +...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999976 78899999885432 2234567899999999 99999999998764 3468
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++|+||+.+ +|.+++.... +.+..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|
T Consensus 85 ~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 85 YLVFEYMET-DLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred EEEeccccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEee
Confidence 999999975 9999987642 788889999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc---ccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 217 FDLSNQAPDAAAR---LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 217 fg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 230 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9998765433211 11234568899999998765 4578899999999999999999999965432211000000000
Q ss_pred cCChhh--------HhHhhcc---cCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 293 KLSEDK--------VKQCVDT---KLG---GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 293 ~~~~~~--------~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
...... ....+.. ... ......++.++.++|.+||+.+|.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 0001110 000 01112256789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=274.19 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=196.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
.++.+.+..||.|..|.||+++.+ +|...|||........ .++++..+.++..- ++|+||+++++|.....+++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 445666778999999999999987 7999999999765443 35677777776555 4899999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|.+.- -+..++.... .++++.-+-++..-+++||.||..+. +|+|||+||.|||+|+.|.+||||||++
T Consensus 171 elMs~-C~ekLlkrik--------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIK--------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHH-HHHHHHHHhc--------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 98853 3444444333 23888888899999999999999875 4999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
-.+-+.... ....|-+.|||||.+. ...|+.++||||||++++||.||+.||.... ..-+
T Consensus 240 GrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--------------tdFe 302 (391)
T KOG0983|consen 240 GRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--------------TDFE 302 (391)
T ss_pred ceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--------------ccHH
Confidence 776654433 4456889999999986 4578999999999999999999999997541 1222
Q ss_pred hHhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+..+++..- .......+++.+.+++..||++|+.+||...++++
T Consensus 303 ~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 303 VLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2233332111 11122237889999999999999999999999876
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=285.61 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=196.1
Q ss_pred eeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
||.|+||.||++... +++.+++|.+..... ..+.+.+|+.++++++||||+++++.+..+...++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 699999999875433 245678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (356)
.+++.... .+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 81 ASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred HHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 99997643 2889999999999999999999999 99999999999999999999999999875433211
Q ss_pred ------cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 229 ------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 229 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
........++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---------------~~~~~~ 213 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---------------EIFQNI 213 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHH
Confidence 11123456788999999998888999999999999999999999999644211 111111
Q ss_pred hcccCCCCCCHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 303 VDTKLGGEYPPK--AIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 303 ~~~~~~~~~~~~--~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
..... ..+.. .+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus 214 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 214 LNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred hcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 11111 12222 367899999999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=277.78 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=203.2
Q ss_pred CceeeccCceEEEEEEE-CCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCCCC
Q 018396 71 NSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 147 (356)
...||+|+++.|--+.. .+|..||||++.+.... ..++.+|++++.+. .|+||++++++|+++..+|+|||.+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 35799999999999885 48999999999876433 57889999999998 59999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC---ceeEecccccCCCc
Q 018396 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAP 224 (356)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~~ 224 (356)
|...|.+++. +++.++..+..+|+.||.+||.+| |.||||||+|||..+.. -|||+||.+.....
T Consensus 163 lLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 163 LLSHIQKRKH---------FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred HHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999998875 899999999999999999999999 99999999999997655 48999998865422
Q ss_pred cc-----cccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 225 DA-----AARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 225 ~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
.. ..+....+.+|+..|||||++. ...|+.++|.||||||+|-|+.|.+||.+....+ +-|.....
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CGWdrGe~ 306 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CGWDRGEV 306 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CCccCCCc
Confidence 11 1111123457888999999863 3458999999999999999999999998765432 22222221
Q ss_pred C---hhhHhHhhcccCCCCCCH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 295 S---EDKVKQCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 295 ~---~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
- +..+.+.+..+.- ++|. ..+.+..++|...|..++.+|.++.+++.
T Consensus 307 Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 2333444433321 3333 45678899999999999999999998876
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=283.83 Aligned_cols=239 Identities=23% Similarity=0.286 Sum_probs=189.8
Q ss_pred ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHH-HHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~-l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||.|+||.||+|... +++.||+|.+...... ...+..|..+ ...++|+|++++++++..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999976 7899999998654321 1223444444 4455899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 82 GDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 99999997643 2788999999999999999999999 99999999999999999999999998865433
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh-c
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV-D 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 304 (356)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ......+ .
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~~ 207 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----------------DAVFDNILS 207 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHh
Confidence 1344688899999999888889999999999999999999999964321 1111111 1
Q ss_pred cc--CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 305 TK--LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 305 ~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.. ........++..+.+++.+||+.+|.+||++.++.+.|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 11 11122234678899999999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=291.31 Aligned_cols=267 Identities=21% Similarity=0.301 Sum_probs=195.4
Q ss_pred ceeecc--CceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
..||.| +||+||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++..++..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999976 7999999998754433 35678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++...... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++++||+.+.....
T Consensus 84 ~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 84 GSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred CCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 9999998765321 2788999999999999999999999 99999999999999999999999986433221
Q ss_pred ccccc-----cccccccCcCccCcccccCC--CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc-------cceeccc
Q 018396 226 AAARL-----HSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-------SLVTWAT 291 (356)
Q Consensus 226 ~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~ 291 (356)
..... ......++..|+|||++.+. .++.++|||||||++|+|++|..||......... ....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI 233 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence 11000 00112345679999998764 4789999999999999999999999754321000 0000000
Q ss_pred ccCCh------------------hhH-----hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHH
Q 018396 292 PKLSE------------------DKV-----KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQP 346 (356)
Q Consensus 292 ~~~~~------------------~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~ 346 (356)
..... ... ...............++..+.+||.+||+.||++|||+.++++ .|..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 00000 000 0000111112223456788999999999999999999999986 4444
Q ss_pred hh
Q 018396 347 LL 348 (356)
Q Consensus 347 l~ 348 (356)
+.
T Consensus 314 ~~ 315 (328)
T cd08226 314 VK 315 (328)
T ss_pred HH
Confidence 44
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=287.52 Aligned_cols=243 Identities=28% Similarity=0.416 Sum_probs=194.7
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
|...+.||+|+||+||+|... +++.|++|.+...... ...+.+|+.+++.++|||++++++++.+....+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999976 7899999998653222 24678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+ +|.+++..... .+++..++.++.|++.+|.|||++| ++|+||+|+||+++.++.++|+|||++..
T Consensus 103 ~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 103 CLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 965 78887764331 2789999999999999999999999 99999999999999999999999998764
Q ss_pred CccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
.... ....|+..|+|||++. +..++.++||||||+++|+|++|..||...... ...
T Consensus 171 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---------------~~~ 229 (313)
T cd06633 171 SSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------------SAL 229 (313)
T ss_pred cCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------------HHH
Confidence 3221 3446889999999984 456788999999999999999999998644211 111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
................+..+.+++.+||+.+|.+||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 230 YHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111111223345678999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.98 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=200.3
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
|++.+.||.|++|.||+|... +++.+++|.+...... ...+.+|+.+++.++|+||+++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 677889999999999999976 7899999998654332 456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
.+ +|.+++..... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 81 DT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred CC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 76 88888876431 2889999999999999999999999 999999999999999999999999998766
Q ss_pred ccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....................
T Consensus 149 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 149 GSPVRP--YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred CCCccc--ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 543311 1234578899999998876 7899999999999999999999999654321110000000000000000000
Q ss_pred hc----------ccCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VD----------TKLG---GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~----------~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. .... .......+.++.++|.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 0000 1122356788999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=288.05 Aligned_cols=243 Identities=24% Similarity=0.301 Sum_probs=203.8
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeeeEEecCCee
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 136 (356)
....+|..+.+||+|+||.|.+|..+ +.+.+|||+++++-. +.+--+.|-++|... +-|.++++...|..-+++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34567889999999999999999987 788999999976422 122334566666555 457899999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
|+||||+.||+|...|+.... +.+..+..++..|+-||-+||++| |++||||.+|||++.+|++||+|
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence 999999999999999987664 778889999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||+++..-.... .+..++|||.|+|||.+...+|+.++|+||+||+||||+.|++||++.+ .
T Consensus 494 FGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD----------------E 555 (683)
T KOG0696|consen 494 FGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----------------E 555 (683)
T ss_pred cccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC----------------H
Confidence 999876544333 3478899999999999999999999999999999999999999998663 2
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN 336 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 336 (356)
+++.+.+... .-.+|...+.+...++...|.+.|.+|..
T Consensus 556 ~elF~aI~eh-nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 556 DELFQAIMEH-NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHHHHc-cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 3333333222 12678888999999999999999999964
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=289.61 Aligned_cols=246 Identities=27% Similarity=0.406 Sum_probs=196.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
+.|...+.||+|+||.||+|+.. ++..+++|.+..... ...++.+|+++++.++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999976 688999998864321 2346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+. ++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 95 e~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 162 (308)
T cd06634 95 EYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (308)
T ss_pred EccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccc
Confidence 9997 488887754321 2788999999999999999999999 999999999999999999999999988
Q ss_pred CCCccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
...... ....+++.|+|||++. ...++.++|||||||++|+|++|..||..... ..
T Consensus 163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------------~~ 221 (308)
T cd06634 163 SIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------MS 221 (308)
T ss_pred eeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH---------------HH
Confidence 654322 3345788999999875 35678899999999999999999999854311 01
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.................++..+.++|.+||+.+|.+||++.++++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 11111111111112335667899999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=290.59 Aligned_cols=265 Identities=23% Similarity=0.290 Sum_probs=197.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCC-----
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----- 134 (356)
..++|++.+.||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999987 689999999865422 2356778999999999999999999887654
Q ss_pred -----eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 135 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
..++++||+++ +|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~ 152 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNK 152 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 78999999987 77777765421 2889999999999999999999999 9999999999999999
Q ss_pred CceeEecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee
Q 018396 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 288 (356)
+.+||+|||++.......... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.............
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 153 GQIKLADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred CcEEeCcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999999987664432211 122345778999998865 457889999999999999999999997543211100000
Q ss_pred cccccCChhhHhHhhc--------------ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 289 WATPKLSEDKVKQCVD--------------TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 289 ~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
................ .... ......+..+.+++..||+.+|.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000000000000 0000 011124678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=295.10 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=197.2
Q ss_pred HhCCCCC-CceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCch---------------HHHHHHHHHHHhccCCceeee
Q 018396 64 KTDNFGT-NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---------------QEFLAQVSMVSRLKNENVVEL 126 (356)
Q Consensus 64 ~~~~~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~hp~iv~~ 126 (356)
..++|.. .+.||.|+||.||+|..+ +++.||+|++....... ..+.+|+.+++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3466764 577999999999999976 78999999886533221 246789999999999999999
Q ss_pred eeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE
Q 018396 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (356)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (356)
++++..++..+++|||+.+ +|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill 152 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMAS-DLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFI 152 (335)
T ss_pred eEEEecCCcEEEEEecccc-CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEE
Confidence 9999999999999999974 9999986543 2788999999999999999999999 9999999999999
Q ss_pred ccCCceeEecccccCCCccccc------------cccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCC
Q 018396 207 FDDDIAKISDFDLSNQAPDAAA------------RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 273 (356)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~ 273 (356)
+.++.++|+|||++........ ........+++.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999876541110 0111223468889999998764 46899999999999999999999
Q ss_pred CCCCCCCCCCccceecccccCChhhHhHhhc-----------ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 274 PVDHTLPRGQQSLVTWATPKLSEDKVKQCVD-----------TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 274 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
||....+........................ ...........+..+.++|.+||+.+|.+|||+++++.
T Consensus 233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 9975532211000000000000000000000 00000111234577899999999999999999999986
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.57 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=195.9
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhc---cCCceeeeeeEEecCCe-----
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL---KNENVVELVGYYVDGPL----- 135 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~----- 135 (356)
|++.+.||.|+||.||+|.++ +++.||+|.+...... ...+.+|+.+++++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999987 6899999999754322 23466787777666 69999999999988776
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++++||+.+ +|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEe
Confidence 9999999975 899988764321 2889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce-eccc---
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TWAT--- 291 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~--- 291 (356)
|||++......... ....++..|+|||++.+..++.++|+|||||++|+|++|.+||............ ....
T Consensus 150 dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07838 150 DFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS 226 (287)
T ss_pred ccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCC
Confidence 99998776433221 2335788999999999989999999999999999999999999754322110000 0000
Q ss_pred -ccCChhh--HhHhhcccCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 292 -PKLSEDK--VKQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 292 -~~~~~~~--~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+.... .......... .......+..+.++|.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 0000000000 1112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=290.45 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=199.0
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEec-CCee
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLR 136 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~ 136 (356)
....++|++.+.||.|+||.||+|... +++.||+|.+.... ...+.+.+|+.+++.++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999977 89999999886432 224567889999999999999999998865 5678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++++||+ +++|.+++.... ++...+..++.|++.||.|||+++ ++|+||+|.||++++++.++|+|
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred EEEeehh-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence 9999998 458998886543 778888899999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc---------
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL--------- 286 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~--------- 286 (356)
||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........
T Consensus 152 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 152 FGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9998754321 123457889999998765 5689999999999999999999999965432110000
Q ss_pred eecccccCChhhHhHhh-cccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 287 VTWATPKLSEDKVKQCV-DTKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..+........ ....+ ........+ ..++..+.++|.+||+.+|++|||+.+++..
T Consensus 227 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 227 DDVINTICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHhccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 01111 001111111 1245789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=295.47 Aligned_cols=269 Identities=25% Similarity=0.331 Sum_probs=201.5
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCC--
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP-- 134 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-- 134 (356)
+....++|++.+.||+|+||.||+|... ++..||+|++...... ...+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445678999999999999999999966 7999999998653222 346788999999999999999999887554
Q ss_pred ----eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 135 ----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 135 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
..++|++|+ +++|.+++.... +++..+..++.|++.||.|||+.| ++||||||+||++++++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~ 155 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDC 155 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 358999998 679998886432 889999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 289 (356)
.++|+|||++....... ....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||..............
T Consensus 156 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07880 156 ELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230 (343)
T ss_pred CEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999987654321 33457889999999876 4578999999999999999999999975432110000000
Q ss_pred ccc--------cCChhhHhHhhcc--cCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 018396 290 ATP--------KLSEDKVKQCVDT--KLG----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 290 ~~~--------~~~~~~~~~~~~~--~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~ 348 (356)
... .+........... ... ......++..+.++|.+||+.||.+|||+.+++. .++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 000 0000000000000 000 0011234567899999999999999999999994 555543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=288.78 Aligned_cols=255 Identities=19% Similarity=0.253 Sum_probs=188.4
Q ss_pred CceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHHHHHh
Q 018396 78 SYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILH 153 (356)
Q Consensus 78 ~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 153 (356)
+++.||.++.. +++.||+|++.... .....+.+|+.+++.++|+||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44555555544 68999999987542 224578899999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccccc----
Q 018396 154 GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR---- 229 (356)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~---- 229 (356)
..... .+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||.+.........
T Consensus 92 ~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 92 THFPE-------GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred Hhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 64322 2788899999999999999999999 999999999999999999999999988654322111
Q ss_pred -ccccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc------cceeccc-ccCCh--h
Q 018396 230 -LHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ------SLVTWAT-PKLSE--D 297 (356)
Q Consensus 230 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~-~~~~~--~ 297 (356)
.......++..|+|||++.+ ..++.++|+||+||++|+|++|..||......... ....+.. ..... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 11123456788999999876 35889999999999999999999999754321100 0000000 00000 0
Q ss_pred hH--------hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KV--------KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. ................+.++.+++.+||+.||.+|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00 0000011112234456678999999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=287.74 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=196.2
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 138 (356)
...++|++.+.||+|+||.||+|.+. +++.||||.+...... ...+..|+.++..+ .||||+++++++.++...++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 34578999999999999999999987 5899999998754332 34566677766666 59999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+|||+.+ +|.+++..... .+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+||
T Consensus 92 v~e~~~~-~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 92 CMELMST-CLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred EeeccCc-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcc
Confidence 9999865 77777765321 28889999999999999999997 47 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCC----CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|++......... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||......
T Consensus 160 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------ 224 (296)
T cd06618 160 GISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------------ 224 (296)
T ss_pred ccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------------
Confidence 998765432221 2335788999999987553 788999999999999999999999642110
Q ss_pred CChhhHhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 294 LSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 294 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.+.+........ .......++.++.+++.+||+.+|.+||++.++++.
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 225 --FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011111111111 111112356789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=286.99 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=197.9
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecC--CeeEEEEE
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAYE 141 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e 141 (356)
|++.+.||.|++|.||+|... +++.+|+|.+.... .....+.+|+.+++.++|||++++++++.+. +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999987 68999999997653 2235688899999999999999999999887 89999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 81 YMDH-DLTGLLDSPE--------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cccc-cHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence 9985 8999887542 12889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH-
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV- 299 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 299 (356)
........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........................
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 149 PYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred eccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 66543211 1123356788999998765 45789999999999999999999999755432110000000000000000
Q ss_pred -------hHhhc------ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 -------KQCVD------TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 -------~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..... ..+.......++..+.+++.+||+.+|.+||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 00000011113678899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.67 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=198.1
Q ss_pred CCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCee
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 136 (356)
+|++.+.||.|+||.||.|... +|+.||+|.+.... ...+.+.+|+.+++.+ +|+||+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999863 68899999986432 1235678899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++|+||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 81 HLILDYINGGELFTHLSQRER---------FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence 999999999999999976432 788899999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCC--CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... .
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------------~ 215 (290)
T cd05613 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK------------N 215 (290)
T ss_pred Cccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc------------c
Confidence 9998765432211 11234588999999998753 4678999999999999999999999633111 1
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
....+...+.. ....++..++..+.+++.+||+.+|.+|| ++.+++.
T Consensus 216 ~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 216 SQAEISRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cHHHHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11111111111 11234455677899999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=276.44 Aligned_cols=209 Identities=26% Similarity=0.397 Sum_probs=177.3
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC---C--CCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec-C
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR---S--GRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD-G 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~ 133 (356)
+-...|+....||+|.+|.||+|..+ + ...+|||.++.+... ....-+|+.+++.|+|||++.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 44567999999999999999999743 2 237999999765332 3567799999999999999999999887 8
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC----
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---- 209 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---- 209 (356)
..+++++||.+. +|++.|...+.... ..++...+..++.||+.|+.|||++- |+||||||.||||..+
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPER 172 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCcc
Confidence 889999999998 99999987654332 24888999999999999999999998 9999999999999877
Q ss_pred CceeEecccccCCCccccccc-cccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCC
Q 018396 210 DIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (356)
|+|||+|||+++.+...-... .....+.|.+|.|||.+.| ..|+.+.|||++|||+.||++-.+-|.+..
T Consensus 173 G~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred CeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 899999999999877654433 3456678999999999987 468999999999999999999999887643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=290.62 Aligned_cols=264 Identities=25% Similarity=0.322 Sum_probs=198.1
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC--
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG-- 133 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-- 133 (356)
.+....++|++.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 45556789999999999999999999965 7899999998754322 35677899999999999999999987643
Q ss_pred ----CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 134 ----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 134 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
...+++++++ +++|.+++.... +++..++.++.|++.||+|||+++ ++|+||||+||+++++
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 3467777776 679998886543 889999999999999999999999 9999999999999999
Q ss_pred CceeEecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee
Q 018396 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 288 (356)
+.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.............
T Consensus 157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998765332 133467899999998876 567889999999999999999999996443211000000
Q ss_pred --------cccccCChhhHhHhhc---ccCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 289 --------WATPKLSEDKVKQCVD---TKLGG---EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 289 --------~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.....+........+. ..... ......+.++.++|.+||+.||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000000001100 00000 001123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=281.20 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=196.8
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC------CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
+|.+.+.||+|+||.||++... .+..+++|++... ......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999976 4555666655431 11233566789999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
+||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||+
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCc
Confidence 9999999999998653221 123889999999999999999999999 999999999999975 5699999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----------------~~~ 213 (260)
T cd08222 152 SRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----------------LSV 213 (260)
T ss_pred eeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----------------HHH
Confidence 8765432221 2344578899999999888889999999999999999999999953311 111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+........+..++.++.++|.+||+.+|++||++.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 214 VLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111112222345567789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=285.62 Aligned_cols=254 Identities=21% Similarity=0.269 Sum_probs=200.3
Q ss_pred CCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCee
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 136 (356)
+|++.+.||+|++|.||++... +++.||+|.+.... .....+.+|+.+++++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999842 57889999886432 1235677899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++||||+.+++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence 99999999999999987543 2788999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCC--CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
||++......... ......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...... .
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------------~ 215 (288)
T cd05583 149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ------------N 215 (288)
T ss_pred Ccccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc------------c
Confidence 9998765433211 112345889999999987655 788999999999999999999999633111 0
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
........+.. .....+..++..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 216 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 216 SQSEISRRILK-SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred hHHHHHHHHHc-cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11111111111 1123444566789999999999999999998877665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=294.49 Aligned_cols=270 Identities=23% Similarity=0.322 Sum_probs=205.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCC-----eeE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 137 (356)
+|++.+.||.|++|.||+|... +++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+.. ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999976 689999999876432 2457889999999999999999999988775 789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
++|+|+.+ +|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+||
T Consensus 81 lv~e~~~~-~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred EEecchhh-hHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence 99999985 8999887543 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCcccccc-ccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc--
Q 018396 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK-- 293 (356)
Q Consensus 218 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 293 (356)
|++......... .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||..................
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 998876543210 111334578899999999887 7899999999999999999999999755321100000000000
Q ss_pred ------CChhhHhHhhcc-cCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhc
Q 018396 294 ------LSEDKVKQCVDT-KLG-----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLN 349 (356)
Q Consensus 294 ------~~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~~ 349 (356)
.........+.. ... .......+..+.++|.+||+.+|.+|||+++++. .|+.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 001111111110 000 0112235678999999999999999999999998 3665543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=297.26 Aligned_cols=240 Identities=20% Similarity=0.274 Sum_probs=201.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..+.|+....+|.|+|+.|-.+... +++..++|++.+... +..+|+.++... +||||+++.+.+.++...|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4678888889999999999999976 789999999987632 233566555544 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE-ccCCceeEeccccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill-~~~~~vkl~Dfg~a 220 (356)
.+.|+-|.+.+...+ ....++..|+++|+.|+.|||.+| +|||||||+|||+ ++.|+++|+|||.+
T Consensus 397 ~l~g~ell~ri~~~~----------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred hccccHHHHHHHhcc----------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence 999999888887665 333778889999999999999999 9999999999999 68999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
+..... ....+-|..|.|||++....|++++||||||++||+|++|+.||..... + .
T Consensus 464 ~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~---------------~---~ 520 (612)
T KOG0603|consen 464 SELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA---------------G---I 520 (612)
T ss_pred hhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc---------------h---H
Confidence 887665 1233568899999999999999999999999999999999999975421 1 1
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
++......+++...+++..++|+.+||+.||.+||++.++..
T Consensus 521 ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 521 EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 222222233444778899999999999999999999999876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=255.24 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=203.3
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.|...+.||+|.+|+||+|+++ +++.||+|.+..+..+ .....+|+-+|+.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999976 7999999998765443 46788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
|.. +|..+...-... ++.+.+..++.|+++||.++|+++ +.||||||.|++|+.+|.+|++|||+++.
T Consensus 83 cdq-dlkkyfdslng~--------~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGD--------LDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred hhH-HHHHHHHhcCCc--------CCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhh
Confidence 976 999998765432 888999999999999999999999 99999999999999999999999999988
Q ss_pred CccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
++....-. ...+.|.+|.+|.++.|. -|+...|+||.|||+.|+.. |.+.|-+.+-.++...+-+.-...+.+.+.
T Consensus 151 fgipvrcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 151 FGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred cCCceEee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 87654332 334569999999999985 47999999999999999998 777776554333322222221112211111
Q ss_pred ---HhhcccCCCCCC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 ---QCVDTKLGGEYP---------PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ---~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+-....-++ +.....-++++.+.|.-+|.+|.++++.++
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111111111 233344578999999999999999998776
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=283.62 Aligned_cols=261 Identities=22% Similarity=0.356 Sum_probs=196.3
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEEec
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
|++.+.||.|++|.||+|... +++.|+||.+...... .....+|+..+++++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999986 6889999998654332 234567899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
+++|.+++..... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceec
Confidence 7799999876541 12789999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce-eccccc----CChh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TWATPK----LSED 297 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~----~~~~ 297 (356)
..... .....++..|+|||++.+ ..++.++|+||||+++++|++|++||......+..... ...... +...
T Consensus 150 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07830 150 RSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226 (283)
T ss_pred cCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence 43221 133457889999998754 55789999999999999999999999654322110000 000000 0000
Q ss_pred -hHhHhhcccCC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 -KVKQCVDTKLG-------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 -~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........... .......+..+.++|.+||+.+|.+|||++|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000 0001122567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=293.59 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=196.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecC------C
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------P 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~ 134 (356)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999976 789999999865322 234578899999999999999999988754 3
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..++++||+.. +|.+++.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEeccccc-CHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 46899999865 77776531 1788999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||++....... ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.................
T Consensus 159 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~- 232 (342)
T cd07879 159 LDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG- 232 (342)
T ss_pred eeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-
Confidence 9999987643221 33457889999999876 4688999999999999999999999975432110000000000
Q ss_pred CChhhHhHhh---------cc--cC-CCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhc
Q 018396 294 LSEDKVKQCV---------DT--KL-GGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLN 349 (356)
Q Consensus 294 ~~~~~~~~~~---------~~--~~-~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~~ 349 (356)
.......... .. .. ... ..+..+..+.++|.+||+.||.+||++++++. .++.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000000 00 00 000 01124567899999999999999999999995 4666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=295.06 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=194.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecC---------
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDG--------- 133 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--------- 133 (356)
.++|++.+.||.|+||.||+|... +++.||+|.+...... .+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999976 7899999998654433 45688999999999999999999876543
Q ss_pred -----CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc
Q 018396 134 -----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (356)
Q Consensus 134 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (356)
...++++||+.+ +|.+++.... +++..++.++.||+.||.|||+.| ++||||||+||+++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 357899999975 9998886543 789999999999999999999999 999999999999974
Q ss_pred -CCceeEecccccCCCccccccc-cccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 018396 209 -DDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (356)
Q Consensus 209 -~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~ 285 (356)
++.++|+|||++.......... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||....+.....
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5678999999987653221110 1122357889999998754 567889999999999999999999996543211100
Q ss_pred ceecccccCChhhHhH--------hhcccCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 286 LVTWATPKLSEDKVKQ--------CVDTKLGGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 286 ~~~~~~~~~~~~~~~~--------~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+......... ......... .....+.++.++|.+||+.||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000000 000000000 11234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=290.50 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=194.5
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC-------
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG------- 133 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------- 133 (356)
.++|++.+.||.|+||.||+|..+ +++.+|+|.+...... ...+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999977 7899999988643222 34577899999999999999999887543
Q ss_pred -CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 134 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
..++++++|+.+ +|.+.+.... ..+++..+..++.|++.||.|||++| ++|+||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--------VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 346999999976 7777776432 12899999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccc---------cccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCC
Q 018396 213 KISDFDLSNQAPDAAARL---------HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (356)
+|+|||++.......... ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||.......
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999987654322111 11234568889999987654 57899999999999999999999997543321
Q ss_pred CccceecccccCChh------hHhHhhcccCCCCC-------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 283 QQSLVTWATPKLSED------KVKQCVDTKLGGEY-------PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
............... .+............ .......+.++|.+||+.+|.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 100000000000000 00000000000000 0122367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=299.84 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=210.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCC-EEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGR-AAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
...++.+...||.||||.|-++..++.. .+|+|++++. ....+.+..|-.+|..++.|.||++|..|.+...+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3456778889999999999999977433 4889888653 2335678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
+||.|-||.|+..+..+.. ++...+..++..+++|++|||++| ||+|||||+|.+++.+|-+||.|||
T Consensus 498 LmEaClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hHHhhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence 9999999999999988765 888899999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+|+.......+ -+++|||.|.|||.+.+..++.++|.||||+++|||++|.+||.+.++..
T Consensus 566 FAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---------------- 626 (732)
T KOG0614|consen 566 FAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---------------- 626 (732)
T ss_pred hHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH----------------
Confidence 99998876654 67899999999999999999999999999999999999999998765432
Q ss_pred HhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 018396 299 VKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPN 336 (356)
Q Consensus 299 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps 336 (356)
..+.+..++ ...+|...+....+||++....+|.+|..
T Consensus 627 tYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 627 TYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 233333333 34677788888999999999999999976
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=304.12 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=223.2
Q ss_pred CCCCceeeccCceEEEEEEEC-C----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
....++||+|+||+||+|.+- . .-+||+|++...... ..++++|+.+|.+++|||++++++++.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 444678999999999999963 3 347899988765443 578999999999999999999999998765 88899
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
+|+++|+|.++++..+.. +.....+.|..||++|+.|||.+. +|||||...||||.+-.+|||.|||++
T Consensus 777 q~mP~G~LlDyvr~hr~~--------igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDN--------IGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HhcccchHHHHHHHhhcc--------ccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence 999999999999887643 788899999999999999999998 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhH
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+...............-.+.|||=|.+....|+.++||||+||++||++| |..||+ .++.+++
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~----------------gi~~~eI 909 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD----------------GIPAEEI 909 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC----------------CCCHHHh
Confidence 98876655443344444678999999999999999999999999999998 999996 4566788
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
..+++.+.+...|+-|+.+++.++.+||..|+..||+++++...+.++...
T Consensus 910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 888888888899999999999999999999999999999999999887654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=308.11 Aligned_cols=271 Identities=23% Similarity=0.373 Sum_probs=223.3
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC----C----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeE
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR----S----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGY 129 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~ 129 (356)
+....++..+.+.||+|.||.|++|... . ...||||.+...... .+.+..|+++|+.+ .|+||+.+++.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3344455566779999999999999832 1 457999998765443 56789999999999 69999999999
Q ss_pred EecCCeeEEEEEecCCCCHHHHHhcCCCCCCCC-C----C--CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCC
Q 018396 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK-P----G--PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (356)
Q Consensus 130 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~----~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~ 202 (356)
+..+...++|+||+..|+|.+++...+...... . . ..+...+.+.++.||+.|++||++.. +|||||...
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999999887111111 1 1 24889999999999999999999998 999999999
Q ss_pred cEEEccCCceeEecccccCCCcccccccccccc-ccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCC
Q 018396 203 NVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV-LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (356)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (356)
|||+..+..+||+|||+|+.............. .-...|||||.+....|+.++||||+|++|||+++ |..||.+.
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-- 525 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-- 525 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC--
Confidence 999999999999999999865554333211111 12446999999999999999999999999999999 99999532
Q ss_pred CCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 281 RGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
.....+.+.+..+.+.+.|..|+.+++++|..||+.+|++||++.++.+.|+..+.
T Consensus 526 -------------~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 526 -------------PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -------------CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11445566788889999999999999999999999999999999999999998653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=295.66 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=198.7
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCe---
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL--- 135 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~--- 135 (356)
...++|++.+.||+|++|.||+|.+. +++.||+|++..... ....+.+|+.+++.++|||++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999987 788999999865322 23557789999999999999999988776554
Q ss_pred ---eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 136 ---RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 136 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
.++|+||+ +++|.+++.... +++..++.++.|++.||.|||+.| ++|+||+|+||++++++.+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence 89999998 569999987532 899999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce-ecc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TWA 290 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~ 290 (356)
+|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ...
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 99999998766432 133457889999998865 46788999999999999999999999654321110000 000
Q ss_pred -------cccCChhhHhHhhcccC---CCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 291 -------TPKLSEDKVKQCVDTKL---GGEY---PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 291 -------~~~~~~~~~~~~~~~~~---~~~~---~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+........+.... .... ....+..+.++|.+||+.+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000011111111000 0000 1123678999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=298.98 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=218.1
Q ss_pred HHHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEe-----
Q 018396 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV----- 131 (356)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~----- 131 (356)
+.+....+.|++..++|.|.+|.||++..+ +++.+|+|+.......++++..|.++|+.+ .|||++.++++|.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 334445678999999999999999999976 799999999998888888999999999988 6899999999986
Q ss_pred cCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 132 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
.++.+|||||||.+|+..|+++..... .+.|..+..|++.++.|+.+||++. ++|||||-.|||++.++.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~-------rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGN-------RLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAE 161 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhccc-------chhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCc
Confidence 468899999999999999999877632 3899999999999999999999998 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccC-----CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
|||+|||++.++.....+ .....|||.|||||++.- ..|+..+|+||||++..||.-|.+|+.+.-+.
T Consensus 162 VKLvDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----- 234 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----- 234 (953)
T ss_pred EEEeeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----
Confidence 999999998877554332 366789999999999963 35788999999999999999999999755322
Q ss_pred eecccccCChhhHhHh-hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 287 VTWATPKLSEDKVKQC-VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+..+ .++......+..-+.++.++|..||.+|-++||+..++++
T Consensus 235 ----------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 ----------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 112222 2333344557788899999999999999999999999886
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=274.51 Aligned_cols=235 Identities=26% Similarity=0.333 Sum_probs=195.2
Q ss_pred eeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
||.|+||.||++... +++.+++|.+..... ....+.+|+.+++.++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 689999999876433 234688899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (356)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 81 FSHLSKEG---------RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence 99997654 2789999999999999999999998 99999999999999999999999999876544321
Q ss_pred cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCC
Q 018396 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (356)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (356)
......++..|+|||.+.+...+.++|+||||+++|+|++|..||..... ......+.. ..
T Consensus 149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---------------~~~~~~~~~--~~ 209 (250)
T cd05123 149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---------------KEIYEKILK--DP 209 (250)
T ss_pred --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---------------HHHHHHHhc--CC
Confidence 12445678899999999888889999999999999999999999964421 111111222 12
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 018396 309 GEYPPKAIAKMAAVAALCVQYEADFRPNMGI 339 (356)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e 339 (356)
...+...+..+.+++.+||..||++||++.+
T Consensus 210 ~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2344455788999999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=288.58 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=192.4
Q ss_pred CCCCCceeeccCceEEEEEEEC-C--CCEEEEEEcCCCCC---chHHHHHHHHHHHhc-cCCceeeeeeEEec----CCe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-S--GRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYVD----GPL 135 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~----~~~ 135 (356)
+|++.+.||+|+||.||++... + +..||+|.+..... ..+.+.+|+.+++++ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999976 4 78999999864321 235678899999999 59999999987542 245
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.+++++|+. ++|.+++.... .+++..++.++.||+.||.|||++| ++||||||+|||++.++.++|+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence 788888886 58999986543 2889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccc--ccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec---
Q 018396 216 DFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--- 289 (356)
Q Consensus 216 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~--- 289 (356)
|||++......... .......|++.|+|||++.+ ..++.++||||+|+++|+|++|.+||..............
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99998765432211 11133468999999998765 5689999999999999999999999975432110000000
Q ss_pred -----ccccCChhhHhHhhcc---cCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 -----ATPKLSEDKVKQCVDT---KLGG---EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 -----~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+........... .... ......+..+.+++.+||+.+|.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000000 0000 011123567999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=281.15 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=198.9
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
|+..+.||+|++|.||+|... +++.+++|.+.... ...+.+..|+.+++.++|+|++++++++.+.+..++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999977 69999999997643 22456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
.+ +|.+++..... .+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~-~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 81 DM-DLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred Cc-CHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccccc
Confidence 85 99999986531 2889999999999999999999999 999999999999999999999999998766
Q ss_pred ccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||......+....................
T Consensus 149 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 149 GIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred CCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 443221 1233457889999998776 7899999999999999999999999654321110000000000000000000
Q ss_pred h-----c---ccC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 V-----D---TKL----GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~-----~---~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. + ... .....+..+..+.++|.+||+.+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0 000 00111123668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=271.69 Aligned_cols=220 Identities=21% Similarity=0.239 Sum_probs=179.5
Q ss_pred cCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHHHHHhcC
Q 018396 77 GSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGK 155 (356)
Q Consensus 77 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 155 (356)
|.+|.||++.+. +++.||+|.+..... ..+|...+....||||+++++++.+.+..+++|||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999987 789999999976432 334455555667999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccccccccccc
Q 018396 156 KGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235 (356)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 235 (356)
.. +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++++|||.+....... ...
T Consensus 80 ~~---------l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~ 142 (237)
T cd05576 80 LN---------IPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGE 142 (237)
T ss_pred cC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccC
Confidence 32 889999999999999999999999 9999999999999999999999999876554321 223
Q ss_pred ccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHH
Q 018396 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKA 315 (356)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (356)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ........+..+
T Consensus 143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~ 201 (237)
T cd05576 143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWV 201 (237)
T ss_pred CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccC
Confidence 45778999999988889999999999999999999998875321100 000111233445
Q ss_pred HHHHHHHHHHhhccCCCCCCCHH
Q 018396 316 IAKMAAVAALCVQYEADFRPNMG 338 (356)
Q Consensus 316 ~~~l~~li~~cl~~~P~~Rps~~ 338 (356)
+..+.++|.+||+.||.+||++.
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCC
Confidence 67899999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.62 Aligned_cols=145 Identities=26% Similarity=0.359 Sum_probs=130.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ...+..|+.+++.++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999987 7899999998754322 25678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+.+++|.+++..... +.+..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 83 mEy~~g~~L~~li~~~~~---------l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGY---------FDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred EeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 999999999999975432 788899999999999999999999 99999999999999999999999998
Q ss_pred cC
Q 018396 220 SN 221 (356)
Q Consensus 220 a~ 221 (356)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=274.66 Aligned_cols=276 Identities=24% Similarity=0.358 Sum_probs=210.8
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHh--ccCCceeeeeeEEecC----Ce
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDG----PL 135 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hp~iv~~~~~~~~~----~~ 135 (356)
....++..+.+.||+|.||.||+|.++ |+.||||++... ++....+|.++.+. |+|+||+.|++.-..+ ..
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 334567888899999999999999999 889999999644 34567777777664 5999999999874422 35
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-----CCCCCeeecCCCCCcEEEccCC
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-----~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
+|||++|.+.|+|+|||..+. ++....++++..++.||++||. +|.|.|.|||||..||||.++|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred EEEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 799999999999999999865 8899999999999999999995 5778899999999999999999
Q ss_pred ceeEecccccCCCccccc--cccccccccCcCccCcccccCC----CC--CccchhhhHHHHHHHHHcCCCCCCCCCCCC
Q 018396 211 IAKISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMTG----QM--SSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~--~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (356)
..-|+|+|+|........ .......+||..|||||++... .+ -..+||||||+++||++-+..- .+.....
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~-ggi~eey 432 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES-GGIVEEY 432 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc-CCEehhh
Confidence 999999999876544321 1224567899999999988532 11 2358999999999999753211 1111111
Q ss_pred CccceecccccCChhhHhHhhcc-cCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 283 QQSLVTWATPKLSEDKVKQCVDT-KLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
+.++..+...+.+.+++.+++.- +++...| ..+...+.++|+.||..+|.-|.|+=-|-+.|.++.+..
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 22223333345566666666543 3343333 245577889999999999999999999999999988643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=278.17 Aligned_cols=262 Identities=16% Similarity=0.254 Sum_probs=204.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC--C----ceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--E----NVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--p----~iv~~~~~~~~~~~~~ 137 (356)
.++|.+.+.||+|.||.|-.+.+. ++..||||+++.-....+..+-|+++|+++.+ | -+|++.++|.-.++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 678999999999999999999966 68999999998766666777889999999943 3 3788889999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---------
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--------- 208 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--------- 208 (356)
||+|.+ |-++.+++..+... +++...+..++.|++.++.+||+.+ ++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred EEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence 999998 44999999887653 3889999999999999999999998 999999999999852
Q ss_pred -----------CCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCC
Q 018396 209 -----------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (356)
Q Consensus 209 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (356)
+..|+|+|||.|..-... ....+.|..|.|||++.+-.++..+||||+||||+|+++|...|+.
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 225899999998764332 2556789999999999999999999999999999999999999987
Q ss_pred CCCCCCccceecccccCChhhH-------------------------hHhhcccC----CCCCCHHHHHHHHHHHHHhhc
Q 018396 278 TLPRGQQSLVTWATPKLSEDKV-------------------------KQCVDTKL----GGEYPPKAIAKMAAVAALCVQ 328 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~----~~~~~~~~~~~l~~li~~cl~ 328 (356)
..........+.....++...+ ....+... ...........+++|+.+||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 6543211111111111111111 11111110 011122345679999999999
Q ss_pred cCCCCCCCHHHHHH
Q 018396 329 YEADFRPNMGIVLK 342 (356)
Q Consensus 329 ~~P~~Rps~~ell~ 342 (356)
+||.+|+|+.|++.
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999986
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=272.17 Aligned_cols=271 Identities=22% Similarity=0.319 Sum_probs=229.7
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEe
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYV 131 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~ 131 (356)
++.....+++...++-+|.||.||.|.++ +.+.|-+|.++..... ...++.|.-.+..+.|||++.+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 44445567888889999999999999764 2345667777554333 345778888888999999999999876
Q ss_pred -cCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 132 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
+....++++.+..-|+|..|+...+. ...+....+.-.+...++.|++.|++|||+++ +||.||...|.+|++.-
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~-~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRG-DDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhcc-CCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 45677888899999999999996663 33333445778888999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceec
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 289 (356)
+|||+|=.+++.+...+.............||+||.+.+..|+.++|+|||||++|||+| |+.||.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya------------- 500 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA------------- 500 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc-------------
Confidence 999999999998877766655455556789999999999999999999999999999999 999995
Q ss_pred ccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.+.+.++...+..+++...|.+||++++.+|..||..+|++||+++++..-|.++..+
T Consensus 501 ---eIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 501 ---EIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ---ccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 4567788888999999999999999999999999999999999999999999987654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=267.86 Aligned_cols=253 Identities=21% Similarity=0.259 Sum_probs=204.4
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCC
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~ 134 (356)
+....++|.++++||+|++++|.+++.+ +.+.+|+|+++++- .+..-...|-.+..+. +||.+|.+...|....
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3345678999999999999999999976 78999999987542 2223345566666555 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
++++|.||++||+|.-.++.++. ++++.+..+...|..||.|||++| |++||||.+|+|++..|++||
T Consensus 325 rlffvieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikl 392 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKL 392 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceee
Confidence 99999999999999888877764 899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
+|+|+++.--..... +..++|||.|+|||.+.+..|+..+|+|+|||+++||+.|+.||+-.-. ......
T Consensus 393 tdygmcke~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm--------~n~d~n 462 (593)
T KOG0695|consen 393 TDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM--------DNPDMN 462 (593)
T ss_pred cccchhhcCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC--------CCcccc
Confidence 999998765433222 3678999999999999999999999999999999999999999964310 001122
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN 336 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 336 (356)
+.+-+.+++..+. ..+|...+-....+++.-|++||.+|..
T Consensus 463 tedylfqvilekq-iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 463 TEDYLFQVILEKQ-IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhHHHHHHHhhhc-ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 3344445443322 2445556666778899999999999964
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=281.17 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=200.9
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCch--------HHHHHHHHHHHhccCCceeeeeeEEe-cCCe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--------QEFLAQVSMVSRLKNENVVELVGYYV-DGPL 135 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~ 135 (356)
++|-++.+||+|||+.||+|.+- ..+.||+|+-.....+. +...+|..+.+.|+||.||++|+++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 35777788999999999999965 68889999765544332 23467899999999999999999986 6778
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCce
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIA 212 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~v 212 (356)
++-|+|||+|.+|.-|+...+. +++.++..|+.||+.||.||.... ++|+|-||||.|||+.+ .|.+
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccccee
Confidence 8999999999999999988775 899999999999999999999985 45999999999999964 4789
Q ss_pred eEecccccCCCccccccc-----cccccccCcCccCcccccC----CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCC
Q 018396 213 KISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~ 283 (356)
||+|||+++...+..... .+....||.+|++||.+.- ...+.++||||+|||+|+++.|+.||+......
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ- 691 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ- 691 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-
Confidence 999999999876544331 2345679999999998752 346889999999999999999999998663210
Q ss_pred ccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 284 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+ +....+....+-.+ ..-+.++.+..++|.+||++.-++|....++..
T Consensus 692 -dI-------LqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 -DI-------LQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -HH-------HhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 00 00111111111111 222456778999999999999999999888764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=268.88 Aligned_cols=265 Identities=22% Similarity=0.347 Sum_probs=201.4
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEe--------cC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYV--------DG 133 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--------~~ 133 (356)
+.|+...++|+|.||.||+|+.+ +|+.||+|++..+. .-.....+|+.+|..|+|+|++.+++.|. +.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45777889999999999999977 78889988775422 22456789999999999999999988765 23
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
..+|+|+.+|+. +|.-++....- .++..++..++.++..||.|+|+.. |+|||+|+.|+||+.+|.++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v--------r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV--------RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK 164 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc--------cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence 458999999998 99998876542 2889999999999999999999998 99999999999999999999
Q ss_pred EecccccCCCcccccc--ccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec-
Q 018396 214 ISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW- 289 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~- 289 (356)
|+|||+++.+...... ...+..+.|.+|.+||.+.| ..|+++.|||+.||++.+|++|.+-|++.....+..++..
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 9999999765433221 11234566999999999887 5789999999999999999999999988766433222221
Q ss_pred -------ccccCChhhHhHhhccc-CCCCC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 -------ATPKLSEDKVKQCVDTK-LGGEY---------PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 -------~~~~~~~~~~~~~~~~~-~~~~~---------~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.++....-.+.+.++.. +.... +-.-.++..+|+.++|..||.+|+++.+++.
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11222222222222111 10000 1111347789999999999999999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=282.34 Aligned_cols=210 Identities=24% Similarity=0.308 Sum_probs=176.3
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
|..++.||-|+||.|.+++.. +...||+|.+.+...- ....+.|-.||...+.+-||++|..|.+.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 555678999999999999844 6788999999764332 24467788899999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
++||++..+|....- +.+..+..++..+..|+++.|+.| +|||||||+|||||.+|++||+||||++-
T Consensus 711 IPGGDmMSLLIrmgI---------FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGI---------FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred cCCccHHHHHHHhcc---------CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 999999999987653 888899999999999999999999 99999999999999999999999999853
Q ss_pred Cccc---cc-------------------------------------cccccccccCcCccCcccccCCCCCccchhhhHH
Q 018396 223 APDA---AA-------------------------------------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFG 262 (356)
Q Consensus 223 ~~~~---~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 262 (356)
+... .+ +......+||+.|+|||++....|+..+|+||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 2110 00 0001235799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCC-ccceec
Q 018396 263 VVLLELLTGRKPVDHTLPRGQ-QSLVTW 289 (356)
Q Consensus 263 ~il~~l~~g~~pf~~~~~~~~-~~~~~~ 289 (356)
||||||+.|+.||....+.+. ...+.|
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 999999999999988877653 333333
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=266.35 Aligned_cols=252 Identities=25% Similarity=0.294 Sum_probs=193.3
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHH-HHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
.+-+..||.|+||+|++-.++ +|+..|||.|..... +.++++.|... ++.-++||||++++..-.++..|+.||.+
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 334567999999999999977 899999999976543 45678888876 44557899999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
.- +|..+...-...+ ...+++.-+-.+....+.||.||-..- +|+|||+||+|||++..|.|||||||.+-++
T Consensus 146 d~-SlDklYk~vy~vq----~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQ----KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred hh-hHHHHHHHHHHHH----hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 65 6655443211000 012788888889999999999998864 5999999999999999999999999998887
Q ss_pred ccccccccccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
.++... +...|-..|||||.+.. ..|+.++||||||++|||+.||..||...+. .-+.+.+
T Consensus 219 v~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--------------vfeql~~ 281 (361)
T KOG1006|consen 219 VDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--------------VFEQLCQ 281 (361)
T ss_pred HHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--------------HHHHHHH
Confidence 665443 45568889999999863 4589999999999999999999999964421 0111222
Q ss_pred hhcccC-CCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 302 CVDTKL-GGEYP---PKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 302 ~~~~~~-~~~~~---~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
++.... ....+ .+++..+..+|.-||.+|-..||.+.+++++
T Consensus 282 Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 282 VVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 221111 01111 2467889999999999999999999998763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=254.60 Aligned_cols=235 Identities=29% Similarity=0.407 Sum_probs=194.9
Q ss_pred CceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHHHHHhc
Q 018396 78 SYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG 154 (356)
Q Consensus 78 ~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 154 (356)
+||.||+|... +++.+++|++...... .+.+.+|++.+++++|+|++++++.+......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 6899999999765433 47889999999999999999999999999999999999999999999976
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccccc
Q 018396 155 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234 (356)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 234 (356)
... +++..++.++.+++.++.+||+.+ ++|+||+|.||++++++.++|+|||.+........ ...
T Consensus 81 ~~~---------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 145 (244)
T smart00220 81 RGR---------LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTT 145 (244)
T ss_pred ccC---------CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccc---ccc
Confidence 542 788999999999999999999999 99999999999999999999999999877655421 244
Q ss_pred cccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHH
Q 018396 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK 314 (356)
Q Consensus 235 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (356)
..++..|++||.+.+..++.++||||||+++++|++|..||.... ........+...........
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---------------~~~~~~~~~~~~~~~~~~~~ 210 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---------------QLLELFKKIGKPKPPFPPPE 210 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------cHHHHHHHHhccCCCCcccc
Confidence 567889999999988888999999999999999999999996421 11222222222211111111
Q ss_pred --HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 315 --AIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 315 --~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
++.++.+++.+||..+|.+||++.++++
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 6678999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=244.44 Aligned_cols=271 Identities=15% Similarity=0.259 Sum_probs=203.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeeeEEecC--CeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDG--PLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~--~~~~lv 139 (356)
..++|++.+.+|+|.++.||.|..- +++.++||+++... .+.+.+|+.+|+.|. ||||++++++..+. ....++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5678999999999999999999965 78899999997543 367899999999996 99999999998864 456799
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-CceeEeccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFD 218 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Dfg 218 (356)
+||..+.+...+... ++...+..++.+++.||.|||+.| |+|||+||.|+||+.. -.++|+|||
T Consensus 114 FE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred hhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecc
Confidence 999999888777643 778889999999999999999999 9999999999999854 579999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCC-CCCcccee--------
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVT-------- 288 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~-~~~~~~~~-------- 288 (356)
+|......... ...+.+..|.-||.+.. ..|+.+-|+|||||++..|++.+-||-.... .++.-.+.
T Consensus 179 LAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 179 LAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred hHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 99877654433 44467788999998875 5689999999999999999999988854332 21111000
Q ss_pred --ccc--ccCChhhHhHhhcccCC--------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhccCCCC
Q 018396 289 --WAT--PKLSEDKVKQCVDTKLG--------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLNTRSGP 354 (356)
Q Consensus 289 --~~~--~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~~~~~~~ 354 (356)
+.. ...-+.....++....+ .+-..-.+++..+|+.+.|..|.++|+|++|.+. .+..+.+..+.+
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~~ 335 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESSR 335 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhcc
Confidence 000 00000111111111110 1111123578999999999999999999999887 455555554443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=285.30 Aligned_cols=269 Identities=17% Similarity=0.187 Sum_probs=172.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-C----CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeE------Eec
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY------YVD 132 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~------~~~ 132 (356)
..++|++.+.||+|+||.||+|... + +..||+|++...... +....+ .++...+.++..++.. ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 5678999999999999999999976 5 789999987643221 111111 1222222222222211 245
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCC-----------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVK-----------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
+...++|+||+.+++|.+++....... ............+..++.|++.||.|||+++ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 678999999999999999997543110 0001111233456789999999999999999 99999999
Q ss_pred CcEEEcc-CCceeEecccccCCCccccccccccccccCcCccCcccccCC----------------------CCCccchh
Q 018396 202 SNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG----------------------QMSSKSDV 258 (356)
Q Consensus 202 ~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 258 (356)
+|||+++ ++.+||+|||+|......... ......+++.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999986 579999999999765432211 22456789999999966422 23445699
Q ss_pred hhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCC------CCHHHHHHHHHHHHHhhccCCC
Q 018396 259 YSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGE------YPPKAIAKMAAVAALCVQYEAD 332 (356)
Q Consensus 259 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~P~ 332 (356)
|||||++|||+++..|++.....-.. ...........+...+......+ ..........+||.+||++||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~---~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNR---QLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHH---HHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999977765422100000 00000001111111111111000 0011123456899999999999
Q ss_pred CCCCHHHHHH
Q 018396 333 FRPNMGIVLK 342 (356)
Q Consensus 333 ~Rps~~ell~ 342 (356)
+|||+.++++
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=270.92 Aligned_cols=271 Identities=21% Similarity=0.276 Sum_probs=184.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEE-----------------CCCCEEEEEEcCCCCCc-hH--------------HHHHH
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVL-----------------RSGRAAAIKKLDSSKQP-DQ--------------EFLAQ 111 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~-~~--------------~~~~e 111 (356)
..++|++.++||+|+||.||+|.. ..++.||||.+...... .+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 23568999998653221 12 23346
Q ss_pred HHHHHhccCCce-----eeeeeEEec--------CCeeEEEEEecCCCCHHHHHhcCCCC---------------CCCCC
Q 018396 112 VSMVSRLKNENV-----VELVGYYVD--------GPLRVLAYEHASKGSLHDILHGKKGV---------------KGAKP 163 (356)
Q Consensus 112 ~~~l~~l~hp~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~---------------~~~~~ 163 (356)
+.++.+++|.++ +++++++.. .+..++|+||+++++|.+++...... .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 566666542 35689999999999999999753211 00111
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccC
Q 018396 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243 (356)
Q Consensus 164 ~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 243 (356)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.++|+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 223567889999999999999999999 999999999999999999999999998655332211 1122335889999
Q ss_pred cccccCCC--------------------C--CccchhhhHHHHHHHHHcCCC-CCCCCCCCCCccceecccccCChhhHh
Q 018396 244 PEYAMTGQ--------------------M--SSKSDVYSFGVVLLELLTGRK-PVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 244 PE~~~~~~--------------------~--~~~~DvwslG~il~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
||.+.... + ....||||+||++|+|++|.. ||......... ... .......+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~---~~~~~~~~r 454 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQ---YDNDLNRWR 454 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhh---ccchHHHHH
Confidence 99876432 1 124699999999999999875 76432111000 000 000000111
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEA---DFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~Rps~~ell~ 342 (356)
........-......++...+|+.++|..+| .+|+|++|+|+
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111112122234557789999999999866 68999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=269.39 Aligned_cols=197 Identities=22% Similarity=0.392 Sum_probs=174.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCch---------HHHHHHHHHHHhcc---CCceeeeeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---------QEFLAQVSMVSRLK---NENVVELVGYY 130 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~e~~~l~~l~---hp~iv~~~~~~ 130 (356)
+..+|...+.||+|+||.|++|.++ +...|+||.|.++..-. ..+-.|+++|..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4567999999999999999999988 67889999997754322 12346999999997 99999999999
Q ss_pred ecCCeeEEEEEec-CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 131 VDGPLRVLAYEHA-SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 131 ~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
++++.+||+||.. +|.+|.++|...+. +++.++..|++|++.|+++||++| |||||||-+|+.++.+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSN 706 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecC
Confidence 9999999999976 46699999987664 899999999999999999999999 9999999999999999
Q ss_pred CceeEecccccCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCC
Q 018396 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVD 276 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~ 276 (356)
|.+||+|||.|........ ..++||..|.|||++.|.+| +..-|||+||++||.+.....||.
T Consensus 707 g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999887766543 56789999999999999988 677899999999999999998884
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=254.78 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=205.3
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCC-----ee
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LR 136 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~ 136 (356)
.+.+-.+.||.|+||.||.+.+. +|+.||+|++..-.. ..+.+.+|+++|..++|.|++..++...... .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 35667889999999999999976 899999998864322 2567889999999999999999988765432 45
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
|+++|.+.. +|...|-... .++...+.-+.+||++||.|||+.+ |.||||||.|+|++++-.+||||
T Consensus 133 YV~TELmQS-DLHKIIVSPQ---------~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQ---------ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred HHHHHHHHh-hhhheeccCC---------CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecc
Confidence 777888765 7877775443 2777888899999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||+++........ +.+..+.|..|.|||.++| ..|+.+.||||.|||+.||+..+..|+...+..+..++...-...+
T Consensus 200 FGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs 278 (449)
T KOG0664|consen 200 FGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS 278 (449)
T ss_pred cccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence 9999876554433 2344567899999999997 5689999999999999999999999998877766555554444444
Q ss_pred hhhHhHhhcc--------cCC-CC--------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 296 EDKVKQCVDT--------KLG-GE--------YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 296 ~~~~~~~~~~--------~~~-~~--------~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.+.+...-+. ..+ .. .+.....+...++..++..||.+|.+..+.+..+
T Consensus 279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 4433322111 110 01 1113335677889999999999999998877654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=280.07 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=189.7
Q ss_pred CCCCceeeccCceE-EEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 68 FGTNSLIGEGSYGR-VYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 68 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
|.-.+.+|.|+-|+ ||+|... ++.||||.+-.+.. .-..+|+..|+.- .|||||++++.-.++...||..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 44456789999877 7899887 78999999865432 3457899999888 699999999999999999999999976
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---C--CceeEeccccc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---D--DIAKISDFDLS 220 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~--~~vkl~Dfg~a 220 (356)
+|.+++... ...... ......+.++.|++.||++||+.+ ||||||||.||||.. + .+++|+|||++
T Consensus 588 -sL~dlie~~-~~d~~~----~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 588 -SLQDLIESS-GLDVEM----QSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred -hHHHHHhcc-ccchhh----cccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 999999875 111100 111456788999999999999998 999999999999976 3 47899999999
Q ss_pred CCCccccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhh
Q 018396 221 NQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 221 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+.+....... ......||-+|+|||++....-+.++|||||||++|+.++ |.+||+.....+. .
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------------N 724 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------------N 724 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------------h
Confidence 9876543322 2356679999999999999888889999999999999998 6999975532110 0
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+..-...........++ +..+||.+|+.++|..||++.+|+.
T Consensus 725 Il~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 725 ILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00000000111122222 8899999999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=264.57 Aligned_cols=264 Identities=19% Similarity=0.259 Sum_probs=205.6
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC------CceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN------ENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------p~iv~~~~~~~~~~~~~ 137 (356)
..+|.+....|+|-||+|..|... -|..||||+|..+..-.+.=+.|+++|++|+. -|++.++..|...++++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 457888888999999999999976 57799999998876655666789999999964 38999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-CceeEec
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISD 216 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~D 216 (356)
||+|.+.. +|.+++.......+ +....+..++.|++.||..|-..| |+|.||||+||||++. ..+||||
T Consensus 511 lVFE~Lsl-NLRevLKKyG~nvG------L~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 511 LVFEPLSL-NLREVLKKYGRNVG------LHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred EEehhhhc-hHHHHHHHhCcccc------eeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeecc
Confidence 99999966 99999988765432 677889999999999999999999 9999999999999875 5789999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcc-----------
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS----------- 285 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~----------- 285 (356)
||.|........ +.+..+..|.|||.+.|.+|+...|+||.||+||||.||+..|-+.+......
T Consensus 581 fGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 581 FGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred Cccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 999988766543 23345678999999999999999999999999999999999887654421100
Q ss_pred ------------------ceecccccCCh-------------hhHhH-hhcccCCCCCCHHHHHHHHHHHHHhhccCCCC
Q 018396 286 ------------------LVTWATPKLSE-------------DKVKQ-CVDTKLGGEYPPKAIAKMAAVAALCVQYEADF 333 (356)
Q Consensus 286 ------------------~~~~~~~~~~~-------------~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~ 333 (356)
+.......++. ..+.. ++.......-.......+.+|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 11100011111 11111 11111111222345678999999999999999
Q ss_pred CCCHHHHHH
Q 018396 334 RPNMGIVLK 342 (356)
Q Consensus 334 Rps~~ell~ 342 (356)
|.|..+.|+
T Consensus 737 Rit~nqAL~ 745 (752)
T KOG0670|consen 737 RITVNQALK 745 (752)
T ss_pred cCCHHHHhc
Confidence 999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=232.20 Aligned_cols=204 Identities=29% Similarity=0.369 Sum_probs=167.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC--CCchHHHHHHHHHHHh-ccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..++......||+|++|.|-+-++. +|...|+|.+... .+..++.++|+.+..+ ..+|++|.+++.+.+....|+.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3455666778999999999888876 8999999999754 3345667788877544 4789999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
||.+.- +|..+..+--.. +..+++..+-+++..++.||.|||++- .++|||+||.|||++.+|+||+||||.
T Consensus 124 ME~M~t-Sldkfy~~v~~~-----g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKK-----GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred HHHhhh-hHHHHHHHHHhc-----CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence 999965 887776543222 223888899999999999999999985 499999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCccccc----CCCCCccchhhhHHHHHHHHHcCCCCCCCC
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAM----TGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (356)
+-.+.++... +...|-.-|+|||.+. ...|+.++||||||++++||.+++.||...
T Consensus 196 sG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 196 SGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 8877665432 3345778899999875 347899999999999999999999999643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=248.28 Aligned_cols=132 Identities=22% Similarity=0.389 Sum_probs=116.4
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-----C---CceeeeeeEEe----c
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----N---ENVVELVGYYV----D 132 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h---p~iv~~~~~~~----~ 132 (356)
.+|.+.++||.|.|++||+|.+. ..+.||+|+.+......+..+.|+++|++++ | .+||+++++|. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 68999999999999999999976 7889999999877777778889999999983 2 47999999987 5
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (356)
+.+++||+|++ |.+|..+|.....+. ++...+..|++||+.||.|||... +|+|-||||+|||+.
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 67899999999 559999998776543 899999999999999999999985 599999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=240.43 Aligned_cols=258 Identities=21% Similarity=0.220 Sum_probs=198.4
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecC------Ce
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PL 135 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~~ 135 (356)
.+|.-++.+|.|.- .|..|.+. .++.||+|++.... ...++..+|...+..++|+||++++.++... ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777888999998 77777766 78999999886432 2245677899999999999999999998744 35
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.|+|||++.. +|.+++... ++-..+..++.|++.|++|||+.| |+||||||+||++..+..+||.
T Consensus 96 ~y~v~e~m~~-nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~ 160 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILME-----------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKIL 160 (369)
T ss_pred HHHHHHhhhh-HHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeec
Confidence 7999999976 999998832 777889999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||+|...... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+.+-.++...+........
T Consensus 161 dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 161 DFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred cchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 99999776544 123566789999999999998899999999999999999999999876544332222211111111
Q ss_pred hhhHhHh-----------------------hcccCC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQC-----------------------VDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~-----------------------~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+.++ .+.... .+.+.--...+++++.+||-.||++|.|++++|+
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1111110 011111 1112223456889999999999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=226.68 Aligned_cols=210 Identities=32% Similarity=0.540 Sum_probs=184.1
Q ss_pred eeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHHH
Q 018396 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (356)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 150 (356)
||+|.+|.||++... +++.+++|++...... .+.+.+|+..++.+.|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999976 5899999999866543 4678999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeEecccccCCCcccccc
Q 018396 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAAR 229 (356)
Q Consensus 151 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~ 229 (356)
++.... ..++...++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 81 LLKENE--------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred HHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 997652 12788999999999999999999999 999999999999999 89999999999876544321
Q ss_pred ccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCC
Q 018396 230 LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (356)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (356)
......+...|++||.+... .++.+.|+|++|+++++|
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------- 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------- 187 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence 11334578899999998877 788999999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 309 GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
..+.+++..|++.+|.+||++.++++.|
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4689999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-34 Score=260.31 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=205.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..++|+....+|.|.+|.||+|+++ +++..|+|+++....+ ..-+..|+-+++..+||||+.+++.|...+.+|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4578999999999999999999977 8999999999876554 3556789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
||.+|+|.+..+... ++++.++..+.+..++||.|||+.| -+|||||-.||++++.|.||++|||.+.
T Consensus 93 ycgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred ecCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence 999999999887654 3889999999999999999999999 8999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++..... ....+.||+.|||||+.. .+.|...+|||++|++..|+---++|....-+. ..
T Consensus 161 qitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---------------r~ 223 (829)
T KOG0576|consen 161 QITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---------------RA 223 (829)
T ss_pred hhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---------------HH
Confidence 6654322 236778999999999763 578999999999999999998877775433211 11
Q ss_pred HhHhhcccCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTKLGG---EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+.-...+.+.. +-...-++.+.+|++.||.++|.+|||++.+|+
T Consensus 224 l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 224 LFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111111111 112234567889999999999999999998765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-33 Score=228.79 Aligned_cols=246 Identities=20% Similarity=0.347 Sum_probs=190.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeE-EecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGY-YVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~-~~~~~~~~lv~ 140 (356)
..+.|.+.+.||+|.||.+-+++++ ++..+|+|.++.......+|.+|+..--.| .|.||+..|++ |+..+.+.+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4567999999999999999999988 789999999999888889999999876666 58899988774 67788889999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc--CCceeEeccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFD 218 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg 218 (356)
||++.|+|.+-+.... +.+.....++.|++.|+.|+|+++ +||||||.+||||-. ..+|||||||
T Consensus 102 E~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred ccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence 9999999999887754 888899999999999999999999 999999999999953 4589999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccC---C--CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---G--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+....+... ....-+..|.+||.... . ...+.+|+|.||+++|.+++|.+||+.... ...+...| ..
T Consensus 169 ~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~--~~ 240 (378)
T KOG1345|consen 169 LTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEW--EQ 240 (378)
T ss_pred cccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHH--HH
Confidence 987655432 22234667999997642 2 246789999999999999999999984321 11111111 11
Q ss_pred CChhhHhHhhcccCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHH
Q 018396 294 LSEDKVKQCVDTKLGGEYP---PKAIAKMAAVAALCVQYEADFRPNMGI 339 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~Rps~~e 339 (356)
+. .+.....| ...++.+..+.++-|..++++|=-..+
T Consensus 241 w~---------~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 241 WL---------KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred Hh---------cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 11 11111222 234567888999999999999933333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=233.55 Aligned_cols=266 Identities=22% Similarity=0.303 Sum_probs=199.6
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCe
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 135 (356)
+....+.|..+.+||+|.|++||+|... ..+.||+|.+..... ...+.+|+++|..+ .+.||+++.+.+...+.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4445678999999999999999999843 478899999876543 45689999999999 58999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeE
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKI 214 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl 214 (356)
..+|+||+++.+..+++.. ++...+..+++.++.||.++|.+| ||||||||.|+|.+. -+.-.|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred eEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence 9999999999999999865 778999999999999999999999 999999999999985 467899
Q ss_pred ecccccCCCccc-------c-----------c----------------c--------ccccccccCcCccCcccccC-CC
Q 018396 215 SDFDLSNQAPDA-------A-----------A----------------R--------LHSTRVLGTFGYHAPEYAMT-GQ 251 (356)
Q Consensus 215 ~Dfg~a~~~~~~-------~-----------~----------------~--------~~~~~~~gt~~y~aPE~~~~-~~ 251 (356)
+|||+|...... . . . .......||++|.|||++.. ..
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 999998611000 0 0 0 00113569999999999986 45
Q ss_pred CCccchhhhHHHHHHHHHcCCCCCCCCCCC---------------------CCccceecc-cccCChhhHhHhhccc---
Q 018396 252 MSSKSDVYSFGVVLLELLTGRKPVDHTLPR---------------------GQQSLVTWA-TPKLSEDKVKQCVDTK--- 306 (356)
Q Consensus 252 ~~~~~DvwslG~il~~l~~g~~pf~~~~~~---------------------~~~~~~~~~-~~~~~~~~~~~~~~~~--- 306 (356)
.++++||||.|+|+..++++..||-..... .......|. +......+.....+..
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 688999999999999999999998543221 000111111 0111111111111111
Q ss_pred --CC-------C-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 307 --LG-------G-EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 307 --~~-------~-~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. . ......+..+.+|+.+||..||.+|.|+++.|+
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 11 1 112233458999999999999999999999886
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=220.30 Aligned_cols=198 Identities=33% Similarity=0.494 Sum_probs=172.2
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
|++.+.||.|++|.||++... +++.+++|.+..... ..+.+.+|++.++.++|+|++++++++......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567789999999999999987 589999999986543 35678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++...... +++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....
T Consensus 81 ~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 81 GGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred CCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 99999999865421 678899999999999999999998 9999999999999999999999999987765
Q ss_pred cccccccccccccCcCccCcccc-cCCCCCccchhhhHHHHHHHHHcCCCCCCC
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (356)
..... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 150 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 150 RDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred Ccccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 44211 11344678899999998 667778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=259.34 Aligned_cols=196 Identities=19% Similarity=0.192 Sum_probs=137.8
Q ss_pred hccC-CceeeeeeEE-------ecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 018396 117 RLKN-ENVVELVGYY-------VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188 (356)
Q Consensus 117 ~l~h-p~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 188 (356)
.++| +||+++++++ ...+.++.++|++ +++|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~ 98 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--------RSVDAFECFHVFRQIVEIVNAAHS 98 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--------ccccHHHHHHHHHHHHHHHHHHHh
Confidence 4455 5777777776 2334567778887 459999997432 238899999999999999999999
Q ss_pred CCCCCeeecCCCCCcEEEccCC-------------------ceeEecccccCCCccccc--------------ccccccc
Q 018396 189 KAEPRIIHRNIKSSNVLLFDDD-------------------IAKISDFDLSNQAPDAAA--------------RLHSTRV 235 (356)
Q Consensus 189 ~~~~~ivH~Dlkp~Nill~~~~-------------------~vkl~Dfg~a~~~~~~~~--------------~~~~~~~ 235 (356)
+| |+||||||+||||+..| .+|++|||+++....... .......
T Consensus 99 ~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 99 QG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred CC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 99 99999999999996544 455666666543211000 0001123
Q ss_pred ccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHH
Q 018396 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKA 315 (356)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (356)
.||+.|+|||++.+..++.++|||||||+||||++|.+|+.... ........... .......
T Consensus 176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----------------~~~~~~~~~~~-~~~~~~~ 237 (793)
T PLN00181 176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----------------RTMSSLRHRVL-PPQILLN 237 (793)
T ss_pred CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----------------HHHHHHHHhhc-Chhhhhc
Confidence 57899999999999999999999999999999999988874221 00001100001 0111112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 316 IAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 316 ~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 345678899999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=203.43 Aligned_cols=163 Identities=22% Similarity=0.212 Sum_probs=126.8
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... .+++..++.++.|++.||.|||+++ ||+|||++.++.+++ ||++.....
T Consensus 1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 689999976432 2899999999999999999999985 999999999999999 998876543
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
. ...||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..++..
T Consensus 62 ~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--------------~~~~~~~~~ 120 (176)
T smart00750 62 E-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--------------AILEILLNG 120 (176)
T ss_pred c-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--------------HHHHHHHHH
Confidence 2 1258999999999999999999999999999999999999996432110 111111111
Q ss_pred cCC-----CCCCHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 306 KLG-----GEYPPKAIA--KMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 306 ~~~-----~~~~~~~~~--~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
... ...+..... ++.++|.+||+.+|.+|||+.++++.+..+.
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 110 012233343 6999999999999999999999999887664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=200.87 Aligned_cols=260 Identities=21% Similarity=0.279 Sum_probs=207.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
-.|++++.||+|.||.++.|.+- +++.||||.=. ......++..|.+..+.|. .++|...+.+...+-.-.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 36999999999999999999966 89999999544 3445567899999999995 699999999999999999999998
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-----CceeEeccc
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-----DIAKISDFD 218 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-----~~vkl~Dfg 218 (356)
|-+|.|++.-+... ++..++..+|.|++.-++|+|++. +|+|||||+|+||... ..|.|+|||
T Consensus 107 -GPSLEDLFD~CgR~--------FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRR--------FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred -CcCHHHHHHHhcCc--------ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEecc
Confidence 55999998876643 999999999999999999999999 9999999999999744 358999999
Q ss_pred ccCCCcccccccc-----ccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 219 LSNQAPDAAARLH-----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 219 ~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|+...+.....+ .....||..||+=-...|...+.+.|+-|||-++++.|-|..||++.-.....
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK--------- 245 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK--------- 245 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH---------
Confidence 9998877544322 34567999999998888999999999999999999999999999876432111
Q ss_pred CChhhHhHhhcccCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 294 LSEDKVKQCVDTKLGGEY---PPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.+...+-+.+..-.. -.+.|.++..-+.-.=+.+-.+-|..+-+...+.+++..
T Consensus 246 ---~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 246 ---EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ---HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 112222222111111 123466777777777778888899999988888887754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=209.13 Aligned_cols=262 Identities=19% Similarity=0.253 Sum_probs=198.2
Q ss_pred CCCCCceeeccCceEEEEEEECC--CCEEEEEEcCCCCCc-hHHHHHHHHHHHhccC----CceeeeeeEE-ecCCeeEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKN----ENVVELVGYY-VDGPLRVL 138 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h----p~iv~~~~~~-~~~~~~~l 138 (356)
+|.+.+.||+|+||.||.+...+ ...+|+|........ ...+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999764 357888877654322 2268889999888863 6889999988 57788999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-----Ccee
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-----DIAK 213 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-----~~vk 213 (356)
||+.+ |.+|.++....... .++..++..++.|++.+|++||+.| ++||||||+|+++... ..+.
T Consensus 99 VM~l~-G~sL~dl~~~~~~~-------~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPG-------RFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred EEecc-CccHHHHHHhCCCC-------CcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence 99888 66999988655422 3899999999999999999999999 9999999999999865 3699
Q ss_pred EecccccCCCc--cccc---c---ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 018396 214 ISDFDLSNQAP--DAAA---R---LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (356)
Q Consensus 214 l~Dfg~a~~~~--~~~~---~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~ 285 (356)
|.|||+++... .... . .......||..|+++....+...+.+.|+||++.++.+++.|..||........
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-- 245 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-- 245 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--
Confidence 99999998322 1111 1 112345699999999999999999999999999999999999999965432111
Q ss_pred ceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 286 LVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
...+................+.++..+...+-..+...+|....+...|.+.....
T Consensus 246 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 ----------KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ----------HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111111111122233456666767777789999999999999998876553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=189.81 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=203.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC-CceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e 141 (356)
..+.|.+++.||+|+||-+|.|..- +|+.||||+-.. .....++..|..+.+.|++ ..|..+..+..+.+.-.+||+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578999999999999999999965 899999996543 3334568889999999976 677777888888999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCceeEeccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFD 218 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~Dfg 218 (356)
.+ |-+|.++++-.... ++..+++.++-|++.-++|+|.++ ++||||||+|+|..- ...+.++|||
T Consensus 92 LL-GPsLEdLfnfC~R~--------ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRR--------FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred cc-CccHHHHHHHHhhh--------hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEecc
Confidence 98 55999998766542 889999999999999999999999 999999999999964 3579999999
Q ss_pred ccCCCcccccccc-----ccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 219 LSNQAPDAAARLH-----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 219 ~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|+.+.+.....+ .+...||..|.+--...+...+.+.|+-|+|.+|..+.-|..||++..+....
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~--------- 230 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK--------- 230 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH---------
Confidence 9998766543322 34567999999877667777788899999999999999999999876543211
Q ss_pred CChhhHhHhhcccCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 294 LSEDKVKQCVDTKLGGEYP---PKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.+...+.+.+..-... ...|.++.-.+.-|=..--++-|...-+-+.+.-|....
T Consensus 231 ---QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 231 ---QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred ---HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 1111122221111111 123567777888888888888898888877777666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=207.89 Aligned_cols=164 Identities=20% Similarity=0.193 Sum_probs=127.7
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC--CCCEEEEEEcCCCC----C--chHHHHHHHHHHHhccCCceee-eeeEEecC
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSK----Q--PDQEFLAQVSMVSRLKNENVVE-LVGYYVDG 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~----~--~~~~~~~e~~~l~~l~hp~iv~-~~~~~~~~ 133 (356)
...++|.+.+.||+|+||+||+|+++ +++.+|||++.... . ....+.+|+++|+.++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 35578999999999999999999865 57778999875331 1 2356889999999999999985 4432
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCC-CCCcEEEccCCce
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI-KSSNVLLFDDDIA 212 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dl-kp~Nill~~~~~v 212 (356)
...++||||++|++|... .. .. ...++.|++.+|.|||++| |+|||| ||+|||++.++.+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence 458999999999999632 11 11 1357889999999999999 999999 9999999999999
Q ss_pred eEecccccCCCcccccccc------ccccccCcCccCcccccC
Q 018396 213 KISDFDLSNQAPDAAARLH------STRVLGTFGYHAPEYAMT 249 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 249 (356)
+|+|||+|........... -....+++.|+|||.+..
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999987654321110 134567888999998853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=194.20 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=197.3
Q ss_pred CCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
.+..+|.+...|..|+|+++ |..+++|++...... ..+|..|.-.|+.+.||||+.+++.+.....+.++..|++.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 33457888999999999998 455777877654333 35688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeec-CCCCCcEEEccCCceeEe--cccccCC
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR-NIKSSNVLLFDDDIAKIS--DFDLSNQ 222 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~-Dlkp~Nill~~~~~vkl~--Dfg~a~~ 222 (356)
|+|+.++++..... .+-.++..++.++++|+.|||+.. +++-| -|....+++|++.+.+|. |--++.+
T Consensus 272 gslynvlhe~t~vv-------vd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVV-------VDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred hHHHHHHhcCccEE-------EecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeee
Confidence 99999999876533 677889999999999999999986 34444 588999999999876664 3222111
Q ss_pred CccccccccccccccCcCccCcccccCCCC---CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
.....-.|.|++||.+...+. -.++|+|||++++|||-|...||....+. +--
T Consensus 343 ---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm---------------ecg 398 (448)
T KOG0195|consen 343 ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM---------------ECG 398 (448)
T ss_pred ---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch---------------hhh
Confidence 122334789999999876654 34789999999999999999999755332 112
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
..+-..+++-.+|+..+..+..||.-|++-||.+||.+..++-.|+++.
T Consensus 399 mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 399 MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 3344567778899999999999999999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-24 Score=194.77 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=197.7
Q ss_pred CCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCC-ceeeeeeEEecCCeeEEEEEe
Q 018396 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNE-NVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~e~ 142 (356)
|++.+.||.|+||.||++... ..+++|.+...... ...+.+|+.+++.+.|+ +++.+.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999987 77999998764332 56788999999999988 799999999888788999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-ceeEecccccC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~ 221 (356)
+.++++.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.
T Consensus 80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 9999999777765421 13888999999999999999999999 99999999999999988 79999999987
Q ss_pred CCccccccc----cccccccCcCccCcccccC---CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 222 QAPDAAARL----HSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 222 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
......... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~------------~ 218 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS------------S 218 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc------------c
Confidence 554433221 2356679999999999987 57889999999999999999999997644321 0
Q ss_pred ChhhHhHhhcccC----CCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 295 SEDKVKQCVDTKL----GGEYP----PKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 295 ~~~~~~~~~~~~~----~~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
........+.... ..... ......+.+++..++..+|..|.+..+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 219 ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0111111111111 11111 1223578899999999999999998887664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-27 Score=226.35 Aligned_cols=248 Identities=18% Similarity=0.227 Sum_probs=185.6
Q ss_pred CCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCC--chHHHH---HHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFL---AQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~---~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
+|...+.||++.|-+|.+|.++.|. |+||++-+... .-..+. .|++ ...+++||.+.+.-+.+.....|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6888999999999999999988776 99998865432 223333 3444 455689999999988888888899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|..+ +|+|.+..+. .+...+...++.|++.||..+|+.| |+|+|||.+||||++-.-+.|+||..-+
T Consensus 102 yvkh-nLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHhh-hhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 9987 9999998765 3778888999999999999999999 9999999999999999999999998644
Q ss_pred CC--cc---ccccccccccccCcCccCcccccCC----------C-CCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018396 222 QA--PD---AAARLHSTRVLGTFGYHAPEYAMTG----------Q-MSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (356)
Q Consensus 222 ~~--~~---~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~ 284 (356)
.. +. .+....-.+...-.+|+|||.+... . .+++.||||+||++.||++ |++||.-.
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------ 242 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------ 242 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------
Confidence 22 11 1111111222234589999987531 1 4678999999999999998 89999532
Q ss_pred cceecccc-cCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 285 SLVTWATP-KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 285 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
.+..|... ....+.+.+.++. ..++++|..|++.||.+|.++++.|+..+.
T Consensus 243 QL~aYr~~~~~~~e~~Le~Ied-----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 243 QLLAYRSGNADDPEQLLEKIED-----------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHHhHhccCccCHHHHHHhCcC-----------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11112111 2222333332221 258999999999999999999999987554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=223.13 Aligned_cols=252 Identities=18% Similarity=0.260 Sum_probs=187.9
Q ss_pred CCCceeeccCceEEEEEEEC-CCCEEEEEEcC----CCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD----SSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
.....+|.|++|.|+.+... ....++.|... ..... ...+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988877744 34444544432 11111 122556777788889999988888777766666669
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|||++ +|..++..... +...++-.++.|++.|++|+|+.| +.|||+|++|+++..+|.+||+|||.+
T Consensus 401 E~~~~-Dlf~~~~~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK---------LTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAA 467 (601)
T ss_pred hcccH-HHHHHHhcccc---------cchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcc
Confidence 99999 99999987622 778889999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc--ccccccccCcCccCcccccCCCCCc-cchhhhHHHHHHHHHcCCCCCCCCCCCCCcc-ceecccccCCh
Q 018396 221 NQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVTWATPKLSE 296 (356)
Q Consensus 221 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~ 296 (356)
..+...... ......+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||.-....+... ...+...
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~---- 543 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ---- 543 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc----
Confidence 766544333 3456778999999999999999965 5899999999999999999996543332221 0000000
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... ........+...+.+|.+||+.+|.+|.|+++|++
T Consensus 544 ---~~~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 ---RNIFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---cccccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000000 00122345678899999999999999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=206.88 Aligned_cols=224 Identities=25% Similarity=0.322 Sum_probs=186.6
Q ss_pred eeeccCceEEEEEEE----CCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEEecC
Q 018396 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
++|.|.||.|++++. ..+..+|+|++.+.... ......|..++...+ ||.+|++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998762 25788999988653221 224456777888886 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
||+|...+..... +.+.....+...++.+++++|+.+ ++|||+|++||+++.+|++++.|||+++..-
T Consensus 81 gg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred cchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhH
Confidence 9999888776654 778888889999999999999999 9999999999999999999999999988765
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... .+||..|||||++. .+..++|+||+|+++++|++|..||.. +.+..+..
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------------~~~~~Il~ 201 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------------DTMKRILK 201 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------------HHHHHHhh
Confidence 5432 28999999999888 678899999999999999999999963 22333333
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 337 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 337 (356)
.. ...|.+.+..+.+++..++..+|.+|.-.
T Consensus 202 ~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 AE--LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hc--cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 22 26778889999999999999999999755
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=183.00 Aligned_cols=170 Identities=14% Similarity=0.180 Sum_probs=133.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHH----------HHHHHHHHHhccCCceeeeeeEEecC
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----------FLAQVSMVSRLKNENVVELVGYYVDG 133 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~hp~iv~~~~~~~~~ 133 (356)
..++|+..++||.|+||.||++.. ++..+|+|++.......+. +.+|+..+.++.|++|..+.+++.+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999766 5778999999754433222 57889999999999999998886643
Q ss_pred --------CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEE
Q 018396 134 --------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (356)
Q Consensus 134 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (356)
...+++|||++|.+|.++.. ++. ....+++.+|..+|+.| ++|+|++|.||+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nil 167 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFI 167 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEE
Confidence 35889999999999988732 222 24569999999999999 999999999999
Q ss_pred EccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHH
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 269 (356)
++.+| ++|+|||........... ...+....++.++|+||||+++..+.
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99988 999999987655322110 01344556778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=175.99 Aligned_cols=139 Identities=18% Similarity=0.161 Sum_probs=107.6
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCc----------hH-----------------HHHHHHHHHHhccCCce
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP----------DQ-----------------EFLAQVSMVSRLKNENV 123 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~-----------------~~~~e~~~l~~l~hp~i 123 (356)
...||+|+||.||+|...+|+.||||++...... .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998654221 01 12348999999987776
Q ss_pred eeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCCeeecCCCCC
Q 018396 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEPRIIHRNIKSS 202 (356)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-H~~~~~~ivH~Dlkp~ 202 (356)
.....+... ..++||||++|+++........ .++...+..++.|++.+|.++ |+.| |+||||||+
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~ 147 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY 147 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 433332222 2389999999977765432221 278899999999999999999 7888 999999999
Q ss_pred cEEEccCCceeEecccccCCCc
Q 018396 203 NVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
|||++ ++.++|+|||+|....
T Consensus 148 NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HEEEE-CCcEEEEEccccccCC
Confidence 99998 5789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=182.74 Aligned_cols=236 Identities=18% Similarity=0.241 Sum_probs=146.5
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccC----------CceeeeeeE--
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKN----------ENVVELVGY-- 129 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h----------p~iv~~~~~-- 129 (356)
.+...+.||.|+++.||.+++. +++.+|+|+....... .+.+++|......+.+ -.++-.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556778999999999999987 7999999987543322 3455555544333221 112211111
Q ss_pred -------EecC---C-----eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 018396 130 -------YVDG---P-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194 (356)
Q Consensus 130 -------~~~~---~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~i 194 (356)
+... . ..+++|+-+. ++|.+++..-...... ...+.......+..|+++.+++||..| +
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l 166 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYG---L 166 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence 1111 1 2355666664 4888776531111000 111344455667789999999999999 9
Q ss_pred eecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccC--------CCCCccchhhhHHHHHH
Q 018396 195 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--------GQMSSKSDVYSFGVVLL 266 (356)
Q Consensus 195 vH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ 266 (356)
||+||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||+++|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999999999877665543221 234578999997643 24688899999999999
Q ss_pred HHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 018396 267 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFR 334 (356)
Q Consensus 267 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 334 (356)
.|++|..||+...+...... . -..+. +.++.+..||.++|+.+|++|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~-----------~---------f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW-----------D---------FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG-----------G---------GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc-----------c---------chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999975533211100 1 11334 678899999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=169.56 Aligned_cols=187 Identities=15% Similarity=0.099 Sum_probs=142.3
Q ss_pred CCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchH-----HHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEEe
Q 018396 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ-----EFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.+...|++|+||+|+.+.. .+.+++.+.+........ .+.+|+++|++|. |+++.+++++ +..+++|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 578899888876655333 5789999999995 4789999886 347999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCC-CCCcEEEccCCceeEecccccC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI-KSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dl-kp~Nill~~~~~vkl~Dfg~a~ 221 (356)
+.|.+|.+.+.. ....++.|++.+|.++|++| |+|||| ||+|||++.+|.++|+|||+|.
T Consensus 80 I~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 80 LAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred ecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 999998654321 01346789999999999999 999999 7999999999999999999998
Q ss_pred CCcccccc----c-------cccccccCcCccCcccccCC-CCC-ccchhhhHHHHHHHHHcCCCCCCCCC
Q 018396 222 QAPDAAAR----L-------HSTRVLGTFGYHAPEYAMTG-QMS-SKSDVYSFGVVLLELLTGRKPVDHTL 279 (356)
Q Consensus 222 ~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~~l~~g~~pf~~~~ 279 (356)
........ . .......++.|++|+...-- ..+ ...++++.|+-+|.++|+..++-++.
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 65433210 0 01112257888888855432 233 56789999999999999998875443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-23 Score=170.29 Aligned_cols=140 Identities=17% Similarity=0.155 Sum_probs=110.2
Q ss_pred CCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---------------------------hHHHHHHHHHHHhccCCc
Q 018396 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------------------------DQEFLAQVSMVSRLKNEN 122 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~hp~ 122 (356)
+.+.||+|+||.||+|...+|+.||||++...... ...+..|+..+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999878999999998754211 112357888999999988
Q ss_pred eeeeeeEEecCCeeEEEEEecCCCCHHHH-HhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCC
Q 018396 123 VVELVGYYVDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIK 200 (356)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlk 200 (356)
+.....+... ..++||||++|+++... +.... ++...+..++.|++.++.++|+ .| |+|||||
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlk 145 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVP----------LEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLS 145 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhcc----------CCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 7544443332 24899999998755433 33221 6778899999999999999999 88 9999999
Q ss_pred CCcEEEccCCceeEecccccCCCcc
Q 018396 201 SSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+||+++ ++.++|+|||++.....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecCC
Confidence 9999998 89999999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=180.63 Aligned_cols=197 Identities=19% Similarity=0.236 Sum_probs=143.1
Q ss_pred cCCceeeeeeEEec---------------------------CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHH
Q 018396 119 KNENVVELVGYYVD---------------------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171 (356)
Q Consensus 119 ~hp~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 171 (356)
+|||||.+.++|.+ +..+|+||.-++. +|.+++-.+. .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence 59999999887653 2457899988876 9999998765 67788
Q ss_pred HHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc--cCC--ceeEecccccCCCccccc----cccccccccCcCccC
Q 018396 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDD--IAKISDFDLSNQAPDAAA----RLHSTRVLGTFGYHA 243 (356)
Q Consensus 172 ~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~--~vkl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~a 243 (356)
...++.|+++|+.|||++| |.|||+|.+|||+. +|+ .+.|+|||++---....- ....-..-|.-..||
T Consensus 343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 8889999999999999999 99999999999995 343 578999998632221100 001122346778899
Q ss_pred cccccCCCC------CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHH
Q 018396 244 PEYAMTGQM------SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (356)
Q Consensus 244 PE~~~~~~~------~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (356)
||+....+- -.++|.|+.|.+.||+++..-||...-.. .++...+++.- ....+..+++
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----------~L~~r~Yqe~q----LPalp~~vpp 484 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----------LLDTRTYQESQ----LPALPSRVPP 484 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-----------eechhhhhhhh----CCCCcccCCh
Confidence 998764321 24789999999999999999999652110 11111122111 1244567788
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 318 KMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 318 ~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.+++++...|+.||.+|++..-....|
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHH
Confidence 999999999999999999987655544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=196.37 Aligned_cols=209 Identities=25% Similarity=0.355 Sum_probs=149.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
..+|..++.+..|++|.||.++++ +.+.+|+| +.+... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc--cccccCCccee-------------------
Confidence 468999999999999999999988 67788884 443321 1111 33333445444
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
|+-...+..... ++. +++.+++|||+.| |+|||+||+|++|+.-|++|++|||+++..
T Consensus 136 --gDc~tllk~~g~---------lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP---------LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred --chhhhhcccCCC---------Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 455555544332 222 2277899999999 999999999999999999999999997643
Q ss_pred ccc-------------cccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 224 PDA-------------AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 224 ~~~-------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
... .........+|||.|+|||++....|+..+|+|++|+|+|+.+.|..||.++++....
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------ 267 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------ 267 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------
Confidence 211 1112234678999999999999999999999999999999999999999877443211
Q ss_pred cccCChhhHhHhh-cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 018396 291 TPKLSEDKVKQCV-DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN 336 (356)
Q Consensus 291 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 336 (356)
..++ +.....+.....+.+++++|...|+.+|..|.-
T Consensus 268 ---------g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 268 ---------GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ---------hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 1111 111111223345678999999999999999953
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=194.38 Aligned_cols=197 Identities=23% Similarity=0.233 Sum_probs=157.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc---CCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~ 140 (356)
....|.+.+.||+|+||.||.|...+|+.||+|+=.....++-. =-.+++.+|+ -+.|..+...+.-.+.-++|+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY--I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY--ICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee--ehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 34578889999999999999999888999999986655444221 1223444444 245556666666677789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-------CCcee
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-------DDIAK 213 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-------~~~vk 213 (356)
||.+.|+|.++++..+. +++..++.++.|++..++.||..+ |||+||||+|+||.. .--++
T Consensus 774 ey~~~Gtlld~~N~~~~---------m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNKV---------MDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred eccccccHHHhhccCCC---------CCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 99999999999995543 889999999999999999999999 999999999999952 23589
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCC
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 274 (356)
|+|||.+-...--.....-...++|-.+--+|+..|.+++...|.|.|+.+++-|++|+.-
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999998654322111223566789999999999999999999999999999999998863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=160.90 Aligned_cols=135 Identities=16% Similarity=0.149 Sum_probs=104.7
Q ss_pred CCCceeeccCceEEEEEEECCCCEEEEEEcCCCCC-chHHHHHHHHHHHhc-----cCCceeeeeeEEecCC---e-eEE
Q 018396 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRL-----KNENVVELVGYYVDGP---L-RVL 138 (356)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~---~-~~l 138 (356)
.-...||+|+||.||. +......+||++..... ..+.+.+|+.+++.+ .||||+++++++.++. . +.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999995 54333347998865422 356789999999999 5799999999998763 3 347
Q ss_pred EEEe--cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhhCCCCCeeecCCCCCcEEEcc----CCc
Q 018396 139 AYEH--ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL-EYLHEKAEPRIIHRNIKSSNVLLFD----DDI 211 (356)
Q Consensus 139 v~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l-~~lH~~~~~~ivH~Dlkp~Nill~~----~~~ 211 (356)
|+|| +.+++|.+++.... +++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.
T Consensus 83 I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCc
Confidence 8999 55789999996532 4444 35577888777 9999999 999999999999974 347
Q ss_pred eeEeccccc
Q 018396 212 AKISDFDLS 220 (356)
Q Consensus 212 vkl~Dfg~a 220 (356)
++|+||+.+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=172.08 Aligned_cols=216 Identities=23% Similarity=0.355 Sum_probs=163.4
Q ss_pred HHhccCCceeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 018396 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194 (356)
Q Consensus 115 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~i 194 (356)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+....- .+++.....+.++|+.||.|||+.. -.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--------~~d~~F~~s~~rdi~~Gl~ylh~s~--i~ 70 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--------KLDYFFILSFIRDISKGLAYLHNSP--IG 70 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--------CccHHHHHHHHHHHHHHHHHHhcCc--ce
Confidence 4678999999999999999999999999999999999987432 2788889999999999999999985 13
Q ss_pred eecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCC-------CCccchhhhHHHHHHH
Q 018396 195 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-------MSSKSDVYSFGVVLLE 267 (356)
Q Consensus 195 vH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~~ 267 (356)
.|+.++..|.+++....+||+|||+.................-...|.|||.+.+.. .+.+.|+||+|++++|
T Consensus 71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 999999999999999999999999977664311111112222356799999987642 4567999999999999
Q ss_pred HHcCCCCCCCCCCCCCccceecccccCChhhHhHhhc---ccCCCCCC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 268 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD---TKLGGEYP--PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 268 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+++...||........ . .+.+..+.+ ..++.... .+..+++..++..||.-+|.+||+++.+-.
T Consensus 151 i~~r~~~~~~~~~~~~----------~-~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVED----------P-DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHhccCccccccccCC----------h-HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9999999975321110 0 111111111 11122221 144557999999999999999999999999
Q ss_pred HHHHhhccC
Q 018396 343 ALQPLLNTR 351 (356)
Q Consensus 343 ~L~~l~~~~ 351 (356)
.++.+....
T Consensus 220 ~~~~~~~~~ 228 (484)
T KOG1023|consen 220 KLLTINKGG 228 (484)
T ss_pred hhhhhcccc
Confidence 988877654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=158.65 Aligned_cols=150 Identities=16% Similarity=0.146 Sum_probs=114.0
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEE--ECCCCEEEEEEcCCCCCc-------------------------hHHHHHHH
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV--LRSGRAAAIKKLDSSKQP-------------------------DQEFLAQV 112 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~e~ 112 (356)
.+......|.+.+.||+|+||.||+|. ..+|+.||+|++...... ...+.+|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 334444568999999999999999998 348999999998653210 01246799
Q ss_pred HHHHhccCC--ceeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 018396 113 SMVSRLKNE--NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190 (356)
Q Consensus 113 ~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 190 (356)
..++++.+. .+.+++++ ...++||||+.|.+|........ .+....+..++.|++.++.+||+.|
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC
Confidence 999999753 33344432 23589999999988876543221 1556667889999999999999996
Q ss_pred CCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 191 ~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
+++|+||||+||+++ ++.++|+|||.+.....
T Consensus 169 --~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 169 --ELVHGDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred --CEEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 599999999999999 88999999998765443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-21 Score=173.61 Aligned_cols=171 Identities=27% Similarity=0.375 Sum_probs=130.1
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
..+||.|++|.-.+|.++|...+... ..++.....++.|++.++.| ++ .+|+|+||.||+...+..+|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e------~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGE------ERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCccc------ccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhh
Confidence 35789999999999999998665432 25677888999999999999 77 99999999999999999999
Q ss_pred EecccccCCCcccc----ccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCcccee
Q 018396 214 ISDFDLSNQAPDAA----ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 214 l~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 288 (356)
|.|||+........ .........||+.||+||.+.+..|+.++||||||++|+|++. =...|...
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------- 466 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------- 466 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------
Confidence 99999987665443 1223456789999999999999999999999999999999987 33333211
Q ss_pred cccccCChhhHhHhhcccCCCCCCHHHH---HHHHHHHHHhhccCCCCCCCHH
Q 018396 289 WATPKLSEDKVKQCVDTKLGGEYPPKAI---AKMAAVAALCVQYEADFRPNMG 338 (356)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~cl~~~P~~Rps~~ 338 (356)
..+..+. .+.+|+... +.-+.|+.+++.+.|.+||++.
T Consensus 467 --------~t~~d~r----~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 467 --------ATLTDIR----DGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred --------Hhhhhhh----cCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 1111111 122232221 2446899999999999999433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-19 Score=152.04 Aligned_cols=133 Identities=23% Similarity=0.331 Sum_probs=111.9
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---------hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+.||+|++|.||+|.. .+..+++|+....... ...+.+|+.++..+.|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 4778999976543211 13467899999999999888777777777889999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
++|++|.+++.... . ....++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986431 2 77889999999999999999 99999999999999 78899999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-19 Score=150.66 Aligned_cols=131 Identities=24% Similarity=0.336 Sum_probs=105.9
Q ss_pred eeeccCceEEEEEEECCCCEEEEEEcCCCCC-c--------hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-P--------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~--------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
.||+|+||.||+|... +..+++|....... . ...+.+|+++++.+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999854 67899998653221 1 144668999999998887655555555666789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
+|++|.+++.... . .++.+++.+|.+||+.| ++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999875421 1 68899999999999999 99999999999999 889999999998664
Q ss_pred c
Q 018396 224 P 224 (356)
Q Consensus 224 ~ 224 (356)
.
T Consensus 140 ~ 140 (199)
T TIGR03724 140 D 140 (199)
T ss_pred C
Confidence 3
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-19 Score=149.35 Aligned_cols=140 Identities=16% Similarity=0.125 Sum_probs=109.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc-----------------------hHHHHHHHHHHHhccC
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-----------------------DQEFLAQVSMVSRLKN 120 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h 120 (356)
....|.+.+.||+|+||.||++...+|+.||||++...... ......|+.++..+.|
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 33458889999999999999999888999999987543211 1125678888888877
Q ss_pred Cc--eeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecC
Q 018396 121 EN--VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 198 (356)
Q Consensus 121 p~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~D 198 (356)
++ +...++ ....+++|||++|++|.+.... .....++.+++.++.++|+.| ++|+|
T Consensus 93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred cCCCCCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 74 444443 2456899999999998765321 234568889999999999999 99999
Q ss_pred CCCCcEEEccCCceeEecccccCCCcc
Q 018396 199 IKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 199 lkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|+||+++.++.++|+|||.+.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=166.88 Aligned_cols=137 Identities=22% Similarity=0.295 Sum_probs=110.4
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEE-cCCCCC--------chHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKK-LDSSKQ--------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~~--------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
...|...+.||+|+||.||++.+.... +++|+ +.+... ..+.+.+|+++++.++|++++....+..+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344567889999999999999876433 44443 222111 12457889999999999999887777777778
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ +++.++|+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence 899999999999999875 23568899999999999999 9999999999999 67899999
Q ss_pred cccccCCC
Q 018396 216 DFDLSNQA 223 (356)
Q Consensus 216 Dfg~a~~~ 223 (356)
|||++...
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99997653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-20 Score=178.38 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=192.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC--CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 139 (356)
..|.+.+.||+|+|+.|-.+... ....+|+|.+...... ...+..|..+-+.+. |.|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45777888999999999888754 3556777766554322 234455777777776 99999999999999999999
Q ss_pred EEecCCCCHHHHHh-cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCCeeecCCCCCcEEEccCC-ceeEec
Q 018396 140 YEHASKGSLHDILH-GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKAEPRIIHRNIKSSNVLLFDDD-IAKISD 216 (356)
Q Consensus 140 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~~~~ivH~Dlkp~Nill~~~~-~vkl~D 216 (356)
++|..|+++.+.+. .... ..+...+-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|
T Consensus 100 ~~~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST--------GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred cCcccccccccccccCCcc--------CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCC
Confidence 99999999998884 2220 1455667788999999999999 888 99999999999999999 999999
Q ss_pred ccccCCCcc-cccccccccccc-CcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 217 FDLSNQAPD-AAARLHSTRVLG-TFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 217 fg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
||+|..+.. ..........+| ++.|+|||...+. ...+..|+||+|+++.-+++|..|++........ ...|....
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~ 247 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK 247 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc
Confidence 999988776 333333455678 9999999999885 4478899999999999999999999765433321 11111110
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 341 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell 341 (356)
................+++.+++..+|..|.+.+++-
T Consensus 248 -----------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 -----------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -----------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0111122334455678899999999999999988864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.1e-17 Score=139.63 Aligned_cols=135 Identities=16% Similarity=0.207 Sum_probs=103.7
Q ss_pred Cceee-ccCceEEEEEEECCCCEEEEEEcCCCC--------------CchHHHHHHHHHHHhccCCce--eeeeeEEecC
Q 018396 71 NSLIG-EGSYGRVYFGVLRSGRAAAIKKLDSSK--------------QPDQEFLAQVSMVSRLKNENV--VELVGYYVDG 133 (356)
Q Consensus 71 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~hp~i--v~~~~~~~~~ 133 (356)
...|| .||.|+||.+... +..++||.+.... .....+.+|++++..|.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34787 8999999998876 6789998774311 112457889999999988774 5666654332
Q ss_pred -Ce---eEEEEEecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc
Q 018396 134 -PL---RVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (356)
Q Consensus 134 -~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (356)
.. .++|+|+++| .+|.+++.... ++.. .+.+++.+|.+||+.| |+|+||||+|||++.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~ 177 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDP 177 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcC
Confidence 22 2599999997 68999886432 4433 3568999999999999 999999999999999
Q ss_pred CCceeEecccccCCC
Q 018396 209 DDIAKISDFDLSNQA 223 (356)
Q Consensus 209 ~~~vkl~Dfg~a~~~ 223 (356)
++.++|+|||.+...
T Consensus 178 ~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 178 DGKFWLIDFDRGELR 192 (239)
T ss_pred CCCEEEEECCCcccC
Confidence 999999999987654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.8e-18 Score=140.44 Aligned_cols=136 Identities=17% Similarity=0.225 Sum_probs=97.8
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCch---HHH----------------------HHHHHHHHhccCCc--e
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEF----------------------LAQVSMVSRLKNEN--V 123 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~e~~~l~~l~hp~--i 123 (356)
.+.||+|+||.||+|...+++.||||++....... ..+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 56899999999999998889999999886533211 111 24555555554432 3
Q ss_pred eeeeeEEecCCeeEEEEEecCCCCHHH-HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCC
Q 018396 124 VELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKS 201 (356)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp 201 (356)
.+.++. ...+++|||++++++.. .+.... . ...+..++.+++.++.++|. .+ ++|+||||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----------~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p 143 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----------L-LEDPEELYDQILELMRKLYREAG---LVHGDLSE 143 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----------h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCCh
Confidence 344432 24689999999955321 111110 1 15577899999999999999 88 99999999
Q ss_pred CcEEEccCCceeEecccccCCCcc
Q 018396 202 SNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
+||+++ ++.++|+|||.+.....
T Consensus 144 ~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 144 YNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred hhEEEE-CCcEEEEECcccccccC
Confidence 999999 89999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-16 Score=127.47 Aligned_cols=135 Identities=20% Similarity=0.211 Sum_probs=112.3
Q ss_pred CCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC--CceeeeeeEEecCCeeEEEEEecCCCC
Q 018396 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~ 147 (356)
+.+.||.|.++.||++...+ ..+++|....... ...+.+|+.+++.+++ .++.+++.+...++..++++||+.++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 45789999999999999864 7899998866543 4678899999999976 588999998888888999999999877
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+..+ +......++.+++.++.++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 80 ~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7544 2345566788999999999986333399999999999999989999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-14 Score=134.01 Aligned_cols=142 Identities=22% Similarity=0.261 Sum_probs=98.9
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCch-----------------------------------------HHHH
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-----------------------------------------QEFL 109 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------------------------------~~~~ 109 (356)
.+.||.|++|.||+|+.++|+.||||+........ -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986532110 0133
Q ss_pred HHHHHHHhc----cCCceeeeeeEEe-cCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHH-HH
Q 018396 110 AQVSMVSRL----KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-GL 183 (356)
Q Consensus 110 ~e~~~l~~l----~hp~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~-~l 183 (356)
+|+..+.++ ++.+-+.+-.++. .....++||||++|++|.++....... .. ...++.+++. .+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--------LD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--------CC---HHHHHHHHHHHHH
Confidence 444444444 2322233333332 244578999999999998876532110 22 2345555555 46
Q ss_pred HHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 184 ~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
..+|..| ++|+|++|.||+++.++.++++|||++......
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 7889998 999999999999999999999999998776543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.4e-13 Score=128.81 Aligned_cols=167 Identities=16% Similarity=0.237 Sum_probs=127.0
Q ss_pred EEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCC
Q 018396 85 GVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK 162 (356)
Q Consensus 85 ~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 162 (356)
|..+ ++.+|.|+........ .+...+.++.|+.++||||+++++.++..+..|+|+|-+.- |..++..
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~-------- 100 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE-------- 100 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--------
Confidence 4433 6888998888765542 34567888999999999999999999999999999999864 7777765
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCcc
Q 018396 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242 (356)
Q Consensus 163 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 242 (356)
+....+..-+.||+.||.+||+.+ +++|++|.-+.|+|+..|..||++|.++......... .....---.|.
T Consensus 101 ----l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~ 172 (690)
T KOG1243|consen 101 ----LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFD 172 (690)
T ss_pred ----hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhccc
Confidence 344566677899999999999765 5999999999999999999999999987554332211 01111223456
Q ss_pred CcccccCCCCCccchhhhHHHHHHHHHcC
Q 018396 243 APEYAMTGQMSSKSDVYSFGVVLLELLTG 271 (356)
Q Consensus 243 aPE~~~~~~~~~~~DvwslG~il~~l~~g 271 (356)
.|+.+-... ...|.|.|||++++++.|
T Consensus 173 ~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 173 DPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 666433222 457999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.1e-15 Score=126.59 Aligned_cols=202 Identities=22% Similarity=0.331 Sum_probs=140.5
Q ss_pred HHHHhccCCceeeeeeEEec-----CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 018396 113 SMVSRLKNENVVELVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187 (356)
Q Consensus 113 ~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 187 (356)
.-|-++.|.|||++..|+.+ ..+..+++||+..|+|.++|++.+... ..+......+|..||+.||.|||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-----~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-----KALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-----hhhhHHHHHHHHHHHHhhhhhhh
Confidence 34566789999999988764 456788899999999999998776533 23777788899999999999999
Q ss_pred hCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc--ccccccccccccCcCccCcccccCCCCCccchhhhHHHHH
Q 018396 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 265 (356)
Q Consensus 188 ~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 265 (356)
+..+ +++|+++..+.|++..+|-+|+.--.-...... .........-.+.++|.|||.=.....+.++|||++|...
T Consensus 194 s~~P-piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SCDP-PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred ccCC-ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 9964 599999999999999999888753211111000 0000011223467899999976666678899999999999
Q ss_pred HHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh---hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 266 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC---VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 266 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+|.-+..--...... ....+..... .... .-+.++.+|++..|..||++.+++.
T Consensus 273 lemailEiq~tnseS~-----------~~~ee~ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESK-----------VEVEENIANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHHheeccCCCcce-----------eehhhhhhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhc
Confidence 9998877643221100 0011111111 1111 1256789999999999999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-14 Score=134.68 Aligned_cols=248 Identities=21% Similarity=0.231 Sum_probs=181.5
Q ss_pred CCCCCCceeec--cCceEEEEEEE--C-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCee
Q 018396 66 DNFGTNSLIGE--GSYGRVYFGVL--R-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (356)
Q Consensus 66 ~~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 136 (356)
..|-+.+.+|. |.+|.||.+.. . ++..+|+|.-.... .....-.+|+.....+ .|+|.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677788999 99999999987 5 78889998743221 2223345667666666 589999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHhhhCCCCCeeecCCCCCcEEEccC-Cc
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----GLEYLHEKAEPRIIHRNIKSSNVLLFDD-DI 211 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~----~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~ 211 (356)
++-+|++. .+|.++...... .++...++..+.+... ||.++|..+ ++|-|+||.||+...+ ..
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~--------~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN--------FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred eeeecccc-chhHHhhhcccc--------cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence 99999996 588888765543 2677788888888888 999999999 9999999999999999 88
Q ss_pred eeEecccccCCCcccccccc---ccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee
Q 018396 212 AKISDFDLSNQAPDAAARLH---STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 288 (356)
.+++|||+...+........ .....|...|++||. ....++...|+|++|.+..+-.++..++...-..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------- 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNS------- 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCC-------
Confidence 99999999887766542211 122357788999995 4567888999999999999998877765322000
Q ss_pred cccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.|.. +...-+..++-..-+.++...+..+++.+|..|++++.+..
T Consensus 334 ----~W~~-----~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 ----SWSQ-----LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----Cccc-----cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0100 00000111122222345666899999999999999888654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.1e-14 Score=114.20 Aligned_cols=130 Identities=15% Similarity=0.081 Sum_probs=96.9
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCcee-eeeeEEecCCeeEEEEEecCCCCHHH
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEHASKGSLHD 150 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~L~~ 150 (356)
+.|+.|.++.||++... ++.+++|...........+..|+.+++.+.+.+++ +++.+. ....++||||++|.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 56888999999999876 77899998865543334567899999988655443 444443 334589999999988754
Q ss_pred HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--CCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 151 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
. . .. ...++.+++.+|..||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~----~----------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 E----D----------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c----c----------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 3 0 11 1235678999999999987 22259999999999998 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.1e-14 Score=134.83 Aligned_cols=147 Identities=16% Similarity=0.236 Sum_probs=95.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEECC-CCEEEEEEcCCCCCc-----------------------------------hH-
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQP-----------------------------------DQ- 106 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-----------------------------------~~- 106 (356)
....|+. +.||+|++|.||+|+.++ |+.||||++...-.. .+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3445776 789999999999999885 999999998754210 01
Q ss_pred -----HHHHHHHHHHhc----cCCceeeeeeEEec-CCeeEEEEEecCCCCHHHHH--hcCCCCCCCCCCCCCCHHHHHH
Q 018396 107 -----EFLAQVSMVSRL----KNENVVELVGYYVD-GPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVK 174 (356)
Q Consensus 107 -----~~~~e~~~l~~l----~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~~~~~~ 174 (356)
++.+|+..+.++ .+.+.+.+-.++.+ ....++||||+.|+.+.++- ...... ...+....+..
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d-----~~~la~~~v~~ 271 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD-----MKLLAERGVEV 271 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC-----HHHHHHHHHHH
Confidence 122333333333 23333433333332 45678999999999998753 221100 00133333444
Q ss_pred HHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC----ceeEecccccCCCccc
Q 018396 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDA 226 (356)
Q Consensus 175 ~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~vkl~Dfg~a~~~~~~ 226 (356)
++.|+ ...| ++|+|++|.||+++.+| .++++|||++......
T Consensus 272 ~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 272 FFTQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 44444 3567 99999999999999888 9999999998776543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.4e-11 Score=109.80 Aligned_cols=269 Identities=16% Similarity=0.160 Sum_probs=163.2
Q ss_pred CCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeE------Eec-CCeeEEEEE
Q 018396 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGY------YVD-GPLRVLAYE 141 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~------~~~-~~~~~lv~e 141 (356)
..+.||+|+-+.+|-.-.- ...+.|++.......+. ..++.|... .||-+-.=+.+ .-+ +...-++|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 3568999999999865422 22466777654433221 122222222 34422110111 112 223567777
Q ss_pred ecCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 142 HASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
.+++. .+..++......+ ..+...|...+.+++.++.+...||..| .+-+|+.++|+|+.+++.|.|.|=..-
T Consensus 91 ~v~g~~pI~~~y~p~tRRq---s~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQ---SYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred cCCCccchhhhcCchhhcc---cCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 77664 3444444333222 2344889999999999999999999999 999999999999999999999986532
Q ss_pred CCCccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcC-CCCCCCCCCCCCc--cce-eccc
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQ--SLV-TWAT 291 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g-~~pf~~~~~~~~~--~~~-~~~~ 291 (356)
...... ......+|...|.+||.-. +...+...|.|.||+++++++.| ++||.+-...... ... .+..
T Consensus 165 qi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 222111 1124567899999999644 34557789999999999999985 9999764322110 000 0000
Q ss_pred ccCChhhHhHhhcccCCCCCCH-HHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHHhhccC
Q 018396 292 PKLSEDKVKQCVDTKLGGEYPP-KAIAKMAAVAALCVQY--EADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~--~P~~Rps~~ell~~L~~l~~~~ 351 (356)
..+....-...-........|- -.++.+..|..+|+.. ++.-|||++.++..|..+-.+.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0000000000000001112222 3357788888999853 3668999999999998876544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.6e-12 Score=104.75 Aligned_cols=136 Identities=17% Similarity=0.142 Sum_probs=97.4
Q ss_pred CceeeccCceEEEEEEECC-------CCEEEEEEcCCCCC----------------------c-hHHH----HHHHHHHH
Q 018396 71 NSLIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSKQ----------------------P-DQEF----LAQVSMVS 116 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~----------------------~-~~~~----~~e~~~l~ 116 (356)
...||.|--+.||.|...+ +..+|||+...... . ...+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998543 47899998642110 0 1122 37888999
Q ss_pred hccC--CceeeeeeEEecCCeeEEEEEecCCCCHHH-HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCC
Q 018396 117 RLKN--ENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEP 192 (356)
Q Consensus 117 ~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-H~~~~~ 192 (356)
++.. -++.+.+++ ..-++||||+.+..+.. .+... .++......+..+++.+|..| |+.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~g-- 145 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECN-- 145 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 8853 355555554 46789999997754321 22211 144556677889999999998 8888
Q ss_pred CeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+||+||++.||++. ++.+.|+|||.+....
T Consensus 146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred -eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999999996 5789999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.1e-14 Score=136.31 Aligned_cols=249 Identities=20% Similarity=0.205 Sum_probs=175.2
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
...+.+.+.+.+-+|.++.++.+.-. +|...++|+...... ..+..+.+-.++-.-.+|.++.....+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567888888999999999988744 555555554433211 1222333333333335677777666666778899
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
++++|..+++|...++.-.. .+..-+......+..++++||... ++|+|++|.|++...+|+.++.||
T Consensus 881 L~~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDF 948 (1205)
T ss_pred hhhHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcc
Confidence 99999999999998876542 333444556667888999999997 899999999999999999999999
Q ss_pred cccCCCccc---------------------cc--------cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHH
Q 018396 218 DLSNQAPDA---------------------AA--------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 268 (356)
Q Consensus 218 g~a~~~~~~---------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l 268 (356)
|.....+.. .. ........||+.|.+||.+.+......+|+|+.|+++++.
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence 843211100 00 0012235689999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 018396 269 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMG 338 (356)
Q Consensus 269 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 338 (356)
++|.+||....+..... .++.... ....+...+.+..+++...+..+|.+|..+.
T Consensus 1029 l~g~pp~na~tpq~~f~---------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIFE---------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hcCCCCCCCcchhhhhh---------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999998665432211 1111111 1133445667889999999999999997765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.4e-13 Score=123.69 Aligned_cols=249 Identities=18% Similarity=0.166 Sum_probs=176.7
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC--CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhc-cCCceeeeeeEEecCCee
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 136 (356)
....+|..+..||.|.|+.|+....+ ++..|++|.+...-.. +..-..|+.+...+ .|.+++..+..+..-+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999987743 6889999988654332 12224566666666 588888888887777788
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-CceeEe
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKIS 215 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~ 215 (356)
|+-.|||+++++...+.-.- .+.+...+.+..|++.++.++|+.. ++|+|++|.||++..+ +.-++.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~---------~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQ---------MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred cCchhhhcCcchhhhhHHHH---------hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcc
Confidence 89999999988766552111 1677788899999999999999999 9999999999999886 778999
Q ss_pred cccccCCCcccccccccccccc-CcCc-cCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 216 DFDLSNQAPDAAARLHSTRVLG-TFGY-HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~g-t~~y-~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|||++..+.... ..... +..| .++.......+..+.|++|||..+.+.+++..--....
T Consensus 410 ~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------- 470 (524)
T KOG0601|consen 410 DFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------------- 470 (524)
T ss_pred ccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------------
Confidence 999876532221 11122 3334 35555567788999999999999999998775332110
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
....+..... ...+.....+..+...+...++..||++.++....+-..
T Consensus 471 ----~~~~i~~~~~--p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 471 ----QSLTIRSGDT--PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ----cceeeecccc--cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0011111100 111223367788889999999999999998876555443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.5e-12 Score=106.44 Aligned_cols=141 Identities=18% Similarity=0.256 Sum_probs=104.5
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccC--CceeeeeeEEecC---CeeEEEEEecC
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKN--ENVVELVGYYVDG---PLRVLAYEHAS 144 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~---~~~~lv~e~~~ 144 (356)
+.|+.|.++.||++...+|+.+++|....... ....+..|+++++.+.+ .++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887668899998865443 34568899999999965 3456677766553 26689999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------- 190 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---------------------------------- 190 (356)
|.++.+.+... .++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 84 GRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred CEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 98887755311 1455556666667777777666421
Q ss_pred -------------------CCCeeecCCCCCcEEEcc--CCceeEecccccCC
Q 018396 191 -------------------EPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQ 222 (356)
Q Consensus 191 -------------------~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a~~ 222 (356)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 123899999999999998 66789999997654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=4e-11 Score=95.97 Aligned_cols=130 Identities=21% Similarity=0.299 Sum_probs=97.5
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEc-CCCCCc---h-----HHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKL-DSSKQP---D-----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~~---~-----~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
..+++|+-+.++.+.+. |..+++|.- .+.... + ..-.+|+.++.++.--.|.--.=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 445666643 332221 1 3346788888888654444444455578889999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
.+|..|.+++.... ..++..+=.-+.-||..| |+|+||.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~----------------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEAR----------------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcc----------------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999987641 346677777789999999 99999999999997766 89999999764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.6e-11 Score=94.01 Aligned_cols=143 Identities=21% Similarity=0.243 Sum_probs=105.4
Q ss_pred CCceeeccCceEEEEEEECCCCEEEEEEcCCC-CC--------chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS-KQ--------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~--------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
...++-+|+-+.|+.+.+. |+.+.||.-... .. ...+..+|+++|.++.--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5668899999999999887 777777754321 11 1245678899888886444443334556777788999
Q ss_pred EecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC---ceeEec
Q 018396 141 EHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISD 216 (356)
Q Consensus 141 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~D 216 (356)
||++| .++.+++....... ........++.+|-..+.-||.++ ++|+||..+||++..++ .+.++|
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred EeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence 99987 47888887665322 223333678899999999999999 99999999999998765 358999
Q ss_pred ccccCCC
Q 018396 217 FDLSNQA 223 (356)
Q Consensus 217 fg~a~~~ 223 (356)
||++...
T Consensus 160 fgls~~s 166 (229)
T KOG3087|consen 160 FGLSSVS 166 (229)
T ss_pred ecchhcc
Confidence 9997543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.6e-10 Score=104.22 Aligned_cols=221 Identities=14% Similarity=0.151 Sum_probs=157.2
Q ss_pred ceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEe----cCCeeEEEEEecCC-CCHHHH
Q 018396 79 YGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYV----DGPLRVLAYEHASK-GSLHDI 151 (356)
Q Consensus 79 ~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~----~~~~~~lv~e~~~~-~~L~~~ 151 (356)
-.+.|++... +|..|++|+++..... ......-+++++++.|+|+|++.+++. .+..+.+|++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3568999966 8999999999543222 223455688899999999999999887 34568899999986 578887
Q ss_pred HhcCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 152 LHGKKGVK------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 152 l~~~~~~~------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
.-...... ....+...++..+|.++.|+..||.++|+.| +..+-|.|.+|+++.+.+++|..+|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 75443322 1222344788999999999999999999999 99999999999999999999998887544433
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
.. . |-+.+ -.+-|.=.||.++..|.+|..--... ........+
T Consensus 446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~--------------d~~~~s~~~---- 488 (655)
T KOG3741|consen 446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRT--------------DSTQSSHLT---- 488 (655)
T ss_pred CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccc--------------cchHHHHHH----
Confidence 21 0 00111 22468888999999999986542110 001111011
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.+...++.++++++.-....++++ -++.+++..+
T Consensus 489 ----~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 489 ----RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ----HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 223567788889998888888886 6788887654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-09 Score=94.07 Aligned_cols=139 Identities=16% Similarity=0.054 Sum_probs=96.4
Q ss_pred eeeccCceEEEEEEECCCCEEEEEEcCCCC------------CchHHHHHHHHHHHhccCC--ceeeeeeEEec-----C
Q 018396 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSK------------QPDQEFLAQVSMVSRLKNE--NVVELVGYYVD-----G 133 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~e~~~l~~l~hp--~iv~~~~~~~~-----~ 133 (356)
.+-......|++... .|+.+.||...... .......+|+..+.+|..- .....+.+.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 343344444666555 47789999664322 1112467888888887432 23344444432 2
Q ss_pred CeeEEEEEecCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc----
Q 018396 134 PLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---- 208 (356)
Q Consensus 134 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---- 208 (356)
...++|+|++++. +|.+++...... .........++.+++..+.-||..| |+|+|+++.|||++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG 177 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence 3578999999986 899998643211 1456677789999999999999999 999999999999975
Q ss_pred ---CCceeEecccccCC
Q 018396 209 ---DDIAKISDFDLSNQ 222 (356)
Q Consensus 209 ---~~~vkl~Dfg~a~~ 222 (356)
++.+.|+||+.+..
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 46899999997743
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.5e-10 Score=92.06 Aligned_cols=124 Identities=19% Similarity=0.223 Sum_probs=80.7
Q ss_pred EEEEEECCCCEEEEEEcCCCCC----------------------c-----hHHHHHHHHHHHhccCC--ceeeeeeEEec
Q 018396 82 VYFGVLRSGRAAAIKKLDSSKQ----------------------P-----DQEFLAQVSMVSRLKNE--NVVELVGYYVD 132 (356)
Q Consensus 82 V~~~~~~~~~~vavK~~~~~~~----------------------~-----~~~~~~e~~~l~~l~hp--~iv~~~~~~~~ 132 (356)
||.|...+|..+|+|+...... . .....+|++.|.++..- ++.+.+++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 8999988899999998643210 0 12346799999999765 455666542
Q ss_pred CCeeEEEEEecC--CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-hhhCCCCCeeecCCCCCcEEEccC
Q 018396 133 GPLRVLAYEHAS--KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY-LHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 133 ~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~-lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
.-.+||||+. |..+..+.... +.......++.+++..+.. +|..| ++|+||.+.||+++++
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~ 143 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG 143 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT
T ss_pred --CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc
Confidence 3579999998 65555544322 1123345567777775555 57888 9999999999999887
Q ss_pred CceeEecccccCCCc
Q 018396 210 DIAKISDFDLSNQAP 224 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~ 224 (356)
.+.|+|||.+....
T Consensus 144 -~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 144 -KVYIIDFGQAVDSS 157 (188)
T ss_dssp -CEEE--GTTEEETT
T ss_pred -eEEEEecCcceecC
Confidence 89999999876544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.9e-11 Score=113.13 Aligned_cols=151 Identities=20% Similarity=0.321 Sum_probs=107.3
Q ss_pred HHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccc-------cccccCcCccCcccccC
Q 018396 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-------TRVLGTFGYHAPEYAMT 249 (356)
Q Consensus 177 ~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~ 249 (356)
.+++.|+.|+|+.. ++||++|.|++|.++..+.+||+.|+.+............ ....-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999985 6999999999999999999999999987665442221111 11123568999999999
Q ss_pred CCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhc
Q 018396 250 GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQ 328 (356)
Q Consensus 250 ~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 328 (356)
...+.++|+||+|+++|.+.. |+.-+...... .. .......+......++.+.+.++++-+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~------------~~-~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL------------LS-YSFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc------------ch-hhhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 888999999999999999995 55554332111 00 01111111112224456778899999999999
Q ss_pred cCCCCCCCHHHHHH
Q 018396 329 YEADFRPNMGIVLK 342 (356)
Q Consensus 329 ~~P~~Rps~~ell~ 342 (356)
.++.-||++..++.
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999997776643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.3e-09 Score=89.45 Aligned_cols=135 Identities=16% Similarity=0.165 Sum_probs=98.5
Q ss_pred CCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCC------------------C-----chHHHHHHHHHHHhccCC--
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK------------------Q-----PDQEFLAQVSMVSRLKNE-- 121 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~-----~~~~~~~e~~~l~~l~hp-- 121 (356)
-+.++..||.|--|.||.|...+|.++|||.=.... . ......+|+++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356778999999999999999999999999532110 0 012346789999998654
Q ss_pred ceeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 122 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
.+.+.+++ ++-.+|||+.+|..|...-- .....-.++..|+.-+..+-..| +||+|+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------------~~en~~~il~~il~~~~~~~~~G---iVHGDlSe 230 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL--------------DVENPDEILDKILEEVRKAYRRG---IVHGDLSE 230 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC--------------cccCHHHHHHHHHHHHHHHHHcC---ccccCCch
Confidence 56565543 56789999999977655431 12233445555666666666778 99999999
Q ss_pred CcEEEccCCceeEecccccCC
Q 018396 202 SNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~ 222 (356)
-||+++++|.+.++||--+..
T Consensus 231 fNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 231 FNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred heEEEecCCCEEEEeCccccc
Confidence 999999999999999976544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-07 Score=79.13 Aligned_cols=145 Identities=13% Similarity=0.085 Sum_probs=103.8
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCC-------CCchHHHHHHHHHHHhccCC--ceeeeeeEEe---cC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS-------KQPDQEFLAQVSMVSRLKNE--NVVELVGYYV---DG 133 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-------~~~~~~~~~e~~~l~~l~hp--~iv~~~~~~~---~~ 133 (356)
.++--.---|+||.|-|+..... |..+-+|.-... ......|.+|+..+++|..- .+.+.. ++. .+
T Consensus 18 ~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~ 95 (216)
T PRK09902 18 GDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIE 95 (216)
T ss_pred CceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccC
Confidence 33333334567999999987766 446888876411 22456799999999988532 244444 222 11
Q ss_pred --CeeEEEEEecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 134 --PLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 134 --~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
-..+||+|-+.| .+|.+++...... ..+......++.+++.++.-||+.| +.|+|+.+.||+++.+|
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~~-------~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g 165 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQHAVS-------PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEG 165 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcCCcC-------CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCC
Confidence 235789997765 4899988654321 1566777889999999999999999 99999999999998777
Q ss_pred c--eeEecccccCC
Q 018396 211 I--AKISDFDLSNQ 222 (356)
Q Consensus 211 ~--vkl~Dfg~a~~ 222 (356)
. |.++||.-++.
T Consensus 166 ~~~v~lIDlEk~r~ 179 (216)
T PRK09902 166 KAEAGFLDLEKSRR 179 (216)
T ss_pred CeeEEEEEhhccch
Confidence 7 99999986544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.3e-08 Score=83.51 Aligned_cols=107 Identities=24% Similarity=0.224 Sum_probs=81.7
Q ss_pred hHHHHHHHHHHHhccC--CceeeeeeEEecC----CeeEEEEEecCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHH
Q 018396 105 DQEFLAQVSMVSRLKN--ENVVELVGYYVDG----PLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177 (356)
Q Consensus 105 ~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (356)
.....+|...+..|.. -.+.+.+.+.... ...++|+|++++. +|.+++..... .+......++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~ 125 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLR 125 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHH
Confidence 3457788888777743 2334445554432 2458999999884 79999876432 44556778999
Q ss_pred HHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC---ceeEecccccCCC
Q 018396 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQA 223 (356)
Q Consensus 178 qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~ 223 (356)
+++..+.-||..| |+|+|+++.|||++.++ .+.++||+.+...
T Consensus 126 ~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 126 ALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999 99999999999999887 8999999976543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.85 E-value=1e-07 Score=81.58 Aligned_cols=144 Identities=12% Similarity=0.093 Sum_probs=86.1
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeeeEEecCCeeEEEEEecCCCC-H
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGYYVDGPLRVLAYEHASKGS-L 148 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~-L 148 (356)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+.+.+.+..+.+...++||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 25568889876533 345678999999998643 24677777777888889999999963 2
Q ss_pred HHHHhcCC----------------CCCCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHhhh-CCCCCeeecCC
Q 018396 149 HDILHGKK----------------GVKGAKPGPVLSWAQRVK-IAV----------GAAR-GLEYLHE-KAEPRIIHRNI 199 (356)
Q Consensus 149 ~~~l~~~~----------------~~~~~~~~~~~~~~~~~~-~~~----------qi~~-~l~~lH~-~~~~~ivH~Dl 199 (356)
.+.+.... -.....+. ........ +.. .+.. ...+|.. ...+.++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21211100 00000000 11110000 000 0001 1111211 12334899999
Q ss_pred CCCcEEEccCCceeEecccccCC
Q 018396 200 KSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 200 kp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999997643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.1e-08 Score=91.78 Aligned_cols=143 Identities=20% Similarity=0.224 Sum_probs=93.0
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---------------------------hH--------------HHHH
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------------------------DQ--------------EFLA 110 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~--------------~~~~ 110 (356)
..|+.++-|.||+|+.++|+.||||+....-.. .. ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 579999999999999999999999997543211 00 1233
Q ss_pred HHHHHHhcc----CCceeeeeeEE-ecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018396 111 QVSMVSRLK----NENVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185 (356)
Q Consensus 111 e~~~l~~l~----hp~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 185 (356)
|...+.+++ ...-+.+-.++ +-.....++|||++|..+.+...-.... .+...+.....++. +..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--------~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--------IDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--------CCHHHHHHHHHHHH--HHH
Confidence 444444442 22222333333 2346678999999999888874322211 44333333333322 222
Q ss_pred hhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccc
Q 018396 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (356)
Q Consensus 186 lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (356)
+-..| ++|.|..|.||+++.+|++.+.|||+........
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 33356 9999999999999999999999999987766543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2e-09 Score=100.88 Aligned_cols=191 Identities=18% Similarity=0.139 Sum_probs=139.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc-eeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~e~ 142 (356)
++.-+.....+++|+++++++.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..++.+++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 34445555668899999999987543333446655433 44667899999999999 77777777778889999999
Q ss_pred cCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 143 ASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 143 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
+.++ +....+.... ..+...+...+.+.-+++++++|+.- -+|+| ||+..+ +.++..||+...
T Consensus 316 ~s~~rs~~~~~~~se--------~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSE--------IALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPP 379 (829)
T ss_pred hcCCccccccCChhh--------Hhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCc
Confidence 9876 2222221111 11334445556677788899999974 58998 777655 678999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCC
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (356)
.+.... ..+...+++.++|||+.....+....|+|++|+-..+|.-|.+|-..
T Consensus 380 ~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 380 QLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 776554 23667899999999999999999999999999988888888887654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.3e-07 Score=75.28 Aligned_cols=135 Identities=14% Similarity=0.163 Sum_probs=89.3
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHH----------HHHHHHHHHhccC---CceeeeeeEE-
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----------FLAQVSMVSRLKN---ENVVELVGYY- 130 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~h---p~iv~~~~~~- 130 (356)
.++|...+++-......|.+.... |+.+++|.......-.++ ..+.+..+.++.. -....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 467888888888888888776665 688999987654332222 1223333333322 2222222222
Q ss_pred ----ecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE
Q 018396 131 ----VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (356)
Q Consensus 131 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (356)
.-....+++|||++|..|.++.. ++. .++..+..++.-||+.| ++|+|..|.|+++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv 168 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLV 168 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEE
Confidence 12344568999999988876642 222 24456777899999999 9999999999999
Q ss_pred ccCCceeEecccccC
Q 018396 207 FDDDIAKISDFDLSN 221 (356)
Q Consensus 207 ~~~~~vkl~Dfg~a~ 221 (356)
++++ ++++||+...
T Consensus 169 ~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 169 SNNG-IRIIDTQGKR 182 (229)
T ss_pred ECCc-EEEEECcccc
Confidence 8655 8999997643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=9.1e-07 Score=76.07 Aligned_cols=77 Identities=14% Similarity=0.164 Sum_probs=56.3
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeeeEEe---cCCeeEEEEEecCCC
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGYYV---DGPLRVLAYEHASKG 146 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~~~---~~~~~~lv~e~~~~~ 146 (356)
+.|+.|..+.||++...+ +.+++|..... .....+.+|..+++.+... .+.+++.+.. .....+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 578999999999999886 68999987655 3456788899998888432 3445555332 334578999999998
Q ss_pred CHHH
Q 018396 147 SLHD 150 (356)
Q Consensus 147 ~L~~ 150 (356)
.+..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 7777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.2e-06 Score=76.16 Aligned_cols=75 Identities=17% Similarity=0.091 Sum_probs=53.9
Q ss_pred eeccCc-eEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEEecCCCCHHHH
Q 018396 74 IGEGSY-GRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDI 151 (356)
Q Consensus 74 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 151 (356)
|..|.. +.||+.... +..+++|+..... ...+.+|+++++.+. +-.+.+++.+....+..++||++++|.+|.+.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 788998765 4788899876543 345778999988884 34455777777766778999999999777644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.8e-07 Score=71.79 Aligned_cols=129 Identities=20% Similarity=0.235 Sum_probs=90.5
Q ss_pred CCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCcee-eeeeEEecCCeeEEEEEecCCCC
Q 018396 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~ 147 (356)
+..+.|++|++|.||++.+. |..+|+|+-.. +.....+..|+++|..+..-++- +++.|.. -++.|||..|-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 34678999999999999998 55788886543 44457789999999999876554 4444432 334499999988
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCC-CCcEEEccCCceeEecccccCC
Q 018396 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK-SSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlk-p~Nill~~~~~vkl~Dfg~a~~ 222 (356)
|.++-... +.. -...++..---|-..| |-|..|. |...++.+++.+.|+||..|+.
T Consensus 99 L~~~~~~~------------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87776532 112 2334445544556667 9999987 5555555666999999998763
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.2e-07 Score=75.01 Aligned_cols=151 Identities=17% Similarity=0.202 Sum_probs=98.2
Q ss_pred CHHHHHHHhCCCCCCceee---ccCceEEEEEEECCCCEEEEEEcCCCCCchH--------------------H-----H
Q 018396 57 SVDELKEKTDNFGTNSLIG---EGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--------------------E-----F 108 (356)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg---~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------------~-----~ 108 (356)
+...+....++..+....| .|--+.||+|...++..+|+|++......-+ + .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3445555566666655544 5666779999988899999999864322210 1 2
Q ss_pred HHHHHHHHhccC--CceeeeeeEEecCCeeEEEEEecCCCC-HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018396 109 LAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGS-LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185 (356)
Q Consensus 109 ~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 185 (356)
.+|+.-|+++.. =.+.+-+.+. ...|||||+.... -.-.|.. ..+...++..+..++++.+.-
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----------v~~e~~e~~~~~~~~v~~~~~ 181 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----------VPLELEEAEGLYEDVVEYMRR 181 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----------CCcCchhHHHHHHHHHHHHHH
Confidence 356666777632 2333334332 3568999985421 1111111 113333577778888888888
Q ss_pred hhh-CCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 186 LHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 186 lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|-. .+ +||+||+.-|||+. ++.+.|+|||-|.....
T Consensus 182 l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 182 LYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred HHHhcC---cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 877 56 99999999999999 88999999998766543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.7e-06 Score=83.76 Aligned_cols=77 Identities=13% Similarity=0.150 Sum_probs=56.6
Q ss_pred CceeeccCceEEEEEEECCC---CEEEEEEcCCCCC--chHHHHHHHHHHHhcc-CCce--eeeeeEEecC---CeeEEE
Q 018396 71 NSLIGEGSYGRVYFGVLRSG---RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK-NENV--VELVGYYVDG---PLRVLA 139 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hp~i--v~~~~~~~~~---~~~~lv 139 (356)
.+.++.|.++.+|+....++ ..+++|+...... ....+.+|+++++.+. |.++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46688899999999876643 4688887654332 2356889999999995 6554 6777777654 457899
Q ss_pred EEecCCCC
Q 018396 140 YEHASKGS 147 (356)
Q Consensus 140 ~e~~~~~~ 147 (356)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99999854
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.2e-05 Score=69.43 Aligned_cols=73 Identities=11% Similarity=0.083 Sum_probs=48.5
Q ss_pred ceeeccCceEEEEEEECC--CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc-eeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 72 SLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
+.|..|-...+|++...+ ++.|++|+............+|+.+++.+.... ..+++.... -.+++||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999998664 678999977644322233457888888885332 344444332 2379999998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.2e-06 Score=70.14 Aligned_cols=73 Identities=14% Similarity=0.136 Sum_probs=45.7
Q ss_pred ceeeccCce-EEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC---ceeeeeeEEecC---CeeEEEEEecC
Q 018396 72 SLIGEGSYG-RVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---NVVELVGYYVDG---PLRVLAYEHAS 144 (356)
Q Consensus 72 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp---~iv~~~~~~~~~---~~~~lv~e~~~ 144 (356)
..|+.|+.. .||+. +..+++|.... ......+.+|+++++.+... .+.+.++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 456766666 58876 34577886544 33345788999999888532 233444433222 23478999999
Q ss_pred CCCHH
Q 018396 145 KGSLH 149 (356)
Q Consensus 145 ~~~L~ 149 (356)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.1e-05 Score=63.74 Aligned_cols=127 Identities=17% Similarity=0.191 Sum_probs=91.1
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCC-----------------CchHHHHHHHHHHHhcc------CCceeeee
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----------------QPDQEFLAQVSMVSRLK------NENVVELV 127 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~e~~~l~~l~------hp~iv~~~ 127 (356)
...||+|+.=.||. +.+....+||+..... ....+..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999988884 5556678899887655 12355667777666655 67899999
Q ss_pred eEEecCCeeEEEEEecCC------CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 128 GYYVDGPLRVLAYEHASK------GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
|+.++.--.-+|+|.+.+ -+|.+++.... ++. .....+ -.-..||-+.+ |+.+|++|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~ 146 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELRQAL---DEFKRYLLDHH---IVIRDLNP 146 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHHHHH---HHHHHHHHHcC---CeecCCCc
Confidence 999998888888887643 37888886543 444 333333 34456777777 99999999
Q ss_pred CcEEEccCC----ceeEec
Q 018396 202 SNVLLFDDD----IAKISD 216 (356)
Q Consensus 202 ~Nill~~~~----~vkl~D 216 (356)
.||++.... .+.|+|
T Consensus 147 ~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ccEEEEecCCCceEEEEEe
Confidence 999996432 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.5e-06 Score=68.60 Aligned_cols=102 Identities=25% Similarity=0.217 Sum_probs=80.4
Q ss_pred HHHHHHHHhccC-CceeeeeeEEecCCeeEEEEEecCCCCHHHH---HhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 018396 109 LAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDI---LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184 (356)
Q Consensus 109 ~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 184 (356)
..|.-+++.+.+ +++.+++|+|- .+++.||...+++... +.... ..+|..+.+++.+++..+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~---------~~~w~~R~~iA~~lL~~l~ 73 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFL---------QSPWEQRAKIALQLLELLE 73 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccccc---------ccCHHHHHHHHHHHHHHHH
Confidence 357888999976 69999999983 3567899987666432 11100 1689999999999999999
Q ss_pred HhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 185 ~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
+++......+.-.|++++|+-++++|++|++|.+.+...
T Consensus 74 ~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 74 ELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999864445889999999999999999999999875443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.3e-05 Score=69.08 Aligned_cols=77 Identities=16% Similarity=0.028 Sum_probs=56.6
Q ss_pred CCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC---CceeeeeeEEec---CCeeEEEEEec
Q 018396 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN---ENVVELVGYYVD---GPLRVLAYEHA 143 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h---p~iv~~~~~~~~---~~~~~lv~e~~ 143 (356)
-.+.||.|..+.||.....++ .+++|.. +.......+.+|.+.|+.|.. -.+.++++++.+ .+..++|||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 345799999999999876655 4677764 332244678999999998853 356777777654 36689999999
Q ss_pred CCCCH
Q 018396 144 SKGSL 148 (356)
Q Consensus 144 ~~~~L 148 (356)
+|.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.9e-05 Score=69.11 Aligned_cols=142 Identities=11% Similarity=0.049 Sum_probs=77.4
Q ss_pred eeccCceEEEEEEECCCCEEEEEEcCCCCCch-HHHHHHHHHHHhccCCce-eeeeeEEecCCeeEEEEEecCCCCHHHH
Q 018396 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGSLHDI 151 (356)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~~ 151 (356)
+..|-.+.+|+... +++.+++|......... -...+|.++++.+..-.+ .+++... . -++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 45677888998874 46678899765433221 235788999888854323 2333332 2 3689999998654321
Q ss_pred --------------HhcCCCCCCCCCCCCCCHHH-HHHHHHH---------HHHHHHHhhhC-----CCCCeeecCCCCC
Q 018396 152 --------------LHGKKGVKGAKPGPVLSWAQ-RVKIAVG---------AARGLEYLHEK-----AEPRIIHRNIKSS 202 (356)
Q Consensus 152 --------------l~~~~~~~~~~~~~~~~~~~-~~~~~~q---------i~~~l~~lH~~-----~~~~ivH~Dlkp~ 202 (356)
+..- .........+.... +..+..+ +...+..+-.. .+..++|+|+.|.
T Consensus 79 ~~~~~~~~~~la~~l~~l--H~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 79 QFVALDLLLELAALLHQL--HSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccCchhHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1100 00001111122211 1111111 11112212111 1224899999999
Q ss_pred cEEEccCCceeEecccccCCC
Q 018396 203 NVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~ 223 (356)
||++++++ +.|+||+.+...
T Consensus 157 Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred cEEEeCCC-CEEEeccccCcC
Confidence 99999877 789999977543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.5e-05 Score=75.62 Aligned_cols=141 Identities=18% Similarity=0.197 Sum_probs=88.7
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCch--------------------------------H------HHHHHH
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD--------------------------------Q------EFLAQV 112 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------------~------~~~~e~ 112 (356)
.+.||..+.|.||+|+.++|+.||||+-+..-... + +|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 35799999999999999999999999865432110 0 122333
Q ss_pred HH----HHhccCCc---eeeeeeEEe-cCCeeEEEEEecCCCCHHHH--HhcCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 018396 113 SM----VSRLKNEN---VVELVGYYV-DGPLRVLAYEHASKGSLHDI--LHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182 (356)
Q Consensus 113 ~~----l~~l~hp~---iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 182 (356)
+- .+.+.|-+ -|.+-.++. -.....|+|||++|..+.|. |.... ++...+..-+.+...
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l~~~~~- 314 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKLVEAYL- 314 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHHHHHHH-
Confidence 32 22233434 122222222 23467899999999866554 33333 555544444443332
Q ss_pred HHHhhhCCCCCeeecCCCCCcEEEcc----CCceeEecccccCCCccc
Q 018396 183 LEYLHEKAEPRIIHRNIKSSNVLLFD----DDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 183 l~~lH~~~~~~ivH~Dlkp~Nill~~----~~~vkl~Dfg~a~~~~~~ 226 (356)
.-+-..| ++|+|=.|.||++.. ++.+.+.|||+.......
T Consensus 315 -~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 315 -EQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred -HHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2222345 999999999999984 568999999997766543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.4e-05 Score=80.56 Aligned_cols=195 Identities=19% Similarity=0.238 Sum_probs=136.7
Q ss_pred HHHHHHHHhccCCceeeeeeEEecCCee----EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 018396 109 LAQVSMVSRLKNENVVELVGYYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184 (356)
Q Consensus 109 ~~e~~~l~~l~hp~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 184 (356)
.-|+..+..+.|+|++.++.|....... .+..+++...++...+..-.. ++....+.+..++..||.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---------i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---------IPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---------cCHHHHHHHHHHHhhhHH
Confidence 3456678888999999999987654332 344577877788887766543 788999999999999999
Q ss_pred HhhhCCCCCeeecCCCCC---cEEEccCCceeEe--cccccCCCccccccccccccccCcCccCcccccCCCCCcc--ch
Q 018396 185 YLHEKAEPRIIHRNIKSS---NVLLFDDDIAKIS--DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK--SD 257 (356)
Q Consensus 185 ~lH~~~~~~ivH~Dlkp~---Nill~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~D 257 (356)
|+|+.. ..|.-+... +.-++.++.+.+. ||+.+....+.... ....-+..+.++|......+..+ .|
T Consensus 301 ~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~d 374 (1351)
T KOG1035|consen 301 YLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTD 374 (1351)
T ss_pred HHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhH
Confidence 999986 666655554 4445566677777 99888777654432 23334667788887776655544 69
Q ss_pred hhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 018396 258 VYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 337 (356)
Q Consensus 258 vwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 337 (356)
+|.+|..+..+..|..+-.... ........ .....+.+...+|+.-++++|+++
T Consensus 375 L~~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 375 LWCLGLLLLQLSQGEDISEKSA------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHHHHHhhhhhcCccccccc------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccch
Confidence 9999999999998776542110 00111110 111157788899999999999999
Q ss_pred HHHHHHH
Q 018396 338 GIVLKAL 344 (356)
Q Consensus 338 ~ell~~L 344 (356)
.+++...
T Consensus 429 ~~ll~~~ 435 (1351)
T KOG1035|consen 429 LELLTHP 435 (1351)
T ss_pred hhhhhch
Confidence 9998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.04 E-value=9.5e-05 Score=61.20 Aligned_cols=124 Identities=26% Similarity=0.402 Sum_probs=85.3
Q ss_pred CCCCCCceeeccCc-eEEEEEEECCCCEEEEEEcCC---CC-------------------CchHHHHHHHHHHHhc---c
Q 018396 66 DNFGTNSLIGEGSY-GRVYFGVLRSGRAAAIKKLDS---SK-------------------QPDQEFLAQVSMVSRL---K 119 (356)
Q Consensus 66 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~-------------------~~~~~~~~e~~~l~~l---~ 119 (356)
.+++..+.||.|.- |.||++... |+.+|+|+... .. .....|..|.+...+| .
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999987 67999999311 00 0012356677765555 4
Q ss_pred CCce--eeeeeEEecC------------------CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHH
Q 018396 120 NENV--VELVGYYVDG------------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179 (356)
Q Consensus 120 hp~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi 179 (356)
+.++ |++++|..-. ..+.||.||.+... .+. ..-+.+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~----~~~~~~~ 173 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQ----IRDIPQM 173 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccc----hhHHHHH
Confidence 5566 8888886311 12345666554422 022 2235577
Q ss_pred HHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 180 ~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
.+-+..+|..| |+-+|+++.|.. +| +|+|||.+
T Consensus 174 ~~dl~~~~k~g---I~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLG---IVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCC---eeeccCcccccc---CC--EEEecccC
Confidence 77788999999 999999999986 33 89999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.6e-05 Score=67.02 Aligned_cols=74 Identities=20% Similarity=0.192 Sum_probs=48.7
Q ss_pred ceeeccCceEEEEEEECC-------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeeeEEecCCeeEEEEEec
Q 018396 72 SLIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~ 143 (356)
+.|..|-...+|+....+ ++.+++|+.........+..+|+++++.+....+ .+++.++.. .+|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 345667778899988654 5789999876544333456788888888853322 344444432 3578998
Q ss_pred CCCCHH
Q 018396 144 SKGSLH 149 (356)
Q Consensus 144 ~~~~L~ 149 (356)
+|..+.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 886654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00033 Score=63.04 Aligned_cols=164 Identities=17% Similarity=0.208 Sum_probs=89.3
Q ss_pred CHHHHHHHhCCCCC-----CceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeeeE
Q 018396 57 SVDELKEKTDNFGT-----NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY 129 (356)
Q Consensus 57 ~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~ 129 (356)
+.+++....+.|.+ .+.++.|....+|++...++ .+++|+..... ....+..|++++..|... .+.+++..
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 34455555555655 34567777789999876544 68889775532 234566777887777422 23333331
Q ss_pred ------EecCCeeEEEEEecCCCCHH-----------HHH---hcCCC-CCCCCCC--CCCCHHHHH------------H
Q 018396 130 ------YVDGPLRVLAYEHASKGSLH-----------DIL---HGKKG-VKGAKPG--PVLSWAQRV------------K 174 (356)
Q Consensus 130 ------~~~~~~~~lv~e~~~~~~L~-----------~~l---~~~~~-~~~~~~~--~~~~~~~~~------------~ 174 (356)
....+..+++++|++|..+. ..+ +.... ....... ..-.|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 12345678999999885431 111 11000 0000000 001111100 0
Q ss_pred HHHHHHHHHHHhhh----CCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 175 IAVGAARGLEYLHE----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 175 ~~~qi~~~l~~lH~----~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
....+...++++.. .-+..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 11123334444532 1123499999999999999888778999997643
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00028 Score=65.16 Aligned_cols=74 Identities=18% Similarity=0.156 Sum_probs=53.8
Q ss_pred ceeeccCceEEEEEEECCC-CEEEEEEcCCC--------CCchHHHHHHHHHHHhcc---CCceeeeeeEEecCCeeEEE
Q 018396 72 SLIGEGSYGRVYFGVLRSG-RAAAIKKLDSS--------KQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~--------~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv 139 (356)
+.||.|.++.||++...+| +.++||.-... ....++...|.+.|+.+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998766 48999985411 123456777888888763 2456677766 55668899
Q ss_pred EEecCCCC
Q 018396 140 YEHASKGS 147 (356)
Q Consensus 140 ~e~~~~~~ 147 (356)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00048 Score=62.35 Aligned_cols=163 Identities=17% Similarity=0.171 Sum_probs=84.6
Q ss_pred CHHHHHHHhCCCCC-----CceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc--eeeeee-
Q 018396 57 SVDELKEKTDNFGT-----NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVG- 128 (356)
Q Consensus 57 ~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~--iv~~~~- 128 (356)
+..++......|.+ .+.|+.|....+|.....+| .+++|+.. ....+.+..|+.+++.|.... +.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 34445444455654 34566777789999887654 68999876 223344555666666663211 222222
Q ss_pred -----EEecCCeeEEEEEecCCCCHH-----------HHHh---cCC-CCCCCCC-CCCCCH-HHHHH------------
Q 018396 129 -----YYVDGPLRVLAYEHASKGSLH-----------DILH---GKK-GVKGAKP-GPVLSW-AQRVK------------ 174 (356)
Q Consensus 129 -----~~~~~~~~~lv~e~~~~~~L~-----------~~l~---~~~-~~~~~~~-~~~~~~-~~~~~------------ 174 (356)
+....+..+++++|++|..+. +.+. ... ....... ...+.+ .....
T Consensus 85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (319)
T PRK05231 85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA 164 (319)
T ss_pred CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence 122355678999999986431 1111 000 0000000 001111 11110
Q ss_pred HHHH-HHHHHHHhhhC----CCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 175 IAVG-AARGLEYLHEK----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 175 ~~~q-i~~~l~~lH~~----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
.+.+ +...+..+... -+..+||+|+.|.||+++.+...-|+||+.+..
T Consensus 165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122222211 123499999999999998766568999997654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00039 Score=62.21 Aligned_cols=149 Identities=17% Similarity=0.163 Sum_probs=84.2
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeeeE------EecCCeeEEEEEe
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY------YVDGPLRVLAYEH 142 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~------~~~~~~~~lv~e~ 142 (356)
.+.|..|....+|+....+ ..+++|+... .....+..|+++++.|.+. .+.+++.. ....+..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 4456778778999987654 4688998765 3345677888888887432 23343331 2234567899999
Q ss_pred cCCCCHHH-----------HH---hcCC-CCCCC-CCCCCCCHHHHH----------HHHHHHHHHHHHhhh----CCCC
Q 018396 143 ASKGSLHD-----------IL---HGKK-GVKGA-KPGPVLSWAQRV----------KIAVGAARGLEYLHE----KAEP 192 (356)
Q Consensus 143 ~~~~~L~~-----------~l---~~~~-~~~~~-~~~~~~~~~~~~----------~~~~qi~~~l~~lH~----~~~~ 192 (356)
++|..+.. .+ +... ..... .......|.... .....+..++.++.+ .-+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99865421 00 0000 00000 000111111110 011122333444443 1122
Q ss_pred CeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
.++|+|+.|.||++++++.+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 499999999999999887778999987654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00046 Score=63.04 Aligned_cols=147 Identities=14% Similarity=0.186 Sum_probs=79.1
Q ss_pred ceeeccCceEEEEEEECC-----CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~ 145 (356)
..|-.|-...+|++...+ ++.|++|+........-+..+|+.+++.+..-++ .++++.+..+ .|.+|+++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 345558889999987532 3689999876543322234678888888854333 3445555333 47888877
Q ss_pred CCHHHH--------------HhcCCCCCCCCCCCCCCHHHHHHHHHHH-----------------HHHHHH----hhh-C
Q 018396 146 GSLHDI--------------LHGKKGVKGAKPGPVLSWAQRVKIAVGA-----------------ARGLEY----LHE-K 189 (356)
Q Consensus 146 ~~L~~~--------------l~~~~~~~~~~~~~~~~~~~~~~~~~qi-----------------~~~l~~----lH~-~ 189 (356)
.+|... +..--............+..+..+..++ ...+.. +.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 655311 0000000000000011122222222111 111111 121 1
Q ss_pred CCCCeeecCCCCCcEEEcc-CCceeEecccccCC
Q 018396 190 AEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQ 222 (356)
Q Consensus 190 ~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~ 222 (356)
....++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1234899999999999986 46899999987643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=4.5e-05 Score=67.02 Aligned_cols=133 Identities=16% Similarity=0.157 Sum_probs=93.3
Q ss_pred CCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCC------------------c-----hHHHHHHHHHHHhccC--C
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ------------------P-----DQEFLAQVSMVSRLKN--E 121 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~-----~~~~~~e~~~l~~l~h--p 121 (356)
-+.+++.||-|--+-||.+-...|.+.++|.=..... . .-...+|+..|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4678899999999999999999899999985321110 0 0123467888888842 2
Q ss_pred ceeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 122 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
-+.+.+ +.++-++|||++.|..|.+.-+.. . +..+...+..-+.-|-.+| +||+|..-
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~------------d---~~~ly~~lm~~Iv~la~~G---lIHgDFNE 230 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHVE------------D---PPTLYDDLMGLIVRLANHG---LIHGDFNE 230 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeecC------------C---hHHHHHHHHHHHHHHHHcC---ceecccch
Confidence 233444 345678899999888876654322 1 2223334444466677788 99999999
Q ss_pred CcEEEccCCceeEecccccC
Q 018396 202 SNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~ 221 (356)
=||++.+++.++++||--+.
T Consensus 231 FNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 231 FNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred heeEEecCCCEEEeechHhh
Confidence 99999999999999997543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=8.9e-06 Score=83.90 Aligned_cols=162 Identities=10% Similarity=-0.049 Sum_probs=116.1
Q ss_pred HHHHHHHHHhccCCceeeeeeEEe--cCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018396 108 FLAQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185 (356)
Q Consensus 108 ~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 185 (356)
...|...++...|+++...+.-.. +....+..++++.+|.+.+.|.+..... +.+...-+.....+.+.+..-
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-----~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-----PDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-----CcchhchHHHHHHHHHhccch
Confidence 344445566678888876665444 3445688899999999999997654321 224444444444444666666
Q ss_pred hhhCC--CCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHH
Q 018396 186 LHEKA--EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGV 263 (356)
Q Consensus 186 lH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 263 (356)
+|+.. -.-.+|+++|+-|.+|..+..|+++++|+.+........ .+...+++.|++|+....-.++.++|+|..|+
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred hhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 66542 123689999999999999999999999999833322111 24556788899999887788888899999999
Q ss_pred HHHHHHcCCCCCC
Q 018396 264 VLLELLTGRKPVD 276 (356)
Q Consensus 264 il~~l~~g~~pf~ 276 (356)
.+|....|..+|-
T Consensus 1429 ~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHhcccHHHH
Confidence 9999998888874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0021 Score=56.96 Aligned_cols=73 Identities=14% Similarity=0.090 Sum_probs=48.2
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc---CCceeeeeeEEecCCeeEEEEEecCCC
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~e~~~~~ 146 (356)
.+.|+.|..+.+|+.. .+++.+.||+-. ......+..|++-|+.|. .-.+.+.+.+....+..++++||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999877 557889999876 333467889999998883 345778888887777789999999865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0023 Score=56.57 Aligned_cols=31 Identities=13% Similarity=0.362 Sum_probs=25.6
Q ss_pred CeeecCCCCCcEEEccCCc-eeEecccccCCC
Q 018396 193 RIIHRNIKSSNVLLFDDDI-AKISDFDLSNQA 223 (356)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~-vkl~Dfg~a~~~ 223 (356)
.++|+|+.|.||++++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 569999987553
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0027 Score=56.79 Aligned_cols=153 Identities=13% Similarity=0.192 Sum_probs=80.2
Q ss_pred CCceeeccCceEEEEEEECCCCEEEEEEcCCC---CCchHHHHHHHHHHHhccC--CceeeeeeEEecCC--eeEEEEEe
Q 018396 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGP--LRVLAYEH 142 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~--~~~lv~e~ 142 (356)
+.+....|.-..+|..... ++.+++. .... ........+|+.+++.+.- --+...++.+.++. ..|.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3344433444445555544 7788888 4321 1123456678888888753 23344455555554 66999999
Q ss_pred cCCCCHHHHHhcCC---------------------CCCCCCCC--------CCCCHHHHHHH--------HHHHHHHHHH
Q 018396 143 ASKGSLHDILHGKK---------------------GVKGAKPG--------PVLSWAQRVKI--------AVGAARGLEY 185 (356)
Q Consensus 143 ~~~~~L~~~l~~~~---------------------~~~~~~~~--------~~~~~~~~~~~--------~~qi~~~l~~ 185 (356)
++|..+.+.+.... ........ +...+...+.. .-.......+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 99843322211110 00000000 00001111100 0011111233
Q ss_pred hhhC-----CCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 186 LHEK-----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 186 lH~~-----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
|+.+ +.+.++|+|+.+.|++++.++-+-|.||+++..-.
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 3322 23359999999999999999889999999886543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0028 Score=57.62 Aligned_cols=72 Identities=10% Similarity=0.156 Sum_probs=44.9
Q ss_pred eeeccCceEEEEEEECC----CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeeeEEecCCeeEEEEEecCCCC
Q 018396 73 LIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~ 147 (356)
.|..|=...+|+....+ +..|++|+........-...+|..+++.+..-++ .++++++..+ +|.+|+++.+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCC
Confidence 44447778899887542 2478999876543322334678888888864333 3455554322 4788887755
Q ss_pred H
Q 018396 148 L 148 (356)
Q Consensus 148 L 148 (356)
|
T Consensus 97 l 97 (330)
T PLN02421 97 L 97 (330)
T ss_pred C
Confidence 4
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0015 Score=58.69 Aligned_cols=139 Identities=22% Similarity=0.240 Sum_probs=90.8
Q ss_pred CCceeeccCceEEEEEEECCCCEEEEEEcCCCCC-----------------------chHH----HHHHHHHHHhccCCc
Q 018396 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-----------------------PDQE----FLAQVSMVSRLKNEN 122 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------------~~~~----~~~e~~~l~~l~hp~ 122 (356)
+...|..|--+-||.|...+|..+|||+++.+-. +.+. ...|++-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3455777888899999988899999998753211 0111 235777788876544
Q ss_pred eeeeeeEEecCCeeEEEEEecCCCC-HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 123 VVELVGYYVDGPLRVLAYEHASKGS-LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
|.----... ..-.|||+|+.... -.-.|... .++...+..+-.+++.-+.-|-+.. ++||.||.-
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~----------~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSE 293 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDA----------SLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSE 293 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccccc----------cCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhh
Confidence 321111111 12468899985311 11122211 2666677888888888888887765 599999999
Q ss_pred CcEEEccCCceeEecccccCCC
Q 018396 202 SNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
-|+|+ .+|.+.|+|.+-+...
T Consensus 294 fN~Ly-hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 294 FNLLY-HDGKLYIIDVSQSVEH 314 (520)
T ss_pred hhheE-ECCEEEEEEccccccC
Confidence 99998 5678999999876544
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0055 Score=55.62 Aligned_cols=79 Identities=20% Similarity=0.169 Sum_probs=51.5
Q ss_pred eeeccCceEEEEEEECCC-CEEEEEEcCC-----C---CCchHHHHHHHHHHHhcc--CC-ceeeeeeEEecCCeeEEEE
Q 018396 73 LIGEGSYGRVYFGVLRSG-RAAAIKKLDS-----S---KQPDQEFLAQVSMVSRLK--NE-NVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-----~---~~~~~~~~~e~~~l~~l~--hp-~iv~~~~~~~~~~~~~lv~ 140 (356)
.+|.|....||++...+| +.++||.-.. . ..+..+..-|.+.|+... .| .+.+++.+ +.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997744 5899997531 1 223455667778877763 24 45555544 666777999
Q ss_pred EecCCC-CHHHHHh
Q 018396 141 EHASKG-SLHDILH 153 (356)
Q Consensus 141 e~~~~~-~L~~~l~ 153 (356)
|+++.. .|...+.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 998542 3444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0083 Score=54.45 Aligned_cols=71 Identities=18% Similarity=0.186 Sum_probs=47.3
Q ss_pred cCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeee---e--EEecCCeeEEEEEecCCCC
Q 018396 77 GSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELV---G--YYVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 77 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~---~--~~~~~~~~~lv~e~~~~~~ 147 (356)
+.-..||+....++..+++|+..........+..|++.+..|... .++... + ....++..+.++++.+|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 456779999887788899998875555667788888888777321 122111 1 1223456788899988753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0077 Score=55.70 Aligned_cols=79 Identities=14% Similarity=0.136 Sum_probs=52.7
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcC-----CCC---CchHHHHHHHHHHHhcc---CCceeeeeeEEecCCeeEEE
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLD-----SSK---QPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~-----~~~---~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv 139 (356)
.+.||.|....||+.... ++.++||.-. ... ....+-..|++.|+.+. ..++.+++.++. +...++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998875 4569999765 221 13344455677776663 246777887755 557788
Q ss_pred EEecCC--CCHHHHH
Q 018396 140 YEHASK--GSLHDIL 152 (356)
Q Consensus 140 ~e~~~~--~~L~~~l 152 (356)
||++++ ..+.+.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 2444443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0012 Score=55.83 Aligned_cols=28 Identities=25% Similarity=0.551 Sum_probs=20.3
Q ss_pred eeecCCCCCcEEE-ccCCceeEecccccC
Q 018396 194 IIHRNIKSSNVLL-FDDDIAKISDFDLSN 221 (356)
Q Consensus 194 ivH~Dlkp~Nill-~~~~~vkl~Dfg~a~ 221 (356)
++|.|+.+.||++ +.++.++++||..|.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 8999999999999 888999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.014 Score=52.73 Aligned_cols=146 Identities=21% Similarity=0.302 Sum_probs=84.4
Q ss_pred eeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc------eeeeee----EEecCCeeEEEEEec
Q 018396 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVG----YYVDGPLRVLAYEHA 143 (356)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~------iv~~~~----~~~~~~~~~lv~e~~ 143 (356)
|.+ .-..+|+....+|+. ++|+.... ....++..|...+..|.-.. +...-| ....+.+.+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 567799988876665 99998887 66778888999988884211 222222 111223677889999
Q ss_pred CCCCHHH------------HH---hc-CCCCCCCCCC--CCCCHH-------------HHHHHHHHHHHHHHHhhhCC--
Q 018396 144 SKGSLHD------------IL---HG-KKGVKGAKPG--PVLSWA-------------QRVKIAVGAARGLEYLHEKA-- 190 (356)
Q Consensus 144 ~~~~L~~------------~l---~~-~~~~~~~~~~--~~~~~~-------------~~~~~~~qi~~~l~~lH~~~-- 190 (356)
+|..+.. ++ +. .+......+. ....|. .-.....++...+..+.+.-
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9876662 00 00 0000100111 011221 00113334444444444321
Q ss_pred --C---CCeeecCCCCCcEEEccCCc-eeEecccccCC
Q 018396 191 --E---PRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQ 222 (356)
Q Consensus 191 --~---~~ivH~Dlkp~Nill~~~~~-vkl~Dfg~a~~ 222 (356)
+ ..+||+|+.|+||+++.+.. +.++||+-+..
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1 12899999999999998874 89999997643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.01 Score=53.43 Aligned_cols=64 Identities=16% Similarity=0.140 Sum_probs=39.0
Q ss_pred EEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeeeE------EecCCeeEEEEEecCCCCH
Q 018396 81 RVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY------YVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 81 ~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~------~~~~~~~~lv~e~~~~~~L 148 (356)
.||++...+| .+++|+.... ...+..++..+..|... .+.+++.. ...++..+++++|++|.++
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4888876544 6889987532 34455667777666322 23333321 2235678999999998543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0013 Score=61.58 Aligned_cols=188 Identities=19% Similarity=0.274 Sum_probs=102.4
Q ss_pred EEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecC-CeeEEEEEecCCCCHHHHHhcCCCCCC
Q 018396 82 VYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKG 160 (356)
Q Consensus 82 V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~ 160 (356)
++.|..+.|..+ ..-+.... ...++...+.+++.+.|+|...++++.... .+..+|+|++.. +|.+.+..+....
T Consensus 5 ~~~a~~~~~~~c-~nglplt~-~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~- 80 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLTP-NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKD- 80 (725)
T ss_pred EEehhcCCCccc-cCCCcCCC-cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccch-
Confidence 455555544433 33333322 235677889999999999999999987643 347788999855 9999887654210
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcC
Q 018396 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240 (356)
Q Consensus 161 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 240 (356)
. ++. .++ +.|- |+ ++++| .++..
T Consensus 81 ---------~-------s~~-------~~~---~~~~-----~~-------~~~td-~~~t~------------------ 103 (725)
T KOG1093|consen 81 ---------E-------SLL-------AHG---VLHL-----NI-------IYITD-HFLTK------------------ 103 (725)
T ss_pred ---------h-------hhc-------ccc---ccee-----hh-------hhccc-ccccc------------------
Confidence 0 000 111 2222 11 23333 01000
Q ss_pred ccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHH
Q 018396 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMA 320 (356)
Q Consensus 241 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 320 (356)
| |- ...+++||||+|.++.++.-|..-+................ ....+......+ . .+..++.....
T Consensus 104 ~--~~-----~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~-~~d~~~~~~a~e-~---~~~~~~d~~~~ 171 (725)
T KOG1093|consen 104 Y--PS-----PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY-TDDQELLSTAME-H---LIQLLADKKRL 171 (725)
T ss_pred C--CC-----CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc-cCchhHHHHHHH-H---HHHHhhhHhHH
Confidence 0 10 11149999999999999999887664332111100000000 000000000000 0 22345667788
Q ss_pred HHHHHhhccCCCCCCCHHHHHH
Q 018396 321 AVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 321 ~li~~cl~~~P~~Rps~~ell~ 342 (356)
++...|+-..|..||...++.+
T Consensus 172 ~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 172 PLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHhccCCccccccccchhHHhc
Confidence 9999999999999987665543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0077 Score=55.40 Aligned_cols=80 Identities=16% Similarity=0.142 Sum_probs=53.5
Q ss_pred CceeeccCceEEEEEEEC-CCCEEEEEEcC----CC---CCchHHHHHHHHHHHhcc--CC-ceeeeeeEEecCCeeEEE
Q 018396 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLD----SS---KQPDQEFLAQVSMVSRLK--NE-NVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~---~~~~~~~~~e~~~l~~l~--hp-~iv~~~~~~~~~~~~~lv 139 (356)
.+.||.|.-..||++... +++.++||.-. .. ..+.++..-|.+.|+... .| ++.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 457899999999999975 35679998643 11 223456677888888763 34 45556654 66677889
Q ss_pred EEecCCC-CHHHHH
Q 018396 140 YEHASKG-SLHDIL 152 (356)
Q Consensus 140 ~e~~~~~-~L~~~l 152 (356)
||+++.. .|.+.+
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9988542 344444
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0092 Score=51.74 Aligned_cols=79 Identities=18% Similarity=0.124 Sum_probs=56.2
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec-CCCCHH
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA-SKGSLH 149 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~-~~~~L~ 149 (356)
...+..|..+.|+.++..+|..+++|+.........+... ...|+..+-...|++++. +.....+++|.+ ++.+|.
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g-~~~L~~w~G~GaVrll~~--d~~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARG-EAALRWWNGRGAVRLLAA--DPERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhH-HhHhheeCCCCceeeecc--ccccchhhhhhccCCCchh
Confidence 3456679999999999889999999988654432222212 244777788888999987 445677888998 445776
Q ss_pred HHH
Q 018396 150 DIL 152 (356)
Q Consensus 150 ~~l 152 (356)
++.
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 665
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.018 Score=51.80 Aligned_cols=30 Identities=13% Similarity=0.204 Sum_probs=27.1
Q ss_pred CeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
.++|+|+.++|++++.++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.04 Score=51.03 Aligned_cols=74 Identities=18% Similarity=0.223 Sum_probs=43.9
Q ss_pred ceeeccCceEEEEEEECCC--C-----EEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeeeEEecCCeeEEEEEec
Q 018396 72 SLIGEGSYGRVYFGVLRSG--R-----AAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~--~-----~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~ 143 (356)
+.|..|-.+.+|++...++ . .|.++........--+..+|+.+++.+...++ .++++.+. -+++.||+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence 3455588899999975432 2 24444432222212234578899999865443 45555543 25889999
Q ss_pred CCCCHH
Q 018396 144 SKGSLH 149 (356)
Q Consensus 144 ~~~~L~ 149 (356)
+|.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 886553
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.02 Score=48.02 Aligned_cols=115 Identities=14% Similarity=0.189 Sum_probs=70.7
Q ss_pred cCceEEEEEEECCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCHHHHHhc
Q 018396 77 GSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG 154 (356)
Q Consensus 77 G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 154 (356)
++-++.-.+..+=| ...+|++..... ...-+..+..++.++. .|+++..- ++-.+-+++|.|.....
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 44444444443323 345555554332 2455778888887765 36666632 44456688898854111
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 155 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
. .. .+..-=+.+|...|+.. ...+|+|..|+|||-|..|-+||.|=+.
T Consensus 142 ------------~-~~---N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ------------N-FS---NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ------------c-hh---HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 0 00 01111146688889552 2499999999999999999999999774
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.05 Score=56.99 Aligned_cols=149 Identities=16% Similarity=0.161 Sum_probs=80.0
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-------CCceeeeee-----EEec-CC--ee
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-------NENVVELVG-----YYVD-GP--LR 136 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-------hp~iv~~~~-----~~~~-~~--~~ 136 (356)
+.|+ |..-.+|+....+|..+++|+..... .......|.+.|..|. .|.++...+ .... .+ ..
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 45688899887778899999987643 3344555666666552 233333221 1111 22 45
Q ss_pred EEEEEecCCCCHHHHHhcCC------------------CCCCCCCCCCCCH-----------------HHHHHHHHHHHH
Q 018396 137 VLAYEHASKGSLHDILHGKK------------------GVKGAKPGPVLSW-----------------AQRVKIAVGAAR 181 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~-----------------~~~~~~~~qi~~ 181 (356)
+.+++|.+|..+.+...... ..........+.| .....++.+++.
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 67899999977654211000 0000000011111 111222223332
Q ss_pred HHH-----HhhhCCCCCeeecCCCCCcEEEccCC--cee-EecccccCCC
Q 018396 182 GLE-----YLHEKAEPRIIHRNIKSSNVLLFDDD--IAK-ISDFDLSNQA 223 (356)
Q Consensus 182 ~l~-----~lH~~~~~~ivH~Dlkp~Nill~~~~--~vk-l~Dfg~a~~~ 223 (356)
.+. .+.+. +..+||+|+.+.||+++.++ ++. |+|||-+...
T Consensus 189 ~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 189 RFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred HHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 222 12111 22399999999999999875 555 9999987654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.024 Score=51.20 Aligned_cols=53 Identities=23% Similarity=0.261 Sum_probs=47.4
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 167 ~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
..++++..++.+.+..+.-+..+- ++-|||+..+||+|+ +|.|.|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 567889999999999888888775 589999999999999 99999999999874
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.12 Score=48.78 Aligned_cols=74 Identities=9% Similarity=0.072 Sum_probs=45.5
Q ss_pred CceeeccCceEEEEEEECC---------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCcee-eeeeEEecCCeeEEEE
Q 018396 71 NSLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAY 140 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv-~~~~~~~~~~~~~lv~ 140 (356)
.+.|..|=...+|++...+ ++.|.+++.-.....--...+|..+++.+..-+|- ++++.+. -..+.
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~ 185 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE 185 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence 3456667788899987542 45788888755433322445688887777543332 3444442 34568
Q ss_pred EecCCCCH
Q 018396 141 EHASKGSL 148 (356)
Q Consensus 141 e~~~~~~L 148 (356)
+|++|.+|
T Consensus 186 efi~g~~l 193 (442)
T PTZ00296 186 EWLYGDPL 193 (442)
T ss_pred EeeCCccC
Confidence 89887643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 356 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-43 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-34 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-132
Identities = 111/296 (37%), Positives = 173/296 (58%), Gaps = 11/296 (3%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-SSKQPDQEFLAQVSM 114
+ + +L+E T+NF LIG G +G+VY GVLR G A+K+ S Q +EF ++
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+S ++ ++V L+G+ + +L Y++ G+L L+G P +SW QR++
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRLE 143
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-ST 233
I +GAARGL YLH +A IIHR++KS N+LL ++ + KI+DF +S + + + H ST
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD-QTHLST 199
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
V GT GY PEY + G+++ KSDVYSFGVVL E+L R + +LPR +L WA
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349
+ +++Q VD L + P+++ K A C+ ++ RP+MG VL L+ L
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-129
Identities = 102/293 (34%), Positives = 165/293 (56%), Gaps = 12/293 (4%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL--DSSKQPDQEFLAQVSM 114
S+ EL+ +DNF +++G G +G+VY G L G A+K+L + ++ + +F +V M
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+S + N++ L G+ + R+L Y + + GS+ L + + P L W +R +
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQR 135
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-ST 233
IA+G+ARGL YLH+ +P+IIHR++K++N+LL ++ A + DF L+ H +T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTT 193
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS--LVTWAT 291
V GT G+ APEY TG+ S K+DV+ +GV+LLEL+TG++ D L+ W
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344
L E K++ VD L G Y + + ++ VA LC Q RP M V++ L
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-123
Identities = 111/321 (34%), Positives = 175/321 (54%), Gaps = 26/321 (8%)
Query: 42 EMKTVTVQPIAVPVISVDELKEKTDNF------GTNSLIGEGSYGRVYFGVLRSGRAAAI 95
E K++ V S ELK T+NF + +GEG +G VY G + + A+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 96 KKLDS-----SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150
KKL + +++ Q+F ++ ++++ ++EN+VEL+G+ DG L Y + GSL D
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210
L G P LSW R KIA GAA G+ +LHE IHR+IKS+N+LL +
Sbjct: 120 RLSCLDG------TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAF 170
Query: 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
AKISDF L+ + A + ++R++GT Y APE + G+++ KSD+YSFGVVLLE++T
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIIT 229
Query: 271 GRKPVDHTLPRGQQSLVTWATPKLSEDK-VKQCVDTKLGGEYPPKAIAKMAAVAALCVQY 329
G VD R Q L+ E+K ++ +D K+ ++ M +VA+ C+
Sbjct: 230 GLPAVDEH--REPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHE 286
Query: 330 EADFRPNMGIVLKALQPLLNT 350
+ + RP++ V + LQ + +
Sbjct: 287 KKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 2e-77
Identities = 72/314 (22%), Positives = 121/314 (38%), Gaps = 33/314 (10%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
+ + L ++ + G +G V+ L A+K + + +V +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 116 SRLKNENVVELVGYYVDGPLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+K+EN+++ +G G L KGSL D L V+SW +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNE 122
Query: 172 RVKIAVGAARGLEYLHE-------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
IA ARGL YLHE +P I HR+IKS NVLL ++ A I+DF L+ +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279
+ + +GT Y APE + D+Y+ G+VL EL + D +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 280 PRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPK------AIAKMAAVAALCVQYEADF 333
S + +++ V K +A + C ++A+
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 334 RPNMGIVLKALQPL 347
R + G V + + +
Sbjct: 303 RLSAGCVGERITQM 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-59
Identities = 72/302 (23%), Positives = 134/302 (44%), Gaps = 37/302 (12%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
I E++ + ++G G++G V R + AIK+++S + + F+ ++ +
Sbjct: 5 IDYKEIEVE-------EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQL 55
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
SR+ + N+V+L G ++ P+ L E+A GSL+++LHG + P P + A +
Sbjct: 56 SRVNHPNIVKLYGACLN-PVC-LVMEYAEGGSLYNVLHGAE------PLPYYTAAHAMSW 107
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTR 234
+ ++G+ YLH +IHR++K N+LL + KI DF + H T
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTN 162
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294
G+ + APE S K DV+S+G++L E++T RKP +
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--------------FDEIGG 208
Query: 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGP 354
++ V + ++ C + RP+M ++K + L+ G
Sbjct: 209 PAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268
Query: 355 SK 356
+
Sbjct: 269 DE 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-56
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 33/228 (14%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQV 112
I +L T + E G ++ G + G +K L D S + ++F +
Sbjct: 7 IDFKQLNFLT-------KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKGAKPGPVLSWA 170
+ + NV+ ++G P GSL+++LH V+ +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQS 111
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q VK A+ ARG+ +LH EP I + S +V++ +D A+IS D+
Sbjct: 112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------F 163
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSS----KSDVYSFGVVLLELLTGRKP 274
S + + APE A+ + +D++SF V+L EL+T P
Sbjct: 164 QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-56
Identities = 84/286 (29%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG GS+G V+ G A+K L D + EFL +V+++ RL++ N+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
P + E+ S+GSL+ +LH L +R+ +A A+G+ YLH +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKS------GAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
P I+HRN+KS N+L+ K+ DF LS S GT + APE
Sbjct: 158 -PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDE 214
Query: 251 QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA------TPKLSEDKVKQCVD 304
+ KSDVYSFGV+L EL T ++P + L Q V A ++ +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGN-LNPAQ---VVAAVGFKCKRLEIPRN----L-- 264
Query: 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350
P ++AA+ C E RP+ ++ L+PL+ +
Sbjct: 265 -------NP----QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-55
Identities = 70/336 (20%), Positives = 113/336 (33%), Gaps = 52/336 (15%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLA--QVS 113
+ E DN LIG G YG VY G L R A+K S Q F+ +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFINEKNIY 59
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-----LAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
V ++++N+ + L E+ GSL L
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SD 109
Query: 169 WAQRVKIAVGAARGLEYLHE------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-- 220
W ++A RGL YLH +P I HR++ S NVL+ +D ISDF LS
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 221 ----NQAPDAAARLHSTRVLGTFGYHAPEYAM-------TGQMSSKSDVYSFGVVLLELL 269
+ +GT Y APE + D+Y+ G++ E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 270 TGRKPVDH--TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP---------KAIAK 318
+ ++P Q + T + + ++ V + + P A+
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE--KQRPKFPEAWKENSLAVRS 287
Query: 319 MAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGP 354
+ C +A+ R + + L+
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-55
Identities = 82/317 (25%), Positives = 139/317 (43%), Gaps = 64/317 (20%)
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPD------ 105
+P ++ +E++ + IG+G +G V+ G L AIK L
Sbjct: 13 LPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65
Query: 106 --QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
QEF +V ++S L + N+V+L G + P V+ E G L+ L K
Sbjct: 66 KFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP----- 118
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218
+ W+ ++++ + A G+EY+ + P I+HR+++S N+ L D AK++DF
Sbjct: 119 ---IKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELLTGRKPV 275
LS Q+ + + +LG F + APE + + + K+D YSF ++L +LTG P
Sbjct: 175 LSQQSVHS-----VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
Query: 276 DHTLPRGQQSLVTWA-----TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYE 330
D G+ + P + ED C PP ++ V LC +
Sbjct: 229 DE-YSYGKIKFINMIREEGLRPTIPED----C---------PP----RLRNVIELCWSGD 270
Query: 331 ADFRPNMGIVLKALQPL 347
RP+ ++K L L
Sbjct: 271 PKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-55
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-----QEFLAQVSMVSRLKNENVVELVG 128
IG G +G+VY G A+K D + + + + LK+ N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ P L E A G L+ +L GK+ + V AV ARG+ YLH+
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHD 123
Query: 189 KAEPRIIHRNIKSSNVLL--------FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+A IIHR++KSSN+L+ + I KI+DF L+ + G +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYA 179
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE S SDV+S+GV+L ELLTG P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-53
Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 39/295 (13%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ-EFLAQVSMVSRLKNENVVELVGYYV 131
+G+G +G+ R +G +K+L + Q FL +V ++ L++ NV++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
E+ G+L I+ W+QRV A A G+ YLH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK--------SMDSQYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLS------------NQAPDAAARLHSTRVLGTF 239
IIHR++ S N L+ ++ ++DF L+ ++ R V+G
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
+ APE K DV+SFG+VL E++ LPR +
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN----------- 235
Query: 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGP 354
V L PP + C + + RP+ + L+ L +G
Sbjct: 236 ---VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 31/281 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG GS+G VY G A+K L + Q Q F +V ++ + ++ N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
L ++ + SL+ LH + + IA ARG++YLH K
Sbjct: 90 TAPQLAIVT-QWCEGSSLYHHLH--------ASETKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE---YA 247
IIHR++KS+N+ L +D+ KI DF L+ + + ++ G+ + APE
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL 307
+ S +SDVY+FG+VL EL+TG+ P + R Q + + + +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM---VGRGSLSPDLS--- 248
Query: 308 GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
+ +M + A C++ + D RP+ +L ++ L
Sbjct: 249 --KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 62/298 (20%), Positives = 108/298 (36%), Gaps = 46/298 (15%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYY 130
IG+G +G+VY G AI+ +D + + + F +V + ++ENVV +G
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ P + +L+ ++ K VL + +IA +G+ YLH K
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHAPE-- 245
I+H+++KS NV D+ I+DF L G + APE
Sbjct: 151 ---ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 246 -------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
S SDV++ G + EL P P + W
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEA---IIWQ-------- 254
Query: 299 VKQCVDTKLGGEYPPKAI-AKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355
+ T + + +++ + C +E + RP ++ L+ L S
Sbjct: 255 ----MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-50
Identities = 64/326 (19%), Positives = 120/326 (36%), Gaps = 46/326 (14%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFL 109
P+ V +++ IG+G YG V+ G R G A+K ++++
Sbjct: 28 PLLVQRTIAKQIQMV-------KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE 79
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGP 165
++ +++EN++ + + G ++ GSL+D L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------- 130
Query: 166 VLSWAQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L +K+A + GL +LH + +P I HR++KS N+L+ + I+D L+
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 221 --NQAPDAAARLHSTRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ + +GT Y PE Q +D+YSFG++L E+ R
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-R 248
Query: 273 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP--------KAIAKMAAVAA 324
+ Q S + +++ V K P + + +M +
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK--KLRPSFPNRWSSDECLRQMGKLMT 306
Query: 325 LCVQYEADFRPNMGIVLKALQPLLNT 350
C + R V K L + +
Sbjct: 307 ECWAHNPASRLTALRVKKTLAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 60/301 (19%), Positives = 113/301 (37%), Gaps = 41/301 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G+G YG V+ G + G A+K S + ++ L++EN++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 133 GPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ GSL+D L L ++I + A GL +LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHI 123
Query: 189 -----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFG 240
+ +P I HR++KS N+L+ + I+D L+ +Q+ + ++ RV GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKR 182
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294
Y APE + D+++FG+VL E+ R + + +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDP 241
Query: 295 SEDKVKQCVDTKLGGEYPP--------KAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346
S + +++ V + P + +A + C R + K L
Sbjct: 242 SFEDMRKVVCVD--QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 347 L 347
+
Sbjct: 300 I 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 68/307 (22%), Positives = 118/307 (38%), Gaps = 41/307 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
IG+G +G V+ G R G A+K S ++ A++ L++EN++ +
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 133 GPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
++ GSL D L+ ++ +K+A+ A GL +LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHM 157
Query: 189 -----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFG 240
+ +P I HR++KS N+L+ + I+D L+ + A D + RV GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216
Query: 241 YHAPE-----YAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294
Y APE M S ++D+Y+ G+V E+ R + Q
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDP 275
Query: 295 SEDKVKQCVDTKLGGEYPP--------KAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346
S +++++ V + P +A+ MA + C R + K L
Sbjct: 276 SVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 347 LLNTRSG 353
L
Sbjct: 334 LSQQEGI 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 71/294 (24%), Positives = 113/294 (38%), Gaps = 61/294 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG G++G V+ G LR+ A+K +FL + ++ + + N+V L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L G L +++ AA G+EYL K
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--------TEGARLRVKTLLQMVGDAAAGMEYLESK- 232
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-------- 242
IHR++ + N L+ + ++ KISDF +S R Y
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMS-------------REEADGVYAASGGLRQV 277
Query: 243 -----APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296
APE G+ SS+SDV+SFG++L E + G P P LS
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY----------------PNLSN 321
Query: 297 DKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
+ ++ V+ GG P + + C YE RP+ + + LQ +
Sbjct: 322 QQTREFVEK--GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 24/211 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG GS+ VY G+ + A +L K E F + M+ L++ N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 129 YYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ VL E + G+L L + + +GL+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK--------RFKV-MKIKVLRSWCRQILKGLQ 143
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
+LH + P IIHR++K N+ + KI D L+ + A+ V+GT + A
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMA 198
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE + DVY+FG+ +LE+ T P
Sbjct: 199 PEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 46/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY G+ AIK+L +S + ++E L + +++ + N +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + ++++ + G L D + K + + V A+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
++ R++HR++ + NVL+ KI+DF L+ ++LG
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E + + +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 252 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+HR+++++N+L+ ++ + K++DF L+ D + APE A+ G+ +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 359
Query: 254 SKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--E 310
KSDV+SFG++L EL T GR P P + +V V+ G
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPY----------------PGMVNREVLDQVER--GYRMP 401
Query: 311 YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350
PP+ + + C + E + RP + L+ +
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 335 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+HR+++++N+L+ ++ + K++DF L+ D + APE A+ G+ +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 442
Query: 254 SKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--E 310
KSDV+SFG++L EL T GR P P + +V V+ G
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPY----------------PGMVNREVLDQVER--GYRMP 484
Query: 311 YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350
PP+ + + C + E + RP + L+ +
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYY 130
LIG G +G+V+ G+ IK++ + + ++E V +++L + N+V G +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCW 73
Query: 131 VDGPLRVLAY----------------EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
E KG+L + ++G K L ++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------LDKVLALE 126
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ +G++Y+H K ++I+R++K SN+ L D KI DF L + R TR
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TR 180
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y +PE + + D+Y+ G++L ELL
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IG+G+ G VY + + +G+ AI++++ +QP +E + + ++ KN N+V + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V L V+ E+ + GSL D++ + Q + + LE+LH
Sbjct: 88 VGDELWVVM-EYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN- 135
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
++IHR+IKS N+LL D K++DF Q ++ + ++GT + APE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 191
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
K D++S G++ +E++ G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IGEGS+G+ GR IK+++ S+ +E +V++++ +K+ N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + + ++ G L ++ +KGV Q + V L+++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDWFVQICLALKHVHD 143
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+ +I+HR+IKS N+ L D ++ DF ++ + +GT Y +PE
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICE 198
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
++KSD+++ G VL EL T +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G + AIK + +++F+ + ++ +L + +V+L G ++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L E G L D L ++G + + + + + G+ YL E
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
+IHR++ + N L+ ++ + K+SDF ++ D +++ F +PE +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSR 181
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
SSKSDV+SFGV++ E+ + G+ P
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ A+K + + FLA+ +++ L+++ +V+L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E +KGSL D L + G + + + A G+ ++ ++
Sbjct: 256 PIYIIT-EFMAKGSLLDFLKSDE-------GSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
IHR+++++N+L+ + KI+DF L+ D ++ R F APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L+E++T GR P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 35/284 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV- 131
+G G YG VY GV + A+K L +EFL + +++ +K+ N+V+L+G V
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG--VC 285
Query: 132 --DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ P ++ E + G+L D L +S + +A + +EYL +K
Sbjct: 286 TREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK 337
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
IHRN+ + N L+ ++ + K++DF LS H+ + APE
Sbjct: 338 ---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 250 GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308
+ S KSDV++FGV+L E+ T G P P + +V + ++
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYR 437
Query: 309 GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352
E P K+ + C Q+ RP+ + +A + + S
Sbjct: 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
E +E+ +G GS+G V+ ++G A+KK+ +E + + L
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGL 107
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ +V L G +GP + E GSL ++ K L + +
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---------KQMGCLPEDRALYYLGQ 158
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQ-APDAAARLHSTR-- 234
A GLEYLH + RI+H ++K+ NVLL D A + DF + PD + T
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ GT + APE M +K D++S ++L +L G P
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L FLA+ +++ +L+++ +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ GSL D L G L+ + + +A A G+ ++ E+
Sbjct: 81 PIYIIT-EYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
IHR+++++N+L+ D KI+DF L+ D ++ R F APE G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 186
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L E++T GR P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 45/221 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV R + AIK L + K +E + + ++ +L N +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L ++ E A G LH L GK+ + + ++ + G++YL E
Sbjct: 78 VCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 128
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--FGYH---- 242
K +HR++ + NVLL + AKISDF LS + LG Y
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 172
Query: 243 --------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SS+SDV+S+GV + E L+ G+KP
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 22/210 (10%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
+G G VY AIK + + +E L S+L ++N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN--SSQLSHQNIV 74
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
++ + L E+ +L + + GP LS + G++
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAINFTNQILDGIK 125
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ H+ RI+HR+IK N+L+ + KI DF ++ +A + + VLGT Y +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSP 181
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E A +D+YS G+VL E+L G P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 64/301 (21%), Positives = 116/301 (38%), Gaps = 59/301 (19%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G +G VY G L A+K L + +FL + ++ + NV+ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 128 G--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G +G V+ + G L + + + + + A+G++Y
Sbjct: 93 GICLRSEGSPLVV-LPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 143
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHST---RVLGTFGY 241
L K + +HR++ + N +L + K++DF L+ R ++ V G
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA--------RDMYDKEYYSVHNKTGA 192
Query: 242 H------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 294
A E T + ++KSDV+SFGV+L EL+T G P P +
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----------------PDV 236
Query: 295 SEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352
+ + + G P + V C +A+ RP+ ++ + + +T
Sbjct: 237 NTFDITVYLLQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294
Query: 353 G 353
G
Sbjct: 295 G 295
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 46/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY G+ AIK+L +S + ++E L + +++ + N +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + ++++ + G L D + K + + V A+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
++ R++HR++ + NVL+ KI+DF L+ ++LG
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E + + +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ----VSMVSRLKNENVVELV 127
IG G + VY L G A+KK+ D + A + ++ +L + NV++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+++ + E A G L ++ K K ++ K V LE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
+ R++HR+IK +NV + + K+ D L HS ++GT Y +PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 208
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ KSD++S G +L E+ + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 5e-32
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 37/214 (17%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V G + A+K + + EF + + +L + +V+ G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ S G L + L G L +Q +++ G+ +L +
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEMCYDVCEGMAFLESH---Q 124
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH----------- 242
IHR++ + N L+ D K+SDF ++ R + Y
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT-------------RYVLDDQYVSSVGTKFPVKW 171
Query: 243 -APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SSKSDV++FG+++ E+ + G+ P
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 17/223 (7%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVS 116
+ + +++ IG GSYGR G+ K+LD + E +++V+++
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 117 RLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
LK+ N+V +D L Y E+ G L ++ KG K L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVL 114
Query: 174 KIAVGAARGLEYLHEKAEP--RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
++ L+ H +++ ++HR++K +NV L K+ DF L+ +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y +PE + KSD++S G +L EL P
Sbjct: 175 T--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 46/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G +G V+ GV + IK + S +Q Q + + L + ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G L+++ ++ GSL D + +G L + V A+G+ YL
Sbjct: 81 LGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAKGMYYL 131
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
E ++HRN+ + NVLL +++DF ++ +L
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVA-------------DLLPPDDKQLLYS 175
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E G+ + +SDV+S+GV + EL+T G +P
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 33/210 (15%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG+G +G V G R G A+K K D++ Q FLA+ S++++L++ N+V+L+G V
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG--V 254
Query: 132 ---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + E+ +KGSL D L + VL +K ++ +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYH--APE 245
+HR++ + NVL+ +D++AK+SDF L + ST+ G APE
Sbjct: 308 N---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPE 356
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ S+KSDV+SFG++L E+ + GR P
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-32
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ L +E +V+L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ + G L + L + Q +++ +EYL K +
Sbjct: 92 RPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
+HR++ + N L+ D + K+SDF LS D +++ V F PE M +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 197
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
SSKSD+++FGV++ E+ + G+ P
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
++G G V+ LR R A+K L + D F AQ + L + +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIV 75
Query: 125 EL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ G + P L Y E+ +L DI+H + GP ++ + +++ A
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADA 125
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLGT 238
+ L + H+ IIHR++K +N+++ + K+ DF ++ D+ + T V+GT
Sbjct: 126 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y +PE A + ++SDVYS G VL E+LTG P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 47/222 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V G + + A+K L + E LA+ +++ +L N +V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G ++ E A G L+ L + + +++ + G++YL
Sbjct: 85 GICEAESWMLVM-EMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 134
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG--YH--- 242
E +HR++ + NVLL AKISDF LS + L Y
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-------------KALRADENYYKAQT 178
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SSKSDV+SFGV++ E + G+KP
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+GEG +G VY GV + + A+K K D + ++F+++ ++ L + ++V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P ++ E G L L + L V ++ + + YL
Sbjct: 80 GIIEEEPTWIIM-ELYPYGELGHYLE--------RNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH----- 242
+HR+I N+L+ + K+ DF LS R + Y+
Sbjct: 131 SI---NCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVT 174
Query: 243 -------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+PE + ++ SDV+ F V + E+L+ G++P
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 44/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E + L+ L KK + +R + +H
Sbjct: 76 DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 125
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-- 245
+ I+H ++K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 126 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 246 ---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
++S KSDV+S G +L + G+ P
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 44/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E + L+ L KK + +R + +H
Sbjct: 95 DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 144
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-- 245
+ I+H ++K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 145 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 246 ---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
++S KSDV+S G +L + G+ P
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGY 129
+G G +G V+ AIK++ + ++ + +V +++L++ +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 130 YVDGP---------LRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+++ +V Y + K +L D ++G+ ++ + L ++
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI---- 127
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-----------NQAPDA 226
A +E+LH K ++HR++K SN+ DD+ K+ DF L P
Sbjct: 128 --AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLT 270
A H+ +V GT Y +PE + G S K D++S G++L ELL
Sbjct: 183 AYARHTGQV-GTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 71/295 (24%), Positives = 123/295 (41%), Gaps = 34/295 (11%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + P + ++ ++ L +E++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 127 VG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
G L+++ E+ GSL D L + AQ + A G+
Sbjct: 99 KGCCEDAGAASLQLVM-EYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGM 147
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--RLHSTRVLGTFGY 241
YLH + IHR++ + NVLL +D + KI DF L+ P+ R+ F Y
Sbjct: 148 AYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
APE + SDV+SFGV L ELLT + + +++ ++
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLT 261
Query: 301 QCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353
+ ++ G P K A++ + C + EA FRP ++ L+ + G
Sbjct: 262 ELLER--GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 45/221 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV R + AIK L + K +E + + ++ +L N +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L ++ E A G LH L GK+ + + ++ + G++YL E
Sbjct: 404 VCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 454
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--FGYH---- 242
K +HRN+ + NVLL + AKISDF LS + LG Y
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 498
Query: 243 --------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SS+SDV+S+GV + E L+ G+KP
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 55/306 (17%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+K+L S ++F ++ ++ L ++ +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G LR++ E+ G L D L + L ++ + + +G+E
Sbjct: 91 GVSYGPGRQSLRLVM-EYLPSGCLRDFLQ--------RHRARLDASRLLLYSSQICKGME 141
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG--YH 242
YL + R +HR++ + N+L+ + KI+DF L+ ++L Y
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLA-------------KLLPLDKDYYV 185
Query: 243 ------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289
APE S +SDV+SFGVVL EL T K + ++
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGC 243
Query: 290 ATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347
+ ++ + ++ G PP A++ + LC RP+ + L L
Sbjct: 244 ERDVPALSRLLELLEE--GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
Query: 348 LNTRSG 353
+ G
Sbjct: 302 WSGSRG 307
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 30/230 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
+GEG + V L G A+K++ +Q D+E + M + N++ LV Y
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 131 VDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ +G+L + + + G L+ Q + + +G RGLE +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-------GTF 239
H HR++K +N+LL D+ + D NQA L T
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 240 GYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
Y APE + + + ++DV+S G VL ++ G P D +G
Sbjct: 208 SYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 29/208 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-- 131
IG+G +G V G R G A+K + + Q FLA+ S++++L++ N+V+L+G V
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLG--VIV 84
Query: 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E+ +KGSL D L + VL +K ++ +EYL
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN- 136
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYH--APEYA 247
+HR++ + NVL+ +D++AK+SDF L + ST+ G APE
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEAL 186
Query: 248 MTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ S+KSDV+SFG++L E+ + GR P
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 48/224 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL----DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+GS+G V G + A+K L S + +F+ +V+ + L + N++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L G + P++++ E A GSL D L +G + AV A G+ Y
Sbjct: 86 LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 136
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG--YH- 242
L K R IHR++ + N+LL D+ KI DF L R L Y
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLM-------------RALPQNDDHYVM 180
Query: 243 -----------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE T S SD + FGV L E+ T G++P
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV- 131
+G G YG VY GV + A+K L +EFL + +++ +K+ N+V+L+G V
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG--VC 78
Query: 132 --DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ P ++ E + G+L D L +S + +A + +EYL +K
Sbjct: 79 TREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK 130
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH------- 242
IHR++ + N L+ ++ + K++DF LS R++ Y
Sbjct: 131 ---NFIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKF 174
Query: 243 -----APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + S KSDV++FGV+L E+ T G P
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-31
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IGEGS G V SGR A+K +D KQ +E L V ++ ++ NVVE+ Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V L VL E G+L DI+ L+ Q + + L YLH +
Sbjct: 113 VGEELWVLM-EFLQGGALTDIV---------SQVR-LNEEQIATVCEAVLQALAYLHAQ- 160
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+IHR+IKS ++LL D K+SDF Q + S ++GT + APE
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRS 216
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
+++ D++S G++++E++ G P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-31
Identities = 64/293 (21%), Positives = 125/293 (42%), Gaps = 28/293 (9%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+KKL S+++ ++F ++ ++ L+++N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G L+++ E+ GSL D L K + + ++ +G+E
Sbjct: 109 GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 159
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARLHSTRVLGTFGYH 242
YL K R IHR++ + N+L+ +++ KI DF L+ P ++ F Y
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY- 215
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
APE + S SDV+SFGVVL EL T + + + ++ + +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 303 VDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353
+ G P ++ + C + RP+ + + + + +G
Sbjct: 276 LKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 22/210 (10%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
L+G G G VY R A+K + + D F A+ RL+ +VV
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREART--AGRLQEPHVV 97
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ + + + L +L + GP L+ + V I L+
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLR--------RQGP-LAPPRAVAIVRQIGSALD 148
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
H HR++K N+L+ DD A + DF ++ A +GT Y AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAP 204
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E + ++D+Y+ VL E LTG P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 43/221 (19%), Positives = 87/221 (39%), Gaps = 30/221 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E L+ L KK + +R + +H
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 172
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-- 245
+ I+H ++K +N L D + K+ DF ++NQ + +G Y PE
Sbjct: 173 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 246 ---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
++S KSDV+S G +L + G+ P
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 64/293 (21%), Positives = 125/293 (42%), Gaps = 28/293 (9%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+KKL S+++ ++F ++ ++ L+++N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G L+++ E+ GSL D L K + + ++ +G+E
Sbjct: 78 GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 128
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARLHSTRVLGTFGYH 242
YL K R IHR++ + N+L+ +++ KI DF L+ P ++ F Y
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY- 184
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
APE + S SDV+SFGVVL EL T + + + ++ + +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 303 VDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353
+ G P ++ + C + RP+ + + + + +G
Sbjct: 245 LKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-31
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
++G+G+YG VY G L + AIK++ + L + +++ LK++N+V+ +G +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E GSL +L K G + + +++ GL+YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LEGLKYLHDN- 141
Query: 191 EPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+I+HR+IK NVL+ + KISDF S + + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 250 GQM--SSKSDVYSFGVVLLELLTGRKP 274
G +D++S G ++E+ TG+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 55/232 (23%), Positives = 105/232 (45%), Gaps = 50/232 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D + ++F + +++ L++E++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 127 VGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQRVKIA 176
G V PL ++ +E+ G L+ L + + L +Q + IA
Sbjct: 83 YG--VCGDGDPLIMV-FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
A G+ YL + +HR++ + N L+ + + KI DF +S R +
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-------------RDV 183
Query: 237 GTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ PE M + +++SDV+SFGV+L E+ T G++P
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 44/220 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IGEG +G V+ G+ S AIK K +S ++FL + + + + ++V+L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P+ ++ E + G L L L A + A + L YL
Sbjct: 83 GVITENPVWIIM-ELCTLGELRSFLQ--------VRKYSLDLASLILYAYQLSTALAYLE 133
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH----- 242
K R +HR+I + NVL+ +D K+ DF LS R + Y+
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKG 177
Query: 243 -------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+ FGV + E+L G KP
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 64/233 (27%), Positives = 100/233 (42%), Gaps = 51/233 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+GE +G+VY G L AIK L + +EF + + +RL++ NVV
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKPGPVLSWAQRVKI 175
L+G V D PL ++ + + S G LH+ L + L V +
Sbjct: 77 LLG--VVTKDQPLSMI-FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A G+EYL ++H+++ + NVL++D KISD L R
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF-------------RE 177
Query: 236 LGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ APE M G+ S SD++S+GVVL E+ + G +P
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 62/309 (20%), Positives = 115/309 (37%), Gaps = 68/309 (22%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVV 124
+G+G++ +++ GV R +K L + + + F SM+S+L ++++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G V G +L E GSL L K ++ ++++A A +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK--------KNKNCINILWKLEVAKQLAAAMH 127
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDD--------IAKISDFDLSNQAPDAAARLHSTRVL 236
+L E +IH N+ + N+LL ++ K+SD +S +
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------ITV 171
Query: 237 GTFGYH-------APEYAMTGQM-SSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 287
PE + + +D +SFG L E+ + G KP+
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL------------ 219
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347
L + Q + + P A++A + C+ YE D RP+ +++ L L
Sbjct: 220 ----SALDSQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
Query: 348 LNTRSGPSK 356
P
Sbjct: 274 FTPDLVPRG 282
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 49/225 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G +G VY G L A+K L + +FL + ++ + NV+ L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 128 G--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G +G V+ + G L + + + + + A+G+++
Sbjct: 157 GICLRSEGSPLVVL-PYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKF 207
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--- 242
L K + +HR++ + N +L + K++DF L+ R + +
Sbjct: 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA-------------RDMYDKEFDSVH 251
Query: 243 ------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E T + ++KSDV+SFGV+L EL+T G P
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 46/259 (17%)
Query: 43 MKTVTVQPIAVPVISVDELKE-KTDNFGTNSLIGEGSYGRVYFGVLRSGRAA------AI 95
M +V + + + V + E + + +G+GS+G VY GV + AI
Sbjct: 1 MASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 96 KKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHD 150
K + +S + EFL + S++ +VV L+G V P V+ E ++G L
Sbjct: 61 KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVI-MELMTRGDLKS 117
Query: 151 ILHGKKGVKGAKP-GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209
L + P S ++ +++A A G+ YL+ + +HR++ + N ++ +D
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174
Query: 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKS 256
KI DF ++ R + Y+ +PE G ++ S
Sbjct: 175 FTVKIGDFGMT-------------RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221
Query: 257 DVYSFGVVLLELLT-GRKP 274
DV+SFGVVL E+ T +P
Sbjct: 222 DVWSFGVVLWEIATLAEQP 240
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IGEG +G V+ G+ S AIK K +S ++FL + + + + ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P+ ++ E + G L L +K L A + A + L YL
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLE 508
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
K R +HR+I + NVL+ +D K+ DF LS D+ S L APE
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI 564
Query: 248 MTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ +S SDV+ FGV + E+L G KP
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 47/224 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG+G +G VY G AIK + Q + FL + ++ L + NV+ L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 128 GYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G + L + + G L + P + + + ARG+EYL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGMEYL 140
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
E+ + +HR++ + N +L + K++DF L+ R + Y+
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLA-------------RDILDREYYSVQQ 184
Query: 243 -----------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E T + ++KSDV+SFGV+L ELLT G P
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 63/290 (21%), Positives = 117/290 (40%), Gaps = 25/290 (8%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAA 94
E K ++ Q V + D+ ++ S +G G+ G V+ + SG A
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLVMA 62
Query: 95 IKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL 152
K + +P + + ++ ++ + +V G + + EH GSL +L
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 153 HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212
+ P +L K+++ +GL YL EK +I+HR++K SN+L+
Sbjct: 123 KKAGRI----PEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI 171
Query: 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
K+ DF +S Q D+ A + V GT Y +PE S +SD++S G+ L+E+ GR
Sbjct: 172 KLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
Query: 273 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAV 322
P+ + + + + + + A+
Sbjct: 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 49/234 (20%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV 123
+F +++G+G++G+V R AIKK+ +++ L++V +++ L ++ V
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 124 VELVGYYVDGPLRVLAY-------------EHASKGSLHDILHGKKGVKGAKPGPVLSWA 170
V +++ V E+ G+L+D++ +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLF 122
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
+++ L Y+H + IIHR++K N+ + + KI DF L+ + L
Sbjct: 123 RQI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 231 HS------------TRVLGTFGYHAPE-YAMTGQMSSKSDVYSFGVVLLELLTG 271
T +GT Y A E TG + K D+YS G++ E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 53/218 (24%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNEN 122
+ + +G+G++G+VY +G AA K +++ + + ++++ ++ +++ +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 123 VVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
+V+L+G YY DG L ++ E G++ I+ L+ Q +
Sbjct: 78 IVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLE 128
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH K RIIHR++K+ NVL+ + +++DF +S + + S +GT +
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYW 183
Query: 242 HAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKP 274
APE M M K+D++S G+ L+E+ P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 40/272 (14%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSM 114
I + L++ F L+G G+YG+VY G +++G+ AAIK +D + ++E +++M
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 115 VSRLKN-ENVVELVGYYVDGPLRVLAY------EHASKGSLHDILHGKKGVKGAKPGPVL 167
+ + + N+ G ++ + E GS+ D+ +K K L
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL------IKNTKGNT-L 126
Query: 168 SWAQRVKIAV---GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
IA RGL +LH+ ++IHR+IK NVLL ++ K+ DF +S Q
Sbjct: 127 KEEW---IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKPVDHTL 279
R ++ +GT + APE + KSD++S G+ +E+ G P+
Sbjct: 181 RTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238
Query: 280 P-RGQQSLVTWATPKLSEDK--------VKQC 302
P R + P+L K ++ C
Sbjct: 239 PMRALFLIPRNPAPRLKSKKWSKKFQSFIESC 270
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-30
Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 17/212 (8%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV 123
+ F +GEGSYG VY + +G+ AIK++ QE + ++S++ + + +V
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQCDSPHV 86
Query: 124 VELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
V+ G Y+ + L ++ E+ GS+ DI+ + L+ + I +G
Sbjct: 87 VKYYGSYFKNTDLWIVM-EYCGAGSVSDIIRLRNKT--------LTEDEIATILQSTLKG 137
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LEYLH R IHR+IK+ N+LL + AK++DF ++ Q D A+ ++ V+GT +
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWM 192
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + +D++S G+ +E+ G+ P
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 49 QPIAVPVISVDELKEK-TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD- 105
P+ + + LK + F IG+GS+G V+ G+ R+ + AIK +D + D
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE 63
Query: 106 -QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG 164
++ +++++S+ + V + G Y+ + E+ GS D+L +PG
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPG 114
Query: 165 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
P L Q I +GL+YLH + + IHR+IK++NVLL + K++DF ++ Q
Sbjct: 115 P-LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
D + ++ +GT + APE SK+D++S G+ +EL G P
Sbjct: 171 DTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 45/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G G V +G LR AIK L +++ ++FL++ S++ + + N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G G L ++ E+ GSL L G + Q V + G G+ YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMRYLS 168
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG--TFGYH--- 242
+ +HR++ + NVL+ + + K+SDF LS RVL +
Sbjct: 169 DL---GYVHRDLAARNVLVDSNLVCKVSDFGLS-------------RVLEDDPDAAYTTT 212
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE SS SDV+SFGVV+ E+L G +P
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
IG G +G VY G+L++ AIK L +++ +FL + ++ + + N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ G+L L K G S Q V + G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKYL 163
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFGY 241
+HR++ + N+L+ + + K+SDF LS D ++T + T
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT--- 217
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+SFG+V+ E++T G +P
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 54/231 (23%), Positives = 101/231 (43%), Gaps = 49/231 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L ++S+ Q+F + +++ L+++++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 127 VGYYV---DGPLRVLAYEHASKGSLHDIL------HGKKGVKGAKPGPVLSWAQRVKIAV 177
G V PL ++ +E+ G L+ L L Q + +A
Sbjct: 109 FG--VCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
A G+ YL +HR++ + N L+ + KI DF +S R +
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS-------------RDIY 209
Query: 238 TFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ PE + + +++SDV+SFGVVL E+ T G++P
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G +G V G L+ AIK L +++ ++FL + S++ + + N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G ++ E+ GSL L K + Q V + G A G++YL
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR--------KHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFGYH 242
+ +HR++ + N+L+ + + K+SDF L D ++TR + T
Sbjct: 165 DM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+PE + +S SDV+S+G+VL E+++ G +P
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 50/226 (22%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L +S + ++ ++ L +EN+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 127 VG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
G ++++ E GSL + L K ++ Q++K AV +G+
Sbjct: 89 KGICTEDGGNGIKLIM-EFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGM 139
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL--GTFGY 241
+YL + + +HR++ + NVL+ + KI DF L+ + + Y
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT-------------KAIETDKEYY 183
Query: 242 H------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE M + SDV+SFGV L ELLT
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 49/229 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G V G L+ A+K + +SS++ +EFL++ + + + NV+ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 127 VG-------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+G + P+ +L G LH L + + +K V
Sbjct: 102 LGVCIEMSSQGIPKPMVIL--PFMKYGDLHTYL---LYSRLETGPKHIPLQTLLKFMVDI 156
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+EYL + +HR++ + N +L DD ++DF LS + + +
Sbjct: 157 ALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------------KKIYSG 200
Query: 240 GYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
Y+ A E +SKSDV++FGV + E+ T G P
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 50/230 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPD-QEFLAQVSMVSRLKNENVVEL 126
+G+G +G V L+ + A+K K D D +EFL + + + + +V +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 127 VG--------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
VG + P+ +L G LH L + + L V+ V
Sbjct: 91 VGVSLRSRAKGRLPIPMVIL--PFMKHGDLHAFL---LASRIGENPFNLPLQTLVRFMVD 145
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A G+EYL + IHR++ + N +L +D ++DF LS R + +
Sbjct: 146 IACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS-------------RKIYS 189
Query: 239 FGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
Y+ A E + SDV++FGV + E++T G+ P
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRL-KN 120
+F S +G GSYG V+ GR A+K+ S + ++ LA+V ++ ++
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V L + +G + L E SL G L AQ
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--------AWGASLPEAQVWGYLRDTL 167
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
L +LH + ++H ++K +N+ L K+ DF L + A A + G
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPR 221
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + G + +DV+S G+ +LE+ +
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 48/240 (20%), Positives = 92/240 (38%), Gaps = 35/240 (14%)
Query: 54 PVISVDELKEKTD-------NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQP 104
P + D+ E+T +F ++G G+ G + + + R A+K++
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64
Query: 105 DQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
D+E V ++ NV+ D + +A E + +L + + +
Sbjct: 65 DRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQK 111
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218
+ + + GL +LH I+HR++K N+L+ + A ISDF
Sbjct: 112 DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 219 LSNQ-APDAAARLHSTRVLGTFGYHAPEY---AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L + A + + V GT G+ APE + D++S G V +++
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
+ EK ++F +L+G+GS+ VY + +G AIK +D + + MV R+
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA------MYKAGMVQRV 58
Query: 119 KNE----------NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
+NE +++EL Y+ D V L E G ++ L +
Sbjct: 59 QNEVKIHCQLKHPSILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNRVKP--------F 109
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S + G+ YLH I+HR++ SN+LL + KI+DF L+ Q
Sbjct: 110 SENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++ GT Y +PE A +SDV+S G + LL GR P
Sbjct: 167 EKHYTL--CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 66/257 (25%), Positives = 100/257 (38%), Gaps = 29/257 (11%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN 120
K D+ +G G+YG V SG+ A+K++ ++ + L + + R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 121 -ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V G + E SL P +L KIAV
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG-----KIAVSI 118
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ LE+LH K +IHR++K SNVL+ K+ DF +S D A+ G
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 240 GYHAPE----YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP--RGQQSLVTWATPK 293
Y APE S KSD++S G+ ++EL R P D + + +V +P+
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233
Query: 294 LSEDK--------VKQC 302
L DK QC
Sbjct: 234 LPADKFSAEFVDFTSQC 250
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 70/278 (25%), Positives = 116/278 (41%), Gaps = 20/278 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPDQEFLAQ-VSMVSRLKNEN 122
D++ +IG G+ V AIK+++ Q + L + + +S+ + N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V +V L + S GS+ DI+ K G L + I G
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEG 133
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR---VLGTF 239
LEYLH+ IHR++K+ N+LL +D +I+DF +S + +GT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 240 GYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSED 297
+ APE + K+D++SFG+ +EL TG P P + + P L
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP 335
+ + K G K+ KM +LC+Q + + RP
Sbjct: 251 VQDKEMLKKYG-----KSFRKM---ISLCLQKDPEKRP 280
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 72/303 (23%), Positives = 122/303 (40%), Gaps = 63/303 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G + A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + R + E + G L L + L+ + +A A G +Y
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQY 155
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L E IHR+I + N LL +AKI DF ++ R + Y+
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRASYY 199
Query: 243 -------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT 288
PE M G +SK+D +SFGV+L E+ + G P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY------------- 246
Query: 289 WATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346
P S +V + V + GG + P + + C Q++ + RPN I+L+ ++
Sbjct: 247 ---PSKSNQEVLEFVTS--GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301
Query: 347 LLN 349
Sbjct: 302 CTQ 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 45/260 (17%), Positives = 94/260 (36%), Gaps = 34/260 (13%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKT--DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIK 96
P MK + + ++ ++ +++ + +G + ++ + + A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 97 KLD--------SSKQPDQEFLAQVSMVSRLKNE----------NVVELVGYYVDGPLRV- 137
K + + + + ++ S KNE + G + V
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN-YDEVY 119
Query: 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197
+ YE+ S+ V + I Y+H + I HR
Sbjct: 120 IIYEYMENDSILKFDE-YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHR 176
Query: 198 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS---S 254
++K SN+L+ + K+SDF S D ++ +R GT+ + PE + + S +
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR--GTYEFMPPE-FFSNESSYNGA 231
Query: 255 KSDVYSFGVVLLELLTGRKP 274
K D++S G+ L + P
Sbjct: 232 KVDIWSLGICLYVMFYNVVP 251
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 32/222 (14%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 127 VGY-YVDGPLRVLAYEHASKGSLHDILHGKK-------GVKGAKPGPVLSWAQRVKIAVG 178
+G G L + E+A G+L D L + LS Q + A
Sbjct: 92 LGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS R V T
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKT 199
Query: 239 FG-----YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
G + A E ++ SDV+S+GV+L E+++ G P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 59/241 (24%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
IGEG++GRV+ A+K L ++S +F + ++++ N N+V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDIL---------------HGKKGVKGAKPGPVL 167
L+G V P+ +L +E+ + G L++ L + + P L
Sbjct: 115 LLG--VCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S A+++ IA A G+ YL E+ + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS------- 221
Query: 228 ARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 273
R + + Y+ PE + +++SDV+++GVVL E+ + G +
Sbjct: 222 ------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 274 P 274
P
Sbjct: 276 P 276
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 39/216 (18%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G+G +G VY +S A+K L ++ L + + +L+ E
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQLRREVEIQSHLRHP 69
Query: 122 NVVELVGYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L GY+ D RV L E+A G+++ L K +
Sbjct: 70 NILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-----------TYITE 117
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A L Y H K R+IHR+IK N+LL KI+DF S AP + + GT
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTD-LCGT 170
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y PE K D++S GV+ E L G+ P
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 63/303 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G + A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + R + E + G L L + L+ + +A A G +Y
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETR--PRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L E IHR+I + N LL +AKI DF ++ R + GY+
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRAGYY 240
Query: 243 -------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT 288
PE M G +SK+D +SFGV+L E+ + G P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY------------- 287
Query: 289 WATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346
P S +V + V + GG + P + + C Q++ + RPN I+L+ ++
Sbjct: 288 ---PSKSNQEVLEFVTS--GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342
Query: 347 LLN 349
Sbjct: 343 CTQ 345
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 67/238 (28%), Positives = 105/238 (44%), Gaps = 20/238 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENVVELVGY 129
IG G+YG V V SG+ A+K++ S+ ++ L + +V R + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ E S + + P +L KI + + L +L E
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLKEN 144
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE---- 245
+IIHR+IK SN+LL K+ DF +S Q D+ A+ TR G Y APE
Sbjct: 145 L--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDP 199
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD--HTLPRGQQSLVTWATPKLSEDKVKQ 301
A +SDV+S G+ L EL TGR P +++ +V P+LS + ++
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 34/283 (12%), Positives = 64/283 (22%), Gaps = 44/283 (15%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAA 94
+ A E T TV P L + + G V+ + A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 95 IKKLDSSKQPDQEFLAQV----SMVSRLKNENVVELVGYY-------------------- 130
+K + + L ++ +RL E+ E
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 131 ------VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+L AS L + + R
Sbjct: 152 SPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAA 208
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
L K ++H + N+ + D + D + Y
Sbjct: 209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPR 260
Query: 245 EYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285
E+ T + + + G+ + + P P + S
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 24/228 (10%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-DQEFLAQ-VSMVSRL 118
+ + +G G +G V + +G AIK+ P ++E + ++ +L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 119 KNENVVELV------GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ NVV L +LA E+ G L L+ + G K GP+ +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAAR 229
+ + L YLHE RIIHR++K N++L I KI D + +
Sbjct: 130 I------SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--E 178
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
L + V GT Y APE + + D +SFG + E +TG +P
Sbjct: 179 LCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 70/316 (22%), Positives = 133/316 (42%), Gaps = 74/316 (23%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V A+K L D++++ + ++++ M+ + K++N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 123 VVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQR 172
++ L+G DGPL V+ E+ASKG+L + L P +++
Sbjct: 149 IINLLG--ACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA------------ 250
Query: 233 TRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 278
R + Y+ APE + +SDV+SFGV++ E+ T G P
Sbjct: 251 -RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---- 305
Query: 279 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPN 336
P + +++ + + K G + P ++ + C RP
Sbjct: 306 ------------YPGIPVEELFKLL--KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPT 351
Query: 337 MGIVLKALQPLLNTRS 352
+++ L +L +
Sbjct: 352 FKQLVEDLDRILTLTT 367
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 70/317 (22%), Positives = 134/317 (42%), Gaps = 70/317 (22%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG++G+V A+K L D++++ + ++++ M+ + K++N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 123 VVELVGY-YVDGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L P +++ V
Sbjct: 103 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+ R
Sbjct: 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA-------------R 205
Query: 235 VLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280
+ Y+ APE + +SDV+SFGV++ E+ T G P
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP------ 259
Query: 281 RGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMG 338
P + +++ + + K G + P ++ + C RP
Sbjct: 260 ----------YPGIPVEELFKLL--KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 307
Query: 339 IVLKALQPLLNTRSGPS 355
+++ L +L +
Sbjct: 308 QLVEDLDRILTLTTNEE 324
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 30/301 (9%), Positives = 87/301 (28%), Gaps = 48/301 (15%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAA 94
++ A + + ++ P EL E+ +++G+ +G +
Sbjct: 48 MQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE 107
Query: 95 IKKLDSSKQPDQE-----------------------------FLAQVSMVSRLKNENVVE 125
+ +++P F+ +V + + ++
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167
Query: 126 LVG----YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
+ +V + ++ + ++L + L R+++ + R
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVHHARLQLTLQVIR 222
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L LH ++H ++ +++L ++ F+ A+A R
Sbjct: 223 LLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAVSPIGRGFAPPET 278
Query: 242 HAPE-----YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296
A M+ D ++ G+ + + P G + + + +
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQ 338
Query: 297 D 297
Sbjct: 339 P 339
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 75/316 (23%), Positives = 132/316 (41%), Gaps = 74/316 (23%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRLKN-EN 122
+GEG++G+V A+K L D++++ + ++++ M+ + +N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 123 VVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQR 172
++ L+G DGPL V+ E+ASKG+L + L P LS
Sbjct: 137 IINLLG--ACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA------------ 238
Query: 233 TRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 278
R + Y+ APE + +SDV+SFGV+L E+ T G P
Sbjct: 239 -RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---- 293
Query: 279 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPN 336
P + +++ + + K G + P ++ + C RP
Sbjct: 294 ------------YPGVPVEELFKLL--KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 339
Query: 337 MGIVLKALQPLLNTRS 352
+++ L ++ S
Sbjct: 340 FKQLVEDLDRIVALTS 355
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 57/261 (21%), Positives = 95/261 (36%), Gaps = 35/261 (13%)
Query: 26 PAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFG 85
+PG V A +P + VD + +G+G + + +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEI 60
Query: 86 V-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------NVVELVGYYVDGP 134
+ A K + S L + ++ E +VV G++ D
Sbjct: 61 SDADTKEVFAGKIVPKSL------LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-N 113
Query: 135 LRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
V + E + SL ++ +K + + A+ G +YLH R
Sbjct: 114 DFVFVVLELCRRRSLLELHKRRKALTEPE-------ARY--YLRQIVLGCQYLHRN---R 161
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+IHR++K N+ L +D KI DF L+ + R GT Y APE S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 219
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
+ DV+S G ++ LL G+ P
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 35/236 (14%)
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ 111
+P + VD + +G+G + + + + A K + S L +
Sbjct: 4 IPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL------LLK 55
Query: 112 VSMVSRLKNE----------NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKG 160
++ E +VV G++ D V + E + SL ++ +K +
Sbjct: 56 PHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRKALTE 114
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ A+ G +YLH R+IHR++K N+ L +D KI DF L+
Sbjct: 115 PE-------ARY--YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+ R GT Y APE S + DV+S G ++ LL G+ P +
Sbjct: 163 TKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 35/214 (16%), Positives = 74/214 (34%), Gaps = 23/214 (10%)
Query: 74 IGEG--SYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF---LAQVSMVSRLKNENVVELV 127
IG+G V +G +++++ ++ ++ + + N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
++ + + GS D++ ++ I G + L+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLI------CTHFMDG-MNELAIAYILQGVLKALDYIH 145
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-----GTFGYH 242
+HR++K+S++L+ D +S + R +
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 243 APEYAMTGQM--SSKSDVYSFGVVLLELLTGRKP 274
+PE +KSD+YS G+ EL G P
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 49/233 (21%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVV 124
+G G++G+V + R A+K L ++ + ++++ ++ + + NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 125 ELVG--YYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVLSWAQRVKI 175
L+G GPL V+ E G+L L K+ L+ +
Sbjct: 95 NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+ A+G+E+L + + IHR++ + N+LL + ++ KI DF L+ R
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA-------------RD 197
Query: 236 LGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ + APE + +SDV+SFGV+L E+ + G P
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 33/304 (10%), Positives = 89/304 (29%), Gaps = 55/304 (18%)
Query: 37 EAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAI 95
++ A + + ++ P EL E+ +++G+ +G + +
Sbjct: 44 QSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEV 103
Query: 96 KKLDSSKQPDQE-----------------------------FLAQVSMVSRLKNENVVEL 126
+++P F+ +V + + ++ +
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163
Query: 127 VGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
D R Y +L G+ + + L R+++ + R L
Sbjct: 164 RLDERDMWVLSRFFLYPRMQ-SNLQTF--GEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH ++H ++ +++L ++ F+ + + G+ P
Sbjct: 221 SLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVSRGFEPP 271
Query: 245 EYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
E M+ D ++ G+V+ + P+ G + +
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN 331
Query: 294 LSED 297
+ +
Sbjct: 332 IPQP 335
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 27/210 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQV----SMVSRLKNENVVELV 127
+G+G +G VY ++ A+K L S+ + Q+ + S L++ N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 128 GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
Y+ D R+ L E A +G L+ L HG+ + + A L
Sbjct: 81 NYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-----------TFMEELADALH 128
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
Y HE+ ++IHR+IK N+L+ KI+DF S AP R + GT Y P
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTM--CGTLDYLPP 181
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E K D++ GV+ E L G P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 41/227 (18%)
Query: 72 SLIGEGSYGRVYFGV-LR-SGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENV 123
I G G +Y + +GR +K L S D E Q ++ + + ++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQF--LAEVVHPSI 141
Query: 124 VEL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V++ + D + Y E+ SL K L A+ + +
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLE 190
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLG 237
L YLH +++ ++K N++L ++ K+ D A +R++S + G
Sbjct: 191 ILPALSYLHSI---GLVYNDLKPENIML-TEEQLKLIDLG-------AVSRINSFGYLYG 239
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
T G+ APE + +D+Y+ G L L + G
Sbjct: 240 TPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 59/241 (24%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+GEG +G+V + A+K L ++S ++ L++ +++ ++ + +V++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDIL---------------HGKKGVKGAKPGPVL 167
L G DGPL ++ E+A GSL L L
Sbjct: 91 LYG--ACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
+ + A ++G++YL E +++HR++ + N+L+ + KISDF LS
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS------- 197
Query: 228 ARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 273
R + + A E +++SDV+SFGV+L E++T G
Sbjct: 198 ------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 274 P 274
P
Sbjct: 252 P 252
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 48/231 (20%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVV 124
+G G++G+V + A+K L + + ++++ ++S L EN+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 125 ELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIA 176
L+G GP+ V+ E+ G L + L K V A S + +
Sbjct: 114 NLLG--ACTHGGPVLVIT-EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
A+G+ +L K IHR++ + NVLL + +AKI DF L AR ++
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL--------ARD----IM 215
Query: 237 GTFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
Y APE + +SDV+S+G++L E+ + G P
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 58/249 (23%), Positives = 102/249 (40%), Gaps = 34/249 (13%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENVVELVGY 129
+G G+ G+V+ ++G A+K++ S + + L + +V + + +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
++ +A E + + + P +L K+ V + L YL EK
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPI----PERILG-----KMTVAIVKALYYLKEK 143
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE---- 245
+IHR++K SN+LL + K+ DF +S + D A+ R G Y APE
Sbjct: 144 H--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDP 198
Query: 246 -YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP--RGQQSLVTWATPKLSEDK---- 298
++DV+S G+ L+EL TG+ P + ++ P L
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258
Query: 299 -----VKQC 302
VK C
Sbjct: 259 DFQSFVKDC 267
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 35/238 (14%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK 119
+ + + ++G GS G V F GR A+K++ E + +++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----IKLLTESD 66
Query: 120 N-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ NV+ +A E + +L D++ K + + + +
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN--VSDENLKLQKEYNPISLLRQ 123
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLL-------------FDDDIAKISDFDLSNQAPD 225
A G+ +LH +IIHR++K N+L+ ++ ISDF L +
Sbjct: 124 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 226 AAARLHSTR--VLGTFGYHAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + GT G+ APE +++ D++S G V +L+ K
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 30/239 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNEN 122
+ + ++G+G+ V+ G + +G AIK ++ +P + + ++ +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 123 VVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + R VL E GSL+ +L G L + V
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV------V 122
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARLHSTRVL 236
G+ +L E I+HRNIK N++ + K++DF + + D + S +
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LY 176
Query: 237 GTFGYHAPE--------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 286
GT Y P+ + + D++S GV TG P PR + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 35/246 (14%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ----VSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S + E V + +L++ N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
Y+ L E+ GS D+L K L + + GA +GL YLH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIAAVTHGALQGLAYLHS 172
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+IHR++K+ N+LL + + K+ DF ++ A +GT + APE +
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVIL 223
Query: 249 TGQMS---SKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSEDK------ 298
K DV+S G+ +EL + P+ + + +P L
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 283
Query: 299 --VKQC 302
V C
Sbjct: 284 NFVDSC 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 41/221 (18%), Positives = 78/221 (35%), Gaps = 27/221 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL-KNENVVELV 127
IG G +G V+ V G AIK+ Q L +V + L ++ +VV
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ + ++ E+ + GSL D + + L + + RGL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLLLQVGRGLRYIH 132
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA------------AARLHSTRV 235
++H +IK SN+ + I + + + R+ S +V
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 236 L-GTFGYHAPE-YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
G + A E K+D+++ + ++
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 44/248 (17%), Positives = 85/248 (34%), Gaps = 40/248 (16%)
Query: 53 VPVISVD-ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAA------AIKKLDSSKQPD 105
+P I E + + + L+GEG++ +VY A +K +
Sbjct: 51 LPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-- 108
Query: 106 QEFLAQVSMVSRLKNE---NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK 162
EF ++ RLK ++ ++ VL E S G+L + ++ K
Sbjct: 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK----NT 164
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---------- 212
P V+ + A+ +E +H+ IIH +IK N +L + +
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 213 -KISDF----DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS-KSDVYSFGVVLL 266
+ D D+ T T G+ E ++ + + + D + +
Sbjct: 222 LALIDLGQSIDMKLFPKGTIF----TAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVY 276
Query: 267 ELLTGRKP 274
+L G
Sbjct: 277 CMLFGTYM 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 34/227 (14%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKN-ENVVELVGY 129
++ EG + VY + SGR A+K+L S+++ + Q V + +L N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 130 YVDGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
G L KG L + L K + LS +KI R
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL------KKMESRGPLSCDTVLKIFYQTCRA 148
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------DLSNQAPDAAARLHS 232
++++H + +P IIHR++K N+LL + K+ DF D S A A
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 233 TRVLGTFGYHAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKP 274
T Y PE + S K D+++ G +L L + P
Sbjct: 208 ITRNTTPMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 50/234 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVV 124
+G G++G+V + A+K L + + ++++ ++S L N N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 125 ELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVK 174
L+G + GP V+ E+ G L + L K+ L +
Sbjct: 91 NLLGACTIGGPTLVIT-EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A+G+ +L K IHR++ + N+LL I KI DF L+ R
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-------------R 193
Query: 235 VLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ + APE + +SDV+S+G+ L EL + G P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 30/239 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNEN 122
+ + ++G+G+ V+ G + +G AIK ++ +P + + ++ +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 123 VVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + R VL E GSL+ +L G L + V
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV------V 122
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARLHSTRVL 236
G+ +L E I+HRNIK N++ + K++DF + + D + S +
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LY 176
Query: 237 GTFGYHAPE--------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 286
GT Y P+ + + D++S GV TG P PR + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-24
Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 53/244 (21%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-----------------QPDQEFLAQVSM 114
IG+GSYG V A+K L K +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 115 VSRLKNE----------NVVELVGYYV-DGPLRVLAY---EHASKGSLHDILHGKKGVKG 160
+ ++ E NVV+L V D P Y E ++G + ++ K
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
LS Q +G+EYLH + +IIHR+IK SN+L+ +D KI+DF +S
Sbjct: 134 ------LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS---SKSDVYSFGVVLLELLTGRKP-VD 276
N+ + A L +T GT + APE + DV++ GV L + G+ P +D
Sbjct: 185 NEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 277 HTLP 280
+
Sbjct: 243 ERIM 246
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 54/239 (22%), Positives = 104/239 (43%), Gaps = 55/239 (23%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVV 124
+G G++G+V A+K L + + ++++ M+++L +EN+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 125 ELVGY-YVDGPLRVLAYEHASKGSLHDIL--------------HGKKGVKGAKPGPVLSW 169
L+G + GP+ ++ E+ G L + L +K ++ + VL++
Sbjct: 113 NLLGACTLSGPIYLIF-EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
+ A A+G+E+L K +HR++ + NVL+ + KI DF L+
Sbjct: 172 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA--------- 219
Query: 230 LHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
R + + + APE G + KSDV+S+G++L E+ + G P
Sbjct: 220 ----RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 4e-22
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ R+ + VG +V Y + K +L D ++ + ++ + G L
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------DLSN 221
+IA +E+LH K ++HR++K SN+ DD+ K+ DF +
Sbjct: 172 --QIA----EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271
A T +GT Y +PE S K D++S G++L ELL
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SGRAA 93
P M + P ++ T F ++G+GS+G V + +G+
Sbjct: 2 PGSMMDHLHATPGMF-------VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC 54
Query: 94 AIKKLD----SSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149
A+K + K + L +V ++ +L + N+++L ++ D L E + G L
Sbjct: 55 AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 150 D--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207
D I + A A+ ++ + + Y+H+ +I+HR++K N+LL
Sbjct: 115 DEIISRKRFSEVDA--------ARIIRQVLSG---ITYMHKN---KIVHRDLKPENLLLE 160
Query: 208 DDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 264
+I DF LS + +GT Y APE + G K DV+S GV+
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216
Query: 265 LLELLTGRKP 274
L LL+G P
Sbjct: 217 LYILLSGCPP 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 61 LKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SGRAAAIK---KLDSSKQPDQEFLAQV 112
+ K + +G G+YG V + + AIK K S + + L +V
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWA 170
+++ L + N+++L ++ D L E G L D I K A A
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA--------A 139
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAA 227
+K + + YLH+ I+HR++K N+LL + + KI DF LS +
Sbjct: 140 VIIKQVLSG---VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
LGT Y APE + + K DV+S GV+L LL G P
Sbjct: 194 KM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEG+YG V V + A A+K +D + D + + + L +ENVV+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
+G ++ L E+ S G L D + + + A+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLMA 116
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 240
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE + + DV+S G+VL +L G P D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-19
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 57/233 (24%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
L+GEGSYG+V + + A+K L K + + +K E
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKK-----LRRIPNGEANVKKEIQLLRRLRHK 66
Query: 122 NVVELVG-YYVDGPLRV-LAYEHASKGS--LHD-ILHGKKGVKGAKPGPVLSWAQRVKIA 176
NV++LV Y + ++ + E+ G + D + +
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-------------------FP 107
Query: 177 VGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
V A GLEYLH + I+H++IK N+LL KIS ++ AA
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 229 --RLHSTRVLGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDH 277
+++ G+ + PE A K D++S GV L + TG P +
Sbjct: 165 DDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEG+YG V V + A A+K +D + D + + + L +ENVV+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
+G ++ L E+ S G L D + + + A+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLMA 116
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 240
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE + + DV+S G+VL +L G P D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 64/263 (24%), Positives = 105/263 (39%), Gaps = 44/263 (16%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SG 90
+ + + Q IA+ +++K G + +G G+YG V +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 91 RAAAIKKLDSSK-------------QPDQEFLAQ-VSMVSRLKNENVVELVGYYVDGPLR 136
AIK + S+ + E + +S++ L + N+++L + D
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 137 VLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194
L E G L + I K A A +K + + YLH+ I
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDA--------ANIMKQILSG---ICYLHKH---NI 167
Query: 195 IHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+HR+IK N+LL + + KI DF LS+ +L LGT Y APE + +
Sbjct: 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRD--RLGTAYYIAPE-VLKKK 223
Query: 252 MSSKSDVYSFGVVLLELLTGRKP 274
+ K DV+S GV++ LL G P
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPP 246
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 63/231 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G G++G+V G +G A+K L+ K + + +V ++K E
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQK------IRSLDVVGKIKREIQNLKLFRHP 71
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + E+ S G L D + + ++
Sbjct: 72 HIIKL--YQVISTPTDFFMVMEYVSGGELFDYI-----------------CKHGRVEEME 112
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
AR ++Y H ++HR++K NVLL AKI+DF LSN D L
Sbjct: 113 ARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR 168
Query: 232 STRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
++ G+ Y APE YA + D++S GV+L LL G P D
Sbjct: 169 TS--CGSPNYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLPFD 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 7e-18
Identities = 59/245 (24%), Positives = 80/245 (32%), Gaps = 47/245 (19%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK-----KLDSSKQPDQEFLAQ-VSMVSRLKNENVVEL 126
IG+GSYG V + + AIK K+ D E + V ++ +L + N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG-------- 178
Y D L E G L D L+ K + Q
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 179 ----------------AAR-------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--K 213
+ L YLH + I HR+IK N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 214 ISDFDLSN--QAPDAAARLHSTRVLGTFGYHAPE--YAMTGQMSSKSDVYSFGVVLLELL 269
+ DF LS + T GT + APE K D +S GV+L LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 270 TGRKP 274
G P
Sbjct: 271 MGAVP 275
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 27/208 (12%), Positives = 50/208 (24%), Gaps = 48/208 (23%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS----MVSRLKNENVVEL 126
G + + + R A+ +D + L + +SR+ V +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ ++ E GSL ++ P P ++ A +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSP----VGAIRAMQSLAAAADAA 145
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
H + S V + D L
Sbjct: 146 HRAG---VALSIDHPSRVRVSIDGDVV----------------------LAYPATMPDA- 179
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + D+ G L LL R P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWP 201
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+GS+G V R + + A+K ++ + D + + V ++ +L + N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 130 YVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
D + E + G L D I + A A+ +K + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFSG---ITYMH 138
Query: 188 EKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ I+HR++K N+LL + KI DF LS ++ +GT Y AP
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKD--RIGTAYYIAP 192
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E + G K DV+S GV+L LL+G P
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
IG+G++ +V + +GR AIK +D ++ + L + V ++ L + N+V+L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 130 YV-DGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
V + + L E+AS G + D L HG+ + + ++Y
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGR-----------MKEKEARSKFRQIVSAVQY 129
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
H+K RI+HR++K+ N+LL D KI+DF SN+ G Y APE
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYAAPE 183
Query: 246 ------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLP 280
Y + DV+S GV+L L++G P L
Sbjct: 184 LFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNEN 122
F ++G G++ V+ R G+ A+K + S L ++++ ++K+EN
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVG 178
+V L Y L + S G L D IL ++GV K A + ++ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDA--------SLVIQQVLS 117
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRV 235
A ++YLHE I+HR++K N+L ++ I+DF LS + +
Sbjct: 118 A---VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STA 167
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY APE S D +S GV+ LL G P
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 38/221 (17%)
Query: 74 IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + + A+K+++ + +++++ LK+ NV+ L +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKVF 87
Query: 131 VDGPLR--VLAYEHASKGSLHD---ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ R L +++A HD I+ + K K L + G+ Y
Sbjct: 88 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARL---------HS 232
LH ++HR++K +N+L+ + KI+D ARL
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLFNSPLKPLADL 192
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
V+ TF Y APE + + +K+ D+++ G + ELLT
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 18/207 (8%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVGYY 130
+G G++G V+ R SG IK ++ + A++ ++ L + N++++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
D + E G L + + + LS ++ L Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 191 EPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
++H+++K N+L D KI DF L+ + GT Y APE
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA-GTALYMAPE-V 197
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKP 274
++ K D++S GVV+ LLTG P
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 63/231 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G G++G+V G +G A+K L+ K + + +V +++ E
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQK------IRSLDVVGKIRREIQNLKLFRHP 76
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + + E+ S G L D + + ++
Sbjct: 77 HIIKL--YQVISTPSDIFMVMEYVSGGELFDYI-----------------CKNGRLDEKE 117
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
+R G++Y H ++HR++K NVLL AKI+DF LSN D L
Sbjct: 118 SRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR 173
Query: 232 STRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
++ G+ Y APE YA + D++S GV+L LL G P D
Sbjct: 174 TS--CGSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGTLPFD 217
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 45/223 (20%), Positives = 79/223 (35%), Gaps = 39/223 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
L+G G +G VY G+ + AIK ++ + D ++ +R+ E
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW---GELPNGTRVPMEVVLLKKVSSG 106
Query: 122 --NVVELVGYYVDGPLRVLAYEHAS-KGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIA 176
V+ L+ ++ VL E L D G L
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-----------LQEELARSFF 155
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQAPDAAARLHSTRV 235
+ + H ++HR+IK N+L+ + K+ DF D
Sbjct: 156 WQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF-- 208
Query: 236 LGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDH 277
GT Y PE+ + + V+S G++L +++ G P +H
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 51/224 (22%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG G++G + A+K ++ D+ ++ L++ N+V V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF--KEV 84
Query: 132 -DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
P + + E+AS G L++ + + + AR
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI-----------------CNAGRFSEDEARFFFQQLLS 127
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGT 238
G+ Y H +I HR++K N LL D A KI DF S + + + ST +GT
Sbjct: 128 GVSYCHSM---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS-QPKST--VGT 180
Query: 239 FGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE Y +DV+S GV L +L G P +
Sbjct: 181 PAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 25/208 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG GS+G V V + + A KK+ D + Q + ++ L + N++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 132 DGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
D L E + G L + + A A+ +K + A + Y H+
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLSA---VAYCHKL 125
Query: 190 AEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
+ HR++K N L D K+ DF L+ + ++ T+V GT Y +P+
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKV-GTPYYVSPQ- 178
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ G + D +S GV++ LL G P
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 53/266 (19%), Positives = 106/266 (39%), Gaps = 20/266 (7%)
Query: 14 KASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSL 73
K + G + + + P + D++ +
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEE 164
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
+G G++G V+ R+ G A K + + + D+E + + + +S L++ +V L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
D V+ YE S G L + + + +S + V+ +GL ++HE
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHEN-- 274
Query: 192 PRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPEYAM 248
+H ++K N++ + K+ DF L+ P + ++ GT + APE A
Sbjct: 275 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAPEVAE 329
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +D++S GV+ LL+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 35/222 (15%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR-----------LKN 120
L+G+G +G V+ G L AIK + ++ L+ +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGS-LHD--ILHGKKGVKGAKPGPVLSWAQRVKIAV 177
V+ L+ ++ +L E L D G G ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-----------CFFG 146
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVL 236
+++ H + ++HR+IK N+L+ AK+ DF D
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDF--D 199
Query: 237 GTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDH 277
GT Y PE+ Q + + V+S G++L +++ G P +
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 20/215 (9%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIK-----KLDSSKQPDQEFLAQ-VSMVSRLKNENVVEL 126
IG+G + V + R G+ A+K K SS E L + S+ LK+ ++VEL
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ Y + + +E L + VK A G V S A L Y
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
H+ IIHR++K VLL + + K+ F ++ Q ++ +GT + A
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278
PE DV+ GV+L LL+G P T
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 64/231 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+GEGS+G+V ++ + A+K + L + M R++ E
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQL------LKKSDMHMRVEREISYLKLLRHP 69
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + + E+A G L D + ++ ++
Sbjct: 70 HIIKL--YDVITTPTDIVMVIEYAG-GELFDYI-----------------VEKKRMTEDE 109
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
R +EY H +I+HR++K N+LL D+ KI+DF LSN D L
Sbjct: 110 GRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLK 165
Query: 232 STRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
++ G+ Y APE YA + DV+S G+VL +L GR P D
Sbjct: 166 TS--CGSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 50/220 (22%), Positives = 81/220 (36%), Gaps = 38/220 (17%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------N 122
+G G+ G V R + AI+ + K + ++ E
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS-AREADPALNVETEIEILKKLNHPC 201
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
++++ ++ D + E G L D + + + K
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-----------LYFYQML 249
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLG 237
++YLHE IIHR++K NVLL + + KI+DF S + + L T G
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 303
Query: 238 TFGYHAPE---YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T Y APE T + D +S GV+L L+G P
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 66/265 (24%), Positives = 108/265 (40%), Gaps = 35/265 (13%)
Query: 24 NNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEK-----TDNFGTNSLIGEGS 78
++ +G G + T + P ++ + +D F S +G G+
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGA 65
Query: 79 YGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYVDGPLR 136
VY + + A+K L K D++ + + ++ RL + N+++L +
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 137 VLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
L E + G L D I+ +KG + A A VK + A + YLHE
Sbjct: 124 SLVLELVTGGELFDRIV--EKGYYSERDA--------ADAVKQILEA---VAYLHEN--- 167
Query: 193 RIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
I+HR++K N+L D KI+DF LS L T GT GY APE
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVC-GTPGYCAPEILRG 224
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
+ D++S G++ LL G +P
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 38/223 (17%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKN-ENVVELVGY 129
++GEG++ RV + + + A+K ++ + + + V M+ + + NV+EL+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 130 YVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ + L +E GS+ I K+ A + V+ A L++
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEA--------SVVVQDVASA---LDF 126
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLS------NQAPDAAARLHSTRVL 236
LH K I HR++K N+L + KI DFDL + T
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC- 182
Query: 237 GTFGYHAPEYAMTGQMSSKS-----DVYSFGVVLLELLTGRKP 274
G+ Y APE + D++S GV+L LL+G P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-16
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 41/234 (17%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIK-----KLDSSKQPDQEFLAQV--- 112
E + + T S +G G++G V+ V + +K K+ + L +V
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 113 -SMVSRLKNENVVELVGYYVDGPLRVLAYE-HASKGSLHD--ILHGKKGVKGAKPGPVLS 168
+++SR+++ N+++++ + + L E H S L H + L
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-----------LD 128
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
I + YL K IIHR+IK N+++ +D K+ DF +
Sbjct: 129 EPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--G 183
Query: 229 RLHSTRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+L T GT Y APE Y + +++S GV L L+ P
Sbjct: 184 KLFYTFC-GTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFC 231
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 47/224 (20%), Positives = 77/224 (34%), Gaps = 37/224 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------- 121
+G G V + + + A+K +D + + E
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
N+++L Y L ++ KG L D K + ++ +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--------RKIMRALLEV 136
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ LH+ I+HR++K N+LL DD K++DF S Q GT
Sbjct: 137 ---ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVC-GTP 187
Query: 240 GYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
Y APE + D++S GV++ LL G P H
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNEN 122
D + +G G++G V+ V ++ GR K +++ D+ + +S++++L +
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
++ L + D VL E S G L D + + +S A+ + A G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQACEG 161
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQA-PDAAARLHSTRVLGTF 239
L+++HE I+H +IK N++ + KI DF L+ + PD ++ T
Sbjct: 162 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV----TTATA 214
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE + +D+++ GV+ LL+G P
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKN 120
+ + ++G+GS+G V R + A+K ++ + D + + V ++ +L +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N+++L D + E + G L D I + A A+ +K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFS 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRV 235
+ Y+H+ I+HR++K N+LL + KI DF LS R+
Sbjct: 133 G---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI 184
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y APE + G K DV+S GV+L LL+G P
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 57/281 (20%), Positives = 109/281 (38%), Gaps = 29/281 (10%)
Query: 7 CEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE-LKEKT 65
++ + S++G N +K + V A P + K
Sbjct: 23 SMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQ 82
Query: 66 DNF------GTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSR 117
++G G +G+V+ + G A K + + D+E + +S++++
Sbjct: 83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIA 176
L + N+++L + VL E+ G L D I+ + L+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYN-------LTELDTILFM 193
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHST 233
G+ ++H+ I+H ++K N+L D KI DF L+ + P ++
Sbjct: 194 KQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--- 247
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT + APE +S +D++S GV+ LL+G P
Sbjct: 248 -NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQPDQEF----LAQVSMVSRLKN---ENV 123
IG G+YG VY SG A+K + + + +V+++ RL+ NV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 124 VEL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L D ++V L +EH D+ + P P L +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAETIKDLMRQ 128
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----T 233
RGL++LH I+HR++K N+L+ K++DF L AR++S T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMALT 177
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y APE + ++ D++S G + E+ +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNE- 121
++F + +IG G +G VY +G+ A+K LD K E LA NE
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--------LNER 240
Query: 122 NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAVGA 179
++ LV D P V ++Y + L IL G G + + +
Sbjct: 241 IMLSLVST-GDCPFIVCMSYAFHTPDKLSFILDLMNG------GDLHYHLSQHGVFSEAD 293
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
R GLE++H + +++R++K +N+LL + +ISD L+
Sbjct: 294 MRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-- 348
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
V GT GY APE G S D +S G +L +LL G P
Sbjct: 349 -ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
+GEGS+ V + S +A A+K + + + + +++ + + N+V+L +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76
Query: 132 DGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
D L E + G L + I KK A + ++ V A + ++H
Sbjct: 77 DQLHTFLVMELLNGGELFERIK--KKKHFSETEA--------SYIMRKLVSA---VSHMH 123
Query: 188 EKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ ++HR++K N+L D++ KI DF + P L + T Y AP
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E D++S GV+L +L+G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 46/212 (21%), Positives = 86/212 (40%), Gaps = 29/212 (13%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V G+ A +++ K D + L + + LK+ N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 130 YVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ L ++ + G L + I+ + A + ++ + A + +
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADA--------SHCIQQILEA---VLH 125
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
H+ ++HRN+K N+LL K++DF L+ + GT GY
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE D+++ GV+L LL G P
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 41/261 (15%)
Query: 31 GGFYVKEAPAKEMKTVTVQP----IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV 86
G F + AP +K + I V +++ + +IG GS+G V+
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 87 LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY-YVDGPLRV-----LAY 140
L AIKK+ Q + ++ ++ +K+ NVV+L + Y +G + L
Sbjct: 61 LVESDEVAIKKV---LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKAEPRII 195
E+ + +++ +K P +K + R L Y+H I
Sbjct: 118 EYVPE-TVYRASRHYAKLKQTMP------MLLIKLYMYQLL----RSLAYIHSI---GIC 163
Query: 196 HRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQM 252
HR+IK N+LL + K+ DF + + +R Y APE
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATN 218
Query: 253 SSKS-DVYSFGVVLLELLTGR 272
+ + D++S G V+ EL+ G+
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQ 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 38/232 (16%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
K D + + +G G+ G V R + AIK + K + ++
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGS-AREADPALNVET 64
Query: 121 E----------NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLS 168
E ++++ ++ D + E G L D + + +
Sbjct: 65 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC------- 116
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPD 225
+ A ++YLHE IIHR++K NVLL + + KI+DF S +
Sbjct: 117 -KLYFYQMLLA---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 226 AAARLHSTRVLGTFGYHAPE---YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L T GT Y APE T + D +S GV+L L+G P
Sbjct: 170 --TSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 56/288 (19%), Positives = 98/288 (34%), Gaps = 46/288 (15%)
Query: 13 RKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN- 71
R+A + + N K A+ T + ++ F
Sbjct: 37 RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKY 96
Query: 72 ---SLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE------ 121
+IG G V V R+ G A+K ++ + + + + + E
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE-EVREATRRETHILRQ 155
Query: 122 -----NVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQR 172
+++ L+ Y L ++ KG L D + +K K
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT--EKVALSEKET--------RSI 205
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
++ + A + +LH I+HR++K N+LL D+ ++SDF S
Sbjct: 206 MRSLLEA---VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLR 257
Query: 233 TRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY APE + D+++ GV+L LL G P
Sbjct: 258 ELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 62/259 (23%), Positives = 103/259 (39%), Gaps = 43/259 (16%)
Query: 43 MKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLRS-GRAAAIKK 97
M+TV V I +L + F IG GSY + ++ A+K
Sbjct: 1 MQTVGVHSIVQ------QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI 54
Query: 98 LDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGK 155
+D SK+ E ++ ++ R N++ L Y DG + E G L D IL +
Sbjct: 55 IDKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--R 109
Query: 156 KGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-- 210
+ + A + + +EYLH + ++HR++K SN+L D+
Sbjct: 110 QKFFSEREA--------SAVLFTITKT---VEYLHAQ---GVVHRDLKPSNILYVDESGN 155
Query: 211 --IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLE 267
+I DF + Q L T T + APE + Q + D++S GV+L
Sbjct: 156 PESIRICDFGFAKQLRAENGLLM-TPC-YTANFVAPE-VLERQGYDAACDIWSLGVLLYT 212
Query: 268 LLTGRKPVDHTLPRGQQSL 286
+LTG P + + +
Sbjct: 213 MLTGYTPFANGPDDTPEEI 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 50/239 (20%), Positives = 89/239 (37%), Gaps = 44/239 (18%)
Query: 56 ISVDELKEKTDNFG-----TNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFL 109
+ + K + ++G G G+V R G+ A+K L S + QE
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE-- 71
Query: 110 AQVSMVSRLKN-ENVVELVGYYVDGPLRVLAY----EHASKGSLHD-ILHGKKGVKG--- 160
V + ++V ++ Y + E G L I ++G +
Sbjct: 72 --VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTE 127
Query: 161 --AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKIS 215
A A+ ++ A +++LH I HR++K N+L + + K++
Sbjct: 128 REA--------AEIMRDIGTA---IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
DF + + A + T T Y APE + D++S GV++ LL G P
Sbjct: 174 DFGFAKETTQNALQ---TPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 53/224 (23%), Positives = 103/224 (45%), Gaps = 47/224 (20%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLA--QVSMVSRLKNENVVEL 126
IG+G++G V+ ++G+ A+KK +++ K+ P A ++ ++ LK+ENVV L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNL 81
Query: 127 VGYYVDGPLRVLAYEHASKGSL--------HDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ + KGS+ HD+ G+ + ++ ++
Sbjct: 82 IEICRTKASP----YNRCKGSIYLVFDFCEHDL----AGLLSNVLVK-FTLSEIKRVMQM 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRV 235
GL Y+H +I+HR++K++NVL+ D + K++DF L+ + A ++ ++ RV
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 236 LGTFGYHAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ T Y PE Y D++ G ++ E+ T
Sbjct: 190 V-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V ++ G A K +++ K D + L + + +L++ N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 130 YVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ L ++ + G L + + A + ++ + + + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--------SHCIQQILES---IAYCH 145
Query: 188 EKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
I+HRN+K N+LL K++DF L+ + D + GT GY +P
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFA-GTPGYLSP 199
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E S D+++ GV+L LL G P
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 41/205 (20%), Positives = 83/205 (40%), Gaps = 19/205 (9%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G G +G V+ V S + K + ++S+++ ++ N++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
V+ +E S + + ++ L+ + V L++LH
Sbjct: 73 MEELVMIFEFISGLDIFERINTS--------AFELNEREIVSYVHQVCEALQFLHSH--- 121
Query: 193 RIIHRNIKSSNVLLFDDDIA--KISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPEYAMT 249
I H +I+ N++ + KI +F + Q P RL + Y+APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LFTAPEYYAPEVHQH 177
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
+S+ +D++S G ++ LL+G P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 8e-14
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 4/113 (3%)
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
L+ + + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ + APE + +SDV+SFGV+L E+ + G P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 8e-14
Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V ++ G A K +++ K D + L + + +L++ N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 130 YVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ L ++ + G L + I+ + A + ++ + + + Y
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADA--------SHCIQQILES---IAY 120
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
H I+HRN+K N+LL K++DF L+ + D + GT GY
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFA-GTPGYL 174
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE S D+++ GV+L LL G P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 65/274 (23%), Positives = 109/274 (39%), Gaps = 62/274 (22%)
Query: 24 NNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVY 83
P+ ++ ++ TV P P + + ++ +IG GS+G VY
Sbjct: 18 QQPSAFGSMKVSRDKDGSKVTTVVATPGQGP------DRPQEVSYTDTKVIGNGSFGVVY 71
Query: 84 FGVLR-SGRAAAIKKLDSSKQPDQEF-LAQVSMVSRLKNENVVELVGY-YVDGPLRV--- 137
L SG AIKK+ D+ F ++ ++ +L + N+V L + Y G +
Sbjct: 72 QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 138 --LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKA 190
L ++ + +++ + + + + PV+ VK + R L Y+H
Sbjct: 128 LNLVLDYVPE-TVYRVA--RHYSRAKQTLPVI----YVKLYMYQLF----RSLAYIHSF- 175
Query: 191 EPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHS----------TRVLGTF 239
I HR+IK N+LL D + K+ DF A+ +R
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRGEPNVSYICSRY---- 221
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + S DV+S G VL ELL G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGY 129
+GEG+YG VY GR A+K+ LD+ + P + ++S++ L + N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L +E D+ K V L +Q RG+ + H+
Sbjct: 88 IHSERCLTLVFEFME----KDL----KKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQH 138
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRVLGTFGYHAPEYA 247
RI+HR++K N+L+ D K++DF L+ P R ++ V+ T Y AP+
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---RSYTHEVV-TLWYRAPDVL 191
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGR 272
M + S S D++S G + E++TG+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG VY G A+KK L+ + P + ++S++ LK+ N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
VL +EH D+ K + G L + G+ Y H++
Sbjct: 69 IHTKKRLVLVFEHLD----QDL----KKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHSTRVLGTFGYHAPEYA 247
R++HR++K N+L+ + KI+DF L+ P R ++ ++ T Y AP+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIV-TLWYRAPDVL 172
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGR 272
M + S + D++S G + E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 51/222 (22%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG V+ + A+K+ LD + P L ++ ++ LK++N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKHKNIVRL-- 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG--AKPGPVLSWAQRVKI 175
HD+LH K + K L
Sbjct: 67 --------------------HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF 106
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHST 233
+GL + H + ++HR++K N+L+ + K+++F L+ P R +S
Sbjct: 107 LFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSA 160
Query: 234 RVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
V+ T Y P+ ++ S S D++S G + EL +P
Sbjct: 161 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 39/218 (17%)
Query: 74 IGEGSYGRVYFG--VLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKN---ENVV 124
IGEG+YG+V+ + GR A+K+ + + ++ P + +V+++ L+ NVV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 77
Query: 125 EL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
L D ++ L +EH D+ P P + +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTETIKDMMFQL 129
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TR 234
RGL++LH R++HR++K N+L+ K++DF L AR++S T
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTS 178
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y APE + ++ D++S G + E+ +
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 27/213 (12%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V +S G A K + + + R + + N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L Y + VL E S G L D L K+ LS + G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LH K +I H ++K N++L D +I K+ DF L+++ D + GT +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + ++D++S GV+ LL+G P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 31/224 (13%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR------ 117
D + T +G G + V +S G A K + + + R
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 118 -LKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 174
+++ NV+ L Y + +L E + G L D + A + +K
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA--------TEFLK 121
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARL 230
+ + YLH +I H ++K N++L D ++ KI DF L+++ D
Sbjct: 122 QILNG---VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF 174
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ GT + APE + ++D++S GV+ LL+G P
Sbjct: 175 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-NV 123
D F ++G G +G V+ ++ +G+ A KKL+ ++ L + E +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN------KKRLKKRKGYQGAMVEKKI 238
Query: 124 VELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKG-------VKGAKPGPVLSWAQRVKI 175
+ V V LAY +K L ++ G + P + +
Sbjct: 239 LAKV----HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
GLE+LH++ II+R++K NVLL DD +ISD L+ + +
Sbjct: 295 TAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYA 350
Query: 236 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
GT G+ APE + G+ S D ++ GV L E++ R P
Sbjct: 351 -GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 37/219 (16%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------DQEFLAQ-----VSMVSRLKNE 121
I GSYG V GV G AIK++ ++ FL + + +++ +
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 122 NVVELVGYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
N++ L + L E L ++H ++ V+S
Sbjct: 90 NILGL--RDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--------IVISPQHIQY 138
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
GL LHE ++HR++ N+LL D++ I DF+L+ + A + T
Sbjct: 139 FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTH 192
Query: 235 VLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ Y APE M + +K D++S G V+ E+ +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 41/224 (18%), Positives = 83/224 (37%), Gaps = 38/224 (16%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN- 120
D++ +G G Y V+ + + + +K L K ++ ++ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGG 90
Query: 121 ENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L D R A EH + + L+
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYE 138
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHST---- 233
+ L+Y H I+HR++K NV++ + ++ D+ L A +
Sbjct: 139 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL--------AEFYHPGQEY 187
Query: 234 --RVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
RV + + PE + QM S D++S G +L ++ ++P
Sbjct: 188 NVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 52/236 (22%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQPDQEF----LAQV 112
++K + + +GEG + VY + + AIKK L + L ++
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG- 160
++ L + N++ L D K + +
Sbjct: 64 KLLQELSHPNIIGL----------------------LDAFGHKSNISLVFDFMETDLEVI 101
Query: 161 -AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
VL+ + + +GLEYLH+ I+HR++K +N+LL ++ + K++DF L
Sbjct: 102 IKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158
Query: 220 SNQ--APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ +P+ R ++ +V+ T Y APE +M D+++ G +L ELL
Sbjct: 159 AKSFGSPN---RAYTHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 60/280 (21%), Positives = 100/280 (35%), Gaps = 41/280 (14%)
Query: 13 RKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDN---FG 69
+ S PF P P + PA+ Q V S ++K+
Sbjct: 6 QGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV 65
Query: 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELV 127
T+ ++G G G+V + + A+K L + +E V + R ++V +V
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIV 121
Query: 128 GYYVDGPLRVLAY----EHASKGSLHD-ILHGKKGVKG-----AKPGPVLSWAQRVKIAV 177
Y + E G L I +G + A ++ +K
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREA--------SEIMKSIG 171
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTR 234
A ++YLH I HR++K N+L I K++DF + + +T
Sbjct: 172 EA---IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTP 223
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T Y APE + D++S GV++ LL G P
Sbjct: 224 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 2e-12
Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V + G+ A K + + + R +++ N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAAR 181
L + + VL E S G L D + +K A Q +K +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLA--EKESLTEDEA--------TQFLKQILD--- 119
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHSTRVLG 237
G+ YLH K RI H ++K N++L D ++ K+ DF ++++ +A + + G
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKN--IFG 173
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T + APE + ++D++S GV+ LL+G P
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-NV 123
+ F ++G+G +G V +R +G+ A KKL+ ++ + + + NE +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE------KKRIKKRKGEAMALNEKQI 237
Query: 124 VELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GA 179
+E V + V LAY + +K +L +L G G + + A
Sbjct: 238 LEKV----NSRFVVSLAYAYETKDALCLVLTLMNG------GDLKFHIYHMGQAGFPEAR 287
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
A GLE LH + RI++R++K N+LL D +ISD L+ P+ +
Sbjct: 288 AVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTI 342
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
RV GT GY APE + + + S D ++ G +L E++ G+ P
Sbjct: 343 KGRV-GTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 45/237 (18%), Positives = 83/237 (35%), Gaps = 50/237 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEF-LAQVSMVSRLKNENVVELVGYYV 131
+G GS+G V SG+ A+KK+ D + ++ ++ L + N+++LV Y+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWA----------------QRVKI 175
K V + +K
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 176 AVGAA----------------RGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFD 218
+ + R + ++H I HR+IK N+L+ D+ K+ DF
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 219 LSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ + + + +R Y APE + + S D++S G V EL+ G+
Sbjct: 188 SAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE------FLAQVSMVSRLKNENVVEL 126
+G G+Y VY G+ +G A+K++ + D E + ++S++ LK+EN+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 127 VGYYVDGPLRVLAYEHASK--GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L +E D +G + V + ++ +GL
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL------LQGLA 122
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ HE +I+HR++K N+L+ K+ DF L+ +A S+ V+ T Y AP
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSSEVV-TLWYRAP 177
Query: 245 E-------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ Y S+ D++S G +L E++TG+
Sbjct: 178 DVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V +S G A K + + + R + + NV+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L Y + VL E S G L D L K+ LS + G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQ-APDAAARLHSTRVLGTFG 240
LH K +I H ++K N++L D +I K+ DF L+++ + + GT
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGTPE 183
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE + ++D++S GV+ LL+G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 44/224 (19%)
Query: 66 DNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKK--LDSSKQPDQEFLAQVSMVSRLKNEN 122
+ + +GEG+Y VY G + A+K+ L+ + + +VS++ LK+ N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG--AKPGPVLSW 169
+V L HDI+H +K + K G +++
Sbjct: 62 IVTL----------------------HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINM 99
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
RGL Y H + +++HR++K N+L+ + K++DF L+ +A +
Sbjct: 100 HNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTK 155
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ V+ T Y P+ + S D++ G + E+ TGR
Sbjct: 156 TYDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLK-NENVVELVG 128
+G G + V + +S G+ A K L + Q + + ++++ K V+ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 129 YYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----GL 183
Y + +L E+A+ G + L + ++S + + G+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCL--------PELAEMVS----ENDVIRLIKQILEGV 144
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFG 240
YLH+ I+H ++K N+LL KI DF +S + A L ++GT
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELRE--IMGTPE 198
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE +++ +D+++ G++ LLT P
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 51/252 (20%), Positives = 94/252 (37%), Gaps = 42/252 (16%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK 97
P M +++ D F + G+G++G V G + +G + AIKK
Sbjct: 2 PGSMMSLNAAAAADERS------RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK 55
Query: 98 LDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR--------VLAYEHASKGSLH 149
+ + L + ++ L + N+V+L Y + E+ +LH
Sbjct: 56 VIQDPRFRNRELQIMQDLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLH 113
Query: 150 DILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204
+ A P +K + R + LH + + HR+IK NV
Sbjct: 114 RCCRNYYRRQVAPP------PILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNV 162
Query: 205 LLFDDD-IAKISDFDLSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQMSSKS-DVYS 260
L+ + D K+ DF + + + + +R Y APE Q + + D++S
Sbjct: 163 LVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWS 217
Query: 261 FGVVLLELLTGR 272
G + E++ G
Sbjct: 218 VGCIFAEMMLGE 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YL + RIIHR++K N+LL + I+DF+++ P +T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180
Query: 242 HAPE--YAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + G S + D +S GV ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 45/232 (19%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD-----SSKQPDQEFLAQVSMV 115
K++ ++F ++GEGS+ V + R AIK L+ + + ++
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVM 84
Query: 116 SRLKNENVVELVGYYVDGPLR---VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
SRL + V+L + D + L+Y K G +L + ++
Sbjct: 85 SRLDHPFFVKLYFTFQD-DEKLYFGLSY-----------------AKN---GELLKYIRK 123
Query: 173 V-KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223
+ R LEYLH K IIHR++K N+LL +D +I+DF +
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 180
Query: 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
+ + + +GT Y +PE +T + + KS D+++ G ++ +L+ G P
Sbjct: 181 SPESKQARANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 47/219 (21%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVGYYV 131
+G G G V+ V + AIKK+ + + L ++ ++ RL ++N+V++ + +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--FEI 76
Query: 132 DGPLRVLAYEHASKGS---------------LHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
GP + + L ++L L
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----------LLEEHARLFM 126
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLS-NQAPDAAARLHSTR 234
RGL+Y+H ++HR++K +N+ + +D + KI DF L+ P + + H +
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 235 VLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
L T Y +P ++ +K+ D+++ G + E+LTG+
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 1e-11
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVGY 129
IGEGSYG V+ +G+ AIKK S+ L ++ M+ +LK+ N+V L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 130 YVDGPLRVLAYEHASKGSLHDILHG-KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ L +E+ H +LH + +G V S + + + + H+
Sbjct: 71 FRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQT------LQAVNFCHK 120
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
IHR++K N+L+ + K+ DF + + + + V T Y +PE +
Sbjct: 121 H---NCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVA-TRWYRSPELLV 175
Query: 249 TGQMSSKS-DVYSFGVVLLELLTGR 272
DV++ G V ELL+G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V ++G A+KKL S+ A+ + ++ +K+ENV+ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGL- 93
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P R L H L++I+ +K L+ +
Sbjct: 94 -LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQIL 142
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +TR
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSR 117
+ + + L+GEGSYG V +GR AIKK S D+ + ++ ++ +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQ 80
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L++EN+V L+ L +E ++ D L G V + ++
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN--GLDYQVVQKYLFQI---- 133
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
G+ + H IIHR+IK N+L+ + K+ DF + + A ++ V
Sbjct: 134 --INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEVA- 186
Query: 238 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T Y APE + K+ DV++ G ++ E+ G
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG G+ G V R AIKKL S+ + A+ + ++ + ++N++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIGL- 89
Query: 128 GYYVDGPLRV--------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V P + + E +L ++ + L + +
Sbjct: 90 -LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQM 136
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
G+++LH IIHR++K SN+++ D KI DF L A A T + T
Sbjct: 137 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTR 190
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y APE + D++S G ++ E++ G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG G+ G V R AIKKL S+ + A+ + ++ + ++N++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISL- 126
Query: 128 GYYVDGPLRV--------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V P + L E +L ++ + L + +
Sbjct: 127 -LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQM 173
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
G+++LH IIHR++K SN+++ D KI DF L+ A + T + T
Sbjct: 174 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTR 227
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y APE + D++S G ++ E++ +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V V R+G AIKKL + E A+ + ++ +++ENV+ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHENVIGL- 89
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P L L ++ +K L + +
Sbjct: 90 -LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----------LGEDRIQFLVYQML 138
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL Y+H IIHR++K N+ + +D KI DF L+ QA TR
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ E++TG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 57/225 (25%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
+GEG+YG VY + + AIK+ L+ ++ P + +VS++ L++ N++EL
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA-IREVSLLKELQHRNIIEL-- 98
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV------------KGAKPGPVLSWAQRVKIA 176
++H + K P +S
Sbjct: 99 --------------------KSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL 138
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------KISDFDL--SNQAPDAAA 228
G+ + H + R +HR++K N LL A KI DF L + P
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQN-LLLSVSDASETPVLKIGDFGLARAFGIPI--- 191
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
R + ++ T Y PE + + S S D++S + E+L
Sbjct: 192 RQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V + RSG AIKKL S+ E A+ + ++ +++ENV+ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIGL- 88
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P L + L I+ K S + +
Sbjct: 89 -LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-----------FSEEKIQYLVYQML 136
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL+Y+H ++HR++K N+ + +D KI DF L+ A TR
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----- 188
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE ++ +++ D++S G ++ E+LTG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-DQEFLAQ-----VSMVSRLKNENVVEL 126
IGEG+YG V + AIKK+ P + + Q + ++ R ++EN++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS----PFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 127 VGYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ + + + L+ +L + LS
Sbjct: 91 --NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQI 137
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGT 238
RGL+Y+H A ++HR++K SN+LL KI DF L+ PD T + T
Sbjct: 138 LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + + +KS D++S G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 37/237 (15%)
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLA 110
+ + +L+ K +++ +IG G++G V ++R + + A+K L + +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFE------MI 108
Query: 111 QVSMVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
+ S + E + + + + P V L Y L+ ++ G G +++
Sbjct: 109 KRSDSAFFWEERDI-MA--FANSPWVVQLFYAFQDDRYLYMVMEYMPG------GDLVNL 159
Query: 170 AQRVKIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
+ AR L+ +H IHR++K N+LL K++DF
Sbjct: 160 MSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK----SDVYSFGVVLLELLTGRKP 274
+ T V GT Y +PE + D +S GV L E+L G P
Sbjct: 217 KMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 52/212 (24%), Positives = 81/212 (38%), Gaps = 25/212 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
IG GS+G +Y G + +G AIK + K + + + ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+G V+ E SL D L K S + +A +EY+H K
Sbjct: 76 EGDYNVMVMELLGP-SLED-LFNFCSRK-------FSLKTVLLLADQMISRIEYIHSK-- 124
Query: 192 PRIIHRNIKSSNVLLFDDDIAK---ISDFDLSNQAPDAAARLH-----STRVLGTFGYHA 243
IHR++K N L+ I DF L+ + DA H + + GT Y A
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 244 PEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
G + S + D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 49/237 (20%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVS 113
V +++ ++F +IG G++G V V++ + + A+K L +K + + +
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVA--VVKLKNADKVFAMKIL--NKW----EMLKRA 116
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ + E V LV D L Y +L+ ++ G G +L+ +
Sbjct: 117 ETACFREERDV-LV--NGDSKWITTLHYAFQDDNNLYLVMDYYVG------GDLLTLLSK 167
Query: 173 V--KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
++ AR ++ +H+ +HR+IK N+L+ + +++DF +
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-----DVYSFGVVLLELLTGRKP 274
+ S V GT Y +PE + D +S GV + E+L G P
Sbjct: 225 LMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH + +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + ++ D + GVV+ E++ GR P
Sbjct: 316 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 50/239 (20%), Positives = 95/239 (39%), Gaps = 38/239 (15%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVS 113
V+ + E++ + D+F +IG G++ V ++ +G+ A+K + +K + +
Sbjct: 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM--NKW----DMLKRG 103
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
VS + E V LV D L + + L+ ++ G G +L+ +
Sbjct: 104 EVSCFREERDV-LV--NGDRRWITQLHFAFQDENYLYLVMEYYVG------GDLLTLLSK 154
Query: 173 V--KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
+I AR ++ +H +HR+IK N+LL +++DF +
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY-------SFGVVLLELLTGRKP 274
A + S +GT Y +PE + Y + GV E+ G+ P
Sbjct: 212 L-RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 2e-09
Identities = 55/382 (14%), Positives = 110/382 (28%), Gaps = 111/382 (29%)
Query: 34 YVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGS-YGRVY--FGVLRSG 90
+V K+ VQ + ++S +E+ +I F L S
Sbjct: 29 FVDNFDCKD-----VQDMPKSILSKEEIDH---------IIMSKDAVSGTLRLFWTLLSK 74
Query: 91 RAAAIKK-LDSSKQPDQEFLAQ----------------VSMVSRLKNENVVELVGYYVDG 133
+ ++K ++ + + +FL + RL N+N V Y V
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV-FAKYNVSR 133
Query: 134 P-----LRVLAYEHASKGSLHDILHGKKG---------------VKGAKPGPVLSWAQRV 173
LR E ++ ++ G G V+ + W
Sbjct: 134 LQPYLKLRQALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-W---- 186
Query: 174 KIAVGAARG-------LEYLHEKAEPRIIHRNIKSSNV-LLFDDDIAKISDFDLSNQAPD 225
+ + L+ L + +P R+ SSN+ L A++ S +
Sbjct: 187 -LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 226 AAARL------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279
L + + F +T + +D L T +DH
Sbjct: 246 C---LLVLLNVQNAKAWNAFNLSCK-ILLTTRFKQVTD------FLSAATTTHISLDHH- 294
Query: 280 PRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIA----KMAAVAALC--------- 326
+L TP + + + +D + + P + + +++ +A
Sbjct: 295 ---SMTL----TPDEVKSLLLKYLDCRP-QDLPREVLTTNPRRLSIIAESIRDGLATWDN 346
Query: 327 -VQYEAD-FRPNMGIVLKALQP 346
D + L L+P
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEP 368
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 36/96 (37%), Positives = 58/96 (60%), Gaps = 11/96 (11%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTF 239
L++LH II+R++K N+LL D++ I K++DF LS ++ D + +S GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILL-DEEGHI-KLTDFGLSKESIDHEKKAYS--FCGTV 190
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + + ++S D +SFGV++ E+LTG P
Sbjct: 191 EYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 4e-09
Identities = 28/96 (29%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTF 239
L +LH+K II+R++K N++L + + K++DF L ++ H+ GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIML-NHQGHV-KLTDFGLCKESIHDGTVTHT--FCGTI 185
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + +++ D +S G ++ ++LTG P
Sbjct: 186 EYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + ++ D + GVV+ E++ GR P
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 12/101 (11%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
R ++ LH +IHR++K SN+L+ + K+ DF L+ ++AA +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 241 --------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE +T S++ DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 5e-09
Identities = 42/248 (16%), Positives = 76/248 (30%), Gaps = 54/248 (21%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---------DSSKQPDQEFLAQVSMV 115
T+ IGEG +G V+ + AIK + S ++ +E L ++ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 116 SRLKN---------ENVVELVGYY-VDGP-----LRVLAYEHASKGSLHDILHGKKGVKG 160
L E + L + V G L+ + +++KGS +D K +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 161 --------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206
+ S A I L R HR++ NVLL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLL 195
Query: 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP--EYAMTGQMSSKSDVYSFGVV 264
+ K+ + + + G +Y ++ V+ +
Sbjct: 196 KKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 265 LLELLTGR 272
+L TG
Sbjct: 245 DEDLFTGD 252
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 45/216 (20%), Positives = 75/216 (34%), Gaps = 59/216 (27%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV 131
+G G G+V + + A+K L + +E V + R + ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYE 81
Query: 132 DGPLRVLAY----EHASKGSLHD-ILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAAR 181
+ E G L I +G + A ++ +K A
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREA--------SEIMKSIGEA-- 129
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGT 238
++YLH I HR++K N+L I K++DF A + G
Sbjct: 130 -IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---------TTGE 173
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y D++S GV++ LL G P
Sbjct: 174 -KY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH+K II+R++K NVLL + K++DF + + + GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDY 190
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + + + D ++ GV+L E+L G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K I++R++K N+LL D KI+DF + + A+ ++ GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + GQ + S D +SFGV+L E+L G+ P
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLH I++R++K N+LL ++DF L + + + + GT Y
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEY 205
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + Q ++ D + G VL E+L G P
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL +L K II+R++K NV+L + KI+DF + + + GT Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 508
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 509 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 47/216 (21%), Positives = 79/216 (36%), Gaps = 31/216 (14%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK-LDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IGEGS+G ++ G L + + AIK S P + + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFGQ 76
Query: 132 DGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+G VL + SL D+L G+K S A ++ +HEK
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQSIHEK 125
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAK-----ISDFDLSNQAPDAAARLH-----STRVLGTF 239
+ +++R+IK N L+ + + DF + D + H + GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 240 GYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
Y G + S + D+ + G V + L G P
Sbjct: 183 RY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL +L K II+R++K NV+L + KI+DF + + + GT Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 48/249 (19%), Positives = 90/249 (36%), Gaps = 56/249 (22%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG GSYG V R AIKK+ + + + +++++RL +++VV++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKV- 117
Query: 128 GYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ P V + E A + + L+ +
Sbjct: 118 -LDIVIPKDVEKFDELYVVLEIADS-DFKKLF---------RTPVYLTELHIKTLLYNLL 166
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 237
G++Y+H I+HR++K +N L+ D K+ DF L+ + + ++L +
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 238 TFG----------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + + +++ DV+S G + ELL K
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 275 VDHTLPRGQ 283
Sbjct: 284 NVAYHADRG 292
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQA-PDAAARLHSTRVLGT 238
LE+LH+ II+R+IK N+LL D + + ++DF LS + D R + GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILL-DSNGHV-VLTDFGLSKEFVADETERAYD--FCGT 223
Query: 239 FGYHAPEYAMTGQMS-SKS-DVYSFGVVLLELLTGRKP 274
Y AP+ G K+ D +S GV++ ELLTG P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
IG GS+G +Y G +++ AIK ++ K + L + + L+ + + + V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+G VL + SL D L K LS + +A +E++H K+
Sbjct: 74 EGDYNVLVMDLLGP-SLED-LFNFCSRK-------LSLKTVLMLADQMINRVEFVHSKS- 123
Query: 192 PRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFGYHA 243
+HR+IK N L+ + I DF L+ + D + H + + GT Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 244 PEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
G + S + D+ S G VL+ L G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 47/279 (16%), Positives = 89/279 (31%), Gaps = 61/279 (21%)
Query: 35 VKEAPAKEMKTVT---VQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGR 91
VK A A + + AV I D + IG+G +G +Y + S
Sbjct: 4 VKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAA---WKVGLPIGQGGFGCIYLADMNSSE 60
Query: 92 AAAIK-----KLDSSKQPDQEF-------LAQVSMVSRLKNENVVELVG----------Y 129
+ K++ S A+ + + ++ +G
Sbjct: 61 SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 130 YVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
R + + L I + K+ S +++++ LEY+H
Sbjct: 121 KNGKSYRFMIMDRFGS-DLQKIYEANAKR----------FSRKTVLQLSLRILDILEYIH 169
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKI--SDFDLSNQAPDAAARLH-----STRVLGTFG 240
E +H +IK+SN+LL + ++ D+ L+ + GT
Sbjct: 170 EH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT-- 224
Query: 241 YHAPEYA-----MTGQMSSKSDVYSFGVVLLELLTGRKP 274
E+ S + D+ G +++ LTG P
Sbjct: 225 ---IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 45/215 (20%), Positives = 78/215 (36%), Gaps = 29/215 (13%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
IG G++G + G L + AIK + Q L + + ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 133 GPLRVLAYEHASKGSLHDI--LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
G + E SL D+ L + S + IA+ +EY+H K
Sbjct: 77 GKYNAMVLELLGP-SLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEYVHSKN 125
Query: 191 EPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFG 240
+I+R++K N L+ + I DF L+ + D + H + GT
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 241 YHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
Y G + S + D+ + G + + L G P
Sbjct: 183 Y-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 42/223 (18%), Positives = 89/223 (39%), Gaps = 37/223 (16%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN---------- 120
+G G + V+ + + A+K + K + ++ ++ R+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 121 -ENVVELVGY-YVDGPLR---VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++++L+ + GP V+ +E + +L ++ + + +I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG-------IPLIYVKQI 136
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------KISDFDLSNQAPDAAAR 229
+ GL+Y+H + IIH +IK NVL+ D KI+D + +
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---- 190
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
H T + T Y +PE + +D++S ++ EL+TG
Sbjct: 191 -HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 48/261 (18%), Positives = 90/261 (34%), Gaps = 47/261 (18%)
Query: 44 KTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIK--KLDS 100
+ + Q + P V + E + + IG G +G +Y A K++
Sbjct: 16 ENLYFQSMPFPEGKVLDDMEG-NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY 74
Query: 101 SKQP--DQEF-----LAQVSMVSRLKNENVVELVG----------YYVDGPLRVLAYEHA 143
+ E +A+ + + ++ +G + R + E
Sbjct: 75 QENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL 134
Query: 144 SKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201
L I +G VL ++ + LEY+HE +H +IK+
Sbjct: 135 GI-DLQKISGQNGTFKKST-----VL------QLGIRMLDVLEYIHEN---EYVHGDIKA 179
Query: 202 SNVLLFDDDIAKI--SDFDLSNQAPDAAARLH----STRVL-GTFGYHAPEYAMTG-QMS 253
+N+LL + ++ +D+ LS + + GT + A G +S
Sbjct: 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF-TSLDAHKGVALS 238
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
+SDV G +L L G+ P
Sbjct: 239 RRSDVEILGYCMLRWLCGKLP 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-GTFGY 241
EYLH +I+R++K N+L+ +++DF + + T L GT
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEA 204
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + + +K+ D ++ GV++ E+ G P
Sbjct: 205 LAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 51/240 (21%), Positives = 92/240 (38%), Gaps = 61/240 (25%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG GSYG VY + + AIKK+ ++ + + +++++RLK++ ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL- 90
Query: 128 GYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----I 175
Y + P + + E A L + L+ + +K +
Sbjct: 91 -YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI---------FLT-EEHIKTILYNL 138
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+G ++HE + IIHR++K +N LL D K+ DF L+ +
Sbjct: 139 LLG----ENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 236 LGTFG--------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + + +KS D++S G + ELL +
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 9e-07
Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 12/95 (12%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-GTFG 240
LEYLH K II+R++K N+LL + KI+DF + PD T L GT
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPD 168
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE ++ + +KS D +SFG+++ E+L G P
Sbjct: 169 YIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 27/112 (24%), Positives = 49/112 (43%), Gaps = 23/112 (20%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+ ++YLH ++HR++K SN+LL + K++DF LS + ++ +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 241 -------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +K D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE------NVV 124
+IG+GS+G+V + + A+K + + K+ ++ ++ ++ L+ + NV+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 125 ELVGYYVDGPLR---VLAYEHASKGSLHDILHGKKG-VKGAKPGPVLSWAQRVKIAVGAA 180
++ + R + +E S +L++++ KK +G V +A +
Sbjct: 163 HMLENFT---FRNHICMTFELLSM-NLYELI--KKNKFQGFSLPLVRKFAHSI------L 210
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQAPDAAARLHSTRVLGT 238
+ L+ LH+ RIIH ++K N+LL + K+ DF S +R
Sbjct: 211 QCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR---- 263
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
F Y APE + + D++S G +L ELLTG
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQAPDAAARLHSTRVLGTF 239
L +L E IIH ++K N+LL + + KI DF S Q + F
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRF 223
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y +PE + D++S G +L+E+ TG
Sbjct: 224 -YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 29/135 (21%), Positives = 45/135 (33%), Gaps = 46/135 (34%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDI------------------------------ 211
GL+YLH K RIIH +IK N+LL ++
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 212 -----------AKISDFDLSNQAPDAAARL---HSTRVLGTFGYHAPEYAMTGQMSSKSD 257
K ++ A A H T + T Y + E + ++ +D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 258 VYSFGVVLLELLTGR 272
++S + EL TG
Sbjct: 276 IWSTACMAFELATGD 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 50/258 (19%), Positives = 84/258 (32%), Gaps = 56/258 (21%)
Query: 57 SVDELKEK---TDNFGTN----SLIGEGSYGRVYFGVLRSGRAAAIK--------KLDSS 101
S++ L TD G S + G +Y S KLD+
Sbjct: 26 SLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK 85
Query: 102 KQP---DQEFL---AQVSMVSRLKNENVVELVG----YY---VDGPLRVLAYEHASKGSL 148
+Q F A+ V++ K L+ R L + SL
Sbjct: 86 DGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SL 144
Query: 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208
L P VLS +++A LE+LHE +H N+ + N+ +
Sbjct: 145 QSALD-------VSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194
Query: 209 DDIAKI--SDFDLSNQAPDA----AARLHSTRVL-GTFGYHAPEYA-----MTGQMSSKS 256
+D +++ + + + + + A S G E+ S +S
Sbjct: 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRS 249
Query: 257 DVYSFGVVLLELLTGRKP 274
D+ S G +L+ L G P
Sbjct: 250 DLQSLGYCMLKWLYGFLP 267
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 356 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.74 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.62 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.6 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.55 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.4 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.08 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.0 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.97 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.97 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.96 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.75 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.6 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.84 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.54 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.21 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.87 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.9 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-62 Score=438.08 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=208.5
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
.++|++++.||+|+||+||+|+++ +|+.||||++.+.... .+.+.+|+.+|++|+|||||++++++.+.+.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999987 7999999999765433 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|||+||+|.++|...... .+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|
T Consensus 103 Ey~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp ECCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred eCCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccc
Confidence 999999999999765432 2789999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
+........ ....+||+.|+|||++.+..|+.++|||||||++|||++|++||..... .+.+.
T Consensus 173 ~~~~~~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---------------~~~~~ 235 (350)
T 4b9d_A 173 RVLNSTVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---------------KNLVL 235 (350)
T ss_dssp SCCCHHHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---------------HHHHH
T ss_pred eeecCCccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---------------HHHHH
Confidence 887654322 2456799999999999999999999999999999999999999965421 11122
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+.... ....+..++.++.+||.+||++||.+|||++|+++
T Consensus 236 ~i~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 236 KIISGS-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCC-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222222 22445567789999999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-62 Score=433.10 Aligned_cols=266 Identities=24% Similarity=0.412 Sum_probs=222.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
++|.+.+.||+|+||+||+|++. ++..||||++...... .++|.+|+++|++|+|||||++++++.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888999999999999999863 4778999999754332 4678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 139 AYEHASKGSLHDILHGKKGV----KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
||||+++|+|.+++...... ........+++.+++.++.||+.||.|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999764310 01112234899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--------------- 234 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--------------- 234 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---------------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------------
Confidence 99999976554443333345579999999999999999999999999999999998 99999643
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
+...+...+........|..+++++.+||.+||+.||++|||+++|++.|+.+...
T Consensus 235 -~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 235 -SNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 33444555555555667788899999999999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-61 Score=433.67 Aligned_cols=266 Identities=24% Similarity=0.379 Sum_probs=216.5
Q ss_pred CCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
++|.+.+.||+|+||+||+|+++ +++.||||++...... .++|.+|+++|++++|||||++++++.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778889999999999999864 4788999999754332 4679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 139 AYEHASKGSLHDILHGKKGVKG------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
||||+++|+|.+++........ ......+++.+++.++.||+.||.|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999986543211 111235899999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 291 (356)
||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~------------- 264 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL------------- 264 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-------------
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC-------------
Confidence 9999999987655443333455679999999999999999999999999999999999 99999643
Q ss_pred ccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
+...+...+....+.+.|..+++++.+||.+||+.||++|||++||++.|+.+...
T Consensus 265 ---~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 265 ---SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 23344444555556677788899999999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-61 Score=429.36 Aligned_cols=265 Identities=27% Similarity=0.356 Sum_probs=224.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++++.+.||+|+||+||+|.+. +++.||||++..... ..+.|.+|+.++++++|||||++++++.+.+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34667789999999999999863 467899999975432 2468999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 138 LAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
+||||+++|+|.++|........ ......+++..++.++.||+.||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999976532211 111234899999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceec
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 289 (356)
.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~----------- 251 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----------- 251 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC-----------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-----------
Confidence 999999999987655544434456679999999999999999999999999999999998 89999643
Q ss_pred ccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
+...+...+..+...+.|..++.++.+||.+||+.||.+|||+.||++.|+.+.+
T Consensus 252 -----~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 252 -----SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp -----CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred -----CHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 3344555555566667788889999999999999999999999999999987643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=430.49 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=213.3
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||+||+|+++ +++.||||++.+. ....+.+.+|+++|+.|+|||||++++++.+.+.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999987 8999999999643 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||++||+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|
T Consensus 112 Ey~~gG~L~~~i~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp CCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 99999999999986543 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
+..............+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+. ...+.
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---------------~~~~~ 244 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------------GLIFA 244 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HHHHH
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHH
Confidence 877544333334567899999999999999999999999999999999999999964421 11122
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 341 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell 341 (356)
.+.... ..++..+++++.+||.+||++||.+|||++|++
T Consensus 245 ~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 245 KIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 222222 244556778899999999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=423.17 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=210.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..+++++.+.||+|+||+||+|+++. .||||+++..... .+.|.+|+.++++++|||||++++++.+ +.++|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34678889999999999999998763 5999999754433 3568999999999999999999998764 5689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|||++|+|.+++..... .+++..++.++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|
T Consensus 111 Ey~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp ECCSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EcCCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCc
Confidence 99999999999976532 2899999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccC---CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
+..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ..
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---------------~~ 244 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---------------RD 244 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---------------HH
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---------------HH
Confidence 87654333333356689999999999964 4589999999999999999999999975422 11
Q ss_pred hHhHhhcccC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCCCC
Q 018396 298 KVKQCVDTKL----GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355 (356)
Q Consensus 298 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~~~ 355 (356)
.+...+.... ....+..+++++.+||.+||+.||++|||+.+|++.|+.|.......+
T Consensus 245 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~~ 306 (307)
T 3omv_A 245 QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKIN 306 (307)
T ss_dssp HHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC--
T ss_pred HHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCCC
Confidence 2222222221 123456778899999999999999999999999999999887665443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-61 Score=431.52 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=211.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
+.|++.+.||+|+||+||+|+++ +|+.||||++..... ..+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999987 899999999965432 3466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
+||+|.+++.... +++..+..++.||+.||+|||++| |+||||||+||||+.+|.+||+|||+|+..
T Consensus 154 ~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 154 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 9999999997643 899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
...... ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||..... ......+
T Consensus 221 ~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----------------~~~~~~i 282 (346)
T 4fih_A 221 SKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----------------LKAMKMI 282 (346)
T ss_dssp CSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHH
T ss_pred CCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHH
Confidence 543222 2567899999999999999999999999999999999999999965421 1122222
Q ss_pred cccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 304 DTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 304 ~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.... ....+..+++++.+||.+||++||++|||++|+++
T Consensus 283 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 283 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2111 22334566789999999999999999999999987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-61 Score=429.60 Aligned_cols=255 Identities=23% Similarity=0.271 Sum_probs=212.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
.+.|++.+.||+|+||.||+|+++ +|+.||||++..... ..+|+.+++.|+|||||++++++.+++.+||||||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 456888899999999999999987 799999999976433 247999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-ceeEecccccCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQ 222 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~~ 222 (356)
+||+|.+++..... +++..+..++.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+|+.
T Consensus 133 ~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 133 EGGSLGQLIKQMGC---------LPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp TTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred CCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 99999999986542 899999999999999999999999 99999999999999987 699999999987
Q ss_pred Ccccccc---ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 223 APDAAAR---LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 223 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
....... ......+||+.|||||++.+..|+.++|||||||++|||++|++||........ .
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---------------~ 265 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---------------C 265 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---------------H
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---------------H
Confidence 6543221 122446799999999999999999999999999999999999999975532211 1
Q ss_pred hHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 300 KQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 300 ~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
..+..... ....+..+++++.+||.+||++||.+|||+.|+++.|...+..
T Consensus 266 ~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 266 LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp HHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 11111111 1134556788999999999999999999999999999887643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=439.28 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=212.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
+.|++.+.||+|+||.||+|+++ +|+.||||++..... ..+.+.+|+.+|+.++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999987 899999999975433 3567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
+||+|.+++.... +++..+..++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|...
T Consensus 231 ~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 231 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 9999999997654 899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
...... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+... ......+
T Consensus 298 ~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----------------~~~~~~i 359 (423)
T 4fie_A 298 SKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----------------LKAMKMI 359 (423)
T ss_dssp CSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHH
T ss_pred CCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHH
Confidence 543222 2567899999999999999999999999999999999999999964421 1122222
Q ss_pred cccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 304 DTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 304 ~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.... ....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 360 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 360 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2111 22334456788999999999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-60 Score=413.27 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=195.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||+||+|+++ +|+.||||++.+... ....+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999976 799999999965432 24578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+ +|+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||+++++.+||+|||
T Consensus 91 vmEy~-~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDK---------MSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp EEECC-CEEHHHHHHHSCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSS
T ss_pred EEeCC-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecC
Confidence 99999 6799999976542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
+|+........ ...+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.... ..
T Consensus 158 la~~~~~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~----------------~~ 218 (275)
T 3hyh_A 158 LSNIMTDGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES----------------IP 218 (275)
T ss_dssp CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----------------HH
T ss_pred CCeecCCCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC----------------HH
Confidence 99876543322 45689999999999998886 579999999999999999999996432 11
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+...+... ....+..+++++.+||.+||+.||++|||++|+++
T Consensus 219 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 219 VLFKNISNG-VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHHHHT-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 222222211 12345567788999999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-59 Score=412.44 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=199.7
Q ss_pred CCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec----CCeeEEEE
Q 018396 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAY 140 (356)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~ 140 (356)
++.+.||+|+||+||+|.++ ++..||+|++...... .+.+.+|+.++++|+|||||++++++.+ ...+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56778999999999999987 7899999998654332 3568999999999999999999999864 35689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeEecccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~ 219 (356)
||++||+|.+++..... +++..+..++.||+.||+|||+++. +|+||||||+||||+. +|.+||+|||+
T Consensus 109 Ey~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp ECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcC
Confidence 99999999999986542 8999999999999999999999853 3999999999999984 79999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
|+...... ....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||..... ...+
T Consensus 179 a~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~---------------~~~~ 238 (290)
T 3fpq_A 179 ATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---------------AAQI 238 (290)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---------------HHHH
T ss_pred CEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---------------HHHH
Confidence 97544321 245689999999998865 699999999999999999999999964321 1122
Q ss_pred hHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+.... ....+...++++.+||.+||+.||.+|||++|+++
T Consensus 239 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 239 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222211 11223334568999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-59 Score=423.48 Aligned_cols=277 Identities=21% Similarity=0.337 Sum_probs=230.0
Q ss_pred CHHHHHHHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccC-Cceeeee
Q 018396 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKN-ENVVELV 127 (356)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h-p~iv~~~ 127 (356)
+..+|.-..++|++.+.||+|+||+||+|.+. +++.||||.+...... .+.+.+|+.+|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34556666789999999999999999999864 2357999999765443 3568999999999965 9999999
Q ss_pred eEEec-CCeeEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCC
Q 018396 128 GYYVD-GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (356)
Q Consensus 128 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dl 199 (356)
+++.+ ++.+++|||||++|+|.++|....... .......+++..++.++.||+.||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 99865 567899999999999999997654211 0111234899999999999999999999999 999999
Q ss_pred CCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCC
Q 018396 200 KSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 278 (356)
Q Consensus 200 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~ 278 (356)
||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987655443333456679999999999999999999999999999999998 99999644
Q ss_pred CCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 279 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
. ....+...+....+...|..+++++.+||.+||+.||.+|||+.+|++.|+.++...
T Consensus 292 ~---------------~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 292 K---------------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp C---------------CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred C---------------HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 2 123344555556666777888899999999999999999999999999999998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=416.36 Aligned_cols=246 Identities=21% Similarity=0.281 Sum_probs=201.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
++|++.+.||+|+||+||+|+.. +++.||||++.+... ....+.+|+++|++++|||||++++++.+.+.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 578999999975422 23468889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||++||+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||
T Consensus 104 vmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEcCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccc
Confidence 9999999999999987543 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+|+........ ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+. .+.
T Consensus 172 la~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---------------~~~ 234 (304)
T 3ubd_A 172 LSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---------------KET 234 (304)
T ss_dssp EEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HHH
T ss_pred cceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---------------HHH
Confidence 99865443322 2456899999999999999999999999999999999999999964421 111
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~ 342 (356)
+..+.... ...|..+++++.+||.+||++||++|||+ +|+++
T Consensus 235 ~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 235 MTMILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 22222222 24556678899999999999999999985 67765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=413.23 Aligned_cols=275 Identities=23% Similarity=0.310 Sum_probs=208.5
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCC----eeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~~~lv~e 141 (356)
++|.+.+.||+|+||+||+|++. |+.||||++............|+..+.+++|||||++++++.+.+ .++||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 46788899999999999999985 889999999754332233345566667889999999999998654 5799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeeecCCCCCcEEEccCCceeEec
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-----EPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
|+++|+|.+++.... +++..+..++.|++.||+|||++. .++||||||||+||||+.++.+||+|
T Consensus 82 y~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp CCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999998654 899999999999999999999871 12399999999999999999999999
Q ss_pred ccccCCCcccccc--ccccccccCcCccCcccccCC------CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee
Q 018396 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 288 (356)
||+|+........ ......+||+.|+|||++.+. .++.++|||||||++|||+||.+||........ ....
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-p~~~ 230 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYD 230 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc-cchh
Confidence 9998765433221 122346799999999998764 367899999999999999999998865432211 1111
Q ss_pred cccccCChhhHhHh-hcccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 289 WATPKLSEDKVKQC-VDTKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 289 ~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
..........+... ....++...+ .+++..+.+||.+||+.||.+|||+.||++.|+++....+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 11112222333332 3334444443 2567789999999999999999999999999999986653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-57 Score=402.94 Aligned_cols=248 Identities=21% Similarity=0.380 Sum_probs=191.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCC-------
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP------- 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------- 134 (356)
.++|++.+.||+|+||+||+|+++ +|+.||||++...... .+.+.+|+.+|++|+|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 456999999999999999999987 8999999998654433 357889999999999999999999987544
Q ss_pred -----eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 135 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
.+|+|||||++|+|.+++....... ...+..++.++.||+.||+|||++| |+||||||+|||++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD 154 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC
Confidence 3799999999999999998654321 1456778999999999999999999 9999999999999999
Q ss_pred CceeEecccccCCCcccccc----------ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCC
Q 018396 210 DIAKISDFDLSNQAPDAAAR----------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (356)
|.+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 99999999999876543221 11234579999999999999999999999999999999996 774220
Q ss_pred CCCCccceecccccCChhhHhHhhcccCCCCCCH---HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 280 PRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP---KAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+. ...+........++ ..++.+.+||.+||+.||.+|||+.|+++
T Consensus 232 -----------------~~-~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -----------------ER-VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -----------------HH-HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------------HH-HHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11111111223333 34467789999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-55 Score=401.71 Aligned_cols=265 Identities=22% Similarity=0.350 Sum_probs=203.6
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec------CC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD------GP 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~------~~ 134 (356)
.++|++++.||+|+||+||+|+++ +|+.||||++...... .+.+.+|+++|+.|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999987 8999999999765443 3567899999999999999999998753 46
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.+||||||+. |+|.+++..... +++..+..++.||+.||.|||++| ||||||||+|||++.+|.+||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~---------l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQP---------LTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEEeCCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEE
Confidence 7899999996 589999976542 899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccc--cccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 215 SDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
+|||+|+....... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+.......+....
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 99999987644321 1223467899999999998875 56999999999999999999999997654321111110000
Q ss_pred --------ccCChhhHhHhhccc-CCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 292 --------PKLSEDKVKQCVDTK-LGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 292 --------~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...........+... .....+ +..++++.+||.+||..||.+|||++|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000001111111100 000111 134578899999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=389.47 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=200.8
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 137 (356)
...++|++.+.||+|+||+||+|+.+ +++.||+|.+.... ....+.+|+++|+.+ +||||+++++++.+.+.+|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 45678999999999999999999863 46789999987643 345688999999998 6999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-CceeEec
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISD 216 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~D 216 (356)
+||||+++|+|.+++.. +++.++..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|
T Consensus 97 lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp EEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence 99999999999999842 889999999999999999999999 9999999999999876 8999999
Q ss_pred ccccCCCcccccc--------------------------ccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHH
Q 018396 217 FDLSNQAPDAAAR--------------------------LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELL 269 (356)
Q Consensus 217 fg~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~ 269 (356)
||+|+........ ......+||+.|+|||++.+. .|+.++||||+||++|+|+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 9999754332110 011345799999999999875 5899999999999999999
Q ss_pred cCCCCCCCCCCCC-Cccce-------------------ecccccCChhhHhHhhcc------------------cCCCCC
Q 018396 270 TGRKPVDHTLPRG-QQSLV-------------------TWATPKLSEDKVKQCVDT------------------KLGGEY 311 (356)
Q Consensus 270 ~g~~pf~~~~~~~-~~~~~-------------------~~~~~~~~~~~~~~~~~~------------------~~~~~~ 311 (356)
+|+.||....... +...+ .................. ....+.
T Consensus 242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 9999995432210 00000 000000000000000000 000011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 312 PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 312 ~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....++++.+||.+||+.||.+|||++|+++
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 2234678899999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=409.79 Aligned_cols=247 Identities=24% Similarity=0.331 Sum_probs=204.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHH---HHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQ---VSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e---~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|++.++||+|+||+||+|+.+ +|+.||||++.+. ........+| +.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999987 8999999999642 1222333344 5667778999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
|+||||++||+|.++|..... +++..+..++.||+.||+|||++| ||||||||+||||+.+|++||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecc
Confidence 999999999999999986542 899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCccccc-CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||+|+...... ....+||+.|+|||++. +..|+.++|||||||++|+|++|.+||...... .
T Consensus 336 FGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-------------~ 398 (689)
T 3v5w_A 336 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-------------D 398 (689)
T ss_dssp CTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-------------C
T ss_pred cceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------------H
Confidence 99998765432 24568999999999996 467999999999999999999999999643211 1
Q ss_pred hhhHh-HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 018396 296 EDKVK-QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 342 (356)
Q Consensus 296 ~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~ 342 (356)
...+. .+... ...++..+++++.+||.+||++||.+|++ ++||++
T Consensus 399 ~~~i~~~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 399 KHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHHHhhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11111 12222 22456667889999999999999999998 677765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=410.40 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=210.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||+|+||.||+|.++ +|+.||+|++...... .+.+.+|+.+|+.|+|||||++++++.+...+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999987 8999999998765433 45688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC--CceeEeccccc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDFDLS 220 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~Dfg~a 220 (356)
++||+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 236 ~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a 304 (573)
T 3uto_A 236 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 304 (573)
T ss_dssp CCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred cCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence 999999999965432 2899999999999999999999999 9999999999999854 89999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
+........ ...+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+... .+.+.
T Consensus 305 ~~~~~~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---------------~~~~~ 366 (573)
T 3uto_A 305 AHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---------------DETLR 366 (573)
T ss_dssp EECCTTSEE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---------------HHHHH
T ss_pred eEccCCCce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---------------HHHHH
Confidence 877554332 456899999999999999999999999999999999999999975421 11122
Q ss_pred HhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+..... .......+++++.+||.+||+.||.+|||+.|+++
T Consensus 367 ~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 367 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222111 11222356778999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=376.37 Aligned_cols=285 Identities=38% Similarity=0.642 Sum_probs=235.2
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
++....++|++.+.||+|+||.||+|..++++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 344567899999999999999999999888999999998765433 4678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++...... ...+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||
T Consensus 113 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred EEEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999765421 123899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++................||+.|+|||++.+..++.++||||||+++|+|++|+.||....+........|.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 98765433322223445689999999999989999999999999999999999999987655443333222221122222
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
+...++.......+..++..+.+++.+||+.||++|||+.++++.|+.++....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 333444555556778999999999999999999999999999999999887654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=373.24 Aligned_cols=269 Identities=23% Similarity=0.383 Sum_probs=222.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEec
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~ 132 (356)
..++|++.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578999999999999999999852 3457999999765433 35688999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEE
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (356)
.+..++||||+++|+|.+++....... ...+...+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 999999999999999999998754210 0111234889999999999999999999999 999999999999
Q ss_pred EccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~ 284 (356)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~------ 309 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------ 309 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC------
Confidence 99999999999999986654333222344567889999999999999999999999999999999 99999643
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
....+...+........+..++.++.++|.+||+.||.+|||+.++++.|+.++...
T Consensus 310 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 310 ----------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp ----------CGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 223334444444455666778889999999999999999999999999999988643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=366.50 Aligned_cols=287 Identities=35% Similarity=0.612 Sum_probs=236.9
Q ss_pred cccccCHHHHHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeE
Q 018396 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGY 129 (356)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~ 129 (356)
....++..++....++|++.+.||+|+||.||+|...+++.||||++...... ...+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34566788899999999999999999999999999878999999999764332 3468999999999999999999999
Q ss_pred EecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---CCCCeeecCCCCCcEEE
Q 018396 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK---AEPRIIHRNIKSSNVLL 206 (356)
Q Consensus 130 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~~ivH~Dlkp~Nill 206 (356)
+.+....++||||+.+++|.+++....... ..+++..++.++.|++.||.|||++ | ++||||||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILL 167 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTC-----CCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEE
Confidence 999999999999999999999998765322 2389999999999999999999999 8 9999999999999
Q ss_pred ccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCC--CCCCc
Q 018396 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL--PRGQQ 284 (356)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~--~~~~~ 284 (356)
+.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred CCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence 99999999999999766433222 1234569999999999998899999999999999999999999996321 11112
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
....+..............+.......+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp BHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 222233333333444455556666678889999999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=359.57 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=211.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4568999999999999999999975 79999999986433 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+++|.+++.... +++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp CCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 999999999998653 889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+. .....
T Consensus 165 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~~~~~ 227 (297)
T 3fxz_A 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---------------RALYL 227 (297)
T ss_dssp ECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------HHHHH
T ss_pred ecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHH
Confidence 66543322 24567999999999999999999999999999999999999999644211 11111
Q ss_pred hhc-ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 302 CVD-TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 302 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
... .......+..++..+.+||.+||+.||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111 11122334566788999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=368.72 Aligned_cols=274 Identities=26% Similarity=0.312 Sum_probs=219.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCC----eeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~~~lv 139 (356)
..++|++.+.||+|+||.||+|++. ++.||||++...........+|+.+++.++||||+++++++.+.. .+++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 4468999999999999999999887 789999999765544556677899999999999999999998744 47999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC----------CCCCeeecCCCCCcEEEccC
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK----------AEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----------~~~~ivH~Dlkp~Nill~~~ 209 (356)
|||+++|+|.+++.... +++..++.++.|++.||.|||+. + |+||||||+|||++.+
T Consensus 101 ~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTT
T ss_pred EecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCC
Confidence 99999999999997654 89999999999999999999999 8 9999999999999999
Q ss_pred CceeEecccccCCCccccccccccccccCcCccCcccccCC-----CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018396 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (356)
+.+||+|||++................||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 99999999999765443332223446799999999999863 4566889999999999999999999876554433
Q ss_pred cceecccccCChhhHhHhhccc-CCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 285 SLVTWATPKLSEDKVKQCVDTK-LGGEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
..............+...+... ..... ....+.++.+||.+||+.||.+|||+.++++.|+++.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 3333222233333333333222 22222 2256678999999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=354.85 Aligned_cols=258 Identities=24% Similarity=0.423 Sum_probs=222.3
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||+|.+.+++.||+|++.......+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46799999999999999999999888899999998877777889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 89 ~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 89 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp TCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999976542 2889999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~----------------~~~~~~~~ 220 (269)
T 4hcu_A 158 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----------------NSEVVEDI 220 (269)
T ss_dssp CHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------HHHHHHHH
T ss_pred ccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC----------------HHHHHHHH
Confidence 43222 2234456788999999999999999999999999999999 999996432 22333333
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
........+...+..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 221 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 33334444555678899999999999999999999999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=362.10 Aligned_cols=268 Identities=31% Similarity=0.416 Sum_probs=210.4
Q ss_pred HHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
...++|++.+.||+|+||.||+|... ++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 34578999999999999999999875 788999999765543 24678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|.+++...... ..+++..++.++.|++.||.|||++|. +|+||||||+||+++.++.+||+|||+
T Consensus 113 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999864321 127899999999999999999999863 399999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ....
T Consensus 186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---------------~~~~ 248 (309)
T 3p86_A 186 SRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---------------AQVV 248 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---------------HHHH
T ss_pred Ccccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHH
Confidence 876543322 12455789999999999999999999999999999999999999964421 1111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCCCC
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~~~ 355 (356)
............+..+++.+.+||.+||+.||.+|||+.++++.|+.++....+|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 249 AAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 12222233345566777889999999999999999999999999999998766554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=355.39 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=220.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
..++|++.+.||+|+||.||+|.+.++..||+|++.......+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 34679999999999999999999998889999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
.+++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 102 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 102 ANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp TTCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999976432 2899999999999999999999999 999999999999999999999999999765
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ........
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~----------------~~~~~~~~ 233 (283)
T 3gen_A 171 LDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----------------TNSETAEH 233 (283)
T ss_dssp CCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS----------------CHHHHHHH
T ss_pred cccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc----------------ChhHHHHH
Confidence 443222 1233456788999999999999999999999999999998 99999643 22333333
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
+........+..+++.+.++|.+||+.+|.+|||+.++++.|.++++..|
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~es 283 (283)
T 3gen_A 234 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283 (283)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhccC
Confidence 44444444555567789999999999999999999999999999987653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=363.35 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=209.7
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
...++|++.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 34678999999999999999999986 8999999998654332 3567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++..... +++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 92 v~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp EECCCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred EEECCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999976542 889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCC-ccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++........ ....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.... ..
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----------------~~ 220 (328)
T 3fe3_A 160 FSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN----------------LK 220 (328)
T ss_dssp CCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS----------------HH
T ss_pred CceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC----------------HH
Confidence 9876543322 2456799999999999988875 79999999999999999999996442 11
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+...+... ....+...+.++.+||.+||+.||.+|||++++++
T Consensus 221 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 221 ELRERVLRG-KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHHHHC-CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhC-CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222222111 11334456778999999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=360.91 Aligned_cols=261 Identities=27% Similarity=0.435 Sum_probs=217.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
.++|++.+.||+|+||.||+|.+. + +..||||++...... .+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999975 3 345999999764333 4568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 128 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCC
Confidence 9999999999999975432 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ..
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~----------------~~ 260 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM----------------TN 260 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS----------------CH
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC----------------CH
Confidence 99876543221 11223346788999999999999999999999999999999 99999643 23
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
..+...+........+..++..+.+||.+||+.||.+|||+.++++.|+.++....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 33444444444555666778899999999999999999999999999999986543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=351.53 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=220.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
..++|++.+.||+|+||.||+|..+++..||+|++.......+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45689999999999999999999988889999999877777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++...
T Consensus 86 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp TTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceec
Confidence 99999999976532 2889999999999999999999999 999999999999999999999999998766
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......
T Consensus 155 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----------------~~~~~~~ 217 (268)
T 3sxs_A 155 LDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT----------------NSEVVLK 217 (268)
T ss_dssp CTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC----------------HHHHHHH
T ss_pred chhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC----------------hHHHHHH
Confidence 543322 1233456778999999998899999999999999999999 999996432 2222222
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
+........+..+++.+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus 218 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 218 VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred HHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 3333333444556778999999999999999999999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=371.35 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=221.8
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
....++|++.+.||+|+||.||+|.++ +++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 334568889999999999999999987 7899999998754322 2457899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 190 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp EEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred EEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCC
Confidence 9999999999999976432 2889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++................+++.|+|||++.+..++.++|||||||++|||++ |..||... ...
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~----------------~~~ 322 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL----------------SNQ 322 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS----------------CHH
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----------------CHH
Confidence 9876544322222222345778999999998899999999999999999998 99999643 333
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.....+........+..++..+.+||.+||+.||.+|||+.++++.|+++...
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 323 QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 44455555555566677888999999999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=359.61 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=214.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467999999999999999999987 799999998865433 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 89 ~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp CTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 999999999986432 2899999999999999999999999 99999999999999999999999999976
Q ss_pred Cccccccc------------cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 223 APDAAARL------------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 223 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||....+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---- 233 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---- 233 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----
Confidence 54332211 01145799999999999999999999999999999999999999875433221100
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
......... ..+..+++.+.++|.+||+.||++|||+.++++.|+++...
T Consensus 234 ------~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 234 ------LNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ------BCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------hhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 011111111 12344556799999999999999999999999999988653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=364.86 Aligned_cols=271 Identities=25% Similarity=0.379 Sum_probs=226.5
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEe
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYV 131 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~ 131 (356)
...++|++.+.||+|+||.||+|.+. .+..||+|++...... ...+.+|+++++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999853 2357999999765443 35688999999999 9999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcE
Q 018396 132 DGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (356)
Q Consensus 132 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (356)
+.+..++||||+++|+|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 9999999999999999999998764211 1112234899999999999999999999999 99999999999
Q ss_pred EEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCC
Q 018396 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQ 283 (356)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~ 283 (356)
|++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~----- 297 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----- 297 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----
Confidence 999999999999999987655433333344567889999999999999999999999999999999 99999643
Q ss_pred ccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 284 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
....+...+........+..++.++.+||.+||+.||.+|||+.++++.|+++++..+
T Consensus 298 -----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 298 -----------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp -----------CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -----------CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2334445555555555666778899999999999999999999999999999986654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=358.68 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=209.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999987 7999999998642 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 84 ~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence 999999999999976542 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+......... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ...+
T Consensus 152 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----------------~~~~ 213 (337)
T 1o6l_A 152 CKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----------------HERL 213 (337)
T ss_dssp CBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----------------HHHH
T ss_pred hhhcccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----------------HHHH
Confidence 8764332221 245679999999999999999999999999999999999999996432 1112
Q ss_pred hH-hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 300 KQ-CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 300 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
.. +.... ...+..++.++.+||.+||+.||.+|| +++++++
T Consensus 214 ~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 214 FELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 22 22221 234556778899999999999999999 8999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=359.30 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=208.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3578999999999999999999987 8999999998654322 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 85 e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp ECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence 99999999999975532 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
................||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ...
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------------~~~ 218 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--------------QEY 218 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--------------HHH
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--------------HHH
Confidence 86654333323345679999999999988776 778999999999999999999997543211 111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...............++..+.+||.+||+.||.+|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 219 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1222222222222455678899999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=366.67 Aligned_cols=265 Identities=26% Similarity=0.396 Sum_probs=219.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||.||+|... +++.||||++...... ...+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999943 5678999999754333 34688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC---cee
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAK 213 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vk 213 (356)
++||||+++|+|.+++........ ....+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhhccccC--ccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999987543211 1124889999999999999999999999 99999999999999555 599
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~-------------- 290 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-------------- 290 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------------
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------------
Confidence 999999875543332222344568999999999999999999999999999999998 99999643
Q ss_pred cCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
....+...+........+..++..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus 291 --~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 291 --SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp --CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 23334444444444555667788899999999999999999999999999987754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=363.57 Aligned_cols=276 Identities=21% Similarity=0.330 Sum_probs=224.3
Q ss_pred CHHHHHHHhCCCCCCceeeccCceEEEEEEE-----C-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeee
Q 018396 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVL-----R-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELV 127 (356)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~ 127 (356)
....+....++|++.+.||+|+||.||+|.+ . +++.||||++...... .+.+.+|+.+++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 4455666778999999999999999999983 2 5689999999765433 35688999999999 789999999
Q ss_pred eEEecCC-eeEEEEEecCCCCHHHHHhcCCCCCC----------------------------------------------
Q 018396 128 GYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKG---------------------------------------------- 160 (356)
Q Consensus 128 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~---------------------------------------------- 160 (356)
+++.+.+ ..++||||+++|+|.+++........
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9988754 48999999999999999987543100
Q ss_pred -----------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccccc
Q 018396 161 -----------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (356)
Q Consensus 161 -----------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (356)
......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 001123889999999999999999999999 999999999999999999999999999876443333
Q ss_pred ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCC
Q 018396 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (356)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (356)
.......||+.|+|||++.+..++.++||||||+++|+|++ |..||..... ...+...+.....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------------~~~~~~~~~~~~~ 314 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---------------DEEFCRRLKEGTR 314 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---------------SHHHHHHHHHTCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch---------------hHHHHHHHHcCCC
Confidence 33345668999999999999999999999999999999998 9999965421 1223333444444
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 309 GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
...+..+++++.++|.+||+.||.+|||+.++++.|+.+++.
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 455566778899999999999999999999999999998864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=375.64 Aligned_cols=264 Identities=22% Similarity=0.396 Sum_probs=225.1
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
+....++|++.+.||+|+||.||+|.++++..||||++.......+.+.+|+.+++.++||||+++++++. .+..++||
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34455678899999999999999999988889999999877667788999999999999999999999986 66789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 262 e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp CCCTTCBHHHHHHSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred eecCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 999999999999754321 2788999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhH
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||... ....+
T Consensus 332 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~----------------~~~~~ 394 (454)
T 1qcf_A 332 RVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM----------------SNPEV 394 (454)
T ss_dssp GGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----------------CHHHH
T ss_pred eEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC----------------CHHHH
Confidence 876443222 1233346788999999998999999999999999999999 99999643 23344
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
...+....+...+..+++++.+||.+||+.||.+|||+++|++.|+++.....
T Consensus 395 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 395 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 44455555556677788999999999999999999999999999999986543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=357.01 Aligned_cols=269 Identities=24% Similarity=0.367 Sum_probs=222.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
..++|.+.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4578999999999999999999862 4578999999765433 3568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCC
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlk 200 (356)
.++||||+++++|.+++........ ......+++..++.++.||+.||.|||+++ ++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999987543100 001123889999999999999999999999 9999999
Q ss_pred CCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCC
Q 018396 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (356)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (356)
|+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999976654433323344567889999999999899999999999999999999 999996442
Q ss_pred CCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 280 PRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
...+...+........+..+++.+.++|.+||+.||.+|||+.++++.|++++...
T Consensus 258 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 258 ----------------PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp ----------------GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ----------------HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 22334444444444556677889999999999999999999999999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=360.27 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=207.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
..++|++.+.||+|+||.||+|..+ +|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4567999999999999999999987 799999999865432 23678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC----c
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----I 211 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~ 211 (356)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence 999999999999999997643 2899999999999999999999999 99999999999998877 7
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~----------- 223 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----------- 223 (361)
T ss_dssp EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------
T ss_pred EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----------
Confidence 99999999987654322 2456799999999999999999999999999999999999999965421
Q ss_pred ccCChhhHhHhhcccCCCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 292 PKLSEDKVKQCVDTKLGGEYP----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+....+..... ..+ ..++..+.+||.+||..||.+|||+.++++
T Consensus 224 ----~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 224 ----QETLANITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----HHHHHHHHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHHHHHHHhcCC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111112211111 122 234578999999999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=356.76 Aligned_cols=250 Identities=16% Similarity=0.193 Sum_probs=210.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 3578999999999999999999987 789999999987665567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc--CCceeEeccccc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLS 220 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a 220 (356)
+++++|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|||++
T Consensus 83 ~~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 83 ISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp CCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 999999999975431 2899999999999999999999999 999999999999987 789999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....
T Consensus 152 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------------~~~~~ 213 (321)
T 1tki_A 152 RQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---------------QQIIE 213 (321)
T ss_dssp EECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---------------HHHHH
T ss_pred eECCCCCcc---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---------------HHHHH
Confidence 876543322 445789999999999988899999999999999999999999964421 11122
Q ss_pred HhhcccCCCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGE--YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+........ ....++.++.+||.+||..||.+|||+.|+++
T Consensus 214 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222211111 01134678999999999999999999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=376.98 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=226.2
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
...++|++.+.||+|+||.||+|.++ ++..||||++.......+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34567888999999999999999987 58899999998776677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 297 ~~~~g~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp CCTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred ccCCCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccce
Confidence 99999999999864322 2889999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||... ....+.
T Consensus 367 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~----------------~~~~~~ 429 (495)
T 1opk_A 367 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVY 429 (495)
T ss_dssp CCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC----------------CGGGHH
T ss_pred eccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC----------------CHHHHH
Confidence 76543222 1233446789999999998999999999999999999999 99999643 223344
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
..+....+...+..++..+.+||.+||+.||.+|||+.+|++.|+.++...
T Consensus 430 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 430 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 555556666677788899999999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=357.02 Aligned_cols=276 Identities=21% Similarity=0.293 Sum_probs=214.6
Q ss_pred hCCCCCCceeeccCceEEEEEEE----C-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEec--CCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL----R-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~----~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 136 (356)
.++|++.+.||+|+||.||+|++ . +++.||||++...... .+.+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 2 6889999999765433 3578899999999999999999999864 4568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence 999999999999999976542 2889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||....................
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 9999876543221 112334567889999999999999999999999999999999999864311100000000000111
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.......+........+..+++++.++|.+||+.||.+|||+.++++.|+++.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11233333444445566778889999999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=349.18 Aligned_cols=260 Identities=20% Similarity=0.314 Sum_probs=210.5
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999977 7899999998543332 35678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|.+++..... +++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||+
T Consensus 90 ~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp EECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999999976542 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 158 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---------------~~~ 221 (294)
T 4eqm_A 158 AKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV---------------SIA 221 (294)
T ss_dssp STTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH---------------HHH
T ss_pred cccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---------------HHH
Confidence 9876543222 224456999999999999999999999999999999999999999654211 111
Q ss_pred hHhhcccCC---CCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhccCC
Q 018396 300 KQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQPLLNTRS 352 (356)
Q Consensus 300 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ell~~L~~l~~~~~ 352 (356)
...+..... ......+++.+.++|.+||+.||.+|| +++++.+.|+.++....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 111111110 012234567899999999999999998 99999999999876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=345.17 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=220.6
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||+|.+.+++.||+|++.......+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 36789999999999999999999888899999998877677889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++....
T Consensus 87 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 87 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp TCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999976532 2789999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----------------~~~~~~~i 218 (267)
T 3t9t_A 156 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----------------NSEVVEDI 218 (267)
T ss_dssp CHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------HHHHHHHH
T ss_pred ccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC----------------HHHHHHHH
Confidence 33221 1233457889999999998999999999999999999999 899996432 22222333
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
........+..++..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 219 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 219 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 33333344555677899999999999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=359.03 Aligned_cols=273 Identities=25% Similarity=0.359 Sum_probs=219.9
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEec
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD 132 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 132 (356)
+....++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999974 3478999999765433 3568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeec
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~ 197 (356)
.+..++||||+++++|.+++........ ......+++..++.++.||+.||.|||++| |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999986432110 001134899999999999999999999999 9999
Q ss_pred CCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCC
Q 018396 198 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276 (356)
Q Consensus 198 Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~ 276 (356)
||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999876544332222344567899999999999999999999999999999999 999996
Q ss_pred CCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 277 HTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
... .......+........+..++..+.++|.+||+.||.+|||+.++++.|+++.....
T Consensus 279 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMA----------------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCC----------------hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 432 222333333333334556677889999999999999999999999999999886543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=362.00 Aligned_cols=259 Identities=25% Similarity=0.418 Sum_probs=206.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
.++|++.+.||+|+||.||+|+.+ ++..||||++...... .+.+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999864 5778999999765432 3568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 124 v~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCc
Confidence 9999999999999976532 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 219 LSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 219 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||... ..
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~----------------~~ 256 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM----------------SN 256 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC----------------CH
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC----------------CH
Confidence 998765432211 1122345778999999999999999999999999999998 99999643 22
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
..+...+........+..++..+.++|.+||+.||.+|||+.++++.|+.++..
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 333444444444455566778999999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=352.23 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=225.0
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
...++|++.+.||+|+||.||+|.+. ++..||+|++.......+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35678999999999999999999987 68899999998777677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+++|.+++...... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp CCTTEEHHHHHHHCCTT-------TSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred cCCCCcHHHHHHhcccC-------CccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999765432 2889999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .....
T Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~----------------~~~~~ 222 (288)
T 3kfa_A 160 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVY 222 (288)
T ss_dssp TSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----------------GGGHH
T ss_pred eccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----------------HHHHH
Confidence 76543222 1234457889999999999999999999999999999999 999996442 23334
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
..+........+..+++.+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 44444445556667788999999999999999999999999999988754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=371.72 Aligned_cols=263 Identities=26% Similarity=0.444 Sum_probs=219.3
Q ss_pred HHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
...++|++.+.||+|+||.||+|.++.+..||||++.......+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 3456788899999999999999999877889999998776667889999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++|+|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 260 ~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 260 MSKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp CTTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred hcCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 999999999975322 12889999999999999999999999 99999999999999999999999999987
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||... ....+..
T Consensus 330 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~----------------~~~~~~~ 392 (452)
T 1fmk_A 330 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLD 392 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----------------CHHHHHH
T ss_pred cCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC----------------CHHHHHH
Confidence 6543221 1233456789999999999999999999999999999999 99999643 2233444
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
.+....+...+..++..+.+||.+||+.||.+|||+++|++.|+++.....+
T Consensus 393 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 393 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 4455555566778888999999999999999999999999999999876544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=356.39 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=209.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCC----EEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|++.+.||+|+||.||+|.+. +++ .||+|.+.... ...+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999975 444 35888875433 33567899999999999999999999998765 77
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
++++|+.+|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccC
Confidence 89999999999999987542 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.... .
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----------------~ 225 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------------A 225 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------G
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC----------------H
Confidence 99876544333322344457889999999999999999999999999999999 999996442 2
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
..+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 226 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 33444555554555666778899999999999999999999999999998865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=367.85 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=216.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCC-eeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e~ 142 (356)
..++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 3567888999999999999999987 7799999997654 4577999999999999999999999987655 79999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++|+|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 269 ~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp CTTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 9999999999865421 2688999999999999999999999 99999999999999999999999999875
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
..... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.... ...+..
T Consensus 339 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~----------------~~~~~~ 397 (450)
T 1k9a_A 339 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----------------LKDVVP 397 (450)
T ss_dssp CC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC----------------TTTHHH
T ss_pred ccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC----------------HHHHHH
Confidence 43321 22357889999999999999999999999999999998 999996432 223334
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.+....+...+..+++.+.+||.+||+.||.+|||+.++++.|+++...
T Consensus 398 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 398 RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 4445555667778889999999999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=359.74 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=201.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
..++|++.+.||+|+||.||+|+.. +++.||+|++.......+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 3568999999999999999999987 899999999987666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc--eeEeccccc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKISDFDLS 220 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--vkl~Dfg~a 220 (356)
+.+|+|.+++..... +++..++.++.|++.||.|||++| |+||||||+|||++.++. +||+|||++
T Consensus 98 ~~~~~L~~~l~~~~~---------~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 98 ASGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp CCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 999999999976542 899999999999999999999999 999999999999987765 999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCcc-chhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK-SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
........ .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....+
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----------~~~~~ 231 (361)
T 3uc3_A 166 KSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-----------YRKTI 231 (361)
T ss_dssp ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-----------HHHHH
T ss_pred ccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-----------HHHHH
Confidence 75433222 244579999999999988887655 8999999999999999999975432111 11112
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
..+............++.++.+||.+||+.||.+|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 232 QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 22222222222222456789999999999999999999999873
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=361.23 Aligned_cols=248 Identities=21% Similarity=0.322 Sum_probs=204.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 137 (356)
..++|++.+.||+|+||.||+|+.+ +++.||||++.+. ....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999987 7899999998653 22345678899999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+||
T Consensus 101 lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccc
Confidence 99999999999999977543 899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+
T Consensus 169 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------------~~ 231 (353)
T 3txo_A 169 GMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---------------DD 231 (353)
T ss_dssp TTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HH
T ss_pred cceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---------------HH
Confidence 99976433222 12456799999999999998999999999999999999999999964421 11
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM------GIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~ell~ 342 (356)
....+.... ..++...+..+.+||.+||+.||.+||++ +++++
T Consensus 232 ~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 232 LFEAILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 222222222 23455567889999999999999999998 77765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=361.15 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=205.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 137 (356)
..++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ...+.+.+|..+++++ +||||+++++++.+.+.++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4578999999999999999999987 78899999986532 2234578899999887 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+||
T Consensus 130 lV~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEcCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeec
Confidence 99999999999999986543 899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......
T Consensus 198 Gla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~-------~~~~~~ 268 (396)
T 4dc2_A 198 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTED 268 (396)
T ss_dssp TTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHH
T ss_pred ceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc-------chhhHH
Confidence 99976433222 125668999999999999999999999999999999999999999644221110 001111
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM 337 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 337 (356)
.+...+.. .....+..++.++.+||.+||+.||.+||++
T Consensus 269 ~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 269 YLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHhc-cccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 12222211 1224556677889999999999999999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=356.32 Aligned_cols=271 Identities=22% Similarity=0.356 Sum_probs=219.7
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCC--CchHHHHHHHHHHHhc-cCCceeeeeeEEecC
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 133 (356)
...++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34578999999999999999999962 45689999997542 2346789999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCC
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~--------------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dl 199 (356)
+..++||||+++|+|.+++......- .......+++..++.++.||+.||.|||++| |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 99999999999999999998654210 0011134789999999999999999999999 999999
Q ss_pred CCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCC
Q 018396 200 KSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 278 (356)
Q Consensus 200 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~ 278 (356)
||+|||++.++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654433323345567889999999999999999999999999999998 99999654
Q ss_pred CCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 279 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.. .......+........+..+++++.+||.+||+.||.+|||+.++++.|+.+++..
T Consensus 279 ~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 279 PV---------------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CC---------------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred Cc---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 21 12333444444445556667889999999999999999999999999999988654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=354.42 Aligned_cols=266 Identities=21% Similarity=0.335 Sum_probs=201.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCC---EEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
..++|++.+.||+|+||.||+|.+. ++. .||||++.... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3468999999999999999999966 333 79999997643 2246788999999999999999999999877655
Q ss_pred ------EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 137 ------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 137 ------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
+++|||+.+++|.+++........ ...+++..++.++.|++.||.|||++| ++||||||+|||++.++
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGEN---PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhcccc---ccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 999999999999999975432111 113889999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceec
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 289 (356)
.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------- 245 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--------- 245 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---------
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh---------
Confidence 999999999987654433322334456889999999999999999999999999999999 9999975421
Q ss_pred ccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
......+........+..++.++.+||.+||+.||.+|||+.++++.|++++...
T Consensus 246 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 246 -------AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -------HHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 2223333333334455667788999999999999999999999999999998755
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=344.92 Aligned_cols=253 Identities=30% Similarity=0.456 Sum_probs=202.8
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc-----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|.+. ++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999986 789999998754322 36788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc--------CCc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--------DDI 211 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--------~~~ 211 (356)
|||+++++|.+++.... +++..++.++.|++.||.|||+++..+++||||||+||+++. ++.
T Consensus 85 ~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 99999999999996543 899999999999999999999997555889999999999986 678
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
++|+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 155 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------- 219 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----------- 219 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----------
T ss_pred eEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------
Confidence 99999999976554322 345689999999999999999999999999999999999999964321
Q ss_pred ccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
................+..+++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 220 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 220 ----LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----HHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1122223333334455666778899999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=351.12 Aligned_cols=244 Identities=24% Similarity=0.351 Sum_probs=209.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.+. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999987 7999999998643 22346678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 85 ~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence 999999999999986542 889999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------------~~~~ 212 (318)
T 1fot_A 153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---------------MKTY 212 (318)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------------HHHH
T ss_pred ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---------------HHHH
Confidence 9765432 2446799999999999999999999999999999999999999964321 1222
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
..++... ...+...+.++.++|.+||+.||.+|| +++++++
T Consensus 213 ~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 213 EKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 2333322 234556678899999999999999999 8899885
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=350.34 Aligned_cols=271 Identities=21% Similarity=0.342 Sum_probs=223.2
Q ss_pred HHhCCCCCCceeeccCceEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEecC
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 133 (356)
...++|++.+.||+|+||.||+|.. .+++.||+|++...... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456899999999999999999985 25779999999765432 46788999999999 999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcE
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (356)
+..++||||+++|+|.+++....... .......+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 99999999999999999998654310 0011224899999999999999999999999 99999999999
Q ss_pred EEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCC
Q 018396 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQ 283 (356)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~ 283 (356)
+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 253 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--- 253 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc---
Confidence 999999999999999987765443323344567889999999999999999999999999999998 9999965421
Q ss_pred ccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 284 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.......+........+..++..+.++|.+||+.||.+|||+.++++.|++++...
T Consensus 254 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 254 ------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp ------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------------hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 12233333444444445567788999999999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=343.47 Aligned_cols=284 Identities=36% Similarity=0.549 Sum_probs=225.3
Q ss_pred ccccCHHHHHHHhCCCCCC------ceeeccCceEEEEEEECCCCEEEEEEcCCCC-----CchHHHHHHHHHHHhccCC
Q 018396 53 VPVISVDELKEKTDNFGTN------SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNE 121 (356)
Q Consensus 53 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~hp 121 (356)
...++..++...+++|... +.||+|+||.||+|... ++.||+|++.... ...+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4566778888888887766 89999999999999874 7899999986532 2246788999999999999
Q ss_pred ceeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 122 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
||+++++++.+.+..+++|||+++++|.+++...... ..+++..++.++.|++.||.|||++| ++|+||||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp 161 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKS 161 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCH
Confidence 9999999999999999999999999999999754321 23889999999999999999999999 99999999
Q ss_pred CcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCC
Q 018396 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (356)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (356)
+||+++.++.++|+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus 162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 999999999999999999876554332222344578999999998765 5889999999999999999999999765332
Q ss_pred CCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 282 GQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
......... .......+...++.. ....+..++..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 241 ~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 QLLLDIKEE-IEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SBTTHHHHH-HHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHH-hhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111000000 000001122222222 235677889999999999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=358.05 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=208.2
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCe
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 135 (356)
....++|++.+.||+|+||.||+|+.+ +++.||+|++.+. ....+.+..|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345689999999999999999999987 7899999998653 23345678899999877 99999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++||||++||+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999986542 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||++......... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 161 DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---------------- 222 (345)
T 1xjd_A 161 DFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---------------- 222 (345)
T ss_dssp CCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----------------
T ss_pred EChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----------------
Confidence 99999764332221 255689999999999999999999999999999999999999996442
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell~ 342 (356)
...+...+... ....+..++.++.+||.+||+.||.+||++. ++++
T Consensus 223 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 223 EEELFHSIRMD-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHHHhC-CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11122222111 1234455678899999999999999999997 6653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=364.48 Aligned_cols=251 Identities=20% Similarity=0.230 Sum_probs=208.4
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
...++|++.+.||+|+||.||+|... +|+.+|+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999987 7999999999765433 3567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc---cCCceeEe
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKIS 215 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~ 215 (356)
||||+.+|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+
T Consensus 88 v~E~~~gg~L~~~i~~~~~---------~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREY---------YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp EECCCBCCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 9999999999999987543 899999999999999999999999 99999999999998 45789999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.....
T Consensus 156 DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------------- 218 (444)
T 3soa_A 156 DFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------------- 218 (444)
T ss_dssp CCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------------
T ss_pred cCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---------------
Confidence 99999776543322 2446799999999999999999999999999999999999999964321
Q ss_pred hhhHhHhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+..... .......+++++.+||.+||+.||.+|||+.++++
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 219 HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111122222211 11222356778999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=346.72 Aligned_cols=261 Identities=24% Similarity=0.405 Sum_probs=219.9
Q ss_pred HHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
...++|++.+.||+|+||.||+|...++..||+|.+.......+.+.+|+++++.++||||+++++++. .+..++||||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 345689999999999999999999888889999999877667788999999999999999999999986 4568999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++...... .+++..++.++.|++.||.|||++| ++|+||||+||++++++.++|+|||++..
T Consensus 89 ~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp CTTCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 9999999999754311 2889999999999999999999999 99999999999999999999999999877
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.... ......
T Consensus 159 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----------------~~~~~~ 221 (279)
T 1qpc_A 159 IEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----------------NPEVIQ 221 (279)
T ss_dssp CSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----------------HHHHHH
T ss_pred ccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC----------------HHHHHH
Confidence 6543222 1233456889999999998889999999999999999999 999996432 222333
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.+........+..++..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 222 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 33333344455567789999999999999999999999999999988654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=356.13 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=208.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..++|++.+.||+|+||.||+|.++ +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999987 7999999999765433 35678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC---ceeEec
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISD 216 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~D 216 (356)
|||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|
T Consensus 107 ~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred EecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEee
Confidence 99999999999997653 2899999999999999999999999 99999999999998654 599999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .
T Consensus 175 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---------------~ 236 (362)
T 2bdw_A 175 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---------------H 236 (362)
T ss_dssp CTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------H
T ss_pred cCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---------------H
Confidence 999987654332 2446799999999999999999999999999999999999999964321 1
Q ss_pred hhHhHhhcccCC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 297 DKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 297 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.....+...... ......+++++.+||.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 237 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111112111111 11113456789999999999999999999998863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=353.77 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=206.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456999999999999999999987 799999999865332 246789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC----ce
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IA 212 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~v 212 (356)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 157 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI 157 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCE
T ss_pred EEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCE
Confidence 99999999999999997543 2899999999999999999999999 99999999999999887 89
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 158 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------ 222 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------ 222 (326)
T ss_dssp EECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------------
T ss_pred EEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------------
Confidence 9999999977643322 2445799999999999999999999999999999999999999964421
Q ss_pred cCChhhHhHhhcccCCCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 293 KLSEDKVKQCVDTKLGGEYP----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+..+.... ...+ ..++..+.+||.+||+.||.+|||+.++++
T Consensus 223 ---~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 223 ---QETLANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ---HHHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHHhcC--CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111111 1112 234578899999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=351.79 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=209.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCE----EEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA----AAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|++.+.||+|+||.||+|.+. +++. |++|.+.... ...+.+.+|+.+++.++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999976 5554 5777775432 33577899999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
++++++.+|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccC
Confidence 89999999999999986542 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.... .
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~----------------~ 225 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------------A 225 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------G
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC----------------H
Confidence 99987655443333344557889999999999999999999999999999999 999996442 2
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
..+...+........+..++.++.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 226 SEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 334444444445555666788899999999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=354.90 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=211.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCE----EEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA----AAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... .....+.+|+.+++.++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467999999999999999999976 5554 7888775432 22356778999999999999999999886 56688
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+|+||+.+|+|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSC
T ss_pred EEEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCC
Confidence 99999999999999976532 2788899999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----------------~ 223 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR----------------L 223 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----------------T
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC----------------H
Confidence 99987655443333345567889999999999999999999999999999999 999997542 2
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
..+...+........+..++.++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 224 AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp THHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 23333444433444455567789999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=348.15 Aligned_cols=245 Identities=26% Similarity=0.379 Sum_probs=205.3
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
|+..+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 667779999999999999987 799999999875443 356788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
++|.+++.... +++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++.....
T Consensus 127 ~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 127 GALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp CBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence 99999987543 899999999999999999999999 99999999999999999999999999876544
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+...
T Consensus 194 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---------------~~~~~~~~~ 256 (321)
T 2c30_A 194 DVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---------------QAMKRLRDS 256 (321)
T ss_dssp SSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------HHHHHHHHS
T ss_pred Cccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhcC
Confidence 3221 24557999999999999999999999999999999999999999644211 111111111
Q ss_pred cC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 306 KL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 306 ~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. .......++..+.++|.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 257 PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 11222345678999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=342.22 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=210.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCch--------HHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--------QEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 368999999999999999999986 89999999986543321 56889999999999999999999987665
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc----
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---- 211 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---- 211 (356)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++. +++||||||+||+++.++.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSC
T ss_pred -eEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCce
Confidence 799999999999999876442 38999999999999999999999862 3999999999999988776
Q ss_pred -eeEecccccCCCccccccccccccccCcCccCccccc--CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee
Q 018396 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 288 (356)
+||+|||++...... .....||+.|+|||++. ...++.++||||||+++|+|++|..||......
T Consensus 167 ~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------- 234 (287)
T 4f0f_A 167 CAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------- 234 (287)
T ss_dssp CEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-------
T ss_pred eEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-------
Confidence 999999998755432 24457899999999984 456789999999999999999999999654211
Q ss_pred cccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
.................+..+++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 235 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 235 ------KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------HHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11112223334444556667788999999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=347.85 Aligned_cols=249 Identities=25% Similarity=0.318 Sum_probs=199.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---------------------------chHHHHHHHHHH
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------------------------PDQEFLAQVSMV 115 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~e~~~l 115 (356)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3578999999999999999999986 789999999865431 124688999999
Q ss_pred HhccCCceeeeeeEEec--CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 018396 116 SRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193 (356)
Q Consensus 116 ~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ 193 (356)
+.++||||+++++++.+ ....++||||+++++|.+++... .+++..++.++.|++.||.|||++|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999999999986 67899999999999998865432 2899999999999999999999999
Q ss_pred eeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCC---CCccchhhhHHHHHHHHHc
Q 018396 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLT 270 (356)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~ 270 (356)
|+||||||+|||++.++.+||+|||++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 999999999999999999999999998766543222 23457999999999998765 3788999999999999999
Q ss_pred CCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 271 GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 271 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
|..||..... ......+............++.++.+||.+||+.||.+|||+.++++
T Consensus 236 g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 236 GQCPFMDERI---------------MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSCSSCCSSH---------------HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCCccH---------------HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9999964311 01111111111211222345678999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=358.47 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=208.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999987 7899999998642 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+.||+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 94 ~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVH---------FKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp ECCCTTEEHHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccce
Confidence 999999999999986542 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccC---CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
+........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..
T Consensus 162 a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-------------~~ 225 (384)
T 4fr4_A 162 AAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-------------SS 225 (384)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-------------CH
T ss_pred eeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-------------cH
Confidence 987654322 255679999999999874 45899999999999999999999999644221 11
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-MGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ell~ 342 (356)
......+.. ....++..++..+.+||.+||+.||.+||+ ++++++
T Consensus 226 ~~~~~~~~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 226 KEIVHTFET-TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHH-CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHhh-cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112222111 123455567789999999999999999998 677664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=353.90 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=206.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3578999999999999999999986 8999999998642 2224578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+ +|+|.+++..... +++..++.++.|++.||.|||++| |+||||||+|||+++++.+||+|||
T Consensus 87 v~E~~-~g~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKR---------MTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp EECCC-CEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EEECC-CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEec
Confidence 99999 6799998876542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++......... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||............
T Consensus 154 ~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------- 220 (336)
T 3h4j_B 154 LSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------- 220 (336)
T ss_dssp CTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------
T ss_pred cceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------
Confidence 99876544322 45579999999999988776 78999999999999999999999754322111110
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. .....+...++++.+||.+||+.||.+|||++|+++
T Consensus 221 ------~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 ------NS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ------CS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ------Hc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 011233445678999999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=343.24 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=203.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
..++|++.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34689999999999999999999752 457999998764433 356889999999999999999999984 56789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+.+++|.+++..... .+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcc
Confidence 99999999999999976532 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---------------- 223 (281)
T 1mp8_A 161 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---------------- 223 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----------------
T ss_pred ccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH----------------
Confidence 999876543221 1233456789999999998999999999999999999997 9999975421
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
......+........+..++..+.++|.+||+.||.+|||+.++++.|+++++.
T Consensus 224 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 224 NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 122222333333345566778899999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=344.94 Aligned_cols=265 Identities=18% Similarity=0.281 Sum_probs=214.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCC--eeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 139 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999987 69999999997533 23467789999999999999999999988655 78999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE----ccCCceeEe
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKIS 215 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~ 215 (356)
|||+++++|.+++...... ..+++..++.++.|++.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred EeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEc
Confidence 9999999999999865432 12889999999999999999999999 9999999999999 777889999
Q ss_pred cccccCCCccccccccccccccCcCccCccccc--------CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
|||++......... ....||+.|+|||++. +..++.++|||||||++|+|++|..||.........
T Consensus 159 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--- 232 (319)
T 4euu_A 159 DFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--- 232 (319)
T ss_dssp CCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC---
T ss_pred cCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh---
Confidence 99999776544322 3456999999999886 577899999999999999999999999654321110
Q ss_pred ecccccCChhhHhHhhc-----------------------ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 288 TWATPKLSEDKVKQCVD-----------------------TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
...+..++. .......+...+..+.++|.+||+.||++|||++|+++..
T Consensus 233 --------~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 233 --------KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp --------HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred --------HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 001111110 1112245678899999999999999999999999999998
Q ss_pred HHhhccCC
Q 018396 345 QPLLNTRS 352 (356)
Q Consensus 345 ~~l~~~~~ 352 (356)
.+......
T Consensus 305 ~d~~~~~~ 312 (319)
T 4euu_A 305 SDILHRGN 312 (319)
T ss_dssp HHHTC---
T ss_pred HHHhhcCC
Confidence 87654443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=350.96 Aligned_cols=265 Identities=20% Similarity=0.287 Sum_probs=203.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|++.+.||+|+||.||+|.+.+++.||+|++...... ...+.+|+.+++.++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999988999999999754332 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++ +|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 99 e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp ECCSE-EHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cCCCC-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCc
Confidence 99986 88888876542 2889999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh--
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED-- 297 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 297 (356)
......... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......................
T Consensus 167 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 167 RAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp EETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred eecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 766433221 234568999999999876 568999999999999999999999997654332111100000000000
Q ss_pred ----hHhHhhcccC--CCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 ----KVKQCVDTKL--GGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ----~~~~~~~~~~--~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.......... ... ....++.++.+||.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000 000 11234568899999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=350.91 Aligned_cols=268 Identities=23% Similarity=0.381 Sum_probs=219.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEec
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~ 132 (356)
..++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999863 4678999999765433 35688999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEE
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (356)
.+..++||||+++++|.+++........ ......+++..++.++.||+.||.|||++| ++|+||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999986542110 011224889999999999999999999999 999999999999
Q ss_pred EccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~ 284 (356)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------ 263 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------ 263 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC------
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC------
Confidence 99999999999999976654433222344457889999999998889999999999999999999 99999643
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
....+...+........+..++..+.++|.+||+.||.+|||+.++++.|++++..
T Consensus 264 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 264 ----------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp ----------CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 22333334444444455566778899999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=356.17 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=193.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4578999999999999999999987 68899999997543 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCceeEecccc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDL 219 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~Dfg~ 219 (356)
+++++|.+++..... +++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 130 ~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 130 VTGGELFDRIVEKGY---------YSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp CCSCBHHHHHTTCSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 999999999976532 889999999999999999999999 999999999999975 88999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------------~~~~ 260 (349)
T 2w4o_A 198 SKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--------------QFMF 260 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--------------HHHH
T ss_pred ccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--------------HHHH
Confidence 886644322 24457899999999999999999999999999999999999999644211 0111
Q ss_pred hHhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+..... .......++.++.+||.+||+.||.+|||+.++++
T Consensus 261 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 261 RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22222211 11222456778999999999999999999999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=353.75 Aligned_cols=244 Identities=21% Similarity=0.283 Sum_probs=209.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999987 7999999998643 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 120 ~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccccc
Confidence 999999999999986542 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------------~~~~ 247 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------------IQIY 247 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HHHH
T ss_pred ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---------------HHHH
Confidence 9766432 2445799999999999999999999999999999999999999964321 1112
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~ 342 (356)
..+.... ...+..++.++.++|.+||+.||.+||+ ++++++
T Consensus 248 ~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 248 EKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2222222 2345566788999999999999999998 888876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=375.03 Aligned_cols=264 Identities=26% Similarity=0.442 Sum_probs=224.8
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
....++|++.+.||+|+||.||+|.+..+..||||++.......+.+.+|+.+|+.++||||+++++++.+ ...++|||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 33456788899999999999999999877889999998776667889999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 342 ~~~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp CCTTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred hhcCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 99999999999753221 2889999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||... ....+.
T Consensus 412 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~----------------~~~~~~ 474 (535)
T 2h8h_A 412 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----------------VNREVL 474 (535)
T ss_dssp TCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC----------------CHHHHH
T ss_pred ecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----------------CHHHHH
Confidence 76543222 1233456789999999999999999999999999999999 99999643 233344
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
..+....+...+..++..+.+||.+||+.||++|||+++|++.|+++.....+
T Consensus 475 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 475 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 44555555566777888999999999999999999999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=364.10 Aligned_cols=254 Identities=19% Similarity=0.252 Sum_probs=209.6
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCC
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 134 (356)
++....++|++.+.||+|+||.||+|+.+ +++.||+|++.+. ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999987 7899999998642 222345789999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.+++||||++||+|.+++.... +++..++.++.||+.||.|||++| |+||||||+|||++.+|++||
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL 209 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL 209 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEE
Confidence 9999999999999999997643 889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCC----CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
+|||++......... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 210 ~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------- 278 (410)
T 3v8s_A 210 ADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---------- 278 (410)
T ss_dssp CCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH----------
T ss_pred eccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh----------
Confidence 999999766543221 224567999999999998765 78999999999999999999999964421
Q ss_pred cccCChhhHhHhhccc--CCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 018396 291 TPKLSEDKVKQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADF--RPNMGIVLK 342 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~ 342 (356)
......++... ........++.++.+||.+||+.+|.+ ||+++||++
T Consensus 279 -----~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 279 -----VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -----HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -----hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 11222222211 111112245678999999999999988 999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=350.37 Aligned_cols=252 Identities=22% Similarity=0.271 Sum_probs=205.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC------CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|++.+.||+|+||.||+|.++ +++.||||++... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999987 7999999998532 223567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc---eeE
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKI 214 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---vkl 214 (356)
+||||+++++|.+++....... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAG-----FVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEE
T ss_pred EEEeCCCCCCHHHHHHHhcccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEE
Confidence 9999999999998886543211 23789999999999999999999999 999999999999987654 999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 175 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------- 237 (351)
T 3c0i_A 175 GGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------------- 237 (351)
T ss_dssp CCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------------
T ss_pred ecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------------
Confidence 999999776543221 244579999999999999999999999999999999999999996431
Q ss_pred ChhhHhHhhcccCCCCC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 295 SEDKVKQCVDTKLGGEY--PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+......... ...++.++.+||.+||+.||.+|||+.++++
T Consensus 238 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 238 -ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111122221111100 0134678999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=348.44 Aligned_cols=276 Identities=22% Similarity=0.334 Sum_probs=209.5
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc--cCCceeeeeeEEecC----
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL--KNENVVELVGYYVDG---- 133 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l--~hp~iv~~~~~~~~~---- 133 (356)
......++|++.+.||+|+||.||+|... ++.||||++... .......|.+++..+ +||||+++++++.+.
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc--ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 34455678999999999999999999987 889999998543 234455566665554 999999999999877
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC--------CCCCeeecCCCCCcEE
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK--------AEPRIIHRNIKSSNVL 205 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~~~~ivH~Dlkp~Nil 205 (356)
...++||||+++|+|.+++.... +++..++.++.|++.||.|||++ + |+||||||+|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nil 174 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNIL 174 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEE
T ss_pred CceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEE
Confidence 78999999999999999997653 89999999999999999999998 8 999999999999
Q ss_pred EccCCceeEecccccCCCccccccc--cccccccCcCccCcccccCCCCCcc------chhhhHHHHHHHHHcCCCCCCC
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSK------SDVYSFGVVLLELLTGRKPVDH 277 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~~l~~g~~pf~~ 277 (356)
++.++.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|+|++|..|+..
T Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 9999999999999997654432211 1134579999999999988776655 9999999999999999544432
Q ss_pred CCCCCCccceecccccCChhhHhHhhc-ccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 278 TLPRGQQSLVTWATPKLSEDKVKQCVD-TKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
..... ...................+. .......+ ..++.++.+||.+||+.||.+|||+.++++.|+.+.+..
T Consensus 255 ~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 255 VEEYQ-LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCCCC-CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccc-ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 11100 000000001111122222221 22223333 278899999999999999999999999999999998776
Q ss_pred C
Q 018396 352 S 352 (356)
Q Consensus 352 ~ 352 (356)
.
T Consensus 334 ~ 334 (337)
T 3mdy_A 334 D 334 (337)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=353.59 Aligned_cols=249 Identities=21% Similarity=0.275 Sum_probs=208.4
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCee
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 136 (356)
...++|++.+.||+|+||.||+|+.+ +++.||+|++.+. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 35678999999999999999999987 6889999998653 23346678899999988 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
|+||||++||+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEe
Confidence 999999999999999986542 899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .
T Consensus 165 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------------~ 227 (353)
T 2i0e_A 165 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------------D 227 (353)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------H
T ss_pred CCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---------------H
Confidence 999976433222 12456799999999999999999999999999999999999999964321 1
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~ 342 (356)
.....+.... ..++...+.++.+||.+||+.||.+||+ ++++++
T Consensus 228 ~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 228 ELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1222222222 2345567789999999999999999995 477765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=350.62 Aligned_cols=272 Identities=23% Similarity=0.380 Sum_probs=220.0
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEe
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYV 131 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~ 131 (356)
++....++|++.+.||+|+||.||+|.+. +++.||+|.+...... ...+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445678999999999999999999854 3678999999765433 346889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhcCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 132 DGPLRVLAYEHASKGSLHDILHGKKGVK-GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 132 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
+.+..++||||+++++|.+++....... .......+++..++.++.|++.||.|||++| |+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 9999999999999999999997532100 0000112689999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceec
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 289 (356)
.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---------- 245 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------- 245 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----------
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC----------
Confidence 999999999986654433322344567899999999999999999999999999999999 899996432
Q ss_pred ccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.......+........+..++..+.++|.+||+.||.+|||+.++++.|++++..
T Consensus 246 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 246 ------NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ------HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 2222333322223344556778899999999999999999999999999887653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=350.80 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=207.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 138 (356)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+.... .+.+.+|..+++.+ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999987 7899999999754322 34577899999988 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||
T Consensus 88 v~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp EECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999976542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 156 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~~~~~ 226 (345)
T 3a8x_A 156 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDY 226 (345)
T ss_dssp GCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHH
T ss_pred ccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc-------ccccHHH
Confidence 9976433222 124567999999999999999999999999999999999999999643211100 0011112
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM------GIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~ell~ 342 (356)
+...+... ....+...+.++.+||.+||+.||.+||++ .++++
T Consensus 227 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 227 LFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred HHHHHHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 22222211 224455677889999999999999999996 56654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=338.51 Aligned_cols=254 Identities=21% Similarity=0.324 Sum_probs=213.2
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC--CeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 139 (356)
.++|++.+.||+|+||.||+|.+. ++.||+|++...... .+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467999999999999999999987 888999999865433 35688999999999999999999999877 788999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|.+++...... .+++..++.++.|++.||.|||+++. +++|+||||+||+++.++.++|+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EECCTTCBHHHHHHSCSSC-------CCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred ecccCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccc
Confidence 9999999999999865431 38999999999999999999999753 399999999999999999999999988
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCc---cchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
+..... ....||+.|+|||++.+..++. ++||||||+++|+|++|..||.... ..
T Consensus 160 ~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---------------~~ 217 (271)
T 3kmu_A 160 KFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NM 217 (271)
T ss_dssp CCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC---------------HH
T ss_pred eeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC---------------hH
Confidence 654322 3346899999999998765544 7999999999999999999996432 11
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
...............+..++..+.++|.+||+.||.+|||++++++.|+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 22233334444455666778899999999999999999999999999999865
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=351.99 Aligned_cols=252 Identities=21% Similarity=0.359 Sum_probs=204.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccC--CceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|...+++.||||++...... .+.+.+|+.+++.++| |||+++++++.+....++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34679999999999999999999888999999998765433 3567899999999976 999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||| +.+++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||
T Consensus 87 v~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG 152 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG 152 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EEe-CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecc
Confidence 999 557799999987542 889999999999999999999999 99999999999996 6889999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccC-----------CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------- 225 (343)
T 3dbq_A 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------- 225 (343)
T ss_dssp SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------
T ss_pred cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------
Confidence 9987755433323345679999999999865 6789999999999999999999999964311
Q ss_pred ecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
........++.......+...+.++.+||.+||+.||.+|||+.++++.
T Consensus 226 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 226 -------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1123344444444445555566789999999999999999999999873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=341.54 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=216.1
Q ss_pred hCCCCCCc-eeeccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 65 TDNFGTNS-LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
.++|.+.. .||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 9999999999999854 5778999999765332 46788999999999999999999999 5567899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+.+++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCT
T ss_pred EEEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccc
Confidence 9999999999999975432 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----------------~ 219 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----------------G 219 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------T
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----------------H
Confidence 98766433221 11233456889999999998889999999999999999998 999996442 2
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
......+........+..+++.+.++|.+||+.||.+|||+.++++.|+.+..+...
T Consensus 220 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 220 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 233333444444456667788999999999999999999999999999998865433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=348.64 Aligned_cols=261 Identities=19% Similarity=0.259 Sum_probs=211.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||+|+||.||+|... +++.||||++..... .+.+.+|+.+++.+ +||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 468999999999999999999976 789999999865433 34588999999999 999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc-----eeEecc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-----AKISDF 217 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl~Df 217 (356)
+ +++|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++. +||+||
T Consensus 87 ~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 87 L-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred C-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 9 8899999986421 2899999999999999999999999 999999999999998887 999999
Q ss_pred cccCCCccccccc-----cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 218 DLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 218 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
|++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--------- 225 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--------- 225 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH---------
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH---------
Confidence 9998654432211 12456799999999999999999999999999999999999999976532110
Q ss_pred cCChhhHhHhhcccCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 293 KLSEDKVKQCVDTKLGGEY---PPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
......+......... ...++ ++.+++..||+.||.+||++.+|++.|+++....
T Consensus 226 ---~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 226 ---KERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ---HHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---HHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0111111111110000 01134 8999999999999999999999999999887543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=349.13 Aligned_cols=270 Identities=24% Similarity=0.374 Sum_probs=219.6
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC-CC-----CEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEec
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SG-----RAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~ 132 (356)
....++|++.+.||+|+||.||+|.+. ++ ..||+|.+...... .+.+.+|+.+++.+ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 344578999999999999999999975 33 47999999765432 35688999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (356)
.+..++||||+++|+|.+++........ ......+++..++.++.|++.||.|||++| |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 9999999999999999999975431100 001123789999999999999999999999 99999999999999
Q ss_pred cCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccc
Q 018396 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 286 (356)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~ 286 (356)
.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------ 272 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV------ 272 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS------
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch------
Confidence 999999999999986654333222344567889999999999999999999999999999998 9999965421
Q ss_pred eecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 287 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
.......+........+..++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus 273 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 273 ---------NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp ---------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 122333444444444455567889999999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=342.34 Aligned_cols=263 Identities=18% Similarity=0.205 Sum_probs=214.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 467999999999999999999975 79999999986543 335688999999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc-----eeEecc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-----AKISDF 217 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl~Df 217 (356)
+ +++|.+++..... .+++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+||
T Consensus 88 ~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 88 L-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred c-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 9 8899999986532 2899999999999999999999999 999999999999987775 999999
Q ss_pred cccCCCcccccc-----ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 218 DLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 218 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
|++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--------- 226 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--------- 226 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH---------
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc---------
Confidence 999766543221 112455799999999999999999999999999999999999999976432111
Q ss_pred cCChhhHhHhhcccCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 293 KLSEDKVKQCVDTKLGG---EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
......+....... .....+++++.+++.+||+.||.+|||+++|++.|+++++...
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 227 ---KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp ---HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---HHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 11111111111000 1112346789999999999999999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=358.31 Aligned_cols=252 Identities=18% Similarity=0.238 Sum_probs=196.5
Q ss_pred HhCCCCCC-ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHH-hccCCceeeeeeEEec----CCee
Q 018396 64 KTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVS-RLKNENVVELVGYYVD----GPLR 136 (356)
Q Consensus 64 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~----~~~~ 136 (356)
..++|.+. +.||+|+||+||+|.++ +++.||||++.. ...+.+|+.++. ..+||||+++++++.. ...+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 45677776 68999999999999987 799999999853 245778888874 4589999999998875 6678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCcee
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (356)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEE
Confidence 999999999999999986532 13899999999999999999999999 999999999999997 78999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|+|||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 205 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------- 271 (400)
T 1nxk_A 205 LTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------- 271 (400)
T ss_dssp ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS----------
T ss_pred EEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc----------
Confidence 999999976543322 2456789999999999999999999999999999999999999976533211
Q ss_pred CChhhHhHhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 294 LSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 294 ~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.......+..... .......++.++.+||.+||+.||.+|||+.++++.
T Consensus 272 -~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 272 -SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011111111111 111123467789999999999999999999999973
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=355.52 Aligned_cols=250 Identities=21% Similarity=0.261 Sum_probs=208.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||+|..+ +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4578999999999999999999987 789999999875433 24568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc--CCceeEecccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDL 219 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~ 219 (356)
|+.+++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 129 ~~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 129 FLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp CCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred cCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999999975431 2899999999999999999999999 999999999999974 47899999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+
T Consensus 198 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---------------~~~~ 259 (387)
T 1kob_A 198 ATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---------------LETL 259 (387)
T ss_dssp CEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---------------HHHH
T ss_pred ceecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---------------HHHH
Confidence 9876543221 345689999999999999999999999999999999999999975421 1111
Q ss_pred hHhhccc--CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+.... ........++.++.+||.+||+.||.+|||+.++++
T Consensus 260 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 260 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1111111 112233456778999999999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=347.26 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=199.2
Q ss_pred hCCCCCCceeeccCceEEEEEEE----CCCCEEEEEEcCCCC-----CchHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999997 378999999997642 223457889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++||||+++++|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGI---------FMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEE
Confidence 9999999999999999976542 889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 164 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------- 226 (327)
T 3a62_A 164 DFGLCKESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------------- 226 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------------
T ss_pred eCCcccccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---------------
Confidence 99998764332221 2455799999999999999999999999999999999999999964421
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
......+.... ...+...+.++.+||.+||+.||.+|| ++.++++
T Consensus 227 ~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 227 KKTIDKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11122222222 234455678899999999999999999 7778876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=346.89 Aligned_cols=276 Identities=21% Similarity=0.330 Sum_probs=222.3
Q ss_pred CHHHHHHHhCCCCCCceeeccCceEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeee
Q 018396 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELV 127 (356)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~ 127 (356)
...++....++|++.+.||+|+||.||+|.+ .+++.||||++...... ...+.+|+.+++.+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445555678999999999999999999984 25689999999765443 34688999999999 789999999
Q ss_pred eEEecCC-eeEEEEEecCCCCHHHHHhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCC
Q 018396 128 GYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (356)
Q Consensus 128 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dl 199 (356)
+++...+ ..++||||+++++|.+++......... .....+++..++.++.|++.||.|||+++ ++||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987654 589999999999999999876431100 00123789999999999999999999999 999999
Q ss_pred CCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCC
Q 018396 200 KSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 278 (356)
Q Consensus 200 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~ 278 (356)
||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654333323345567899999999999999999999999999999998 99999654
Q ss_pred CCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 279 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.. ...+...+........+..+++.+.++|.+||+.||.+|||+.++++.|+.++..
T Consensus 255 ~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 255 KI---------------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CC---------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ch---------------hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 21 1222233333333344555677899999999999999999999999999998854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=355.77 Aligned_cols=249 Identities=20% Similarity=0.360 Sum_probs=202.9
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc--CCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK--NENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||.||+|...+++.||||++...... .+.+.+|+.+++.++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999998765433 356889999999996 599999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
| +.+++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 136 E-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp E-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred e-cCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 9 567799999986542 788999999999999999999999 99999999999995 689999999999
Q ss_pred CCCccccccccccccccCcCccCcccccC-----------CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 289 (356)
................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------- 272 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--------- 272 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---------
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---------
Confidence 87754433222345679999999999865 3688999999999999999999999964311
Q ss_pred ccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+..+++.......+...+.++.+||.+||+.||.+|||+.++++
T Consensus 273 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 273 -----QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -----HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 112334444444444445455678999999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=341.15 Aligned_cols=263 Identities=19% Similarity=0.267 Sum_probs=201.2
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|++.+.||+|+||+||+|.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999987 7899999999754333 3678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+ +|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 9987 66666654321 2899999999999999999999999 9999999999999999999999999997
Q ss_pred CCccccccccccccccCcCccCcccccCCC-CCccchhhhHHHHHHHHHcCCCCCCCCCCCC-CccceecccccCChhh-
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRG-QQSLVTWATPKLSEDK- 298 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~- 298 (356)
........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ................
T Consensus 150 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 150 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred ecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 66433222 24457899999999998765 7999999999999999999888863322110 0000000000000000
Q ss_pred --HhHhhc---------ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 --VKQCVD---------TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 --~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.....+ ...........+.++.+||.+||+.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000 00011222346678999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=343.78 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=202.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHh--ccCCceeeeeeEEec----CCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVD----GPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hp~iv~~~~~~~~----~~~~~ 137 (356)
..++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++.+ ....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 356899999999999999999988 4889999998653 34556667777666 799999999998654 35689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeeecCCCCCcEEEccC
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--------EKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
+||||+++|+|.+++.... +++..++.++.|++.||.||| +.+ |+||||||+|||++.+
T Consensus 83 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTT
T ss_pred EehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCC
Confidence 9999999999999996543 899999999999999999999 888 9999999999999999
Q ss_pred CceeEecccccCCCcccccc--ccccccccCcCccCcccccCC------CCCccchhhhHHHHHHHHHcC----------
Q 018396 210 DIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLELLTG---------- 271 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g---------- 271 (356)
+.+||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 99999999998654332221 112344799999999999876 455789999999999999999
Q ss_pred CCCCCCCCCCCCccceecccccCChhhHhHhhc-ccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 272 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD-TKLGGEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 272 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
..||....+.. ........... ....... +..++..+.+||.+||+.||.+|||+.++++.|+
T Consensus 230 ~~pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 230 KPPFYDVVPND-----------PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp CCTTTTTSCSS-----------CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccccccCCCC-----------cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 66765432211 11122222211 1112222 2357789999999999999999999999999998
Q ss_pred Hh
Q 018396 346 PL 347 (356)
Q Consensus 346 ~l 347 (356)
++
T Consensus 299 ~i 300 (301)
T 3q4u_A 299 KI 300 (301)
T ss_dssp HH
T ss_pred cc
Confidence 76
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=351.06 Aligned_cols=270 Identities=26% Similarity=0.371 Sum_probs=218.1
Q ss_pred CCCCceeeccCceEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEec--CCeeEE
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVL 138 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 138 (356)
|++.+.||+|+||.||++.+. +++.||||++...... .+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999988642 6889999999865432 3568899999999999999999999987 467899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++.... +++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||
T Consensus 113 v~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred EEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcc
Confidence 999999999999997654 889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...... ......+........
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTVL 258 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhHH
Confidence 99876543221 1123455788899999999989999999999999999999999998643110 000001111112222
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.+...+........+..++.++.+||.+||+.||.+|||+.++++.|+.+.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 344445555555667778889999999999999999999999999999987654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=344.16 Aligned_cols=267 Identities=22% Similarity=0.335 Sum_probs=205.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCC--
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP-- 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-- 134 (356)
..++|.+.+.||+|+||.||+|... ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4567999999999999999999854 3458999999765433 356889999999999999999999988655
Q ss_pred ---eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 135 ---LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 135 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
..++||||+++++|.+++........ ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETG---PKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTS---CCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcC---CccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 35999999999999999964432111 123899999999999999999999999 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 290 (356)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------- 255 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---------- 255 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----------
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH----------
Confidence 99999999987654432222344557889999999999999999999999999999999 8999964421
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
......+........+..++..+.++|.+||+.||.+|||+.++++.|+++++...
T Consensus 256 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 256 ------HEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ------GGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ------HHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 22222232333334555677889999999999999999999999999999987643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=346.86 Aligned_cols=266 Identities=26% Similarity=0.389 Sum_probs=214.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEE--EEEEcCCC--CCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAA--AIKKLDSS--KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~v--avK~~~~~--~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 138 (356)
.++|++.+.||+|+||.||+|+.. ++..+ |+|.+... ....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367999999999999999999976 56644 89988643 22346788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 139 AYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
||||+++++|.+++........ ......+++..++.++.||+.||.|||++| ++||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 9999999999999976531000 001123899999999999999999999999 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 290 (356)
+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 181 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~----------- 246 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----------- 246 (327)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------
T ss_pred EEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-----------
Confidence 99999999875433221 133456889999999998889999999999999999998 999996442
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
.......+........+..++..+.+||.+||+.||.+|||+.++++.|+.++....
T Consensus 247 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 247 -----CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp -----HHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -----HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 222333333333444556677889999999999999999999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=348.03 Aligned_cols=252 Identities=20% Similarity=0.316 Sum_probs=201.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCC------
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 134 (356)
..++|++.+.||+|+||.||+|+++ +++.||||++..... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4567999999999999999999987 899999999865432 3467899999999999999999999986543
Q ss_pred ---------------------------------------------------eeEEEEEecCCCCHHHHHhcCCCCCCCCC
Q 018396 135 ---------------------------------------------------LRVLAYEHASKGSLHDILHGKKGVKGAKP 163 (356)
Q Consensus 135 ---------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 163 (356)
..+++|||+++++|.+++.......
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---- 159 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE---- 159 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG----
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc----
Confidence 3799999999999999998754321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcccccc----------cccc
Q 018396 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR----------LHST 233 (356)
Q Consensus 164 ~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~ 233 (356)
...+..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++......... ....
T Consensus 160 --~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 160 --DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp --GSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred --chhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 2567788999999999999999999 999999999999999999999999998876543211 1123
Q ss_pred ccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCH
Q 018396 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP 313 (356)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (356)
...||+.|+|||++.+..++.++|||||||++|+|++|..|+... .................
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~ 296 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------------------VRIITDVRNLKFPLLFT 296 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------------------HHHHHHHHTTCCCHHHH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------------------HHHHHHhhccCCCcccc
Confidence 456999999999999999999999999999999999987765211 11111111111111223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 314 KAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 314 ~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..++.+.+||.+||+.||.+|||+.++++
T Consensus 297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 297 QKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred cCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 55678899999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=355.79 Aligned_cols=245 Identities=20% Similarity=0.277 Sum_probs=197.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHH-HHhccCCceeeeeeEEecCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
..++|++.+.||+|+||.||+|+.+ +++.||+|++.+... ....+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3468999999999999999999987 788999999865432 23445666665 57789999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||++||+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+||
T Consensus 116 lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999986542 889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+
T Consensus 184 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---------------~~~ 246 (373)
T 2r5t_A 184 GLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---------------TAE 246 (373)
T ss_dssp CBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---------------HHH
T ss_pred ccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---------------HHH
Confidence 99875332221 2255689999999999999999999999999999999999999996431 112
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGI 339 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e 339 (356)
....++.... ..+..++..+.+||.+||+.||.+||++.+
T Consensus 247 ~~~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 247 MYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 2222333222 334456778999999999999999999853
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=343.09 Aligned_cols=266 Identities=19% Similarity=0.317 Sum_probs=204.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467999999999999999999976 799999999975332 23567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+.+++|.+++....... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg 181 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQK-----RLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLG 181 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-
T ss_pred EEecCCCCCHHHHHHHhcccc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEecc
Confidence 999999999999997532111 12889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++......... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ....
T Consensus 182 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------------~~~~ 245 (310)
T 2wqm_A 182 LGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--------------NLYS 245 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C--------------CHHH
T ss_pred ceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch--------------hHHH
Confidence 98765443221 2345689999999999999999999999999999999999999964311 1111
Q ss_pred HhHhh-cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 299 VKQCV-DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 299 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
....+ ...........++.++.++|.+||+.||.+|||+.++++.|+++.+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 11111 11122222245677899999999999999999999999999999866543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=341.59 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=204.1
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||+|... ++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 357899999999999999999986 788999998643 345678999999999999999999998764 4899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh---CCCCCeeecCCCCCcEEEccCCc-eeEeccccc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE---KAEPRIIHRNIKSSNVLLFDDDI-AKISDFDLS 220 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~~ivH~Dlkp~Nill~~~~~-vkl~Dfg~a 220 (356)
+++|.+++...... ..+++..++.++.|++.||.|||+ ++ |+||||||+||+++.++. +||+|||++
T Consensus 83 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 83 GGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred CCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccc
Confidence 99999999865421 126889999999999999999999 66 999999999999998886 799999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....
T Consensus 154 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------------~~~~~ 214 (307)
T 2eva_A 154 CDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--------------AFRIM 214 (307)
T ss_dssp ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--------------HHHHH
T ss_pred ccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--------------HHHHH
Confidence 7654321 3346899999999999999999999999999999999999999643211 11111
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
..+........+..++..+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 215 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 215 WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 112222233344556778999999999999999999999999999987544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=343.85 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=200.6
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|++.+.||+|+||.||+|...+++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999988999999999765432 36788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+ +|.+++..... .+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp CSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred cCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 986 99999976532 2889999999999999999999999 99999999999999999999999999865
Q ss_pred CccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec-----ccccCCh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-----ATPKLSE 296 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~ 296 (356)
....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.............. ....+..
T Consensus 150 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 150 FGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 4322211 1344689999999998764 589999999999999999999999975432110000000 0000000
Q ss_pred hhHhHhhcccCC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDTKLG-------GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.......+.... .......+.++.+||.+||+.||.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000 0112235678899999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=339.90 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=198.7
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.++|++.+.||+|+||.||+|... ..||+|++...... .+.+.+|+.+++.++||||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999865 35999999765443 35688999999999999999999965 5567899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 100 ~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 100 WCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred ecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 9999999999965432 2889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
...............||+.|+|||++. +..++.++||||||+++|+|++|..||..... ...
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------------~~~ 233 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---------------RDQ 233 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC---------------HHH
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch---------------HHH
Confidence 655433222234557899999999986 56788899999999999999999999965421 112
Q ss_pred HhHhhcccC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 299 VKQCVDTKL----GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 299 ~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
+...+.... .......++..+.+||.+||+.||.+|||+.++++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 222222111 112234567889999999999999999999999999998864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=342.60 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=212.4
Q ss_pred HhCCCCCCc-eeeccCceEEEEEEE--C-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 64 KTDNFGTNS-LIGEGSYGRVYFGVL--R-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 64 ~~~~~~~~~-~lg~G~~g~V~~~~~--~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
..++|++.+ .||+|+||.||+|.+ . +++.||||++...... .+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788887 999999999999964 3 5788999999765332 46788999999999999999999999 56778
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++||||+++++|.+++..... +++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhCcC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEcc
Confidence 999999999999999987542 889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccC
Q 018396 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---------------- 224 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---------------- 224 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC----------------
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC----------------
Confidence 99987664432211 1123346788999999998889999999999999999999 99999643
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
....+...+........+..++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 225 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22333444444444455667788999999999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=339.25 Aligned_cols=263 Identities=23% Similarity=0.339 Sum_probs=211.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEE-ecCCee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYY-VDGPLR 136 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~-~~~~~~ 136 (356)
...+|++.+.||+|+||.||+|.... ...+|+|.+...... .+.+.+|+.++++++||||+++++++ ...+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34578999999999999999999642 236899998764433 35688999999999999999999985 456688
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
+++|||+.+++|.+++..... .+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECS
T ss_pred EEEEeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECc
Confidence 999999999999999976432 2789999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc--ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccccc
Q 018396 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.....
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------------- 238 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------------- 238 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-------------
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-------------
Confidence 9999876543321 11234457889999999999999999999999999999999 6666654321
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
......+........+..++..+.+++.+||+.||.+|||++++++.|+++++....
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 239 ---FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ---TTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ---HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111222222223333445667899999999999999999999999999999886654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=338.07 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=211.7
Q ss_pred CCCCCceeeccCceEEEEEEEC-CC---CEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCee-EEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR-VLA 139 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~lv 139 (356)
.|++.+.||+|+||.||+|.+. ++ ..+|+|.+...... .+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666789999999999999854 23 37999998764443 35688999999999999999999999876655 999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
+||+.+++|.+++..... .+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||+
T Consensus 102 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp ECCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred EecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCC
Confidence 999999999999976432 2789999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccc--ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 220 SNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 220 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
+......... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+... ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~---------------~~~~ 235 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH---------------IDPF 235 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---------------SCGG
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc---------------CCHH
Confidence 9866543321 1223456789999999999999999999999999999999955554322 1222
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
.....+........+..++..+.+++.+||+.||.+|||+.++++.|+++++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 236 DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2333333333444555667889999999999999999999999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=345.17 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=209.5
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-C----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
.++|++.+.||+|+||.||+|... + +..||+|++...... ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 357888899999999999999865 2 235999999765433 346889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+++++|.+++..... .+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+||
T Consensus 123 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCC
Confidence 99999999999999976432 2899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCC
Q 018396 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 218 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||... .
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~----------------~ 255 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----------------S 255 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----------------C
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC----------------C
Confidence 999876543221 11123346788999999999999999999999999999998 99999643 2
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
...+...+........+..++..+.++|.+||+.||.+||++.++++.|++++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 256 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 22333333334344455667788999999999999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=361.67 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=208.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3478999999999999999999987 89999999986432 224578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 94 v~E~~~gg~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGR---------LDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEECCSSEEHHHHTTSSSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence 9999999999999976432 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ..
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---------------~~ 223 (476)
T 2y94_A 162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---------------PT 223 (476)
T ss_dssp SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---------------HH
T ss_pred chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---------------HH
Confidence 9977654322 245579999999999998776 7899999999999999999999964421 11
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+..... ..+...++++.+||.+||+.||.+|||+.++++
T Consensus 224 ~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 224 LFKKICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1122222211 234445678999999999999999999999997
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=354.10 Aligned_cols=243 Identities=21% Similarity=0.272 Sum_probs=197.4
Q ss_pred CceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999986 799999999976542 356789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE--ccCCceeEecccccCCCccc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill--~~~~~vkl~Dfg~a~~~~~~ 226 (356)
.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 174 ~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 174 FDRIIDESY--------NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp HHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred HHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 999875432 2889999999999999999999999 9999999999999 56679999999999876543
Q ss_pred cccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhccc
Q 018396 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK 306 (356)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (356)
... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+..++...
T Consensus 243 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------------~~~~~~i~~~~ 304 (373)
T 2x4f_A 243 EKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---------------AETLNNILACR 304 (373)
T ss_dssp CBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---------------HHHHHHHHHTC
T ss_pred ccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHHHhcc
Confidence 322 345699999999999988999999999999999999999999965421 11122222221
Q ss_pred CC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 307 LG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 307 ~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. ......+++++.+||.+||+.||.+|||+.++++
T Consensus 305 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 305 WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 1112345678999999999999999999999997
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=342.32 Aligned_cols=272 Identities=22% Similarity=0.339 Sum_probs=216.3
Q ss_pred CCCCCCceeeccCceEEEEEEE-----CCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecC--Cee
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 136 (356)
+.|++.+.||+|+||.||+|++ .+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688999999999999999983 2689999999975432 346789999999999999999999999876 678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++||||+++++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECc
Confidence 999999999999999965432 2899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+......... ..........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~ 248 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK-MIGPTHGQMT 248 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCGGGH
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh-ccCCcccccC
Confidence 9999776543221 1224456788899999999999999999999999999999999987432100000 0000001122
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
.......+........+..+++.+.+||.+||+.||.+|||+.++++.|+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 233344444445556667788899999999999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=362.08 Aligned_cols=256 Identities=18% Similarity=0.245 Sum_probs=208.6
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCC
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 134 (356)
++....++|++.+.||+|+||+||+|+.+ +++.||+|++.+. ......+.+|..++..++||||+++++++.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 34445678999999999999999999987 6889999998642 122344889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEE
Confidence 99999999999999999986321 2899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 289 (356)
+|||++......... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 217 ~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------- 286 (437)
T 4aw2_A 217 ADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------- 286 (437)
T ss_dssp CCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---------
T ss_pred cchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---------
Confidence 999999765443221 223467999999999987 56789999999999999999999999965421
Q ss_pred ccccCChhhHhHhhcccCCCCCC---HHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 018396 290 ATPKLSEDKVKQCVDTKLGGEYP---PKAIAKMAAVAALCVQYEADF--RPNMGIVLK 342 (356)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~--Rps~~ell~ 342 (356)
.+....++........+ ..+++++.+||.+||..+|++ ||+++|+++
T Consensus 287 ------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 287 ------VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ------HHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ------hHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11122222211111112 236778999999999988888 999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=346.33 Aligned_cols=266 Identities=21% Similarity=0.328 Sum_probs=191.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|++.+.||+|+||.||+|.++ +++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3568999999999999999999976 789999999865432 3467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++ +|.+++........ ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 83 e~~~~-~L~~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNT---PRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EecCC-CHHHHHHhcccccc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccc
Confidence 99985 99999876532111 123889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee----------c
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----------W 289 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~----------~ 289 (356)
......... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||............. |
T Consensus 156 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 156 RAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp EETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred eecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 765432221 234568999999999976 468999999999999999999999997553211000000 0
Q ss_pred cc-----------ccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 AT-----------PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 ~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. .......+...+.... ....+.++.+||.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 0000000111111111 1124567999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=343.99 Aligned_cols=254 Identities=25% Similarity=0.425 Sum_probs=205.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CC-------CEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG-------RAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
.++|++.+.||+|+||.||+|.+. ++ ..||+|++..... ..+.+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999966 34 4799999865433 34678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc----
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---- 211 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---- 211 (356)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGT
T ss_pred CEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccc
Confidence 9999999999999999986542 2789999999999999999999999 999999999999998887
Q ss_pred ----eeEecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCC-CCCCCCCCCCCcc
Q 018396 212 ----AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGR-KPVDHTLPRGQQS 285 (356)
Q Consensus 212 ----vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~-~pf~~~~~~~~~~ 285 (356)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++|. +||....
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~------ 223 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD------ 223 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------
T ss_pred ccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc------
Confidence 999999998765433 23457899999999987 67899999999999999999955 4543221
Q ss_pred ceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 286 LVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
.......... ....+...+.++.++|.+||+.||.+|||+.++++.|+++++...+
T Consensus 224 ----------~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 224 ----------SQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp ----------HHHHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred ----------hHHHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 1111111111 1122233356789999999999999999999999999999876544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=351.75 Aligned_cols=269 Identities=16% Similarity=0.252 Sum_probs=205.6
Q ss_pred HhCCCCCCceeecc--CceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 64 KTDNFGTNSLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
..++|++.+.||+| +||.||+|+++ +++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34689999999999 99999999987 7999999999754332 356778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+++++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCG
T ss_pred EEEEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence 999999999999999865322 2899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCcccccc-----ccccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 218 DLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 218 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
|.+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 987654322111 11233468999999999987 67899999999999999999999999765432211000000
Q ss_pred c-c------cCChhh-------------HhHhh---------cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018396 291 T-P------KLSEDK-------------VKQCV---------DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 341 (356)
Q Consensus 291 ~-~------~~~~~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell 341 (356)
. . ...... ..... ........+..+++.+.+||.+||+.||.+|||+.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0 0 000000 00000 00001123345567899999999999999999999998
Q ss_pred H
Q 018396 342 K 342 (356)
Q Consensus 342 ~ 342 (356)
+
T Consensus 333 ~ 333 (389)
T 3gni_B 333 N 333 (389)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=336.14 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=209.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
..++|++.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 34689999999999999999998542 346999999765332 46788999999999999999999998654 568
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+.+++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+||
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCC
T ss_pred EEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCcc
Confidence 99999999999999976432 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 158 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~---------------- 220 (281)
T 3cc6_A 158 GLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN---------------- 220 (281)
T ss_dssp CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG----------------
T ss_pred CCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh----------------
Confidence 999876543221 1233456889999999998999999999999999999998 9999964321
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
......+........+..+++.+.++|.+||+.||.+|||+.++++.|+++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 221 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp GGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 22222333333334455567889999999999999999999999999998864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=336.43 Aligned_cols=253 Identities=26% Similarity=0.319 Sum_probs=208.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3567999999999999999999987 78999999986432 23467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++
T Consensus 85 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999987543 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
................||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~ 218 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--------------QEY 218 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--------------HHH
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--------------HHH
Confidence 76654332222345678999999999987765 778999999999999999999997543211 111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...............++..+.++|.+||+.||.+|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 219 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1111111111222345678999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=345.72 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=212.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEE-----C-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVL-----R-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-----~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
..++|++.+.||+|+||.||+|.. . +++.||||++...... ...+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346899999999999999999983 2 5789999999754332 4568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCce
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIA 212 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~v 212 (356)
.++||||+++++|.+++........ ....+++..++.++.|++.||.|||++| ++||||||+|||++. +..+
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSS--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred cEEEEecCCCCcHHHHHHhhccccc--ccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999987643211 1123889999999999999999999999 999999999999984 4469
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 291 (356)
+|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------------ 250 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------------ 250 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------------
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC------------
Confidence 9999999865433322222244567899999999999999999999999999999998 999996432
Q ss_pred ccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.......+........+..++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 251 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 251 ----NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ----HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 2223333333333445566778899999999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=349.21 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=204.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||+|.++ +++.||+|++...... ..+|++++.++ +||||+++++++.++...++|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4567999999999999999999987 7899999999765433 45688888888 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC----CceeEecc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD----DIAKISDF 217 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~----~~vkl~Df 217 (356)
|+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||+.++ +.+||+||
T Consensus 97 ~~~gg~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 97 LMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp CCCSCBHHHHHHTCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred CCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 9999999999976542 899999999999999999999999 9999999999998543 35999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|++......... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 165 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------------~~~~ 229 (342)
T 2qr7_A 165 GFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-------------DTPE 229 (342)
T ss_dssp TTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-------------SCHH
T ss_pred CCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-------------CCHH
Confidence 999866543222 2445789999999999888899999999999999999999999974321 1112
Q ss_pred hHhHhhcc-cC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDT-KL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~-~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+...+.. .. .......++.++.+||.+||..||.+|||+.++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 230 EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22222221 11 12233456788999999999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=342.65 Aligned_cols=244 Identities=23% Similarity=0.279 Sum_probs=194.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||+||+|.+. +++.||||++....... .....|+..+..+ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999987 79999999986644332 3344555555554 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+ +++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 136 ~e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTT
T ss_pred Eecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcccee
Confidence 9999 5699998876542 2899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||... ...
T Consensus 204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------------------~~~ 261 (311)
T 3p1a_A 204 LVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------------------EGW 261 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------------------HHH
T ss_pred eeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------------------cHH
Confidence 876654332 244568999999998876 7899999999999999999997666321 111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+.........+..++.++.++|.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 262 QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111111111112234678999999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=354.75 Aligned_cols=267 Identities=20% Similarity=0.257 Sum_probs=207.4
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-----CCceeeeeeEEecC
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----NENVVELVGYYVDG 133 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hp~iv~~~~~~~~~ 133 (356)
+.....++|++.+.||+|+||.||+|.+. +++.||||++.........+..|+.+++.+. ||||+++++++...
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 33445688999999999999999999986 7899999999765555567788999999996 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-----
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----- 208 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----- 208 (356)
+..++||||+ +++|.+++...... .+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999 88999999876532 2889999999999999999999999 999999999999975
Q ss_pred --------------------CCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHH
Q 018396 209 --------------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 268 (356)
Q Consensus 209 --------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l 268 (356)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7899999999987644322 445789999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc-------------cC----------------CCCCCHHHHHHH
Q 018396 269 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-------------KL----------------GGEYPPKAIAKM 319 (356)
Q Consensus 269 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~----------------~~~~~~~~~~~l 319 (356)
++|+.||.............................. .. ........++.+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 9999999754322111000000001111000000000 00 000001112678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHH
Q 018396 320 AAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 320 ~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+||.+||+.||.+|||+.|+++
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCChhhCCCHHHHhc
Confidence 89999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=338.77 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=207.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecC-CeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG-PLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~ 142 (356)
..++|++.+.||+|+||.||+|... ++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..++||||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 3568999999999999999999886 7899999997543 456789999999999999999999987544 578999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++++|.+++...... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++..
T Consensus 97 ~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp CTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCCCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccc
Confidence 9999999999764321 2688899999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
..... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.... ......
T Consensus 167 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----------------~~~~~~ 225 (278)
T 1byg_A 167 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----------------LKDVVP 225 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----------------GGGHHH
T ss_pred ccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC----------------HHHHHH
Confidence 54332 23357889999999999999999999999999999998 999996432 122233
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.+........+..+++.+.++|.+||+.||.+|||+.++++.|+++...
T Consensus 226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 3333334455566778999999999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=365.79 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=211.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|..+ +|+.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999987 7999999998642 23345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||++||+|.+++...... .+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 263 mEy~~gg~L~~~l~~~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQA-------GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEcCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccc
Confidence 9999999999999765422 2899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+......... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+
T Consensus 333 a~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~------------~~~~~i 397 (576)
T 2acx_A 333 AVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK------------IKREEV 397 (576)
T ss_dssp CEECCTTCCE---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC------------CCHHHH
T ss_pred ceecccCccc---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc------------hhHHHH
Confidence 9776543221 3457999999999999999999999999999999999999999754321 112222
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
...+.. ....++..++.++.+||.+||+.||.+|| +++|+++
T Consensus 398 ~~~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 398 ERLVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 222221 12344556778999999999999999999 7888876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=342.07 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=200.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999987 6999999998765443 355778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++
T Consensus 82 e~~~~~~l~~~~~~~~~---------~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG---------VPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp ECCSEEHHHHHHHTSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCCchHHHHHhhhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 99999999998876542 889999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||........................
T Consensus 150 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 150 RLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 766533222 234568999999999876 66899999999999999999999999765322111000000000000000
Q ss_pred hHhhcc----cCC-----CCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDT----KLG-----GEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~----~~~-----~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... ... ... ...++..+.+||.+||+.||.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 000 000 0234667899999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=361.33 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=200.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|... +++.||||++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999987 7999999998642 2233567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
||||+++++|.+++..... +++..+..++.||+.||.|||+ +| |+||||||+|||++.++.+||+||
T Consensus 226 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EECCCSSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCC
T ss_pred EEeeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccC
Confidence 9999999999999976542 8999999999999999999998 88 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|++......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..
T Consensus 294 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----------------~~ 355 (446)
T 4ejn_A 294 GLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----------------HE 355 (446)
T ss_dssp CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----------------HH
T ss_pred CCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----------------HH
Confidence 999764433222 245679999999999999999999999999999999999999996432 11
Q ss_pred hHhHh-hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 298 KVKQC-VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 298 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
.+... .... ...+...++++.+||.+||+.||.+|| |++++++
T Consensus 356 ~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 356 KLFELILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 22222 2221 234555678899999999999999999 9999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=345.34 Aligned_cols=247 Identities=20% Similarity=0.263 Sum_probs=182.4
Q ss_pred CceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
.+.||+|+||.||+|.++ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999987 7899999998543 3466789999999997 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC---ceeEecccccCCCcc
Q 018396 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPD 225 (356)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~~~ 225 (356)
.+++..... +++..++.++.|++.||.|||++| |+||||||+|||++.++ .+||+|||++.....
T Consensus 94 ~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 94 FERIKKKKH---------FSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp HHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 999987542 899999999999999999999999 99999999999998766 899999999976544
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (356)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........+..
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---------~~~~~~~~~~i~~ 230 (325)
T 3kn6_A 162 DNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT---------CTSAVEIMKKIKK 230 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----------------CCCHHHHHHHHTT
T ss_pred CCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc---------cccHHHHHHHHHc
Confidence 3222 2445689999999999999999999999999999999999999975432110 0111112222221
Q ss_pred -cCCCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 306 -KLGGE--YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 306 -~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..... ....+++++.+||.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11111 11245788999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=337.76 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=208.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEec----------
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD---------- 132 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~---------- 132 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 4467999999999999999999987 89999999996543 457789999999999999999998754
Q ss_pred ------CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE
Q 018396 133 ------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (356)
Q Consensus 133 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (356)
....++||||+++++|.+++...... .+++..++.++.|++.||.|||++| ++|+||||+||++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 155 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFL 155 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEE
Confidence 45589999999999999999765321 2889999999999999999999999 9999999999999
Q ss_pred ccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
+.++.++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------- 224 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------- 224 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------
T ss_pred cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------
Confidence 9999999999999876654322 13456899999999999999999999999999999999999887311
Q ss_pred eecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 287 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
......... ...+..++..+.++|.+||+.||.+|||+.++++.|..+......
T Consensus 225 ---------~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 225 ---------SKFFTDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ---------HHHHHHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ---------HHHHHHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 011111111 122334556789999999999999999999999999998866543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=333.95 Aligned_cols=254 Identities=19% Similarity=0.284 Sum_probs=209.8
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC-CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
...++|++.+.||+|+||.||+|.+. ++..+|+|++... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 35578999999999999999999987 6789999998654 233577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE---ccCCceeEecc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDF 217 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Df 217 (356)
||+++++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+||
T Consensus 86 e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRV---------FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp ECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 99999999999976542 899999999999999999999999 9999999999999 78899999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|++........ .....||+.|+|||++.+. ++.++||||||+++|+|++|..||..... ..
T Consensus 154 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------------~~ 214 (277)
T 3f3z_A 154 GLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---------------SE 214 (277)
T ss_dssp TTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---------------HH
T ss_pred ccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---------------HH
Confidence 99876654332 2445689999999988654 89999999999999999999999964321 11
Q ss_pred hHhHhhcccCCCCCCH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhc
Q 018396 298 KVKQCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLN 349 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~~ 349 (356)
....+..... ..+. .+++.+.++|.+||+.||.+|||+.++++ .+++.+.
T Consensus 215 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 215 VMLKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 1112222111 2222 34678999999999999999999999986 4555443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=348.39 Aligned_cols=275 Identities=22% Similarity=0.306 Sum_probs=218.6
Q ss_pred hCCCCCCceeeccCceEEEEEEE-----CCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEe--cCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYV--DGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~ 136 (356)
.++|++.+.||+|+||.||+|++ .+++.||+|++...... .+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999984 26889999999765433 356889999999999999999999886 56678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++||||+++++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+|||++.++.+||+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcc
Confidence 999999999999999976432 2899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...........
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~ 249 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-RMMGCERDVPA 249 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHCC----CCH
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-hhccccccccc
Confidence 9999866433221 122344578889999999998999999999999999999999999864321100 00000011112
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
...+...+........+..+++.+.+||.+||+.||.+|||+.++++.|+.+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 23344445555555667778889999999999999999999999999999987644
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=335.60 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=207.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999987 7899999998654332 35678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc---eeEec
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKISD 216 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~D 216 (356)
|||+.+++|.+++..... +++..++.++.|++.||.|||++| ++||||||+||+++.++. +||+|
T Consensus 84 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp ECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred EecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEee
Confidence 999999999998876542 899999999999999999999999 999999999999986655 99999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 152 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------- 212 (284)
T 3kk8_A 152 FGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---------------- 212 (284)
T ss_dssp CTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------
T ss_pred ceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----------------
Confidence 9998766543322 345789999999999999999999999999999999999999964321
Q ss_pred hhHhHhh-cccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCV-DTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~-~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+ .... .......+++++.++|.+||+.||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 213 HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111111 1111 11122345678999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=350.10 Aligned_cols=271 Identities=18% Similarity=0.239 Sum_probs=205.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEECC------CCEEEEEEcCCCCCc------------hHHHHHHHHHHHhccCCceee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVE 125 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~hp~iv~ 125 (356)
..++|++.+.||+|+||.||+|.+.. ++.||||++...... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999763 478999998654321 112334555667778999999
Q ss_pred eeeEEecC----CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 126 LVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 126 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
+++++... ...++||||+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp 180 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKA 180 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCH
Confidence 99998764 5589999999 8999999986532 2899999999999999999999999 99999999
Q ss_pred CcEEEc--cCCceeEecccccCCCccccccc-----cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCC
Q 018396 202 SNVLLF--DDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (356)
Q Consensus 202 ~Nill~--~~~~vkl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 274 (356)
+|||++ .++.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999 88999999999997665432211 11334599999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 275 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 275 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
|........ ....... .....+...++..+. ...++.++.++|..||+.+|.+||++.+|++.|++++....
T Consensus 261 f~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 261 WEDNLKDPK--YVRDSKI-RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp TGGGTTCHH--HHHHHHH-HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccccccCHH--HHHHHHH-HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 974321100 0000000 000111222222211 12335689999999999999999999999999999886543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=357.62 Aligned_cols=255 Identities=18% Similarity=0.223 Sum_probs=206.7
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCC
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 134 (356)
+.....++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ...+.+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 44445688999999999999999999987 79999999986421 12345788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.+|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEE
Confidence 99999999999999999976431 2899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCccccc-------CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
+|||++......... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 204 ~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------- 275 (412)
T 2vd5_A 204 ADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------- 275 (412)
T ss_dssp CCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-------
T ss_pred eechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-------
Confidence 999999766443221 123467999999999987 35689999999999999999999999965421
Q ss_pred ecccccCChhhHhHhhccc--CC-CCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 018396 288 TWATPKLSEDKVKQCVDTK--LG-GEYPPKAIAKMAAVAALCVQYEADFR---PNMGIVLK 342 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~l~~li~~cl~~~P~~R---ps~~ell~ 342 (356)
.+....++... .. ...+..++.++.+||.+||. +|.+| |+++|+++
T Consensus 276 --------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 276 --------AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp --------HHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred --------HHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11122222211 11 11224567889999999999 99998 58999876
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=338.27 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=200.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC------CchHHHHHHHHHHHhcc---CCceeeeeeEEecC
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLK---NENVVELVGYYVDG 133 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~ 133 (356)
..++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999976 79999999986322 12356778888877775 99999999999876
Q ss_pred C-----eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc
Q 018396 134 P-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (356)
Q Consensus 134 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (356)
. ..+++|||+.+ +|.+++...... .+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 155 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECT
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 5 58999999975 999999876432 2899999999999999999999999 999999999999999
Q ss_pred CCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee
Q 018396 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 288 (356)
++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232 (308)
T ss_dssp TSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999986654322 245678999999999999999999999999999999999999997543211100000
Q ss_pred cc-----cccCChh-hH-hHhhcccCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 289 WA-----TPKLSED-KV-KQCVDTKLG---GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 289 ~~-----~~~~~~~-~~-~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. ...+... .. ......... ......+++.+.+||.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 0000000 00 000000000 0011234578899999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=342.24 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=203.9
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
.....++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 3445689999999999999999999987 7899999998754322 2568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++++||+++++|.+++..... +++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGP---------LAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEecCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEe
Confidence 9999999999999999986532 889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||++......... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------------- 240 (309)
T 2h34_A 177 DFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------------- 240 (309)
T ss_dssp SCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------------
T ss_pred cCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------------
Confidence 99998766543221 12345689999999999999999999999999999999999999964321
Q ss_pred hhhHhHhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhccCC
Q 018396 296 EDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQPLLNTRS 352 (356)
Q Consensus 296 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ell~~L~~l~~~~~ 352 (356)
..+...+.... ....+..++.++.++|.+||+.||.+|| |++++++.|+.++....
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 241 -SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -HHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -HHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 11112221111 1123345667899999999999999999 99999999999876553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=350.01 Aligned_cols=259 Identities=22% Similarity=0.346 Sum_probs=200.9
Q ss_pred CCCCCceeeccCceEEEEEEEC--C--CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEe-cCCeeEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR--S--GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVLA 139 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv 139 (356)
.|++.+.||+|+||.||+|... + +..||+|.+..... ..+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677789999999999999864 2 23689999875433 2467889999999999999999999865 45688999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 170 ~e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp EECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccc
Confidence 999999999999976432 2788999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccc--ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCCh
Q 018396 220 SNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 220 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
+......... .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||......
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--------------- 303 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------------- 303 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---------------
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---------------
Confidence 9865433211 11233457889999999999999999999999999999999 77788644221
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
.....+........+..++..+.++|.+||+.||.+|||+.++++.|++++....
T Consensus 304 -~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 304 -DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -CHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1112222222334455667889999999999999999999999999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=340.53 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=206.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
..++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999987 789999999865332 24678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC----c
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----I 211 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~ 211 (356)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++||||||+||+++.++ .
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 999999999999999997643 2889999999999999999999999 99999999999999888 7
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------- 223 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----------- 223 (321)
T ss_dssp EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------
T ss_pred EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----------
Confidence 99999999876654322 1445689999999999999999999999999999999999999964421
Q ss_pred ccCChhhHhHhhcccCCCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 292 PKLSEDKVKQCVDTKLGGEYP----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+....+..... ..+ ...+..+.+||.+||+.||.+|||+.++++
T Consensus 224 ----~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 224 ----QETLANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----HHHHHHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----HHHHHHHHhccc--ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111111111111 112 234567999999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=349.14 Aligned_cols=272 Identities=24% Similarity=0.343 Sum_probs=203.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHH--HHhccCCceeeeeeEEe-----cCCee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSM--VSRLKNENVVELVGYYV-----DGPLR 136 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~--l~~l~hp~iv~~~~~~~-----~~~~~ 136 (356)
..++|++.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++.+. ....+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 457899999999999999999977 48899999986443 3344444444 45589999999997543 23367
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---------CCCCeeecCCCCCcEEEc
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK---------AEPRIIHRNIKSSNVLLF 207 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---------~~~~ivH~Dlkp~Nill~ 207 (356)
++||||+++|+|.+++.... .++..++.++.||+.||.|||+. + |+||||||+|||++
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVK 154 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEEC
T ss_pred EEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEc
Confidence 89999999999999997654 68899999999999999999999 8 99999999999999
Q ss_pred cCCceeEecccccCCCccccc------cccccccccCcCccCcccccC-------CCCCccchhhhHHHHHHHHHcCCCC
Q 018396 208 DDDIAKISDFDLSNQAPDAAA------RLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLTGRKP 274 (356)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p 274 (356)
.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 999999999999976543211 111234569999999999987 3566789999999999999999777
Q ss_pred CCCCCCCCCcc--ceecccccCChhhHhHhhc-ccCCCCC------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 275 VDHTLPRGQQS--LVTWATPKLSEDKVKQCVD-TKLGGEY------PPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 275 f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
|.......... .................+. ....... ...++..+.+||.+||+.||.+|||++++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 64432221110 0000111111122222221 1112222 2357788999999999999999999999999999
Q ss_pred HhhccC
Q 018396 346 PLLNTR 351 (356)
Q Consensus 346 ~l~~~~ 351 (356)
+++...
T Consensus 315 ~ll~~~ 320 (336)
T 3g2f_A 315 ELMMIW 320 (336)
T ss_dssp HHHHCC
T ss_pred HHHHHH
Confidence 998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=348.11 Aligned_cols=243 Identities=21% Similarity=0.309 Sum_probs=205.6
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---------chHHHHHHHHHHHhccCCceeeeeeEEec
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 132 (356)
...++|++.+.||+|+||.||+|.+. +++.||||++..... ....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 35678999999999999999999976 789999999876432 22356789999999999999999999999
Q ss_pred CCeeEEEEEecCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 133 GPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 133 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
.+..++||||+.+| +|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPR---------LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 99999999999776 99999986542 899999999999999999999999 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (356)
+||+|||++......... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 169 ~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------- 236 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------- 236 (335)
T ss_dssp EEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred EEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence 999999999776543322 34579999999999998877 88999999999999999999999642110
Q ss_pred cccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.... ...+..++.++.+||.+||+.||.+|||+.++++.
T Consensus 237 ------------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ------------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 11222356689999999999999999999999984
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=367.56 Aligned_cols=255 Identities=28% Similarity=0.432 Sum_probs=210.1
Q ss_pred CCCCc-eeeccCceEEEEEEEC---CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 68 FGTNS-LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 68 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
+.+.. .||+|+||.||+|.++ ++..||||++..... ..+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33334 7999999999999864 456799999976432 35789999999999999999999999976 56999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 416 ~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp CCTTCBHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred eCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 9999999999975432 3899999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccc-cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhH
Q 018396 222 QAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 222 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||... ....+
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~----------------~~~~~ 548 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----------------KGPEV 548 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----------------CSHHH
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----------------CHHHH
Confidence 765432211 1122345789999999999999999999999999999998 99999643 22344
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
...+....+...+..++.++.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus 549 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 549 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 555555566677778889999999999999999999999999999987643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=341.49 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=200.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCe---
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPL--- 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~--- 135 (356)
..++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999976 7899999999765333 2467889999999999999999999876543
Q ss_pred -eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 136 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.++||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEE
T ss_pred ccEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEE
Confidence 4999999999999999976542 899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------------ 225 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------------ 225 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------------
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------------
Confidence 999999766543221 1223456899999999999999999999999999999999999999654211
Q ss_pred CChhhHhHhhcccCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHH-HHHHHHHhhccC
Q 018396 294 LSEDKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGI-VLKALQPLLNTR 351 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~e-ll~~L~~l~~~~ 351 (356)
............. .....++.++.++|.+||+.||.+||++.+ +...|..+.+..
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 226 ---SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp ---HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred ---HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 1111111111100 001224678999999999999999996555 555666665544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=335.99 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=205.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999987 68899999985432 224568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||
T Consensus 87 v~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred EEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence 9999999999999976542 889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++........ ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ...
T Consensus 155 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----------------~~~ 214 (279)
T 3fdn_A 155 WSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----------------YQE 214 (279)
T ss_dssp EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----------------HHH
T ss_pred ccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc----------------HHH
Confidence 9866544322 34578999999999999999999999999999999999999996432 111
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+. ......+..++..+.+||.+||+.||.+|||+.++++
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 215 TYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHHH-HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHH-hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 1122344556778999999999999999999999997
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=357.62 Aligned_cols=260 Identities=21% Similarity=0.235 Sum_probs=197.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecC------
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------ 133 (356)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999977 789999999975422 245678999999999999999999999654
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
...++||||+.+ +|.+.+... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence 457999999987 577777432 789999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc---
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA--- 290 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~--- 290 (356)
|+|||++........ .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.....+...+...
T Consensus 205 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 205 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp ECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999987654322 24567999999999999999999999999999999999999999765321110000000
Q ss_pred -----cccCChhhHhHhhcccCC-C-----------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 291 -----TPKLSEDKVKQCVDTKLG-G-----------------EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 291 -----~~~~~~~~~~~~~~~~~~-~-----------------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..... ......+..... . ......+.++.+||.+||+.||.+|||++|+++
T Consensus 282 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 282 PCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CCHHHHTTSC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHcc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 011111111000 0 001123678999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=349.91 Aligned_cols=264 Identities=19% Similarity=0.280 Sum_probs=215.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCC--eeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 139 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+++++.++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999987 69999999997533 23467789999999999999999999988655 78999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE----ccCCceeEe
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKIS 215 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~ 215 (356)
|||+++++|.+++...... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEe
Confidence 9999999999999765421 12889999999999999999999999 9999999999999 777889999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccC--------CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
|||++......... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 159 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--- 232 (396)
T 4eut_A 159 DFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--- 232 (396)
T ss_dssp CGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC---
T ss_pred cCCCceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch---
Confidence 99999876554322 34579999999998865 56788999999999999999999999754321110
Q ss_pred ecccccCChhhHhHhhc-----------------------ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 288 TWATPKLSEDKVKQCVD-----------------------TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
...+..++. .......+...+..+.+++.+||+.||++|||+.++++.+
T Consensus 233 --------~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 233 --------KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp --------HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred --------HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 000111110 0112244578889999999999999999999999999999
Q ss_pred HHhhccC
Q 018396 345 QPLLNTR 351 (356)
Q Consensus 345 ~~l~~~~ 351 (356)
+++++..
T Consensus 305 ~~il~~~ 311 (396)
T 4eut_A 305 SDILHRM 311 (396)
T ss_dssp HHHHTCE
T ss_pred HHHhhce
Confidence 9988753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=340.42 Aligned_cols=261 Identities=22% Similarity=0.341 Sum_probs=201.0
Q ss_pred hCCCCCC-ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEE
Q 018396 65 TDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 65 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
.+.|++. +.||+|+||.||+|.+. +++.||||++..... ....+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678884 78999999999999976 799999999965533 356789999999985 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc---eeEecc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKISDF 217 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~Df 217 (356)
||+++++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 91 e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp ECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 99999999999986542 889999999999999999999999 999999999999998775 999999
Q ss_pred cccCCCccccc-----cccccccccCcCccCcccccC-----CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 218 DLSNQAPDAAA-----RLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 218 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--- 235 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG--- 235 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC---
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc---
Confidence 99876542211 111123468999999999875 45789999999999999999999999765433211
Q ss_pred ecccccCCh---hhHhHhhcccCCCCCCH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 288 TWATPKLSE---DKVKQCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 288 ~~~~~~~~~---~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
|....... ..+...+.... ...+. .++..+.+||.+||+.||.+|||+.++++
T Consensus 236 -~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 236 -WDRGEACPACQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp -C----CCHHHHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -ccccccchhHHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11011100 11112221111 12222 24678999999999999999999999988
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=336.56 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=210.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.+.|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356999999999999999999976 78999999986543 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|.+++.... +++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.
T Consensus 101 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 101 YLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp CCTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 999999999997543 899999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ......
T Consensus 168 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----------------~~~~~~ 229 (303)
T 3a7i_A 168 QLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH----------------PMKVLF 229 (303)
T ss_dssp ECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----------------HHHHHH
T ss_pred ecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC----------------HHHHHH
Confidence 66543221 244578999999999999999999999999999999999999996432 111222
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.+........+..++..+.+||.+||+.||.+|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 230 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 222222233444566789999999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=343.70 Aligned_cols=245 Identities=27% Similarity=0.412 Sum_probs=203.2
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
+.|++.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45889999999999999999975 7899999998754332 246789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+. |+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 134 e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 201 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred ecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCc
Confidence 9998 488888864332 2899999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
...... ....||+.|+|||++. +..++.++|||||||++|+|++|..||..... ..
T Consensus 202 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---------------~~ 260 (348)
T 1u5q_A 202 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------MS 260 (348)
T ss_dssp BSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------------HH
T ss_pred eecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---------------HH
Confidence 765432 3457999999999985 56789999999999999999999999964321 11
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.+..+.........+..++..+.+||.+||+.||.+|||++++++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 261 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1222222222222334556789999999999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=345.24 Aligned_cols=270 Identities=25% Similarity=0.259 Sum_probs=208.5
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC------CCchHHHHHHHHHHHhccCCceeeeeeEEecC
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 133 (356)
+....++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4456678999999999999999999986 7889999998542 23356789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCC-------------------------------CCCCCCCCHHHHHHHHHHHHHH
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKG-------------------------------AKPGPVLSWAQRVKIAVGAARG 182 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~qi~~~ 182 (356)
+..++||||+++|+|.+++........ ......+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999963211100 0001124577888999999999
Q ss_pred HHHhhhCCCCCeeecCCCCCcEEEccCC--ceeEecccccCCCcccccc--ccccccccCcCccCcccccC--CCCCccc
Q 018396 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMT--GQMSSKS 256 (356)
Q Consensus 183 l~~lH~~~~~~ivH~Dlkp~Nill~~~~--~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 256 (356)
|.|||+++ |+||||||+||+++.++ .+||+|||++......... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 8999999998765332111 11245568999999999875 6789999
Q ss_pred hhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCC--CHHHHHHHHHHHHHhhccCCCCC
Q 018396 257 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEY--PPKAIAKMAAVAALCVQYEADFR 334 (356)
Q Consensus 257 DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~R 334 (356)
|||||||++|+|++|..||..... .+....+......... ...+++.+.+||.+||+.||.+|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND---------------ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH---------------HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh---------------HHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 999999999999999999964421 1222233332222111 12356789999999999999999
Q ss_pred CCHHHHHH--HHHHhh
Q 018396 335 PNMGIVLK--ALQPLL 348 (356)
Q Consensus 335 ps~~ell~--~L~~l~ 348 (356)
||+.++++ .|.++.
T Consensus 323 ps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 323 FDAMRALQHPWISQFS 338 (345)
T ss_dssp CCHHHHHHSHHHHTTS
T ss_pred CCHHHHhcChhhccCh
Confidence 99999988 455544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=336.95 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=199.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|++.+.||+|+||.||+|... ++..+|+|++.... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4467999999999999999999987 78999999986543 33577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE---ccCCceeEecc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDF 217 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Df 217 (356)
||+++++|.+++....... ..+++..++.++.|++.||.|||++| |+||||||+||++ +.++.+||+||
T Consensus 100 e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARG-----KALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EeCCCCcHHHHHHhhhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEee
Confidence 9999999999986532111 12899999999999999999999999 9999999999999 45678999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|++........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||..... .
T Consensus 172 g~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~----------------~ 231 (285)
T 3is5_A 172 GLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL----------------E 231 (285)
T ss_dssp CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------H
T ss_pred ecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH----------------H
Confidence 99976654322 24556899999999875 5689999999999999999999999964421 1
Q ss_pred hHhHhhcccCC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........... .......++.+.+||.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 232 EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111100 0001124567899999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=336.34 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=188.3
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
++...++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 3445678999999999999999999986 79999999986432 223678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~ 154 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIA 154 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEE
Confidence 9999999999999999986532 2899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 155 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------- 221 (278)
T 3cok_A 155 DFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------- 221 (278)
T ss_dssp CCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------
T ss_pred eecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------
Confidence 99998766433221 13456899999999999989999999999999999999999999754321110
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... ....+..++.++.++|.+||+.||.+|||+.++++
T Consensus 222 ----~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 ----NKVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----HHHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000000 11233445678999999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=344.04 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=208.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|.+.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4468999999999999999999987 688999999865321 24567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+.+++|.+++..... +++..++.++.||+.||.|||++| |+|+||||+||+++.++.++|+|||
T Consensus 119 v~e~~~~~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp EECCCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence 9999999999999876542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.
T Consensus 187 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------------~~~ 249 (335)
T 2owb_A 187 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------KET 249 (335)
T ss_dssp TCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---------------HHH
T ss_pred CceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---------------HHH
Confidence 98765432221 2445789999999999999999999999999999999999999964321 111
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+.... ...+..++..+.+||.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 250 YLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHHTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHhcCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11121111 1234455678999999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=349.87 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=193.5
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc-CCceeeeeeEEecCC--e
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGP--L 135 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~--~ 135 (356)
...++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35678999999999999999999987 7999999998654322 356788999999997 999999999997544 7
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++||||+.+ +|.+++.... +++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+
T Consensus 86 ~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp EEEEEECCSE-EHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEecccCc-CHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEec
Confidence 8999999985 9999997643 889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccc-------------------ccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCC
Q 018396 216 DFDLSNQAPDAA-------------------ARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPV 275 (356)
Q Consensus 216 Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf 275 (356)
|||+|+...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 999997543210 0111234579999999999986 67899999999999999999999999
Q ss_pred CCCCCCCCccceecccccCChhhH------------hHhhc------ccCCC------------CCCHHHHHHHHHHHHH
Q 018396 276 DHTLPRGQQSLVTWATPKLSEDKV------------KQCVD------TKLGG------------EYPPKAIAKMAAVAAL 325 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~------~~~~~------------~~~~~~~~~l~~li~~ 325 (356)
.+.........+.........+.+ ..... ..... .....+++++.+||.+
T Consensus 232 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 765322111000000000000000 00000 00000 0011345689999999
Q ss_pred hhccCCCCCCCHHHHHHH
Q 018396 326 CVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 326 cl~~~P~~Rps~~ell~~ 343 (356)
||+.||.+|||++|+++.
T Consensus 312 ~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKH 329 (388)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred hhccCcccCCCHHHHhCC
Confidence 999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=360.04 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=210.6
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.+. ......+.+|+.+++.++||||+++++++.+...+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999987 7999999998643 22346688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||++||+|.+++....... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 264 mE~~~gg~L~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDN-----PGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeccCCCHHHHHHHhhccc-----ccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecce
Confidence 99999999999997654211 23899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
+......... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+
T Consensus 336 a~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~------------~~~~~~ 401 (543)
T 3c4z_A 336 AVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK------------VENKEL 401 (543)
T ss_dssp CEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC------------CCHHHH
T ss_pred eeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc------------hhHHHH
Confidence 9876543221 24457999999999999999999999999999999999999999754221 111222
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~ 342 (356)
...+... ...++..++..+.+||.+||+.||.+||++ +++++
T Consensus 402 ~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 402 KQRVLEQ-AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHhhc-ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 2222111 124456677899999999999999999975 66664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=342.86 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=203.2
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEec------
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD------ 132 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~------ 132 (356)
+....++|++.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 3445678999999999999999999986 789999999987666678899999999999 89999999999986
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
....++||||+++++|.+++...... .+++..++.++.||+.||.|||++| ++|+||||+||+++.++.+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 56889999999999999999865321 2889999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
+|+|||++......... .....||+.|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 169 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------- 239 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------- 239 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------
T ss_pred EEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------
Confidence 99999998776433221 23456899999999987 56789999999999999999999999964321
Q ss_pred ecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+.........+..++..+.++|.+||..||.+|||+.++++
T Consensus 240 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 --------MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --------HHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --------HHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111122221222223345678999999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=346.35 Aligned_cols=257 Identities=20% Similarity=0.268 Sum_probs=200.5
Q ss_pred hCCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCc------------hHHHHHHHHHHHhccCCceeeeee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVELVG 128 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~hp~iv~~~~ 128 (356)
.++|++.+.||+|+||.||+|... ++..+|+|++...... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5788999998765432 123567888899999999999999
Q ss_pred EEec----CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcE
Q 018396 129 YYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (356)
Q Consensus 129 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (356)
++.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 182 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANL 182 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHE
Confidence 9887 78899999999 899999997654 2899999999999999999999999 99999999999
Q ss_pred EEccCC--ceeEecccccCCCccccccc-----cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCC
Q 018396 205 LLFDDD--IAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (356)
Q Consensus 205 ll~~~~--~vkl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (356)
|++.++ .+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999887 99999999997664332110 11345789999999999999999999999999999999999999953
Q ss_pred CCCCCCccceecccccCChhhHhHhhcccCCCCCCH---------HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 278 TLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP---------KAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
.... ...... .........+. .++.++.++|.+||+.||.+|||+++|++.|+.+.
T Consensus 263 ~~~~--------------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 263 NLKD--------------PVAVQT-AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp GTTC--------------HHHHHH-HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccc--------------cHHHHH-HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2111 000000 00000111111 34568999999999999999999999999998865
Q ss_pred c
Q 018396 349 N 349 (356)
Q Consensus 349 ~ 349 (356)
-
T Consensus 328 ~ 328 (345)
T 2v62_A 328 I 328 (345)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=333.15 Aligned_cols=265 Identities=20% Similarity=0.306 Sum_probs=210.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEE-ecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY-VDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||+|++. +++.||+|++..... .+.+.+|+.+++.++|++++..+.++ .++...++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 3578999999999999999999975 899999999865433 35688999999999988766655554 67788899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE---ccCCceeEeccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg 218 (356)
|+ +++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||
T Consensus 86 ~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp CC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred ec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 99 8899999974432 2899999999999999999999999 9999999999999 488999999999
Q ss_pred ccCCCccccccc-----cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 219 LSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 219 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------- 225 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-------- 225 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS--------
T ss_pred CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh--------
Confidence 987665432211 1245578999999999999999999999999999999999999997643221111
Q ss_pred CChhhHhHhhcccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCC
Q 018396 294 LSEDKVKQCVDTKLGGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSG 353 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~ 353 (356)
....+........ ....+++++.++|.+||+.||.+|||+.++++.|+++......
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 226 ----KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----hhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 1111111111000 1123457899999999999999999999999999998866543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=333.51 Aligned_cols=263 Identities=20% Similarity=0.313 Sum_probs=206.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEE-ecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY-VDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+|+.+++.++|++++..+..+ .+.+..+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4578999999999999999999975 789999998654332 24588899999999988766666554 67888899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE---ccCCceeEeccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg 218 (356)
|+ +++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 86 ~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp CC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred cc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 99 8899999975432 2899999999999999999999999 9999999999999 788999999999
Q ss_pred ccCCCcccccc-----ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 219 LSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 219 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------- 225 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-------- 225 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS--------
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh--------
Confidence 99876543221 11235578999999999999999999999999999999999999997653322111
Q ss_pred CChhhHhHhhcccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 294 LSEDKVKQCVDTKLGGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
....+........ ....+++++.++|.+||+.||.+|||++++++.|++++...
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 226 ----KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----hhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 1111111111000 01223578999999999999999999999999999988654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=346.06 Aligned_cols=275 Identities=21% Similarity=0.299 Sum_probs=215.4
Q ss_pred hCCCCCCceeeccCceEEEEEEE-----CCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCC--ee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGP--LR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~ 136 (356)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... .+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999984 26889999999765433 457889999999999999999999987543 78
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred EEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence 999999999999999986542 2889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||......-.............
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 9998776543221 112334567889999999988899999999999999999999999853210000000000000001
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
...+...+........+..++.++.++|.+||+.||.+|||+.++++.|+++...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1122333333334455667788999999999999999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=341.81 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=208.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEe----cCCeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYV----DGPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~----~~~~~~l 138 (356)
.++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 467999999999999999999985 799999998865332 3467889999999999999999999987 3457899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
|+||+.+++|.+++....... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKG-----NFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEeCCCCcHHHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence 999999999999997632211 23899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccc-------cccccccCcCccCcccccCCC---CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee
Q 018396 219 LSNQAPDAAARL-------HSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 219 ~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 288 (356)
++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------- 252 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------- 252 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-------
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-------
Confidence 887654321110 012345799999999987654 688999999999999999999999532100
Q ss_pred cccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
.......+........+..++..+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus 253 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 253 -------GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp -------TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred -------cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 011111122222223334566789999999999999999999999999999875443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=331.84 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=211.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999987 6889999998542 2234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||
T Consensus 92 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGR---------FDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp EECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999986542 889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ...
T Consensus 160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------------~~~ 220 (284)
T 2vgo_A 160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---------------TET 220 (284)
T ss_dssp TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------------HHH
T ss_pred ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---------------hHH
Confidence 986554322 2445789999999999999999999999999999999999999964321 111
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~ 348 (356)
...+... ....+...+..+.++|.+||+.||.+|||+.++++ .+....
T Consensus 221 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 221 HRRIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 1112211 12344556778999999999999999999999997 455443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=367.36 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=208.8
Q ss_pred ceeeccCceEEEEEEEC---CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.+++.++|||||++++++.+ +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 5678999999754322 4678999999999999999999999865 568899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 454 g~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 454 GPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCHHHHHhhCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 999999976542 889999999999999999999999 99999999999999999999999999976644
Q ss_pred cccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 226 AAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||... ....+...+
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~----------------~~~~~~~~i 585 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----------------KGSEVTAML 585 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----------------CHHHHHHHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----------------CHHHHHHHH
Confidence 3221 11233456789999999999999999999999999999998 99999643 334455566
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
........+..++.++.+||..||+.||++|||+.+|++.|+++..+
T Consensus 586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 66666677778889999999999999999999999999999988653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=350.20 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=194.3
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---------chHHHHHHHHHHHhccCCceeeeeeEEec
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 132 (356)
...++|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45688999999999999999999987 789999999864321 12347899999999999999999999854
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC--
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-- 210 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-- 210 (356)
+..++||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSS
T ss_pred -CceEEEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCc
Confidence 558999999999999999876542 899999999999999999999999 99999999999997544
Q ss_pred -ceeEecccccCCCccccccccccccccCcCccCcccccC---CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 211 -IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 211 -~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 279 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----- 350 (419)
T 3i6u_A 279 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----- 350 (419)
T ss_dssp CCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-----
T ss_pred ceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-----
Confidence 599999999987654332 245679999999999863 56788999999999999999999999654211
Q ss_pred eecccccCChhhHhHhhcccCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 287 VTWATPKLSEDKVKQCVDTKLGGEYP---PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+...+........+ ..++..+.+||.+||+.||.+|||+.++++
T Consensus 351 ----------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 351 ----------VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ----------CCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----------HHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111111111111111 124678999999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=335.93 Aligned_cols=259 Identities=20% Similarity=0.294 Sum_probs=208.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEe--cCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~ 137 (356)
..++|++.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.+++.++||||+++++++. .....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4578999999999999999999987 7899999999764432 356889999999999999999999875 467899
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--CCCeeecCCCCCcEEEccCCceeEe
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
+||||+++++|.+++....... ..+++..++.++.|++.||.|||+++ ..+++|+||||+||+++.++.+||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKER-----QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEeCCCCCCHHHHHHhhcccC-----CCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 9999999999999997643211 23889999999999999999999986 1239999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 159 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---------------- 220 (279)
T 2w5a_A 159 DFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---------------- 220 (279)
T ss_dssp CCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----------------
T ss_pred cCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC----------------
Confidence 99998765433211 134568999999999999999999999999999999999999996442
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 345 (356)
...+...+........+..++.++.++|.+||+.||.+|||+.++++.+.
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 221 QKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 22222233333333445567788999999999999999999999998653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=356.91 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=205.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..++|++.+.||+|+||+||+|.++ +++.||||++... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999987 8999999998532 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc---cCCceeEec
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISD 216 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~D 216 (356)
|||+.+++|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|
T Consensus 100 ~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp ECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred EEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEE
Confidence 999999999999876542 899999999999999999999999 99999999999995 456799999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... .
T Consensus 168 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------------~ 228 (486)
T 3mwu_A 168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---------------Y 228 (486)
T ss_dssp CSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------H
T ss_pred CCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------H
Confidence 999976544322 244579999999999876 599999999999999999999999964421 1
Q ss_pred hhHhHhhcccCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDTKLGG--EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+.+..+....... .....+++++.+||.+||+.||.+|||+.++++
T Consensus 229 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112222222111 112345678999999999999999999999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=357.19 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=203.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--------------CchHHHHHHHHHHHhccCCceeeeee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--------------QPDQEFLAQVSMVSRLKNENVVELVG 128 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~hp~iv~~~~ 128 (356)
..++|++.+.||+|+||+||+|..+ +++.||+|++.... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 5678999999999999999999987 78999999986543 22457889999999999999999999
Q ss_pred EEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc
Q 018396 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (356)
Q Consensus 129 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (356)
++.+....++||||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLEN 181 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEec
Confidence 99999999999999999999999976542 899999999999999999999999 999999999999987
Q ss_pred CC---ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 018396 209 DD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (356)
Q Consensus 209 ~~---~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~ 285 (356)
++ .+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||.....
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----- 252 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND----- 252 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred CCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 76 699999999977654322 24557999999999887 4699999999999999999999999965421
Q ss_pred ceecccccCChhhHhHhhcccCCCCCC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 286 LVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+..+.........+ ..++.++.+||.+||+.||.+|||++++++
T Consensus 253 ----------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 253 ----------QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ----------HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----------HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111222211111100 234678999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=347.11 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=197.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCC------
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 134 (356)
.++|++.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999986 7999999999654333 356789999999999999999999998653
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..++||||+ +++|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEE
Confidence 469999999 779999998643 889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 170 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 170 LDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244 (367)
T ss_dssp CCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred Eeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998765432 244578999999999887 67999999999999999999999999765322111000000000
Q ss_pred --------CChhhHhHhhccc--C----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 --------LSEDKVKQCVDTK--L----GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 --------~~~~~~~~~~~~~--~----~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+........+... . ........++.+.+||.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0001111111000 0 00122345678999999999999999999999988
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=340.83 Aligned_cols=269 Identities=21% Similarity=0.293 Sum_probs=198.9
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHHhccCCceeeeeeEEecC
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 133 (356)
.....++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3445688999999999999999999976 7899999999753221 24678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
+..++||||+.+ +|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+|
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 152 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred CceEEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEE
Confidence 999999999987 89998876432 2778899999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc--
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-- 290 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 290 (356)
|+|||++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||...............
T Consensus 153 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~ 230 (346)
T 1ua2_A 153 LADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230 (346)
T ss_dssp ECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999876543222 2445789999999998764 5899999999999999999999999755321100000000
Q ss_pred ---cccCCh-hhHhHhhcccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 291 ---TPKLSE-DKVKQCVDTKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 291 ---~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
...+.. ......+........+ ..++.++.+||.+||+.||.+|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 0000000000000111 2345789999999999999999999999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=359.35 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=206.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999987 8999999998643 2335678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE---ccCCceeEe
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKIS 215 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~ 215 (356)
||||+.+++|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 104 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp EECCCCSCBHHHHHHTCSC---------CBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 9999999999999976542 899999999999999999999999 9999999999999 467899999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.....
T Consensus 172 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------------- 232 (484)
T 3nyv_A 172 DFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------------- 232 (484)
T ss_dssp CTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred eeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---------------
Confidence 9999876543322 134569999999998876 699999999999999999999999965421
Q ss_pred hhhHhHhhcccCCCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 296 EDKVKQCVDTKLGGE--YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+..+........ ....+++++.+||.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 233 YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 111222222222111 12356778999999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=333.78 Aligned_cols=253 Identities=20% Similarity=0.332 Sum_probs=206.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356999999999999999999987 799999999864322 246789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC----ce
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IA 212 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~v 212 (356)
++||||+++++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.++ .+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKES---------LTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCE
T ss_pred EEEEeecCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCce
Confidence 999999999999999976432 899999999999999999999999 99999999999998877 89
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
+|+|||++......... ....|++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 152 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------- 217 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----------- 217 (283)
T ss_dssp EECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----------
T ss_pred EEEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----------
Confidence 99999998766543221 3456899999999999999999999999999999999999999644211
Q ss_pred cCChhhHhHhhcccCCCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhc
Q 018396 293 KLSEDKVKQCVDTKLGGEYP----PKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLN 349 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~~ 349 (356)
.....+.... ...+ ..++..+.+++.+||+.||.+|||+.++++ .++.+..
T Consensus 218 ----~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 218 ----ETLTNISAVN--YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ----HHHHHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ----HHHHHhHhcc--cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1111111111 1111 233567999999999999999999999998 5565543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=336.69 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=213.3
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHh--ccCCceeeeeeEEecCC---
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDGP--- 134 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hp~iv~~~~~~~~~~--- 134 (356)
......++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 34455678999999999999999999985 889999998643 34567888888887 79999999999998776
Q ss_pred -eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeeecCCCCCcEE
Q 018396 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--------EKAEPRIIHRNIKSSNVL 205 (356)
Q Consensus 135 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------~~~~~~ivH~Dlkp~Nil 205 (356)
..++||||+++|+|.+++.... +++..++.++.|++.||.||| +.+ ++||||||+|||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl 179 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL 179 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred ceeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence 8899999999999999997643 899999999999999999999 788 999999999999
Q ss_pred EccCCceeEecccccCCCccccccc--cccccccCcCccCcccccCCC------CCccchhhhHHHHHHHHHcC------
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQ------MSSKSDVYSFGVVLLELLTG------ 271 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~~l~~g------ 271 (356)
++.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 9999999999999987654332211 124457899999999988653 33689999999999999999
Q ss_pred ----CCCCCCCCCCCCccceecccccCChhhHhHhh-cccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018396 272 ----RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV-DTKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVL 341 (356)
Q Consensus 272 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell 341 (356)
..||...... ......+...+ ........+ ..++..+.+||.+||+.||.+|||+.+++
T Consensus 260 ~~~~~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 260 HEDYQLPYYDLVPS-----------DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp CCCCCCTTTTTSCS-----------SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred ccccccCccccCcC-----------cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 6676543221 11112222222 222333333 36778999999999999999999999999
Q ss_pred HHHHHhhccCC
Q 018396 342 KALQPLLNTRS 352 (356)
Q Consensus 342 ~~L~~l~~~~~ 352 (356)
+.|+++.....
T Consensus 329 ~~L~~i~~~~~ 339 (342)
T 1b6c_B 329 KTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHTTC
T ss_pred HHHHHHHHHhc
Confidence 99999987653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=369.25 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=209.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 137 (356)
..++|++.+.||+|+||.||+|+.+ +++.||||++.+. ....+.+..|..++..+ +||+|+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999987 7889999998642 23346678899999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+||||+.+|++||+||
T Consensus 419 lV~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DF 486 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCC
T ss_pred EEEeCcCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeec
Confidence 99999999999999987542 899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|++........ .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..... .+
T Consensus 487 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---------------~~ 549 (674)
T 3pfq_A 487 GMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------------DE 549 (674)
T ss_dssp TTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HH
T ss_pred ceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---------------HH
Confidence 99975433222 23567899999999999999999999999999999999999999964421 12
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNM-----GIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~ 342 (356)
....++... ..++...+.++.+||.+||+.||.+||++ ++|++
T Consensus 550 ~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 550 LFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 222333322 24556678899999999999999999998 67665
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=333.86 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=205.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4567999999999999999999987 799999999975433 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE---ccCCceeEeccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg 218 (356)
|+++++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||
T Consensus 87 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 87 LVSGGELFDRILERGV---------YTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp CCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred cCCCccHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 9999999999976542 889999999999999999999999 9999999999999 778899999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------------~~ 214 (304)
T 2jam_A 155 LSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----------------SK 214 (304)
T ss_dssp TTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HH
T ss_pred cceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------------HH
Confidence 987654321 1344689999999999999999999999999999999999999964321 11
Q ss_pred HhH-hhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQ-CVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~-~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
... +..... .......++..+.++|.+||+.||.+|||+.++++
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 215 LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 111111 12223456778999999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=344.81 Aligned_cols=265 Identities=19% Similarity=0.253 Sum_probs=195.2
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
...++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999977 7899999999755433 3456789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc-----cCCcee
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-----DDDIAK 213 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-----~~~~vk 213 (356)
||||+.+ +|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 111 v~e~~~~-~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp EEECCSE-EHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEE
T ss_pred EEecCCC-CHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEE
Confidence 9999986 99999987643 889999999999999999999999 99999999999994 455699
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc--
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-- 290 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 290 (356)
|+|||++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...............
T Consensus 178 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 178 IGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence 9999998765432221 2345689999999999874 4899999999999999999999999754321100000000
Q ss_pred ---cccCChh-hHhHhh--cccCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 291 ---TPKLSED-KVKQCV--DTKLGGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 291 ---~~~~~~~-~~~~~~--~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+... ...... ....... .+..++.++.+||.+||+.||.+|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 000000 0000000 01114568899999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=348.57 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=200.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC-----C
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG-----P 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~ 134 (356)
..++|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3468999999999999999999987 7899999999754333 35788999999999999999999998766 5
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..|+||||+.+ +|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~~~---------l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTPIF---------LTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCCc-CHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence 79999999875 99999976532 899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCcccccc--------------------ccccccccCcCccCcccc-cCCCCCccchhhhHHHHHHHHHcCCC
Q 018396 215 SDFDLSNQAPDAAAR--------------------LHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELLTGRK 273 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~ 273 (356)
+|||++......... ......+||+.|+|||++ .+..++.++|||||||++|+|++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876443211 112456789999999986 56679999999999999999999776
Q ss_pred CCCCCCCCCCccceecc------------------------------------cccCChhhHhHhhccc-CCCCCC----
Q 018396 274 PVDHTLPRGQQSLVTWA------------------------------------TPKLSEDKVKQCVDTK-LGGEYP---- 312 (356)
Q Consensus 274 pf~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~-~~~~~~---- 312 (356)
||......+...+.... ...+........+... .....+
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence 66533111110000000 0000111111111110 011111
Q ss_pred -HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 313 -PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 313 -~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+..++++.+||.+||+.||.+|||++|+++
T Consensus 331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 331 YPSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 235678999999999999999999999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=356.00 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=202.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..++|++.+.||+|+||.||+|+++ ++..||+|++.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4457999999999999999999987 78999999986542 2356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC---CceeEec
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISD 216 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~D 216 (356)
|||+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.. +.+||+|
T Consensus 115 ~e~~~~g~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp EECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence 999999999999876542 889999999999999999999999 9999999999999764 5599999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||..... .
T Consensus 183 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------------~ 243 (494)
T 3lij_A 183 FGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---------------Q 243 (494)
T ss_dssp CTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------H
T ss_pred CCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------H
Confidence 999977654332 24567999999999876 5699999999999999999999999965421 1
Q ss_pred hhHhHhhcccCCCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDTKLGGE--YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+....+........ ....++..+.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 244 EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 11112222111111 11245678999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=343.70 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=206.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999987 7899999998765333 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
|+++++|.+++..... +++..++.++.|++.||.|||++ | |+|+||||+|||++.++.++|+|||++
T Consensus 112 ~~~~~~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp CCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCC
Confidence 9999999999987542 88999999999999999999996 8 999999999999999999999999998
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc--------------
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-------------- 286 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~-------------- 286 (356)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 180 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 180 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp HHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred ccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 6543321 2445789999999999999999999999999999999999999975432110000
Q ss_pred ---------eec---ccccCCh-hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 287 ---------VTW---ATPKLSE-DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 287 ---------~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+ ....... +....+............++.++.+||.+||+.||.+|||++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 0000000 1111111111111222335678999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=343.73 Aligned_cols=259 Identities=17% Similarity=0.238 Sum_probs=207.6
Q ss_pred hCCCCCCceeeccCceEEEEEEECC---------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceee----------
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE---------- 125 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~---------- 125 (356)
.++|++.+.||+|+||.||+|.... ++.||+|++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 4689999999999999999999763 789999998754 35889999999999999987
Q ss_pred -----eeeEEec-CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCC
Q 018396 126 -----LVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (356)
Q Consensus 126 -----~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dl 199 (356)
+++++.. +...++||||+ +++|.+++...... .+++..++.++.||+.||.|||+++ |+||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Di 185 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH-------VLSERSVLQVACRLLDALEFLHENE---YVHGNV 185 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCC
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence 5666665 78899999999 89999999865221 2899999999999999999999999 999999
Q ss_pred CCCcEEEccCC--ceeEecccccCCCccccccc-----cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCC
Q 018396 200 KSSNVLLFDDD--IAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272 (356)
Q Consensus 200 kp~Nill~~~~--~vkl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 272 (356)
||+|||++.++ .+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999998 99999999998765433211 113347899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccceecccccCChhhHhHhhc---ccCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018396 273 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD---TKLG-----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKAL 344 (356)
Q Consensus 273 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 344 (356)
.||...... ...+..... .... ......++.++.+||.+||+.||.+|||++++++.|
T Consensus 266 ~pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 266 LPWTNCLPN--------------TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp CTTGGGTTC--------------HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred CCcccCCcC--------------HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 999644211 111111111 0000 000113457899999999999999999999999999
Q ss_pred HHhhccCC
Q 018396 345 QPLLNTRS 352 (356)
Q Consensus 345 ~~l~~~~~ 352 (356)
++++....
T Consensus 332 ~~~~~~~~ 339 (352)
T 2jii_A 332 EALLQDLR 339 (352)
T ss_dssp HHHHHHTT
T ss_pred HHHHHhcC
Confidence 99986653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=332.59 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=208.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3467999999999999999999987 688999999865322 24567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||
T Consensus 93 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp EEECCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence 9999999999999876542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------------~~~ 223 (294)
T 2rku_A 161 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------KET 223 (294)
T ss_dssp TCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---------------HHH
T ss_pred CceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------HHH
Confidence 98765432221 2445689999999999998999999999999999999999999964421 111
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+.... ...+..++..+.++|.+||+.||.+|||++++++
T Consensus 224 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 224 YLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11121111 1334456678999999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=340.61 Aligned_cols=269 Identities=22% Similarity=0.321 Sum_probs=199.6
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999987 7999999999754322 12455799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+ +|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp CSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred ccc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 985 99999876542 3889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc--------cc-
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA--------TP- 292 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------~~- 292 (356)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||............... .+
T Consensus 150 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 150 KSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 5433222 234568999999999876 56899999999999999999999999765322110000000 00
Q ss_pred cCChhhHhHhhcccCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 018396 293 KLSEDKVKQCVDTKLGGE----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~ 348 (356)
.................. ....++.++.+||.+||+.||.+|||++|+++ .|..+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 000000000000000000 11234568899999999999999999999988 444443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=339.42 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=205.4
Q ss_pred HHHHhCCCCCC-ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhc-cCCceeeeeeEEecCC
Q 018396 61 LKEKTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (356)
Q Consensus 61 ~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~ 134 (356)
.....++|.+. +.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.+ +||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34455678877 89999999999999987 799999999875332 246788999999999 5699999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCc
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDI 211 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~ 211 (356)
..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||++| |+||||||+|||++. ++.
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELA-------EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred eEEEEEEecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 99999999999999999865432 23899999999999999999999999 999999999999987 789
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 173 ~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------- 238 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----------- 238 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------
T ss_pred EEEeeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------
Confidence 999999999876543322 445799999999999999999999999999999999999999964421
Q ss_pred ccCChhhHhHhhc--ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 292 PKLSEDKVKQCVD--TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 292 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+.. ..........++..+.+||.+||+.||.+|||++++++
T Consensus 239 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 239 ----QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ----HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111111 11222333456778999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=339.39 Aligned_cols=261 Identities=21% Similarity=0.236 Sum_probs=194.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCC-----
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----- 134 (356)
..++|++.+.||+|+||.||+|... +++.||||++...... ...+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3478999999999999999999977 7899999998754332 356789999999999999999999997655
Q ss_pred -eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 135 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
..++||||+.+ +|.+++... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cceEEEEEcCCC-CHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEE
Confidence 78999999986 888888632 789999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 168 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999976654321 24457899999999999999999999999999999999999999765321110000000000
Q ss_pred CCh-------hhHhHhhcc---------------cC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 LSE-------DKVKQCVDT---------------KL---GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 ~~~-------~~~~~~~~~---------------~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
... ......... .. ........+.++.+||.+||+.||.+|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 000000000 00 00111234778999999999999999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=333.14 Aligned_cols=259 Identities=24% Similarity=0.269 Sum_probs=195.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++....... ..+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999986 78999999997654332 2234445557888999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
|||+++ +|.+++....... ..+++..++.++.|++.||.|||++ | ++||||||+||+++.++.+||+|||
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKG-----QTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred Eehhcc-chHHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecC
Confidence 999985 8888876421111 2389999999999999999999998 9 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccc----cCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYA----MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
++......... ....||+.|+|||++ .+..++.++||||||+++|+|++|..||.... .
T Consensus 156 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------------~ 218 (290)
T 3fme_A 156 ISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG--------------T 218 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS--------------C
T ss_pred Ccccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC--------------c
Confidence 99776543322 344689999999996 45678999999999999999999999996431 1
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~ 348 (356)
....+...+...........++.++.++|.+||+.||.+|||+.++++ .+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 219 PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp HHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred hHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 122233333333333333456778999999999999999999999998 555443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=337.40 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=205.8
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---------hHHHHHHHHHHHhc-cCCceeeeeeE
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRL-KNENVVELVGY 129 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l-~hp~iv~~~~~ 129 (356)
.....++|++.+.||+|+||.||+|... +|+.||||++...... .+.+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999987 7999999998654321 24567899999999 79999999999
Q ss_pred EecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 130 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
+......++||||+++++|.+++..... +++..++.++.||+.||.|||+.| ++|+||||+|||++.+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVA---------LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN 236 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 9999999999999999999999976432 899999999999999999999999 9999999999999999
Q ss_pred CceeEecccccCCCccccccccccccccCcCccCcccccC------CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCC
Q 018396 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~ 283 (356)
+.++|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--- 310 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--- 310 (365)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---
Confidence 9999999999876654322 245679999999998863 3588899999999999999999999964321
Q ss_pred ccceecccccCChhhHhHhhcccCCCCCC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 284 QSLVTWATPKLSEDKVKQCVDTKLGGEYP--PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+.........+ ..++..+.++|.+||+.||.+|||+.++++
T Consensus 311 ------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 ------------ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ------------HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111111111100 123567999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=342.43 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=205.8
Q ss_pred hCCCCCCceeeccCceEEEEEEE----CCCCEEEEEEcCCCC-----CchHHHHHHHHHHHhc-cCCceeeeeeEEecCC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~ 134 (356)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999997 368999999987532 2245577899999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEE
Confidence 99999999999999999976542 889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 201 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------- 269 (355)
T 1vzo_A 201 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---------- 269 (355)
T ss_dssp SCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----------
T ss_pred eeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----------
Confidence 999999765433221 2234579999999999986 347899999999999999999999996442211
Q ss_pred cCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018396 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLKA 343 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~ 343 (356)
....+...+.. .....+..++..+.+||.+||+.||.+|| |++++++.
T Consensus 270 --~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 270 --SQAEISRRILK-SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --CHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --hHHHHHHHHhc-cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11111111111 12244556678899999999999999999 99999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=352.77 Aligned_cols=194 Identities=25% Similarity=0.370 Sum_probs=154.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec-----CCe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD-----GPL 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~ 135 (356)
.++|++.+.||+|+||.||+|.++ +++.||||++...... .+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999977 7999999999754333 3568899999999999999999999843 357
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVY---------LTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccc-cchhhhcccCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeec
Confidence 899999985 599999976532 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccc-------------------------ccccccccCcCccCcccc-cCCCCCccchhhhHHHHHHHHH
Q 018396 216 DFDLSNQAPDAAAR-------------------------LHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELL 269 (356)
Q Consensus 216 Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~ 269 (356)
|||+++........ ......+||+.|+|||++ .+..++.++|||||||++|||+
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence 99999875422110 112345789999999986 4667999999999999999999
Q ss_pred cC
Q 018396 270 TG 271 (356)
Q Consensus 270 ~g 271 (356)
+|
T Consensus 279 tg 280 (458)
T 3rp9_A 279 NM 280 (458)
T ss_dssp TT
T ss_pred Hh
Confidence 94
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=338.70 Aligned_cols=259 Identities=16% Similarity=0.163 Sum_probs=207.9
Q ss_pred HHhCCCCCCceeeccCceEEEEEE------ECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc---CCceeeeeeEEecC
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGV------LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDG 133 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~ 133 (356)
...++|++.+.||+|+||.||+|. ..+++.||+|++... ....+..|+.+++.++ |+||+.+++++...
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 345779999999999999999994 337899999999754 3456788888888886 89999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-----
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----- 208 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----- 208 (356)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 9999999999999999999753221 1123899999999999999999999999 999999999999998
Q ss_pred ------CCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCC
Q 018396 209 ------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (356)
Q Consensus 209 ------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (356)
++.+||+|||+|................||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999965432222222355679999999999999999999999999999999999999995332110
Q ss_pred CccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHhhccC
Q 018396 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFR-PNMGIVLKALQPLLNTR 351 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-ps~~ell~~L~~l~~~~ 351 (356)
. .+...+. .. ..++.+.+++..||+.+|.+| |+++++.+.|++++...
T Consensus 293 ~------------------~~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 C------------------KPEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp E------------------EECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred e------------------eechhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 0000000 11 124567889999999999999 68889999998887653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=329.35 Aligned_cols=246 Identities=20% Similarity=0.277 Sum_probs=202.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999987 899999999875432 245678899999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC---------
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--------- 209 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~--------- 209 (356)
||||+++++|.+++....... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIM-----SYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------
T ss_pred EEEecCCCcHHHHHHhhcccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccc
Confidence 999999999999997642211 12889999999999999999999999 9999999999999844
Q ss_pred ----------CceeEecccccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCC
Q 018396 210 ----------DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (356)
Q Consensus 210 ----------~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (356)
..++|+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|++|.+|+...
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 47999999998766543 234589999999999875 5678999999999999999999876422
Q ss_pred CCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 279 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.....+. .......+..++..+.++|.+||+.||.+|||+.++++
T Consensus 235 ------------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 ------------------DQWHEIR-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------------------HHHHHHH-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------------hHHHHHH-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111111 12223344556778999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=329.46 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=199.3
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec----CCeeE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRV 137 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~ 137 (356)
+.|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888889999999999999986 7889999998654322 3568899999999999999999998865 45689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc-cCCceeEec
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISD 216 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~D 216 (356)
+||||+++++|.+++..... +++..++.++.|++.||.|||+++. +++|+||||+||+++ .++.++|+|
T Consensus 106 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEecCCCCHHHHHHHccC---------CCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEee
Confidence 99999999999999986542 8899999999999999999999852 399999999999998 789999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... .
T Consensus 176 fg~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------~ 235 (290)
T 1t4h_A 176 LGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---------------A 235 (290)
T ss_dssp TTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---------------H
T ss_pred CCCcccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc---------------H
Confidence 99986544332 234568999999998764 589999999999999999999999964321 1
Q ss_pred hhHhHhhccc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+... .....+...++++.++|.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 236 AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111111111 111122233467999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=332.52 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=202.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 4568999999999999999999987 69999999997643 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.+++|.+++..... .+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++..
T Consensus 106 ~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 106 CGAGSVSDIIRLRNK--------TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp CTTEEHHHHHHHHTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 999999999974321 2899999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... ......
T Consensus 175 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~ 237 (314)
T 3com_A 175 LTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---------------RAIFMI 237 (314)
T ss_dssp CBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---------------HHHHHH
T ss_pred hhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---------------HHHHHH
Confidence 5443221 24456899999999999999999999999999999999999999643211 111111
Q ss_pred hcc-cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 303 VDT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 303 ~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
... ......+..++..+.++|.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 238 PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred hcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111 1111223445678999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=328.14 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=203.2
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
++|.....||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44555669999999999999976 788999999875433 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCceeEecccccCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQ 222 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~ 222 (356)
++++|.+++...... ..+++..++.++.|++.||.|||++| ++|+||||+||+++. ++.++|+|||++..
T Consensus 102 ~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 102 PGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp SEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred CCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccc
Confidence 999999999765321 12678899999999999999999999 999999999999987 89999999999876
Q ss_pred CccccccccccccccCcCccCcccccCCC--CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
....... .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||..... ......
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------------~~~~~~ 236 (295)
T 2clq_A 173 LAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE--------------PQAAMF 236 (295)
T ss_dssp SCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS--------------HHHHHH
T ss_pred cCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc--------------hhHHHH
Confidence 5432211 24456899999999987643 78999999999999999999999953211 011111
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...........+..++.++.++|.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 237 KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred hhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111122333455667788999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=336.61 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=200.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3468999999999999999999987 6999999998654433 34577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+.+++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||+
T Consensus 103 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNG---------LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp EECCSEEHHHHHHHSTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCcchHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCC
Confidence 999999999888765432 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+......... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.......................
T Consensus 171 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 171 ARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 9765443222 2345689999999999875 789999999999999999999999975532111000000000000000
Q ss_pred Hh---------HhhcccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VK---------QCVDTKLGGEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~---------~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. ....+...... .+.+++.+.+||.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000001 1234678999999999999999999999886
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=329.07 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=201.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC-----CCchHHHHHHHHHHHhccCCceeeeeeEEe--cCCe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-----KQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~ 135 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999976 7899999998753 233567899999999999999999999984 5568
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.++||||+.++ |.+++...... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEK-------RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTC-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEehhccCC-HHHHHHhCccc-------ccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEee
Confidence 89999999885 77777654322 2889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCC--CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|||++................||+.|+|||++.+.. ++.++||||||+++|+|++|..||....
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------------- 217 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------------- 217 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------------
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------------
Confidence 999987654322222224556899999999988654 3789999999999999999999996432
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.......+... ....+..++..+.++|.+||+.||.+|||+.++++
T Consensus 218 --~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 218 --IYKLFENIGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp --HHHHHHHHHHC-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHHHHHHHhcC-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111222111 11334456778999999999999999999999997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=327.43 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=199.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999987 7999999998643 2234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||
T Consensus 89 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp EEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecc
Confidence 9999999999999976542 889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++......... ....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.... ..
T Consensus 157 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----------------~~ 217 (276)
T 2h6d_A 157 LSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----------------VP 217 (276)
T ss_dssp GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS----------------HH
T ss_pred cccccCCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc----------------HH
Confidence 98776543221 34568999999999988765 689999999999999999999996431 11
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.....+.... ...+..++..+.++|.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 218 TLFKKIRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1122221111 1234445678999999999999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=345.77 Aligned_cols=200 Identities=23% Similarity=0.300 Sum_probs=175.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc------cCCceeeeeeEEecCCee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL------KNENVVELVGYYVDGPLR 136 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l------~hp~iv~~~~~~~~~~~~ 136 (356)
...+|++.+.||+|+||.||+|.+. +++.||||++.........+.+|+.+++.+ +|+||+++++++......
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3467999999999999999999977 689999999976554456778899888887 567999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc--eeE
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKI 214 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--vkl 214 (356)
++||||+. ++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEE
T ss_pred EEEEeccC-CCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEE
Confidence 99999996 5999999876532 2889999999999999999999999 999999999999999987 999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCC
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (356)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus 244 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 244 IDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999998654432 234578999999999999999999999999999999999999997653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=343.11 Aligned_cols=260 Identities=19% Similarity=0.225 Sum_probs=204.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc--------CCceeeeeeEEe----
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK--------NENVVELVGYYV---- 131 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------hp~iv~~~~~~~---- 131 (356)
.++|++.+.||+|+||.||+|++. +++.||||++.......+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999976 7889999999765545577889999999985 788999999987
Q ss_pred cCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCC
Q 018396 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 132 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~ 210 (356)
++...++||||+ +++|.+++...... .+++..++.++.||+.||.|||++ | |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 567899999999 55777776654321 289999999999999999999998 8 99999999999998775
Q ss_pred -------------------------------------------------ceeEecccccCCCccccccccccccccCcCc
Q 018396 211 -------------------------------------------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241 (356)
Q Consensus 211 -------------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 241 (356)
.+||+|||++...... .....||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence 7999999998766432 2445789999
Q ss_pred cCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee------cccccCChh------------------
Q 018396 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------WATPKLSED------------------ 297 (356)
Q Consensus 242 ~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~------~~~~~~~~~------------------ 297 (356)
+|||++.+..++.++|||||||++|+|++|..||............. .........
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 99999999999999999999999999999999997654322110000 000000000
Q ss_pred ---------hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 ---------KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.....+.. ....+...+..+.+||.+||+.||.+|||+.|+++
T Consensus 340 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000 11346788899999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=333.96 Aligned_cols=256 Identities=16% Similarity=0.283 Sum_probs=202.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeeeEEec--CCeeEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVD--GPLRVLAY 140 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~ 140 (356)
.++|++.+.||+|+||.||+|.+. +++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.+ ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 467999999999999999999976 7999999998743 3567899999999997 9999999999987 67889999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-ceeEecccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDL 219 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~ 219 (356)
||+.+++|.+++.. +++..++.++.|++.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 113 e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp ECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred eccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 99999999999853 788999999999999999999999 99999999999999777 899999999
Q ss_pred cCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+......... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... +.. .........
T Consensus 178 a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~-~~~~~~~~~ 252 (330)
T 3nsz_A 178 AEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVR-IAKVLGTED 252 (330)
T ss_dssp CEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHH-HHHHHCHHH
T ss_pred ceEcCCCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHH-HHHhcCCch
Confidence 9765443322 44578999999999887 67899999999999999999999999543211000 000 000000000
Q ss_pred HhHhhc-----------------------ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVD-----------------------TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+. .......+..++.++.+||.+||+.||.+|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 101000 00111122235678999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=347.22 Aligned_cols=262 Identities=21% Similarity=0.325 Sum_probs=210.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC-CceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+|+++++.|+| +++..+..++.+.+..++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 478999999999999999999976 799999998765433 3458899999999987 5666666777788899999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE---ccCCceeEecccc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDL 219 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg~ 219 (356)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+
T Consensus 85 ~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred C-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 9 8899999985432 2899999999999999999999999 9999999999999 6889999999999
Q ss_pred cCCCccccccc-----cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 220 SNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 220 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
+.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~---------- 222 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK---------- 222 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH----------
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH----------
Confidence 98765433211 123567999999999999999999999999999999999999999765322111
Q ss_pred ChhhHhHhhcccCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 295 SEDKVKQCVDTKLGG---EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
..+..+....... .....++.++.+||..||+.+|.+||++.+|++.|++++...
T Consensus 223 --~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 223 --QKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp --HHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1111111111100 001233578999999999999999999999999999987644
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=332.36 Aligned_cols=253 Identities=21% Similarity=0.356 Sum_probs=202.2
Q ss_pred HHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc--CCceeeeeeEEecCCeeE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK--NENVVELVGYYVDGPLRV 137 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~ 137 (356)
...++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345679999999999999999999888999999998654333 356789999999997 599999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
++|| +.+++|.+++..... +++..++.++.|++.||.|||+++ ++||||||+||+++ ++.+||+||
T Consensus 105 lv~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Df 170 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF 170 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCC
T ss_pred EEEe-cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeec
Confidence 9999 567799999986542 889999999999999999999999 99999999999996 589999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccC-----------CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
|++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------ 244 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------ 244 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------
Confidence 99987654433222345568999999999875 4688899999999999999999999964321
Q ss_pred eecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 287 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
....+...++.......+...+.++.++|.+||+.||.+|||+.++++.
T Consensus 245 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 --------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1122333444444444455556789999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=331.54 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=201.2
Q ss_pred hCCCCCCceeeccCceEEEEEEEC--CCC--EEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGR--AAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||.||+|.+. +++ .||+|++..... ..+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 367999999999999999999853 333 689999875422 2467889999999999999999999998765 8
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++|+||+.+++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred eeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcc
Confidence 899999999999999976432 2889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccC
Q 018396 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------------- 230 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------------- 230 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------------
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------------
Confidence 9998776443221 11234457888999999998889999999999999999999 9999964421
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
......+.........+..++..+.++|.+||+.||.+|||+.++++.|+++....
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 231 -SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp -HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred -HHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11122222222233444566788999999999999999999999999999887554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=332.47 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=198.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---------chHHHHHHHHHHHhccCCceeeeeeEEecC
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 133 (356)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ....+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4467999999999999999999987 789999999865421 123478999999999999999999998766
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc--
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-- 211 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-- 211 (356)
. .++||||+++++|.+++.... .+++..++.++.||+.||.|||++| ++||||||+||+++.++.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~ 154 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDC 154 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCC
Confidence 5 899999999999999997543 2899999999999999999999999 999999999999987664
Q ss_pred -eeEecccccCCCccccccccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce
Q 018396 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (356)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (356)
+||+|||++........ .....||+.|+|||++. ...++.++|||||||++|+|++|..||.......
T Consensus 155 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----- 226 (322)
T 2ycf_A 155 LIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----- 226 (322)
T ss_dssp CEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-----
T ss_pred eEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-----
Confidence 99999999877654322 13456899999999874 5678999999999999999999999996542211
Q ss_pred ecccccCChhhHhHhhcccCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 288 TWATPKLSEDKVKQCVDTKLGGEYP---PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+...+........+ ..++..+.+||.+||+.||.+|||+.++++
T Consensus 227 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 ----------SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----------CHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----------HHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111111111111111 134578999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=328.46 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=205.9
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----------chHHHHHHHHHHHhcc-CCceeeeeeEE
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----------PDQEFLAQVSMVSRLK-NENVVELVGYY 130 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~-hp~iv~~~~~~ 130 (356)
...++|++.+.||+|+||.||+|.++ +++.||||++..... ..+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 35678999999999999999999987 789999999865431 1245778999999995 99999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 131 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
.+....++||||+++++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM 161 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCC
Confidence 999999999999999999999986532 899999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCccccc------CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (356)
.++|+|||++........ .....|++.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---- 234 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---- 234 (298)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred cEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----
Confidence 999999999876554322 24456899999999885 45688999999999999999999999964321
Q ss_pred cceecccccCChhhHhHhhcccCC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+...... ......++..+.++|.+||+.||.+|||+.++++
T Consensus 235 -----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 -----------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -----------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----------HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111112221111 1122356778999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=331.75 Aligned_cols=251 Identities=20% Similarity=0.347 Sum_probs=201.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4568999999999999999999987 689999999875433 35678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.
T Consensus 97 ~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp CCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred eCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999999999875432 2899999999999999999999999 9999999999999999999999999875
Q ss_pred CCccccccccccccccCcCccCcccc-----cCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYA-----MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
....... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||......
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------- 228 (302)
T 2j7t_A 166 KNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------------- 228 (302)
T ss_dssp HHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------
T ss_pred ccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---------------
Confidence 4322211 12345689999999988 3677899999999999999999999999654211
Q ss_pred hhHhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
........... ....+..++..+.++|.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 229 RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111111111 11233456678999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=361.65 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=213.1
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCC
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 134 (356)
.....++|++.+.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.+++.++||||+++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3344577999999999999999999975 2457999998754333 367889999999999999999999985 45
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..++||||+++|+|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL 532 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL 532 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred ceEEEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEE
Confidence 68999999999999999976532 2889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 533 ~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-------------- 597 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------------- 597 (656)
T ss_dssp CCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------------
T ss_pred EecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------------
Confidence 999999876543322 1233456789999999999999999999999999999997 999996442
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.......+........+..++..+.++|.+||+.||.+|||+.++++.|+.+++.
T Consensus 598 --~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 598 --NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 2223333333334455667788999999999999999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=347.34 Aligned_cols=250 Identities=12% Similarity=0.161 Sum_probs=192.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHH---HHHhccCCceeeee-------eE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVS---MVSRLKNENVVELV-------GY 129 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~---~l~~l~hp~iv~~~-------~~ 129 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888999999999999999975 7999999998632 223467889994 55556899999998 66
Q ss_pred EecCC-----------------eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 018396 130 YVDGP-----------------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192 (356)
Q Consensus 130 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~ 192 (356)
+.+.+ ..+++|||+ +|+|.+++........ ....+++..++.++.||+.||.|||++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT--TTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc--ccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 66553 388999999 5799999986532110 0112446888899999999999999999
Q ss_pred CeeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCC-----------CCCccchhhhH
Q 018396 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----------QMSSKSDVYSF 261 (356)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvwsl 261 (356)
|+||||||+|||++.++.+||+|||++...... .....| +.|+|||++.+. .++.++|||||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 999999999999999999999999998764432 134567 999999999887 89999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018396 262 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 341 (356)
Q Consensus 262 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell 341 (356)
||++|+|++|+.||........... +.. ....+++++.+||.+||+.||.+|||+.+++
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~~~---------------~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGSEW---------------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHHHHHSSCCC------CCSGG---------------GGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHHHHHCCCCCcccccccchhh---------------hhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 9999999999999965432211100 000 0123456789999999999999999999998
Q ss_pred H--HHHHh
Q 018396 342 K--ALQPL 347 (356)
Q Consensus 342 ~--~L~~l 347 (356)
+ .+.++
T Consensus 359 ~hp~f~~~ 366 (377)
T 3byv_A 359 ETPEYEQL 366 (377)
T ss_dssp TSHHHHHH
T ss_pred hChHHHHH
Confidence 6 44444
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=335.64 Aligned_cols=266 Identities=20% Similarity=0.294 Sum_probs=200.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec--------
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD-------- 132 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~-------- 132 (356)
.++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999986 8999999998654332 4578899999999999999999999886
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
.+..++||||+.+ +|.+.+..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 4568999999986 88888765432 2899999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccc--cccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec
Q 018396 213 KISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 289 (356)
||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999876542211 111244568999999999876 4579999999999999999999999976532211000000
Q ss_pred c--------cccCChhhHhHhhcccCCCCCC--H-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 A--------TPKLSEDKVKQCVDTKLGGEYP--P-----KAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 ~--------~~~~~~~~~~~~~~~~~~~~~~--~-----~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. .+..........+......... . ..++.+.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 0000000000000000000000 0 11456899999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=334.81 Aligned_cols=262 Identities=17% Similarity=0.273 Sum_probs=205.6
Q ss_pred hCCCCCCceeeccCceEEEEEEE-C-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC------ceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVL-R-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE------NVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp------~iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||.||+|.+ . +++.||+|++.......+.+.+|+.+++.++|+ +++++++++.+.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999997 3 688999999976554456788999999998765 499999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc--------
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-------- 208 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-------- 208 (356)
++||||+ +++|.+++...... .+++..++.++.|++.||.|||++| |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFL-------PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEcCC-CCCHHHHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccC
Confidence 9999999 78999999875432 2889999999999999999999999 999999999999987
Q ss_pred -----------CCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCC
Q 018396 209 -----------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (356)
Q Consensus 209 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (356)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 668999999998764432 2445789999999999999999999999999999999999999975
Q ss_pred CCCCCCccceecccccCChhh--------------------------HhHhhcc-cCCCCCCHHHHHHHHHHHHHhhccC
Q 018396 278 TLPRGQQSLVTWATPKLSEDK--------------------------VKQCVDT-KLGGEYPPKAIAKMAAVAALCVQYE 330 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~ 330 (356)
..................... ....... .........+++.+.+||.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 432211000000000000000 0000000 0011234466889999999999999
Q ss_pred CCCCCCHHHHHH
Q 018396 331 ADFRPNMGIVLK 342 (356)
Q Consensus 331 P~~Rps~~ell~ 342 (356)
|.+|||+.|+++
T Consensus 317 P~~Rpt~~ell~ 328 (339)
T 1z57_A 317 PAKRITLREALK 328 (339)
T ss_dssp TTTSCCHHHHTT
T ss_pred cccccCHHHHhc
Confidence 999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=342.74 Aligned_cols=270 Identities=19% Similarity=0.261 Sum_probs=200.7
Q ss_pred HHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEec---------
Q 018396 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--------- 132 (356)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--------- 132 (356)
...++|++.+.||+|+||.||+|.+. +++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 45678999999999999999999976 8999999998654332 3479999999999999999999843
Q ss_pred -----------------------------CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 018396 133 -----------------------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183 (356)
Q Consensus 133 -----------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 183 (356)
....++||||+++ +|.+.+....... ..+++..++.++.||+.||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSG-----RSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHH
Confidence 3348899999985 8887776421111 2389999999999999999
Q ss_pred HHhhhCCCCCeeecCCCCCcEEEc-cCCceeEecccccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhH
Q 018396 184 EYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSF 261 (356)
Q Consensus 184 ~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvwsl 261 (356)
.|||++| |+||||||+|||++ .++.+||+|||++......... ....||+.|+|||++.+. .++.++|||||
T Consensus 155 ~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 9999999 99999999999998 6889999999999866443322 445689999999998875 48999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccC-------------CCCCCHHHHHHHHHHHHHhhc
Q 018396 262 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKL-------------GGEYPPKAIAKMAAVAALCVQ 328 (356)
Q Consensus 262 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~ 328 (356)
||++|+|++|+.||.....................+.+... .... ....+..++.++.+||.+||+
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRM-NPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH-CTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh-CcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 99999999999999765322111000000000000100000 0000 001233456789999999999
Q ss_pred cCCCCCCCHHHHHH--HHHHhh
Q 018396 329 YEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 329 ~~P~~Rps~~ell~--~L~~l~ 348 (356)
.||.+|||+.|+++ .++++.
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHHHH
T ss_pred CChhhCCCHHHHhcCHHHHHHH
Confidence 99999999999996 455544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=336.26 Aligned_cols=277 Identities=19% Similarity=0.254 Sum_probs=197.4
Q ss_pred HHHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCe--
Q 018396 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL-- 135 (356)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-- 135 (356)
.......++|++.+.||+|+||.||+|.+. +++.||||++...........+++..++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345667889999999999999999999987 78999999987665556677888999999999999999999875333
Q ss_pred -----eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--hCCCCCeeecCCCCCcEEEcc
Q 018396 136 -----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--EKAEPRIIHRNIKSSNVLLFD 208 (356)
Q Consensus 136 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~~~~ivH~Dlkp~Nill~~ 208 (356)
.++||||+.+ +|.+.+....... ..+++..++.++.|++.||.||| ++| |+||||||+|||++.
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQ-----VAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNE 166 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEET
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeC
Confidence 7899999987 5555443211111 12789999999999999999999 888 999999999999997
Q ss_pred -CCceeEecccccCCCccccccccccccccCcCccCcccccCCC-CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 209 -DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 209 -~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
++.+||+|||++......... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 899999999999876543322 3456899999999987654 89999999999999999999999976532111000
Q ss_pred eecccccCChhhHhHhhcc----------------cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 018396 287 VTWATPKLSEDKVKQCVDT----------------KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~ 348 (356)
............+. .+.. ..........+.++.+||.+||+.||.+|||+.|+++ .|.++.
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 244 IVRVLGCPSREVLR-KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHCCCCHHHHH-HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHcCCCCHHHHH-hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00000000000000 0000 0001122235778999999999999999999999997 355544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=336.66 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=190.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhcc-CCceeeeeeEEe--------cC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLK-NENVVELVGYYV--------DG 133 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~-hp~iv~~~~~~~--------~~ 133 (356)
..+|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999986 7899999988544322 456889999999996 999999999984 34
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
...++++||+. |+|.+++...... ..+++..++.++.||+.||.|||+++. +|+||||||+|||++.++.+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEE
T ss_pred ceEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEE
Confidence 45899999997 5999988653211 138999999999999999999999852 399999999999999999999
Q ss_pred EecccccCCCccccccc----------cccccccCcCccCcccc---cCCCCCccchhhhHHHHHHHHHcCCCCCCCCCC
Q 018396 214 ISDFDLSNQAPDAAARL----------HSTRVLGTFGYHAPEYA---MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (356)
|+|||++.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432210 01244589999999998 566789999999999999999999999964321
Q ss_pred CCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 281 RGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
.. ..............+..+.+||.+||+.||.+|||+.++++.|+.+.....
T Consensus 259 ~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 259 LR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 10 111111112222334568899999999999999999999999999886543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=334.25 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=204.0
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecC-----Cee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~ 136 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999987 7889999999754433 36788999999999999999999998754 468
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++|+||+.+ +|.+++.... +++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 106 ~iv~e~~~~-~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp EEEEECCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEcccCc-CHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEe
Confidence 999999985 9999997653 899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccc-cccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...................
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99998765432221 1244579999999998764 558999999999999999999999997654322111110000001
Q ss_pred ChhhHh--------Hhhcc-cCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 295 SEDKVK--------QCVDT-KLGGEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 295 ~~~~~~--------~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+.+. ..... ...... ...++.++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111000 00000 000111 1234578999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=345.69 Aligned_cols=253 Identities=10% Similarity=0.034 Sum_probs=184.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhc--cCCceeeee-------eEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL--KNENVVELV-------GYY 130 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l--~hp~iv~~~-------~~~ 130 (356)
..+|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345899999999999999999987 7899999999875532 34567786555555 699988755 444
Q ss_pred ecC-----------------CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHhh
Q 018396 131 VDG-----------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR------VKIAVGAARGLEYLH 187 (356)
Q Consensus 131 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~------~~~~~qi~~~l~~lH 187 (356)
... ...++||||++ ++|.+++...... +.+..+ +.++.||+.||.|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--------YVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--------cchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 332 33899999999 7999999865321 333444 677799999999999
Q ss_pred hCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccC--CCCCccchhhhHHHHH
Q 018396 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVL 265 (356)
Q Consensus 188 ~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 265 (356)
++| |+||||||+|||++.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||||++
T Consensus 212 ~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 SKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 999 9999999999999999999999999998664322 23457799999999987 6799999999999999
Q ss_pred HHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 266 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 266 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
|+|++|+.||....+......... .................++..+.+||.+||+.||++|||+.++++
T Consensus 284 ~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPGIKGSWKRP--------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHSSCSTTBCCTTCTTCCCBC--------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHhCCCCCCCcCcccccchhhh--------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999976643321111100 000000111111222355678999999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=334.71 Aligned_cols=270 Identities=22% Similarity=0.321 Sum_probs=199.7
Q ss_pred HHHHHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc------------hHHHHHHHHHHHhccCCceee
Q 018396 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVE 125 (356)
Q Consensus 58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~hp~iv~ 125 (356)
..++....++|++.+.||+|+||.||+|...+++.||||++...... .+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998643221 267889999999999999999
Q ss_pred eeeEEec-----CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCC
Q 018396 126 LVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (356)
Q Consensus 126 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlk 200 (356)
+++++.. ....++||||+.+ +|.+++..... .+++..++.++.||+.||.|||++| |+|||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 161 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH 161 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred eeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence 9999853 3468999999985 88888875432 3899999999999999999999999 9999999
Q ss_pred CCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCC
Q 018396 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (356)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (356)
|+||+++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999975443322 244578999999999887 678999999999999999999999997643
Q ss_pred CCCCccceeccccc--------CChhhHhHhhcccCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 280 PRGQQSLVTWATPK--------LSEDKVKQCVDTKLGG-------EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 280 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.............. .........+...... ......++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 21100000000000 0000111111111100 011233567899999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=344.00 Aligned_cols=260 Identities=25% Similarity=0.335 Sum_probs=185.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC------
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------ 133 (356)
..++|++.+.||+|+||.||+|.+. +|+.||||++...... ...+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999976 7899999999764332 35678999999999999999999998754
Q ss_pred CeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
...++++|++ +++|.+++.... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp CCCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred CeEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEE
Confidence 5679999999 679999887533 899999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc--
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-- 290 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 290 (356)
|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999765432 244578999999999887 67899999999999999999999999765332111100000
Q ss_pred ------cccCChhhHhHhhcccCC-CCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 291 ------TPKLSEDKVKQCVDTKLG-GEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 291 ------~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+........+..... ... ....++.+.+||.+||+.||.+|||+.++++
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 001111111111111100 001 1123567899999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=336.68 Aligned_cols=263 Identities=23% Similarity=0.324 Sum_probs=203.4
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
++....++|++.+.||+|+||.||+|.... .+|+|++..... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 344456889999999999999999999863 499999875432 234577899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
++++||+++++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||+++ ++.++|+|
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECC
T ss_pred EEEeecccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEee
Confidence 999999999999999976431 2888999999999999999999999 99999999999998 68999999
Q ss_pred ccccCCCccccc---cccccccccCcCccCcccccC---------CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018396 217 FDLSNQAPDAAA---RLHSTRVLGTFGYHAPEYAMT---------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (356)
Q Consensus 217 fg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (356)
||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---- 248 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---- 248 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH----
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 999876532211 111234458999999999874 3578899999999999999999999964421
Q ss_pred cceecccccCChhhHhHhhccc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 285 SLVTWATPKLSEDKVKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
......+... ........++.++.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus 249 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 249 ------------EAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp ------------HHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred ------------HHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111111111 1111122455679999999999999999999999999999886653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=345.90 Aligned_cols=268 Identities=22% Similarity=0.282 Sum_probs=197.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecC------CeeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PLRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~------~~~~ 137 (356)
..+|++.+.||+|+||.||+|.+. +++.||||++...... ..+|+++++.++||||+++++++... ..++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 346999999999999999999987 7999999998654322 34799999999999999999987531 2367
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-CceeEec
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISD 216 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~D 216 (356)
+||||+++ +|.+++...... ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEecc
Confidence 89999986 777766532111 123899999999999999999999999 9999999999999965 5789999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+........
T Consensus 201 FG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 201 FGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp CTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred chhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999865443222 345789999999998765 789999999999999999999999976532111000000000001
Q ss_pred hhhHhHhhcccCC--------C-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 018396 296 EDKVKQCVDTKLG--------G-----EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 296 ~~~~~~~~~~~~~--------~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~ 348 (356)
.+.+... ..... . .++...+.++.+||.+||+.||.+|||+.|+++ .++++.
T Consensus 278 ~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 278 REQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1111110 00000 0 012234678999999999999999999999986 455443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=335.57 Aligned_cols=264 Identities=17% Similarity=0.219 Sum_probs=203.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc----h--------------HHHHHHHHHHHhccCCceee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP----D--------------QEFLAQVSMVSRLKNENVVE 125 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~--------------~~~~~e~~~l~~l~hp~iv~ 125 (356)
..++|++.+.||+|+||.||+|.. +++.||+|++...... . +.+.+|+.+++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999999 8999999998642111 1 77899999999999999999
Q ss_pred eeeEEecCCeeEEEEEecCCCCHHHH------HhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecC
Q 018396 126 LVGYYVDGPLRVLAYEHASKGSLHDI------LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRN 198 (356)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~D 198 (356)
+++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ +| ++|+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~d 177 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-------TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRD 177 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-------CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCC
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecC
Confidence 99999999999999999999999998 44321 1238999999999999999999999 88 99999
Q ss_pred CCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCC-CCCc-cchhhhHHHHHHHHHcCCCCCC
Q 018396 199 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSS-KSDVYSFGVVLLELLTGRKPVD 276 (356)
Q Consensus 199 lkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~~l~~g~~pf~ 276 (356)
|||+||+++.++.++|+|||++....... .....||+.|+|||++.+. .++. ++||||||+++|+|++|..||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999987654431 2455789999999999887 6666 9999999999999999999997
Q ss_pred CCCCCC-CccceecccccCCh--hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 277 HTLPRG-QQSLVTWATPKLSE--DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 277 ~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... .............. ..................++.++.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 553210 00000000000000 0000000000000111445678999999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=333.18 Aligned_cols=270 Identities=25% Similarity=0.321 Sum_probs=188.6
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
....++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999965 78999999986543 234567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++++|.+++....... ......+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EehhccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999997521110 001123899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccc---cccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 219 LSNQAPDAAA---RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 219 ~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.............. ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~ 243 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---ND 243 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT---SS
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc---cC
Confidence 9876543211 111234568999999999876 5689999999999999999999999976532211000000 00
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. . .............++.++.++|.+||+.||.+|||+.++++
T Consensus 244 ~~-~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PP-S---LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CC-C---TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CC-c---cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 0 00000001122334568899999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=322.89 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=207.1
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
+...++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 445678999999999999999999987 7999999998543 233567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC---CceeE
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKI 214 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vkl 214 (356)
+|+||+.+++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.+||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEccCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEE
Confidence 99999999999999876542 889999999999999999999999 9999999999999764 47999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
+|||++......... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus 166 ~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------- 228 (287)
T 2wei_A 166 IDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------------- 228 (287)
T ss_dssp CSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred eccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------------
Confidence 999998765433221 33458999999998875 4899999999999999999999999644211
Q ss_pred ChhhHhHhhcccCCCCC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHh
Q 018396 295 SEDKVKQCVDTKLGGEY--PPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPL 347 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l 347 (356)
.....+......... ...++.++.++|.+||+.||.+|||+.++++ .+.+.
T Consensus 229 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 229 --DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp --HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred --HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 111111111111111 1245678999999999999999999999998 44443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=342.12 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=196.5
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCC------eeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP------LRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------~~~l 138 (356)
..+|++.+.||+|+||.||+|.+..+..+|+|++...... ..+|+.+++.++||||+++++++.... ..++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4579999999999999999999886666999888654332 236999999999999999999986433 3789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc-cCCceeEecc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDF 217 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Df 217 (356)
||||+.+ ++.+.+....... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+||
T Consensus 116 v~e~~~~-~l~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 116 VLEYVPE-TVYRASRHYAKLK-----QTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp EEECCSE-EHHHHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EeeccCc-cHHHHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 9999987 4444433211100 12889999999999999999999999 99999999999999 7999999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
|++......... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.........
T Consensus 187 G~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 187 GSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp TTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999776443322 445789999999998765 5899999999999999999999999765322111000000000011
Q ss_pred hhHhHhh----cccC---CC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhh
Q 018396 297 DKVKQCV----DTKL---GG-----EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA--LQPLL 348 (356)
Q Consensus 297 ~~~~~~~----~~~~---~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~--L~~l~ 348 (356)
+.+...- ...+ .. ..+...++++.+||.+||+.||.+|||+.++++. ++++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 1110000 0000 00 0112356789999999999999999999999973 44443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=334.68 Aligned_cols=260 Identities=16% Similarity=0.222 Sum_probs=202.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-----------CCceeeeeeEEec
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----------NENVVELVGYYVD 132 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------hp~iv~~~~~~~~ 132 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++.......+.+.+|+.++++++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 468999999999999999999986 7899999999865555667889999998886 7999999999886
Q ss_pred CC----eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEc
Q 018396 133 GP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLF 207 (356)
Q Consensus 133 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~ 207 (356)
.+ ..+++||++ +++|.+++...... .+++..++.++.||+.||.|||++ | |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME 166 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEe
Confidence 44 789999999 88999999865432 288999999999999999999998 9 99999999999995
Q ss_pred c------CCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCC
Q 018396 208 D------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (356)
Q Consensus 208 ~------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (356)
. .+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 241 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence 3 348999999998765432 13457899999999999999999999999999999999999999755321
Q ss_pred CCccceec------ccccCCh---------------------------hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhc
Q 018396 282 GQQSLVTW------ATPKLSE---------------------------DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQ 328 (356)
Q Consensus 282 ~~~~~~~~------~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 328 (356)
........ ....... ......... ....+..++.++.+||.+||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~ 319 (373)
T 1q8y_A 242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQ 319 (373)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGC
T ss_pred ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhc
Confidence 10000000 0000000 000011111 124567889999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 018396 329 YEADFRPNMGIVLK 342 (356)
Q Consensus 329 ~~P~~Rps~~ell~ 342 (356)
.||.+|||+.++++
T Consensus 320 ~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 320 LDPRKRADAGGLVN 333 (373)
T ss_dssp SSTTTCBCHHHHHT
T ss_pred cCccccCCHHHHhh
Confidence 99999999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=326.86 Aligned_cols=265 Identities=20% Similarity=0.294 Sum_probs=202.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC--CCCEEEEEEcCCCC---CchHHHHHHHHHHHhc---cCCceeeeeeEEe----
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL---KNENVVELVGYYV---- 131 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~---- 131 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 67899999886422 2234567788877776 8999999999987
Q ss_pred -cCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC
Q 018396 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (356)
Q Consensus 132 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (356)
.....++||||+. ++|.+++...... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG 157 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCC
Confidence 5677899999998 4999999865432 2889999999999999999999999 99999999999999999
Q ss_pred ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc----
Q 018396 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL---- 286 (356)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~---- 286 (356)
.++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 158 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 158 QIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 999999999987654332 2455789999999999999999999999999999999999999976532110000
Q ss_pred ------eecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 287 ------VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 287 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..|.........................++..+.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000000000000000001122345678899999999999999999999995
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=336.65 Aligned_cols=273 Identities=19% Similarity=0.288 Sum_probs=185.9
Q ss_pred hCCCCC-CceeeccCceEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEe--cCCeeEE
Q 018396 65 TDNFGT-NSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRVL 138 (356)
Q Consensus 65 ~~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~l 138 (356)
.+.|++ .++||+|+||.||+|.++ +++.||||++..... ...+.+|+.+++.++||||+++++++. .....++
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 345776 568999999999999965 578999999975433 456889999999999999999999995 4778999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE----ccCCceeE
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKI 214 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl 214 (356)
||||+.+ +|.+++..............+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999976 88888864332111111123889999999999999999999999 9999999999999 67789999
Q ss_pred ecccccCCCcccccc-ccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc------
Q 018396 215 SDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL------ 286 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~------ 286 (356)
+|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999876543211 122456789999999999874 589999999999999999999999975533110000
Q ss_pred -------------eecccc-cC-ChhhHhHhh-cccCCCC--------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 287 -------------VTWATP-KL-SEDKVKQCV-DTKLGGE--------YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 287 -------------~~~~~~-~~-~~~~~~~~~-~~~~~~~--------~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..|... .. ........+ ....... .....+..+.+||.+||+.||.+|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 00 000000000 0000000 00011457889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=330.76 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=198.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCee---
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR--- 136 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~--- 136 (356)
..++|.+.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999987 7999999999765433 35678999999999999999999999877655
Q ss_pred ---EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCcee
Q 018396 137 ---VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (356)
Q Consensus 137 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (356)
++||||+.+ +|.+++... +++..++.++.|++.||.|||++| |+||||||+|||++.++.+|
T Consensus 120 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 120 YDFYLVMPFMQT-DLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp CCCEEEEECCCE-EHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEEccccc-cHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence 999999984 898887432 889999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec---
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--- 289 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~--- 289 (356)
|+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 185 L~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999997654322 44578999999999987 6789999999999999999999999975432110000000
Q ss_pred -----ccccCChhhHhHhhcccC---CCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 -----ATPKLSEDKVKQCVDTKL---GGE---YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 -----~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+............. ... ....+++.+.+||.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000000011110000 000 11234678999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=326.48 Aligned_cols=250 Identities=20% Similarity=0.366 Sum_probs=196.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEec----------
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD---------- 132 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~---------- 132 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 3467999999999999999999986 79999999996544445678899999999999999999998765
Q ss_pred ---CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 133 ---GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 133 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
....++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES 152 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence 4568999999999999999986432 2788999999999999999999999 9999999999999999
Q ss_pred CceeEecccccCCCccccc------------cccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCC
Q 018396 210 DIAKISDFDLSNQAPDAAA------------RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVD 276 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~ 276 (356)
+.++|+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 9999999999876543210 1112345689999999999864 68999999999999999998 553
Q ss_pred CCCCCCCccceecccccCChhhHhHhh---cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 277 HTLPRGQQSLVTWATPKLSEDKVKQCV---DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
... ........+ ........+...+..+.++|.+||+.||.+|||+.++++
T Consensus 230 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 230 TGM---------------ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp SHH---------------HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cch---------------hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 210 001111111 112223344556678999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=333.55 Aligned_cols=200 Identities=26% Similarity=0.306 Sum_probs=173.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CC-----ceeeeeeEEecCCee
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NE-----NVVELVGYYVDGPLR 136 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp-----~iv~~~~~~~~~~~~ 136 (356)
..++|++.+.||+|+||.||+|... +++.||||++.........+..|+.+++.++ |+ +|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 4578999999999999999999987 7889999999765444566778899988885 54 499999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh--CCCCCeeecCCCCCcEEEc--cCCce
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE--KAEPRIIHRNIKSSNVLLF--DDDIA 212 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~~~ivH~Dlkp~Nill~--~~~~v 212 (356)
++||||+.+ +|.+++...... .+++..++.++.|++.||.|||. .| |+||||||+|||++ .++.+
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCE
T ss_pred EEEEecCCC-CHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcE
Confidence 999999975 999999875422 28899999999999999999994 57 99999999999995 47789
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCC
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (356)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999776432 144578999999999999999999999999999999999999998653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=330.40 Aligned_cols=262 Identities=16% Similarity=0.253 Sum_probs=202.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CC-CEEEEEEcCCCCCchHHHHHHHHHHHhccCCc------eeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG-RAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~------iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||.||+|... ++ +.||+|++.......+.+.+|+.+++.++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 478999999999999999999976 44 68999999765555667889999999997765 89999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEE----------
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---------- 206 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---------- 206 (356)
++||||+ +++|.+++...... .+++..++.++.||+.||.|||++| |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQ-------PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEecc-CCChHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence 9999999 55787777654321 2889999999999999999999999 9999999999999
Q ss_pred ---------ccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCC
Q 018396 207 ---------FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (356)
Q Consensus 207 ---------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (356)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999998764332 1445789999999999999999999999999999999999999975
Q ss_pred CCCCCCccceecccccCChhh--------------------------HhHhhc-ccCCCCCCHHHHHHHHHHHHHhhccC
Q 018396 278 TLPRGQQSLVTWATPKLSEDK--------------------------VKQCVD-TKLGGEYPPKAIAKMAAVAALCVQYE 330 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~ 330 (356)
..................... ...... ...........+.++.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 432110000000000000000 000000 00001223455778999999999999
Q ss_pred CCCCCCHHHHHH
Q 018396 331 ADFRPNMGIVLK 342 (356)
Q Consensus 331 P~~Rps~~ell~ 342 (356)
|.+|||+.++++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=327.07 Aligned_cols=242 Identities=20% Similarity=0.337 Sum_probs=194.5
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-------hHHHHHHHHHHHhc----cCCceeeeeeE
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRL----KNENVVELVGY 129 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l----~hp~iv~~~~~ 129 (356)
....++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345678999999999999999999976 7899999999754321 23356789999998 89999999999
Q ss_pred EecCCeeEEEEEe-cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc-
Q 018396 130 YVDGPLRVLAYEH-ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF- 207 (356)
Q Consensus 130 ~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~- 207 (356)
+.+.+..++|+|+ +.+++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGP---------LGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL 174 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEET
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeC
Confidence 9999999999999 788999999986542 899999999999999999999999 99999999999999
Q ss_pred cCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCC-ccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
.++.++|+|||++........ ....||+.|+|||++.+..+. .++||||||+++|+|++|+.||....
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------- 243 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------- 243 (312)
T ss_dssp TTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred CCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------
Confidence 889999999999876654322 345689999999999877664 58999999999999999999995321
Q ss_pred eecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 287 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..... ....+..++..+.++|.+||+.||.+|||+.++++
T Consensus 244 --------------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 --------------EILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --------------HHHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------HHhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 11233456678999999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=328.83 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=201.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecC-----Ce
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~ 135 (356)
..++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999987 7899999999754433 35678999999999999999999987654 67
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.+++|||+.+ +|.+++.... +++..++.++.|++.||.|||++| ++||||||+|||++.++.+||+
T Consensus 89 ~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EEEEECCCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccCc-cHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence 8999999985 9999997643 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccc--------cccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 216 DFDLSNQAPDAAARL--------HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999987654322111 1123468999999998765 6789999999999999999999999976532110000
Q ss_pred e---------ecccccCChhhHhHhhcccCC-CC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 287 V---------TWATPKLSEDKVKQCVDTKLG-GE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 287 ~---------~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. ...............+..... .. ....++.++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000000011111111111000 00 11245678999999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=327.71 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=197.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCe-----
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----- 135 (356)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... ...+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999987 7999999999764433 3567899999999999999999999987654
Q ss_pred -eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 136 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.+++|||+.+ +|.+++... +++..++.++.||+.||.|||++| ++||||||+||+++.++.+||
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMGLK-----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCSE-EGGGTTTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEeccccC-CHHHHhcCC-----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEE
Confidence 4999999984 888877431 889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc---
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA--- 290 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~--- 290 (356)
+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242 (353)
T ss_dssp CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998765432 134568999999999887 67899999999999999999999999754321100000000
Q ss_pred -----cccCChhhHhHhhc---ccC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 291 -----TPKLSEDKVKQCVD---TKL---GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 291 -----~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+........+. ... .......++.++.+||.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000001110 000 01223456788999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=323.32 Aligned_cols=265 Identities=19% Similarity=0.277 Sum_probs=194.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEe----------
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYV---------- 131 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~---------- 131 (356)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3478999999999999999999987 689999999865432 2467889999999999999999999874
Q ss_pred ----cCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc
Q 018396 132 ----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (356)
Q Consensus 132 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (356)
+....++||||+. ++|.+++.... +++..++.++.|++.||.|||++| ++||||||+||+++
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQGP----------LLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN 154 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcCC----------ccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 4467899999998 49999996533 889999999999999999999999 99999999999997
Q ss_pred -cCCceeEecccccCCCcccccc-ccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018396 208 -DDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (356)
Q Consensus 208 -~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (356)
+++.+||+|||++......... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5679999999999876432111 11234457999999998875 67899999999999999999999999755321110
Q ss_pred cceecccccCChhhHhHhhc-------ccC-CCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 285 SLVTWATPKLSEDKVKQCVD-------TKL-GGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~-------~~~-~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.................... ... ... ....++.++.+||.+||+.||.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000011111111000 000 000 11235678999999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=326.40 Aligned_cols=257 Identities=27% Similarity=0.347 Sum_probs=180.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHH-HHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..++|++.+.||+|+||.||+|... +++.||||++...... ...+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3478999999999999999999987 7899999999765332 234555655 67778999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
|||+.+ +|.+++...... ....+++..++.++.|++.||.|||++ | ++||||||+||+++.++.+||+|||
T Consensus 100 ~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCS
T ss_pred EeecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCC
Confidence 999986 888887632110 012388999999999999999999998 9 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccc----cCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYA----MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
++......... ....||+.|+|||++ .+..++.++||||||+++|+|++|..||......... ... ..
T Consensus 172 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~----~~ 243 (327)
T 3aln_A 172 ISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-LTQ----VV 243 (327)
T ss_dssp SSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CC----CC
T ss_pred Cceeccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-HHH----Hh
Confidence 99776543222 334689999999998 4567899999999999999999999999754221100 000 00
Q ss_pred ChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. .....+.......++..+.+||.+||+.||.+|||+.++++
T Consensus 244 ~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 K------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 00001111112345678999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=327.83 Aligned_cols=255 Identities=18% Similarity=0.252 Sum_probs=178.2
Q ss_pred HhCCCCCCc-eeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEec----CCeeE
Q 018396 64 KTDNFGTNS-LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRV 137 (356)
Q Consensus 64 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~ 137 (356)
..++|++.+ .||+|+||.||+|.++ +++.||||++.... ....+....++.++||||+++++++.. ....+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 456788854 6999999999999987 79999999986432 222233344677799999999999876 45689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCceeE
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKI 214 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vkl 214 (356)
+||||+++|+|.+++...... .+++..++.++.|++.||.|||++| |+||||||+||+++. ++.+||
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQ-------AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CC-------CCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEE
T ss_pred EEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEE
Confidence 999999999999999865421 3899999999999999999999999 999999999999986 455999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 173 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--------- 239 (336)
T 3fhr_A 173 TDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--------- 239 (336)
T ss_dssp CCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred eccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---------
Confidence 9999987654322 134568999999999988889999999999999999999999996543221100
Q ss_pred ChhhHhHhh--cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHH
Q 018396 295 SEDKVKQCV--DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQP 346 (356)
Q Consensus 295 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~ 346 (356)
.....+. ...........++.++.+||.+||+.||.+|||+.++++ .+.+
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 240 --GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred --hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0000000 001111222345678999999999999999999999998 4444
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=330.29 Aligned_cols=244 Identities=19% Similarity=0.343 Sum_probs=201.2
Q ss_pred HHHHHhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhcc--CCceeeeeeE
Q 018396 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLK--NENVVELVGY 129 (356)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~--hp~iv~~~~~ 129 (356)
+.....++|++.+.||+|+||.||+|... +++.||||++..... ....+.+|+.+++.++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999976 789999999865322 1245678999999996 5999999999
Q ss_pred EecCCeeEEEEEecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc-
Q 018396 130 YVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF- 207 (356)
Q Consensus 130 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~- 207 (356)
+.+.+..++++|++.+ ++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL 184 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeC
Confidence 9999999999999986 899999986542 889999999999999999999999 99999999999999
Q ss_pred cCCceeEecccccCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
+++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------- 253 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------- 253 (320)
T ss_dssp TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------
Confidence 78999999999987665432 134568999999999987766 678999999999999999999995321
Q ss_pred eecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 287 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... ...+..++.++.+||.+||+.||.+|||++++++
T Consensus 254 --------------~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 --------------EIIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --------------HHHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------hhhccc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001110 1122334568899999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=319.10 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=182.2
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
..++|++.+.||+|+||.||+|.+. +++.||||++....... +.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 4578999999999999999999987 79999999997654432 2234445568888999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
|||+ ++.+..+...... .+++..++.++.|++.||.|||++ | ++|+||||+||+++.++.+||+|||
T Consensus 103 ~e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp ECCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred Eecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECC
Confidence 9999 4456555543221 288999999999999999999995 8 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
++......... ....||+.|+|||++. +..++.++||||||+++|+|++|..||.....
T Consensus 171 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------- 234 (318)
T 2dyl_A 171 ISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------------- 234 (318)
T ss_dssp TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------------
T ss_pred CchhccCCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------------
Confidence 98765443221 3456899999999984 45688999999999999999999999964311
Q ss_pred CChhhHhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 LSEDKVKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+........ .......++.++.++|.+||+.||.+|||+.++++
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 235 -DFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -HHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111122221111 11111235678999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=330.49 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=189.3
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+.+..++||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345567889999999998877678999999998643 235678899999886 89999999999999999999999996
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC-------------Cc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-------------DI 211 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-------------~~ 211 (356)
|+|.+++......... .....+..++.++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 93 -gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 93 -LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp -EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred -CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 5999999865432110 001233456789999999999999999 9999999999999754 48
Q ss_pred eeEecccccCCCccccccc--cccccccCcCccCcccccC-------CCCCccchhhhHHHHHHHHHc-CCCCCCCCCCC
Q 018396 212 AKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (356)
+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998765432211 1234579999999999975 568999999999999999999 99999643211
Q ss_pred CCccceecccccCChhhHhH-hhc-ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 282 GQQSLVTWATPKLSEDKVKQ-CVD-TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. ..+.. ... ..........++.++.+||.+||+.||.+|||+.++++
T Consensus 247 ~--------------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 E--------------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H--------------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--------------HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 00000 000 01111234577889999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.36 Aligned_cols=275 Identities=22% Similarity=0.284 Sum_probs=206.8
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEec------CC
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD------GP 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~------~~ 134 (356)
..++|++.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|+.+++.++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 4478999999999999999999976 7899999998764332 4568899999999999999999998765 67
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc---
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--- 211 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--- 211 (356)
..++||||+++++|.+++...... ..+++..++.++.|++.||.|||+.| |+||||||+||+++.++.
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCE
T ss_pred eEEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCcee
Confidence 889999999999999999865421 12778889999999999999999999 999999999999997764
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCc-------
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ------- 284 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~------- 284 (356)
++|+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 163 vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~ 239 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239 (676)
T ss_dssp EEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--
T ss_pred EEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcc
Confidence 999999999876543322 4567899999999999999999999999999999999999999653111000
Q ss_pred ccee-cccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHHhhccC
Q 018396 285 SLVT-WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGI-----VLKALQPLLNTR 351 (356)
Q Consensus 285 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e-----ll~~L~~l~~~~ 351 (356)
.... ....... ...................+..+.++|.+||..||.+|||+.+ +.+.++.+++..
T Consensus 240 ~~~~~~~~~~l~-g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 240 SNEHIVVYDDLT-GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp ----CCSCCCCS-SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred cchhhhhhhhhc-cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000 0000000 0000000001112345567889999999999999999999988 567777777644
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=309.69 Aligned_cols=232 Identities=16% Similarity=0.122 Sum_probs=187.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++....... +.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999987 68999999998664432 6788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||++|++|.+++... ....++..++.|++.||.|||++| |+||||||+|||++.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred EEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-
Confidence 9999999999999542 345578889999999999999999 9999999999999999999998543
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce-ecccccCChhh
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TWATPKLSEDK 298 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~ 298 (356)
|++ .++.++|||||||++|+|++|+.||............ .........
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 224 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE-- 224 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCC--
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCC--
Confidence 233 3688999999999999999999999865432211000 000000000
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.. .....+++++.++|.+||+.||.+| |+.++++.|+++....
T Consensus 225 ~~---------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 225 PA---------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HH---------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hh---------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00 1112346679999999999999999 9999999999987654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=329.55 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=188.5
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEEEEecC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.+|++.+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++||||+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 46888999999999997766566799999999965433 2356899999999 79999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CC--ceeEecccc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DD--IAKISDFDL 219 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~--~vkl~Dfg~ 219 (356)
+ +|.+++...... .....++.++.||+.||.|||+++ |+||||||+|||++. ++ .++|+|||+
T Consensus 102 g-~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 102 A-TLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp E-EHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred C-CHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 5 999999865421 334456789999999999999999 999999999999953 33 578999999
Q ss_pred cCCCcccccc-ccccccccCcCccCccccc---CCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccC
Q 018396 220 SNQAPDAAAR-LHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 220 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
+......... .......||+.|+|||++. +..++.++|||||||++|+|++ |..||.....
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------------- 235 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------------- 235 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------------
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------------
Confidence 9876543211 1224467999999999997 4567889999999999999999 9999954321
Q ss_pred ChhhHhHhhccc-C-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 295 SEDKVKQCVDTK-L-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 295 ~~~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.......... . ........+..+.+||.+||+.||.+|||+.++++
T Consensus 236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 236 --RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --HHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111111110 0 11122355677899999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=339.94 Aligned_cols=239 Identities=19% Similarity=0.289 Sum_probs=194.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC--CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCe-----
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~----- 135 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999976 6899999998754332 3567899999999999999999999987655
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.|+||||++|++|.+++.. . +++..++.++.||+.||.|||++| |+||||||+|||++.+ .+||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-~----------l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-K----------LPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEEEEECCCCEECC----C-C----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred eEEEEEeCCCCcHHHHHhC-C----------CCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence 7999999999999987754 1 899999999999999999999999 9999999999999875 89999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||...... ...
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~ 285 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLP 285 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCC
T ss_pred ecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccc
Confidence 99998765432 345699999999988765 488999999999999999999988642110 000
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhh
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQPLL 348 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ell~~L~~l~ 348 (356)
. .......++.+.++|.+||+.||.+|| +++++...|..++
T Consensus 286 ~------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 E------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp T------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 011123456889999999999999999 5666777776654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=300.86 Aligned_cols=228 Identities=18% Similarity=0.299 Sum_probs=180.9
Q ss_pred HhCCCCCC-ceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHH-HhccCCceeeeeeEEec----CCee
Q 018396 64 KTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV-SRLKNENVVELVGYYVD----GPLR 136 (356)
Q Consensus 64 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~hp~iv~~~~~~~~----~~~~ 136 (356)
..++|.+. +.||+|+||.||+|.+. +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 45678877 78999999999999986 789999999853 34577888887 56699999999999876 6788
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCcee
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (356)
++||||+++++|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEeecCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999999875422 3899999999999999999999999 999999999999998 78999
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|+|||++.... +..++.++|||||||++|+|++|..||............. ..
T Consensus 161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---~~ 213 (299)
T 3m2w_A 161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TR 213 (299)
T ss_dssp ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---CS
T ss_pred Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---HH
Confidence 99999874322 2446788999999999999999999996543221100000 00
Q ss_pred CChhhHhHhhcccCCCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 LSEDKVKQCVDTKLGGEYP----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. .. ....+ ..++.++.++|.+||+.||.+|||+.++++
T Consensus 214 ~~--------~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 214 IR--------MG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SC--------TT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hh--------hc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 00 00111 234678999999999999999999999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=313.36 Aligned_cols=236 Identities=17% Similarity=0.146 Sum_probs=183.6
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCC---------chHHHHHHHHHHHhcc---------CCceeee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLK---------NENVVEL 126 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~---------hp~iv~~ 126 (356)
.++|++.+.||+|+||.||+|++ +++.||||++..... ..+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 589999999975432 1267889999999886 6666666
Q ss_pred eeEE-----------------ec-------------CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHH
Q 018396 127 VGYY-----------------VD-------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176 (356)
Q Consensus 127 ~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 176 (356)
.+++ .+ ....++||||+++|++.+.+.... +++..++.++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~----------~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL----------SSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTC----------CCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcC----------CCHHHHHHHH
Confidence 5543 32 788999999999997777664422 8899999999
Q ss_pred HHHHHHHHHhh-hCCCCCeeecCCCCCcEEEccCC--------------------ceeEecccccCCCcccccccccccc
Q 018396 177 VGAARGLEYLH-EKAEPRIIHRNIKSSNVLLFDDD--------------------IAKISDFDLSNQAPDAAARLHSTRV 235 (356)
Q Consensus 177 ~qi~~~l~~lH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~ 235 (356)
.||+.||.||| +++ |+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus 168 ~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~ 237 (336)
T 2vuw_A 168 HQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV 237 (336)
T ss_dssp HHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred HHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence 99999999999 899 99999999999999887 899999999976543 234
Q ss_pred ccCcCccCcccccCCCCCccchhhhHHHH-HHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcc-----cCCC
Q 018396 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVV-LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT-----KLGG 309 (356)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~i-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 309 (356)
.||+.|+|||++.+.. +.++|||||+++ .+++++|..||.... +.......+... ....
T Consensus 238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--------------~~~~~~~~~~~~~~~~~~~~~ 302 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--------------WLHYLTDKMLKQMTFKTKCNT 302 (336)
T ss_dssp ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--------------HHHHHHHHHHHTCCCSSCCCS
T ss_pred EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--------------hhhHHHHhhhhhhccCcccch
Confidence 7999999999998766 889999998777 777888999984210 000001111110 1111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018396 310 EYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 341 (356)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell 341 (356)
..+..+++++.+||.+||+.| |++|++
T Consensus 303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 303 PAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 223468899999999999976 999988
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=312.50 Aligned_cols=246 Identities=12% Similarity=0.157 Sum_probs=180.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccC-Ccee-------------
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKN-ENVV------------- 124 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h-p~iv------------- 124 (356)
....|...+.||+|+||.||+|.+. +|+.||||++..... ..+.+.+|+.+++.+.| +|..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3445778899999999999999976 799999999874322 24678899999999976 2211
Q ss_pred --e------eeeEEec-----CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 018396 125 --E------LVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191 (356)
Q Consensus 125 --~------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~ 191 (356)
. +..++.. ....+++|+++ +++|.+++....... .....+++..++.++.|++.||.|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 1 1111111 22356666665 569999985221000 00123778899999999999999999999
Q ss_pred CCeeecCCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccc----------cCCCCCccchhhhH
Q 018396 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA----------MTGQMSSKSDVYSF 261 (356)
Q Consensus 192 ~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvwsl 261 (356)
|+||||||+|||++.++.+||+|||++...... .....| +.|+|||++ .+..++.++|||||
T Consensus 232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred --cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 999999999999999999999999998765543 244567 999999999 55568889999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 018396 262 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVL 341 (356)
Q Consensus 262 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell 341 (356)
||++|+|++|+.||......... ...+... ..+++.+.+||.+||+.||.+|||+.+++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~---------------~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGS---------------EWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCS---------------GGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHCCCCCCCcchhhhH---------------HHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999999999754322110 0111100 12346799999999999999999977765
Q ss_pred H
Q 018396 342 K 342 (356)
Q Consensus 342 ~ 342 (356)
+
T Consensus 363 ~ 363 (413)
T 3dzo_A 363 E 363 (413)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=281.86 Aligned_cols=185 Identities=15% Similarity=0.070 Sum_probs=130.9
Q ss_pred eeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-----------chHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEE
Q 018396 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-----------PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 139 (356)
..+.|++|.+..++.. .|+.+++|++.+... ..+++.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3556777766666543 689999999865421 124688999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||++|++|.++|..... ++.. .|+.||+.||+|||++| ||||||||+|||++.+|.+||+|||+
T Consensus 321 MEyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGl 385 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGS 385 (569)
T ss_dssp EECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeeccc
Confidence 999999999999986542 5543 47899999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCC
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf 275 (356)
|+........ ....+||+.|+|||++.+ .+..++|+||+|+++++|.++..++
T Consensus 386 Ar~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 386 IVTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp EESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CeeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 9876543322 245689999999999876 4667899999999988876655543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=243.87 Aligned_cols=185 Identities=16% Similarity=0.119 Sum_probs=145.7
Q ss_pred CCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---------hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
...+.||+|+||.||+|.. .++.+++|........ .+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 4788999986543221 23478999999999999999666666677788999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+
T Consensus 418 mE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp EECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred EECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence 999999999999865 3478999999999999999 999999999999998 999999999
Q ss_pred cCCCccccccc-----cccccccCcCccCcccccC--CCCCccchhhhHHHHHHHHHcCCCCCC
Q 018396 220 SNQAPDAAARL-----HSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVD 276 (356)
Q Consensus 220 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (356)
++......... ......||+.|+|||++.. ..|+..+|+||..+-..+...++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 98876543221 1245679999999999986 678888999999998888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=201.51 Aligned_cols=160 Identities=14% Similarity=0.076 Sum_probs=124.4
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCC-------------------chHHHHHHHHHHHhccCCc
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-------------------PDQEFLAQVSMVSRLKNEN 122 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~hp~ 122 (356)
......|.+.+.||+|+||.||+|.+.+|+.||+|++..... ....+.+|+.+++.++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 334455667799999999999999997799999999964321 1345789999999999 4
Q ss_pred eeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCC
Q 018396 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (356)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~ 202 (356)
+++.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||++| |+||||||+
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~ 222 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQY 222 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch---------------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH
Confidence 666665543 55699999999999998 421 123469999999999999999 999999999
Q ss_pred cEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccC----------CCCCccchhhh
Q 018396 203 NVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT----------GQMSSKSDVYS 260 (356)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws 260 (356)
|||++ ++.++|+|||+|. .+..+.|||++.. ..++..+|+|.
T Consensus 223 NILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSV---------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp SEEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred HEEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999 9999999999874 2445788887743 34455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.4e-22 Score=173.47 Aligned_cols=136 Identities=16% Similarity=0.156 Sum_probs=106.2
Q ss_pred CCCCCceeeccCceEEEEEEE-CCCCE--EEEEEcCCCCCc-------------------------hHHHHHHHHHHHhc
Q 018396 67 NFGTNSLIGEGSYGRVYFGVL-RSGRA--AAIKKLDSSKQP-------------------------DQEFLAQVSMVSRL 118 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l 118 (356)
-|++.+.||+|+||.||+|.. .+|+. ||||++...... ...+.+|+.+++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 57888 999987543211 12578899999999
Q ss_pred cCCce--eeeeeEEecCCeeEEEEEecCC-C----CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCC
Q 018396 119 KNENV--VELVGYYVDGPLRVLAYEHASK-G----SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKA 190 (356)
Q Consensus 119 ~hp~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ 190 (356)
.|+++ ..++.. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 88754 334432 357899999942 3 67776532 123456789999999999999 998
Q ss_pred CCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 191 ~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
|+||||||+|||++. .++|+|||+|...
T Consensus 192 ---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 ---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=9.5e-20 Score=165.20 Aligned_cols=142 Identities=11% Similarity=0.131 Sum_probs=101.7
Q ss_pred HHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---------------hHH--------HHHHHHHHHhc
Q 018396 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------------DQE--------FLAQVSMVSRL 118 (356)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------~~~--------~~~e~~~l~~l 118 (356)
.....-|++.+.||.|+||.||+|...+|+.||||++...... ... ..+|...|.++
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 3333449999999999999999999989999999987532110 011 12456666666
Q ss_pred cCCceeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecC
Q 018396 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 198 (356)
Q Consensus 119 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~D 198 (356)
.+.++.-..-+.. ...+|||||++|++|.++... .....++.|++.+|.+||+.| |||||
T Consensus 171 ~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH~~g---IVHrD 230 (397)
T 4gyi_A 171 YEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLAKHG---LIHGD 230 (397)
T ss_dssp HHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HhcCCCCCeeeec--cCceEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 5443321111111 124799999999888665321 124567899999999999999 99999
Q ss_pred CCCCcEEEccCC----------ceeEecccccCCC
Q 018396 199 IKSSNVLLFDDD----------IAKISDFDLSNQA 223 (356)
Q Consensus 199 lkp~Nill~~~~----------~vkl~Dfg~a~~~ 223 (356)
|||.|||++++| .+.|+||+-+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999998876 3899999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.4e-14 Score=123.73 Aligned_cols=145 Identities=17% Similarity=0.106 Sum_probs=113.7
Q ss_pred HHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEE
Q 018396 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l 138 (356)
+......|++...++.|+.+.||++... ++.+++|+..... .....+.+|+.+++.+. +..+.+++++..+.+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3456678998889999999999999765 6889999986421 22345889999999984 6678889999888899999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC----------------------------
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------- 190 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---------------------------- 190 (356)
||||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~--------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED--------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEECCSSEEHHHHCCT--------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred EEEecCCeehhhccCC--------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence 9999999999876421 1123367788999999999810
Q ss_pred ----------------------------CCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 191 ----------------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 191 ----------------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
...++|+|++|.||++++++.+.|+||+.+
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 133899999999999987656679999865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-12 Score=113.64 Aligned_cols=137 Identities=12% Similarity=0.031 Sum_probs=98.5
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc--eeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~--iv~~~~~~~~~~~~~lv~e~~ 143 (356)
..|.+..+.+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++.+..+++..++||||+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 344443343456669999998767788999987654 2345788999999986544 556888888888899999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------------
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--------------------------------- 190 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--------------------------------- 190 (356)
+|.+|. ... .. ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~~------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 98 PGQDLL--SSH------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp SSEETT--TSC------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCcccC--cCc------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 998884 211 11 1245566667777777642
Q ss_pred ----------------------CCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 191 ----------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 191 ----------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.1e-11 Score=112.93 Aligned_cols=141 Identities=18% Similarity=0.197 Sum_probs=104.9
Q ss_pred CCceeeccCceEEEEEEECCCCEEEEEEcC--CCC--CchHHHHHHHHHHHhcc--CCceeeeeeEEecC---CeeEEEE
Q 018396 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSK--QPDQEFLAQVSMVSRLK--NENVVELVGYYVDG---PLRVLAY 140 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~---~~~~lv~ 140 (356)
..+.|+.|.++.||++... +..+++|+.. ... .....+.+|+.+++.|. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999998876 4678999876 332 12356788999999996 35578888887766 4589999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC------------------------------
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA------------------------------ 190 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~------------------------------ 190 (356)
||++|..+.+... ..++......++.+++..|..||+..
T Consensus 121 e~v~G~~l~~~~~-----------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp ECCCCBCCCCTTC-----------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EecCCeecCCCcc-----------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 9999977744211 11677788889999999999999731
Q ss_pred -------------------------CCCeeecCCCCCcEEEccCCc--eeEecccccCC
Q 018396 191 -------------------------EPRIIHRNIKSSNVLLFDDDI--AKISDFDLSNQ 222 (356)
Q Consensus 191 -------------------------~~~ivH~Dlkp~Nill~~~~~--vkl~Dfg~a~~ 222 (356)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 235999999999999997753 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=3.4e-11 Score=107.01 Aligned_cols=183 Identities=19% Similarity=0.179 Sum_probs=118.5
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCc--eeeeeeEEecCC---eeEEEEEecC
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NEN--VVELVGYYVDGP---LRVLAYEHAS 144 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~--iv~~~~~~~~~~---~~~lv~e~~~ 144 (356)
.+.++.|..+.||++. ..+++|+.... .....+.+|+++++.+. +.. +.+++....... ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999873 56899986432 23467889999998884 322 334444433333 3488999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-----------------------------------
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK----------------------------------- 189 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----------------------------------- 189 (356)
|.+|.+..... ++..+...++.+++..+..||+.
T Consensus 100 G~~l~~~~~~~-----------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 100 GVPLTPLLLNN-----------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEECCHHHHHT-----------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred CeECCcccccc-----------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 98886533211 56666677777777777777751
Q ss_pred --------------------CCCCeeecCCCCCcEEEcc--CCceeEecccccCCCccccccccccccccCcCc---cCc
Q 018396 190 --------------------AEPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY---HAP 244 (356)
Q Consensus 190 --------------------~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aP 244 (356)
..+.++|+|++|.||++++ .+.+.|+||+.+......... . ....+ ..|
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---~---~~~~~~~~~~~ 242 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---I---SLMEDDEEYGM 242 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---H---TTCCTTTSCCH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---H---HHHhhccccCH
Confidence 1234899999999999998 456789999987543211100 0 00011 223
Q ss_pred cccc----C-CCC---------CccchhhhHHHHHHHHHcCCCCC
Q 018396 245 EYAM----T-GQM---------SSKSDVYSFGVVLLELLTGRKPV 275 (356)
Q Consensus 245 E~~~----~-~~~---------~~~~DvwslG~il~~l~~g~~pf 275 (356)
+... . +.. ....+.|+++.++|.+.+|..+|
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2211 0 011 11258999999999999999876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=5.6e-08 Score=84.51 Aligned_cols=133 Identities=12% Similarity=0.071 Sum_probs=94.7
Q ss_pred eeccCce-EEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEEecCCCCHHH
Q 018396 74 IGEGSYG-RVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (356)
Q Consensus 74 lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 150 (356)
+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.|. +-.+.+++.++.+.+..++|||+++|.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4445544 68988765 5678999976432 3456888999999884 3336678888888899999999999988877
Q ss_pred HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------------
Q 018396 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------------- 190 (356)
Q Consensus 151 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---------------------------------------- 190 (356)
...... .....+..++...|..||...
T Consensus 110 ~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 110 VLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp HHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 654321 122345556666666666421
Q ss_pred ---------------CCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 191 ---------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 191 ---------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1128999999999999987777899998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=9.3e-08 Score=84.78 Aligned_cols=136 Identities=17% Similarity=0.126 Sum_probs=89.3
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC---ceeeeeeEEe-cCCeeEEEEEecCCC
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---NVVELVGYYV-DGPLRVLAYEHASKG 146 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp---~iv~~~~~~~-~~~~~~lv~e~~~~~ 146 (356)
.+.++.|....||+. ++.+++|+-.. ......+.+|+++|+.|.+. .+.+.+.+.. ..+..+++|++++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 356888999999988 56789997422 22245788999999999652 3455565553 445678999999998
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-------------------------------------
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK------------------------------------- 189 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~------------------------------------- 189 (356)
+|.+..-.. ++......++.++...|..||+.
T Consensus 99 ~l~~~~~~~-----------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 99 ILGEDGMAV-----------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp ECHHHHHTT-----------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred ECchhhhhh-----------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 876632111 23333333344444444444332
Q ss_pred --------------------CCCCeeecCCCCCcEEEcc---CCc-eeEecccccCC
Q 018396 190 --------------------AEPRIIHRNIKSSNVLLFD---DDI-AKISDFDLSNQ 222 (356)
Q Consensus 190 --------------------~~~~ivH~Dlkp~Nill~~---~~~-vkl~Dfg~a~~ 222 (356)
.++.++|+|+.|.||+++. ++. +.|+||+.+..
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 48999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=3.1e-07 Score=83.21 Aligned_cols=78 Identities=9% Similarity=0.001 Sum_probs=55.0
Q ss_pred cee-eccCceEEEEEEEC-------CCCEEEEEEcCCCC---C-chHHHHHHHHHHHhccC---CceeeeeeEEecC---
Q 018396 72 SLI-GEGSYGRVYFGVLR-------SGRAAAIKKLDSSK---Q-PDQEFLAQVSMVSRLKN---ENVVELVGYYVDG--- 133 (356)
Q Consensus 72 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~h---p~iv~~~~~~~~~--- 133 (356)
+.| +.|..+.+|+.... +++.+++|+..... . ....+.+|+.+++.|.. -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999988754 26679999865432 1 13457889999888842 3566777776654
Q ss_pred CeeEEEEEecCCCCHH
Q 018396 134 PLRVLAYEHASKGSLH 149 (356)
Q Consensus 134 ~~~~lv~e~~~~~~L~ 149 (356)
+..++|||+++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.40 E-value=5.6e-06 Score=74.17 Aligned_cols=146 Identities=18% Similarity=0.269 Sum_probs=79.7
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-----CCceeeee-e--EEecCCeeEEEEEec
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----NENVVELV-G--YYVDGPLRVLAYEHA 143 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hp~iv~~~-~--~~~~~~~~~lv~e~~ 143 (356)
+.|+.|..+.||++...++ .+++|+.... ...+..|+.+++.|. .|.++... + +....+..+++++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3465577899999987654 5999988752 344555666666653 24333311 0 123466789999999
Q ss_pred CCCCHH-----------H---HHhcC-CCCC---CCC-CCCCCCHHHH-------------------------------H
Q 018396 144 SKGSLH-----------D---ILHGK-KGVK---GAK-PGPVLSWAQR-------------------------------V 173 (356)
Q Consensus 144 ~~~~L~-----------~---~l~~~-~~~~---~~~-~~~~~~~~~~-------------------------------~ 173 (356)
+|.++. + .++.. .... ... ......|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986432 1 11111 1000 000 0001122111 1
Q ss_pred HHHHHHHHHHHHhhh----------CCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 174 KIAVGAARGLEYLHE----------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 174 ~~~~qi~~~l~~lH~----------~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
.+..++..++.+|+. ..+..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 012349999999999999888889999999753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.4e-06 Score=77.48 Aligned_cols=74 Identities=20% Similarity=0.119 Sum_probs=50.1
Q ss_pred CceeeccCceEEEEEEEC-CCCEEEEEEcCCCC--------CchHHHHHHHHHHHhccC--Cc-eeeeeeEEecCCeeEE
Q 018396 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--------QPDQEFLAQVSMVSRLKN--EN-VVELVGYYVDGPLRVL 138 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~h--p~-iv~~~~~~~~~~~~~l 138 (356)
.+.||.|.++.||++... +++.+++|...... .....+..|+++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 56889999764321 123456789999888743 33 3455543 4456789
Q ss_pred EEEecCCC
Q 018396 139 AYEHASKG 146 (356)
Q Consensus 139 v~e~~~~~ 146 (356)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.13 E-value=3e-05 Score=67.76 Aligned_cols=77 Identities=21% Similarity=0.196 Sum_probs=55.8
Q ss_pred CCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCC---ceeeeeeEEecCCeeEEEEEe
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNE---NVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp---~iv~~~~~~~~~~~~~lv~e~ 142 (356)
...-.+.+|.|..+.||+....+|+.|++|+...... ....+..|+..|+.|..- .+.+++.+. .-+++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3444667999999999999999999999998764432 245678999999988431 344455432 24788999
Q ss_pred cCCCC
Q 018396 143 ASKGS 147 (356)
Q Consensus 143 ~~~~~ 147 (356)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.08 E-value=2.8e-05 Score=68.77 Aligned_cols=75 Identities=16% Similarity=0.080 Sum_probs=59.2
Q ss_pred CceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc---CCceeeeeeEEecCCeeEEEEEecCCCC
Q 018396 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 147 (356)
.+.|+.|....+|+.... ++.+++|+.... ....+..|++.|+.|. ...+.+.+.+....+..++||||++|..
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 456899999999998764 678899986532 3466889999998884 3567788888887888999999999875
Q ss_pred H
Q 018396 148 L 148 (356)
Q Consensus 148 L 148 (356)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.00 E-value=4.4e-05 Score=70.57 Aligned_cols=76 Identities=18% Similarity=0.232 Sum_probs=45.2
Q ss_pred CeeecCCCCCcEEEccCCceeEecccccCCCcccccccccccccc--CcCccCcccccCC---CCCccchhhhHHHHHHH
Q 018396 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG--TFGYHAPEYAMTG---QMSSKSDVYSFGVVLLE 267 (356)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~il~~ 267 (356)
.++|+|++|.|||++.++ +.|+||+.+......... ..... ...|.+|+..... ......++.++...+|+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 399999999999998877 999999987654321110 01111 1345555544311 11123445577777777
Q ss_pred HHcCC
Q 018396 268 LLTGR 272 (356)
Q Consensus 268 l~~g~ 272 (356)
.+.+.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.97 E-value=4.6e-05 Score=67.04 Aligned_cols=74 Identities=8% Similarity=0.007 Sum_probs=46.6
Q ss_pred CCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeeeEEecCCeeEEEEEec-CC
Q 018396 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHA-SK 145 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~-~~ 145 (356)
+.-.+.|+.|....+|++ +.+++|+............+|+.+++.+..-.+ .+++.+ +.+..+++++|+ +|
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 333678999999999998 558999876532222234568888877743222 344443 344467899999 66
Q ss_pred CCH
Q 018396 146 GSL 148 (356)
Q Consensus 146 ~~L 148 (356)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.97 E-value=0.0001 Score=65.55 Aligned_cols=75 Identities=13% Similarity=0.138 Sum_probs=51.4
Q ss_pred ceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeeeE-----EecCCeeEEEEEecC
Q 018396 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY-----YVDGPLRVLAYEHAS 144 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~-----~~~~~~~~lv~e~~~ 144 (356)
..|+ |....||++...+|+.+++|...........+..|..+++.|... .+.+++.. ....+..++++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4566 888899988776677899999875444556778888888887421 23333332 223456688999998
Q ss_pred CCC
Q 018396 145 KGS 147 (356)
Q Consensus 145 ~~~ 147 (356)
|.+
T Consensus 111 G~~ 113 (328)
T 1zyl_A 111 GRQ 113 (328)
T ss_dssp CEE
T ss_pred CCC
Confidence 754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.96 E-value=0.00017 Score=63.99 Aligned_cols=164 Identities=14% Similarity=0.192 Sum_probs=87.0
Q ss_pred cCHHHHHHHhCCCCCC-----ceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc--eeeeee
Q 018396 56 ISVDELKEKTDNFGTN-----SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVG 128 (356)
Q Consensus 56 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~--iv~~~~ 128 (356)
++.+++......|.+. +.|+.|....+|+....++ .+++|+.... ...+.+..|+.+++.|.... +.+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 3455666666667653 3456688899999987655 6889988653 22345677888887774211 223321
Q ss_pred E------EecCCeeEEEEEecCCCCHHH-----------H---HhcC-CCCCCCCCC--CCCCHHHHHH-----------
Q 018396 129 Y------YVDGPLRVLAYEHASKGSLHD-----------I---LHGK-KGVKGAKPG--PVLSWAQRVK----------- 174 (356)
Q Consensus 129 ~------~~~~~~~~lv~e~~~~~~L~~-----------~---l~~~-~~~~~~~~~--~~~~~~~~~~----------- 174 (356)
. ....+..+++++|++|..+.. . ++.. ......... ....|...+.
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 123456789999999854311 0 1111 000000000 0011211000
Q ss_pred -HHHHHHHHHHHhhhC----CCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 175 -IAVGAARGLEYLHEK----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 175 -~~~qi~~~l~~lH~~----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
+...+...+..++.. .+..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133344444421 12349999999999999887666899998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.92 E-value=6e-05 Score=61.96 Aligned_cols=101 Identities=15% Similarity=0.152 Sum_probs=66.6
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCccc
Q 018396 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (356)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (356)
+|.+.|..... +++++++|.++.|.+.+|.-+-.+.. -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~--------PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----- 97 (229)
T 2yle_A 34 SLEEILRLYNQ--------PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----- 97 (229)
T ss_dssp EHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------
T ss_pred cHHHHHHHcCC--------CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----
Confidence 79999987763 49999999999999999887632110 12333567999999999988764 1110
Q ss_pred cccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCC
Q 018396 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (356)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 273 (356)
.....+.|||... ...+.+.-|||||+++|..+--..
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123466888653 344677889999999999987333
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=6.2e-05 Score=68.37 Aligned_cols=145 Identities=14% Similarity=0.138 Sum_probs=80.5
Q ss_pred ceeeccCceEEEEEEEC--------CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEEe
Q 018396 72 SLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+.|..|-...+|++... +++.+++|+..........+.+|..+++.|. +.-..++++++.+ .+|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45666888999998864 2478999986443334456778999998884 3223556666543 289999
Q ss_pred cCCCCHHH--------------HHhcCCCCCCCCCCCCC--CHHHHHHHHHHHHH-------------------HHHH--
Q 018396 143 ASKGSLHD--------------ILHGKKGVKGAKPGPVL--SWAQRVKIAVGAAR-------------------GLEY-- 185 (356)
Q Consensus 143 ~~~~~L~~--------------~l~~~~~~~~~~~~~~~--~~~~~~~~~~qi~~-------------------~l~~-- 185 (356)
++|.+|.. .+..--.... ...... .+.++..+..++.. .+..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~-~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEM-PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC-SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCC-CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99855431 1100000000 001111 23444444433321 1222
Q ss_pred --hhhC-CCCCeeecCCCCCcEEEccC----CceeEecccccC
Q 018396 186 --LHEK-AEPRIIHRNIKSSNVLLFDD----DIAKISDFDLSN 221 (356)
Q Consensus 186 --lH~~-~~~~ivH~Dlkp~Nill~~~----~~vkl~Dfg~a~ 221 (356)
|... .+..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 12349999999999999876 789999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00037 Score=62.14 Aligned_cols=147 Identities=11% Similarity=0.095 Sum_probs=73.7
Q ss_pred ceeeccCceE-EEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC--CceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 72 SLIGEGSYGR-VYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 72 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
+.|+.|+... +|+....+++.+++|....... ..+..|+.+++.+.. -.+.+++.+..+. .+++||++.+.++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 3465555554 6676554467788886654321 335567777777642 2344555553333 3789999987777
Q ss_pred HHHHhcCCCC----------------CC-CCCCCCCCHHHHH---------H-----------HHHHHHHHHHHhh---h
Q 018396 149 HDILHGKKGV----------------KG-AKPGPVLSWAQRV---------K-----------IAVGAARGLEYLH---E 188 (356)
Q Consensus 149 ~~~l~~~~~~----------------~~-~~~~~~~~~~~~~---------~-----------~~~qi~~~l~~lH---~ 188 (356)
.+++...... .. ...-+.+...... . ....+...+..+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 6655432110 00 0000112211100 0 0001111222221 1
Q ss_pred CCCCCeeecCCCCCcEEEccC----CceeEecccccCC
Q 018396 189 KAEPRIIHRNIKSSNVLLFDD----DIAKISDFDLSNQ 222 (356)
Q Consensus 189 ~~~~~ivH~Dlkp~Nill~~~----~~vkl~Dfg~a~~ 222 (356)
..+..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123349999999999999874 6789999997754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00011 Score=68.12 Aligned_cols=72 Identities=13% Similarity=0.154 Sum_probs=49.0
Q ss_pred CceeeccCceEEEEEEECC--------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeeeEEecCCeeEEEEE
Q 018396 71 NSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e 141 (356)
.+.|+.|....+|++...+ ++.+++|+.... .....+.+|+.+++.|...++ .++++.+.+ .+|++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3467788889999998652 578999988432 222556789999888853333 456665433 28899
Q ss_pred ecCCCC
Q 018396 142 HASKGS 147 (356)
Q Consensus 142 ~~~~~~ 147 (356)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00012 Score=66.42 Aligned_cols=73 Identities=8% Similarity=0.037 Sum_probs=44.0
Q ss_pred ceeeccCceEEEEEEECC---------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc-eeeeeeEEecCCeeEEEEE
Q 018396 72 SLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~e 141 (356)
+.|+.|....+|++...+ ++.+++|+.............|..+++.|...+ ..++++.. . -++|++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457778889999998653 268899987543222123467888888874333 33555443 2 368999
Q ss_pred ecCCCCH
Q 018396 142 HASKGSL 148 (356)
Q Consensus 142 ~~~~~~L 148 (356)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00032 Score=65.37 Aligned_cols=73 Identities=12% Similarity=0.018 Sum_probs=46.9
Q ss_pred ceeeccCceEEEEEEECC-CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeeeEEecCCeeEEEEEecCCCCH
Q 018396 72 SLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
+.|+.|-...+|++...+ +..+++|+........-...+|+.+++.|...++ .++++.+.. .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 457778889999998774 5789999875432221123588999998865444 466666532 259999987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0005 Score=61.50 Aligned_cols=66 Identities=12% Similarity=0.047 Sum_probs=42.7
Q ss_pred cCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc---CCceeeeeeE------EecCCeeEEEEEecCCCC
Q 018396 77 GSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGY------YVDGPLRVLAYEHASKGS 147 (356)
Q Consensus 77 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~------~~~~~~~~lv~e~~~~~~ 147 (356)
|....||+....+| .+++|+...... ..|+.+++.|. -|++.+.+.. ....+..+++|+|++|..
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~ 107 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPN 107 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCB
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCc
Confidence 33688999987766 899998765432 35666666653 1224444432 234567899999999865
Q ss_pred H
Q 018396 148 L 148 (356)
Q Consensus 148 L 148 (356)
+
T Consensus 108 ~ 108 (339)
T 3i1a_A 108 G 108 (339)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0074 Score=55.48 Aligned_cols=74 Identities=8% Similarity=0.012 Sum_probs=48.2
Q ss_pred CceeeccCceEEEEEEECC--------CCEEEEEEcCCCCCchHHHHHHHHHHHhccC-CceeeeeeEEecCCeeEEEEE
Q 018396 71 NSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e 141 (356)
.+.|..|-...+|+....+ ++.+++++........-+..+|..+++.|.. .-..++++.+. -++|++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 3456778889999998753 5789999875433222234678888888842 22344554332 378899
Q ss_pred ecCCCCH
Q 018396 142 HASKGSL 148 (356)
Q Consensus 142 ~~~~~~L 148 (356)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.54 E-value=0.07 Score=48.62 Aligned_cols=29 Identities=24% Similarity=0.434 Sum_probs=24.3
Q ss_pred eeecCCCCCcEEE------ccCCceeEecccccCC
Q 018396 194 IIHRNIKSSNVLL------FDDDIAKISDFDLSNQ 222 (356)
Q Consensus 194 ivH~Dlkp~Nill------~~~~~vkl~Dfg~a~~ 222 (356)
++|+|+.+.||++ ++++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 3456799999998743
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.21 E-value=0.26 Score=40.37 Aligned_cols=115 Identities=7% Similarity=0.111 Sum_probs=78.1
Q ss_pred cCCceeeeeeEEecCCeeEEEEEecCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeec
Q 018396 119 KNENVVELVGYYVDGPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197 (356)
Q Consensus 119 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~ 197 (356)
.||+.+.. .+..+.+.+.+.++.-..+ ++.. +.. .+....+.++.+|+....+++.+ +|-
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~------------~~~~eKlr~l~ni~~l~~~~~~r-----~tf 103 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS------------FTKNEKLRYLLNIKNLEEVNRTR-----YTF 103 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG------------SCHHHHHHHHHHGGGGGGGGGSS-----EEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh------------cCHHHHHHHHHHHHHHHHHhcCc-----eEE
Confidence 57888866 4666667666666555432 3333 322 77889999999999988666554 788
Q ss_pred CCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCC
Q 018396 198 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (356)
Q Consensus 198 Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (356)
-|.|+||+++.++.+++.=.|+-.. ++|. ..+...=+-.+=+++..+++++..|+
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEecceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 8999999999999999986664211 1221 11222223357788899999999885
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.87 E-value=0.48 Score=38.90 Aligned_cols=114 Identities=9% Similarity=0.035 Sum_probs=77.7
Q ss_pred cCCceeeeeeEEecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-HhhhCCCCCeeec
Q 018396 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE-YLHEKAEPRIIHR 197 (356)
Q Consensus 119 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~-~lH~~~~~~ivH~ 197 (356)
.||++ -..+-.+.+.+.+.++.-+++.=...+.. .+....++++.+|+.... +++. -+|-
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------------~~~~eKlrll~nl~~L~~~~~~~-----r~tf 108 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------------TTLLSRIRAAIHLVSKVKHHSAR-----RLIF 108 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------------SCHHHHHHHHHHHHHHHSSCCSS-----SEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------------cCHHHHHHHHHHHHHHHHHhhhC-----ceeE
Confidence 57777 33444677888888777655433334432 778899999999988777 5555 4788
Q ss_pred CCCCCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccch-hhhHHHHHHHHHcCCCCCC
Q 018396 198 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSD-VYSFGVVLLELLTGRKPVD 276 (356)
Q Consensus 198 Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-vwslG~il~~l~~g~~pf~ 276 (356)
-|.|+||+++.++.++|.=.|+-. -++|.- .+ ..| +-.+=+++..++.++..|+
T Consensus 109 ~l~P~NL~f~~~~~p~i~hRGi~~-------------------~lpP~e-----~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 109 IVCPENLMFNRALEPFFLHVGVKE-------------------SLPPDE-----WD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CCCGGGEEECTTCCEEESCCEETT-------------------TBSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCceEEEeCCCcEEEEEcCCcc-------------------cCCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 899999999999999998666421 123321 11 123 2347778888888888874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.90 E-value=0.2 Score=46.58 Aligned_cols=60 Identities=5% Similarity=0.006 Sum_probs=18.0
Q ss_pred CCCceeeccCceEEEEEEEC-CCCEEEE------EEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEe
Q 018396 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAI------KKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYV 131 (356)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vav------K~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~ 131 (356)
.+.+.|| ||.||++.+. ...+||+ |........ ...+.+|..+++.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3455666 9999999976 3467888 655432222 235778888889999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 356 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-65 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-14 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-65
Identities = 63/283 (22%), Positives = 118/283 (41%), Gaps = 27/283 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
+ +G G +G V+ G A+K L FLA+ +++ +L+++ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L P+ + E+ GSL D L G+K L+ + + +A A G+ +
Sbjct: 73 LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAF 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ E+ IHR+++++N+L+ D KI+DF L+ D + APE
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE 180
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305
G + KSDV+SFG++L E++T + P ++ +V Q ++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPY---------------PGMTNPEVIQNLER 225
Query: 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
P ++ + LC + + RP + L+
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-65
Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 27/289 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVV 124
IG GS+G VY G A + + + + Q Q F +V ++ + ++ N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+GY L + + SL+ LH + + + IA A+G++
Sbjct: 68 LFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMD 118
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YLH K IIHR++KS+N+ L +D KI DF L+ + ++ G+ + AP
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 245 EYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301
E S +SDVY+FG+VL EL+TG+ P + R Q V +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------IFMVGR 224
Query: 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350
+ + M + A C++ + D RP +L +++ L +
Sbjct: 225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-60
Identities = 63/273 (23%), Positives = 112/273 (41%), Gaps = 29/273 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ L +E +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ + G L + L + Q +++ +EYL K +
Sbjct: 72 RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+HR++ + N L+ D + K+SDF LS D S + PE M + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFS 179
Query: 254 SKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYP 312
SKSD+++FGV++ E+ + G+ P + + + + + L P
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYER----------------FTNSETAEHIAQGLRLYRP 223
Query: 313 PKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345
A K+ + C +AD RP I+L +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-60
Identities = 60/277 (21%), Positives = 114/277 (41%), Gaps = 27/277 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G + AIK + +++F+ + ++ +L + +V+L G ++
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L +E G L D L + + + + + G+ YL E
Sbjct: 73 APICLVFEFMEHGCLSDYLR--------TQRGLFAAETLLGMCLDVCEGMAYLEEA---C 121
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+IHR++ + N L+ ++ + K+SDF ++ D ST + +PE + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYS 180
Query: 254 SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPP 313
SKSDV+SFGV++ E+ + K S +V + + T P
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYEN---------------RSNSEVVEDISTGFRLYKPR 225
Query: 314 KAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350
A + + C + + RP +L+ L + +
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (491), Expect = 3e-60
Identities = 68/297 (22%), Positives = 124/297 (41%), Gaps = 27/297 (9%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV 115
+ D+ + + + +G G YG VY GV + A+K L +EFL + +++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+K+ N+V+L+G P + E + G+L D L + +S + +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYM 120
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A + +EYL +K IHR++ + N L+ ++ + K++DF LS H
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGA 176
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295
+ APE + S KSDV++FGV+L E+ T P +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------PGID 221
Query: 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352
+V + ++ E P K+ + C Q+ RP+ + +A + + S
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-60
Identities = 69/301 (22%), Positives = 129/301 (42%), Gaps = 27/301 (8%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
++ D + ++ +G+G +G V+ G AIK L + FL + ++
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM 66
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+L++E +V+L + P+ + E+ SKGSL D L G+ G L Q V +
Sbjct: 67 KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGET-------GKYLRLPQLVDM 118
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A A G+ Y+ +HR+++++N+L+ ++ + K++DF L+ D
Sbjct: 119 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGA 174
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295
+ APE A+ G+ + KSDV+SFG++L EL T + P +
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---------------PGMV 219
Query: 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGPS 355
+V V+ PP+ + + C + E + RP + L+ +
Sbjct: 220 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279
Query: 356 K 356
+
Sbjct: 280 Q 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 6e-60
Identities = 58/295 (19%), Positives = 112/295 (37%), Gaps = 35/295 (11%)
Query: 73 LIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENV 123
+G G++G+V + A+K L S + ++++ ++S L N N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG---------VKGAKPGPVLSWAQRVK 174
V L+G G ++ E+ G L + L K+ L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A+G+ +L K IHR++ + N+LL I KI DF L+ + + +
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294
+ APE + +SDV+S+G+ L EL + +P
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-------------- 252
Query: 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349
+ K + + P A A+M + C + RP +++ ++ ++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-59
Identities = 63/298 (21%), Positives = 117/298 (39%), Gaps = 33/298 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG+G +G V+ G R G A+K S ++ A++ L++EN++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 134 PLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L ++ GSL D L+ ++ +K+A+ A GL +LH +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHME 119
Query: 190 A-----EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH--STRVLGTFGYH 242
+P I HR++KS N+L+ + I+D L+ + A + +GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 243 APEYAMT------GQMSSKSDVYSFGVVLLELLTGRKP----VDHTLPRGQQSLVTWATP 292
APE + ++D+Y+ G+V E+ D+ LP +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 293 KLSEDKVKQCVDTKLGGEY-PPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349
++ + +Q + + + +A+ MA + C R + K L L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-59
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN 120
K D+F S +G G+ G V+ + SG A K + +P + + ++ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V G + + EH GSL +L + K+++
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVI 114
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ + +GT
Sbjct: 115 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 168
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
Y +PE S +SD++S G+ L+E+ GR P+ + + +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-58
Identities = 68/291 (23%), Positives = 120/291 (41%), Gaps = 34/291 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRL 118
+IG G +G VY G+L++ AIK L + Q +FL + ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ N++ L G ++ E+ G+L L K G S Q V + G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRG 118
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLG 237
A G++YL +HR++ + N+L+ + + K+SDF LS D ++T
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297
+ APE + +S SDV+SFG+V+ E++T + +LS
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW---------------ELSNH 220
Query: 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
+V + ++ P + + + C Q E RP ++ L L+
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 9e-58
Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 41/306 (13%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N IGEG++GRV+ A+K L D +F + ++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------------GAK 162
N N+V+L+G G L +E+ + G L++ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
P LS A+++ IA A G+ YL E + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282
A + PE + +++SDV+++GVVL E+ + +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY----- 244
Query: 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
++ ++V V P ++ + LC RP+ + +
Sbjct: 245 ----------GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 343 ALQPLL 348
LQ +
Sbjct: 295 ILQRMC 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-57
Identities = 71/315 (22%), Positives = 140/315 (44%), Gaps = 41/315 (13%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQP 104
P PV+ +++K + +IGEG++G+V ++ AAIK++ +SK
Sbjct: 1 PTIYPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 53
Query: 105 DQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---- 159
++F ++ ++ +L + N++ L+G LA E+A G+L D L + ++
Sbjct: 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 160 ---GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216
LS Q + A ARG++YL +K + IHR++ + N+L+ ++ +AKI+D
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170
Query: 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
F LS + T + A E ++ SDV+S+GV+L E+++
Sbjct: 171 FGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227
Query: 277 HTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN 336
++ ++ + + E P ++ + C + + RP+
Sbjct: 228 ---------------CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 272
Query: 337 MGIVLKALQPLLNTR 351
+L +L +L R
Sbjct: 273 FAQILVSLNRMLEER 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-57
Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 34/298 (11%)
Query: 60 ELKEKTDNFGTNSL-IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPD--QEFLAQVS 113
+L K DN + +G G++G V GV R AIK L + +E + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
++ +L N +V L+G L +L E A G LH L GK+ + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--------IPVSNVA 112
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHS 232
++ + G++YL EK +HR++ + NVLL + AKISDF LS D +
Sbjct: 113 ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292
+ ++APE + SS+SDV+S+GV + E L+ +
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYK 214
Query: 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350
K+ +V ++ E PP+ ++ A+ + C Y+ + RP+ V + ++ +
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-57
Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 33/285 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
IG+G +G V G R G A+K + + Q FLA+ S++++L++ N+V+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQ 64
Query: 126 LVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+G V+ + + E+ +KGSL D L + VL +K ++ +E
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAME 117
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL +HR++ + NVL+ +D++AK+SDF L+ +A + AP
Sbjct: 118 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAP 169
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304
E + S+KSDV+SFG++L E+ + + P++ V V+
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPY---------------PRIPLKDVVPRVE 214
Query: 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349
+ P + V C +A RP+ + + L+ +
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 5e-57
Identities = 67/310 (21%), Positives = 126/310 (40%), Gaps = 44/310 (14%)
Query: 57 SVDELKEKTDNFGTN---------SLIGEGSYGRVYFGVLRS----GRAAAIKKLDS--S 101
+ ++ E F +IG G +G V G L+ AIK L S +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 102 KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA 161
++ ++FL++ S++ + + NV+ L G ++ E GSL L G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-- 125
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
+ Q V + G A G++YL + +HR++ + N+L+ + + K+SDF LS
Sbjct: 126 ------TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 222 QAPDAAARLHSTRVLG---TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278
D + T LG + APE + +S SDV+S+G+V+ E+++ +
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---- 232
Query: 279 LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG 338
++ V ++ P + + + C Q + + RP G
Sbjct: 233 -----------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 339 IVLKALQPLL 348
++ L ++
Sbjct: 282 QIVNTLDKMI 291
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-56
Identities = 59/306 (19%), Positives = 119/306 (38%), Gaps = 40/306 (13%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N ++G G++G+V A+K L + ++++ M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 118 LKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG--------------VKGAK 162
L + EN+V L+G L +E+ G L + L K+ ++ +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
VL++ + A A+G+E+L K +HR++ + NVL+ + KI DF L+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282
+ + + APE G + KSDV+S+G++L E+ + +P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
+ + + P A ++ + C +++ RP+ +
Sbjct: 274 AN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 343 ALQPLL 348
L L
Sbjct: 320 FLGCQL 325
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-56
Identities = 64/308 (20%), Positives = 121/308 (39%), Gaps = 40/308 (12%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQ--EF 108
VI L +F +IG G +G VY G L A+K L+ + +F
Sbjct: 21 VIGPSSL---IVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
L + ++ + NV+ L+G + + + G L + + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------P 127
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-- 225
+ + + A+G+++L K + +HR++ + N +L + K++DF L+ D
Sbjct: 128 TVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285
+ + T + A E T + ++KSDV+SFGV+L EL+T P P +
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVN 239
Query: 286 LVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345
L ++ Q P + V C +A+ RP+ ++ +
Sbjct: 240 TFDITVYLLQGRRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
Query: 346 PLLNTRSG 353
+ +T G
Sbjct: 290 AIFSTFIG 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-54
Identities = 68/281 (24%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 74 IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELV 127
+G G++G V G + + A+K L + E LA+ +++ +L N +V ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G +L E A G L+ L + + +++ + G++YL
Sbjct: 75 GICEAESW-MLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 124
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPEY 246
E +HR++ + NVLL AKISDF LS D T ++APE
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305
+ SSKSDV+SFGV++ E + G+KP + +V ++
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG----------------MKGSEVTAMLEK 225
Query: 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346
P +M + LC Y+ + RP V L+
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 9e-54
Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 38/282 (13%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
++F +G+G +G VY + S A+K L ++ + +V + S L++
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
N++ L GY+ D L E+A G+++ L + A
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELA 116
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
L Y H K R+IHR+IK N+LL KI+DF S AP + T + GT
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 169
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Y PE K D++S GV+ E L G+ P + + ++ + +
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229
Query: 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
D + + +++ RP + VL+
Sbjct: 230 GARD-----------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 9e-53
Identities = 58/293 (19%), Positives = 113/293 (38%), Gaps = 34/293 (11%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQPD--QEFLAQVSMVS 116
K F ++G G++G VY G+ AIK+L + P +E L + +++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
+ N +V L+G + ++++ + G L D + K +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQYLLNWC 117
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
V A+G+ YL ++ R++HR++ + NVL+ KI+DF L+ H+
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296
+ A E + + +SDV+S+GV + EL+T +
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPA 219
Query: 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349
++ ++ PP + + C +AD RP ++ +
Sbjct: 220 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-52
Identities = 57/287 (19%), Positives = 111/287 (38%), Gaps = 31/287 (10%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK 119
+ +++ IG GSYGR + G+ K+LD + E +++V+++ LK
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 120 NENVVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+ N+V +D L E+ G L ++ KG K L +++
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMT 116
Query: 178 GAARGLEYLHEK--AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
L+ H + ++HR++K +NV L K+ DF L+ + +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAF 174
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295
+GT Y +PE + KSD++S G +L EL P +
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA----------- 223
Query: 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
K+++ ++ Y + + + + RP++ +L+
Sbjct: 224 -GKIREGKFRRIPYRYSDELN----EIITRMLNLKDYHRPSVEEILE 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 6e-52
Identities = 65/301 (21%), Positives = 124/301 (41%), Gaps = 36/301 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS--------GRAAAIKKL--DSSKQPDQEFLAQVSMV 115
D +GEG++G+V A+K L D++++ + ++++ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 116 SRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVL 167
+ +N++ L+G + E+ASKG+L + L ++ P L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
+T + APE + +SDV+SFGV+L E+ T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY----------- 238
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347
P + +++ + + + P ++ + C RP +++ L +
Sbjct: 239 ----PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
Query: 348 L 348
+
Sbjct: 295 V 295
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-51
Identities = 69/306 (22%), Positives = 130/306 (42%), Gaps = 27/306 (8%)
Query: 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLD--SSKQ 103
A V DE + + + +G+GS+G VY GV + AIK ++ +S +
Sbjct: 6 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 65
Query: 104 PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
EFL + S++ +VV L+G G ++ E ++G L L + P
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 164 -GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
S ++ +++A A G+ YL+ + +HR++ + N ++ +D KI DF ++
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282
+ + L + +PE G ++ SDV+SFGVVL E+ T +
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------ 236
Query: 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
LS ++V + V + P + + +C QY RP+ ++
Sbjct: 237 ---------QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
Query: 343 ALQPLL 348
+++ +
Sbjct: 288 SIKEEM 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-51
Identities = 61/278 (21%), Positives = 104/278 (37%), Gaps = 38/278 (13%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG GS+ VY G+ + A +L +K Q F + M+ L++ N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 130 YVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ VL E + G+L L K V+ +GL++
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQF 127
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH + P IIHR++K N+ + KI D L+ + + V+GT + AP
Sbjct: 128 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304
E + DVY+FG+ +LE+ T P Q ++
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------------YRRVTS 227
Query: 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
+ AI ++ + C++ D R ++ +L
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 4e-51
Identities = 56/285 (19%), Positives = 117/285 (41%), Gaps = 34/285 (11%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNEN 122
D + +G+G++G+VY + + AA K +D+ + + ++++ ++ +++ + N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L+ + + E + G++ ++ + L+ +Q +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDA 122
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH+ +IIHR++K+ N+L D K++DF +S + R S +GT +
Sbjct: 123 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWM 177
Query: 243 APEYAMTGQM-----SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297
APE M K+DV+S G+ L+E+ P P + + P
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-- 235
Query: 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
P + + C++ D R +L+
Sbjct: 236 ------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-50
Identities = 60/300 (20%), Positives = 112/300 (37%), Gaps = 34/300 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSR 117
D +G G++G+V + R A+K L ++ + ++++ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 118 LKNE-NVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVLS 168
+ + NVV L+G G ++ E G+L L K+ L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288
+ + APE + +SDV+SFGV+L E+ + P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
+L E P +M C E RP +++ L LL
Sbjct: 245 EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-50
Identities = 65/282 (23%), Positives = 113/282 (40%), Gaps = 34/282 (12%)
Query: 73 LIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVEL 126
IGEG +G V+ G+ S A AIK + ++FL + + + + ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + P+ ++ E + G L L +K L A + A + L YL
Sbjct: 74 IGVITENPVWII-MELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYL 124
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
K R +HR+I + NVL+ +D K+ DF LS D+ +++ + APE
Sbjct: 125 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPES 180
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK 306
+ +S SDV+ FGV + E+L + + V ++
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQ---------------GVKNNDVIGRIENG 225
Query: 307 LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348
PP + ++ C Y+ RP + L +L
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-50
Identities = 69/281 (24%), Positives = 112/281 (39%), Gaps = 30/281 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNEN 122
+++ +GEG+YG V V R + A A+K +D + D + ++ + L +EN
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
VV+ G+ +G ++ L E+ S G L D + G + + G
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAG 115
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ YLH I HR+IK N+LL + D KISDF L+ ++ GT Y
Sbjct: 116 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 243 APEYAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301
APE + + DV+S G+VL +L G P D Q+ W K + K+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKK 231
Query: 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
+A + + R + + K
Sbjct: 232 I---------DSAPLALLHK----ILVENPSARITIPDIKK 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 1e-49
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 41/277 (14%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S + Q+ + +V + +L++ N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
Y+ L E+ + + KK L + + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLHS 133
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+IHR++K+ N+LL + + K+ DF ++ + +GT + APE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVIL 184
Query: 249 T---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDT 305
GQ K DV+S G+ +EL + P+ + + Q
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------------YHIAQNESP 232
Query: 306 KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
L + + C+Q RP ++LK
Sbjct: 233 ALQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-49
Identities = 66/289 (22%), Positives = 127/289 (43%), Gaps = 33/289 (11%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSM 114
S+ + + + IG+G+ G VY + + +G+ AI++++ +QP +E + ++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+ KN N+V + Y+ G + E+ + GSL D++ Q
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIAA 120
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ + LE+LH ++IHR+IKS N+LL D K++DF Q + +
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRST 175
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSLVTWATPK 293
++GT + APE K D++S G++ +E++ G P ++ R + T TP+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235
Query: 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
L + P K A C+ + + R + +L+
Sbjct: 236 L---------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-48
Identities = 68/289 (23%), Positives = 107/289 (37%), Gaps = 35/289 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLD----SSKQPDQEFLAQVSMVSR 117
+ +G+GS+G V G + + A+K L S + +F+ +V+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L + N++ L G + P++ + E A GSL D L +G + AV
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAV 118
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-STRVL 236
A G+ YL K R IHR++ + N+LL D+ KI DF L P
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296
F + APE T S SD + FGV L E+ T + L Q
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------------ 223
Query: 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQ 345
+ + P + V C ++ + RP + L
Sbjct: 224 --LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-45
Identities = 53/248 (21%), Positives = 92/248 (37%), Gaps = 17/248 (6%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQV----SMVS 116
K++ ++F ++GEGS+ V L + R AIK L+ + + V ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
RL + V+L + D +A G L +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYT 114
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
LEYLH IIHR++K N+LL +D +I+DF + + + + +
Sbjct: 115 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296
GT Y +PE SD+++ G ++ +L+ G P + E
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231
Query: 297 DKVKQCVD 304
+ D
Sbjct: 232 KFFPKARD 239
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (382), Expect = 2e-43
Identities = 52/281 (18%), Positives = 105/281 (37%), Gaps = 31/281 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSMVSRLKNENV 123
D++ + +G G++G V+ +G A K + + + D+E ++ +S L++ +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V L + D V+ YE S G L + + + +S + V+ +GL
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQVCKGL 137
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
++HE +H ++K N++ K+ DF L+ + +T GT +
Sbjct: 138 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEF 191
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301
APE A + +D++S GV+ LL+G P V + +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
+ + + + R + L+
Sbjct: 252 I---------SEDGKDFIRK----LLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (382), Expect = 2e-43
Identities = 61/289 (21%), Positives = 112/289 (38%), Gaps = 33/289 (11%)
Query: 60 ELKEKT--DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSMV 115
E+K+ + D + +G G++G V+ V +GR K +++ D+ ++S++
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++L + ++ L + D VL E S G L D + +S A+ +
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--------AEDYKMSEAEVINY 132
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDAAARLHST 233
A GL+++HE I+H +IK N++ KI DF L+ + +T
Sbjct: 133 MRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 189
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
T + APE + +D+++ GV+ LL+G P V +
Sbjct: 190 ---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246
Query: 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
ED P+A + +Q E R + L+
Sbjct: 247 FDEDAFSSV---------SPEAKDFIKN----LLQKEPRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-43
Identities = 47/284 (16%), Positives = 100/284 (35%), Gaps = 30/284 (10%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
KE + + +G G +G V+ V S + K + ++S+++ ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
N++ L + V+ +E S + + ++ L+ + V
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYVHQVC 112
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGT 238
L++LH I H +I+ N++ KI +F + Q + +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
Y+APE +S+ +D++S G ++ LL+G P + + A E+
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226
Query: 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
K+ +A+ + + E R L+
Sbjct: 227 FKEI---------SIEAMDFVDR----LLVKERKSRMTASEALQ 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (370), Expect = 2e-42
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 36/296 (12%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLK 119
+D + ++G G V+ LR R A+K L + D F + + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 120 NENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+ +V + GPL + E+ +L DI+H + ++ + +++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEV 116
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-R 234
A + L + H+ IIHR++K +N+++ + K+ DF ++ D+ + T
Sbjct: 117 IADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294
V+GT Y +PE A + ++SDVYS G VL E+LTG P P P
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233
Query: 295 SEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQPLLN 349
A + AV + + R + L + N
Sbjct: 234 PS-------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 146 bits (369), Expect = 3e-42
Identities = 58/295 (19%), Positives = 102/295 (34%), Gaps = 46/295 (15%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----------QEFLAQVSM 114
+N+ ++G G V + + + A+K +D + + L +V +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 115 VSRLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
+ ++ N+++L Y L ++ KG L D L K LS +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETR 113
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
KI + LH+ I+HR++K N+LL DD K++DF S Q
Sbjct: 114 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 167
Query: 234 RVLGTFGYHAPEYAMTGQM------SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
V GT Y APE + D++S GV++ LL G P H ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
+ + +Y ++ + + R L
Sbjct: 228 MSGNYQFGSPEWD---------DYSDTVKDLVSR----FLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-41
Identities = 50/245 (20%), Positives = 96/245 (39%), Gaps = 20/245 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV-----SMVSRLK 119
++F + ++G+GS+G+V+ + + + AIK L + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ + + + E+ + G L + ++ A
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEI 112
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
GL++LH K I++R++K N+LL D KI+DF + + A+ + GT
Sbjct: 113 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTP 167
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
Y APE + + + D +SFGV+L E+L G+ P + P
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 227
Query: 300 KQCVD 304
K+ D
Sbjct: 228 KEAKD 232
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (362), Expect = 2e-40
Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 25/231 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKN 120
++F + +IG G +G VY +G+ A+K LD KQ + L + M+S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 121 ---ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+V + + + + G LH L A A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMRFYAA 114
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD L+ +G
Sbjct: 115 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVG 167
Query: 238 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
T GY APE G S +D +S G +L +LL G P + + +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 2e-39
Identities = 57/284 (20%), Positives = 100/284 (35%), Gaps = 34/284 (11%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNE 121
D + ++G G++ V R+ + AIK + +E +++++ ++K+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V L Y G L + S G L D + K + ++
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLD 118
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
++YLH+ I+HR++K N+L + +D ISDF LS + + GT
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGT 172
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
GY APE S D +S GV+ LL G P + A +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS-- 230
Query: 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
Y ++ + + R L+
Sbjct: 231 -----------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-39
Identities = 65/294 (22%), Positives = 112/294 (38%), Gaps = 36/294 (12%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVG 128
S IGEG+YG V + AIKK+ + Q L ++ ++ R ++EN++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 129 YYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ + H L+ +L + LS RGL+
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLK 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHSTRVLGTFGYHA 243
Y+H ++HR++K SN+LL KI DF L+ A PD T + T Y A
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 244 PEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
PE + + +KS D++S G +L E+L+ R Q + + S++ +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 303 VDTKLGG--------------EYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
++ K P A +K + + + R + L
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (347), Expect = 7e-39
Identities = 50/289 (17%), Positives = 98/289 (33%), Gaps = 32/289 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY- 130
IG GS+G +Y G + +G AIK + + + + ++ + + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+G V+ E + S + +A +EY+H K
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK---------FSLKTVLLLADQMISRIEYIHSK- 122
Query: 191 EPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLH-----STRVLGTFGYH 242
IHR++K N L+ + I DF L+ + DA H + + GT Y
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
+ + + S + D+ S G VL+ G P ++ + K ++
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-- 238
Query: 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351
++ A C D +P+ + + + L + +
Sbjct: 239 -------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-38
Identities = 52/294 (17%), Positives = 102/294 (34%), Gaps = 37/294 (12%)
Query: 72 SLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQEFLAQV------SMVSRLKNENV 123
+ IGEG+YG+V+ GR A+K++ + L+ + + ++ NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 124 VELVGYYVDGPLR-----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L L +EH + + P P + +
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--------VPEPGVPTETIKDMMFQ 124
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
RGL++LH R++HR++K N+L+ K++DF L+ ++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVT 178
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV----------T 288
Y APE + ++ D++S G + E+ + + Q +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
W + + ++ + C+ + R + L
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (342), Expect = 3e-38
Identities = 44/291 (15%), Positives = 89/291 (30%), Gaps = 34/291 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYY 130
IGEGS+G ++ G L + + AIK + + L + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+G VL + + G S A ++ +HEK
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSIHEK- 120
Query: 191 EPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFG 240
+++R+IK N L+ + ++ + DF + D + H + GT
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Y + + + S + D+ + G V + L G P + +++
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---------ERIG 229
Query: 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351
+ + E + D P+ + +L
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 136 bits (343), Expect = 4e-38
Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 22/244 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
+F +G GS+GRV+ R +GR A+K L + + M+S + +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
++ + G + D + ++ G L +L + A
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAKFYAAEVC 114
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
LEYLH K II+R++K N+LL + KI+DF + PD + + GT
Sbjct: 115 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 166
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Y APE T + D +SFG+++ E+L G P + + A + +
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226
Query: 301 QCVD 304
D
Sbjct: 227 DVKD 230
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (337), Expect = 2e-37
Identities = 49/292 (16%), Positives = 104/292 (35%), Gaps = 28/292 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNEN 122
+ + IGEG+YG VY G A+KK+ K+ + + ++S++ LK+ N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L VL +EH + + + G L + G
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNG 112
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ Y H++ R++HR++K N+L+ + KI+DF L+ + ++ +
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRA 168
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE------ 296
+ + S+ D++S G + E++ G Q + +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 297 ------DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
D + + + + ++ + + R L+
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-36
Identities = 64/312 (20%), Positives = 107/312 (34%), Gaps = 36/312 (11%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL 109
+A P D +E ++ +IG GS+G VY L SG AIKK+ K+
Sbjct: 7 VATPGQGPDRPQE--VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKN 61
Query: 110 AQVSMVSRLKNENVVELVGYYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
++ ++ +L + N+V L ++ D L ++ + H +
Sbjct: 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------ 115
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQ 222
L R L Y+H I HR+IK N+LL D + K+ DF + Q
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282
+ + + + +S DV+S G VL ELL G+
Sbjct: 173 LVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 283 QQSLVTWA------------TPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYE 330
Q + P +E K Q + P+ + A+ + ++Y
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 331 ADFRPNMGIVLK 342
R
Sbjct: 291 PTARLTPLEACA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-36
Identities = 44/213 (20%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNE 121
+NF IGEG+YG VY + +G A+KK+ + + + ++S++ L +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+ L +E + + + +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIKSYLFQLLQ 113
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL + H R++HR++K N+L+ + K++DF L+ +A R ++ V+ +
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTLWYR 169
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S+ D++S G + E++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 7e-36
Identities = 60/302 (19%), Positives = 111/302 (36%), Gaps = 35/302 (11%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD------QEFLAQVSMVSRLKNENVVE 125
+GEG + VY + + + AIKK+ + + + L ++ ++ L + N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+ + L ++ I L+ + + +GLEY
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEY 115
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH+ I+HR++K +N+LL ++ + K++DF L+ T + T Y APE
Sbjct: 116 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPE 170
Query: 246 YAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED------K 298
+M D+++ G +L ELL + Q + + +E+
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 299 VKQCVDTKLGGEYPPKAIAKMAAVAAL-----CVQYEADFRPNMGIVLKALQPLLNTRSG 353
+ V K P I A L + R LK + R G
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSNRPG 288
Query: 354 PS 355
P+
Sbjct: 289 PT 290
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-35
Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 19/244 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLKN 120
++F L+G+G++G+V +GR A+K L ++ + + ++ ++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ L + E+A+ G L L ++ + +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIV 115
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
LEYLH + +++R+IK N++L D KI+DF L + A + GT
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPE 170
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Y APE D + GVV+ E++ GR P + L+ +
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230
Query: 301 QCVD 304
+
Sbjct: 231 EAKS 234
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 9e-35
Identities = 56/289 (19%), Positives = 107/289 (37%), Gaps = 40/289 (13%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-------QEFLAQVSMVSR 117
D + T +G G + V +G A K + + ++ +VS++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+++ NV+ L Y + +L E + G L D L K+ L+ + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLK 120
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHST 233
G+ YLH +I H ++K N++L D ++ KI DF L+++
Sbjct: 121 QILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFK 174
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
+ GT + APE + ++D++S GV+ LL+G P + + V+ +
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342
+ EY A + + R + L+
Sbjct: 235 FED-------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-34
Identities = 44/217 (20%), Positives = 82/217 (37%), Gaps = 27/217 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-------QEFLAQVSMVSRLKN--EN 122
L+G G +G VY G+ + AIK ++ + D +V ++ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
V+ L+ ++ VL E ++G L
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFFWQVLEA 122
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+ + H ++HR+IK N+L+ + K+ DF D T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 277
PE+ + +S V+S G++L +++ G P +H
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 6e-34
Identities = 45/226 (19%), Positives = 86/226 (38%), Gaps = 27/226 (11%)
Query: 60 ELKEKT--DNFG-TNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
++K+ D++ T+ ++G G G+V R+ A+K L + +E
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL---HW 59
Query: 116 SRLKNENVVELVGYYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ ++V +V Y + ++ E G L + + + +
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQAFTERE 112
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAA 228
+I ++YLH I HR++K N+L + I K++DF + + +
Sbjct: 113 ASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T Y APE + D++S GV++ LL G P
Sbjct: 170 LTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (308), Expect = 8e-33
Identities = 48/244 (19%), Positives = 86/244 (35%), Gaps = 22/244 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
D F +G GS+GRV SG A+K LD K + L + ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + D + E+ + G + L S A
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIV 151
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
EYLH +I+R++K N+L+ +++DF + + + + GT
Sbjct: 152 LTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPE 203
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
APE ++ + D ++ GV++ E+ G P P + +
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSS 263
Query: 301 QCVD 304
D
Sbjct: 264 DLKD 267
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-31
Identities = 48/246 (19%), Positives = 104/246 (42%), Gaps = 11/246 (4%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IG+G++G V+ R +G+ A+KK+ + + L ++ ++ LK+ENVV L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ + H G+ + ++ ++ GL Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHR- 135
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRVLGTFGYHAPEYA 247
+I+HR++K++NVL+ D + K++DF L+ + T + T Y PE
Sbjct: 136 --NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 248 MTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK 306
+ + D++ G ++ E+ T + + Q +L++ ++ + + +
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253
Query: 307 LGGEYP 312
L +
Sbjct: 254 LYEKLE 259
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-31
Identities = 40/205 (19%), Positives = 80/205 (39%), Gaps = 17/205 (8%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG V+ R + A+K++ + L ++ ++ LK++N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L +E + + +GL + H +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFLFQLLKGLGFCHSR 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
++HR++K N+L+ + K+++F L+ +A R +S V+ +
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
S+ D++S G + EL +P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 6e-31
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 18/235 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
+G G+YG V V R+G AIKKL Q + + ++ ++ +++ENV+ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + GK L + + +GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHA 139
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
IIHR++K N+ + +D KI DF L+ QA T + T Y APE +
Sbjct: 140 A---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVIL 191
Query: 249 TGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
+ D++S G ++ E++TG+ + Q + T + V++
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 2e-28
Identities = 37/213 (17%), Positives = 81/213 (38%), Gaps = 11/213 (5%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+G G + V+ + + A+K + K + ++ ++ R+ + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 132 DGPLRVLAY--EHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLE 184
+ L++L + G ++ G + +I+ GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 185 YLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
Y+H + IIH +IK NVL+ D + +++ H T + T Y +
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
PE + +D++S ++ EL+TG +
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 109 bits (273), Expect = 6e-28
Identities = 37/218 (16%), Positives = 82/218 (37%), Gaps = 26/218 (11%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-N 120
D++ +G G Y V+ + + + +K L K+ ++ ++ ++ L+
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGG 89
Query: 121 ENVVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L D R L +EH + + L+
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYE 137
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLG 237
+ L+Y H I+HR++K NV++ + ++ D+ L+ +
Sbjct: 138 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVA 191
Query: 238 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
+ + PE + QM D++S G +L ++ ++P
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-27
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 25/234 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQPD-----QEFLAQVSMVS 116
+NF ++G G+YG+V+ +G+ A+K L + + + ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 117 RLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++ +V L + L ++ + G L L ++ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIY 134
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
LE+LH+ II+R+IK N+LL + ++DF LS + A +
Sbjct: 135 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDF 190
Query: 236 LGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
GT Y AP+ G D +S GV++ ELLTG P + Q+ +
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-27
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 26/249 (10%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL 118
E + + S +G G+YG V ++G A+KKL Q + ++ ++ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 119 KNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
K+ENV+ L+ + V H L++I+ +K L+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQ 124
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
+ RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +
Sbjct: 125 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTG 177
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
V + + D++S G ++ ELLTGR T Q L+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 294 LSEDKVKQC 302
+ +K+
Sbjct: 238 PGAELLKKI 246
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-25
Identities = 48/243 (19%), Positives = 86/243 (35%), Gaps = 28/243 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG G+ G V R AIKKL Q + ++ ++ + ++N++ L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 129 YYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+ + L E I + + G
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------DHERMSYLLYQMLCG 131
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+++LH IIHR++K SN+++ D KI DF L+ A T + T Y
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
APE + D++S G ++ E++ + Q + V + +K+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 303 VDT 305
T
Sbjct: 246 QPT 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.1 bits (163), Expect = 7e-14
Identities = 26/160 (16%), Positives = 46/160 (28%), Gaps = 27/160 (16%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----------QPDQEFLAQVSMVSRLKN 120
L+GEG V+ +K D F +R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ +L G V P +A L D + ++
Sbjct: 66 RALQKLQGLAV--PKVYAWEGNAVLMELIDAKELYRVR----------VENPDEVLDMIL 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ + + I+H ++ NVL+ ++ I I DF S
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 356 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.52 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.44 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-60 Score=415.02 Aligned_cols=252 Identities=26% Similarity=0.323 Sum_probs=210.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.++|++.+.||+|+||+||+|+++ +|+.||||++..... ..+.+.+|+++++.++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999987 799999999865432 23568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+++|+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||+++++.+||+|||+|+
T Consensus 84 y~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence 999999999997543 2899999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
..............+||+.|+|||++.+..+ +.++|||||||++|+|++|++||....... ....
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--------------~~~~ 217 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--------------QEYS 217 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--------------HHHH
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--------------HHHH
Confidence 7765443333456789999999999988876 578999999999999999999996542211 1111
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..............+++++.+||.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 222222222233456778999999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-60 Score=417.38 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=228.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
..++|++.+.||+|+||+||+|+++ +++.||||++.......+++.+|+.+|++++|||||++++++.+++..++||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4467888999999999999999987 688999999988777778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+++|+|.+++...... .+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 95 ~~~g~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred ccCcchHHHhhhcccc-------chHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999765432 3899999999999999999999999 99999999999999999999999999987
Q ss_pred CccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
....... ......||+.|+|||++.+..|+.++|||||||++|||++|..||... .....+...
T Consensus 165 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~---------------~~~~~~~~~ 228 (287)
T d1opja_ 165 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG---------------IDLSQVYEL 228 (287)
T ss_dssp CCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT---------------CCHHHHHHH
T ss_pred cCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc---------------chHHHHHHH
Confidence 6543322 223445899999999999999999999999999999999977666422 234455566
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
+......+.+..+++++.+||.+||+.||.+|||+++|++.|+.+....
T Consensus 229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 6666667777888899999999999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-59 Score=408.97 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=214.2
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
++|++.+.||+|+||.||+|.+.+++.||||++.......+++.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 57889999999999999999998888999999988777778899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 85 GCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred CcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccC
Confidence 999999876542 3889999999999999999999999 99999999999999999999999999987654
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcC-CCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... ......||+.|+|||++.+..++.++|||||||++|||+|+ .+||... ....+...+.
T Consensus 154 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----------------~~~~~~~~i~ 216 (263)
T d1sm2a_ 154 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----------------SNSEVVEDIS 216 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----------------CHHHHHHHHH
T ss_pred CCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----------------CHHHHHHHHH
Confidence 3322 22345689999999999999999999999999999999994 5555422 2334444555
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.......+..+++++.+||.+||+.||++|||+++|++.|+++.++
T Consensus 217 ~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 217 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 5555566777788999999999999999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-59 Score=410.53 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=212.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
++|++.+.||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+.+++.++|||||++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999976 79999999986543 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
+||+|.+++.... +++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|...
T Consensus 100 ~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 100 AGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp TTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 9999999987653 899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
...... .....||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ...+....
T Consensus 167 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---------------~~~~~~~~ 229 (293)
T d1yhwa1 167 TPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---------------LRALYLIA 229 (293)
T ss_dssp CSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------------HHHHHHHH
T ss_pred cccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---------------HHHHHHHH
Confidence 543322 2456799999999999999999999999999999999999999964421 11122222
Q ss_pred cc-cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 304 DT-KLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 304 ~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.. ......+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 21 1223445567789999999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-59 Score=404.66 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=210.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||+||+|+++ +++.||+|++.+. ....+.+.+|+.+++.++|||||++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 467999999999999999999987 7899999998642 23356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++|+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 85 mEy~~~g~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp EECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred EeecCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 999999999999986543 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
|....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------~~~ 212 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----------------QET 212 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHH
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH----------------HHH
Confidence 98765432 2456799999999999999999999999999999999999999964421 111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+.. .....+..+++++.+||.+||+.||.+|||++|+++
T Consensus 213 ~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 213 YKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHT-TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHc-CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 221111 112345567789999999999999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=405.89 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=207.7
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..++|++.+.||+|+||+||+|+.+ ..||||++..... ..+.+.+|+.++++++|||||++++++. .+..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 3578999999999999999999865 3599999975432 2467889999999999999999999875 45689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||+++|+|.+++..... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 83 Ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla 151 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151 (276)
T ss_dssp ECCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred ecCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccce
Confidence 99999999999976542 2899999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccC---CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
................||+.|+|||++.+ ..|+.++|||||||++|||+||+.||....+. .
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---------------~ 216 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---------------D 216 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---------------H
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH---------------H
Confidence 87655443333456679999999999864 35799999999999999999999999754221 1
Q ss_pred hHhHhhcccCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 298 KVKQCVDTKLG----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 298 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.+...+..... ...+..+++++.+||.+||+.||.+|||+++|++.|+.+.++
T Consensus 217 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 217 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 22222222211 123456678999999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-59 Score=407.75 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=221.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
..++|++.+.||+|+||.||+|.+++++.||||++.......+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 346788999999999999999999888899999998877777889999999999999999999998755 5679999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+..
T Consensus 90 ~~g~L~~~~~~~~~~-------~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp TTCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence 999999988655432 2899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+... .....+...+
T Consensus 160 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~---------------~~~~~~~~~i 223 (272)
T d1qpca_ 160 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG---------------MTNPEVIQNL 223 (272)
T ss_dssp SSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT---------------CCHHHHHHHH
T ss_pred cCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC---------------CCHHHHHHHH
Confidence 543322 224456899999999999999999999999999999999965554322 2233344445
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
....+...+..+++++.+||.+||+.||++|||+++|++.|+++.++
T Consensus 224 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 55555666777888999999999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-58 Score=399.14 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=224.6
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
++|++.+.||+|+||+||+|++++++.||||++.......+++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 68999999999999999999999888999999988777788999999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||+++++.+||+|||++.....
T Consensus 84 g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 84 GCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred CcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999999766543 2889999999999999999999999 99999999999999999999999999987654
Q ss_pred ccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
.... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||... +..++...+.
T Consensus 153 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~----------------~~~~~~~~i~ 215 (258)
T d1k2pa_ 153 DEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----------------TNSETAEHIA 215 (258)
T ss_dssp SSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS----------------CHHHHHHHHH
T ss_pred CCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC----------------CHHHHHHHHH
Confidence 3332 2234568999999999999999999999999999999998 89999643 3344555555
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
...+...|..+++++.+||.+||+.||++|||++++++.|.++
T Consensus 216 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 5566677778888999999999999999999999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-59 Score=407.73 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=200.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec--CCeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 138 (356)
.++|++.+.||+|+||+||+|+++ +|+.||+|++...... .+.+.+|++++++++|||||++++++.+ ...+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 468999999999999999999987 7999999999776543 3467899999999999999999999865 456899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC--CCeeecCCCCCcEEEccCCceeEec
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE--PRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
||||+++|+|.+++....... ..+++..++.++.||+.||+|||+++. .+|+||||||+|||++.++.+||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKER-----QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred EEecCCCCcHHHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 999999999999996532111 238999999999999999999998642 2499999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (356)
||+|......... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.... .
T Consensus 158 FG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~----------------~ 219 (269)
T d2java1 158 FGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----------------Q 219 (269)
T ss_dssp HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----------------H
T ss_pred ccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC----------------H
Confidence 9999876543322 245679999999999999999999999999999999999999996432 2
Q ss_pred hhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+...+........+..+++++.+||.+||+.||.+|||++|+++
T Consensus 220 ~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 220 KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2233333333333456677889999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-58 Score=407.82 Aligned_cols=258 Identities=25% Similarity=0.445 Sum_probs=209.2
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCC---EEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
++|++.+.||+|+||+||+|+++ +++ .||||.+...... .+.+.+|+++|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56888899999999999999976 333 5889988754433 35789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++|+|.+++..... .+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCccc
Confidence 999999999999876542 3899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccc---cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCC
Q 018396 220 SNQAPDAAARL---HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 220 a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|+......... ......||+.|+|||++.+..++.++|||||||++|||+| |..||... .
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~----------------~ 238 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----------------T 238 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----------------C
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC----------------C
Confidence 98765432221 1123457899999999999999999999999999999998 89999643 2
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
...+...+....+...+..++.++.+||.+||+.||.+|||+.+|++.|++++..
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 239 NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 3344455555555667778889999999999999999999999999999998864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-58 Score=403.78 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=209.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 143 (356)
+.|++.+.||+|+||+||+|+++ +++.||||++..... ..+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999987 799999999976433 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++|+|.+++..... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|...
T Consensus 92 ~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 92 AGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp TTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 99999999865432 2899999999999999999999999 999999999999999999999999999766
Q ss_pred ccccccccccccccCcCccCccccc-----CCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
...... .....||+.|+|||++. +..|+.++|||||||++|+|++|+.||....+. +.
T Consensus 161 ~~~~~~--~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---------------~~ 223 (288)
T d2jfla1 161 TRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---------------RV 223 (288)
T ss_dssp HHHHHH--HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---------------GH
T ss_pred CCCccc--ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---------------HH
Confidence 543222 24567999999999984 456899999999999999999999999754221 11
Q ss_pred HhHhhccc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTK-LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+..+.... .....+..+++++.+||.+||+.||.+|||++|+++
T Consensus 224 ~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222221 122344567789999999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=407.36 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=207.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
++|++.+.||+|+||+||+|+++ +++.||||++.+. ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999986 7999999998642 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (356)
||++||+|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 88 Ey~~gg~L~~~~~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp CCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EccCCCCHHHhhhccCC---------CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccc
Confidence 99999999999886653 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
+..............+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... .....
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------------~~~~~ 220 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------------YLIFQ 220 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HHHHH
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---------------HHHHH
Confidence 877544333333556799999999999999999999999999999999999999964421 11112
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+.... ...+..+++++.+||.+||+.||.+|||++|++.
T Consensus 221 ~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 221 KIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 222221 2345567788999999999999999999998643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=407.37 Aligned_cols=264 Identities=22% Similarity=0.369 Sum_probs=219.3
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CC-----CEEEEEEcCCCC--CchHHHHHHHHHHHhc-cCCceeeeeeEEecCCe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG-----RAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~ 135 (356)
.++|++.+.||+|+||+||+|++. .+ ..||+|.+.... .....+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 467999999999999999999965 22 269999986532 2346789999999998 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~--------------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
.++||||+++|+|.+++....... .......+++..++.++.||+.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 999999999999999997654311 0112235899999999999999999999999 99999999
Q ss_pred CcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCC
Q 018396 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (356)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (356)
+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~- 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP- 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC-
Confidence 999999999999999999987665444333345678999999999999999999999999999999998 899996542
Q ss_pred CCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018396 281 RGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQP 346 (356)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 346 (356)
....+..++....+.+.+..+++++.+||.+||+.||++|||++||++.|..
T Consensus 272 --------------~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 --------------VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp --------------CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------------HHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1233455566666667777888999999999999999999999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=409.65 Aligned_cols=267 Identities=22% Similarity=0.342 Sum_probs=209.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
+.++|++.+.||+|+||+||+|++. +|+.||+|++..... ..+.+.+|+.+|+.++|||||++++++.+.+.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999987 789999999875432 2467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
||++||+|.+++..... +++..++.++.|++.||.|||++ | |+||||||+|||++++|.+||+|||+
T Consensus 84 Ey~~gg~L~~~l~~~~~---------l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp ECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCC
Confidence 99999999999976542 89999999999999999999974 8 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc-ee----------
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-VT---------- 288 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~-~~---------- 288 (356)
|....... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||........... ..
T Consensus 152 a~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 152 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp CHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred ccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence 97654322 2456899999999999999999999999999999999999999975432110000 00
Q ss_pred ------------c---ccccCChhhHhHhhcccCCCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHH
Q 018396 289 ------------W---ATPKLSEDKVKQCVDTKLGGEY-PPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQP 346 (356)
Q Consensus 289 ------------~---~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~ 346 (356)
. .............+........ ....+.++.+||.+||+.||.+|||++|+++ .|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0 0000000001111111111111 1224578999999999999999999999988 4544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-57 Score=404.51 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=195.3
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 140 (356)
..+.|++.+.||+|+||+||+|+++ +++.||||++..... ....+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999987 799999999875432 2356789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc---cCCceeEecc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDF 217 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~Df 217 (356)
||++||+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||+. +++.+||+||
T Consensus 87 E~~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGF---------YTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp CCCCSCBHHHHHHTCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHhhhcccC---------CCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence 99999999999976542 899999999999999999999999 99999999999995 5789999999
Q ss_pred cccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|+|+........ ...+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ..
T Consensus 155 G~a~~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------------~~ 216 (307)
T d1a06a_ 155 GLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---------------AK 216 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------------HH
T ss_pred ceeEEccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---------------HH
Confidence 999876543322 456799999999999999999999999999999999999999964321 11
Q ss_pred hHhHhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 298 KVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 298 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....+..... ....+..+++++.+||.+||++||.+|||++|+++
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 217 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1122222221 22333566788999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-57 Score=396.40 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=215.3
Q ss_pred CCCCCCce-eeccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSL-IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
++|.+... ||+|+||.||+|.++ ++..||||++...... .+.+.+|+++|++++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999865 3457999999764433 4678999999999999999999999865 468999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 mE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence 999999999999865432 2899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChh
Q 018396 220 SNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 220 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||... ...
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~----------------~~~ 219 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----------------KGP 219 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----------------CTH
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC----------------CHH
Confidence 9876543222 22234568999999999999999999999999999999998 99999643 223
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
.+...+..+.+.+.+..+++++.+||.+||+.||++|||+.+|++.|+...
T Consensus 220 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 445555556666777888999999999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=394.95 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=212.8
Q ss_pred CCCCCCceeeccCceEEEEEEECC-C----CEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRS-G----RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
+.|++.++||+|+||.||+|.++. + ..||||++...... ...+.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 468889999999999999999662 2 36999999765433 3468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+.++++.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 9999999999998876542 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||... ....
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~---------------~~~~ 220 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE---------------LSNH 220 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---------------CCHH
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc---------------CCHH
Confidence 99876543222 1223456899999999999999999999999999999999966655322 2334
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.+...+..+.+.+.+..++.++.+||.+||+.||++|||+.+|++.|++++..
T Consensus 221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 55566666667777788889999999999999999999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-57 Score=397.97 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=218.3
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 144 (356)
.++|++.+.||+|+||.||+|++++++.||||++.......+.+.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 36799999999999999999999877889999998877777889999999999999999999999854 56889999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCc
Q 018396 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (356)
Q Consensus 145 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (356)
+|+|..++...... .+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 95 ~g~l~~~~~~~~~~-------~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 95 KGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp TCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CCchhhhhhhcccc-------cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhcc
Confidence 99999998754321 2899999999999999999999999 9999999999999999999999999998765
Q ss_pred cccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhHhhc
Q 018396 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304 (356)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (356)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||... .........+.
T Consensus 165 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~---------------~~~~~~~~~i~ 228 (285)
T d1fmka3 165 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG---------------MVNREVLDQVE 228 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT---------------CCHHHHHHHHH
T ss_pred CCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC---------------CCHHHHHHHHH
Confidence 43322 224456899999999999999999999999999999999966655322 22333444455
Q ss_pred ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCCCC
Q 018396 305 TKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRSGP 354 (356)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~~~ 354 (356)
.....+.+..+++++.+||.+||+.||++|||+++|++.|+.......++
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 55556677788899999999999999999999999999999988766543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-57 Score=401.03 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=206.0
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
.|+..+.||+|+||+||+|++. +++.||||++...... .+.+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4899999999999999999987 7899999999765433 2467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
||.+|+|..++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|.
T Consensus 96 ~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (309)
T ss_dssp CCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred ecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccc
Confidence 999999987766543 2899999999999999999999999 9999999999999999999999999997
Q ss_pred CCccccccccccccccCcCccCcccccC---CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
..... ....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.... ....
T Consensus 164 ~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---------------~~~~ 222 (309)
T d1u5ra_ 164 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---------------AMSA 222 (309)
T ss_dssp SSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---------------HHHH
T ss_pred ccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---------------HHHH
Confidence 65432 34579999999999864 458999999999999999999999996432 1122
Q ss_pred HhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+..+.........+..+++++.+||.+||+.||.+|||++|+++
T Consensus 223 ~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 23333333333334456788999999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=393.75 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=207.2
Q ss_pred ceeeccCceEEEEEEEC---CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEecCC
Q 018396 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 145 (356)
+.||+|+||+||+|.++ +++.||||++...... .+.+.+|+.+|++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 3568999999654332 3578999999999999999999999865 457899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCCcc
Q 018396 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (356)
Q Consensus 146 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (356)
|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 g~L~~~l~~~~~---------l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 92 GPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcHHHHHhhccC---------CCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccc
Confidence 999999986543 899999999999999999999999 99999999999999999999999999986544
Q ss_pred cccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHhh
Q 018396 226 AAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303 (356)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (356)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||... ....+...+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~----------------~~~~~~~~i 223 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----------------KGSEVTAML 223 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC----------------CHHHHHHHH
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC----------------CHHHHHHHH
Confidence 3222 22234568999999999999999999999999999999998 89999643 234445555
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018396 304 DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLL 348 (356)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~ 348 (356)
....+...+..+++++.+||.+||+.||.+|||+++|++.|+...
T Consensus 224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 555666777788899999999999999999999999999887653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=391.97 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=199.0
Q ss_pred CCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec----CCeeEEE
Q 018396 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLA 139 (356)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~~lv 139 (356)
|++.+.||+|+||+||+|.+. +++.||+|++...... .+.+.+|+++|++++|||||++++++.+ ...+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999987 7889999998654332 3568899999999999999999999864 4568999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc-cCCceeEeccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFD 218 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg 218 (356)
|||+++|+|.+++..... +++..++.++.||+.||+|||+++. +|+||||||+|||++ +++.+||+|||
T Consensus 91 mE~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp EECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EeCCCCCcHHHHHhcccc---------ccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecC
Confidence 999999999999976542 8999999999999999999999852 399999999999997 57899999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 298 (356)
+|+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ...
T Consensus 161 la~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~---------------~~~ 220 (270)
T d1t4ha_ 161 LATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---------------AAQ 220 (270)
T ss_dssp GGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---------------HHH
T ss_pred cceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc---------------HHH
Confidence 997644322 245679999999998865 599999999999999999999999964321 112
Q ss_pred HhHhhcccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 299 VKQCVDTKL-GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 299 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+...+.... ....+...++++.+||.+||+.||++|||++|+++
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 222222211 11223334567999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-56 Score=403.25 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=210.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||+|+++ +|+.||||++...... .+.+.+|+.+|++++|||||++++++.+.+.+++|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3568999999999999999999987 7999999999765433 4568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc--CCceeEecccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDL 219 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~ 219 (356)
|++||+|.+++..... .+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 104 FMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp CCCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred cCCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999999965432 2899999999999999999999999 999999999999964 57899999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
|......... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .+.+
T Consensus 173 a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------------~~~~ 234 (350)
T d1koaa2 173 TAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---------------DETL 234 (350)
T ss_dssp CEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HHHH
T ss_pred heeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---------------HHHH
Confidence 9876544322 456799999999999999999999999999999999999999964421 1112
Q ss_pred hHhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+..... .......+++++.+||.+||+.||.+|||++|+++
T Consensus 235 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222211 11222456778999999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=398.72 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=212.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++++.||+|+||.||+|+++ +|+.||||++.+. ....+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 468999999999999999999987 8999999998643 23356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||++||+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 84 ~ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eeccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccc
Confidence 999999999999987653 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
|+........ ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.... ...+
T Consensus 152 a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----------------~~~~ 213 (337)
T d1o6la_ 152 CKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----------------HERL 213 (337)
T ss_dssp CBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----------------HHHH
T ss_pred ccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----------------HHHH
Confidence 9876543322 245689999999999999999999999999999999999999997542 1222
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~ 342 (356)
...+... ....|..+++++.+||.+||++||.+|++ ++++++
T Consensus 214 ~~~i~~~-~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 214 FELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHhcC-CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2222211 23456677889999999999999999995 888877
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-56 Score=402.96 Aligned_cols=250 Identities=21% Similarity=0.260 Sum_probs=211.5
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
..++|++.+.||+|+||.||+|++. +|+.||||++...... ...+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3467999999999999999999986 8999999998765432 4567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEc--cCCceeEecccc
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDL 219 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~~vkl~Dfg~ 219 (356)
|++||+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||+
T Consensus 107 ~~~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 107 FLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp CCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred cCCCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccc
Confidence 9999999998865432 2899999999999999999999999 99999999999998 578999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
|......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+
T Consensus 176 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---------------~~~~ 237 (352)
T d1koba_ 176 ATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---------------LETL 237 (352)
T ss_dssp CEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---------------HHHH
T ss_pred ceecCCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---------------HHHH
Confidence 9877654322 456789999999999999999999999999999999999999964421 1112
Q ss_pred hHhhccc--CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 300 KQCVDTK--LGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
..+.... ........+++++.+||.+||+.||.+|||++|+++
T Consensus 238 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 238 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222211 222334567788999999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=393.09 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=207.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+... ..+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999986 799999999854321 246789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC----ce
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IA 212 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~v 212 (356)
|+||||+++|+|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~---------l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCE
T ss_pred EEEEEcCCCccccchhccccc---------cchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccce
Confidence 999999999999999976542 899999999999999999999999 99999999999998776 59
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
||+|||+|......... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 157 kl~DfG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------ 221 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------ 221 (293)
T ss_dssp EECCCTTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------
T ss_pred EecchhhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------------
Confidence 99999999876543322 455789999999999999999999999999999999999999975421
Q ss_pred cCChhhHhHhhcccCC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 293 KLSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+.+..+...... ...+..++.++.+||.+||+.||.+|||++|+++
T Consensus 222 ---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 ---QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111112111111 0111234678999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=394.71 Aligned_cols=256 Identities=24% Similarity=0.409 Sum_probs=212.8
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCC----EEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
.+|++.+.||+|+||+||+|.+. +|+ .||+|.+.... ...+.+.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 57999999999999999999976 444 58899886432 3356799999999999999999999999875 5677
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
+++++.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred EEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccc
Confidence 8899999999998876542 3899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
+|+...............||+.|+|||++.+..++.++|||||||++|||+| |.+||... +..
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~----------------~~~ 220 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----------------PAS 220 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS----------------CGG
T ss_pred cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC----------------CHH
Confidence 9987655444333345568999999999999999999999999999999998 88998643 233
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
.+...+..+.+...+..+++++.+||.+||+.||.+|||+.+|++.|..+..
T Consensus 221 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 221 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp GHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 4555666666667777888999999999999999999999999999988753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-55 Score=392.49 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=210.6
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+. ....+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 367999999999999999999987 7999999998642 23356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+.||+|..++..... +++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 83 mE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp ECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 999999999999987654 788899999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
|+...... ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... .+..
T Consensus 151 a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---------------~~~~ 210 (316)
T d1fota_ 151 AKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---------------MKTY 210 (316)
T ss_dssp CEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------------HHHH
T ss_pred ceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---------------HHHH
Confidence 98765432 456899999999999999999999999999999999999999964321 1112
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
..+.... ...+...++++.+++.+||++||.+|+ |++++++
T Consensus 211 ~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 211 EKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2222222 244556778899999999999999996 8999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=386.01 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=205.8
Q ss_pred hCCCCCCceeeccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 138 (356)
.++|++.+.||+|+||.||+|++.. +..||||.+...... .+.+.+|+.++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3679999999999999999998752 346889988654433 356899999999999999999999986 467899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEeccc
Q 018396 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (356)
Q Consensus 139 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (356)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+||++++++.+||+|||
T Consensus 85 v~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence 9999999999998865542 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
+|+........ ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.... ..
T Consensus 154 ~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~----------------~~ 216 (273)
T d1mp8a_ 154 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----------------NN 216 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------GG
T ss_pred hheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC----------------HH
Confidence 99876543322 2244568999999999999999999999999999999998 899996542 22
Q ss_pred hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 298 KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
.+...+......+.+..+++++.+||.+||+.||.+|||+++|++.|+.+++.
T Consensus 217 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 217 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 23333344444566778889999999999999999999999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-55 Score=392.59 Aligned_cols=267 Identities=24% Similarity=0.360 Sum_probs=220.0
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
..++|++.+.||+|+||+||+|+.+ +++.||||++...... .+++.+|+.++++++||||+++++++.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999864 3578999999765443 3578999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCC
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlk 200 (356)
.+++|||+.+|+|.+++....... .......+++..++.++.|++.||+|||+++ +||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999997543211 1112234889999999999999999999999 9999999
Q ss_pred CCcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCC-CCCCCCC
Q 018396 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR-KPVDHTL 279 (356)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~-~pf~~~~ 279 (356)
|+|||++.++.+||+|||+|................||+.|+|||++.+..++.++|||||||++|||++|. +||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~- 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-
Confidence 999999999999999999997655444433345567899999999999999999999999999999999985 677543
Q ss_pred CCCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 280 PRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
...++...+........+..+++++.+||.+||+.+|.+|||+.||++.|+++++
T Consensus 247 ---------------~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 247 ---------------AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ---------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---------------CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2233334444444556667788899999999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-56 Score=384.88 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=209.7
Q ss_pred hCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEec-CCeeEEEEEec
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYEHA 143 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~ 143 (356)
.++|++.+.||+|+||.||+|..+ |..||||++..+. ..+.+.+|++++++++||||+++++++.+ .+.+++||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 457888999999999999999986 7789999997543 45779999999999999999999999865 46689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 84 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp TTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceec
Confidence 999999999754321 2789999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCChhhHhHh
Q 018396 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302 (356)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (356)
.... ....+|+.|+|||++.+..++.++|||||||++|||++ |++||... ....+...
T Consensus 154 ~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~----------------~~~~~~~~ 212 (262)
T d1byga_ 154 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----------------PLKDVVPR 212 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----------------CGGGHHHH
T ss_pred CCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC----------------CHHHHHHH
Confidence 4332 34467899999999999999999999999999999998 78888533 23334455
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 303 VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
+....+.+.+..+++++.+||.+||+.||.+|||+.++++.|+++.+.
T Consensus 213 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 555566677778889999999999999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=392.81 Aligned_cols=248 Identities=17% Similarity=0.212 Sum_probs=211.1
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
..++|++.+.||+|+||+||+|.++ +++.||||++.........+.+|+++|+.++|||||++++++.+.+.+|+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4578999999999999999999987 789999999987766667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC--CceeEeccccc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDFDLS 220 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~Dfg~a 220 (356)
++||+|.+++..... .+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 83 ~~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp CCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchh
Confidence 999999999976532 2899999999999999999999999 9999999999999854 48999999999
Q ss_pred CCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHh
Q 018396 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (356)
......... ....+|+.|+|||.+.+..|+.++|||||||++|+|++|..||..... ...+.
T Consensus 152 ~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---------------~~~~~ 213 (321)
T d1tkia_ 152 RQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---------------QQIIE 213 (321)
T ss_dssp EECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---------------HHHHH
T ss_pred hccccCCcc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---------------HHHHH
Confidence 876543322 445789999999999999999999999999999999999999965421 11222
Q ss_pred HhhcccCCCCCCH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 301 QCVDTKLGGEYPP----KAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 301 ~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+..... ..+. .++.++.+||.+||..||.+|||++|+++
T Consensus 214 ~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 214 NIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222222 1222 34678999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=388.97 Aligned_cols=274 Identities=21% Similarity=0.325 Sum_probs=213.2
Q ss_pred HHHHHHhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeE
Q 018396 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGY 129 (356)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~ 129 (356)
.+|.-..++|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 444445578999999999999999999953 3468999999754433 35677788887777 68999999998
Q ss_pred Eec-CCeeEEEEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCC
Q 018396 130 YVD-GPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (356)
Q Consensus 130 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (356)
+.+ +..+++||||+++|+|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 765 4568999999999999999976542110 011234889999999999999999999999 99999999
Q ss_pred CcEEEccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcC-CCCCCCCCC
Q 018396 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLP 280 (356)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~pf~~~~~ 280 (356)
+||||++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~- 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK- 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-
Confidence 9999999999999999999876554443334556799999999999999999999999999999999986 56775431
Q ss_pred CCCccceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 281 RGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
....+...+........+..+++++.+||.+||+.||.+|||++|+++.|+.++..
T Consensus 242 --------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 --------------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp --------------CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 12334444555555666777888999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-54 Score=381.76 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=205.8
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeeeEEecCC----e
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGP----L 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~ 135 (356)
.++|++.+.||+|+||+||+|++. +|+.||||++...... .+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999986 8999999999765432 246889999999999999999999987643 4
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.|+||||++|++|.+++..... +++.+++.++.||+.||+|||++| |+||||||+|||++.++.++|+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEECCCCCEehhhhcccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceee
Confidence 7999999999999999876643 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccc-cccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccC
Q 018396 216 DFDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (356)
Q Consensus 216 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 294 (356)
|||.+........ ........||+.|+|||++.+..++.++|||||||++|+|++|++||....+.
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------------- 220 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------------- 220 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------------
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-------------
Confidence 9998865533222 12234567999999999999999999999999999999999999999754211
Q ss_pred ChhhHhHhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhc
Q 018396 295 SEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRP-NMGIVLKALQPLLN 349 (356)
Q Consensus 295 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ell~~L~~l~~ 349 (356)
+.....+.... .......+++++.++|.+||++||.+|| |++++++.|.++.+
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 221 --SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp --HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred --HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 11112221111 1122234567899999999999999999 89999999988865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=385.50 Aligned_cols=269 Identities=25% Similarity=0.380 Sum_probs=221.9
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC-C-------CCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEec
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR-S-------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~ 132 (356)
..++|++.+.||+|+||.||+|+.. . +..||||++...... ...+.+|+..+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3468999999999999999999854 2 247999999765543 36778899998888 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEE
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (356)
++..++||||+++|+|.+++....... .......+++..++.++.||+.||+|||+++ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 999999999999999999997664211 1122345899999999999999999999999 999999999999
Q ss_pred EccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~ 284 (356)
++.++.+||+|||++................||+.|+|||.+.+..|+.++|||||||++|||++ |.+||...
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~------ 241 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------ 241 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC------
Confidence 99999999999999987766544444456678999999999999999999999999999999998 78888643
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
....+...+..+.....+..+++++.+||.+||+.||.+|||+.||++.|+++++..
T Consensus 242 ----------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 242 ----------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp ----------CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 233455556666666777788889999999999999999999999999999998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-54 Score=392.79 Aligned_cols=244 Identities=21% Similarity=0.281 Sum_probs=209.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
.++|++++.||+|+||.||+|+++ +|+.||||++.+. ....+.+.+|+.+|+.++|||||++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 367999999999999999999987 8999999998642 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+.+|+|.+++..... +++..++.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+
T Consensus 120 ~e~~~~g~l~~~l~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccchhhhHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 999999999999977643 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
|+...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 188 a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---------------~~~~ 247 (350)
T d1rdqe_ 188 AKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------------IQIY 247 (350)
T ss_dssp CEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HHHH
T ss_pred eeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---------------HHHH
Confidence 98765432 456799999999999999999999999999999999999999964421 1111
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
..+.... ...+..+++++.+||.+||+.||.+|+ |++++++
T Consensus 248 ~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 248 EKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2222221 234556778899999999999999994 8999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-54 Score=379.09 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=209.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc----------hHHHHHHHHHHHhcc-CCceeeeeeEEec
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----------DQEFLAQVSMVSRLK-NENVVELVGYYVD 132 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~-hp~iv~~~~~~~~ 132 (356)
.++|++.+.||+|+||+||+|++. +++.||||++.+.... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999986 7999999998764322 135788999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
++..|+||||+++|+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.++.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence 9999999999999999999976542 899999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccC------CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (356)
||+|||+++....... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.....
T Consensus 150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------ 220 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ 220 (277)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------
Confidence 9999999987654332 245679999999998853 4578899999999999999999999975421
Q ss_pred eecccccCChhhHhHhhcccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 287 VTWATPKLSEDKVKQCVDTKL--GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
......+..... .......+++++.+||.+||+.||.+|||++|+++
T Consensus 221 ---------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 221 ---------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112222232222 22334467889999999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=384.75 Aligned_cols=265 Identities=26% Similarity=0.394 Sum_probs=216.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCC--EEEEEEcCCC--CCchHHHHHHHHHHHhc-cCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSS--KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 139 (356)
++|++.+.||+|+||.||+|+++ ++. .||||.+... ....+.+.+|+++|+++ +|||||++++++.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67899999999999999999976 454 4778877533 22346789999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 140 YEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
|||+++|+|.+++....... .......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997652100 0011124899999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCC-CCCCCCCCCCCccceeccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR-KPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~ 291 (356)
||+|||+++........ ....||..|+|||.+.+..++.++|||||||++|||++|. +||...
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~------------- 230 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------------- 230 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------------
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-------------
Confidence 99999999766543322 3456899999999999999999999999999999999965 566433
Q ss_pred ccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
....+...+....+.+.+..+++++.+||.+||+.||++|||+++|++.|+++++...
T Consensus 231 ---~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 231 ---TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ---CHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---CHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 3344444455555667777888999999999999999999999999999999986553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-54 Score=392.18 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=203.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHH---HHHHHHhccCCceeeeeeEEecCCee
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLA---QVSMVSRLKNENVVELVGYYVDGPLR 136 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~---e~~~l~~l~hp~iv~~~~~~~~~~~~ 136 (356)
.++|++.+.||+|+||.||+|++. +|+.||||++.+.. .....+.+ ++.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999987 79999999985422 11233344 46677778899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEec
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
|+||||++||+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred EEEEEecCCCcHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence 999999999999999976543 889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
||+|+...... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||........
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------------ 214 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------------ 214 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH------------
T ss_pred eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH------------
Confidence 99998765432 245579999999999874 5689999999999999999999999975432110
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPN-----MGIVLK 342 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~ 342 (356)
..+.... .......+..+++++.+||.+||+.||.+||| ++++++
T Consensus 215 -~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 215 -HEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -HHHHHHS-SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -HHHHHhc-ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111111 11122344567788999999999999999999 688876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=383.55 Aligned_cols=270 Identities=21% Similarity=0.346 Sum_probs=226.4
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeeeEEecCC
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~ 134 (356)
..++|++.+.||+|+||.||+|++. +++.||||++...... ...+.+|+.+++.+ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3468999999999999999999852 4678999999765443 34688999999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKG---------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~---------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (356)
..+++|||+++|+|.+++........ ......+++..+..++.||+.||+|||+++ +|||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 99999999999999999976543211 112234889999999999999999999999 999999999999
Q ss_pred EccCCceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018396 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (356)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~ 284 (356)
++.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~------ 251 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------ 251 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC------
Confidence 99999999999999988765444444456789999999999999999999999999999999999 55556433
Q ss_pred cceecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 285 SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
...+.+..++....+...+..++.++.+||.+||+.||.+|||+++|++.|+++++..
T Consensus 252 ---------~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 252 ---------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp ---------CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---------CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 1224455666666777777778889999999999999999999999999999887654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=387.39 Aligned_cols=246 Identities=22% Similarity=0.335 Sum_probs=207.4
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHH-hccCCceeeeeeEEecCCeeEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVS-RLKNENVVELVGYYVDGPLRVLA 139 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~lv 139 (356)
++|++.+.||+|+||+||+|+++ +++.||||++.+. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999987 8999999999642 223445667777655 68999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (356)
|||+++|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 mEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccch
Confidence 999999999999986653 889999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhH
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (356)
++........ .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.. ...+
T Consensus 150 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~----------------~~~~ 211 (320)
T d1xjda_ 150 CKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----------------EEEL 211 (320)
T ss_dssp CBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----------------HHHH
T ss_pred hhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----------------HHHH
Confidence 9876543322 245679999999999999999999999999999999999999997542 1222
Q ss_pred hHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 018396 300 KQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMG-IVLK 342 (356)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell~ 342 (356)
...+... ....+..+++++.+||.+||+.||.+|||+. ++++
T Consensus 212 ~~~i~~~-~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 212 FHSIRMD-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHcC-CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2222111 2245556788899999999999999999996 6764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=379.11 Aligned_cols=255 Identities=27% Similarity=0.378 Sum_probs=203.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC--CC--CEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeeeEEecCCeeE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR--SG--RAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 137 (356)
++|++.+.||+|+||.||+|++. ++ ..||||++..... ..+.+.+|+.++++++|||||++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999854 23 3689999875422 23578999999999999999999999976 4678
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
+||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCC
T ss_pred eeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccc
Confidence 99999999999998876542 2899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCcccccc-ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHc-CCCCCCCCCCCCCccceecccccCC
Q 018396 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 218 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|++......... .......|+..|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---------------~ 220 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---------------G 220 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---------------H
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---------------H
Confidence 999876543322 22344567889999999999999999999999999999998 899996442 1
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPL 347 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l 347 (356)
.+....+.....+.+.+..++.++.+||.+||+.||++|||+++|.+.|.+.
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1223334444555566677788999999999999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=383.52 Aligned_cols=251 Identities=19% Similarity=0.247 Sum_probs=201.3
Q ss_pred HhCCCCCCc-eeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHh-ccCCceeeeeeEEec----CCee
Q 018396 64 KTDNFGTNS-LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSR-LKNENVVELVGYYVD----GPLR 136 (356)
Q Consensus 64 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~----~~~~ 136 (356)
..++|++.. .||+|+||+||+|++. +++.||||++.. ...+.+|+.++.+ ++|||||++++++.+ ...+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 356898864 6999999999999986 899999999854 3567889998655 489999999999875 4678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCcee
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (356)
|+|||||+||+|.+++..... ..+++.+++.++.||+.||+|||++| |+||||||+|||++. ++.+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-------CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEE
T ss_pred EEEEECCCCCcHHHHHHhcCC-------CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccc
Confidence 999999999999999976432 13899999999999999999999999 999999999999985 56799
Q ss_pred EecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
|+|||+|+........ ....||+.|+|||++.+..|+.++|||||||++|+|++|++||.+..........
T Consensus 155 l~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------ 225 (335)
T d2ozaa1 155 LTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------ 225 (335)
T ss_dssp ECCCTTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------
T ss_pred ccccceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------
Confidence 9999999876544322 4567999999999999999999999999999999999999999654322111000
Q ss_pred CChhhHhHhhcccCC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 294 LSEDKVKQCVDTKLG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...+...... ......+++++.+||.+||+.||.+|||+.|+++
T Consensus 226 -----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 226 -----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000001111 1112356788999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=381.27 Aligned_cols=259 Identities=21% Similarity=0.265 Sum_probs=196.0
Q ss_pred CCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.+++||+|+||+||+|+++ +|+.||||++...... .+.+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999976 7999999999754322 24688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.++++..+..... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|..
T Consensus 82 ~~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 82 METDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CSEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred hcchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 99977776665433 2788899999999999999999999 99999999999999999999999999987
Q ss_pred CccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc-----cccCCh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-----TPKLSE 296 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~ 296 (356)
....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||......+....+... ...+..
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 6554332 244579999999999875 46799999999999999999999999754322110000000 000000
Q ss_pred -hhHhHhhcccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 -DKVKQCVDTKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 -~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...............+ ...++++.+||.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000000000111 133568999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=374.15 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=208.8
Q ss_pred CceeeccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEec-CCeeEEEEEec
Q 018396 71 NSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYEHA 143 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~ 143 (356)
.++||+|+||+||+|++.. ...||||++...... .+++.+|+++|++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999752 235899999753333 3678999999999999999999999765 56899999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCCC
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (356)
++|+|.+++..... .+.+..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred ecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhc
Confidence 99999999876543 2678889999999999999999999 999999999999999999999999999876
Q ss_pred ccccccc--cccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChhhHhH
Q 018396 224 PDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301 (356)
Q Consensus 224 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (356)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|..||..... ...+..
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~---------------~~~~~~ 245 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---------------TFDITV 245 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHH
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC---------------HHHHHH
Confidence 5432221 12345689999999999999999999999999999999998887754311 111222
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 302 CVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.+....+...+..+++++.+||.+||+.||++|||+.||++.|+.++++.
T Consensus 246 ~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 23333344556677789999999999999999999999999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=379.00 Aligned_cols=275 Identities=23% Similarity=0.305 Sum_probs=206.8
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEecCC----eeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~~~lv~e 141 (356)
++|.+.+.||+|+||.||+|+.. |+.||||++............|+..+..++|||||++++++.+.+ .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 46778889999999999999875 789999999654322222334455556789999999999988643 6899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeeecCCCCCcEEEccCCceeEec
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-----EPRIIHRNIKSSNVLLFDDDIAKISD 216 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (356)
|+++|+|.+++.... +++..++.++.|++.||.|||+.+ .++|+||||||+||||+.++.+||+|
T Consensus 82 y~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp CCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred cccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 999999999998654 899999999999999999999731 12399999999999999999999999
Q ss_pred ccccCCCcccccc--ccccccccCcCccCcccccCCC------CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcccee
Q 018396 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQ------MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (356)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 288 (356)
||++......... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||......... ...
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~ 230 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYD 230 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhh
Confidence 9998765443221 1234567999999999987643 577899999999999999999988654332211 111
Q ss_pred cccccCChhhHhHh-hcccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccCC
Q 018396 289 WATPKLSEDKVKQC-VDTKLGGEYP-----PKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTRS 352 (356)
Q Consensus 289 ~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~~ 352 (356)
.............. .....+...+ ......+.+|+.+||+.||.+|||+.||++.|+++.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 11112222223332 2333333332 2456779999999999999999999999999999886543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=377.57 Aligned_cols=268 Identities=24% Similarity=0.382 Sum_probs=222.6
Q ss_pred HhCCCCCCceeeccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCCe
Q 018396 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (356)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 135 (356)
..++|++.+.||+|+||.||+|.++ ++..||||++...... ...+.+|+.++++++||||+++++++.....
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3478899999999999999999863 3578999999764433 2458899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVK-GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.++||||+.+|+|.+++....... .......+++..+..++.|++.||.|||+++ |+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 999999999999999986542110 0011123788999999999999999999998 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcC-CCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||+|................||+.|+|||.+.+..++.++||||||+++|||++| .+||...
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------------- 239 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------------- 239 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---------------
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---------------
Confidence 999999877655544444556789999999999999999999999999999999997 5777533
Q ss_pred CChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhcc
Q 018396 294 LSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNT 350 (356)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~ 350 (356)
........+......+.+..++..+.+||.+||+.+|.+|||+++|++.|++.++.
T Consensus 240 -~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 240 -SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp -CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -CHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 33344444445555666777888999999999999999999999999999887653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=375.71 Aligned_cols=239 Identities=19% Similarity=0.343 Sum_probs=199.4
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc-------hHHHHHHHHHHHhcc--CCceeeeeeEEecCC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRLK--NENVVELVGYYVDGP 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~ 134 (356)
.++|++.+.||+|+||+||+|++. +|+.||||++.+.... ...+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999987 7999999998643211 234678999999996 899999999999999
Q ss_pred eeEEEEEecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-CCce
Q 018396 135 LRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIA 212 (356)
Q Consensus 135 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~v 212 (356)
..++||||+.+ +++.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++. ++.+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred eEEEEEEeccCcchHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeE
Confidence 99999999986 588888876542 899999999999999999999999 999999999999985 4799
Q ss_pred eEecccccCCCccccccccccccccCcCccCcccccCCCC-CccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc
Q 018396 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (356)
||+|||+|....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....
T Consensus 151 kl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------ 214 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------ 214 (273)
T ss_dssp EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------
Confidence 999999997654432 245679999999999987766 567899999999999999999996321
Q ss_pred ccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+.... ...+..+++++.+||.+||+.||.+|||++|+++
T Consensus 215 ---------~i~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 ---------EIIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---------HHHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------HHhhcc--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011111 1223345678999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=374.38 Aligned_cols=269 Identities=21% Similarity=0.304 Sum_probs=202.0
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|++.+.||+|+||+||+|.+. +|+.||||++..... ..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999986 799999999965432 24678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
|+.+ ++.+++..... ..+++..++.++.|++.||+|||++| ||||||||+|||++.++.+||+|||+|.
T Consensus 82 ~~~~-~~~~~~~~~~~-------~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp CCSE-EHHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred ecCC-chhhhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcce
Confidence 9976 45555543322 12899999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccCcCccCcccccCCC-CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCCh---h
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE---D 297 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~ 297 (356)
........ .....||+.|+|||++.... ++.++|||||||++|+|++|+.||..................... .
T Consensus 151 ~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 151 AFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp HHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred eccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 65433222 24557999999999887765 488999999999999999999999754321100000000000000 0
Q ss_pred hHhHhhc--ccC--CCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHh
Q 018396 298 KVKQCVD--TKL--GGE-----YPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA--LQPL 347 (356)
Q Consensus 298 ~~~~~~~--~~~--~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~--L~~l 347 (356)
......+ ... ... .....+.++.+||.+||+.||.+|||++|+++. |+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000 000 000 011335688999999999999999999999984 5443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=371.25 Aligned_cols=264 Identities=19% Similarity=0.287 Sum_probs=198.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-C-CCEEEEEEcCCC---CCchHHHHHHHHHHHhc---cCCceeeeeeEEec----
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSS---KQPDQEFLAQVSMVSRL---KNENVVELVGYYVD---- 132 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~---~~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~---- 132 (356)
.++|++.+.||+|+||+||+|++. + ++.||||++... ......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999975 4 567999998542 22234567788877766 79999999999853
Q ss_pred -CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCc
Q 018396 133 -GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (356)
Q Consensus 133 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (356)
....++++||+.++++......... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 3568999999998766555443321 2889999999999999999999999 999999999999999999
Q ss_pred eeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce----
Q 018396 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV---- 287 (356)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~---- 287 (356)
+||+|||++........ .....||+.|+|||++.+..|+.++|||||||++|||++|++||....+......+
T Consensus 155 ~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 155 IKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp EEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 99999999887654433 25667999999999999999999999999999999999999999765322110000
Q ss_pred ------ecccccCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 288 ------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 288 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+..........................++.+.+||.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000000000000001122345678899999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-52 Score=369.66 Aligned_cols=263 Identities=20% Similarity=0.281 Sum_probs=200.9
Q ss_pred CCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEEe
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
++|++.+.||+|+||+||+|++++|+.||||++...... .+.+.+|+.+|++++||||+++++++.+.+..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999999999999999765332 46789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccCC
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (356)
+.++.+..+..... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp CSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence 98877766665443 2899999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecc-----cccCCh
Q 018396 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-----TPKLSE 296 (356)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~ 296 (356)
....... .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||......+........ ...+..
T Consensus 150 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 150 FGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 5433222 2445689999999998765 5689999999999999999999999754321110000000 000000
Q ss_pred -hhHhHh------hcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 -DKVKQC------VDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 -~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
...... .............++++.+||.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000001122344578899999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=367.42 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=199.6
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCC------
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 134 (356)
.++|++.+.||+|+||+||+|.++ +|+.||||++...... .+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999987 7999999999765433 356789999999999999999999998654
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
.+++||||+ +.+|..++.... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccc
Confidence 579999999 558888876544 899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (356)
+|||+|....... ....||+.|+|||++.+. .++.++||||+||++|+|++|+.||..................
T Consensus 163 ~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 163 LDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp CCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence 9999997664432 456799999999998764 5689999999999999999999999765322110000000000
Q ss_pred --------CChhhHhHhhc--ccCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhh
Q 018396 294 --------LSEDKVKQCVD--TKLG----GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKA--LQPLL 348 (356)
Q Consensus 294 --------~~~~~~~~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~--L~~l~ 348 (356)
........... .... .......++++.+||.+||..||.+|||++|+++. |+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000000 0000 11223456788999999999999999999999983 65544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=368.59 Aligned_cols=266 Identities=23% Similarity=0.272 Sum_probs=198.9
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeeeEEecCC----eeE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRV 137 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~~~ 137 (356)
.++|++++.||+|+||+||+|.++ +|+.||||++.+.... .+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999976 8999999999765433 357889999999999999999999987543 234
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecc
Q 018396 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (356)
Q Consensus 138 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (356)
++++++.+|+|.+++.... +++..++.++.|++.||+|||++| |+||||||+|||+++++.+||+||
T Consensus 87 ~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEccc
Confidence 5556777899999997653 899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCcccccc-ccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 218 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
|++......... .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||....................
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence 999776543322 12345679999999999854 5678999999999999999999999976532211100000000000
Q ss_pred hh---------hHhHhhcccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018396 296 ED---------KVKQCVDTKLGGEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLKA 343 (356)
Q Consensus 296 ~~---------~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 343 (356)
.. .............. ....+.++.+|+.+||+.||.+|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000000111111 11234678999999999999999999999973
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=366.94 Aligned_cols=268 Identities=23% Similarity=0.282 Sum_probs=198.0
Q ss_pred CCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeeeEEec------CCeeEEE
Q 018396 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD------GPLRVLA 139 (356)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~------~~~~~lv 139 (356)
+|...++||+|+||+||+|++. +|+.||||++...... ..+|+++|++++||||+++++++.. ...+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 5888999999999999999987 7999999999765433 3479999999999999999999853 3357899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-ceeEeccc
Q 018396 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFD 218 (356)
Q Consensus 140 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg 218 (356)
|||++++.+..+...... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||
T Consensus 98 ~Ey~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp EECCSEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred EeccCCccHHHHHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEeccc
Confidence 999987543333321111 123899999999999999999999999 99999999999999775 89999999
Q ss_pred ccCCCccccccccccccccCcCccCcccccC-CCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCChh
Q 018396 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297 (356)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 297 (356)
++......... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+.........+
T Consensus 169 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 169 SAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp TCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred chhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 98876543322 45679999999998875 568999999999999999999999997553221100000000000001
Q ss_pred hHhHhhcc----cC--------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhc
Q 018396 298 KVKQCVDT----KL--------GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLLN 349 (356)
Q Consensus 298 ~~~~~~~~----~~--------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~~ 349 (356)
........ .+ ........++++.+||.+||+.||++|||+.|+++ .|+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 11110000 00 00112235678999999999999999999999997 4666543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=361.90 Aligned_cols=266 Identities=19% Similarity=0.267 Sum_probs=195.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeeeEEec--------
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-------- 132 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-------- 132 (356)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999986 899999999865432 24678899999999999999999998764
Q ss_pred CCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCce
Q 018396 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (356)
Q Consensus 133 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (356)
....+++|||+.++.+..+..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 356899999998866655443332 2889999999999999999999999 9999999999999999999
Q ss_pred eEecccccCCCcccccc--ccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceec
Q 018396 213 KISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289 (356)
Q Consensus 213 kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 289 (356)
||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....+.........
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999999765532221 122345799999999998765 689999999999999999999999975432111000000
Q ss_pred c--------cccCChhhHhHhhcccCCCCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 290 A--------TPKLSEDKVKQCVDTKLGGEYPP-------KAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 290 ~--------~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
. ............+.......... ..++++.+||.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 00000000111111111111111 12457789999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=359.03 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=206.6
Q ss_pred hCCCCCCceeeccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHHhccC-CceeeeeeEEecCC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGP 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~ 134 (356)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ...+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 467999999999999999999862 58899999986532 234568899999999977 89999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..+++|||+.+|+|.+++..... +.+..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred ceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEE
Confidence 99999999999999999987653 788999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCC--CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
+|||++......... ......|++.|+|||.+.+. .++.++|||||||+||+|++|..||.......
T Consensus 171 ~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---------- 239 (322)
T d1vzoa_ 171 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---------- 239 (322)
T ss_dssp SCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----------
T ss_pred eeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----------
Confidence 999999776543332 12456799999999999764 46889999999999999999999997653321
Q ss_pred cCChhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 018396 293 KLSEDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRP-----NMGIVLK 342 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~ 342 (356)
....+.... .......+..+++++.+||.+||++||.+|| |++|+++
T Consensus 240 --~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 240 --SQAEISRRI-LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --CHHHHHHHH-HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --HHHHHHHhc-ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111111111 1112345566788999999999999999999 4788886
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.1e-50 Score=353.50 Aligned_cols=262 Identities=18% Similarity=0.209 Sum_probs=210.7
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC-CceeeeeeEEecCCeeEEEEEe
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~ 142 (356)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.|+| +|++.+++++.++...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 368999999999999999999987 78999999886543 33457889999999976 8999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc-----CCceeEecc
Q 018396 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-----DDIAKISDF 217 (356)
Q Consensus 143 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-----~~~vkl~Df 217 (356)
+ +++|.+++..... .++...+..++.|++.||+|||++| |+||||||+|||++. ++.++|+||
T Consensus 83 ~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred c-CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccc
Confidence 9 6799999876542 2889999999999999999999999 999999999999974 578999999
Q ss_pred cccCCCcccccc-----ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccc
Q 018396 218 DLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292 (356)
Q Consensus 218 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (356)
|+|+........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-------- 222 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-------- 222 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--------
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH--------
Confidence 999876543211 1224567999999999999999999999999999999999999999755322110
Q ss_pred cCChhhHhHhhcccC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhccC
Q 018396 293 KLSEDKVKQCVDTKL---GGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLNTR 351 (356)
Q Consensus 293 ~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~~~ 351 (356)
.....+..... ..+....+++++.+++..|+..+|++||+++.+.+.|+++++..
T Consensus 223 ----~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 223 ----QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp ----HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----HHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 11111111100 00111234578999999999999999999999999999887544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-49 Score=358.93 Aligned_cols=258 Identities=15% Similarity=0.267 Sum_probs=199.1
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeeeEEec--CCeeEEEE
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVD--GPLRVLAY 140 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~ 140 (356)
.++|++++.||+|+||+||+|++. +++.||||++... ..+.+.+|+.+|+.++ ||||+++++++.. ....++||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 367999999999999999999986 7999999998654 3567889999999995 9999999999874 45689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCC-ceeEecccc
Q 018396 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDL 219 (356)
Q Consensus 141 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~ 219 (356)
||+.+++|..+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 112 e~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp ECCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred eecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeeccccc
Confidence 9999999977642 2899999999999999999999999 99999999999998765 699999999
Q ss_pred cCCCccccccccccccccCcCccCcccccCC-CCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCcc-cee---------
Q 018396 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVT--------- 288 (356)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~-~~~--------- 288 (356)
|......... ....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||.......... ...
T Consensus 177 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 177 AEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp CEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred ceeccCCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 9876543322 456789999999998865 47999999999999999999999997543211000 000
Q ss_pred -cc-cccC-ChhhHhHhh--------cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 289 -WA-TPKL-SEDKVKQCV--------DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 289 -~~-~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
+. .... ......... ............++++.+||.+||+.||.+|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 000000000 000111122345678999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-49 Score=353.24 Aligned_cols=262 Identities=19% Similarity=0.275 Sum_probs=201.3
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc-eeeeeeEEecCCeeEEEEEec
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHA 143 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~e~~ 143 (356)
++|++.+.||+|+||.||+|++. +|+.||||++..... .+.+..|+++++.++|+| |+.+..++.+++..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 57999999999999999999986 789999998865433 345889999999998766 555566677888999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEcc---CCceeEeccccc
Q 018396 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLS 220 (356)
Q Consensus 144 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~Dfg~a 220 (356)
.+ +|.+.+..... .+++..+..++.|++.||+|||++| |+||||||+|||++. +..++|+|||+|
T Consensus 86 ~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 86 GP-SLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp CC-BHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred CC-chhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcc
Confidence 54 77766654332 2899999999999999999999999 999999999999863 457999999999
Q ss_pred CCCcccccc-----ccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceecccccCC
Q 018396 221 NQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295 (356)
Q Consensus 221 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 295 (356)
+........ .......||+.|+|||++.+..++.++|||||||++|||++|..||............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~-------- 225 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-------- 225 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H--------
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH--------
Confidence 876543221 1224567999999999999999999999999999999999999999765332111100
Q ss_pred hhhHhHhhcccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhc
Q 018396 296 EDKVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLKALQPLLN 349 (356)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~l~~ 349 (356)
..................+++++.++|..||+.+|.+||+++++.+.|+.+..
T Consensus 226 -~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 226 -ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -HHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00000000000001122456789999999999999999999999999988653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=351.85 Aligned_cols=263 Identities=18% Similarity=0.226 Sum_probs=204.7
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecCCeeEEEEE
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 141 (356)
++|++.+.||+|+||+||+|++. +++.||||++...... ...+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999986 8899999998654332 4678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 142 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
++.+++|..++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+.
T Consensus 82 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD---------LDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSEEHHHHHHHTTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccccccccccccccc---------cchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhh
Confidence 9999999888876543 889999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccCcCccCcccccCCC-CCccchhhhHHHHHHHHHcCCCCCCCCCCCCC-ccceecccccCCh---
Q 018396 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSLVTWATPKLSE--- 296 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~--- 296 (356)
........ .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||........ .............
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 150 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred cccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 76543322 23445788999999988765 68999999999999999999999743322110 0000000000000
Q ss_pred hhHhHhh---------cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 297 DKVKQCV---------DTKLGGEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 297 ~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
....... ............++.+.+||.+||+.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000111223445678999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=358.12 Aligned_cols=260 Identities=20% Similarity=0.215 Sum_probs=191.5
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEec------CC
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD------GP 134 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~------~~ 134 (356)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ...+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999987 7999999999765433 2457899999999999999999999863 46
Q ss_pred eeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeE
Q 018396 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (356)
Q Consensus 135 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (356)
..|+||||+.++ +.+.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred eeEEEEeccchH-HHHhhhc-----------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 889999999775 4444432 1889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccce-------
Q 018396 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV------- 287 (356)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~------- 287 (356)
+|||++........ .....+|+.|+|||++.+..++.++||||+||++|+|++|+.||............
T Consensus 161 ~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 161 LDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred echhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence 99999877654332 25567899999999999999999999999999999999999999754321100000
Q ss_pred ---eccc------------ccCChhhHhHhhccc-CC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018396 288 ---TWAT------------PKLSEDKVKQCVDTK-LG--GEYPPKAIAKMAAVAALCVQYEADFRPNMGIVLK 342 (356)
Q Consensus 288 ---~~~~------------~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 342 (356)
.+.. ............... .. .......+.++.+||.+||..||++|||++|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000000001111000 11 1112346788999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=354.72 Aligned_cols=266 Identities=25% Similarity=0.331 Sum_probs=200.6
Q ss_pred hCCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeeeEEecC-----Ce
Q 018396 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (356)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~ 135 (356)
.++|++.+.||+|+||+||+|++. +|+.||||++.+.... .+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999976 8999999999865443 34678999999999999999999998633 34
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccCCceeEe
Q 018396 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (356)
Q Consensus 136 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (356)
.+++++++.+|+|.+++.... +++..++.++.||+.||+|||++| |+||||||+|||++.+|.+|++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccc
Confidence 466677888999999996543 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccCcCccCcccccCCC-CCccchhhhHHHHHHHHHcCCCCCCCCCCCCCccceeccc---
Q 018396 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT--- 291 (356)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--- 291 (356)
|||++....... ....||+.|+|||.+.+.. ++.++|||||||++|+|++|++||.+.........+....
T Consensus 164 dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 164 DFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp CC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999987765432 4457899999999877654 5889999999999999999999997543211100000000
Q ss_pred -----ccCChhhHhHhhcccCC-CCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 018396 292 -----PKLSEDKVKQCVDTKLG-GEY-----PPKAIAKMAAVAALCVQYEADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 292 -----~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~--~L~~l~ 348 (356)
................. ... ....++++.+||.+||+.||.+|||++|+++ .|.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00000111111111000 011 1134567899999999999999999999998 555543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-43 Score=322.12 Aligned_cols=266 Identities=16% Similarity=0.204 Sum_probs=195.1
Q ss_pred CCCCCCceeeccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-----------CCceeeeeeEEec-
Q 018396 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----------NENVVELVGYYVD- 132 (356)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------hp~iv~~~~~~~~- 132 (356)
++|++++.||+|+||+||+|++. +|+.||||++.+.....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 35999999999999999999986 8999999999876555567788999988875 4789999988764
Q ss_pred -CCeeEEEEEecCCCCH-HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeecCCCCCcEEEccC
Q 018396 133 -GPLRVLAYEHASKGSL-HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 133 -~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~ 209 (356)
....+++++++..+.. ......... ..+.+..+..++.||+.||.|||+ .| |+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV 162 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred cccceeeeeeecccccccccccccccc-------cCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeecc
Confidence 4566677777655433 333322221 238889999999999999999998 77 9999999999999876
Q ss_pred C------ceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHHHHHHcCCCCCCCCCCCCC
Q 018396 210 D------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (356)
Q Consensus 210 ~------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~ 283 (356)
+ .++++|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||........
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 5 39999999987654322 455799999999999999999999999999999999999999975432211
Q ss_pred ccceec------ccccCChh---------------------------hHhHhhcccCCCCCCHHHHHHHHHHHHHhhccC
Q 018396 284 QSLVTW------ATPKLSED---------------------------KVKQCVDTKLGGEYPPKAIAKMAAVAALCVQYE 330 (356)
Q Consensus 284 ~~~~~~------~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 330 (356)
...... .-...... ....... .........+.++.+||.+||..|
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc--cccccCcccCHHHHHHHHHHCCCC
Confidence 000000 00000000 0000111 112345678899999999999999
Q ss_pred CCCCCCHHHHHH--HHHHhh
Q 018396 331 ADFRPNMGIVLK--ALQPLL 348 (356)
Q Consensus 331 P~~Rps~~ell~--~L~~l~ 348 (356)
|.+|||++|+|+ .|++..
T Consensus 316 P~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTCT
T ss_pred hhHCcCHHHHhcCcccCCCC
Confidence 999999999998 355443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=6.7e-27 Score=192.70 Aligned_cols=168 Identities=14% Similarity=0.109 Sum_probs=119.2
Q ss_pred CCCceeeccCceEEEEEEECCCCEEEEEEcCCCCCc-------------------hHHHHHHHHHHHhccCCceeeeeeE
Q 018396 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------------------DQEFLAQVSMVSRLKNENVVELVGY 129 (356)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~e~~~l~~l~hp~iv~~~~~ 129 (356)
.+.+.||+|+||.||+|.+.+|+.||||++...... .....+|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999888999999987532110 1223467888999999999988766
Q ss_pred EecCCeeEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCcEEEccC
Q 018396 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (356)
Q Consensus 130 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (356)
. ..+++|||+++..+.+ +....+..++.|++.+|.|||++| |+||||||+|||++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~ 139 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE 139 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred c----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence 3 2379999998865533 233345678999999999999999 9999999999999865
Q ss_pred CceeEecccccCCCccccccccccccccCcCccCcccccCCCCCccchhhhHHHHH
Q 018396 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 265 (356)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 265 (356)
+ ++|+|||+|...............+.. -.+ +....|+.++|+||+.--+
T Consensus 140 ~-~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 G-IWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp E-EEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred C-EEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence 4 899999998665432211000000000 001 1246778899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=5.2e-09 Score=88.53 Aligned_cols=148 Identities=18% Similarity=0.132 Sum_probs=100.6
Q ss_pred HHHHHHhCCCCCCceeeccCceEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHHhcc-CCceeeeeeEEecCCee
Q 018396 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLR 136 (356)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 136 (356)
.++......|++.+..+-++.+.||+.... ++.+++|+..... .....+.+|..+++.+. +-.+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 356666778887776555556789987644 5668888775432 23345778888888774 33356777777888899
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--------------------------
Q 018396 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-------------------------- 190 (356)
Q Consensus 137 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-------------------------- 190 (356)
++||++++|.++.+...... . ...++.++...+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~-----------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ-----------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS-----------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred EEEEEecccccccccccccc-----------c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence 99999999988866543211 1 1223444455555555421
Q ss_pred ------------------------------CCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 191 ------------------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 191 ------------------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127999999999999887667799998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.52 E-value=1.4e-07 Score=79.06 Aligned_cols=73 Identities=12% Similarity=0.015 Sum_probs=53.4
Q ss_pred eeccC-ceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC--CceeeeeeEEecCCeeEEEEEecCCCCH
Q 018396 74 IGEGS-YGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSL 148 (356)
Q Consensus 74 lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~L 148 (356)
+..|. .+.||+....++..+++|.-.... ...+..|+..++.|.. -.+.+++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 33444 367899988878889999865443 3357788888888743 2356777777888889999999988655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.16 E-value=8.5e-06 Score=72.46 Aligned_cols=75 Identities=20% Similarity=0.109 Sum_probs=49.3
Q ss_pred CceeeccCceEEEEEEEC-CCCEEEEEEcCC------C--CCchHHHHHHHHHHHhcc-C-C-ceeeeeeEEecCCeeEE
Q 018396 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS------S--KQPDQEFLAQVSMVSRLK-N-E-NVVELVGYYVDGPLRVL 138 (356)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~--~~~~~~~~~e~~~l~~l~-h-p-~iv~~~~~~~~~~~~~l 138 (356)
.+.||.|....||++... +++.++||.-.. . .....+...|++.|+.+. + | .+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999865 577899996432 1 122345667888887763 2 2 45555544 5556789
Q ss_pred EEEecCCCC
Q 018396 139 AYEHASKGS 147 (356)
Q Consensus 139 v~e~~~~~~ 147 (356)
+||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.76 E-value=9.9e-05 Score=63.59 Aligned_cols=68 Identities=15% Similarity=0.132 Sum_probs=49.5
Q ss_pred ceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-----eeee--eEEecCCeeEEEEEecCCC
Q 018396 79 YGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-----VELV--GYYVDGPLRVLAYEHASKG 146 (356)
Q Consensus 79 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~--~~~~~~~~~~lv~e~~~~~ 146 (356)
-..||++...+|+.+++|+........+++..|...+..|....+ +..- ..+...+..+.+++++.|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999999889999999988777777889999998888742211 1111 1234566788899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.62 E-value=0.00017 Score=63.82 Aligned_cols=72 Identities=14% Similarity=0.135 Sum_probs=49.2
Q ss_pred ceeeccCceEEEEEEECC--------CCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeeeEEecCCeeEEEEEe
Q 018396 72 SLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEH 142 (356)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~ 142 (356)
+.|+.|-...+|++...+ .+.|++++... ........+|..+++.+. +.-..++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 567778999999998643 35677777653 333455678999988885 3333466766643 578899
Q ss_pred cCCCCH
Q 018396 143 ASKGSL 148 (356)
Q Consensus 143 ~~~~~L 148 (356)
++|.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.44 E-value=0.0003 Score=60.02 Aligned_cols=164 Identities=13% Similarity=0.105 Sum_probs=85.2
Q ss_pred cCHHHHHHHhCCCCCCcee-----eccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC-----Cceee
Q 018396 56 ISVDELKEKTDNFGTNSLI-----GEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-----ENVVE 125 (356)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-----p~iv~ 125 (356)
.+.+++.....+|.++++. ..|--.+.|+....+| .+++|+.... ...+.+..|++++..|.. |..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccce
Confidence 3567788888889886654 3566688899887755 5999998653 234556677777777743 22221
Q ss_pred ee---eEEecCCeeEEEEEecCCCCHH--------------HHHhcC-CCCCCCCCCCCCCH-----------------H
Q 018396 126 LV---GYYVDGPLRVLAYEHASKGSLH--------------DILHGK-KGVKGAKPGPVLSW-----------------A 170 (356)
Q Consensus 126 ~~---~~~~~~~~~~lv~e~~~~~~L~--------------~~l~~~-~~~~~~~~~~~~~~-----------------~ 170 (356)
.. .+.........++.+..+.... ..++.. .............+ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 0122234556666666653221 011100 00000000000000 0
Q ss_pred HHHHHHHHHHHHHHHhhhC-CCCCeeecCCCCCcEEEccCCceeEecccccC
Q 018396 171 QRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (356)
Q Consensus 171 ~~~~~~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (356)
.....+..+...+...+.. -+.++||+|+.++||+++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222223333333321 12239999999999999988877899999763
|